Novel approaches to understanding hENT2 and hENT2 - related proteins : From novel nuclear variants to global networks Nuevos enfoques sobre el estudio de hENT2 y proteínas relacionadas : desde nuevas variantes nucleares a redes globales Natàlia Grañé Boladeras Aquesta tesi doctoral està subjecta a la llicència Reconeixement 3 . 0 . Espanya de Creative Commons . Esta tesis doctoral está sujeta a la licencia Reconocimiento 3 . 0 . España de Creative Commons . This doctoral thesis is licensed under the Creative Commons Attribution 3 . 0 . Spain License . DEPARTAMENT DE BIOQUÍMICA I BIOLOGIA MOLECULAR FACULTAT DE BIOLOGIA UNIVERSITAT DE BARCELONA NOVEL APPROACHES TO UNDERSTANDING hENT2 AND hENT2 - RELATED PROTEINS : FROM NOVEL NUCLEAR VARIANTS TO GLOBAL NETWORKS “Nuevos enfoques sobre el estudio de hENT2 y proteínas relacionadas : desde nuevas variantes nucleares a redes globales” Natàlia Grañé Boladeras Setembre 2012 MEMÒRIA PER OPTAR AL GRAU DE DOCTORA PER LA UNIVERSITAT DE BARCELONA PROGRAMA DE DOCTORAT EN BIOMEDICINA DEPARTAMENT DE BIOQUÍMICA I BIOLOGIA MOLECULAR FACULTAT DE BIOLOGIA UNIVERSITAT DE BARCELONA PRESENTADA PER NATÀLIA GRAÑÉ BOLADERAS La interessada , Natàlia Grañé Boladeras Vistiplau del director , Dr . MARÇAL PASTOR ANGLADA Catedràtic de Bioquímica i Biologia Molecular Departament de Bioquímica i Biologia Molecular Universitat de Barcelona I , a vegades , ens en sortim . I , a vegades , contra tot pronòstic una gran bestiesa capgira allò que crèiem lògic , Tot fent evident , que per un moment , ens en sortim . - Manel - Captatio Benevolentiae A la meva familia A la meva mare (cid:2) Des de que vaig començar a escriure la tesis , ara ja fa uns mesos , he estat evitant aquest moment de sentar - me tranquilament i pensar en lo que han sigut i tot lo que he viscut durant aquests últims 5 anys . Ara que ja no tinc més excuses , em tremola el cos només de pensar en tota la gent amb qui he compartit les diferents etapes , les sensacions viscudes , tan alegries com frustracions , i sincerament puc dir que avui dia sóc molt feliç dʼhaver viscut aquesta aventura . Així que gràcies a tots vosaltres que ho heu fet possible . (cid:2) En primer lloc , moltes gràcies a tu , Marçal , per haver - me donat la oportunitat i haver - me “enredat” en aquesta aventura . Moltes gràcies per la teva conﬁança i el teu suport , crec que nʼhe après molt de tu , i no només com a cientíﬁc . Espero que tu també nʼestiguis tant content com jo i que ens retrobem en el futur ja sigui col·laborant en ciència o bé fent un cafè ( o un “poutine” si et deixes “caure” per Toronto ) . Gràcies per tot , de debò . (cid:2) Ara ve lo pitjor , recordar tota la gent que he tingut al meu voltant durant tant de temps i intentar no posar - me massa sentimental . Difícil ! Recordo quan vaig començar al lab fent el màster . Recordo el trio Pedro - Ekaitz - Miriam i el bon rotllo que portaveu al lab . Crec que si no fos per vosaltres , mai mʼhagués quedat a continuar la tesis . Primer per la vostra qualitat cientíﬁca , crec que sou genials i que nʼhe après molt de vosaltres , sobretot per les ganes i lʼentusiasme que hi poseu . I després , per la vostra alegria i companyerisme ( quantes vegades he creuat la porta del lab demanant - vos socors ! ) . Sens dubte vau ser el millor punt de partida . (cid:2) Isa , Laia , Itzi… Realment us he trobat molt a faltar aquests últims temps ! A part de ser bones companyes , sou unes grans amigues i mʼheu alegrat els dies al lab , més del que us imagineu . Des de compartir receptes de cuina , a anar a esquiar tots plegats . Quan miro totes les fotos que tinc , no puc parar de somriure recordant els bons moments . Espero que a totes us vagi tot molt bé en les vostres noves etapes i que ens puguem retrobar en algun moment , en alguna part del món . (cid:2) Esteﬁ ! ! Gracias por enseñarme tanto desde el principio , fuiste una gran mentora ! Ahora que soy yo la que tiene que explicarle a los “niños” como clonar , me doy cuenta de que sé muchísimo gracias a ti . Estoy muy contenta por vosotros dos y por la nueva etapa que empezasteis , que aunque sean tiempos difíciles , sé que os va a ir todo cada vez mejor . Lore , miLore ! ! Que puedo decir de ti y sólo ocupar unas líneas ? ? Intentando ser breve , creo que eres una magníﬁca persona , excelente compañera de trabajo pero aun mejor amiga ! Tienes un gran corazón y tu sonrisa ( y risa ! ) es oro ! No los pierdas nunca . Sandreta ! Que hagués fet sense tu ? ? Gràcies per ser tan bona amiga , per tot el suport i per tot el bon vi compartit . Hem viscut grans moments que espero que puguem repetir . Cris ! ! He rigut tant amb tu ! ! Mʼencanta la teva manera de ser , tan natural , sense complexes i tan bona persona . És un luxe tenir - te de companya i amiga . Yeral ! La millor col·laboració de RST sens dubte ! Frescura , bon humor i hard - work , el cocktail perfecte . Paula , la nota de “color” del lab . Gracias por tu toque distinto y por tu carácter reposado . Ingrid , sin duda el lab no seria lo mismo sin ti . Gracias por cuidar de todos nosotros cada día . (cid:2) Valerique , mi gordita ! Que decir que no sepas ya ? Que te quiero mil , que eres la mejor amiga que se pueda tener y que echo muchísimo de menos nuestras bravas con Voll - Damn ! Porqué diablos no las importan aquí ? ? Igualmente , no seria lo mismo sin ti ; ) Lo mismo digo para ti , Isa ( “mi Isa” - como se te conoce en el lab ) . Te echo muchísimo de menos , y solo puedo decirte que gracias , inﬁnitas gracias por ser tan buena amiga ( una hermana ) durante tantos años . Son muchísimas aventuras vividas juntas e inﬁnitos buenos momentos para recordar . Gracias por haberlos vivido conmigo . (cid:2) Una no estaria tan a gust a casa si no tingués uns bons veïns , i per sort , nosaltres hem tingut dels millors . Gràcies a tothom del departament , des de la Raquel i el Toni que fan que “màgicament” tot funcioni , a tots els companys de TEC , GMP , MP , TAM , Integrativa i Insulina ( sobretodo tú , Vicente , por ser un gran amigo y por todos los momentos vividos dentro y fuera del lab ) . Un plaer haver compartit la “casa” amb vosaltres durant tot aquest temps . (cid:2) As all of you know , I had the chance to spend my last year of thesis in Toronto ( Canada ) and I will actually stay here for the next coming years . So , I have a lot of people here to thank for all the support during all this time . Fist of all , Imogen , a huge thanks for all your support since the very ﬁrst day , not only in science but also in our personal adventure here in Canada . I do really admire you as a professional , but also as a person . Iʼm very thankful for the opportunity you give me to continue in this great team and keep on learning from all of you . Zlatina , you already know how thankful we are for all your love and support . Itʼs so wonderful to have a canadian mum that takes care of us . Glad to have you and being part of our new family . (cid:2) Alex - B & Alex - C ! ! Guys ! Youʼre such great partners ! Really , you make my life so easy and so happy . Itʼs a pleasure to work with you cause youʼre great scientists but also wonderful people ( I will never forget that day Alex gave me his cells cause mine were contaminated and I had “ a thesis to ﬁnish” ) . So happy to spend some more years with you : ) My “kids” : Nima , Linda , Maliha & Katerina ( If you donʼt know it yet , I always call you “kids” with all my affection ) . Itʼs a pleasure to work with you . You all are adorable and great people . A pity that eventually you will leave , but Iʼm sure youʼll be totally successful in your new stages . Nicole , thanks so much for all this time together and all the chatting and laughing shared in “the ofﬁce” . So happy about your new position at YorkU , thatʼs just the beginning of a great career , no doubt ! Maria Cristina , so glad youʼre back to Toronto . This is gonna be a great team deﬁnitely ! Declan , thank you too for all your help and all the struggling for make the things work . I know weʼll get those wonderful results we expect ; ) (cid:2) The same way I thanked my spanish friends and family , I wanna thank my special people in Canada . Thatʼs you guys ! Graham & Fiona… Thanks so so so much for making our life in Toronto so wonderful ! It wouldnʼt be the same without you . Youʼre one of the main reasons we wanna stay here , cause we love the new family we got here , and youʼre part of the core . So a very sincere thank you for all your support and love , youʼre amazing people and we love you . (cid:2) Finalment , res dʼaixò hagués passat de no ser per la fantàstica família que tinc . Els meus germans per haver sigut sempre al meu costat , per tot el vostre suport i amor incondicional . Sempre heu sigut el meu model a seguir . Estic tan orgullosa de vosaltres , de les persones tan fantàstiques que sou , i meʼn alegro moltíssim de que els dos tingueu aquestes grans companyes , Geni ( + 1 ) i Vanessa . La única part dolenta de tot plegat és que hagi dʼestar lluny de vosaltres , així que ja podeu anar comprant bitllets dʼavió ! Els meus pares… que puc dir sense posar - me a plorar com una bleda . Us trobo moltíssim a faltar ! ! No sé si alguna vegada he tingut la ocasió de dir - vos - ho ( val la pena fer una tesis només per això ) , però sou els millors pares que es pot tenir . Per ser tan lluitadors , per no haver - vos rendit mai , per haver - nos - ho donat tot i estimar - nos sense condicions . Crec que podeu estar orgullosos de la família que tenim , és fantàstica . I personalment , mai podré deixar dʼagrair - vos tot el vostre suport i amor , per haver estat sempre al meu costat , en lo bo i en lo dolent . I per haver - me ensenyat a ser la persona que sóc avui dia . Us estimo . (cid:2) Y a ti Luis , mi cielo . No hay palabras para decir todo lo que siento y todo lo que signiﬁcas para mi . Eres mi amigo , mi amor y mi mayor apoyo . Desde luego , nada de esto valdría la pena si no lo pudiese compartir contigo . Gracias por todo este tiempo a mi lado , por todo el cariño , por todos los ánimos , sobretodo en la recta ﬁnal . Me haces ser mejor persona . Te quiero . List of ﬁgures • Figure 1 . The purine and pyrimidine nucleobases and nucleosides . • Figure 2 . CNTs structural and kinetic features . • Figure 3 . ENTs structural and kinetic features . • Figure 4 . Therapeutic Nucleoside Analogs ( NA ) . • Figure 5 . Protein synthesis and sorting pathways . • Figure 6 . Prototypical examples of protein regulation by phosphorylation . • Figure 7 . A model of integral trafﬁcking from the ER to the NE transport ( INTERNET ) . • Figure 8 . Splicing of pre - mRNA by the spliceosome . • Figure 9 . Generation of complex protein expression patterns by alternative splicing . • Figure 10 . Representation of treatments distribution in a 96 - well plate . • Figure 11 . Representation of a 24 - well plate distribution for transport assays . • Figure 12 . Mounting sequence for protein transference in Wester - Blot technique . • Figure 13 . Representation of the thermal cycling of a standard PCR reaction . • Figure 14 . Strategy for HA tag cloning . • Figure 15 . Representation of the thermal cycling of a site - directed mutagenesis PCR reaction . • Figure 16 . Plasmid vectors used in this thesis . • Figure 17 . Screening by PCR . • Figure 18 . Real - time PCR using TaqMan® probes . • Figure 19 . Real - time PCR using SYBR® Green dye . • Figure 20 . TaqMan @ Low density arrays from Applied - Biosystems . • Figure 21 . MYTH . • Figure 22 . Ampliﬁcation of the hENT2 gene from MCF7 cDNA . • Figure 23 . Screening by PCR . • Figure 24 . Alignment of three predicted ORF for hENT2 spliced variants . • Figure 25 . Representation of hENT2 splicing variants and their putative proteins . • Figure 26 . Open Reading Frames ( ORF ) for each transcript and positions of their HA tag . • Figure 27 . Immunoblots of endogenous hENT2 and hENT2 - HA proteins . • Figure 28 . Distribution of hENT2 - HA and its spliced variants in human cells . • Figure 29 . Co - localization of hENT2 - HA nuclear variants with the nuclear membrane in human cells . • Figure 30 NMD pathway analysis . • Figure 31 . Transport assays of hENT2 and its nuclear variants . • Figure 32 . hENT2 mRNA expression in different cell lines and conditions . • Figure 33 . hENT2 mRNA expression detected by relative real - time PCR in three different cell lines . • Figure 34 . hENT2 mRNA expression in different human tissues . • Figure 35 . Immunocytochemistry of HeLa cells transiently transfected with hENT2 wt HA - tagged construct . • Figure 36 . Immunoblotting of different protein fractions obtained from HeLa cells after Biotinylation . • Figure 37 . ENT - loop peptide design and NetPhosK 1 . 0 analysis . • Figure 38 . mENT1 and hENT1 phosphosites . • Figure 39 . In vitro phosphorylation of h / mENT2 - loop using radio - labeled ATP . • Figure 40 . ENT - loops phosphosites conﬁrmed by mass spectrometry . • Figure 41 . Effect of PKC activation on hENT2 activity . • Figure 42 . Effect of PKC activation on hENT2 trafﬁcking . • Figure 43 . Comparaison of HeLa protein fractions obtained after biotinylation versus total protein extracted from HEK - 293 cells treated with PDD . • Figure 44 . pTLB - 1 vector . • Figure 45 . Bait validation using NubI / NubG control test . • Figure 46 . Bait dependency test . • Figure 47 . Alignment of Gal - 1 binding domain in Cav1 . 2 and m / hENT2 - loop sequences . • Figure 48 . Cartoon showing possible regulation of hENT2 splicing pattern by phosphorylation . • Figure 49 . Transportome design . • Figure 50 . Responsiveness to cytotoxicity assays . • Figure 51 . Genes analyzed by TLDA . • Figure 52 . Correlations between samples based on genes expression proﬁles . • Figure 53 . Correlations between genes . • Figure 54 . Expression values of the clusters obtained from heatmap of gene correlations . • Figure 55 . Cartoon representing genes of a putative novel gene network . • Figure 56 . Heatmap representing correlations between genes expression and responsiveness to treatments . • Figure 57 . Cartoon representing genes with a signiﬁcant correlation to cell responsiveness to paclitaxel treatment . • Figure 58 . Cartoon representing genes with a signiﬁcant correlation to cell responsiveness to cisplatin treatment . • Figure 59 . Cartoon representing a novel network connected to PKC . • Figure 60 . Predicted ORF for the transcript X86681 . • Figure 61 . Immunocytochemistry of hENT2 - HA wt constructs in HeLa cells . List of tables • Table 1 . Cell lines and media used • Table 2 . Conditions of calcium - phosphate transfection mix • Table 3 . Conditions of lipofectamine® 2000 transfection mix • Table 4 . NP - 40 lysis buffer composition • Table 5 . Electrophoresis gel composition • Table 6 . Features of antibodies used • Table 7 . Immunocytochemistry protocol • Table 8 . Immunocytochemistry antibodies dilutions and treatments • Table 9 . PCR ampliﬁcation of hENT2 • Table 10 . Splicing variants of hENT2 • Table 11 . hENT2 - HA constructs • Table 12 . Nuclear - related hENT2 MYTH partners • Table 13 . Mitochondria - related hENT2 MYTH partners • Table 14 . ER - Golgi - Vesicle - Trafﬁcking related hENT2 MYTH partners • Table 15 . Cytoskeletal - related hENT2 MYTH partners • Table 16 . Ribosome related hENT2 MYTH partners • Table 17 . Enzyme - related hENT2 MYTH partners • Table 18 . hENT2 MYTH partners with unknown or miscellaneous functions • Table 19 . hENT2 MYTH partners described as common false positives * • Table 20 . Primers used for this dissertation • Table 21 . Primers used for the HA - hENT2 constructs cloning • Table 22 . Ubq - hENT2 - loop construct sequences • Table 23 . Ubq - mENT2 - loop construct sequences • Table 24 . Values of normalized expression of the Transportome genes in the 15 cell lines . • Table 25 . Values of Pearson coefﬁcient and statistic P - value in correlations between genes . I . INTRODUCTION(cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) 1 (cid:2) 1 BIOLOGICAL RELEVANCE OF NUCLEOSIDES…… . . . ………………… (cid:2) 3 (cid:2) 2 NUCLEOSIDE TRANSPORTERS………………………………………… . . (cid:2) 5 (cid:2) (cid:2) 2 . 1 CONCENTRATIVE NUCLEOSIDE TRANSPORTERS………… . . (cid:2) 6 (cid:2) (cid:2) 2 . 2 CNT STRUCTURE…………………………………………………… (cid:2) 7 (cid:2) (cid:2) 2 . 3 EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS…………… . . 9 (cid:2) (cid:2) 2 . 4 ENT STRUCTURE…………………………………………………… 12 (cid:2) 3 NUCLEOSIDE ANALOGS AS THERAPEUTIC AGENTS……………… . . (cid:2) 15 (cid:2) 4 REGULATORY MECHANISMS OF NUCLEOSIDE TRANSPORTERS . . . (cid:2) 19 (cid:2) (cid:2) 4 . 1 TRANSCRIPTIONAL REGULATION……………………………… . (cid:2) 19 (cid:2) (cid:2) 4 . 2 PROTEIN SYNTHESIS AND POST - TRANSLATIONAL (cid:2) (cid:2) (cid:2) (cid:2) MODIFICATIONS…………………………………… . . …………… . . (cid:2) 21 (cid:2) (cid:2) (cid:2) 4 . 2 . 1 Protein synthesis and sorting…………………………… . (cid:2) 21 (cid:2) (cid:2) (cid:2) 4 . 2 . 2 The Golgi apparatus and glycosylation………………… . . (cid:2) 24 (cid:2) (cid:2) (cid:2) 4 . 2 . 3 Phosphorylation / dephosphorylation…………………… . . (cid:2) 26 (cid:2) (cid:2) (cid:2) 4 . 2 . 4 Protein trafﬁcking to the plasma membrane and other (cid:2) (cid:2) (cid:2) organelles……………………………………………… . . … . (cid:2) 29 (cid:2) 5 ALTERNATIVE SPLICING……………………………………………… . … . . (cid:2) 34 (cid:2) (cid:2) 5 . 1 ALTERNATIVE SPLICING MECHANISM……………………… . …(cid:2) 34 (cid:2) (cid:2) 5 . 2 REGULATION AND DYSREGULATION OF ALTERNATIVE (cid:2) (cid:2) SPLICING…………………………………………………………… . . (cid:2) 38 (cid:2) (cid:2) 5 . 3 ALTERNATIVE SPLICING VARIANTS OF NUCLEOSIDE (cid:2) (cid:2) TRANSPORTERS…………………………………………………… . (cid:2) 39 II . RESEARCH OBJECTIVES(cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) 41 III . MATERIALS AND METHODS(cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) 45 (cid:2) 6 CELL CULTURE………………………………………………………………(cid:2) 47 (cid:2) (cid:2) 6 . 1 INTRODUCTION…………………………………………………… . (cid:2) 47 (cid:2) (cid:2) 6 . 2 CELL CULTURE TECHNIQUE…………………………………… . (cid:2)(cid:2) 47 (cid:2) (cid:2) 6 . 3 CELL LINES CULTURE…………………………………………… . (cid:2)(cid:2) 48 (cid:2) (cid:2) (cid:2) 6 . 3 . 1 Detaching and plating…………………………………… . . (cid:2) 49 (cid:2) (cid:2) (cid:2) 6 . 3 . 2 Freezing and thawing…………………………………… . . (cid:2) 49 (cid:2) (cid:2) 6 . 4 CYCLOHEXIMIDE TREATMENT………………………………… . (cid:2)(cid:2) 50 (cid:2) (cid:2) 6 . 5 TRANSIENT TRANSFECTION FOR HETEROLOGOUS GENE (cid:2) (cid:2) EXPRESSION IN CELLS………………………………………… . . (cid:2)(cid:2) 52 (cid:2) (cid:2) (cid:2) 6 . 5 . 1 Calcium phosphate transfection…………………………(cid:2)(cid:2) 53 (cid:2) (cid:2) (cid:2) 6 . 5 . 2 Lipofectamine® 2000 transfection……………………… . 54 (cid:2) 7 CYTOTOXICITY ASSAYS……………………………………………………(cid:2) 55 (cid:2) (cid:2) 7 . 1 CELL SEEDING AND TREATMENT………………………………(cid:2) 55 (cid:2) (cid:2) 7 . 2 MTT ASSAY………………………………………………………… . (cid:2)(cid:2) 56 (cid:2) 8 NUCLEOSIDE UPTAKE MEASURING………………………………… . (cid:2) (cid:2) 58 (cid:2) (cid:2) 8 . 1 MAMMALIAN CELLS TRANSPORT ASSAY………………… . . (cid:2) (cid:2) 58 (cid:2) (cid:2) 8 . 2 OOCYTES TRANSPORT ASSAY……………………………… . (cid:2) 61 (cid:2) 9 PROTEIN EXPRESSION ANALYSIS…………………………………… . (cid:2) (cid:2) 62 (cid:2) (cid:2) 9 . 1 PROTEIN EXTRACTION FROM CELLULAR LYSATES…… . . (cid:2) (cid:2) 62 (cid:2) (cid:2) (cid:2) 9 . 1 . 1 Protein extraction with NP - 40 buffer………………… . . (cid:2) (cid:2) 62 (cid:2) (cid:2) (cid:2) 9 . 1 . 2 Isolation of crude membrane proteins…………………(cid:2) (cid:2) 63 (cid:2) (cid:2) 9 . 2 DETERMINATION OF PROTEIN CONCENTRATION……… . . (cid:2) (cid:2) 64 (cid:2) (cid:2) (cid:2) 9 . 2 . 1 BCA method………………………………………………(cid:2) (cid:2) 64 (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) 9 . 2 . 2 Bradford method…………………………………………(cid:2) (cid:2) 65 (cid:2) (cid:2) 9 . 3 BIOTINYLATION OF MEMBRANE PROTEINS……………… . . (cid:2) 65 (cid:2) (cid:2) 9 . 4 ELECTROPHORESIS IN SDS - PAGE………………………… . . (cid:2) (cid:2) 67 (cid:2) (cid:2) (cid:2) 9 . 4 . 1 Coomassie staining…………………………………… . . (cid:2) (cid:2) 69 (cid:2) (cid:2) 9 . 5 WESTERN - BLOT TECHNIQUE…………………………………(cid:2) (cid:2) 69 (cid:2) (cid:2) (cid:2) 9 . 5 . 1 Transference…………………………………………… . (cid:2) (cid:2) 70 (cid:2) (cid:2) (cid:2) 9 . 5 . 2 Ponceau staining……………………………………… . . (cid:2) (cid:2) 70 (cid:2) (cid:2) (cid:2) 9 . 5 . 3 Immunodetection……………………………………… . . (cid:2) (cid:2) 71 (cid:2) (cid:2) (cid:2) 9 . 5 . 4 Antibodies used………………………………………… . (cid:2) (cid:2) 72 (cid:2) (cid:2) (cid:2) 9 . 5 . 5 ECL developing………………………………………… . (cid:2) (cid:2) 72 (cid:2) (cid:2) 9 . 6 PROTEIN DETECTION AND ANALYSIS BY MASS (cid:2) (cid:2) SPECTROMETRY…………………………………………………(cid:2) 73 (cid:2) 10 IMMUNOCYTOCHEMISTRY………………………………………………(cid:2)(cid:2) 73 (cid:2) 11 MOLECULAR BIOLOGY TECHNIQUES……………………………… . . (cid:2)(cid:2) 77 (cid:2) (cid:2) 11 . 1 TRANSFORMATION IN COMPETENT CELLS……………… . . (cid:2)(cid:2) 77 (cid:2) (cid:2) (cid:2) 11 . 1 . 1 Transformation in bacteria cells……………………… . . (cid:2)(cid:2) 77 (cid:2) (cid:2) (cid:2) 11 . 1 . 2 Transformation in yeast cells………………………… . . (cid:2)(cid:2) 79 (cid:2) (cid:2) 11 . 2 EXTRACTION OF PLASMID DNA………………………………(cid:2)(cid:2) 79 (cid:2) (cid:2) 11 . 3 GENETIC ENGINEERING TECHNIQUES…………………… . . (cid:2)(cid:2) 80 (cid:2) (cid:2) (cid:2) 11 . 3 . 1 PCR reaction…………………………………………… . (cid:2)(cid:2) 80 (cid:2) (cid:2) (cid:2) 11 . 3 . 2 Site - directed mutagenesis…………………………… . . (cid:2) (cid:2) 83 (cid:2) (cid:2) (cid:2) 11 . 3 . 3 Digestion with restriction endonuclease………………(cid:2)(cid:2) 85 (cid:2) (cid:2) (cid:2) 11 . 3 . 4 DNA visualization and extraction with agarose gel… . (cid:2) (cid:2) 85 (cid:2) (cid:2) (cid:2) 11 . 3 . 5 DNA ligation…………………………………………… . . (cid:2) 86 (cid:2) (cid:2) (cid:2) 11 . 3 . 6 Vectors and plasmids………………………………… . . (cid:2) (cid:2) 87 (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) 11 . 3 . 7 Clone screening by PCR……………………………… . (cid:2)(cid:2) 88 (cid:2) (cid:2) (cid:2) 11 . 3 . 8 DNA sequencing by PCR………………………………(cid:2) (cid:2) 90 (cid:2) (cid:2) 11 . 4 RNA EXTRACTION AND MANIPULATION…………………… . (cid:2)(cid:2) 91 (cid:2) (cid:2) (cid:2) 11 . 4 . 1 RNA extraction from cell culture……………………… . (cid:2)(cid:2) 91 (cid:2) (cid:2) (cid:2) 11 . 4 . 2 cDNA synthesis by reverse transcription…………… . . (cid:2)(cid:2) 91 (cid:2) (cid:2) 11 . 5 REAL - TIME PCR REACTION……………………………………(cid:2)(cid:2) 92 (cid:2) (cid:2) (cid:2) 11 . 5 . 1 TaqMan® reagents………………………………………(cid:2)(cid:2) 92 (cid:2) (cid:2) (cid:2) 11 . 5 . 2 SYBR® Green reagents……………………………… . . (cid:2)(cid:2) 94 (cid:2) (cid:2) (cid:2) 11 . 5 . 3 Microﬂuidic card ( TLDA ) ……………………………… . . (cid:2)(cid:2) 95 (cid:2) (cid:2) (cid:2) 11 . 5 . 4 Real - time PCR calculations……………………………(cid:2) (cid:2) 96 (cid:2) 12 MEMBRANE YEAST TWO - HYBRID ( MYTH ) TECHNIQUE………… . (cid:2)(cid:2) 97 (cid:2) (cid:2) 12 . 1 BAIT GENERATION AND VALIDATION……………………… . . (cid:2)(cid:2) 99 (cid:2) (cid:2) 12 . 2 LIBRARY SCREENING : LARGE - SCALE TRANSFORMATION (cid:2) (cid:2) AND PREY PLASMID RECOVERY…………………………… . . (cid:2)(cid:2) 102 (cid:2) (cid:2) 12 . 3 BAIT DEPENDENCY TESTING AND SCREENING………… . . (cid:2)(cid:2) 104 (cid:2) 13 PROTEIN EXPRESSION IN BACTERIA…………………………………(cid:2) 105 (cid:2) (cid:2) 13 . 1 SYNTHESIS OF ENT2 INTRACELLULAR LOOP PEPTIDES . . (cid:2) 106 (cid:2) 14 IN VITRO PHOSPHORYLATION ASSAYS………………………………(cid:2) 107 IV . RESULTS AND DISCUSSION(cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) 109 15 IDENTIFICATION AND CHARACTERIZATION OF 3 NOVEL NUCLEAR (cid:2) SPLICED VARIANTS OF THE HUMAN EQUILIBRATIVE NUCLEOSIDE (cid:2) TRANSPORTER 2 ( hENT2 ) …………………………………………………(cid:2) 111 (cid:2) (cid:2) 15 . 1 IDENTIFICATION AND CLONING OF NOVEL ALTERNATIVE (cid:2) (cid:2) SPLICING VARIANTS OF hENT2…………………………………(cid:2) 111 (cid:2) (cid:2) (cid:2) (cid:2) 15 . 2 PROTEIN EXPRESSION OF hENT2 - HA TAGGED SPLICED (cid:2) (cid:2) VARIANTS……………………………………………………………(cid:2) 118 (cid:2) (cid:2) 15 . 3 NUCLEAR SPLICED VARIANTS mRNA SURVEILLANCE…… . (cid:2) 125 (cid:2) (cid:2) 15 . 4 FUNCTIONAL CHARACTERIZATION OF hENT2 NUCLEAR (cid:2) (cid:2) VARIANTS………………………………………………………… . . (cid:2) 127 (cid:2) (cid:2) 15 . 5 EXPRESSION ANALYSIS OF hENT2 NUCLEAR VARIANTS . . (cid:2) 131 (cid:2) (cid:2) 15 . 6 DISCUSSION……………………………………………………… . (cid:2) 134 (cid:2) 16 STUDY OF PHOSPHORYLATION STATUS OF hENT2 AND THE ROLE(cid:2) (cid:2) OF PHOSPHORYLATION IN TRAFFICKING……………………………(cid:2) 143 (cid:2) (cid:2) 16 . 1 PREVIOUS FINDINGS…………………………………………… . (cid:2) 143 (cid:2) (cid:2) 16 . 2 BIOINFORMATIC ANALYSIS OF hENT2 PUTATIVE (cid:2) (cid:2) PHOSPHORYLATION SITES…………………………………… . (cid:2) 146 (cid:2) (cid:2) 16 . 3 IN VITRO PHOSPHORYLATION ASSAYS OF ENT2 - LOOPS (cid:2) (cid:2) WITH RADIO - LABELED ATP…………………………………… . (cid:2)(cid:2) 149 (cid:2) (cid:2) 16 . 4 MASS SPECTROMETRY ANALYSIS OF ENT - LOOP (cid:2) (cid:2) PHOSPHOSITES AFTER IN VITRO PHOSPHORYLATION (cid:2) (cid:2) ASSAYS…………………………………………………………… . (cid:2)(cid:2) 151 (cid:2) (cid:2) 16 . 5 EFFECT OF PKC ACTIVATION BY PDD TREATMENT (cid:2) (cid:2) ON hENT2………………………………………………………… . (cid:2)(cid:2) 153 (cid:2) (cid:2) 16 . 6 DISCUSSION………………………………………………………(cid:2)(cid:2) 156 (cid:2) 17 LARGE - SCALE SCREENING FOR hENT2 INTERACTIONS USING (cid:2) MEMBRANE YEAST TWO - HYBRID ( MYTH ) TECHNIQUE……… . … . (cid:2)(cid:2) 161 (cid:2) (cid:2) 17 . 1 BAIT GENERATION AND VALIDATION BY N UB G / I (cid:2) (cid:2) CONTROL TEST………………………………………………… . . (cid:2)(cid:2) 161 (cid:2) (cid:2) 17 . 2 LIBRARY SCREENING AND BAIT DEPENDENCY TEST……(cid:2) 164 (cid:2) (cid:2) (cid:2) (cid:2) 17 . 3 BIOINFORMATIC ANALYSIS…………………………………… . (cid:2)(cid:2) 166 (cid:2) (cid:2) 17 . 4 DISCUSSION OF PUTATIVE hENT2 PARTNERS IDENTIFIED(cid:2) (cid:2) (cid:2) BY MYTH……………………………………………………………(cid:2)(cid:2) 174 (cid:2) (cid:2) 17 . 4 . 1 Nuclear - related hENT2 MYTH putative partners……… . . . … . (cid:2)(cid:2) 175 (cid:2) (cid:2) 17 . 4 . 2 Mitochondria - related hENT2 MYTH partners…………… . … . (cid:2)(cid:2) 180 (cid:2) (cid:2) 17 . 4 . 3 hENT2 MYTH partners with enzymatic activity and (cid:2) (cid:2) (cid:2) (cid:2) other proteins…………………………………………… . . . (cid:2) 181 (cid:2) 18 PHARMACOGENOMIC ANALYSIS OF THE RESPONSIVENESS OF (cid:2) SOLID TUMORS TO DRUG THERAPY : A TRANSPORTOME (cid:2) APPROACH………………………………………………………………… . . (cid:2) 187 (cid:2) (cid:2) 18 . 1 THE TRANSPORTOME PROJECT……………………………… . (cid:2) 187 (cid:2) (cid:2) 18 . 2 CYTOTOXICITY ASSAYS………………………………………… . (cid:2) 189 (cid:2) (cid:2) 18 . 3 GENE EXPRESSION ANALYSIS………………………………… . (cid:2) 192 (cid:2) (cid:2) 18 . 4 CORRELATION BETWEEN GENE EXPRESSION AND (cid:2) (cid:2) TREATMENT RESPONSE…………………………………………(cid:2) 200 (cid:2) (cid:2) 18 . 5 DISCUSSION……………………………………………………… . . (cid:2) 205 V . GENERAL DISCUSSION(cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) 213 VI . CONCLUSIONS(cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) 219 VII . BIBLIOGRAPHY(cid:2)(cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) 223 VIII . RESUMEN EN CASTELLANO(cid:2) (cid:2) (cid:2) (cid:2) (cid:2) 263 19 ANTECEDENTES……………………………………………………………(cid:2) 265 (cid:2) 20 OBJETIVOS GENERALES…………………………………………………(cid:2) 267 (cid:2) 21 RESUMEN DE LOS RESULTADOS OBTENIDOS EN EL PROYECTO(cid:2) (cid:2) DE TESIS…………………………………………………………………… . . (cid:2) 268 (cid:2) (cid:2) (cid:2) (cid:2) 21 . 1 IDENTIFICACIÓN Y CARACTERIZACIÓN DE 3 NUEVAS (cid:2) (cid:2) VARIANTES NUCLEARES DE SPLICING ALTERNATIVO (cid:2) (cid:2) DEL TRANSPORTADOR DE NUCLEÓSIDOS EQUILIBRATIVO (cid:2) (cid:2) HUMANO 2 ( hENT2 ) ……………………………………………… . (cid:2) 268 (cid:2) (cid:2) 21 . 2 ESTUDIO DE LA REGULACIÓN DE hENT2 POR FOSFORILA - (cid:2) (cid:2) CIÓN Y SU EFECTO EN E TRÁFICO A MEMBRANA (cid:2) (cid:2) PLASMÁTICA……………………………………………………… . (cid:2) 271 (cid:2) (cid:2) 21 . 3 DETECCIÓN A GRAN ESCALA DE PROTEÍNAS DE INTER - (cid:2) (cid:2) ACCIÓN DE hENT2 MEDIANTE LA TÉCNICA DE DOBLE - (cid:2) (cid:2) HÍBRIDO EN MEMBRANA DE LEVADURAS ( MYTH ) …………(cid:2)(cid:2) 274 (cid:2) (cid:2) 21 . 4 ANÁLISIS FARMACOGENÓMICO DE LA RESPUESTA A (cid:2) (cid:2) TRATAMIENTOS DE TUMORES SÓLIDOS : PROYECTO (cid:2) (cid:2) TRANSPORTOMA…………………………………………………(cid:2)(cid:2) 277 (cid:2) 22 CONCLUSIONES………………………………………………………… . . (cid:2) 279 IX . APPENDIX I(cid:2)(cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) 281 X . APPENDIX II(cid:2)(cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) (cid:2) 301 23 RECIPES FOR SOLUTIONS AND BUFFERS………………………… . . (cid:2) 303 (cid:2) 24 COMMERCIAL REFERENCES………………………………………… . . (cid:2)(cid:2) 305 (cid:2) 25 EXTERNAL LINKS FROM INTERNET………………………………… . . (cid:2)(cid:2) 308 1 BIOLOGICAL RELEVANCE OF NUCLEOSIDES (cid:2) Nucleosides are glycosylamines consisting of a nucleobase bound to a ribose or deoxyribose sugar via a beta - glycosidic bond ( King et al . 2006 ) . Nucleosides are named according to the base they contain , either a purine ( adenine , guanine or hypoxanthine ) or a pyrimidine ( cytosine , thymine or uracil ) . Purine nucleosides are adenosine , guanosine and inosine , while pyrimidine nucleosides are cytidine , thymidine and uridine ( ﬁgure 1 ) . A nucleoside differs from a nucleotide in lacking a phosphate . Nucleosides can be phosphorylated by speciﬁc kinases in the cell on the primary alcohol group of the sugar , producing nucleotides , which are the molecular building - blocks of DNA and RNA ( Kalckar 1950 ) . (cid:2) Nucleosides are molecules of remarkable importance for the cell due to the several essential processes that are involved in . Scientiﬁc interest in nucleosides dates from 1920s when Cerecedo ( 1927 ) conducted studies on thymidine and uracil metabolism . Since then , nucleoside research has been diversiﬁed to understand their role in the purinergic signalling via adenosine receptors ( Geiger et al . 1985 ; Endres et al . 2004 ; Aymerich et al . 2005 ) , the energetic metabolism involving ATP and GTP ( Grifﬁth & Jarvis 1996 ; Baldwin et al . 1999 ; Cabrita et al . 2002 ; Kong et al . 2004 ) , neuronal and cardioprotection modulated by adenosine during periods of hypoxia or ischemia ( Angelakos & Glassman 1961 ; Rose et al . 2010 ; Takahashi et al . 2010 ) , and nucleoside - derived drugs as therapeutic agents in anticancer and antiviral treatments ( Wiley et al . 1982 ; Pastor - Anglada et al . 1998 ; Xia et al . 2007 ) . (cid:2) Nucleos ( t ) ides can be produced by de novo synthesis pathways , in particular in the liver , but they are more abundantly supplied via ingestion and digestion of nucleic acids , also known as the salvage pathway ( Cabrita et al . 2002 ) . De novo synthesis is an anabolic route that represents a high cost of energy to the cell and there are certain cell types that lack that pathway , such as protozoan parasites , mammalian enterocytes or bone marrow cells ( King et al . 2006 ; Cui et al . 2001 ; Leung et al . 2001 ) . Therefore , the salvage pathway acquires a crucial role as the main via of entrance of nucleosides ( Murray 1971 ) . Introduction 3 F i gu r e 1 . Th e pu r i n e a nd p y r i m i d i n e nu c l e ob ases a nd nu c l e o s i d es . P u r i ne nu c l eoba s e s a r e aden i ne , guan i ne and h y po x an t h i ne w h il e pu r i ne nu c l eo s i de s a r e adeno s i ne , guano s i ne and i no s i ne . P y r i m i d i ne nu c l eoba s e s a r e cy t o s i ne , t h y m i ne and u r a c il w h il e p y r i m i d i ne nu c l eo s i de s a r e cy t i d i ne , t h y m i d i ne and u r i d i ne . P U R I N E S PY R I M I D I N E S NUCLEOBASES A d e n i n e G u a n i n e H y po x a n t h i n e C y t o s i n e T h y m i n e U r ac il NUCLEOSIDES A d e n o s i n e G u a n o s i n e I n o s i n e C y t i d i n e T h y m i d i n e U r i d i n e Novel approaches to understanding hENT2 and hENT2 - related proteins 4 (cid:2) In the salvage pathway , after degradation of nucleic acids obtained through diet or already existing in the organism , nucleotides are broken down into molecules of nucleosides and phosphate by membrane - bound and soluble nucleotidases , which are present at the cell surface and the extracellular environment ( Yegutkin 2008 ) . Given their hydrophilic nature , nucleosides require of specialised class of integral membrane proteins to be internalized and incorporated to the salvage pathway . Those proteins are known as Nucleoside Transporters ( NT ) ( Molina - Arcas et al . 2009 ) . 2 NUCLEOSIDE TRANSPORTERS (cid:2) Nucleoside participation in cell physiology lies on their bioavailability either inside the cell or at the extracellular environment . Modulating nucleoside ﬂux across the plasma membrane is a mechanism to regulate those pathways where nucleosides are involved in . A clear example is the adenosine , a nucleoside that depending on its concentration levels will selectively bind to adenosine receptors , which have different afﬁnity to such substrate . As consequence , adenosine will trigger different pathways and cell responses depending on its presence at the extracellular space ( Choi et al . 2004 ; Beal et al . 2004 ; Elwi et al . 2006 ; Naydenova et al . 2008 ; Huber - Ruano et al . 2010 ) . (cid:2) Furthermore , the effectiveness of anticancer and antiviral treatments using nucleoside analogs will also depend on the capacity of the cell to internalize those substrates . This capacity is different depending on the cell type and environmental conditions of the target , conditioning the responsiveness promoted by the treatment ( Grifﬁth & Jarvis 1996 ; Pastor - Anglada et al . 2005 ) . Since nucleosides are hydrophilic molecules barely diffused across the plasma membrane , nucleoside transporters become crucial pieces in cell physiology but also as pharmacogenomic targets ( Pastor - Anglada et al . 2005 ; King et al . 2006 ; Molina - Arcas et al . 2009 ) . These examples illustrate the relevance of the study of nucleoside transporters to understand their nature and ﬁgure out their mechanisms of regulation , as well as their expression proﬁles . Introduction 5 (cid:2) First evidences of nucleoside and nucleobase transporters date back to the 1990s , when multiple carriers were recognized as such , being responsible of either equilibrative facilitated diffusion or concentrative Na + / co - transport ( Grifﬁth & Jarvis 1996 ) . Based on their kinetic features , nucleoside transporters were classiﬁed into two different families : the Equilibrative Nucleoside Transporters ( ENT ) , codiﬁed by the SLC29 gene family , and the Concentrative Nucleoside Transporters ( CNT ) , codiﬁed by the SLC28 gene family . Although both types of proteins apparently transport the same substrates , ENTs and CNTs are structurally unrelated , as we will clarify in the coming sections . In addition , ENT family is restricted to eukaryotes , whereas CNT family members are also found in eubacteria ( Grifﬁth & Jarvis 1996 ; King et al . 2006 ) . These transporters also show some differences in substrate selectivity , kinetics , regulation and subcellular distribution , a fact that explains this multiplicity of nucleoside transporters ( Zhang et al . 2007 ; Pastor - Anglada et al . 2008 ; Young et al . 2008 ) . For instance , in polarized kidney cells , CNTs seem to be localized primarily to the apical membrane , whereas ENTs proteins are mainly basolateral . Such distribution might facilitate the transepithelial ﬂux of nucleosides ( Errasti - Murugarren et al . 2008 ; Rius et al . 2010 ) . 2 . 1 CONCENTRATIVE NUCLEOSIDE TRANSPORTERS (cid:2) The SLC28 gene family codiﬁes for the concentrative nucleoside transporters . Those proteins mediate a secondary active nucleoside transport against its concentration gradient , coupled to a cation symport ( Na + or H + ) in a unidirectional manner ( King et al . 2006 ) . Despite ﬁve different functional units were initially identiﬁed based on their kinetics , only three isoforms have been cloned in mammals to date : CNT1 ( Q . Q . Huang et al . 1994 ; Ritzel et al . 1997 ) , CNT2 and CNT3 ( Ritzel et al . 2001 ; Hu et al . 2006 ) . (cid:2) The main difference among CNTs is their substrate speciﬁcity and selectivity . All of them transport uridine with values of the afﬁnity constant ( K m ) between 20 - 80 μM but none is capable of transporting nucleobases ( C . Chang et al . 2004 ) . CNT1 Novel approaches to understanding hENT2 and hENT2 - related proteins 6 mediates pyrimidine uptake , while CNT2 internalize purines . On the contrary , CNT3 shows a higher selectivity and transports both purines and pyrimidines ( ﬁgure 2d ) . Some studies showed that CNT1 could also translocate adenosine but it is currently believed that this nucleoside would interact with CNT1 and act as inhibitor ( Lai et al . 2002 ; Larráyoz et al . 2004 ) . Besides differences in substrate selectivity , CNTs also differ in their stoichiometry of sodium ions required for the symport . It has been demonstrated that CNT3 uses two Na + per nucleoside translocated ( Ritzel et al . 2001 ) , while CNT1 and CNT2 activity is coupled to only one cation ( Che et al . 1995 ; Larráyoz et al . 2004 ) (cid:2) CNTs tissue distribution also differs depending on the isoform . CNT1 is predominantly localised in the liver , kidney , intestine and brain ( Pennycooke et al . 2001 ) . In contrast , CNT2 is broadly distributed , compared to CNT1 , and it is also found in heart , skeletal muscle , pancreas , placenta , cervix , prostate and lung . CNT3 has a broad tissue distribution as well and it is localised in mammary glands , pancreas , bone marrow , trachea , intestine , liver , lung , placenta , prostate , testis , brain and heart ( Che et al . 1995 ; Gray et al . 2004 ) . 2 . 2 CNT STRUCTURE (cid:2) First CNTs bidimensional models proposed a 14 transmembrane domain structure with both intracellular N - and C - extremes ( Wang et al . 1997 ) . Nonetheless , further studies supported the existence of 13 transmembrane domains with a N - linked glycosylation sites within their C - terminal region , which has been the accepted model to date ( ﬁgure 2a ) ( J . Wang et al . 1997 ; Hamilton et al . 2001 ; Gray et al . 2004 ) . In this model , the N - and C - termini are long sequences that extend into the intracellular and extracellular environments respectively , suggesting a possible region for regulation or even protein - protein interactions ( Huber - Ruano et al . 2010 ; Pinilla - Macua et al . 2012 ) , although those regions are not present in prokaryotes . Introduction 7 1 2 3 4 5 6 7 8 9 10 11 12 13 NH 3 + COO - N C Out In 1 2 3 IH2 4 5 EH IH1 IH3 HP1 HP2 6 7 8 a ) b ) 92 Å CONCENTRRATIVE NUCLEOSSIDE TRANSPORTERS GENE PROTEIN SUBSTRATE ( K m ) SLC28A1 hCNT1 Urd - 50 μM Tyd - 6 μM Cyd - 34 μM SLC28A2 hCNT2 Ado - 8 μM Guo - 21 μM Ino - 4 . 5 μM Urd - 80 μM SLC28A3 hCNT3 Ado - 15 . 1 μM Guo - 43 μM Ino - 52 . 5 μM Urd - 21 . 6 μM Tyd - 21 . 2 μM Cyd - 15 . 4 μM c ) d ) Figure 2 . CNTs structural and kinetic features . ( a ) The 2D topology proposed for concentrative nucleoside transporters , which contains 13 transmembrane domains as well as the intracellular N - and extracellular glycosylated C - termini . ( b ) Schematic representation of vcCNT topology . The group of helices under the pink triangular background is related to the group of helices under the cyan triangular background by two - fold pseudo - symmetry , with the symmetry axis parallel to the membrane . ( c ) Cartoon representation of the vcCNT trimer viewed from the cytoplasm . Individual protomers are coloured blue , red and green . ( d ) Kinetic properties of the three members of the CNT family . Figures b and c are adapted from Johnson et al . 2012 . Novel approaches to understanding hENT2 and hENT2 - related proteins 8 (cid:2) Recently , it has been presented the crystal structure of a concentrative nucleoside transporter from Vibrio cholerae ( 39 % identical to hCNT3 ) in complex with uridine , which , like its human orthologues , uses a sodium - ion gradient for nucleoside transport ( Johnson et al . 2012 ) . This work reveals that the protein contains eight transmembrane helices ( ﬁgure 2b ) and predicts three more amino - terminal transmembrane helices for hCNTs ( a total of 11 ) , in contrast of what has been accepted to date . Furthermore , crystallisation of vcCNT provides , for ﬁrst time , evidences of homotrimers of a nucleoside transporter ( ﬁgure 2c ) . (cid:2) In addition , chimeric and also mutational studies provided relevant information about critical residues for substrate selectivity , such as Ser319 , Ser353 , Leu354 and Gln320 in CNT1 , as well as Gly313 , Met314 , Thr347 and Val348 in CNT2 ( Hamilton et al . 2001 ; J . Wang et al . 1997 ) . There is also some data regarding structural elements that may determine CNTs stability , sorting and trafﬁcking to the membrane . For instance , the Gly476 in transmembrane domain 11 , the glutamate - enriched region between residues 21 and 28 or the potential protein kinase CK2 domain that led to a loss of brush border - speciﬁc sorting ( Z . Tackaberry et al . 2006 ; Pinilla - Macua et al . 2012 ) 2 . 3 EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS (cid:2) The SLC29 gene family codiﬁes for the equilibrative nucleoside transporters . Those proteins mediate a bidirectional passive nucleoside transport in either direction down the substrate concentration gradient ( Cabrita et al . 2002 ) . These transporters show a broad substrate selectivity but a relative low afﬁnity compared to CNTs ( K m around 40 - 710 μM ) . Unlike the CNTs , there are no ENT homologues identiﬁed in bacteria , however , they have been found in the majority of eukaryotic species , such as fungi , protozoans , nematodes , insects and plants ( Acimovic & Coe 2002 ) . Introduction 9 (cid:2) A total of four members of the ENT family have been identiﬁed in mammals to date : ENT1 - ENT4 . These proteins are classiﬁed according to their sensitivity to the inhibitor nitrobenzylthioinosine ( NBTI ) , a structural analog of adenosine . Thereby , ENT1 is historically known as es ( e quilibrative s ensitive - to NBTI ) transporter ( nanomolar IC 50 values ) , while ENT2 is ei ( e quilibrative i nsensitive - to NBTI ) transporter ( IC 50 values above 10 μM ) . ENT3 and ENT4 were further identiﬁed ( Baldwin et al . 2004 ) . ENT3 is able to transport adenosine and its activity is not inhibitable by NBTI nor Dipyridamole . On the other hand , ENT4 seems to participate in serotonin translocation and it is partially inhibited by Dipyridamole or Dilazep , but not by NBTI . In both cases , ENT3 and ENT4 activities are pH - dependent ( Baldwin et al . 2005 ; Barnes et al . 2006 ) . (cid:2) ENT1 was the ﬁrst member of the ENT family to be cloned from human erythrocytes ( Grifﬁths , Beaumont , et al . 1997a ) . As we already mentioned , ENT1 is highly sensitive to NBTI at nanomolar concentrations , but also to other molecules such as the coronary vasodilators Dilazep , Dipyridamole and Draﬂazine ( Hyde et al . 2001 ; Aguayo et al . 2005 ) . ENT1 is responsible of the uptake of both purines and pyrimidines , with K m afﬁnity values between 40 - 580 μM ( ﬁgure 3c ) . However , although ENT1 has never been described as a nucleobase transporter ( Ward et al . 2000 ; Beal et al . 2004 ) , recent evidences demonstrated a signiﬁcant activity as nucleobase transporter ( Yao et al . 2011 ) . Regarding its expression and distribution , ENT1 is ubiquitously expressed in mammal tissues ( Pennycooke et al . 2001 ; Jennings et al . 2001 ) and , despite it could be thought to be exclusively localized at the plasma membrane , there are some evidences that suggested its presence at the mitochondrial membrane ( Lai et al . 2004 ; E . - W . Lee et al . 2006 ) . (cid:2) ENT2 was the next ENT member to be cloned . It was actually cloned in two different labs simultaneously , in 1997 from cDNA of human placenta ( Grifﬁths , Yao , et al . 1997b ) , and also in 1998 from cDNA of human leukaemia CEM cells ( Crawford et al . 1998 ) . When ENT2 sequence was analyzed , it was observed around 50 % identical to ENT1 in mammals . Surprisingly , the C - terminus of ENT2 protein was nearly identical to a smaller protein previously cloned and identiﬁed as a growth factor - induced Novel approaches to understanding hENT2 and hENT2 - related proteins 10 delayed early response gene , named HNP36 and reported to be located at the nuclear periphery ( Williams et al . 1995 ) . HNP36 sequence analysis suggested that this protein would be originated from a second start codon within the ENT2 open reading frame . Despite its function still remains unknown , it was demonstrated that only the full length protein conferred uridine transport activity to the cells ( Crawford et al . 1998 ) . (cid:2) ENT2 transports a broad range of purine and pyrimidine nucleosides , although with a lower apparent afﬁnity than ENT1 , except in the case of inosine ( Beal et al . 2004 ) . However , ENT2 differs from ENT1 in also being able to transport efﬁciently a wide range of purine and pyrimidine nucleobases ( Crawford et al . 1998 ; Yao et al . 2002 ) . ENT2 mRNA is expressed in a wide range of tissues including brain , heart , placenta , thymus , pancreas , prostate and kidney , but is particularly abundant in skeletal muscle ( Grifﬁths , Yao , et al . 1997b ; Crawford et al . 1998 ; Pennycooke et al . 2001 ) . (cid:2) ENT3 was ﬁrst described in 2001 and characterized more recently ( Hyde et al . 2001 ; Acimovic & Coe 2002 ; Baldwin et al . 2005 ) . In contrast to the SLC29 gene family members ENT1 and ENT2 , ENT3 has been mostly found in intracellular structures . Indeed , ENT3 was initially localized in lysosomes ( Baldwin et al . 2005 ) but later it was shown that it is more likely to be expressed in mitochondria , where it may play a role in the mitochondrial toxicity of certain nucleoside - derived drugs ( Govindarajan et al . 2009 ; Kang et al . 2010 ) . However , recent evidences have suggested that ENT3 is also able to localize to the plasma membrane , although this has only been seen in placental cell lines ( Govindarajan et al . 2009 ) . (cid:2) Like the other ENT family members , ENT3 isoform has a broad tissue distribution . It also shares structural characteristics and a preference for purine and pyrimidine nucleosides and nucleobases ( Baldwin et al . 2005 ) . On the other hand , ENT3 activity appears to be proton dependent in such a way that pH has an effect on its uptake capacity . This fact suggests a plausible evolution to adapt itself to the acidic pH of the lysosomal lumen ( Baldwin et al . 2005 ) . Unlike the other ENT family members , ENT3 is the ﬁrst nucleoside transporter related to a genetic human disease . Introduction 11 The H syndrome ( OMIM 612391 ) is a recently described syndrome caused by mutations in the SLC29A3 gene that encodes for hENT3 . The H syndrome is an autosomal recessive disorder that is characterized by hyperpigmentation , histiocytosis , hypertrichosis and short stature ( Huber - Ruano et al . 2012 ) . (cid:2) The last member of the ENT family identiﬁed to date is ENT4 ( Acimovic & Coe 2002 ) . First ENT4 characterization assays revealed its functionality as a nucleoside transporter by translocating adenosine , despite its low afﬁnity to the substrate ( Baldwin et al . 2005 ) . Further studies corroborated previous observations and clariﬁed the fact this transport activity occurs under acidic pH conditions ( Barnes et al . 2006 ; H . Li et al . 2008 ; M . Zhou et al . 2010 ) . However , controversy still exists since parallel characterization assays suggested ENT4 as a plasma membrane monoamine transporter and so renamed as PMAT , supported by the fact that hENT4 shares a 18 % of identity with hENT1 ( K . Engel et al . 2004 ) . Despite its functionality is not accurate yet , ENT4 has a broad distribution in tissues such as brain , skeletal muscle , kidney , heart and liver , just like the other ENT proteins . 2 . 4 ENT STRUCTURE (cid:2) ENTs are proteins of 450 amino acids approximately . The two dimensional topology predicted for these transporters is made up of 11 transmembrane domains , with the N - terminus facing the cytosolic side and the C - terminus in the extracellular space . Their predicted structure also has an intracellular loop between transmembrane domains 6 and 7 , and a potential glycosylation site in the ﬁrst extracellular loop between transmembrane domains 1 and 2 ( ﬁgure 3a ) ( Grifﬁth et al . 1996 ) . (cid:2) In order to understand the mechanisms by which ENTs are regulated and they interact with and translocate the substrates , several studies performed chimeric and site directed mutagenesis assays with ENT proteins . Unfortunately there is not much known regarding the residues involved in the substrate recognition and translocation . As with the mammalian CNTs , no crystallographic models of the ENTs have been presented to date , probably due to the challenges associated with acquiring sufﬁcient Novel approaches to understanding hENT2 and hENT2 - related proteins 12 protein to conduct structural analyses , what makes it difﬁcult to elucidate structural relevances or mechanisms . (cid:2) Similar to the CNT family , ENTs are proposed to form a pore through which nucleosides and nucleobases are translocated . There are some evidences obtained from nucleoside transporters of Leishmania donovani parasite ( LdNT ) that suggested that this pore is lined by transmembrane domains 1 , 2 , 4 , 5 , 8 , 10 and 11 ( ﬁgure 3b ) ( Arastu - Kapur et al . 2005 , Valdés et al . 2009 ) . This studies also identiﬁed some residues that might play a key role in substrate afﬁnity such as Met 33 , Leu 92 and Gly 179 ( hENT1 ) , Gly 183 and Cys 337 ( LdNT1 ) , Asp 389 and Arg 393 ( LdNT2 ) , and an exofacial Cys 140 ( rENT1 ) . Further studies performed with Plasmodium falciparum ENT1 indicated that the transmembrane domain 11 is an alpha helix indeed , and supported the proposal of that domain lines the translocation pore ( Riegelhaupt et al . 2010 ) . Other works described transmembrane domains 3 - 6 to be implicated in substrate translocation in hENT1 ( Sundaram et al . 2001 ) , leaving the controversy regarding which transmembrane domains comprise this pore unresolved ( Sengupta & Unadkat 2004 ) . However , a very recent mutational study supported the notion that helices 1 , 2 and 7 constitute the extracellular gate of LdNT1 . 1 ( Valdés et al . 2012 ) . (cid:2) There are several studies that described which residues are involved in inhibitor binding or at least might play a key role in ENTs sensitivity to those compounds . Residues better characterised in ENTs inhibition are Trp 29 , Met 33 , Leu 92 , Gly 154 and Gly 179 , Ser 160 , Asn 338 and Leu 442 . ( Vickers et al 1999 ; Hammond 2000 ; Sengupta et al . 2002 ; Visser et al . 2002 ; Endres et al . 2004 ; Sengupta & Unadkat 2004 ; Endres & Unadkat 2005 ; Reyes & Coe 2005 ; Paproski et al . 2008 ) . With regards to trafﬁcking and sorting , Gly 184 has been implicated in trafﬁcking to the plasma membrane while the sequence PEXN ( residues 71 - 74 ) has been proposed to be involved in mitochondrial targeting ( Sengupta et al . 2002 ; E . - W . Lee et al . 2006 ) On the other hand , a dileucine motif at the N - terminus of ENT3 has been suggested to determine its lysosomal sorting ( Baldwin et al . 2005 ) . Introduction 13 1 2 3 4 5 6 7 8 9 10 11 NH 3 + COO - EEQUILIBRATIVEE NUCLEOSIDE TRANSSPORTERS GENE PROTEIN SUBSTRATE ( K m ) INHIBITOR ( IC 50 ) SLC29A1 hENT1 Ado - 40 μM Guo - 140 μM Ino - 170 μM Urd - 260 μM Tyd - 30 μM Cyd - 580 μM NBTI - 0 . 4 nM Dipyridamole - 5 nM SLC29A2 hENT2 Ado - 100 μM Guo - 2700 μM Ino - 50 μM Urd - 250 μM Tyd - 710 μM Cyd - 5610 μM Nucleobases NBTI - 2 . 8 μM Dipyridamole - 356 nM c ) a ) b ) Figure 3 . ENTs structural and kinetic features . ( a ) The 2D topology proposed for equilibrative nucleoside transporters , which contains 11 transmembrane domains as well as the intracellular N - and extracellular C - termini . It also has a potential glycosylation site on the ﬁrst extracellular loop and a remarkable intracellular loop between TM6 - TM7 . ( b ) Proposed ab initio model of LdNT1 . 1 showing side ( top panel ) and cytosolic ( bottom panel ) views . The model pictures a cluster of three aromatic residues ( Phe 48 , Trp 75 and Phe 436 ) that may interact to close an extracellular gate formed by TM1 , TM2 and TM7 . Figure adapted from Valdés et al . ( 2009 ) . ( c ) Kinetic properties of the two members of the ENT family best characterized to date . Novel approaches to understanding hENT2 and hENT2 - related proteins 14 3 NUCLEOSIDE ANALOGS AS THERAPEUTIC AGENTS (cid:2) As previously mentioned , nucleoside transporters in addition to transporting their natural substrates , nucleosides and nucleobases , they also have the capacity of internalizing nucleoside analogs used as therapeutic agents . This kind of drugs are frequently used in treatments of different kinds of cancer such as leukemia , lymphomas and solid tumors , or viral infections like HIV and Hepatitis B . Nucleoside transporters are also clinically relevant given the fact they are the targets in some treatments for cardiovascular and neurological disorders and parasitic infections ( Galmarini et al . 2002 ; Galmarini et al . 2003 ) . However , since there are big differences in NTs expression among the different tissues and population , the pharmacokinetics of such drugs may be compromised depending on the target and the patient proﬁle ( Balnave et al . 1981 ) . (cid:2) As happens with nucleosides and nucleobases , there are two types of nucleoside analogs ( NA ) : pyrimidines such as Cytarabine , Gemcitabine or Capecitabine ; and purines like Fludarabine , Cladribine or Clorafabine ( ﬁgure 4 ) ( Damaraju et al . 2003 ) . One of the ﬁrst nucleoside analogs to be developed was Cytarabine ( deoxycytidine - 1 - β - D - arabinofuranosylcytosine ) , also known as AraC ( Wiley et al . 1982 ) . This NA is mainly internalized by hENT1 , although there are some evidences of its transport via hCNT1 ( Hubeek et al . 2005 ; Chow et al . 2005 ) . It is widely used to treat haematological malignancies such as acute lymphoblastic leukemia , chronic myelocytic leukemia , erythroleukemia and mantle - cell lymphoma ( Lamba 2009 ) . However , since this drug is rapidly metabolised into uracil , Cytarabine is continuously administrated intravenously in order to be effective . Unfortunately , this treatment may result in acquired resistance ( Bardenheuer et al . 2005 ) by the elimination of the drug from inside the cell via multidrug resistant transporters ( Reid et al . 2003 ; Eckford & Sharom 2009 ) . (cid:2) Gemcitabine ( 2ʼ , 2ʼ - diﬂuorodeoxycytidine - dFdC ) , is another pyrimidine nucleoside analog currently used in the chemotherapeutic treatment of cancers such as pancreatic carcinoma , non - Hodgkinʼs lymphoma , non - small lung , cervical , bladder Introduction 15 and breast cancer ( Pérez - Torras et al . 2008 ; Okazaki et al . 2010 ; Farrell et al . 2009 ; O ' Reilly 2009 ; Maase 2001 ; Oguri et al . 2007 ) . Gemcitabine is mainly internalized by hENT1 , although it can also be transported by hENT2 and to a lesser extent by hCNT1 and hCNT3 ( Santini et al . 2011 ) . Like Cytarabine , Gemcitabine is also deaminated and therefore administrated intravenously ( Clarke et al . 2002 ; Gilbert et al . 2006 ; Giovannetti et al . 2008 ) . Once inside the cell , Gemcitabine is phosphorylated into its di - and triphosphate forms ( Kroep et al . 2002 ) . The diphosphate metabolite acts as an inhibitor of the ribonucleotide reductase enzyme , which participates of the synthesis of natural nucleotides ( dNTPs ) . Since the cell runs out of dNTPs , the triphosphate metabolite of Gemcitabine ( dFdCTP ) is subsequently incorporated into DNA ( Prakasha Gowda et al . 2010 ) . Due to its two ﬂuorine groups ( F ) , dFdCTP is not able to create a phosphodiester bond with a subsequent nucleotide , such a way it prevents the elongation of the DNA chain and promotes DNA disintegration and cell death ( Fowler et al . 2008 ) . Gemcitabine is also considered a radiosensitizer ( Mornex & Girard 2006 ) since its incorporation into the DNA chain makes the DNA fragile and highly susceptible to breakage by radiation ( Doyle et al . 2001 ) . (cid:2) Cladribine and Fludarabine , two adenosine analogs , are also used in cancer treatment , specially in leukemias and lymphomas ( Ross et al . 1993 ; Pastor - Anglada et al . 2004 ) . As the previous examples , these drugs are also incorporated into DNA and RNA during its synthesis as a triphosphate metabolite ( Lotﬁ et al . 2001 ; Mackey et al . 2005 ) . In addition , they suppress DNA synthesis by inhibiting DNA polymerases , or DNA repair mechanisms ( Robak et al . 2006 ) . Cladribine uptake is mediated via ENT1 and ENT2 mainly , although rCNT2 has also been reported to translocate this drug ( Gerstin et al . 2002 ; Molina - Arcas et al . 2005 ) . In the case of Fludarabine , ENT1 and ENT2 , together with CNT1 - 3 , are responsible for its internalization ( Molina - Arcas et al . 2005 ; Tsang et al . 2008 ) . Novel approaches to understanding hENT2 and hENT2 - related proteins 16 Figure 4 . Therapeutic Nucleoside Analogs ( NA ) . First line shows NA used in anti - cancer treatments for leukemias , lymphomas and solid tumors . Second line shows NA used in treatments for HIV . Third line shows anti - viral NA used in Hepatitis B patients . Fourth line shows NT inhibitors commonly used as vasodilators . Cytarabine - AraC Gemcitabine Fludarabine Cladribine Zidovudine - AZT Zalcitabine - ddC Didanosine - ddI Lamivudine - 3TC Entecavir Ribavirin Telbivudine A n t i - ca n ce r N A A n t i - v i r a l ( H I V ) N A A n t i - v i r a l ( H B ) N A V a s od il a t o r s ( N T I nh i b . ) NBTI Dipyridamole Dilazep Draﬂazine THERAPEUTIC NUCLEOSIDE ANALOGS Introduction 17 (cid:2) hENT2 plays a crucial role in Fludarabine uptake in Chronic Lymphocytic Leukemia ( CLL ) patients . As reported , sensitivity of CLL cells to this drug was initially correlated with ENT - type transport activity ( Pastor - Anglada et al . 2004 ) . However , studies using polyclonal antibodies against ENT1 and ENT2 epitopes revealed a signiﬁcant correlation between ENT2 protein expression and Fludarabine uptake , as well as ex vivo sensitivity of CLL cells ( Molina - Arcas et al . 2005 ) . Furthermore , a recent study in Mantle Cell Lymphoma ( MCL ) cells described SLC29A2 , gene that encodes for hENT2 protein , as one of the ﬁve predictor genes that compose a new quantitative gene expression - based model developed to predict survival in MCL patients ( Hartmann et al . 2008 ) . Despite the biological foundation of the hENT2 correlation remains unclear , it suggests an important role of this transporter in the clinical outcome of MCL patients . (cid:2) Nucleoside - derived drugs are also commonly used in anti - viral therapies , specially in HIV and Hepatitis B patients ( Zoulim 2005 ; Perez - Bercoff et al . 2007 ) . Some examples are represented in ﬁgure 4 ( Vivet - Boudou et al . 2006 ; Menéndez - Arias 2008 ; Endres et al . 2009 ) . As happens with the other NA described , these anti - viral drugs are tri - phosphorylated and incorporated into the host DNA , preventing the incorporation of the viral DNA and also promoting host DNA disintegration and cell apoptosis . In addition , these nucleoside analogs also inhibit the reverse transcriptase , which is the enzyme that synthesises viral DNA ( Cherry & Wesselingh 2003 ) . Similar to Fludarabine treatment , hENT2 seems to represent an important route for cellular uptake of NA used on HIV therapy since hENT2 can transport AZT , unlike hENT1 , and also exhibits a much greater capacity to transport ddC and ddI ( Beal et al . 2004 ) (cid:2) Based on their role as adenosine transporters , NTs have become clinical targets in cases of cardio - and neuropathies . NT inhibitors like dilazep , dipyridamole and draﬂazine ( ﬁgure 4 ) ( Sundaram et al . 1998 ; Hammond 2000 ; Musa et al . 2002 ; Paproski et al . 2008 ) have been commonly used to inhibit adenosine uptake and increase its extracellular levels promoting vasodilation and / or inhibition of platelet aggregation ( Van Belle 1993 ; Dunwiddie & Diao 2000 ; Visser , Zhang , et al . 2005b ; Noji et al . 2004 ; Chakrabarti & Freedman 2008 ; Young et al . 2008 ) . Following this line , Novel approaches to understanding hENT2 and hENT2 - related proteins 18 since parasites are unable to synthesise their own nucleosides , nucleoside salvage pathways have been an important target in developing new drug therapies against infection by Plasmodium falciparum ( malaria ) , Trypanosoma brucei ( African trypanosomiasis ) and Toxoplasma gondii ( toxoplasmosis ) ( De Koning et al . 2003 ; Safarjalani et al . 2003 ; Quashie et al . 2008 ; Aly et al . 2010 ; Landfear 2010 ; Riegelhaupt et al . 2010 ) . 4 REGULATORY MECHANISMS OF NUCLEOSIDE TRANSPORTERS (cid:2) Most processes in cells do not take place independently of one another or at constant rate . Instead , the catalytic activity of enzymes or the assembly of a macromolecular complex is so regulated that the amount of reaction product or the appearance of the complex is just sufﬁcient to meet the needs of the cell . This ﬁne regulation also occurs to membrane proteins , and nucleoside transporters in particular . Regulation may occur at different points of the life span of a protein , either before the gene transcription or during / after the protein translation . (cid:2) 4 . 1 TRANSCRIPTIONAL REGULATION (cid:2) Transcriptional regulation determines levels of protein expression and it is conducted by multiple protein - binding DNA sequences such as promoters and other types of control elements , together with those regulatory proteins known as transcriptional factors , either activators or repressors . Several examples of transcription regulation of membrane proteins have been described , like the case of the glucose transporter ( GLUT4 ) , the Aquaporin water channel ( AQP2 ) or the human Na + / H + exchanger 3 hNHE3 , among many others ( Nelson et al . 1998 ; Malakooti et al . 2006 ; McGee et al . 2008 ; M . - J . Yu et al . 2009b ) . Introduction 19 (cid:2) Regarding nucleoside transporters , some studies described how hCNT1 is transcriptionally regulated by HNF - 4α and bile acids , and also rCNT2 regulation via TGF - ß ( Valdés et al . 2006 ; Klein et al . 2009 ) . Certainly , ENT1 is the nucleoside transporter most studied regarding transcriptional regulation . Some evidences suggested that ENT1 promoter could be upregulated by the transcription factors Sp1 ( zinc - ﬁnger speciﬁcity protein - 1 ) and MAZ ( myc - associated zinc protein ) ( Abdulla & Coe 2007 ) . More recent studies have been focused on cellular pathways that would be involved in ENT1 regulation ﬁnding that the activation of JNK - cJun pathway negatively regulates mENT1 ( Leisewitz et al . 2011 ) , and that PPARα and γ activation or overexpression resulted in higher hENT1 transport activity ( Montero et al . 2012 ) . (cid:2) Due to the neuro - and cardioprotective role of adenosine in cases of ischemia or hypoxia , different research groups studied the NTs regulation in these situations . These studies described how mENT1 and mENT2 promoters were down - regulated by hypoxia inducible factor 1 ( HIF - 1 ) , as well as during cerebral ischemia ( Chu et al . 2012 ) . In both situations , ENTs downregulation promote an increasing of extracellular adenosine levels , which has a protective effect on the cell by activation of adenosine receptors ( Chaudary et al . 2004 ; Eltzschig et al . 2005 ; Löfﬂer et al . 2007 ) . (cid:2) Other physiological situations have also been involved in changes on ENTs expression . For instance , high - glucose levels , together with its subsequent increasing of NO production , reduces SLC29A1 promoter activity via MAP kinases ( Puebla et al . 2008 ; Farias et al . 2010 ) . In addition , studies on Inﬂammatory Bowel Disease ( IBD ) patients , described a change in mRNA expression of both hENT1 and hENT2 , in such a way that hENTs expression levels were signiﬁcantly higher in IBD patient samples than in healthy intestinal tissue , suggesting a dysregulation on hENTs mRNA levels due to that disease ( Wojtal et al . 2009 ) . (cid:2) Novel approaches to understanding hENT2 and hENT2 - related proteins 20 4 . 2 PROTEIN SYNTHESIS AND POST - TRANSLATIONAL MODIFICATIONS (cid:2) Once a protein has been synthesised from its codifying mRNA sequence , the cell promotes the proper folding and , in many cases , modiﬁes residues or cleaves the polypeptide backbone to generate the ﬁnal protein ( Castro - Fernández et al . 2005 ; J . - C . Wu et al . 2006 ) . Nucleoside transporters , in order to be properly functional , must be delivered to a particular cell membrane and reach their correct location . The following sections will discuss those processes involved in nucleoside transporter synthesis , modiﬁcation , sorting and trafﬁcking necessary to be functional proteins . (cid:2) 4 . 2 . 1 Protein synthesis and sorting : (cid:2) (cid:2) After being exported from the nucleus to the cytosol , nuclear - encoded mRNA transcripts are translated into proteins on cytosolic ribosome . There are two main pathways regarding membrane protein synthesis and sorting . The ﬁrst general process involves targeting of a protein to the membrane of an intracellular organelle and can occur either during or soon after synthesis of the protein by cytosolic translation at the ribosome . Those nascent proteins contain a targeting sequence that leads their sorting to a speciﬁc organelle such as endoplasmic reticulum ( ER ) , mitochondria , chloroplasts , peroxisomes or nucleus , and insertion of the protein into the lipid bilayer of the membrane ( ﬁgure 5 ) ( Lodish et al . 2007 ) . (cid:2) The second general sorting process is known as the secretory pathway and applies to proteins that initially are targeted to the ER membrane and whose ﬁnal destination is the ER itself , the Golgi apparatus , lysosomes and membranes of those organelles and the plasma membrane . In the secretory pathway proteins are transported by small vesicles that bud from the membrane of one organelle and then fuse with the membrane of the next organelle in the pathway ( ﬁgure 5 ) ( Lodish et al . 2007 ) . In order for those proteins to leave the ER , they must be incorporated into a coatomer protein II ( COPII ) vesicle , which trafﬁcs the protein to the Golgi apparatus ( Barlowe 1998 ; Watson & Stephens 2005 ; M . C . S . Lee & Miller 2007 ) . The COPII coat is a protein complex formed by several subunits like Sar1 , a GTPase that initiates the Introduction 21 membrane curvature ( Bonifacino & Glick 2004 ; Bielli et al . 2005 ) and also recruits the other COPII members ( Bi et al . 2002 ; Futai et al . 2004 ) . Several studies deﬁned two ER export signals recognised by COPII complex : the diacidic and the di - hydrophobic motifs , both of them usually localised in cytosolic regions of the protein ( X . Wang et al . 2004 ; Mikosch et al . 2006 ; Zuzarte et al . 2007 ) . The diacidic motifs are typically made up of two acidic amino acid residues separated by another amino acid ( X ) in such motifs as ( ( D / E ) - X - ( D / E ) ) ( Sevier et al . 2000 ; X . Wang et al . 2004 ; Hanton et al . 2005 ) . Di - hydrophobic motifs are usually made up of two phenylalanine , leucine or tyrosine residues ( FF , LL or YY ) ( Wendeler et al . 2007 ) . Some works described associations between COPII vesicle components and serotonin transporter ( SERT ) ( Chanrion et al . 2007 ) or the GABA transporter 1 ( GAT1 ) ( Farhan et al . 2007 ) , suggesting these proteins participate of the secretory pathway . (cid:2) A recent study observed the intracellular N - terminal tail of rCNT2 to be implicated in its plasma membrane sorting ( Pinilla - Macua et al . 2012 ) . However , very few is known regarding ENTs targeting motifs . The RXXV motif for hENT1 and a dileucine repeat for hENT2 present in the extracellular C - terminus were suggested to be crucial for basolateral sorting in renal epithelial cells . In addition , the dileucine repeat was implicated in surface expression of hENT2 , which was drastically reduced when those residues were mutated ( Mangravite et al . 2003 ) . Despite no association of COPII complex and ENTs has been conﬁrmed , sequence analysis of the intracellular regions of hENT2 suggests several putative ER export motifs , all of them conserved in both mENT2 and hENT2 : - DED diacidic motifs between TM8 - 9 - ERE diacidic motifs between TM10 - 11 - Sequences present it the intracellular loop between TM6 - 7 : • YY - di - hydrophobic residues 221 - 222 • ELE - diacidic motifs 234 - 236 • LL - di - hydrophobic residues 241 - 242 • DLDLEKEPESEPD ( DXDXEXEXEXEXD ) - acidic motifs 261 - 273 Novel approaches to understanding hENT2 and hENT2 - related proteins 22 Cyto s o l R i bosomes mRNA Go l g i c omp l e x Lysosome SEC R ETO R Y P ATHWAY R ough e ndop l a s m i c r e t i c u l um P l asmamembrane mRNA ER s i gna l sequen c e I n t ermembrane spa c e Ou t er membrane I nnermembrane Ma t r i x M i to c hondr i on Ch l orop l a s t Thy l a k o i ds Ou t er membrane I nnermembrane S t roma P e rox i s om e Ma t r i x Membrane Nu c l e u s Nu cl ear pore I nner nu cl ear membrane Ou t er nu cl ear membrane 3 4 a 4 b 1 2 2 3 4 5 6 Cy t oso lic pro t e i n 1 Targe ti ng sequen c e Figure 5 . Protein synthesis and sorting pathways . Nuclear - encoded mRNA transcripts are translated into proteins on cytosolic ribosomes after being exported from the nucleus ( step 1 ) . Nascent proteins with an ER targeting sequence ( pink ) are directed to the ER , where translation is completed ( step 2 - left ) . These proteins can move via COPII vesicles to the Golgi complex ( step 3 - left ) and be further delivered to the plasma membrane ( step 4a ) or lysosomes ( step 4b ) . Proteins lacking an ER signal sequence are completed on free ribosomes and released to the cytosol ( step 2 - right ) . Depending on whether they contain an organelle - speciﬁc targeting sequence ( pink ) or not , proteins will remain soluble at the cytosol or be imported into mitochondria , chloroplasts , peroxisomes or the nucleus , or any of these organelle membranes ( steps 3 to 6 - right ) . Figure adapted from Lodish et al . ( 2007 ) . Introduction 23 (cid:2) 4 . 2 . 2 The Golgi apparatus and glycosylation : (cid:2) Most of the proteins synthesised on the rough ER undergo glycosylation in the ER and Golgi . Carbohydrate chains in glycoproteins may be attached to the hydroxyl group in serine and threonine or to the amide nitrogen of asparagine . These are referred to as O - linked and N - linked oligosaccharides , respectively ( Keller & Simons 1997 ) . The more common N - linked oligosacharides are larger and more complex , containing several branches in mammalian cells . Its biosynthesis begins in the rough ER with addition of a preformed precursor containing 14 residues ( Glucose 3 - Mannose 9 - N - Acetylglucosamine 2 ) . The entire 14 - residue precursor is transferred to and asparagine in the tripeptide Asn - X - Ser and Asn - X - Thr ( where X is any amino acid except proline ) ( Helenius & Aebi 2001 ; Suzuki & Lennarz 2002 ; Molinari 2007 ) . Once the protein reaches the Golgi apparatus , the oligosaccharide chain is modiﬁed and the glycosylation process is then completed allowing the protein to be sorted to its ﬁnal destination ( Cheung & Reithmeier 2007 ) . (cid:2) The oligosaccharides attached to glycoproteins serve various functions . For example , some proteins require N - linked oligosaccharides in order to fold properly in the ER . When glycosylation fails , those proteins remain misfolded in the rough ER ( Buck et al . 2004 ; F . Zhou et al . 2005 ; Cheung & Reithmeier 2007 ) . In addition to promote proper folding , N - linked oligosaccharides also confer stability on many secreted glycoproteins . When those proteins are non - glycosylated due to mutations in their asparagine residues , they have been shown to be less stable and degraded faster than their glycosylated forms ( Martínez - Maza et al . 2001 ; Cai et al . 2005 ) . For instance , it has been observed that glycosylation in glucose transporters GLUT1 and GLUT4 enhances their folding and conformational stability as well as cell surface expression ( Tortorella & Pilch 2002 ) . (cid:2) Oligosaccharide on certain cell - surface glycoproteins also play a role in cell - cell adhesion . For example , CAMs ( cell adhesion molecules ) in leukocytes interact with certain CAMs found in endothelial cells lining blood vessel ( Lodish et al . 2007 ) . On the other hand , N - liked glycosylation in aquaporin ( AQP ) transporters has been shown to Novel approaches to understanding hENT2 and hENT2 - related proteins 24 play a role in exiting the Golgi apparatus and proper trafﬁcking to the plasma membrane ( Martínez - Maza et al . 2001 ; Tortorella & Pilch 2002 ; Hendriks et al . 2004 ; Buck et al . 2004 ; Cai et al . 2005 ) . Same evidences were found in the case of the human organic anion transporter ( hOAT4 ) and the human norepinephrine transporter ( NET ) ( Nguyen & Amara 1996 ; F . Zhou et al . 2005 ) . (cid:2) Some other cases have been described , in which glycosylation appeared to be crucial for the proper functionality and activity of some transporters located at the plasma membrane . For instance , ABC transporters were observed to be incapable to transport substrate in the absence of glycosylation ( Draheim et al . 2010 ) . The same effect was shown for the case of the GABA transporters ( Bennett & Kanner 1997 ) . In addition , some glycoproteins have two or more glycosylation sites like the urea transporter ( UT ) - A1 , which each one is glycosylated to a different extent ( G . Chen et al . 2006 ) . (cid:2) Since glycosylation is highly important for the physiology of a protein , those cases in which glycosylation can not be executed properly , many diseases have been attributed to ( Sturiale et al . 2005 ; Freeze & Aebi 2005 ; Kaji et al . 2007 ) . An example of such a disease is congenital muscular dystrophy which results from the lack of glycosylation inalpha - dystroglycan ( Matsumoto et al . 2005 ) . (cid:2) In the case of ENTs , two dimensional models predicted N - glycosylation sites in the extracellular loop between transmembrane domains 1 and 2 , in the Asn 48 for ENT1 and Asn 48 and Asn 57 in the case of ENT2 ( Boleti et al . 1997 ) . Those residues were conﬁrmed by mutational studies in both transporters . For ENT1 , it seems that its glycosylation is involved in nucleoside transport and / or inhibitor binding afﬁnity , as well as maintaining ENT1 structure ( Vickers et al . 1999 ; Sundaram et al . 2001 ; Ward et al . 2003 ; Reyes & Coe 2005 ; Amanchy et al . 2007 ) . Mutation of the N - linked glycosylation sites in ENT2 showed disrupted plasma membrane localization suggesting that this modiﬁcation is need for proper targeting and / or trafﬁcking ( Ward et al . 2003 ) . Introduction 25 (cid:2) 4 . 2 . 3 Phosphorylation / dephosphorylation : (cid:2) Reversible phosphorylation of proteins is an important regulatory mechanism that occurs in both prokaryotic and eukaryotic organisms , in which kinases are the enzymes that phosphorylate proteins while phosphatases dephosphorylate them . This is a fast and reversible regulatory mechanism that takes place after proteins are released from the ER and Golgi apparatus ( Procino et al . 2003 ) . It is based on the balance between phosphorylation and dephosphorylation of proteins and participates in multiple signalling and regulatory pathways within the cell physiology ( Newton 2003 ) . Reversible phosphorylation results in a conformational change in the structure of many enzymes and receptors , causing them to become activated or deactivated , what is also known as switching proteins “on” or “off” ( Olsen et al . 2006 ) . (cid:2) Phosphorylation usually occurs on serine ( S ) , threonine ( T ) and tyrosine ( Y ) residues by adding a phosphate molecule to a polar R group of such amino acid residue ( Amanchy et al . 2007 ) either directly from ATP or GTP molecules , or via interaction with another phosphorylated protein that transfers its phosphate group ( Butt & Pitman 2005 ) . This enzymatic reaction can turn a hydrophobic portion of a protein into a polar and extremely hydrophilic region , specially when it is phosphorylated at multiple sites , in such a way that introduces a conformational change in the protein with its subsequent effects . For instance , in response to extracellular stimuli , many plasma membrane receptors are phosphorylated at multiple tyrosine residues changing its conformation in order to recruit other proteins . Those proteins are subsequently phosphorylated , starting a cascade of phosphorylation events that deﬁne the beginning of a signalling pathway ( ﬁgure 6a ) ( Salazar & Höfer 2009 ) . On the other hand , phosphorylation may regulate the activity of transcription factors at several levels , such as subcellular localization , DNA binding afﬁnity and transcriptional activity ( ﬁgure 6b ) . Furthermore , multisite phosphorylation can also regulate protein stability since it may lead to ubiquitination of the target protein and its degradation by the proteosome ( ﬁgure 6c ) ( Salazar & Höfer 2009 ) . Novel approaches to understanding hENT2 and hENT2 - related proteins 26 Figure 6 . Prototypical examples of protein regulation by phosphorylation . ( a ) Receptor proteins . Binding of a high - afﬁnity ligand to the T - cell receptor ( TCR ) leads to its own phosphorylation and recruiting of ZAP - 70 kinase triggering a signalling cascade . ( b ) Transcription factors . Dephosphorylation of the nuclear factor of activated T - cells ( NFAT ) by calcineurin ( CaN ) induces a conformational change that exposes a nuclear localization signal ( NLS ) , leading to its translocation to the nucleus to bind DNA with maximal transcriptional activity . ( c ) The cell - cycle inhibitor Sic1 requires phosphorylation by the cyclin - dependent kinase Cdc28 on at least six sites before it can be ubiquitinated by the Cdc4 ⁄ SCF complex and degraded by the 26S proteasome . Figure adapted from Salazar & Höfer ( 2009 ) . c ) a ) b ) Introduction 27 (cid:2) In those cases where a protein is phosphorylated at multiple sites , it is more important the number and the order of the reactions rather than the type of site ( S , T or Y ) since that will determine the biological effects of the conformational changes . Therefore , multisite phosphorylation can occur in a variety of ways : sequential - following the order appeared in the protein sequence ; random - phosphate groups added in random order ; cyclic - once all residues are phosphorylated , the last one becomes the ﬁrst to be dephosphorylated generating a cycle ; hierarchical - one event can not happen before another one is done due to conformational inaccessibility ; and compensatory - when a target site is unavailable another site is phosphorylated causing the same biological effect ( Salazar & Höfer 2009 ; Levy et al . 2010 ; Edwards et al . 1999 ) . (cid:2) Several examples have been described regarding regulation of transporters by phosphorylation . For instance , the aquaporin protein 2 ( AQP2 ) , which is trafﬁcked to the plasma membrane when it is phosphorylated by PKA at Ser 256 . However , when PKC is the kinase involved , AQP2 is internalized by endocytosis ( van Balkom et al . 2002 ) . A similar situation happens to the serotonin transporter ( SERT ) , which reduces its transport activity by phosphorylation on a serine residue , and increases its internalization after a subsequent threonine is phosphorylated ( Jayanthi et al . 2005 ) . On the contrary , in the case of the γ - aminobutyric acid ( GABA ) transporter GAT1 , the conformational change produced by phosphorylation slows down its internalization ( Law et al . 2000 ) . An interesting example , also associated with the plasma membrane , is the endothelial nitric oxide synthase ( eNOS ) , where phosphorylation in Ser 635 and Ser 1179 activates its activity and production , while Ser 116 and Ser 617 have negative regulatory effects ( Bauer et al . 2003 ) . (cid:2) Regarding ENTs being regulated by phosphorylation , barely few is known about the mechanism to date . However , there are strong evidences that suggest these transporters might be regulated by phosphorylation either in terms of trafﬁcking and activity . Three putative kinases have been described to play a role in ENTs regulation : CKII , PKA and PKC . Putative CKII phosphorylation sites were predicted in both ENT1 and ENT2 sequences ( Kiss et al . 2000 ; Stolk et al . 2005 ; Robillard et al . 2008 ) . In one Novel approaches to understanding hENT2 and hENT2 - related proteins 28 of those studies , a mENT1 splice variant ( mENT1b ) was identiﬁed and predicted to have a potential CKII phosphorylation site at Ser 254 , within the large intracellular loop located between TM 6 and 7 ( Kiss et al . 2000 ; Handa et al . 2001 ) . Further analysis of nucleoside uptake and inhibitor sensitivity of both mENT1 isoforms ( mENT1a or wild type and mENT1b ) correlated CKII phosphorylation with a major presence of the transporters at the membrane , an increasing in substrate translocation and changes in NBTI sensitivity ( Bone et al . 2007 ) . (cid:2) PKC and PKA have also been studied regarding their role in ENTs regulation . First evidences suggesting the involvement of those kinases in ENTs regulation date from 1998 ( Sen et al . 1998 ) , but it was not until 2002 that the ﬁrst work came up demonstrating hENT1 regulation by PKC ( Coe et al . 2002 ) . In that work , PKC activation is shown to increase hENT1 nucleoside transport activity by the activation of the transporter at the cell surface . Further studies corroborated ENT1 regulation by PKC via adenosine receptors and the MAP kinases pathway ( Grden et al . 2008 ) . Latest data supported a role for PKA and PKC in the phosphorylation of ENT1 within the intracellular loop and showed that PKA can phosphorylate multiple sites within this loop , while PKC speciﬁcally targets serines 279 and 286 and threonine 274 , proving for the ﬁrst time a direct in vitro phosphorylation of ENT1 by PKA and PKC ( Reyes et al . 2011 ) . (cid:2) Despite there are no speciﬁc studies of PKA / PKC phosphorylation on ENT2 , a recent work performed by Lu et al . ( 2010 ) , revealed how adenosine accumulation , due to chronic morphine treatment , was attributable to the alteration of adenosine uptake via ENT2 . Changes in PKC activity were correlated with the attenuation of ENT2 function and thereby an accumulation of extracellular adenosine ( G . Lu et al . 2010 ) . (cid:2) 4 . 2 . 4 Protein trafﬁcking to the plasma membrane and other organelles : (cid:2) After membrane proteins are synthesised and matured along its passage through the ER and Golgi apparatus , they are trafﬁcked to its ﬁnal destination via the secretory pathway ( Aridor & Traub 2002 ) . Those vesicles , which have been originated Introduction 29 at the ER and Golgi , move along the cellular cytoskeleton , interacting either with ﬁlaments of actin or microtubulues ( Stamnes 2002 ; Salmon et al . 2002 ; Rodriguez et al . 2003 ; Racine et al . 2007 ) . (cid:2) The cytoskeleton is formed by two main structures , actin ﬁlaments and microtubules . Actin is a highly conserved protein and it participates in maintaining the cell shape and in cell mobility as well ( van den Ent et al . 2001 ; Otterbein et al . 2002 ; Roffers - Agarwal et al . 2005 ) . The particularity of actin ﬁlaments is the tight networks they form closely associated and lying just beneath the plasma membrane ( Tseng et al . 2005 ) . In fact , there is a constant communication between plasma membrane components and actin cytoskeleton mediated by Phosphatidylinositol 4 , 5 - bisphosphate ( PtdIns - 4 , 5 - P2 ) . The interactive signalling regulates , for instance , the cytoskeleton remodelling during membrane invagination during endocytosis or the signalling cascades via protein - protein interactions ( Sechi & Wehland 2000 ; Robertson et al . 2009 , Saarikangas et al . 2010 ) . On the other hand , microtubules are cylindric structures constituted by dimers of α - and β - tubulin ( Diaz - Font & Beales 2008 ) . These structures also participate of the transport of vesicles and organelles within the cell ( Tietz et al . 2006 ) . (cid:2) Once those vesicles are released from the Golgi apparatus , a set of small GTP - binding proteins , known as Rab proteins , participate in the targeting of the vesicles to the appropriate target membrane ( Lodish et al . 2007 ) . Shortly after a vesicle buds off from the donor membrane , the vesicle coat disassembles to uncover a vesicle - speciﬁc membrane protein known as v - SNARE . Likewise , each type of target membrane in a cell contains speciﬁc t - SNARE membrane proteins . After Rab - mediated docking of a vesicle on its target membrane , the interaction of both cognate SNAREs brings the two membranes close enough together that they can fuse ( Fletcher et al . 2000 ; Leabu 2006 ; Lodish et al . 2007 ; Pocard et al . 2007 ) . Following the vesicle fusion with its target membrane , SNARE proteins dissociate and are recycled back to the ER to join more vesicular structures and trafﬁc other proteins ( Bonifacino & Glick 2004 ) . Novel approaches to understanding hENT2 and hENT2 - related proteins 30 (cid:2) Several studies have described the role of vesicular trafﬁcking and interactions with the cytoskeleton for some transporters at the plasma membrane . For instance , the kidney anion exchanger 1 ( kAE1 ) has been suggested to interact with actin indirectly , what helps to stabilise kAE1 at the basolateral cell surface ( Keskanokwong et al . 2007 ) . Actin has also been involved with both serotonin ( SERT ) and dopamine ( DAT ) transporters , which seemed to co - localize at the cell surface ( Ukairo et al . 2005 ; Gill et al . 2008 ) . On the other hand , microtubules have also been related to some transporters such as the glucose transporter GLUT4 . Depolymeration of microtubules resulted in a decrease in GLUT4 translocation to the plasma membrane and therefore glucose uptake ( Fletcher et al . 2000 ) . A similar case was described for the Na + / H + exchanger ( NHE3 ) , where inhibition of microtubule polymerization after treatment with colchicine resulted in the loss of translocation of the transporter to the plasma membrane ( Sabolić et al . 2002 ) . (cid:2) A recent study identiﬁed the mechanism involved in hENT trafﬁcking to the plasma membrane . In that case , hENT1 is trafﬁcked in association with microtubules and incorporated in the plasma membrane where it subsequently undergoes clathrin - mediated endocytosis and recycling ( Nivillac et al . 2011 ) . On contrary , there is no information currently available regarding ENT2 and the mechanism involved in its trafﬁcking to the plasma membrane . However , there are some evidences that described the participation of RS1 in CNTs transport to the plasma membrane ( Errasti - Murugarren et al . 2012 ) . RS1 is a transporter regulator initially identiﬁed as a short - term post - transcriptional regulator of the high - afﬁnity Na + - coupled glucose transporters ( SGLTI ) ( Korn 2001 ) that coordinately down - regulates the localization and activity at the plasma membrane of the three members of the CNT family , probably acting as inhibitor of their exocytosis ( Errasti - Murugarren et al . 2012 ) . (cid:2) ENTs have been observed to be located at the plasma membrane as well as the mitochondria ( Mangravite et al . 2003 ; E . - W . Lee et al . 2006 ) , but they have also been described to be present at the nuclear membrane . Mani et al . ( 1998 ) demonstrated the presence of functional hENT1 and hENT2 in nuclear envelopes and endoplasmic reticulum of cultured human choriocarcinoma BeWo cells , by functional Introduction 31 reconstitution in proteoliposomes ( Mani et al . 1998 ) . In fact , a spliced variant of ENT2 , named HNP36 , had been previously described as a delayed - early response gene located at the nuclear membrane ( Williams & Lanahan 1995 ) . The lipid bilayer nuclear envelope ( NE ) comprises the outer nuclear membrane ( ONM ) and the inner nuclear membrane ( INM ) . The ONM is contiguous to the ER membrane , whereas the INM has a different protein composition and is associated with underlaying chromatin and lamina . The INM and ONM are joined at the NPC , which form aqueous channels embedded in the NE ( Stewart 2007 ) . There is no evidence to predict whether ENTs would be located at the INM or ONM , however there is a well described mechanism of trafﬁcking for membrane proteins from ER to the INM known as the INTERNET pathway ( Y . - N . Wang et al . 2010 ) . (cid:2) Nuclear translocation of INM proteins is a related example for studying the nuclear trafﬁcking of integral membrane proteins . Multiple mechanisms of nuclear transport , which depend on the unique characteristics of the INM proteins , have been reported , including simple or gated lateral diffusion , veiscle fusion events and classical Nuclear Pore Complex ( NPC ) - mediated nuclear import ( Zuleger et al . 2008 ) . The rules governing the targeting of integral membrane proteins to the INM depend on several characteristics , such as the size of the extralumenal domain , the involvement of the Nuclear Localization Signals ( NLS ) and the afﬁnity of the NLS for the karyopherins / importins . Proteins are the targeted to the INM of the NE through the OMN and NPC . The INM targeting process for the ER - to - NE transport of integral membrane proteins is known as the INTERNET pathway , standing for the INtegral Trafﬁcking from the ER to the NE Transport ( Y . - N . Wang et al . 2010 ) ( ﬁgure 7 ) . Novel approaches to understanding hENT2 and hENT2 - related proteins 32 Figure 7 . A model of integral trafﬁcking from the ER to the NE transport ( INTERNET ) . Integral INM proteins initially inserted into the ER membrane are targeted to the INM of the NE through the ONM and NPC . This INTERNET model may be involved in the nuclear transport of other integral membrane proteins such as cell surface EGFR RTKs . Figure adapted from Wang et al . ( 2010 ) . Introduction 33 5 ALTERNATIVE SPLICING 5 . 1 ALTERNATIVE SPLICING MECHANISM (cid:2) (cid:2) Alternative splicing is a process by which the exons of the RNA produced by transcription of a gene ( a primary gene transcript of pre - mRNA ) are reconnected in multiple ways during RNA splicing . The resulting different mRNAs may be translated into different protein isoforms , thus a single gene may code for multiple proteins ( Black 2003 ) . (cid:2) The splicing model accepted to date consists in that once the pre - mRNA has been transcribed from the DNA ( it includes several introns and exons ) , the exons to be retained in the mRNA are determined during the subsequent splicing process . However , a very recent model described that in the human genome , splicing occurs predominantly during transcription , becoming a co - transcriptional splicing ( Tilgner et al . 2012 ) . Anyway , the regulation and selection of splice sites is done by trans - acting splicing activators and splicing repressor proteins . Splicing of mRNA is performed by a RNA and protein complex known as the spliceosome , containing snRNPs designated U1 , U2 , U4 , U5 and U6 ( U3 is not involved in mRNA splicing ) ( ﬁgure 8 ) ( Ritchie et al . 2009 ) . U1 binds to 5ʼ GU and U2 binds to the branch region with the assistance of the U2AF protein factors . The complex at this stage is known as the spliceosome A complex . Formation of the A complex is usually the key step in determining the end of the intron to be spliced out , and deﬁning the end of the exon to be retained ( Matlin et al . 2005 ) . The U4 , U5 , U6 complex binds , and U6 replaces the U1 position . U1 and U4 leave and the remaining complex performs two transesteriﬁcation reactions . In the ﬁrst transesteriﬁcation , 5ʼ end of the intron is cleaved from the upstream exon and joined to the branch site by a 2ʼ , 5ʼ - phosphodiester bond . In the second transesteriﬁcation , the 3ʼ end of the intron is cleaved from the downstream exon , and the two exons are joined by a phosphodiester bond . The intron is then released in lariat form and degraded ( Black 2003 ; Ritchie et al . 2009 ) . Novel approaches to understanding hENT2 and hENT2 - related proteins 34 Figure 8 . Splicing of pre - mRNA by the spliceosome . ( a ) Intron structure highlighting conserved sequences at the 5′ and 3′ splice sites , the optimal branch sequence , and metazoan polypyrimidine tract . The preferred branch adenosine is indicated ( ⁎ ) . ( b ) Sequential transesteriﬁcation reactions catalyzed by the spliceosome . ( c ) Stepwise assembly of the spliceosome on a pre - mRNA showing sequential association of U1 , U2 , U4 / U6·U5 snRNPs with the intron . Figure adapted from Ritchie et al . ( 2009 ) . Introduction 35 (cid:2) Alternative splicing is one of the most important mechanisms to generate a large number of mRNA and protein isoforms from the surprisingly low number of human genes . Unlike promoter activity , which primarily regulates the amount of transcripts , alternative splicing changes the structure of transcripts and their encoded proteins . Together with nonsense - mediated decay ( NMD ) , at least 25 % of all alternative exons are predicted to regulate transcript abundance . Molecular analyses during the last decade demonstrate that alternative splicing determines the binding properties , intracellular localization , enzymatic activity , protein stability and post - translational modiﬁcations of a large number of proteins . The magnitude of the effects ranges from a complete loss of function or acquisition of a new function to very subtle modulations , which are observed in the majority of cases reported ( ﬁgure 9 ) . Alternative splicing factors regulate multiple pre - mRNAs and recent identiﬁcation of physiological targets showed that a speciﬁc splicing factor regulates pre - mRNAs with coherent biological functions . Therefore , evidences are now supporting that alternative splicing coordinates physiologically meaningful changes in protein isoform expression and is a key mechanism to generate the complex proteome of multicellular organisms ( Stamm et al . 2005 ) . Figure 9 ( next page ) . Generation of complex protein expression patterns by alternative splicing . Cells are indicated as large squares ; the cell nucleus is indicated as a large circle . Three genes are shown in the nucleus and are indicated by different colors . Proteins generated by these genes are shown in the same color on the right of each cell . Boxes indicate exons , horizontal lines show introns . Small ellipses indicate proteins . Each gene has an alternative spliced exon ( AE1 , AE2 and AE3 ) and splicing regulation is achieved by regulatory proteins 1 ( yellow ) and 2 ( green ) that activate an exon after binding to the appropriate enhancer ( yellow or green square in the exon ) . ( a ) None of the splicing regulatory proteins is expressed , leading to skipping of all alternative exons . ( b ) Only the splicing regulatory protein 1 is expressed , resulting in the inclusion of AE1 and the expression of transmembrane protein ( red ) . Binding to exon AE2 cannot activate the inclusion of this exon , as additional factors are needed ( green ) . Novel approaches to understanding hENT2 and hENT2 - related proteins 36 ( c ) Only the splicing regulatory protein 2 is expressed . It induces the alternative exon AE3 that encodes a phosphorylation site , which results in the binding of the protein encoded by gene 2 to the one made by gene 3 . ( d ) Both splicing factors 1 and 2 are expressed . AE2 is activated because the binding of both factors is stabilized by the protein – protein interaction ( red area between the splicing factors ) . Since exon AE2 encodes a premature stop codon , no protein is made ( dashed circle ) . ( e ) External signals can change splice - site selection . In this example , an ion inﬂux into the cell ( orange dashed line ) activates a kinase ( kin ) that phosphorylates the yellow splicing factor 2 . As a result , exon AE2 is skipped and protein is made . Figure adapted from Stamm et al . ( 2005 ) . Introduction 37 5 . 2 . REGULATION AND DYSREGULATION OF ALTERNATIVE SPLICING (cid:2) Organisms regulate alternative splice site selection by changing the concentration and activity of splicing regulatory proteins . This is achieved by de novo protein synthesis , by regulation of the intracellular localization and by phosphorylation ( Stamm 2002 ) . Since splice sites are highly degenerated , protein complexes forming on the pre - mRNA help in the high - ﬁdelity recognition of exons . Serine / arginine - rich ( SR ) proteins and hnRNPs are the major classes of proteins identiﬁed in these complexes . They generally possess RNA - binding and protein - interaction domains that allow weak , transient binding between protein and pre - mRNA as well as between proteins . The combination of these multiple weak interactions ultimately leads to the proper recognition of exons by the spliceosome ( Smith & Valcárcel 2000 ; Maniatis & Tasic 2002 ) . Phosphorylation can either increase or decrease alternative exon usage , which most likely reﬂects that it can both promote and inhibit protein - protein interactions . Protein phosphatases cause the dephosphorylation of SR - proteins , what is necessary for the transesteriﬁcation reaction ( Cao et al . 1997 ) . (cid:2) Studies of the SR - protein class of regulators identiﬁed different kinases , such as MAPK ( Al - Ayoubi et al . 2012 ) , and protein phosphatase 1 as the molecules that control reversible phosphorylation , which regulates not only splice site selection , but also the localization of SR - proteins and mRNA export . The involvement of protein phosphatase 1 explains why second messengers like cAMP and ceramide that control the activity of this phosphatase inﬂuence alternative splicing . The emerging mechanistic links between splicing regulatory proteins and known signal transduction pathways now allow in detail the understanding how cellular signals modulate gene expression by inﬂuencing alternative splicing . This knowledge can be applied to human diseases that are caused by the selection of wrong splice site ( Stamm 2008 ; Novoyatleva et al . 2008 ) . (cid:2) Since a ﬁne - tuned balance of factors regulates splice site selection , a disturbance of this balance can cause human disease by leading to distinct products of gene expression ( Tazi et al . 2009 ; J . - Y . Wu et al . 2003 ) . Antagonistic splice variants of Novel approaches to understanding hENT2 and hENT2 - related proteins 38 genes involved in differentiation , apoptosis , invasion and metastasis often exist in a delicate equilibrium that is found to be perturbed in tumours . In several recent examples , splice variants that are over - expressed in cancer are expressed as hyperoncogenic proteins , which often correlate with poor prognosis , thus suggesting improved diagnosis and follow up treatment . Global gene expression technologies are just beginning to decipher the interplay between alternatively spliced isoforms and protein - splicing factors that will lead to identiﬁcation of the mutations in these trans - acting factors responsible for pathogenic alternative splicing in cancer ( Venables 2006 ; Venables et al . 2009 ) . (cid:2) Research during the last few years identiﬁed a number of low – molecular - mass chemical substances that can change alternative exon usage . Most of these substances act by either blocking histone deacetylases or by interfering with the phosphorylation of splicing factors . How the remaining large number of these substances affect splicing is not yet fully understood . The emergence of these low - molecular - mass substances provides not only probes for studying alternative pre - mRNA splicing , but also opens the door to the possible harnessing of these compounds as drugs to control diseases caused by the selection of ʻwrongʼ splice sites ( Garcia - Blanco et al . 2004 ; Hagiwara 2005 ; Sumanasekera et al . 2008 ) . 5 . 3 ALTERNATIVE SPLICING VARIANTS OF NUCLEOSIDE TRANSPORTERS (cid:2) For nucleoside transporters , very few spliced variants have been described to date and their roles as novel functional transporters remain unclear . For the SLC28 family , the Concentrative Nucleoside Transporters , one spliced variant has been described for the CNT3 family member ( Errasti - Murugarren et al . 2009 ) . In this case , the novel protein does not reach the cytoplasmic membrane but it is retained at the endoplasmic reticulum , except when in a polarized system . This variant seems to be functional although its role inside the cell remains unclear . Introduction 39 (cid:2) In the case of ENTs more variants have been previously described . For mENT1 , the ﬁrst variant was described in 2000 , and is a protein which is identical to the wild type isoform but with 2 extra amino - acids in the internal loop . This addition results in the protein acquiring a new putative CK2 phosphorylation site that makes the protein functional but less active than the wild type ( Kiss et al . 2000 ) . In 2008 , a novel variant was found in which exon 11 had been skipped resulting in the protein missing the last three transmembrane domains . This protein reaches the plasma membrane and is as active as the wild type but less sensitive to the inhibitor NBMPR ( Robillard et al . 2008 ) . Intriguingly , no spliced variants have been described for hENT1 to date . In contrast , many polymorphic variants have been analyzed , in which some cases regulation by CK2 is altered ( Handa et al . 2001 ; Bone et al . 2007 ) , or where the functionality as a nucleoside transporter is modiﬁed ( Osato et al . 2003 ; Fukuchi et al . 2010 ; Kim et al . 2011 ) . (cid:2) ENT2 is the nucleoside transporter with the most spliced variants described so far . In 2005 , a rbENT2 protein isoform was described , which was missing 41 residues but was still functional ( S . K . Wu et al . 2005 ) . Previously , in 2003 , a hENT2 spliced variant was found , which possessed a 40 base pair deletion in exon 9 resulting in a 301 amino acid protein named hENT2A ( Mangravite et al . 2003 ) . This protein never reached the plasma membrane but stayed in an intracellular location within vesicular structures , and consequently no transport activity was determined . The most interesting ENT2 spliced variant found to date , due to its novel location , is the HNP36 protein , which is a 36 KDa hydrophobic nucleolar protein described as a mitogenic delayed - early response gene ( Williams & Lanahan 1995 ; Crawford et al . 1998 ) . Novel approaches to understanding hENT2 and hENT2 - related proteins 40 (cid:2) Nucleoside transporters , besides internalizing their natural substrates , are responsible for the uptake of some anticancer and antiviral nucleoside - derived drugs . Nucleoside - based therapies might associate with chemoresistance and , among other factors , impaired drug uptake into the target cell may be a major cause of unsuccessful therapies . hENT2 plays an important role in leukemias and lymphomas , such as Chronic Lymphocytic Leukemia ( CLL ) ( Pastor - Anglada et al . 2004 ) , due to the fact that hENT2 mediates the cytotoxic effect of ﬂudarabine , a major choice in CLL treatment . In addition , hENT2 has also been identiﬁed as one of the ﬁve genes that allow to predict positive outcome in Mantle Cell Lymphoma ( MCL ) patients ( Hartmann et al . 2008 ) . Thus , it is clear the relevance of nucleoside transporters , specially hENT2 , in anticancer therapies . However , hENT2 mRNA levels did not show any correlation with protein expression and transport activity in CLL ( Molina - Arcas et al . 2003 ) , suggesting , among other possibilities , that not all the mRNA expressed would be translated into protein ( Molina - Arcas et al . 2003 ) . This would be consistent with different hENT2 transcripts of still unknown function . (cid:2) Understanding how a protein implicated in drug uptake and action is regulated is the ﬁrst step to ﬁgure out new strategies to improve nucleoside - based therapies . ENTs have been suggested to be regulated by phosphorylation , and despite some work described the effects of phosphorylation on ENT1 ( Stolk et al . 2005 ; Bone et al . 2007 ; Coe et al . 2002 ; Grden et al . 2008 ; Reyes et al . 2011 ) , there are very few studies about the biological effects of phosphorylation on ENT2 . Moreover , as introduced above , sets of genes might have prognostic value and this anticipates unknown relationships among genes that may help to build up novel gene networks . Elucidating the connection of our target gene in a global gene network , or picturing different protein - protein interactions that regularly take place in the cell , should provide us with valuable information to spot hENT2 , in our case , in a wide image of the cell physiology and its functioning and regulation . Research Objectives 43 Based on these issues , the speciﬁc objectives of this dissertation were : 1 . To Identify and characterise novel splice variants of the human Equilibrative Nucleoside Transporter 2 ( hENT2 ) . 2 . To study the phosphorylation status of hENT2 and the role phosphorylation might play in transporter trafﬁcking and activity . 3 . To perform a large - scale screening for hENT2 protein - protein interactions using the Membrane Yeast Two - Hybrid ( MYTH ) technique . 4 . To identify putative novel gene networks involving nucleoside transporters ( a transportome approach ) and their role in the pharmacogenetic response of solid tumors to drug therapy . Novel approaches to understanding hENT2 and hENT2 - related proteins 44 6 CELL CULTURE 6 . 1 INTRODUCTION (cid:2) Cell culture is the complex process by which cells are grown outside of their natural environment , in a proper atmosphere that provides the conditions need to conserve their physiological , biochemical and genetic properties . Experimenting with cell culture provides notable advantages to the biomedical research since it allows the study and analysis of relatively homogenous cell populations . (cid:2) Culture prepared directly from tissues of a speciﬁc organism is called primary cell culture . Likewise , established or immortalised cell lines can be generated by acquiring the ability to proliferate indeﬁnitely either through random mutation or deliberate modiﬁcation , such as artiﬁcial expression of the telomerase gene . Numerous cell lines were well established as representative of particular cell types . Cell lines are better conserved than primary cell culture and they also allow to perform long term experiments . However , since they lost the proliferation control , they also lost some particular cell features becoming less differentiated than the original tissue . (cid:2) Depending on their capacity of adhesion to the different culture support surface , cells can be grown in suspension or as monolayer . In the last case , cells depend on the binding to the surface and do not start to proliferate until being attached to the support . Generally , cells coming from organs grow in monolayer , while blood cells usually grow in suspension . However , some certain cell lines can form multiple layers or even grow in both ways , monolayer and suspension . 6 . 2 CELL CULTURE TECHNIQUE (cid:2) Working with cell culture entails the maintaining of strict sterile conditions . Therefore , it is need to always work in laminar ﬂow cabinets sterilized with ultraviolet Materials and Methods 47 light ( UV ) and autoclaved material sprayed with ethanol 70 % . Cell culture material includes : i . Laminar ﬂow cabinet with UV system , vacuum system for liquids aspiration and Bunsen burner . ii . Cell culture incubator with a controlled atmosphere at 37ºC , 5 % CO 2 and 95 % relative humidity . iii . Cryogenic equipment : - 20ºC and - 80ºC freezers , liquid nitrogen tank and a freezing container providing the critical 1ºC / min cooling rate required for successful cryopreservation of cells . iv . Thermostated bath at 37ºC . v . Sterilizing material : ethanol 97 % , ﬁlter pump and autoclave system . vi . Inverted optical microscope . vii . Neubauer chamber for cell counting . viii . Other material : pipette controller , plates , ﬂasks etc . 6 . 3 CELL LINES CULTURE (cid:2) Cell line maintaining involves the use of culture medium with all the nutrients required for the cell growing . Those media are regularly supplemented with serum and other components to compensate the lack of growing factors and aminoacids like glutamine . Antibiotics and antimycotics are often added to the medium to prevent infections . (cid:2) Basic cell culture maintaining involves plating part of a grown culture with high density of cells to a new plate or ﬂask with fresh medium to guarantee its viability . Despite cells are immortalized and they could keep on dividing indeﬁnitely , this plating process might cause an undesired accumulation of mutations and senescence of the cells . Therefore , it is needed to amplify and freeze some aliquots of cells of low passages . Novel approaches to understanding hENT2 and hENT2 - related proteins 48 (cid:3) 6 . 3 . 1 Detaching and plating : (cid:2) In order to detach cells from their growing support and plate them in a new surface we need the use of substances such as trypsin or EDTA . Trypsin is a proteolytic enzyme belonging to the group of serine proteases that breaks the intercellular bindings . EDTA is a chelant molecule that retains Ca 2 + ions required for cell - cell adhesion . (cid:2) This process needs to be done inside a laminar ﬂow cabinet in sterile conditions . Once cells reach a certain conﬂuence , depending on the cell line type , we aspirate the medium and add sterile PBS to remove any trace of serum left . Some serum components might interfere with the trypsin action , so it is important to ensure cells are clean before adding trypsin . Subsequently , we aspirate PBS and add the minimum volume of trypsin required for the correct disaggregation of cells . Trypsin volume depends on the size of the support . Incubation at 37ºC during trypsin treatment might be recommended depending on the cell type . Once conﬁrming a correct disaggregation under the microscope , the next step is to add new fresh medium supplemented with serum to inactivate the enzymatic activity of the trypsin . Mechanical disaggregation with a pipette is recommended . (cid:2) Afterwards , cells may be frozen in aliquots and kept at - 80ºC or seeded on new plates or ﬂasks . If the purpose is just to do a regular maintaining of the culture , cells are diluted and plated on a new ﬂask with fresh medium . Dilution factor will depend on the cell type . If the aim is to seed cells for a particular experiment , then it is need to count the density of cells with the Neubauer chamber and dilute the cells to a speciﬁc density to plate them according to the design of the experiment . (cid:3) 6 . 3 . 2 Freezing and thawing : (cid:2) Cell freezing requires the use of cryoprotectant agents like glycerol or DMSO that promote the cell viability after freezing . Freezing medium composition may vary depending on the researcher but in our particular case we used FBS with 10 % DMSO . Materials and Methods 49 Cryoprotectant agents are toxic for the cell at room temperature when their concentration is more than 2 % . Therefore , it is very important to reduce the contact time of the cells with these compounds and proceed rapidly . (cid:2) After trypsinization , cells are centrifuged at 2500 x g for 3 - 5 minutes . Then media is removed and cells are resuspended in freezing medium and aliquoted ( 2 , 000 , 000 cells / tube ) in 2ml cryotubes . Rapidly , cryotubes are introduced into the freezing container at - 80ºC for a minimum of 4h and a maximum of 1 month . Cryotubes are lately conserved in a liquid nitrogen tank for years if wished . Cell lines and media used in this dissertation are described in table 1 . 6 . 4 CYCLOHEXIMIDE TREATMENT (cid:2) Cycloheximide ( CHX ) is an inhibitor of protein biosynthesis in eukariotic organisms , produced by the bacterium Streptomyces griseus . CHX exerts its effect by interfering with the translocation step in protein synthesis thus blocking translational elongation . CHX is widely used in biomedical research to inhibit protein synthesis in eukaryotic cells studied in vitro . It is inexpensive and works rapidly . Its effects are rapidly reversed by simply removing it from the culture medium . (cid:2) CHX may be used to distinguish between proteins translated in the mitochondria and proteins translated in the cytosol . mRNA translated in cytosol or ER from mRNA derived from the nucleus will not be expressed in the presence of CHX . Conversely , translation using mitochondrial ribosomes is unaffected by CHX and mitochondrial genes will continue to be expressed . CHX can also be used in molecular biology to determine the half - life of a protein treating cells with CHX in a time - course experiment and analyzing the protein expression by immunoblotting . In this thesis we mainly used CHX for two different purposes : to reduce protein background at the ER in immunocytochemistry assays , and to block the NMD pathway and determine mRNA surveillance . Novel approaches to understanding hENT2 and hENT2 - related proteins 50 Table 11 . Cell lines and meedia used Cell line Origin Source Medium HeLa Human cervix , epithelial adenocarcinoma ATCC K : CCL - 2 DMEM + 10 % FBS + 1 % Gln + 1 % Anti HEK - 293 Human embryonic kidney , epithelial ATCC K : CRL - 1573 DMEM + 10 % FBS + 1 % Gln + 1 % Anti MCF7 Human mammary gland , epithelial adenocarcinoma ATCC K : HTB - 22 DMEM + 10 % FBS + 1 % Gln + 5 % Anti BeWo Human placenta , epithelial choriocarcinoma ATCC K : CCL - 98 DMEM - F12 + 10 % FBS + 1 % P / S Medium needs to be replaced daily PanC - 1 Human pancreas duct , epithelioid carcinoma Dr . A . Mazo DMEM + 10 % FBS + 1 % Gln + 1 % Anti BxPC3 Human pancreas , epithelial adenocarcinoma Dr . A . Mazo DMEM + 10 % FBS + 1 % Gln + 1 % Anti NP9 Human pancreas , epithelial adenocarcinoma Dr . A . Mazo DMEM - F12 + 10 % FBS + 1 % Anti NP29 Human pancreas , epithelial adenocarcinoma Dr . A . Mazo DMEM - F12 + 10 % FBS + 1 % Anti NP31 Human pancreas , epithelial adenocarcinoma Dr . A . Mazo RPMI 1640 + 10 % FBS + 1 % Gln + 1 % Anti AGS Human stomach , epithelial gastric adenocarcinoma ATCC K : CRL - 1739 F12 - K + 10 % FBS + 1 % Gln + 1 % Anti SNU - 1 Human stomach , epithelial gastric adenocarcinoma ATCC K : CRL - 5971 RPMI 1640 + 10 % FBS + 1 % Gln + 1 % Anti SNU - 5 Human stomach , epithelial gastric adenocarcinoma ATCC K : CRL - 5973 IMDM + 20 % FBS + 1 % Gln + 1 % Anti MKN - 45 Human stomach , epithelial gastric adenocarcinoma DSMZ L : ACC 409 RPMI 1640 + 10 % FBS + 1 % Gln + 1 % Anti KATO III Human stomach , epithelial gastric adenocarcinoma ATCC K : HTB - 103 IMDM + 20 % FBS + 1 % Gln + 1 % Anti Mz - ChA - 1 Human gallbladder , epithelial adenocarcinoma Dr . A . Knuth RPMI 1640 + 1 % GlutaMAX TM - 1 + 1 % Mz - ChA - 2 Human gallbladder , epithelial adenocarcinoma Dr . A . Knuth Sodium Pyruvate + 1 % MEM non - essential aa + 1 % Gln + 1 % P / S + 10 % FBS heat SK - ChA - 1 Human bile duct , epithelial carcinoma Dr . A . Knuth inactivated TFK - 1 Human bile duct , epithelial carcinoma DSMZ L : ACC 344 RPMI 1640 + 10 % FBS + 1 % Gln + 1 % Anti EGI - 1 Human bile duct , epithelial carcinoma DSMZ L : ACC 385 DMEM + 10 % FBS + 1 % Gln + 1 % Anti Gln : L - Glutamine ; Anti : Anntibiotic - antimycotic ; P / S : Penicillin - Streptomycin Materials and Methods 51 (cid:2) Common CHX concentrations used in biology research are within the range of 1 - 20 μg / ml . The classical protocol used for CHX treatment starts preparing the necessary volume of medium pre - warmed at 37ºC , and adding the volume of CHX stock needed to get a desired ﬁnal concentration . Following , old medium is removed from the cell culture and replaced by the fresh medium with CHX incorporated . Since CHX is a photosensitive molecule , we recommend to work with lights off inside the cabinet . After 3 hours incubating the cells at 37ºC with CHX , treatment is removed and cells are ready to continue with the following steps of the experiment . 6 . 5 TRANSIENT TRANSFECTION FOR HETEROLOGOUS GENE EXPRESSION IN CELLS (cid:2) Transfection is the process of deliberately introducing nucleic acids into cells , speciﬁcally for non - viral methods in animals cells . Other terms are used when transfection is virus - mediated ( transduction ) , or when is a non - viral DNA transfer in bacteria or non - animal eukaryotic cells ( transformation ) . Genetic material , such as supercoiled plasmid DNA or siRNA constructs , are transfected into animal cells by typically opening transient pores in the cell membrane to allow the material uptake . (cid:2) Transfection can be carried out by using calcium phosphate , by electroporation , or by mixing a cationic lipid with the material to be transfected in order to produce liposomes , which will fuse with the cell membrane and deposit their cargo inside . Since it is an aggressive technique for the cell , transfection can result in unexpected morphologies and abnormalities in target cells . (cid:2) For most experimental applications , it is sufﬁcient if the transfected genetic material is only transiently expressed . Since the DNA introduced in the transfection process is usually not integrated into the nuclear genome , the foreign DNA will be diluted through mitosis or degraded . If desired , a stable transfection where the transfected material is incorporated into the cell genome must occur . Novel approaches to understanding hENT2 and hENT2 - related proteins 52 (cid:2) To accomplish this , a marker gene is co - transfected , like the neomycin resistance gene . That gene gives the cell some selectable advantage , such as resistance toward the toxin geneticin . Some of the transfected cells will , by chance , have integrated the foreign genetic material into their genomes . If the toxin is then added to the cell culture , only those few cells with the marker gene integrated into their genomes will be able to proliferate , while other cells will die . After applying this selective stress for some time , only cells with a stable transfection remain and can be further cultivated . (cid:3) 6 . 5 . 1 Calcium phosphate transfection : (cid:2) This method is based on the precipitated formed from calcium chloride and the DNA in a phosphate saline solution . Those aggregates are incorporated inside the cell by endocytosis or even phagocytosis . Calcium attached to the DNA protects it from being degraded by nucleases . Size and quality of those aggregates are critical for this protocol , therefore little changes in the pH might increase the efﬁciency drastically . Before transfecting DNA into a determined cell line , pH optimization needs to be done to ensure a maximum efﬁciency of the experiment . Transfection efﬁciency can be analyzed using a GFP vector to determine the percentage of transfected cells at any pH . The same way , GFP plasmid can be used as positive control for any transfection assay . (cid:2) For this kind of transfection method , cells must be around 40 - 60 % conﬂuent . First , old medium is removed and replaced by fresh new medium properly supplemented according to the cell line requirements . Following , transfection mixed is prepared in a sterile tube , adding the different components according to that order : (cid:2) (cid:2) 1st . Sterile water and DNA sample (cid:2) (cid:2) 2nd . Transfection calcium buffer (cid:2) (cid:2) 3rd . Transfection phosphate buffer Materials and Methods 53 (cid:2) Reagents are mixed by bubbling and incubated at room temperature for 15 minutes to form the DNA - calcium aggregates . Then , the transfection mix is added drop by drop to the cell culture and it is incubated overnight at 37ºC . Transfection medium is removed the following day and cells can be assayed within 24 - 72 hours after transfection . (cid:2) DNA used in transfection protocols should be obtained from a maxi - prep , since the concentration and the quality of the DNA is better than a mini - prep . The amount of the DNA added to the transfection mix is 0 . 35 μg / cm 2 , considering the surface of the cell culture support ( plates or wells ) . The volume of the transfection mixed added cannot exceed 10 % of the total volume of the medium added to the cell culture ( table 2 ) . Table 2 . CConditions of calcium - phosphate transfection mix Culture Vessel DNA Sterile water Calcium buffer Phosphate buffer Culture medium 24 - well plate 0 . 7 μg 12 . 5 μl 12 . 5 μl 25 μl 0 . 5 ml 6 - well plate 3 . 5 μg 50 μl 50 μl 100 μl 2 ml 60 - mm plate 7 μg 125 μl 125 μl 250 μl 5 ml 100 - mm plate 21 μg 250 μl 250 μl 500 μl 10 ml 150 - mm plate 52 μg 0 . 75 ml 0 . 75 ml 1 . 5 ml 30 ml (cid:3) 6 . 5 . 2 Lipofectamine® 2000 transfection : (cid:2) Lipofectamine® 2000 transfection is based on the formation of complexes from a cationic lipid and DNA producing liposomes . Those liposomes will fuse with the cell membrane internalizing the genetic material into the cytoplasm . The mortality rate of that technique is even higher than using calcium - phosphate , therefore initial culture should be at 75 - 90 % of conﬂuence before transfection . However , the efﬁciency of transfection is also higher using lipofectamine® and it also allows the transfection of siRNAs . Novel approaches to understanding hENT2 and hENT2 - related proteins 54 (cid:2) Once cells are ready to be transfected , ﬁrst step is to remove the old culture medium and replace it by fresh new non - supplemented medium , since antibiotics and serum might interfere in the liposomes formation . In one sterile tube , lipofectamine® and non - supplemented medium are mixed and incubated at room temperature for 5 minutes . In another sterile tube , DNA is added to non - supplemented medium ( table 3 ) . Both preparations are eventually mixed adding the lipofectamine® to the DNA tube . After mixing , this transfection mix is incubated for 20 minutes at room temperature and added to the cell culture . Cells are incubated for 4 hours at 37ºC . Afterwards , transfection mix is replaced by fresh medium properly supplemented . Cells can be assayed within 24 - 72 hours after transfection . Table 3 . Conditions of lipoffectamine®® 2000 transfection mixx Culture Vessel DNA Non - sup . medium Lipofect . Non - sup . medium Culture medium 24 - well plate 0 . 8 μg 50 μl 2 μl 50 μl 0 . 5 ml 6 - well plate 4 μg 200 μl 10 μl 200 μl 2 ml 60 - mm plate 8 μg 0 . 5 ml 20 μl 0 . 5 ml 5 ml 100 - mm plate 24 μg 1 . 5 ml 60 μl 1 . 5 ml 15 ml 150 - mm plate 60 μg 3 ml 150 μl 3 ml 30 ml 7 CYTOTOXICITY ASSAYS (cid:2) Cytotoxicity assays are performed to determine the cell - killing property of a chemical compound without deﬁning any speciﬁc cellular death mechanism . There are several methods commonly used to detect cell viability , in our case we used the MTT assay . 7 . 1 CELL SEEDING AND TREATMENT (cid:2) To perform this kind of experiments cells are seed on 96 - well plates with the help of a multichannel pipette to ensure each well has the same amount of cells . Next Materials and Methods 55 day , once cells are settled onto the well surface , treatments are administrated for 24 - 72h depending on the experiment . Afterwards , cell viability is determined by MTT assay . (cid:2) There is a speciﬁc strategy when applying the treatments in order to get reliable results . As shown in ﬁgure 10 , the ﬁrst two columns are the control samples , which the treated samples will be relativized to . By control it is understood non - treated cells , only the solvent of the drug will be administrated in case that is not water . A total of 10 different doses can be administrated in one experiment , considering each column one single dose . ( D1 - D10 ) . Doses are usually distributed starting from the more diluted ( D1 ) to the more concentrated ( D10 ) . Quadruplicates are required to reduce the error of the experiment , therefore , lines A - D belong to one experiment and lines E - H belong to another experiment . As a summary , one 96 - well plate allows us to analyze 10 doses of two different compounds at once . 7 . 2 MTT ASSAY (cid:2) The MTT assay is a colorimetric assay for measuring the activity of cellular enzymes that reduce the tetrazolium dye , MTT ( 3 - ( 4 , 5 - Dimethylthiazol - 2 - yl ) - 2 , 5diphenyltetrazolium bromide ) , from a yellow tetrazole to its insoluble purple formazan in living cells . This assay measures cellular metabolic activity via NAD ( P ) H - dependent cellular oxidoreductase enzymes and reﬂects the number of viable cells . MTT assays can be used to measure cytotoxicity ( loss of viable cells ) or cytostatic activity ( shift from proliferative to resting status ) of different compounds and drugs . (cid:2) Detection of the formazan precipitates requires a solubilizing solution able to lysate the cellular membrane and also to dissolve the produced salts , generating a homogeneous purple solution . Common solubilizing agents are DMSO , acidiﬁed ethanol solution , or a solution of SDS in HCl . The absorbance of this coloured solution can be quantiﬁed by measuring at certain wavelength between 500 - 600 nm with an ELISA plate reader . Novel approaches to understanding hENT2 and hENT2 - related proteins 56 The ﬁrst step of the protocol followed in this thesis is to remove the cell medium containing the treatments . MTT is added to the cells dissolved in non - supplemented culture medium at a ﬁnal concentration of 0 . 75 mg / ml . Cells are incubated at 37ºC between 45 minutes and 3h , depending on the cell line . Reaction is done when purple precipitates are noticeable at the bottom of the control wells . Afterwards , MTT solution is carefully removed . Since MTT is a colorimetric assay it is extremely important to make sure there are no drops of medium inside the wells as that would compromise the absorbance readings . Following , 100 μl of DMSO are added to each well to solubilize the formazan product with the help of a shaker . Finally , plates are read at 550 nm with an ELISA plate reader . Results are relativized to the control samples , considering those points 100 % of viability . Figure 10 . Representation of treatments distribution in a 96 - well plate . Since each point requires quadruplicates , lines A - D belong to experiment 1 while lines E - H belong to experiment 2 . The ﬁrst two columns have the control points , what means non - treated cells . Only the solvent of the drug will be administrated to the control wells in case that is not water . Columns 3 - 12 are used for 10 different drug concentrations , applying the lower dose on column 3 ( D1 ) and the highest dose on column 12 ( D10 ) . 1 2 3 4 5 6 7 8 9 10 11 12 A B C D E F G H Control D1 D2 D3 D4 D5 D6 D7 D8 D9 D10 EXPE R I M E N T 1 EXPE R I M E N T 2 Materials and Methods 57 8 NUCLEOSIDE UPTAKE MEASURING (cid:2) The process of measuring the nucleoside uptake in mammalian cells basically consists in incubating cells with a known concentration of cold substrate plus a proper proportion of radio - labelled substrate . Once cells are incubated during the required time , uptake is stopped by removing the radioactive medium and washing cells with a cold stop solution . Afterwards , cells are lysed and measured its up - taken radioactivity , corresponding to the amount of substrate internalized by the cell . (cid:2) For the experiment designing , there are some important considerations to take into account , like the fact that the total concentration of substrate ( cold and radio - labelled together ) should be within the range of the Km of the studied transporter . The assay must always be performed in initial velocity conditions , ensuring the transporter is not saturated . Therefore , it is recommended to perform a previous time - course assay . (cid:2) As we explained in the introduction section , there are two main families of nucleoside transporters according to their sodium - dependent activity . To evaluate the transport activity of CNTs , it is needed to use a transport medium containing NaCl . Unlike the case of ENTs , where a choline - based buffer is used instead . Regarding the total ENT activity , the use of speciﬁc inhibitors will allow to discern between ENT1 and ENT2 activity . The difference between transport activity using choline buffer and choline buffer with NBTI 1 μM , reﬂects the activity due to ENT1 transporter . When medium contains dipyridamole 10 μM , the transport activity detected is non - speciﬁc of ENTs . Subtracting ENT1 and non - speciﬁc values to the total of ENT activity , ENT2 transport activity is then obtained . 8 . 1 MAMMALIAN CELLS TRANSPORT ASSAY (cid:2) In our group , transport assays with mammalian cell lines are performed in 24 - well plates ( ﬁgure 11 ) . Each column of the plate represents quadruplicates of the same Novel approaches to understanding hENT2 and hENT2 - related proteins 58 experimental point . There are three different conditions to be analyzed in every experiment : without inhibitors ( 1 ) , with NBTI 1 μM ( 2 ) and with dipyridamole 10 μM ( 3 ) . Using that deign of the plate , we can perform two different experiment at once . Figure 11 . Representation of a 24 - well plate distribution for transport assays . Each column represents quadruplicates of the same experimental point . Three conditions are tested in every assay : no inhibitors ( 1 , 4 ) , NBTI 1 μM ( 2 , 5 ) and dipyridamole 10 μM ( 3 , 6 ) . This particular design allows us to perform two different experiments at once . Subtracting values from columns 2 and 3 , 5 and 6 to 1 and 4 respectively , ENT1 and ENT2 activity values will be obtained separately . 1 2 3 4 5 6 A B C D (cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:7)(cid:8)(cid:9)(cid:9)(cid:9)(cid:10)(cid:11)(cid:12)(cid:13)(cid:14)(cid:9)(cid:9)(cid:9)(cid:9)(cid:9)(cid:9)(cid:10)(cid:9)(cid:15)(cid:6)(cid:16)(cid:9)(cid:9)(cid:9)(cid:9)(cid:9)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:7)(cid:8)(cid:9)(cid:9)(cid:9)(cid:9)(cid:10)(cid:11)(cid:12)(cid:13)(cid:14)(cid:9)(cid:9)(cid:9)(cid:9)(cid:9)(cid:10)(cid:9)(cid:15)(cid:6)(cid:16) (cid:17)(cid:18)(cid:16)(cid:8)(cid:19)(cid:6)(cid:20)(cid:8)(cid:7)(cid:21)(cid:9)(cid:22) (cid:17)(cid:18)(cid:16)(cid:8)(cid:19)(cid:6)(cid:20)(cid:8)(cid:7)(cid:21)(cid:9)(cid:23) Materials and Methods 59 (cid:2) To perform the experiment , cells are ﬁrst washed twice with choline buffer pre - warmed at 37ºC . Following , cells are incubated for 1 minute with the radioactive solution , which has a ﬁnal substrate concentration of 1 μM and 1 μCi / ml of radioactivity , with or without inhibitors . In total , 250 μl of transport solution are added to each well . Reaction is stopped by washing the samples twice with 1 ml of cold stop buffer . It is important to aspirate all the medium left to remove all the radioactivity not incorporated by cells . At that point , cells can by lysed directly or kept in the - 20ºC freezer to continue with the protocol another day . (cid:2) Cells need to release all the radioactive substrate incorporated in order to determine their transport activity . Therefore , samples are incubated with 100 μl / well of lysis solution for 30 minutes - 1 hour with horizontal shaking . Afterwards , lysates are homogenized by pipetting and transferred into a scintillation vial containing scintillation liquid . A 10 μl aliquot of each well has to be kept to quantify the concentration of total protein , 90 μl will then be used for radioactivity quantiﬁcation . Scintillation liquid is required to convert the energy released during radioactivity decay in light , which is detected by the scintillation counter . (cid:2) Radioactivity values associated to each sample in disintegrations per minute ( DPM ) , are relativized to the respective concentration of protein . This calculation is required to correct possible differences in the number of cells per well , either intra - or inter - experiment . Calculations to be done are : Where AE is the speciﬁc activity of the radioactive transport medium expressed in DPM / pmol . Activity ( pmol / mgprot ) = DPMsample × 10 3 AE × Vsample × [ prot ( μ g / μ l ) ] Novel approaches to understanding hENT2 and hENT2 - related proteins 60 8 . 2 OOCYTES TRANSPORT ASSAY (cid:2) An oocyte is an immature ovum , or egg cell from Xenopus laevis . This cells are commonly used in transport assays due to its clear background for most of the human proteins . In order to work with oocytes , ﬁrst it is needed to clone the gene of interest into a proper vector suitable to generate cRNA . Unlike cell lines , genetic material transfected into oocytes is usually cRNA instead of DNA . The reason is because DNA should be injected into the nucleus to be expressed starting from the gene transcription . Due to its difﬁculty , a better efﬁciency is obtained when cRNA injected at the cytosol , ready to be translated . (cid:2) To perform an in vitro transcription , a T7 promoter sequence has to be introduced before the start codon of our gene of interest . In our case , we cloned the hENT2 genes into the pBSxG vector , which contains a T7 promoter region before its multi - cloning site . cRNA transcripts were subsequently generated according to the mMessage mMachine® Kit manufacturerʼs protocol . The concentration and size of the RNA transcripts was determined using a spectrophotometer and agarose gel electrophoresis . (cid:2) Xenopus laevis oocytes were used for heterologous hENT2 expression since they lack endogenous nucleoside transport activity . Oocytes were removed from adult female frogs by Dr . WJ Brad Hanna , from University of Guelph . After extraction , stage V - VI oocytes were stored overnight at 18 - 20 ºC in ND96 medium . Follicle layers were removed by treating the oocytes with collagenase Type I ( 1 mg / ml ) for 20 - 40 minutes in calcium - free saline . For injections , 75 ng of cRNA were injected into 15 - 20 oocytes per treatment per trial using a nanoinjector . Following injection , oocytes were kept at room temperature for 72 hours in ND96 medium . In order to have a good maintaining , medium has to be changed daily and necrotic oocytes have to be removed since they release cytotoxic material . (cid:2) To assess transport activity , oocytes are incubated for 60 minutes at room temperature in 200 μl of choline chloride transport buffer containing 10 μM of substrate and 0 . 1 mCi / ml of [ 3 H ] radio - labelled substrate . Following incubation , extracellular Materials and Methods 61 substrate is removed using three rapid 1 ml washes with cold choline chloride buffer containing dipyridamole 10 μM . Each single oocyte is then placed into a separate scintillation vial containing 200 μl of SDS 1 % ( w / v ) . Vials are subjected to vigorous shaking for 45 minutes to dissolve the oocyte . Finally , 2 ml of scintillation ﬂuid is added to each vial followed by scintillation counting . In that case , results are expressed as Cpm / oocyte . (cid:2) 9 PROTEIN EXPRESSION ANALYSIS (cid:2) Cellular lysates are obtained from cells seeded on 60 , 100 or 150 mm plates depending on the purpose of the experiment . In this thesis , we used two different types of protein extraction methods depending if our aim was to study the expression of proteins from a total fraction of the extract , or enriched membrane proteins . 9 . 1 PROTEIN EXTRACTION FROM CELLULAR LYSATES (cid:3) 9 . 1 . 1 Protein extraction with NP - 40 buffer : (cid:2) The reagent used for this kind of extraction is NP - 40 or Nonidet P - 40 ( octyl phenoxypolyethoxyethanol ) , a non - ionic , non - denaturing detergent . Nonidet P - 40 is frequently abbreviated as NP - 40 , but should not be confused with a different detergent by the same name ( NP - 40 , nonyl phenoxypolyethoxyethanol ) , which is not powerful enough to break the nuclear membrane , but can break the cytoplasmic membrane . (cid:2) Lysis buffer is composed by NP - 40 1 % buffer ( see recipes section - appendix II ) , and a cocktail of protease inhibitors and sodium orthovanadate . Volumes may vary depending on the surface of the plate where cells are seeded , as we describe in table 4 . Protease inhibitor cocktail solution is ten times concentrated , and it is obtained by dissolving one tablet in 1 ml of NP - 40 1 % buffer . Novel approaches to understanding hENT2 and hENT2 - related proteins 62 Taable 4 . NP - 40 lysis buuffer composition Component 60 mm plate 100 mm plate 150 mm plate NP - 40 1 % buffer 160 μl 400 μl 1 , 120 μl 10X Protease inhibitor cocktail 20 μl 50 μl 140 μl Na 2 VO 3 10 mM 20 μl 50 μl 140 μl Total volume 200 μl 500 μl 1 , 400 μl (cid:2) All the process has to be done on ice , keeping cells and proteins at 4ºC to avoid protein degradation . First , old culture medium is aspirated and cells are carefully washed with PBS twice . At this point , plates can be kept at - 80ºC to proceed later on with the extraction . Lysis buffer is added to the plate and cells are detached by using a plastic scrapper . Cells are collected with the pipette and transferred to an eppendorf tube . Cells suspension is then mixed by vortexing ﬁrst and placed on ice for 10 - 20 minutes . Cells are disrupted by homogenizing with a 1 ml syringe and a 26g needle . Cells homogenate is then centrifuged at 8 , 000 rpm for 5 minutes at 4ºC . Cell debris pelleted is discarded and the supernatant , which contains the total protein extract , can be kept either at 4ºC or - 20ºC . (cid:3) 9 . 1 . 2 Isolation of crude membrane proteins : (cid:2) This protocol must be performed on ice to keep samples at 4ºC all the time . After washing the cell plates with PBS ( see 6 . 3 . 1 ) , lysis buffer supplemented with protease inhibitor cocktail , is added to the cell plates ; 200 μl for 60 mm plates and 500 μl for 100 mm plates . According to the protocol described in 6 . 3 . 1 section , cells are detached using a scrapper and homogenized by vortexing and using a 26g needle . Cells are then centrifuged at max speed for 30 minutes at 4ºC . Cell debris is discarded and supernatant is following ultra - centrifuged at 54 . 000 rpm for 1 hour and 30 minutes at 4ºC . Supernatant is discarded and the transparent pellet is resuspended in crude membranes solubilizing buffer ; 50 μl for proteins coming from a 60 mm plate , and 100 μl for 100 mm plates . Materials and Methods 63 9 . 2 DETERMINATION OF PROTEIN CONCENTRATION (cid:2) In the present thesis , two different methods have been used to quantify protein concentration ; BCA method was used to determine to concentration of samples obtained during transport assays , while Bradford method was used for the other experiments . (cid:3) 9 . 2 . 1 BCA method : (cid:2) The bicinchoninic acid assay ( BCA assay ) is a biochemical assay for determining the total concentration of protein in a solution ( 0 . 5 μg / ml to 1 . 5 mg / ml ) . The total protein concentration is exhibited by a change of color of the sample from green to purple in proportion to the protein concentration , which can then be measured using colorimetric techniques . (cid:2) Firstly , the peptide bonds in protein reduce Cu 2 + ions from the cupric sulphate to Cu + . The amount of Cu 2 + reduced is proportional to the amount of protein present in the solution . Next , two molecules of bicinchoninic acid chelate each Cu + ion , forming a purple - coloured product that strongly absorbs light at a wavelength of 562 nm . The amount of protein present in a solution can be quantiﬁed by measuring the absorption spectra and comparing with a protein solution of known concentrations . (cid:2) For the standard curve , a serial of dilutions are made from the commercial albumin stock present in the BCA assay kit , using the same buffer used during the protein extraction . Duplicates of 10 μl of each standard curve dilution and protein sample are dropped on a 96 - well plate . Commercial A : B solutions are mixed with the proportion of 50 : 1 , and 200 μl / well are added to the 96 - well plate . The plate is gently shaken and incubated at 37ºC for 30 minutes . Afterwards , the plate is room tempered for 10 minutes and absorbance is measured using an ELISA device at 562 nm . Software used for protein quantiﬁcation is called Magellan , from TECAN® . (cid:3) Novel approaches to understanding hENT2 and hENT2 - related proteins 64 9 . 2 . 2 Bradford method : (cid:2) The Bradford assay is a colorimetric protein assay based on an absorbance shift of the dye Coomassie Brilliant Blue G - 250 , in which under acidic conditions the red form of the dye is converted into its blue form to bind to the assayed protein . During the formation of this complex , two types of bond interactions take place : the red form of Coomassie dye ﬁrst donates its free electron to the ionizable groups on the protein , which causes a disruption of the protein native state , consequently exposing its hydrophobic pockets . These pockets on the protein tertiary structure bind non - covalently to the non - polar region of the dye via van der Waals forces , positioning the positive amine groups in proximity with the negative charge of the dye . The bond is further strengthened by the ionic interaction between the two . The binding of the protein stabilizes the blue form of the Coomassie dye ; thus the amount of the complex present in solution is a measure for the protein concentration , and can be estimated by use of an absorbance reading . (cid:2) To perform this assay , the commercial Bradford dye reagent is diluted 1 : 4 with distillate water . 1 ml of this solution is added to each plastic cuvette suitable for spectrophotometer . Depending on the sample to be measured , 2 - 10 μl of protein are added to the cuvettes in duplicates . In parallel , a standard curve is made using a solution of BSA ( Bovine Serum Albumin ) . Cuvettes are then mixed and after 5 minutes the absorbance of the standard curve and also the sample is read at 595 nm . 9 . 3 BIOTINYLATION OF MEMBRANE PROTEINS (cid:2) Biotinylation is the process of covalently attaching biotin to a protein , nucleic acid or other molecule . Biotinylation is rapid , speciﬁc and is unlikely to perturb the natural function of the molecule due to the small size of biotin . Biotin is a vitamin that binds to streptavidin and avidin with an extremely high afﬁnity , fast on - rate , and high speciﬁcity , and these interactions are exploited in many areas of biotechnology to isolate biotinylated molecules of interest . Biotin - binding to streptavidin and avidin is Materials and Methods 65 resistant to extremes of heat , pH and proteolysis , making capture of biotinylated molecules possible in a wide variety of environments . Also , multiple biotin molecules can be conjugated to a protein of interest , which allows binding of multiple streptavidin or avidin protein molecules and increases the sensitivity of detection of the protein of interest . (cid:2) In this thesis we used biotinylation to label membrane proteins exclusively and purify them using streptavidin beads . This protocol has to be realized under cool temperatures , using ice specially during the ﬁrst steps to avoid protein degradation . To perform that kind of technique , a minimum of 5 x 150 mm plates seeded with cells are required to guarantee a decent quantity of protein obtained . (cid:2) Culture plates with cells seeded on it are carefully washed twice with PBS - Ca / Mg . Presence of calcium and magnesium minimizes cell detaching . Cells are then incubated with a sulfo - NHS - LC - biotin 500 μM dissolved in PBS - Ca / Mg for 30 minutes at 4ºC and with soft shaking . Biotin has to be ﬁrst dissolved in dimetilformamide and then diluted in PBS to be used right away . Biotin solution is then aspirated and cells are washed with a solution of PBS - Ca / Mg with glycine 100 mM for 15 minutes three times . Following , cells are lysed using 750 μl of NP - 40 lysis buffer ( supplemented with protease inhibitors and Na 2 VO 3 ) and shaked for 15 minutes . Cells are detached using a plastic scrapper and homogenized by vortexing and using a 26g needle . Homogenate is centrifuged at max speed for 30 minutes at 4ºC . The supernatant is considered the “homogenate” fraction , including total protein but the nuclear fraction . At this point , homogenate fraction can be kept at - 80ºC to continue or repeat the protocol another day . (cid:2) Streptavidin - agarose beads are washed with NP - 40 buffer twice , centrifuging tubes at 2 , 500 rpm for 5 minutes . Once beads are ready , 500 μg of homogenate fraction are incubated with 30 - 50 μl of streptavidin beads solution for 1 hour and 30 minutes at room temperature using an orbital rotator . Following , samples are centrifuged at 2 , 500 rpm for 5 minutes at room temperature ( same conditions for the following washes ) . In this case , the supernatant is considered the intracellular fraction , Novel approaches to understanding hENT2 and hENT2 - related proteins 66 while the pellet contains the streptavidin beads linked to biotin - bound membrane proteins . Streptavidin beads are then washed with 1 ml of NP - 40 1 % buffer , followed by two washes with biotinylation washing buffer 2 and three washes with biotinylation washing buffer 3 . (cid:2) Finally , membrane proteins are disrupted from streptavidin - biotin beads by adding 20 μl of protein loading buffer 5x and 30 μl of ddH 2 O , and incubating samples for 30 minutes at room temperature in an orbital rotator . Samples are then boiled for 5 minutes at 95ºC ( or 30 minutes at 37ºC in case of HA - tagged proteins ) and centrifuged at max speed for one minute to obtain the membrane fraction ( supernatant ) separated from the streptavidin - biotin beads ( pellet ) . Samples are then ready to be analyzed by SDS - PAGE electrophoresis and Western - Blot . 9 . 4 ELECTROPHORESIS IN SDS - PAGE (cid:2) SDS - PAGE , sodium dodecyl sulfate polyacrylamide gel electrophoresis , describes a technique widely used in biochemistry and other ﬁelds to separate proteins according to their electrophoretic mobility , which is a function of the length of a polypeptide chain and its charge , and no other physical features . SDS is an anionic detergent applied to linearize proteins and to impart a negative charge to them . In most proteins , the binding of SDS to the polypeptide chain imparts an even distribution of charge per unit mass , thereby resulting in a fractionation by approximate size during electrophoresis . (cid:2) In SDS - PAGE , proteins migrate through an electric ﬁeld across the acrylamide matrix pores , which size depends on the percentage of acrylamide present in the gel . The system we use is a discontinuous electrophoresis where samples must ﬁrst cross a stacking gel , with a lower percentage of acrylamide ( 5 % ) and lower pH ( pH 6 . 8 ) that promotes proteins alignment before moving into the running gel . Running gel has a higher percentage of acrylamide ( 10 - 15 % ) and a pH of 8 . 8 . Higher concentrations of Materials and Methods 67 acrylamide are used to get a proper separation of small proteins , while lower concentrations are used for bigger proteins . Table 5 . Electropphoresis gel compositionn Running gel 10 % Acrrylamide 12 % Acrrylamide 15 % Acrrylamide Components Small gel Large gel Small gel Large gel Small gel Large gel ddH 2 O 5 ml 15 ml 4 . 5 ml 13 . 5 ml 3 . 75 ml 11 . 25 ml Solution A * 2 . 5 ml 7 . 5 ml 3 ml 9 ml 3 . 75 ml 11 . 25 ml Solution B * 2 . 5 ml 7 . 5 ml 2 . 5 ml 7 . 5 ml 2 . 5 ml 7 . 5 ml APS 10 % 50 μl 150 μl 50 μl 150 μl 50 μl 150 μl TEMED 10 μl 30 μl 10 μl 30 μl 10 μl 30 μl Stacking gel Small gel Large gel ddH 2 O 2 . 3 ml 6 . 9 ml Solution A * 0 . 67 ml 2 ml Solution C * 1 ml 3 ml APS 10 % 30 μl 90 μl TEMED 5 μl 15 μl * Electrophoreesis Solutions described in reciipes section - AAppendix II (cid:2) Acrylamide gels are made according to the instructions describe in table 5 . For small gels we use the Mini Protean II system ( Bio - Rad ) , and for large gels , The Sturdier Vertical Gel Slab SE 400 ( Hoefer ) . Gels can be made right before use or up to 24 hours in advance , being kept at 4ºC in humid conditions . Before running the electrophoresis gel , samples must be denaturalised by adding a proportional volume of protein loading buffer 5x ( PLB 5x ) and heating samples either at 95ºC for 5 minutes or 37ºC for 30 minutes . Samples and protein marker are load into the gel wells and running buffer is added to the electrophoresis system . Small gels usually run at 120 V for approximately 1 . 5 hours , and large gels run at 200 V for 3 . 5 hours , depending on the percentage of acrylamide of the gel . Novel approaches to understanding hENT2 and hENT2 - related proteins 68 (cid:2) 9 . 4 . 1 Coomassie staining : (cid:2) In those cases where protein electrophoresis does not continue with a transference to a nitrocellulose membrane to analyze protein expression by immunodetection , and only presence or absence of protein wants to be detected , protein staining can be applied . We also use protein staining to isolate a gel band containing some protein to be further detected and analyzed by mass spectrometry . (cid:2) There are plenty of protein staining systems , however the most common probably is the Coomassie Brilliant Blue G - 250 , which binds to proteins nonspeciﬁcally . That is a fast and cheap method in which all proteins present in the acrylamide gel are stained with a similar intensity . The main disadvantage of this method is a low sensitivity compared with other staining methods , like silver staining . (cid:2) Staining solution can be prepared in the same lab , however the reagents used are toxic by inhalation and also a destaining step is required , increasing the timing to detect proteins . In this thesis we used a commercial solution , PageBlue TM Protein Staining solution , ready - to - use , with a higher sensitivity and no destaining required . Staining protocol according to manufacturerʼs instructions . 9 . 5 WESTERN - BLOT TECHNIQUE (cid:2) The Western - Blot or immunoblot is a widely accepted analytical technique used to detect speciﬁc proteins in the given sample of tissue homogenate or extract . It uses a previous gel electrophoresis to separate denatured proteins by length of the polypeptide ( see section 9 . 4 ) . The proteins are then transferred to a membrane , typically nitrocellulose or PVDF , where they are detected by using speciﬁc antibodies against the target protein . Materials and Methods 69 (cid:3) 9 . 5 . 1 Transference : (cid:2) Once proteins are separated by electrophoresis ( see section 9 . 4 ) , the gel is dismounted from the electrophoresis system and equilibrated with transfer buffer , previously prepared . Acrylamide gel is then cut to discard the stacking gel and also parts of the gel where there are no proteins or not the target protein . Nitrocellulose membrane is also cut according the ﬁnal size of the gel and equilibrated with transfer buffer as well . (cid:2) For the transference we use a Trans - Blot® semi - dry electrophoretic transfer cell ( Bio - Rad ) . Transfer montage is made as described in ﬁgure 12 : nitrocellulose membrane is close to the positive pole of the transfer cell with the acrylamide gel on top , both of them surrounded by 3 layers of Whatman paper . Transference is ran at 20 V for 1 hour . (cid:3) 9 . 5 . 2 Ponceau staining : (cid:2) Ponceau S is a sodium salt of a diazo dye that is commonly used to prepare a stain for rapid reversible detection of protein bands on nitrocellulose or PVDF membranes from Western - Blot technique , as well as on cellulose acetate membranes . A Ponceau S stain is useful because it does not appear to have a deleterious effect on the sequencing of blotted polypeptides and is therefore one method of choice for locating polypeptides on Western - Blot for blot - sequencing . It is also easily reversed with water washes , facilitating subsequent immunological detection . The stain can be completely removed from the protein bands by continued washing . (cid:2) In our case , we use Ponceau stain to conﬁrm that transference step worked successfully and we can continue with the immunodetection . To stain a nitrocellulose membrane with Ponceau , ﬁrst the membrane is shortly washed with ddH 2 O to remove all the transfer buffer present on it . Then , the membrane is incubated with the Ponceau solution for one minute . Ponceau solution can be recycled and reused as many times Novel approaches to understanding hENT2 and hENT2 - related proteins 70 as we consider . Membrane is then washed with ddH 2 O until protein bands are perfectly deﬁned . Washings can continue until staining fades completely . 9 . 5 . 3 Immunodetection : Detection of the protein of interest contained in a nitrocellulose membrane is performed by the sequential incubation of two different antibodies . Primary antibody is the one that recognises the target protein speciﬁcally , while secondary antibody detects the primary antibody based on the animal used to produce the primary antibody . Secondary antibody is usually conjugated to horseradish peroxidase ( HRP ) , which promotes a luminescence reaction in proportion to the amount of protein . Figure 12 . Mounting sequence for protein transference in Wester - Blot technique . T R A N S F E R E NC E 3X WHATMAN PAPER 3X WHATMAN PAPER NITROCELLULOSE MEMBRANE ACRYLAMIDE GEL + - Materials and Methods 71 (cid:2) Before starting with the immunodetection , nitrocellulose membrane is incubated with a blocking solution of skimmed milk 5 % ( w / v ) in TBS - T for one hour at room temperature with shaking , to block the nonspeciﬁc binding points of the proteins present in the membrane . Following , membrane is incubated with the primary antibody diluted in skimmed milk 1 % ( w / v ) in TBS - T . Incubation may be during 1 hour at room temperature although we recommend to incubate it at 4ºC overnight for better results . Afterwards , membrane is washed with TBS - T buffer for 10 minutes three times . Membrane is then incubated with the secondary antibody , also diluted in skimmed milk 1 % ( w / v ) in TBS - T , at room temperature for 1 hour . Finally , the membrane is washed once with TBS - T and twice with TBS for 10 minutes each washing . (cid:3) 9 . 5 . 4 Antibodies used : (cid:2) Antibodies used in this thesis are summarized in table 6 with recommended dilutions and other indications . Tabble 6 . Featurees of antibodies used Protein Company Specie Dilution * Reactivity ENT2 Abcam Rabbit 1 : 1000 ( WB ) ; 1 : 100 ( ICC ) Mouse , human FLAG Abcam Mouse 1 : 5000 ( WB ) ; 1 : 500 ( ICC ) FLAG tag HA Roche Rat 1 : 2000 ( WB ) , 1 : 200 ( ICC ) HA tag NPC Abcam Mouse 1 : 5000 ( WB ) ; 1 : 500 ( ICC ) Mouse , human , rat Anti - mouse Bio - Rad Goat 1 : 2000 ( WB ) Mouse Anti - rabbit Bio - Rad Goat 1 : 2000 ( WB ) Rabbit Anti - rat Abcam Goat 1 : 5000 ( WB ) Rat * WB : WWestern - Blot ; IICC : Immunocytochemistry (cid:3) 9 . 5 . 5 ECL developing : (cid:2) Detection of the protein of interest is mediated by the peroxidase ( HRP ) conjugated to the secondary antibody , generating a luminescence reaction that is Novel approaches to understanding hENT2 and hENT2 - related proteins 72 visualised by autoradiography . ECL solution is prepared following manufacturerʼs instructions , usually mixing 1 : 1 the two solutions provided in the commercial kit . Nitrocellulose membrane is incubated with ECL mix for 1 minute at room temperature . Afterwards , liquid excess is removed and membrane is introduced inside a plastic transparent cover to be ﬁxed in a cassette suitable for ﬁlm exposure . Exposure time may vary from 1 minute to 1 hour depending on the sample and the antibody . Film is developed in a dark room following the protocol provided by the facility service . 9 . 6 PROTEIN DETECTION AND ANALYSIS BY MASS SPECTROMETRY (cid:2) The following protocol was designed and performed by Declan Williams , PhD student from Dr . Michael Siuʼs lab of Chemical Department and CRMS of York University , Toronto , Canada . (cid:2) Protein disulﬁde bonds were reduced with dithiothreitol , alkylated using iodoacetamide then digested with trypsin . Tryptic ENT phosphopeptides were separated over an acetonitrile gradient and analyzed using multiple reaction monitoring ( MRM ) and MRM - initiated enhanced product ion scans on a Tempo nanoﬂow HPLC - 4000 QTRAP ( AB Sciex ) . Transitions for MRM experiments included mass - to - charge values of all fully tryptic phosphopeptides , their y - ions and the mass - to - charge values of the phosphopeptides following neutral loss of phosphoric acid from serine and threonine or phosphate from tyrosine residues . 10 IMMUNOCYTOCHEMISTRY (cid:2) Immunocytochemistry ( ICC ) is a common laboratory technique that uses antibodies that target speciﬁc peptides or protein antigens in the cell via speciﬁc epitopes . These bound antibodies can be detected using secondary antibodies conjugated to different ﬂuorophores ( different Alexa Fluor® in our case ) , which are detected in a ﬂuorescence or confocal microscope . ICC allows researchers to evaluate Materials and Methods 73 whether or not cells in a particular sample express the antigen in question . In cases where and immunopositive signal is found , ICC also allows researchers to determine which sub - cellular compartments are expressing the antigen . (cid:2) To perform ICC assays , cells are previously seed on 100 mm coverslips contained in a 24 - well plate ( one coverslip per well ) . Cells can then be transfected or treated according to the design of the experiment . In order to have a nice and good quality of images at the microscope , it is recommended to not have highly conﬂuent cells , since shape and morphology would be harder to appreciate . It is also recommended to treat cells with cycloheximide for 3 hours to reduce synthesis at ER background ( see section 6 . 4 ) . ICC protocol consists of a series of incubations with different reagents . Before incubating cells , we recommend to transfer the coverslips with cells seeded on to a new 24 - well plate to avoid contaminations and cross reactions between the ICC reagents and the old culture medium . Cells are incubated with 500 μl / well of different solutions with soft horizontal agitation , following the order described below ( table 7 ) . (cid:2) After incubations and treatments , last step is to mount coverslips on a proper support to be analyzed under ﬂuorescence or confocal microscope . To that purpose , it is required the use of any aqueous Mowiol mounting medium . A drop of mounting medium is placed on a glass slide ensuring there are no air bubbles on top . Coverslip is carefully taken from the 24 - well plate with tweezers and gently dropped upside down on top of the mounting medium . That process is repeated for each coverslip . Slides are left to dry overnight on the bench . It is very important to keep the samples out of light at anytime to not excite the ﬂuorophores and loose signal . Slides can be analyzed right away or kept at 4ºC for future studies with the microscope . (cid:2) Novel approaches to understanding hENT2 and hENT2 - related proteins 74 Table 7 . Immmunocytochemmistry protocol Step Solution Time Notes Washing PBS - Ca / Mg 2 X 5 min Ca / Mg help to avoid cell detaching Fixing PFA 4 % in PBS 15 - 30 min Toxic if swallowed , absorbed or inhaled . Work in hood Washing PBS 3 X 5 min Afterwards , plate can be kept at 4ºC with NaN 3 0 . 3 % in PBS Incubation NH 4 Cl 50 mM in PBS 10 min To reduce autoﬂuorescence Incubation Glycine 20 mM in PBS 10 min To remove traces of other reagents and solutions Permea - bilization Triton® X - 100 0 . 1 % in PBS 10 min To permeabilize cells Washing PBS 3 X 5 min To remove detergent traces Blocking FBS 10 % in PBS 30 min To block non - speciﬁc bindings of the antibodies Antibody * 1st antibody in FBS 10 % 1 hour Antibodies must be ﬁrst centrifuged for 5 minutes at max speed 4ºC to avoid aggregates . Check table 8 . Washing PBS 3 X 5 min Coverslips are transferred to the 24 - well plate Antibody * 2nd antibody in FBS 10 % 45 min Coverslips must be protected from light for next steps Washing PBS 3 X 5 min Plate should be wrapped in aluminium foil Treatment Check table 8 Optional treatments to stain cells apart from the antibodies Washing PBS 3 X 5 min Optional after treatment if required * 25 μl of antiboody solution are dropped on pplastic parafﬁn ﬁl the incubation lm . Coverslips are placed on it upside down for . Materials and Methods 75 Table 88 . Immunocytocheemistry antibbodies dilutions and treatments Treatment Dilution Time Notes Anti - FLAG * 1 : 500 1 hour Mouse monoclonal antibody Anti - HA * 1 : 200 1 hour Rat monoclonal antibody Anti - NPC * 1 : 500 1 hour Mouse monoclonal antibody that targets nuclear membrane DoMo 555 1 : 300 45 minutes Donkey anti - mouse ( red ) . No cross - reaction with rat DoRa 488 1 : 300 45 minutes Donkey anti - rat ( green ) . No cross - reaction with mouse GoMo 488 1 : 300 45 minutes Goat anti - mouse ( green ) GoMo 546 1 : 300 45 minutes Goat anti - mouse ( red ) WGA 1 : 200 in PBS 10 minutes Plasma membrane . Requires washing MitoTracker ® 1 : 1000 in non - supplemented culture medium 45 minutes at 37ºC Mitochondria . Treatment must be applied before the ﬁxing step . Washing required DAPI 300 nM in PBS 5 minutes Nuclei . Requires washing TO - PRO® - 3 1 : 1000 in PBS 10 minutes Nuclei . Last step before mounting . No washing required * Antibodie ss dilution in ICC is usually 10X cconcentrated than the one used in WB (cid:2) Novel approaches to understanding hENT2 and hENT2 - related proteins 76 11 MOLECULAR BIOLOGY TECHNIQUES 11 . 1 TRANSFORMATION IN COMPETENT CELLS (cid:2) In molecular biology , transformation is the genetic alteration of a cell resulting from a direct uptake , incorporation and expression of exogenous genetic material ( DNA ) from its surrounding taken up through the cell membrane . Transformation occurs naturally in some species of bacteria , but it can also be effected by artiﬁcial means in other cells . For transformation to happen , bacteria must be in a state of competence , which occurs as a time - limited response to environmental conditions such as starvation and cell density . (cid:2) In this thesis , we used two different cell system to work on molecular biology : bacteria ( prokaryotic ) and yeast cells ( eukaryotic ) . Protocols used for each case are described below . (cid:3) 11 . 1 . 1 Transformation in bacteria cells : (cid:2) Bacterial transformation may be referred to as a stable genetic change brought about by the uptake of naked DNA ( DNA without associated cells or proteins ) , and competence refers to the state of being able to take up exogenous DNA from the environment . Artiﬁcial competence can be induced through laboratory procedures that involve making the cell passively permeable to DNA by exposing it to conditions that do not normally occur in nature . Typically , the cells are incubated in a solution containing divalent cations , most commonly calcium chloride solution under cold conditions , and then exposed to a pulse of heat shock . (cid:2) The surface of bacteria such as E . coli is negatively charged due to phospholipids and lipopolysaccharides on its cell surface , and the DNA is also negatively charged . One function of the divalent cation is to shield those charges by coordinating the phosphate groups and other negative charges , thereby allowing a DNA molecule to adhere to the cell surface . It is suggested that exposing the cells to Materials and Methods 77 divalent cations in cold condition may also change or weaken the cell surface structure of the cells making it more permeable to DNA . The heat - pulse is thought to create a thermal imbalance on either sides of the cell membrane , which forces the DNA to enter the cells through either pores or the damaged cell wall . (cid:2) The protocol used in this thesis is based on the instructions from the manufacturer that provides commercial competent cells ( see commercial references section - appendix II ) . All material used has to be previously autoclaved and all the protocol must be done under sterile conditions , commonly under a ﬂame . Commercial competent cells are thawed on ice and gently mixed with the pipette tip . Cells are aliquoted in 15 μl of cell mix for each transformation into 1 . 5 ml microcentrifuge tubes on wet ice . 10 - 50 ng of DNA is then added to each reaction tube by mixing gently and incubated on ice for 30 minutes . (cid:2) After incubation , cells are heat - shocked for 45 second at 42ºC , by using either a water bath or a dry thermo - block . Tubes are immediately placed back on ice for two more minutes . 100 μl of pre - warmed medium ( LB in our case ) is added to each transformation mix , and cells are then incubated at 37ºC for one hour at 225 rpm . Cells are then centrifuged at max speed for 15 seconds and all the supernatant but 40 μl is removed . Pelleted cells are resuspended in this 40 μl left and plated on pre - warmed selective plates ( LB plus the proper antibiotic ) . It is recommended to plate half of the transformation mix to keep some cells in case the incubation does not work . Cells can be kept at 4ºC and be plated during the next days . (cid:2) In case the DNA used for transformation comes from a mutagenesis PCR reaction , volumes of the protocol must be readjusted to ensure a better transformation efﬁciency . Modiﬁcations are : 50 - 75 μl of competent cells per reaction , 10 μl of the PCR product as DNA to be transformed , heat - shock for 1 minute 45 seconds , 1 ml of LB added after the heat - shock , centrifugation for 1 minute , 800 μl of LB removed from the supernatant and all the transformed cells should be plated at once . Novel approaches to understanding hENT2 and hENT2 - related proteins 78 (cid:3) 11 . 1 . 2 Transformation in yeast cells : (cid:2) Most species of yeast , including Saccharomyces cerevisiae , may be transformed with exogenous DNA in the environment or under laboratory conditions . Exposing intact yeast cells to alkali cations such as those of caesium or lithium allows the cells to take up plasmid DNA . Later protocols adapted this transformation method , using lithium acetate , polyethylene glycol , and single - stranded DNA ( ssDNA ) . In these protocols , the ssDNA preferentially binds to the yeast cells wall , preventing plasmid DNA from doing so and leaving it available for transformation . The protocol we used is a DTT - based adaptation of a lithium acetate protocol described in Snider et al . ( 2010 ) . (cid:2) Yeast cells coming from a stationary phase culture are aliquoted in 250 μl per reaction into a 1 . 5 ml microcentrifuge tube . Stationary phase cells may come from either an overnight culture , cells on a plate ( resuspending 2 colonies per 100 μl of medium ) or a glycerol stock . Tubes are pulse spun down at max speed and supernatant is then removed . 100 μl of fresh yeast transformation buffer ( see recipes section - appendix II ) are added to each tube together with 100 - 300 ng of DNA , and gently mixed by pipetting . Cells are heat - shocked at 42ºC for 30 minutes at 225 rpm . Samples are then spun down at max speed for 1 minute and supernatant is discarded . Finally , pelleted cells are resuspended in 100 μl of sterile NaCl 0 . 9 % , plated on a proper selective medium and incubated at 37ºC for 2 - 3 days . 11 . 2 EXTRACTION OF PLASMID DNA (cid:2) Transformation in bacteria cells allows to maintain and amplify DNA plasmids . After transfection , cells must grow to a certain volume in order to extract the ampliﬁed DNA . For that , a single colony is picked up and growth in 3 ml of liquid medium , in our case LB plus a proper antibiotic ( commonly ampicillin or kanamycin ) at 37ºC overnight at 225 rpm . Depending on the desired amount of DNA to be obtained , after this overnight incubation , bacteria culture can be scaled up to 100 - 250 ml and incubated with for another overnight at the same conditions . Materials and Methods 79 (cid:2) There are different commercial DNA extraction protocols depending on the amount and purity of the DNA obtained . Mini - prep protocols start from a 3 ml culture and the amount of DNA obtained is around 10 - 40 μg . Maxi - prep protocols start from a 100 - 250 ml culture and the yield is around 100 - 500 μg of DNA , depending on the plasmid features and the starting volume . Timing required for each protocol is quite different , such a way that mini - prep protocol is performed within 30 minutes - 1 hour , while maxi - prep requires 4 - 6 hours depending on the number of samples . There are also differences on the purity of the DNA obtained , where samples obtained from a maxi - prep are more pure and clean from salts since the maxi - prep protocol has an extra puriﬁcation step than the mini - prep protocol . Therefore , we regularly use the mini - prep protocol when DNA obtained will be used for molecular biology purposes , and maxi - prep samples when DNA will be transfected into mammalian cells for cell culture experiments . (cid:2) Both mini - prep and maxi - prep protocols are based on an ionic column exchange . First steps are meant to break the cell membranes to release all the genetic material . From here , DNA is bound to the ionic column to be washed from other bacterial material and eluted using ddH 2 O or elution buffer . In both case , we always follow the manufacturerʼs instructions provided with the kit . 11 . 3 GENETIC ENGINEERING TECHNIQUES (cid:3) 11 . 3 . 1 PCR reaction : (cid:2) The polymerase chain reaction ( PCR ) is a biochemical technique used in molecular biology to amplify a single or a few copies of a piece of DNA across several orders of magnitude , generating thousands to millions of copies of a particular DNA sequence . (cid:2) The method relies on thermal cycling , consisting of cycles of repeated heating and cooling of the reaction promoting DNA melting and enzymatic replication of the Novel approaches to understanding hENT2 and hENT2 - related proteins 80 DNA . Primers ( short DNA fragments ) containing sequences complementary to the target region , along with a DNA polymerase , are key components to enable selective and repeated ampliﬁcation . As PCR progresses , the DNA generated is itself used as template for replication , setting in motion a chain reaction in which the DNA template is exponentially ampliﬁed . PCR can be extensively modiﬁed to perform a wide array of genetic manipulations . (cid:2) Almost all PCR applications employ a heat - stable DNA polymerase , such as Taq polymerase , an enzyme originally isolated from the bacterium Thermus aquaticus . This DNA polymerase enzymatically assembles a new DNA strand from DNA building - blocks , the nucleotides , by using single - stranded DNA as template and DNA oligonucleotides ( also called DNA primers ) , which are required for initiation of DNA synthesis . The vast majority of PCR methods use thermal cycling to a deﬁned series of temperatures steps . These thermal cycling steps are necessary ﬁrst to physically separate the two strands in a DNA double helix at a high temperature , in a process called DNA melting . At a lower temperature , each strand is then used as template in DNA synthesis by the DNA polymerase to selectively amplify the target DNA . The selectivity of PCR results from the use of primers that are complementary to the DNA region targeted for ampliﬁcation under speciﬁc thermal cycling conditions . (cid:2) The typical PCR thermal cycling steps are ( ﬁgure 13 ) : A . Initialization step : Heating the reaction for 5 - 10 minutes to activate the polymerase . B . Denaturation step : It causes DNA melting of the DNA template by disrupting the hydrogen bonds between complementary bases , yielding ssDNA molecules . C . Annealing step : It allows annealing of the primers to the ssDNA template . Annealing temperature depend on the composition and length of the primer but it is usually comprised between 55 and 68ºC . The polymerase binds to the primer - template hybrid to begin DNA formation . Materials and Methods 81 D . Extension / elongation step : The temperature at this step depends on the DNA polymerase used . Taq polymerase is commonly used at 72ºC . DNA polymerase synthesizes a new DNA strand complementary to the DNA template by adding dNTPs in 5ʼ to 3ʼ direction . The extension time depends on both the DNA polymerase speed ( e . g Taq polymerase usually works at 1 Kb / min ) and the length of the DNA fragment to be ampliﬁed . E . Final elongation : Optional step to ensure that any remaining ssDNA is fully extended . F . Final hold : To inactivate the enzyme with cold temperatures and stop the reaction . G . Storage : Short - term storage of the reaction . 95ºC 95ºC 55 - 65ºC 68 - 72ºC 68 - 72ºC 4ºC 10ºC 5 min 30 sec Variable 30 sec 10 min 5 min ∞ A B C D E F G 30 - 35 Cycles Figure 13 . Representation of the thermal cycling of a standard PCR reaction . (cid:2) Primers designing is also a clue step to optimise a PCR reaction . Pairs of primers should have similar melting temperatures since annealing in a PCR occurs for both simultaneously . This temperature depends on the length of the primer , usually around 20 nucleotides , and the composition of guanines and cytosines , which should not be higher than 55 - 60 % . When designing a pair of primers it is also important to double - check they do not hybridise at multiple regions of the DNA template to avoid secondary PCR products . Novel approaches to understanding hENT2 and hENT2 - related proteins 82 (cid:2) In this thesis , the polymerases we used for all the molecular biology work are the Taq polymerase and the Pfu polymerase ( see commercial references section - appendix II ) . To perform the reactions we followed the speciﬁc indications provided by the manufacturer . Sequences of the primers used in this thesis are detailed in the appendix I section ( table 20 ) . (cid:3) 11 . 3 . 2 Site - directed mutagenesis : (cid:2) Site - directed mutagenesis is a molecular biology technique often used in biomolecular engineering , in which a mutation is created at a deﬁned site in a DNA molecule . In general , this form of mutagenesis requires the wild type gene sequence to be known . It is commonly used in protein engineering . The basic procedure consists of the synthesis of a short DNA primer . This synthetic primer contains the desired mutation and is complementary to the template DNA around the mutation site so it can hybridise with the gene of interest . The mutation may be a single base change , multiple base changes , deletion or insertion . The single - stranded primer is then extended using a DNA polymerase , which copies the rest of the gene . (cid:2) In this thesis , we used site - directed mutagenesis to insert the HA tag used for the study of the hENT2 spliced variants ( ﬁgure 14 ) . Bold letters represent the HA tag amino acid sequence . Below the HA sequence , there is the sequence of nucleotides that correspond to the peptide above . The strategy used for PCR generation and insertion of the HA tag was to perform regular mutagenic PCR ampliﬁcations adding 3 new amino acids every time , so after 3 PCRs we would have the HA tag incorporated in our construct . (cid:2) The polymerase used for the site - directed mutagenesis PCR reactions was the PfuTurbo® polymerase . The primers we designed are detailed in the appendix I section ( table 21 ) . The particularity of the primers used is that the forward and reverse sequences are exactly complementaries , such a way both oligonucleotides include the regions to be inserted . Since the polymerase ﬁnishes the reaction at the same point it started , the gene of interest is ampliﬁed together with the plasmid . Materials and Methods 83 Figure 14 . Strategy for HA tag cloning . (cid:2) After the PCR reaction , samples are treated with the endonuclease DpnI , a restriction enzyme that degrades methylated DNA at 37ºC for one hour . As a consequence , template DNA is degraded while the PCR product remains intact since only the DNA coming from bacteria ( template from a mini - prep ) is methylated . PCR product with the site - directed mutation incorporated is transformed into bacteria cells to be ampliﬁed ( see section 11 . 1 . 1 ) . Thermal cycling conditions used for this reaction are detailed in ﬁgure 15 . 95ºC 95ºC 55ºC 68ºC 4ºC 10ºC 5 min 30 sec 18 min 1 min 5 min ∞ 18 Cycles Figure 15 . Representation of the thermal cycling of a site - directed mutagenesis PCR reaction . (cid:2) (cid:3) (cid:2) (cid:4) (cid:5) (cid:3) (cid:4) (cid:2) (cid:6) (cid:4) (cid:5) (cid:6) (cid:2) (cid:7)(cid:8) (cid:9) (cid:2) (cid:2) (cid:2) (cid:9) (cid:9) (cid:10) (cid:2) (cid:2) (cid:2) (cid:7)(cid:8)(cid:7) (cid:2) (cid:2) (cid:2) (cid:10) (cid:8) (cid:9) (cid:2) (cid:2) (cid:2) (cid:10) (cid:7) (cid:9) (cid:2) (cid:2) (cid:2) (cid:9) (cid:9) (cid:8) (cid:2) (cid:2) (cid:10) (cid:8) (cid:9) (cid:2) (cid:2) (cid:2) (cid:7)(cid:8) (cid:9) (cid:2) (cid:2) (cid:10) (cid:9) (cid:10) (cid:2) (cid:6) (cid:2) (cid:11) (cid:5) (cid:3)(cid:7)(cid:8)(cid:9) (cid:3)(cid:7)(cid:8)(cid:10) (cid:3)(cid:7)(cid:8)(cid:11) Novel approaches to understanding hENT2 and hENT2 - related proteins 84 (cid:3) 1 1 . 3 . 3 Digestion with restriction endonucleases : (cid:2) A restriction enzyme or endonuclease is an enzyme that cuts DNA at speciﬁc recognition nucleotide sequences known as restriction sites . Such enzymes , found in bacteria and archaea , are thought to have evolved to provide a defense mechanism against invading viruses . Isolated restriction enzymes are used to manipulate DNA for different scientiﬁc applications . (cid:2) Restriction enzymes are used to assist insertion of genes into plasmid vectors during gene cloning . For optimal use , plasmids that are commonly used for gene cloning are modiﬁed to include a short polylinker sequence , called multiple cloning site ( MCS ) , rich in restriction enzyme recognition sequences with the particularity that those enzymes cut only once inside the vector . To clone a gene fragment into a vector , both plasmid DNA and gene insert are cut with the same restriction enzymes , and then glued together with the assistance of an enzyme known as DNA ligase . (cid:2) Protocols used for digestion with restriction enzymes are the ones provided by the manufacturer . Usually those protocols demand to incubate a certain amount of DNA , from 100 ng to 10 μg , with a proper number of enzymatic units ( 1 unit digests 1 μg of DNA in 1 hour ) for 1 - 3 hours at 30 - 37ºC , depending on the enzyme . In case of double digestions , it is recommended to ﬁnd a common reaction buffer where both enzymes have a high activity . (cid:3) 11 . 3 . 4 DNA visualization and extraction with agarose gel : (cid:2) Agarose gel electrophoresis is a method used to separate a mixed population of DNA and RNA fragments by length , to estimate the size of DNA and RNA fragments or visualise the different products generated after a PCR reaction . Nucleic acid molecules are separated by applying an electric ﬁeld to move the negatively charged molecules through an agarose matrix . Shorter molecules move faster and migrate farther than longer ones because shorter molecules migrate more easily through the pores of the gel . Percentage of agarose used may vary depending on the size of the Materials and Methods 85 molecule of interest . Gels with 1 % of agarose are commonly used for 1 - 3 Kb molecules . For shorter molecules , less than 1 kb , 1 . 5 % of agarose is recommended . On contrary , 0 . 7 % of agarose is frequently used for molecules of more than 3 kb size . (cid:2) After the electrophoresis is completed , the molecules in the gel can be stained to make them visible . The most common dye used to make DNA or RNA bands visible for agarose gel electrophoresis is ethidium bromide ( EtBr ) . It ﬂuoresces under UV light when intercalated into the major groove of DNA or RNA . By running DNA through an EtBr - treated gel and visualizing it with UV light , any band containing more than 20 ng of DNA becomes distinctly visible . EtBr is a known mutagen and safer alternatives are nowadays available , such as SYBR® Safe . SYBR® Safe is a variant of SYBR® Green , a product provided by Invitrogen , that has been shown to have low enough levels of mutagenicity and toxicity to be deemed nonhazardous waste under U . S . Federal regulations . It has similar sensitivity levels to EtBr but is signiﬁcantly more expensive . (cid:2) Agarose gels are made by melting the agarose powder in TAE buffer using a microwave . SYBR® Safe is added after the solution as cooled down to 50ºC approximately and poured to a cast with a comb . While gel is solidifying , DNA samples are prepared by adding a proportion of commercial gel loading dye 6x . Samples are then load into the wells and run at 100 V for 1 - 2 hours . DNA ladders are used to identify the size of the DNA bands . If desired , DNA bands can be extracted from the agarose gel by using a commercial gel extraction kit , following the manufacturerʼs instructions . (cid:3) 11 . 3 . 5 DNA ligation : (cid:2) DNA ligases are a speciﬁc type of enzyme , a ligase , that facilitates the joining of DNA strands together by catalysing the formation of a phosphodiester bond . DNA ligases have become an indispensable tool in modern molecular biology research for generating recombinant DNA sequences by inserting a DNA fragment digested with restriction enzymes into a plasmid . When performing a ligase reaction , it is Novel approaches to understanding hENT2 and hENT2 - related proteins 86 recommended to try different molar rates vector : insert . Calculations to determine the amount of DNA needed are the following : (cid:2) Reaction components are the digested vector , the DNA insert digested if needed , enzyme T4 DNA ligase , reaction buffer 10x and ddH 2 O to the minimum ﬁnal volume possible . Reaction is incubated at 16ºC overnight and transformed into bacteria cells afterwards ( see section 11 . 1 . 1 ) . (cid:3) 11 . 3 . 6 Vectors and plasmids : (cid:2) In molecular biology , a vector is a DNA molecule used as a vehicle to transfer foreign genetic material into another cell . Common to all engineered vector are an origin of replication , a multicloning site ( MCS ) and a selectable marker gene . Plasmids are double - stranded circular DNA sequences that are capable of automatically replicating in a host cell . Plasmid vectors consist of an origin of replication that allows for semi - independent replication of plasmid in the host and also the transgene insert . MCS has the particularity that the restriction enzyme sites present there are not found in any other region of the vector ( see section 11 . 3 . 3 ) . The selectable marker is usually an antibiotic resistance gene ( most frequent are ampicillin and kanamycin ) that allows to select only those cells which have incorporated the plasmid . More complex plasmids include other sophisticated systems , such as the Lac Z promoter , which is activated by IPTG , or the GFP sequence to generate fusion proteins . (cid:2) ng . Vector × Kb . Insert Kb . Vector × molar . rate insertvector = ng . Insert Materials and Methods 87 The plasmids used in this thesis are ( ﬁgure 16 ) : A . pGemT easy : a commercial vector product of Promega that is ready to ligate PCR products with an extra adenosine added in both edges by the polymerase as default . Suitable for bacteria but not mammalian cells . B . pCDNA3 . 1 : Vector used for transient expression in mammalian cells . We cloned hENT2 isoforms from pGemT easy vector to pCDNA3 . 1 by digesting with ApaI and PstI restriction enzymes . C . pBSxG : Vector used for cRNA transcription . We cloned hENT2 isoforms into it by adding SmaI ( blunt ends ) sites at both edges of hENT2 ORFs and digesting the vector with StuI ( blunt ends too ) , since it is known that cRNA is more stable when ﬂanked by ß - globin UT region . D . pTLB - 1 . Vector used for the MYTH screening . hENT2 was cloned by adding PstI and StuI sites at both edges of its ORF . (cid:3) 11 . 3 . 7 Clone screening by PCR : (cid:2) Screening by PCR is a strategy used for the cloning of hENT2 isoforms . After transforming hENT2 mixed isoforms to bacteria cells we obtained a total of 360 colonies , each one containing one single molecule of hENT2 . Optimizing the sequencing of such amount of samples , we ﬁrst performed a screening by PCR of all of them . We grew each colony in 100μL of LB - Ampicilin in 96 wells plates overnight at 37ºC . Next day , we pooled 5μL of the 8 wells from the same column ( ﬁgure 17 ) and ran a PCR amplifying hENT2 using those DNA pools as template . Afterwards , we ran the PCR products in a 1 % agarose gel to visualise which columns might contain interesting isoforms of hENT2 , which were further sequenced . This method allowed us to discard a big number of repetitive molecules and select a smaller number of samples to de sequenced , thereby optimising time and expenses . Novel approaches to understanding hENT2 and hENT2 - related proteins 88 (cid:2)(cid:3) (cid:4)(cid:3) b L R G G M H R S A L S T V S I S L I S N ctaagaggtggtatgcacagatcagctttgtcgacggtatcgataagcttgatatcgaat MCS Cub domain tcctgcagatatacccatggaggccttccgcggagcgctgacgtcagatcttaataggtc S C R Y T H G G L P R S A D V R S - - Bgl II Sal ILinker CEN / ARS LexA VP16 CYCt LEU2 KanR Cub TEF1 pTLB - 1 7821bp (cid:2)(cid:3) (cid:4)(cid:3) Figure 16 . Plasmid vectors used in this thesis . (cid:2) Materials and Methods 89 Figure 17 . Screening by PCR . We make a pool of the 8 wells of each column and then we perform a PCR reaction for each DNA mix . In the agarose gel , each lane shows the PCR products obtained from its corresponding mix . Then , we select those columns where we noticed one or more products of interest to be sequenced . 11 . 3 . 8 DNA sequencing by PCR : DNA sequencing by PCR is based on the usage of dNTPs labelled with ﬂuorochromes . Those dNTPs lack its 3ʼ - hydroxyl group what terminates the elongation step in the PCR reaction . This way , DNA fragments of different sizes are generated according to the moment in which the labelled dNTP was incorporated . Billions of different DNA fragments are then separated by size using capillary electrophoresis . Once the DNA molecule reaches the bottom of the capillary , it is excited by a laser emitting ﬂuorescence at certain wave length . Since the four dNTPs ( A , G , C , T ) are differently labelled , as a result we obtain an electropherogram that will determine the sequence of the analyzed DNA sample . 1 2 3 4 5 6 7 8 9 10 11 12 A B C D E F G H Novel approaches to understanding hENT2 and hENT2 - related proteins 90 (cid:2) To perform this reaction we need a rate of 100 ng of DNA per Kb of the sample , considering the size of the vector plus the insert . Following the manufacturerʼs instructions , we use the BigDye® Terminator v3 . 1 Cycle Sequencing Kit : 1 μl of ready reaction mix , 3 μl of BigDye® sequencing buffer , 1 μl of 20 μM primer , DNA and ddH 2 O up to a ﬁnal volume of 20 μl . The PCR program used is : 96 ºC for 1 min , 25 cycles of 96 ºC for 10 s , 50 ºC for 5 s and 60 ºC for 4 min , and a ﬁnal step of 4 ºC for 5 min . Once the reaction is done , samples are processed and analyzed by the Scientiﬁc and Technical Services of the UB ( CCiTUB ) M . 11 . 4 RNA EXTRACTION AND MANIPULATION (cid:3) 11 . 4 . 1 RNA extraction from cell culture : (cid:2) RNA extraction is the puriﬁcation of RNA from biological samples . This procedure is complicated by the ubiquitous presence of ribonuclease enzymes in cells and tissues , which can rapidly degrade RNA . For the RNA extraction we used the commercial kit “SV Total RNA isolation System” from Promega following the manufacturerʼs instructions . This method is based on the disruptive properties , at the same time than protective , of the association of SDS with guanidinium thiocyanate and the capacity of ß - mercaptoethanol to inactivate the ribonucleases . (cid:3) 11 . 4 . 2 cDNA synthesis by reverse transcription : (cid:2) In the ﬁeld of molecular biology , a reverse transcriptase is a DNA polymerase enzyme that transcribes single - stranded RNA into single - stranded DNA , also known as cDNA . To perform that reaction we used a commercial reverse transcription kit following the manufacturerʼs instructions . This reaction basically contains the reaction buffer , dNTP mix 100 mM , random primers , the MultiScribe TM reverse transcriptase and RNase inhibitor . The thermal cycle conditions are 25ºC for 10 min , 37ºC for 120 min , 85ºC for 5 min and short - term storage at 4ºC . Materials and Methods 91 11 . 5 REAL - TIME PCR REACTION (cid:2) Real - time polymerase chain reaction is a laboratory technique based on the PCR , which is used to amplify and simultaneously quantify a targeted DNA molecule . For one or more speciﬁc sequences in a DNA sample , real - time PCR enables both detection and quantiﬁcation . The quantiﬁcation can be either an absolute number of copies or a relative amount when normalised to a DNA input or additional normalising genes . The procedure follows the general principle of PCR ; its key feature is that the ampliﬁed DNA is detected as the reaction progresses in real time . Two common methods for detection of products are : non - speciﬁc ﬂuorescent dyes that intercalate with any double - stranded DNA , and sequence - speciﬁc DNA probes consisting of oligonucleotides that are labeled with a ﬂuorescent reporter which permits detection only after hybridisation of the probe with its complementary DNA target . (cid:3) 11 . 5 . 1 TaqMan® reagents : (cid:2) TaqMan® probes are hydrolysis probes that are deigned to increase the speciﬁcity of real - time PCR assays . The Taqman® probe principle relies on the 5ʼ - > 3ʼ exonuclease activity of Taq polymerase to cleave a dual - labeled probe during hybridisation to the complementary target sequence and ﬂuorophore - based detection . The resulting ﬂuorescence signal permits quantitative measurements of the accumulation of the product during the exponential staged of the PCR . (cid:2) TaqMan® probes consist of a ﬂuorophore ( e . g . FAM or VIC ) covalently attached to the 5ʼ - end of the oligonucleotide probe and a quencher ( e . g . TAMRA or MGB ) at the 3ʼ - end ( ﬁgure 18 ) . The quencher molecule quenches the ﬂuorescence emitted by the ﬂuorophore when excited by the cyclerʼs light source via Fluorescence Resonance Energy Transfer ( FRET ) . As long as the ﬂuorophore and the quencher are in proximity , quenching inhibits any ﬂuorescence signals . TaqMan® probes are designed such that they anneal within a DNA region ampliﬁed by a speciﬁc set of primers . As the Taq polymerase extends the primer and synthesises the nascent Novel approaches to understanding hENT2 and hENT2 - related proteins 92 strand , the 5ʼ - > 3ʼ exonuclease activity of the polymerase degrades the probe that has annealed to the template . Degradation of the probe releases the ﬂuorophore from it and breaks the close proximity to the quencher thus relieving the quenching effect and allowing ﬂuorescence of the ﬂuorophore . Hence , ﬂuorescence detected is directly proportional to the ﬂuorophore released and the amount of DNA template present in the sample . Figure 18 . Real - time PCR using TaqMan® probes . Materials and Methods 93 (cid:2) TaqMan® is a product of Applied - Biosystems . Commercial and customised probes are provided by them together with the master mix 2x necessary to perform the reaction . Housekeeping genes commonly used are GAPDH , GUSB and 18S . The thermal cycler conditions are provided within the device software also supplied by Applied - Biosystems . Protocols to perform the reaction and the thermal cycler functioning are provided by the manufacturer . (cid:2) 11 . 5 . 2 SYBR® Green reagents : (cid:2) SYBR® Green is an asymmetrical cyanine dye used as a nucleic acid stain in molecular biology . SYBR® Green bind to DNA and the resulting DNA - dye - complex absorbs blue light ( λmax = 497(cid:5)nm ) and emits green light ( λmax = 520(cid:5)nm ) . The stain is used as a dye for the quantiﬁcation of double stranded DNA in real - time PCR causing ﬂuorescence of the dye . An increase in DNA product during PCR leads to an increase of ﬂuorescence intensity and is measured at each cycle , thus allowing DNA concentrations to be quantiﬁed ( ﬁgure 19 ) . However , dsDNA dyes such as SYBR® Green will bind to all dsDNA PCR products , including nonspeciﬁc PCR products such as primer dimer . This can potentially interfere with , or prevent , accurate quantiﬁcation of the intended target sequence . (cid:2) To perform a real - time PCR using SYBR® Green as a detector , ﬁrst it is needed to design a set of primers to amplify the gene of interest , ensuring they do not amplify secondary products by running a regular PCR reaction and visualizing the results on an agarose gel . If it the purpose of the experiment is to analyze different genes within the same sample , amplicons of each set of primers must have the same length , 150 - 200 bp , hence an increase in ﬂuorescence signal is caused by a higher number of copies instead of being consequences of a longer amplicon . The protocol used in SYBR® Green is similar to the one for TaqMan® probes by using a master mix 2x with all the reagents incorporated . This master mix is provided by Applied - Biosystems together with the protocol directions . The same device used in TaqMan® can also be used for detecting SYBR® Green reactions since the software contemplates both protocols . Novel approaches to understanding hENT2 and hENT2 - related proteins 94 Figure 19 . Real - time PCR using SYBR® Green dye . 11 . 5 . 3 Microﬂuidic cards ( TLDA ) : The Applied - Biosystems Low Density Array ( microﬂuidic card ) screens multiple samples against custom - selected gene panels , providing a cost - effective solution to validating the expression of large numbers of genes using smaller numbers of samples . Up to 380 genes can be rapidly examined on the same array using the well - established TaqMan® gene expression reagents . These are predesigned real - time PCR assays available for human , mouse , and rat gene expression research . The TaqMan® Assay can be customised to a design of 6 conﬁgurations : from 11 genes with 4 replicates run on 8 samples , to 380 genes with no replicates run on a single sample . The Low Density array minimises reagent consumption , as reaction volumes of ~ 2 μl not only reduce the cost in terms of consumables but also limit the amount of RNA required per experiment . To perform an analysis using TLDAs , cDNA samples must be prepared according to the protocol provided by the manufacturer . Those samples are load into Materials and Methods 95 the microﬂuidic cards using the ports disposed at one of the sides ( ﬁgure 20 ) . Cards are then centrifuged to equally distribute the cDNA sample among the different spots , each one containing one validated TaqMan® probe , according to the customised design of the card . Microﬂuidic cards are then placed into the thermal cycle device to detect the ﬂuorescence signals as the PCR reaction progresses . (cid:3) 11 . 5 . 4 Real - time PCR calculations : (cid:2) The method of DNA quantiﬁcation by real - time PCR relies on plotting ﬂuorescence against the number of cycles on a logarithmic scale . A threshold for detection of DNA - based ﬂuorescence is set slightly above background , at the beginning of the exponential stage of the ampliﬁcation curve . The number of cycles at which the ﬂuorescence exceeds the threshold is called the cycle threshold , Ct , which is the value used for analysing the results . Calculation steps are the following : 1 . Determine a Ct average for each target gene ( Ct x ) and each housekeeping gene ( Ct HK ) 2 . Calculate ΔCt for each target gene : ΔCt = Ct x - Ct HK 3 . Calculate the standard error ( SE ) of the experiment for each sample : (cid:2) (cid:2) SE Δ Ct = ( SE x ) 2 + ( SE HK ) 2 4 . Calculate ΔΔCt by subtracting ΔCt values from a control or non - treated sample to a treated ( or condition 1 ) sample : (cid:2) (cid:2) ΔΔCt = ΔCt treatment 1 - ΔCt control 5 . Calculate the relative expression of each sample : (cid:2) (cid:2) Relative expression = 2 - ΔΔCt Novel approaches to understanding hENT2 and hENT2 - related proteins 96 Figure 20 . TaqMan® Low density arrays from Applied - Biosystems . (cid:2) 12 MEMBRANE YEAST TWO - HYBRID ( MYTH ) TECHNIQUE (cid:2) Recent research has begun to elucidate the global network of cytosolic and membrane protein interactions . The resulting interactome map facilitates numerous biological studies , including those for cell signalling , protein trafﬁcking and protein regulation . Due to the hydrophobic nature of membrane proteins such as tyrosine kinases , G - protein coupled receptors , membrane bound phosphatases and transporters it is notoriously difﬁcult to study their relationship to signalling molecules , the cytoskeleton , or any other interacting partners . Although conventional yeast - two hybrid is a simple and robust technique that is effective in the identiﬁcation of speciﬁc protein - protein interactions ( PPI ) , it is limited in its use for membrane proteins ( Kittanakom et al . 2009 ) . Materials and Methods 97 (cid:2) Membrane proteins make up approximately one - third of all proteins in a cell , having important functions in signalling , cell structure , and , as discussed before , transport . Membrane proteins are distributed ubiquitously and understanding their PPIs has important implications in medicine since many membrane proteins are drug targets ( A . Engel & Gaub 2008 ) . (cid:2) In 1994 a split - ubiquitin based method was established by Johnsson and Varshavsky ( 1994 ) , when they discovered that ubiquitin , split into two moieties , can re - associate due of the high afﬁnity of the moieties for each other . These two halves were named N ub for N - terminal half of ubiquitin , and C ub for C - terminal half of ubiquitin ( Johnsson & Varshavsky 1994 ) . These researchers fused cDNAs encoding a library of proteins to the N - terminal moiety called N ub . Two variants of N ub are used . N ub I refers to the wild type form bearing Ile13 . The N ub G form bears an Ile13 Gly substitution . This substitution ensures that the afﬁnity between C ub and N ub is decreased such that if the bait and prey interact , C ub and N ub G will be forced together and ubiquitin - speciﬁc proteases will recognize the complete ubiquitin molecule and cleave off the reporter protein from C ub , which can be detected through selective screening ( Johnsson & Varshavsky 1994 ) . (cid:2) This simple , but elegant method for the detection of protein - protein interactions for integral membrane proteins was later adapted for high - throughput screens and this system came to be known as Membrane Yeast - Two Hybrid , MYTH ( ﬁgure 21 ) . The membrane protein of interest is bound to the C or N - terminal moiety of C ub . C ub is fused to transcription factors , which consist of DNA - binding domain LexA from Escherichia coli and VP16 from the herpes simplex virus . This C ub fusion protein is known as the bait . The prey is a N ub G - fused cDNA library . Both the N ub G and C ub fusion proteins are co - expressed in yeast . If an interaction takes place with the bait and the prey , ubiquitin - speciﬁc proteases will recognize the complete ubiquitin molecule and cleave off the transcription factors from C ub . The transcription factors then translocate to the nucleus and activate the reporter genes : LacZ , His3 , Ade2 ( Snider et al . 2010 ) . While MYTH is , by far , the best tool available for examining PPIs of membrane proteins , it does have disadvantages : A high number of false positives can arise during screening , although Novel approaches to understanding hENT2 and hENT2 - related proteins 98 this can be somewhat alleviated by making more stringent growing conditions for the yeast , as well as performing subsequent bait dependency tests to conﬁrm the validity of the interaction . The putative interacting preys are re - screened against the bait as well as non - interacting artiﬁcial bait and if an interaction occurs with the artiﬁcial bait , it is said to be a false positive and the putative prey protein is discarded ( Iyer et al . 2005 ) . (cid:2) Therefore , MYTH technique adapts the principle of split ubiquitin for use as a potent in vivo sensor of protein - protein interactions , allowing large - scale screening for interactors of full - length membrane proteins , from a range of organisms , using Saccharomyces cerevisiae as a host . The followed protocol has been adapted from the one described by Snider et al . in 2010 , which describes a protocol for MYTH bait generation , validation and library screening . The entire MYTH procedure can generally be completed in 4 - 6 weeks . 12 . 1 BAIT GENERATION AND VALIDATION (cid:2) When using MYTH , the bait must be cloned into an appropriate vector for tagging and expression . Currently , a wide variety of bait vectors are available , allowing for both N - and C - terminal tagging , and expression under the control of the promoters of different strengths . In our case , we cloned hENT2 into pTLB1 vector since our transporter has its N - terminal intracellular . Restriction enzymes sites were added at both edges of the hENT2 sequence and ampliﬁed by PCR . That PCR product was then digested and ligated inside the pTLB1 vector , ensuring hENT2 gene was in reading frame with the C ub sequence . Materials and Methods 99 (cid:3) (cid:6) F i gu r e 21 . M Y T H . S p li t - ub i qu i t i n ba s ed M e m b r ane Y ea s t T w o - H y b r i d ( M Y T H ) . T he p r o t e i n o f i n t e r e s t ( B a i t ) i s f u s ed t o t he C - t e r m i na l ha l f o f ub i qu i t i n ( C ub ) , w h il e t he P r e y p r o t e i n i s one o f a nu m be r o f d i ff e r en t p r o t e i n s f r o m a c DN A li b r a r y , w h i c h i s s ub s equen t l y a tt a c hed t o t he N - t e r m i na l ha l f o f ub i qu i t i n ( N ub G ) . ( a ) If no i n t e r a c t i on be t w een t he ba i t and t he p r e y t a k e s p l a c e , t hen t he r epo r t e r sys t e m w ill no t be t u r ned on . ( b ) O n l y w hen an i n t e r a c t i on t a k e s p l a c e a r e t he t w o ha l v e s o f ub i qu i t i n f o r c ed t oge t he r r e s u l t i ng i n ub i qu i t i n s pe c i ﬁc p r o t ea s e s c l ea v i ng o ff t he t r an sc r i p t i on f a c t o r a tt a c hed t o C ub and t u r n i ng on t he r epo r t e r sys t e m . Novel approaches to understanding hENT2 and hENT2 - related proteins 100 (cid:2) Following , ligation product was transformed into E . coli competent cells and grown on speciﬁc selection medium , LB - kanamycin , for plasmid propagation . Plasmid DNA was isolated using a mini - prep commercial kit following manufacturerʼs protocol . Afterwards , bait construct is transformed into a proper MYTH reporter strain , NMY51 in our case . Transformed cells are plated onto appropriate solid selective medium , SD - Leu , and grown at 30ºC for 2 - 3 days . Molecular cloning steps are widely described in section 11 , Molecular Biology Techniques . Medium recipes and product references are found in Snider et al . ( 2010 ) . (cid:2) (cid:2) Before being used in screening , baits must be validated to ensure that they do not activate the reporter system in the absence of an interacting prey ( “self - activate” ) . Only baits that meet this criteria are suitable for screening . The level of self - activation is assessed using the N ub G / I control test , in which the bait is transformed with both interacting N ub I ( positive ) and noninteracting N ub G ( negative ) control preys and grown on selective medium . A bait must grow on selective medium in the presence of the positive control , but not in the presence of the negative control , to be suitable for MYTH . If a bait shows self - activation , the stringency of the selective medium can be improved by the inclusion of up to 100 mM of the His3 - competitive inhibitor 3 - amino - 1 , 2 , 4 - triazole ( 3 - AT ) . Note that if 3 - AT is found to be necessary at these steps , it must be included at the same concentration throughout the entire screening process . (cid:2) For the N ub GI control test , yeast cells containing the bait plasmid are transformed with 100 - 200 ng appropriate N ub I and N ub G control prey plasmids using the protocol described in section 11 . 2 and plated onto SD - WL selection medium plates for 2 - 3 days . Following , one single colony of each plate is resuspended in 100 μl of sterile 0 . 9 % NaCl and diluted serially producing dilutions of 1 : 10 , 1 : 100 and 1 : 1 , 000 . 2 . 5 μl of each undiluted and diluted cells are spotted onto the following transformation and interaction selective media plates : Materials and Methods 101 - SD - WL - SD - WLAH + 3 - AT 25 mM - SD - WLAH - SD - WLAH + 3 - AT 50 mM - SD - WLAH + 3 - AT 10 mM - SD - WLAH + 3 - AT 100 mM Note : SD = Synthetic dropout medium ; - WL = Dropout mix minus tryptophan and leucine ; - WLAH = Dropout mix minus tryptophan , leucine , adenosine and histidine ; 3 - AT = 3 - amino - 1 , 2 , 4 - triazole . (cid:2) Plates are incubated at 30ºC for 3 - 4 days . Afterwards , positive ( N ub I ) and negative ( N ub G ) controls must be compared . Ideally , all transformed strains should show comparable growth on transformation selection medium ( SD - WL ) , but only bait strains containing N ub I control preys should grow on interaction selection medium ( SD - WLAH ± 3 - AT ) . Baits containing N ub G control preys that grow on interaction selection medium are said to be self - activating and are not suitable for screening . 12 . 2 LIBRARY SCREENING : LARGE - SCALE TRANSFORMATION AND PREY PLASMID RECOVERY (cid:2) When carrying out a screening , it is important to calculate the number of individual prey transformants , or coverage , obtained . This is best carried out by plating a small aliquot of the transformation mix onto appropriate transformation selection medium ( SD - WL ) to select for prey transformation ( but not bait - prey interaction ) and the counting of colonies after growth . The level of coverage deemed acceptable will ultimately depend on both the complexity of the library being screened and the individual goals of the experimenter . As a general guideline , however , it is typically tried to obtained coverage equal to at least twice the complexity of the prey library being used . (cid:2) For the large - scale screening , a single colony of validated bait strain ( freshly streaked from the glycerol stocks grown on a SD - L plate ) is inoculated into 4 ml SD - L medium and incubated overnight at 30ºC with shaking . This overnight culture is used to Novel approaches to understanding hENT2 and hENT2 - related proteins 102 inoculate 200 ml SD - L to an initial OD 600 of 0 . 15 and incubate it at 30ºC until a target OD 600 of 0 . 6 - 0 . 7 is reached ( approximately 4 - 5 hours ) . This grown 200 ml culture is then divided in 4 x 50 ml screw - cap sterile tubes and centrifuged at 700g for 5 minutes at 4ºC . Each pellet is then resuspended in 30 ml sterile ddH 2 O by vortexing brieﬂy and centrifuged again at 700 g for 5 minutes at 4ºC . From here , the yeast transformation protocol described in section 11 . 1 . 2 is followed up - scaling volumes to adapt it to the large scale - transformation , where 10 μg of prey library are used for each 50 ml screw - cap tube . (cid:2) Eventually , pellets are resuspended in 4 . 9 ml of sterile NaCl 0 . 9 % . Starting with 100 μl of cell suspension , 1 : 10 , 1 : 100 and 1 : 1 , 000 serial dilutions are prepared with NaCl 0 . 9 % . 100 μl of both 100X and 1 , 000X dilutions are plated onto transformation selection medium SD - WL and incubated at 30ºC for 3 - 4 days . Once grown , these plates can be used to calculate the total number of transformants obtained by counting colonies and using the following equation : Total transformants = Number of Colonies on Plate X Dilution Factor X 49 (cid:2) The remaining 4 . 8 ml of cell suspension are then equally divided and plated onto large 150 mm plates containing appropriate solid interaction selection medium . If 3 - AT was found to be necessary in the N ub GI control test , it has to be then included in the medium at the required concentration . Plates are incubated at 30ºC for 3 - 4 days or until distinct , moderate - to - large - sized single colonies appear . Each single colony is resuspended in 100 μl of sterile NaCl 0 . 9 % and spotted ( 2 . 5 μl ) onto appropriate interaction selection medium + X - Gal . Plates are once more incubated at 30ºC for 3 - 4 days . Afterwards , only colonies that show both blue colour and robust growth are further analyzed . (cid:2) To recover the positive prey plasmids for further analysis , those robustly growing blue colonies have to be ﬁrst grown in 4 mL of SD - W medium at 30ºC overnight . Following , plasmid DNA from the cultures are isolated using a commercial mini - prep kit according to manufacturerʼs manual . One modiﬁcation has to be done Materials and Methods 103 though ; after initial resuspension , a small volume of 0 . 5 mm soda lime glass beads has to be added and vortexed vigorously for 5 minutes to ensure sufﬁcient lysis of the yeast cells . (cid:2) Once prey plasmid DNA from yeast are obtained , they are following transformed into a competent E . coli strain suitable for plasmid propagation ( protocol described in section 11 . 1 . 1 ) . DNA plasmid is then isolated from the transformed E . coli using the commercial kit ( as per the manufacturerʼs instructions ) . 12 . 3 BAIT DEPENDENCY TESTING AND SEQUENCING (cid:2) On completion of screening and identiﬁcation of candidate interactors spurious hits can be ruled out using the bait dependency test . In this test , isolated prey plasmids are transformed back into the original bait , as well as into an unrelated control bait , and cells are grown on selective medium . Only speciﬁc interactors , capable of activating the reporter system in the original bait , but not in the unrelated bait , are considered for further analysis . (cid:2) To perform this conﬁrmation test , prey plasmid DNA obtained from E . coli mini - prep are transformed into both the original bait strain and an unrelated control bait strain , and plated onto appropriate transformation selection medium ( SD - WL ) , following by incubation at 30ºC for 3 - 4 days . Three individual colonies from each transformation plate are resuspended in 100 μl sterile NaCl 0 . 9 % and spotted ( 2 . 5 μl ) each onto appropriate interaction selection medium + X - Gal . Plates are incubated at 30ºC for 3 - 4 days . After that timing , growth of speciﬁc preys in both the original bait and control bait stain are compared . Preys that cause growth and blue coloration with both the control and the original bait strain are considered spurious , likewise those preys that do not reproduce growth and blue colour in the original bait strains . Preys that cause growth and blue coloration in the original but not the control bait strain are considered speciﬁc . Novel approaches to understanding hENT2 and hENT2 - related proteins 104 (cid:2) Positive and speciﬁc original bait preys are then sequenced using the N ub G forward internal sequencing primer . In our case , the library used was N ub G - X , so the primer used for sequencing is 5′ - CCGATACCATCGACAACGTTAAGTCG - 3′ . Protocol followed for sequencing is described in section 11 . 3 . 8 . Once results are obtained , last step is to analyze those sequences by using BLAST F open source software . 13 PROTEIN EXPRESSION IN BACTERIA (cid:2) Protein expression is a subcomponent of gene expression . It consists of the stages after DNA has been transcribed to mRNA . The mRNA is then translated into polypeptide chains , which are ultimately folded into proteins . There are many ways to induce foreign DNA to a cell for expression , and there are many different host cells which may be used for expression . The best expression system of choice depends on the gene involved . Nonetheless , bacterial expression has the advantage of easily producing large amounts of protein , which is required for X - ray crystallography or nuclear magnetic resonance experiments for structure determination , together with other purposes . (cid:2) E . coli is one of the most widely used expression hosts , and DNA is normally introduced in a plasmid expression vector . The techniques for overexpression in E . Coli are well developed and work by increasing the number of copies of the gene , or increasing the binding strength of the promoter region so assisting transcription . For example , a DNA sequence for a protein of interest could be cloned or sub - cloned into a high copy - number plasmid containing the lac promoter , which is then transformed into E . coli . Addition of IPTG , a lactose analog , activates the lac promoter and causes the bacteria to express the protein of interest . Materials and Methods 105 13 . 1 SYNTHESIS OF ENT2 INTRACELLULAR LOOP PEPTIDES (cid:2) Plasmids containing either the intracellular loop ( residues 217 to 289 ) sequence of hENT2 or mENT2 ( preceded by His and Ubiquitin tags ) were synthesized by DNA 2 . 0 G such that , once translated , the resulting peptides are : hENT2 : MHHHHHHMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEG IPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGL VPRGS HLKFARYYLANKSSQAQAQELETKAELLQSDENG IPSSPQKVALTLDLDLEKEPESEPDEPQKPGKPSVFTVFQ KI mENT2 : MHHHHHHMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEG IPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGL VPRGS HLKFARYYLTEKLSQAPTQELETKAELLQADEKNG VPISPQQASPTLDLDPEKEPEPEEPQKPGKPSVFVVFRK (cid:2) The portion of the peptide corresponding to the ENT2 intracellular loop is indicated in bold . Plasmids were transformed into Escherichia coli DH5α bacteria followed by plating onto kanamycin ( 50 μg / ml ) plates . Following overnight incubation at 37ºC a single colony was inoculated into 3 mL LB containing 50 μg / ml of kanamycin and grown at 37ºC for 8 hours . The resulting starter culture was subsequently transferred to 50 ml LB containing 50 μg / ml kanamycin and allowed to grow for a further 14 hours before being transferred to 1L of M9 minimal medium . (cid:2) When the bacterial culture reached an OD 600 = 0 . 7 , IPTG 1 mM was added to induce protein expression . Bacteria were induced at 37ºC for 2 hours and then pelleted at 7000 x g for 20 minutes . Pellets were resuspended in 30 ml T300 and passed through a French press ( 5 times ) to lyse bacteria and release the protein . Unbroken cell debris was pelleted at 16 , 000 rpm for 20 minutes . Novel approaches to understanding hENT2 and hENT2 - related proteins 106 (cid:2) His - Ubiquitin tagged peptides were extracted from the supernatant ( obtained from the previous centrifugation step ) using standard nickel afﬁnity chromatography methods . Brieﬂy , following preparation of the column with NiCl 2 50 mM , protein was bound at a rate of 2 ml / min . The column was then washed at a rate of 5 ml / min ﬁrst with 100 ml T300 and then with 100 ml T300 buffer supplemented with imidazole 10 mM . Bound protein was eluted from the column using 50 ml T300 buffer supplemented with EDTA 20 mM . Presence of the peptide was conﬁrmed using a 10 % SDS gel and Coomassie blue staining . (cid:2) The 50 ml sample was then concentrated at 4000 x g to 4mL using Microcon YM - 3 columns ( Millipore ) and subjected to further puriﬁcation by fast protein liquid chromatography ( FPLC ) using a Sephadex S - 100 16 / 60 column ( GE Biosciences ) . The resulting elution fraction was concentrated to 5ml using Microcon YM - 3 columns . 14 IN VITRO PHOSPHORYLATION ASSAYS (cid:2) In vitro phosphorylation studies were conducted using 10 μg of the ENT2 - loop peptide or Histone H1 as positive control , which was treated with PKC ( 0 . 02 units ) , PKA ( 2500 units ) , CKII ( 500 units ) or CamKII ( 0 . 02 units ) and [ γ - 32P ] - ATP ( 0 . 25 mCi / ml ; for autoradiography ) or non - radiolabeled ATP ( for mass spectrometry ) . Following a 2 hour incubation at 30ºC , samples were mixed with an appropriate volume of protein loading buffer and boiled at 90ºC for 10 minutes . Protein samples were separated by 10 % SDS - PAGE for 3 . 5 hours at 200 V . (cid:2) Following separation , 16kDa bands representing phosphorylated or non - phosphorylated mENT2 and hENT2 peptides were visualised using coomassie blue stain . Gels containing radiolabeled protein were dried and subjected to autoradiography using standard imaging ﬁlm in cassettes lined with a 32 P intensifying screen for one hour at room temperature or overnight at - 80ºC . Gels containing non - radiolabeled samples were prepared for mass spectrometry analysis . Materials and Methods 107 15 IDENTIFICATION AND CHARACTERIZATION OF 3 NOVEL NUCLEAR SPLICED VARIANTS OF THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2 ( hENT2 ) 15 . 1 IDENTIFICATION AND CLONING OF NOVEL ALTERNATIVE SPLICING VARIANTS OF hENT2 (cid:2) Previous work described the existence of two spliced variants of the human equilibrative nucleoside transporter 2 ( hENT2 ) ( Williams & Lanahan 1995 ; Mangravite et al . 2003 ) . Our research also produced evidence for other variants . Therefore , our ﬁrst aim was to identify and clone the various isoforms ( ﬁgure 22 ) . (cid:2) We designed a set of primers based on the published hENT2 sequence ( NM001532 ) and used these to amplify the complete ORF from the cDNA generated from mRNA isolated from the breast cancer cell line MCF7 . The conditions used for the PCR reaction are outlined in table 9 . Table 9 . PCR ampliﬁcation of hENT2 Primer 5ʼ – FL4F 5ʼ - CTTTCACCCCAGGCGCATCCG Primer 3ʼ – FL5R 5ʼ - GGATCTCAGCTCCGGAAGG Reaction Mix Taq polymerase buffer 10X . ……… . . 5 μl Primer 5ʼ ( 20 μM ) …………………… 1 μl Primer 3ʼ ( 20 μM ) …………………… 1 μl dNTPs ( 2 . 5 mM ) …………………… . . 4 μl DMSO ………………………………… 4 μl MgCl 2 ( 25 mM ) … . …………………… 3 μl DNA ………………………… . . … . . . … 50 ng FastStart Taq High Fidelity …… . . … . 2 . 5 U MilliQ water …… to a ﬁnal volume of 50 μl PCR Parameters Denaturation : 94ºC 30s ( 35 cycles ) Annealing : 58ºC 30s Extension : 72ºC 1min 45 s Results and Discussion 111 (cid:2) PCR products were analyzed by standard agarose electrophoresis and initial ampliﬁcations resulted in four different products being ampliﬁed which ranged in size from 1000 and 1500 bp ( ﬁgure 22b ) . We surmised that the largest band was likely to correspond to the wild type ( wt ) isoform of hENT2 ( 1456 bp ) . To ensure that as many isoforms as possible were included in our analysis , we repeated the PCR reaction using four different sources of MCF7 cDNA coming from four different cell batches . We extracted PCR products for cloning by cutting the appropriate section of each lane as shown in ﬁgure 22d . PCR products were ligated into the vector pGemT Easy and transformed into competent E . coli DH5α bacteria as described in the materials and methods section . (cid:2) Cloning resulted in a total of 360 colonies , which were screened by PCR as described in materials and methods . From the colonies isolated , a total of 33 sequences were conﬁrmed to be the full - length hENT2 wt isoform , and 77 appeared to be spliced variants of hENT2 . Results are shown in table 10 , where we describe the most relevant isoforms identiﬁed , based on their prevalence , and the structure of their translated proteins . (cid:2) Our approach allowed us to analyze 360 samples and identify as many different isoforms as possible ( ﬁgure 23 ) . We analyzed 45 DNA pools and 16 candidates were chosen to be sequenced , resulting in a total of 128 different samples of which 110 sequences turned out to be hENT2 , 45 candidates from the upper bands and 65 from the lower bands . (cid:2) To help understand the nature , similarities and differences among the splice variants , we classiﬁed the identiﬁed isoforms into different groups depending on the putative proteins generated by the ORFs . We noted that two variants would generate putative proteins containing the ﬁrst 6 transmembrane domains of the full - length hENT2 protein . One of those variants has been previously deﬁned as hENT2A ( Mangravite et al . 2003 ) . This spliced variant was previously reported as being a protein that did not reach the plasma membrane but which remained in an intracellular location with a vesicular distribution . These data suggested that the isoform we designated as 17G was likely to be a new potential cytoplasmic variant . Novel approaches to understanding hENT2 and hENT2 - related proteins 112 (cid:7) (cid:8)(cid:8) (cid:9) (cid:10) (cid:2) (cid:11) (cid:12) (cid:13)(cid:14) (cid:4) (cid:15) (cid:16) (cid:9) (cid:10) (cid:2) (cid:11) (cid:12) (cid:13)(cid:14) (cid:17)(cid:18)(cid:18)(cid:18) (cid:2) (cid:11)(cid:8) (cid:2) (cid:19)(cid:20)(cid:18)(cid:18) (cid:2) (cid:11)(cid:8) (cid:19)(cid:18)(cid:18) (cid:18) (cid:2) (cid:11)(cid:8) (cid:19)(cid:20)(cid:18)(cid:18) (cid:2) (cid:11)(cid:8) (cid:19)(cid:18)(cid:18)(cid:18) (cid:2) (cid:11)(cid:8) (cid:5) (cid:6) (cid:7) (cid:6) (cid:8) (cid:6) (cid:9) (cid:6) (cid:5) (cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2) (cid:5) (cid:3) (cid:6) (cid:21) (cid:5) (cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2) (cid:2)(cid:2) (cid:19) (cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2) (cid:17) (cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2) (cid:22) (cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2) (cid:23) (cid:5) (cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2) (cid:19) (cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2) (cid:17) (cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2) (cid:22) (cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2)(cid:2) (cid:23) (cid:2) (cid:3) (cid:4) (cid:4) (cid:5) (cid:6) (cid:4) (cid:4) (cid:5) (cid:7) (cid:3) F i gu r e 22 . A m p li ﬁ ca t i on o f t h e h E N T 2 g e n e f r o m M C F 7 c DNA . ( a ) h E N T 2 t r an sc r i p t pa tt e r n c o m p r i s ed o f 12 e x on s . S i t e s o f P CR p r i m e r s a r e s ho w n abo v e and t he open r e ad i ng f r a m e ( O R F ) i s s ho w n a s b l a ck li ne r ep r e s en t i ng a 456 aa p r o t e i n . ( b ) P CR a m p li ﬁc a t i on o f M C F 7 c DN A r e s u l t ed i n f ou r p r odu c t s o f d i ff e r en t m o l e c u l a r w e i gh t . ( c ) P CR a m p li ﬁc a t i on o f f ou r d i ff e r en t s a m p l e s o f M C F 7 c DN A ( l ane s 1 - 4 ) r e s u l t ed i n t he s a m e pa tt e r n o f p r o du c t s . ( d ) S t r a t eg y u s ed t o e x t r a c t t he DN A b y c u tt i ng ea c h l ane i n 2 pa r t s : uppe r band and l o w e r band . Results and Discussion 113 3 4 5 6 13 14 15 16 17 18 23 24 25 26 27 28 29 30 31 39 40 41 42 43 44 45 2000 bp 1500 bp 1000 bp 6 4 16 17 28 30 31 40 45 2000 bp 1500 bp 1000 bp M M F i gu r e 23 . S c r ee n i ng b y P CR . R e s u l t s ob t a i ned f r o m t he P CR sc r een i ng o f s a m p l e s f r o m l o w e r band s . B a s ed on t he d i ff e r en t pa tt e r n s ob s e r v ed , a t o t a l o f 16 DN A poo l s w e r e c ho s en t o be s equen c ed , s a m p l e s h i gh li gh t ed w i t h a c i r c l e t oge t he r w i t h l ane s 2 , 8 , 10 , 20 , 22 , 34 and 35 ( no t s ho w n ) f r o m uppe r band s . Novel approaches to understanding hENT2 and hENT2 - related proteins 114 Tablee 10 . Splicing variants oof hENT2 Sample Deletion Name DB Prevalence Protein TM Domains Localization 10C - NM001532 33 / 45 456 aa 1 - 11 PM 22C 40 bp in exon 9 AF401235 7 / 45 + 7 / 65 301 aa 1 - 6 Intracellular 17G Exon 8 - 10 / 65 361 aa 1 - 6 Intracellular ? 22E 68 bp in exon 4 X86681 2 / 65 336 aa 4 - 11 Nuclei 4A Exon 2 - 5 / 65 336 aa 4 - 11 Nuclei 16D Exon 4 - 6 / 65 302 aa 5 - 11 Nuclei ? 45F Exons 2 and 4 - 9 / 65 302 aa 5 - 11 Nuclei ? 30D 247 bp ( e3 , e4 , e5 ) - 3 / 65 302 aa 5 - 11 Nuclei ? 4D Exon 2 + 40 bp exon 9 - 6 / 65 181 aa 4 - 6 ? 45C Exons 2 and 8 - 2 / 65 241 aa 4 - 6 ? 31F Ex . 2 + ex . 4 + 40 bp ex . 9 - 2 / 65 147 aa 5 - 6 ? Features described in table 10 : Sample , identiﬁer ; Deletion , region of gene deleted compared to hENT2 wt ; Name DB , reference found in GenBank A database for the transcript ; Prevalence , number of repetitions found during the screening ; Protein , length in amino acid of putative protein product based on analyses using Clone Manager software B ; TM Domains , putative transmembrane domains based on analysis using TMHMM 2 . 0 software C ; Localization , conﬁrmed or proposed cellular localization of the protein . (cid:2) (cid:2) In addition , we identiﬁed a variant whose transcript was previously named as X86681 and which is described as missing 68 bp in exon 4 resulting in a translated protein of 36 KDa . This variant is described as a hydrophobic nucleolar protein ( HNP36 ) comprising 326 amino acids ( Williams & Lanahan 1995 ) . However , according to our studies using the ORF Finder software from NCBID ( see ﬁgure 60 - appendix I ) or the Clone Manager software B , the transcript would result in a protein of 336 amino acids . (cid:2) We identiﬁed a novel spliced variant in which exon 2 had been skipped resulting in a predicted ORF of 336 amino acids which is identical to our analysis of the actual structure of HNP36 protein ( ﬁgure 24 ) . We also detected three more variants , which would produce a translated protein containing only the last 7 transmembrane domains ( TMD ) of the wild type protein . This structure consists of one less TMD than HNP36 , indicating the possibility of the existence of another nuclear variant . The existence of different spliced variants of the same protein suggests a multitude of ways of regulating the protein and perhaps multiple roles . Results and Discussion 115 F i gu r e 24 . A li gn m e n t o f t h r ee p r e d i c t e d O R F f o r h E N T 2 s p li ce d va r i a n t s . P r ed i c t ed p r o t e i n f o r t he t r an sc r i p t X 86681 a cc o r d i ng t o O R F F i nde r f r o m NC B I D and C l one M anage r B s o ft w a r e . P r ed i c t ed p r o t e i n f o r ou r no v e l v a r i an t 4 A a l s o c on s i s t i ng o f 336 aa . HN P 36 p r o t e i n s equen c e a s de sc r i bed ( W illi a m s & Lanahan 1995 ) c o m p r i s ed o f 326 aa , l a ck i ng t he 10 ﬁ r s t r e s i due s o f X 86681 and 4 A . Novel approaches to understanding hENT2 and hENT2 - related proteins 116 (cid:2) (cid:3) (cid:4) (cid:5) (cid:6) (cid:7) (cid:8) (cid:9) (cid:10) (cid:2)(cid:1) (cid:2)(cid:2) (cid:2) (cid:3) (cid:4) (cid:5) (cid:6) (cid:7) (cid:2) (cid:3) (cid:4) (cid:5) (cid:6) (cid:7) (cid:5) (cid:6) (cid:7) (cid:8) (cid:9) (cid:10) (cid:2)(cid:1) (cid:2)(cid:2) (cid:6) (cid:7) (cid:8) (cid:9) (cid:10) (cid:2)(cid:1) (cid:2)(cid:2) (cid:5) (cid:6) (cid:7) (cid:5) (cid:6) (cid:24)(cid:25)(cid:2) (cid:26)(cid:15) (cid:3)(cid:4) (cid:2) (cid:26)(cid:27) (cid:8) (cid:24)(cid:28)(cid:15) (cid:26) (cid:2) (cid:3)(cid:3)(cid:4) (cid:24)(cid:29) (cid:3) (cid:30)(cid:30)(cid:2) (cid:5)(cid:6)(cid:7) (cid:8)(cid:9)(cid:10) (cid:26)(cid:27)(cid:28)(cid:9) (cid:4)(cid:4) (cid:9)(cid:9)(cid:9) (cid:31)(cid:25)(cid:24)(cid:9) (cid:4)(cid:4) (cid:9)(cid:9) (cid:31)(cid:28)(cid:24)(cid:9) (cid:4)(cid:4) (cid:9)(cid:9) (cid:31)(cid:31)(cid:28)(cid:9) (cid:4)(cid:4) (cid:9)(cid:9)(cid:9) (cid:9)(cid:31)(cid:25)(cid:30)(cid:9) (cid:4)(cid:4) (cid:9)(cid:9)(cid:9) (cid:24) (cid:24)(cid:9) (cid:4)(cid:4) (cid:9)(cid:9)(cid:9)(cid:9) (cid:24)(cid:26)(cid:29)(cid:9) (cid:4)(cid:4) (cid:30)(cid:26)(cid:24)(cid:9) (cid:4)(cid:4) (cid:17) (cid:5)(cid:6)(cid:7)(cid:8)(cid:9)(cid:4) ! (cid:10)(cid:11)(cid:12) (cid:9) (cid:13)(cid:14) " (cid:12) # (cid:9) # (cid:10) (cid:15)(cid:9)(cid:4) ! (cid:10)(cid:4) (cid:9) (cid:10)(cid:14)(cid:10)(cid:16) $ (cid:4)(cid:5)(cid:14) (cid:17) # (cid:12)(cid:9)(cid:14)(cid:4) $ (cid:9) (cid:18)(cid:14)(cid:10)(cid:16) $ (cid:4)(cid:5)(cid:14) Fi gure 25 . Representation of hENT2 splicing variants and their putative proteins . Left ( Transcripts ) : Wild type isoform is represented in pink . Variants with deletions at the end of the transcript generating putative proteins missing the C - terminal TMDs are shown in yellow . Variants with deletions at the beginning of the transcript generating putative proteins missing the N - terminal TMDs are shown in blue . Variants with deletions at both the N and C - termini of the transcript , generating small putative proteins containing only the central TMDs are shown in green . Right ( Proteins ) : The epitope within the large intracellular loop between TMD 6 and 7 which is recognized by the anti - hENT2 antibody is shown in green . The region of putative protein in which the sequence varies from the wild type protein due to a frame shift because of a deletion is shown in light blue . Results and Discussion 117 (cid:2) We also identiﬁed three spliced variants with deletions at both ends of the transcript resulting in small proteins consisting of only 3 transmembrane domains . It is unlikely that these variants would reach the plasma membrane or be functional based on their short structure . However , since these small variants were well represented in the total pool , we speculate that they may play a regulatory function . (cid:2) We continued further studies on the 6 more prevalent identiﬁed variants together with the wild type isoform , as indicated in table 10 . To conduct expression and functional assays , we cloned the splice variants into pCDNA3 . 1 , which is a vector suitable for heterologous expression . 15 . 2 PROTEIN EXPRESSION OF hENT2 - HA TAGGED SPLICED VARIANTS (cid:2) Following cloning of the putative newly identiﬁed spliced variants for the hENT2 gene , we determined whether these variants were translated into proteins or not . Since commercial antibodies against the hENT2 - loop will recognize many variants , and are therefore not able to help us to distinguish between them , we decided to insert an HA - tag into the variants so each potential protein would be detected individually in a heterologous system . The HA tag consists of a 9 amino acids sequence from the human inﬂuenza hemagglutinin protein and reliable commercial antibodies against this sequence are readily available . Since this is a very small tag , we presume it will not interfere with the sorting and function of the protein , which is a potential problem of much larger tags such as GFP . (cid:2) Before starting the cloning , we analyzed in depth all the theoretical ORF contained in our transcripts in order to add the tag into a proper position . We found that some of the variants included more than one ORF , such as a variant which could produce a protein of 143 aa or another of 120 aa , both of them repeated in some of the cases . Since we could not ensure which ones would be synthesized in advance , we decided to generate all the required constructs to analyze all these theoretical ORF ( ﬁgure 26 ) . Novel approaches to understanding hENT2 and hENT2 - related proteins 118 (cid:9) (cid:10) (cid:2) (cid:10)(cid:10) (cid:2) (cid:9)(cid:11) (cid:19) (cid:12) (cid:2) (cid:9)(cid:13) (cid:15) (cid:12)(cid:14) (cid:20) (cid:12) (cid:15) (cid:9)(cid:12)(cid:15) (cid:9) (cid:16)(cid:16) (cid:9)(cid:10) (cid:10) (cid:9) (cid:16)(cid:16)(cid:9)(cid:12)(cid:15) (cid:9) (cid:16)(cid:16) (cid:12)(cid:14)(cid:13) (cid:9) (cid:16)(cid:16) (cid:15) (cid:10) (cid:9) (cid:9) (cid:16)(cid:16) (cid:15)(cid:13)(cid:9) (cid:9) (cid:16)(cid:16) (cid:15)(cid:15)(cid:13) (cid:9) (cid:16)(cid:16) (cid:15) (cid:10) (cid:10) (cid:9) (cid:16)(cid:16) (cid:9)(cid:11)(cid:17) (cid:9) (cid:16)(cid:16) (cid:15) (cid:10) (cid:10) (cid:9) (cid:16)(cid:16) (cid:9)(cid:10) (cid:10) (cid:9) (cid:16)(cid:16)(cid:9)(cid:12)(cid:15) (cid:9) (cid:16)(cid:16) (cid:9)(cid:17)(cid:9) (cid:9) (cid:16)(cid:16) (cid:18) (cid:2) (cid:18) (cid:2) (cid:18) (cid:2) (cid:18) (cid:2) (cid:18) (cid:2) (cid:18) (cid:2) (cid:18) (cid:2) (cid:18) (cid:2) (cid:18) (cid:2) (cid:18) (cid:2) (cid:18) (cid:2) (cid:18) (cid:2) (cid:18) (cid:2) Figure 26 . Open Reading Frames ( ORF ) for each transcript and positions of their HA tag . In purple are shown the ORFs that would be translated into proteins with a similar or partial structure with respect to the wild type isoform . Samples 22C , 17G and 4D have a common ORF with a 143 aa protein . In the same way , isoforms 22C and 4D share a potential ORF for a protein of 120 aa . HA tags were inserted in speciﬁc positions to be in frame with only one ORF at a time so we would know which possible protein had been synthesized . Results and Discussion 119 (cid:2) For that purpose we designed a set of 26 primers , including forward and reverse oligonucleotides , classiﬁed in 4 groups : Initial HA , to add the tag at the beginning of the ORF ( exon 1 ) , Final HA , to add the tag at the end of the ORF ( exon 12 ) , 4D HA , speciﬁc for the 181 aa protein from the 4D sample ( exon 9 ) , and P120 HA , for those that might produce the 120 aa protein ( exon 11 ) ( table 21 - appendix I ) . As a result , we obtained a total of 13 hENT2 - HA constructs , all of which were veriﬁed by sequencing ( table 11 ) . Table 11 . hENTT2 - HA constructs Sample Protein HA position Name 10C 456 aa Exon 12 F10C - HA 22C 301 aa Exon 1 I22C - HA 143 aa Exon 12 F22C - HA 120 aa Exon 11 P22C - HA 17G 361 aa Exon 1 I17G - HA 143 aa Exon 12 F17G - HA 4A 336 aa Exon 12 F4A - HA 16D 302 aa Exon 12 F16D - HA 178 aa Exon 1 I16D - HA 45F 302 aa Exon 12 F45F - HA 4D 181 aa Exon 9 4D - HA 143 aa Exon 12 F4D - HA 120 aa Exon 11 P4D - HA (cid:2) (cid:2) Once we had generated the hENT2 - HA constructs , we determined which proteins could be synthesized by transfecting the constructs into HEK - 293 cells , using lipofectamine® 2000 . Total protein was extracted 36 hours later with NP - 40 buffer . We then denatured the samples and separated them by SDS - PAGE followed by immunoblotting using a commercial anti - hENT2 antibody and an anti - HA antibody ( ﬁgure 27a ) . Results show the presence of the wild type isoform together with the putative nuclear variants : 4A , 16D and 45F . The molecular weight of these variants corresponds to the expected values of approximately 36KDa for 4A ( HNP36 ) , and 32 KDa for 16D and 45F since they have one transmembrane domain less . The results using the anti - hENT2 antibodies conﬁrm that that antibody can recognize these variants as expected since they possess the conserved intracellular loop between TMD 6 and 7 , which contains the epitope against which the antibody has been designed . Novel approaches to understanding hENT2 and hENT2 - related proteins 120 46 KDa 30 KDa α - HA α - hENT2 1 2 3 4 5 1 2 3 4 5 (cid:21)(cid:22) 37 KDa HeLa BeWo 10C - HA 4A - HA 45F - HA α - hENT2 α - HA 50 KDa (cid:4) (cid:22) (cid:2) Figure 27 . Immunoblots of endogenous hENT2 and hENT2 - HA proteins . ( a ) WB of total protein extracted with NP - 40 extraction buffer from HEK - 293 cells transfected with different constructs : pCDNA3 . 1 ( lane 1 ) , F10C - HA ( lane 2 ) , F4A - HA ( lane 3 ) , F16D - HA ( lane 4 ) and F45F - HA ( lane 5 ) . Membranes were incubated with antibodies anti - hENT2 and anti - HA tag . ( b ) Comparison of endogenous hENT2 total protein extracted from HeLa and BeWo cells versus total protein extracted from HeLa cells transfected with 3 HA - tagged hENT2 isoforms . (cid:2) (cid:2) Results and Discussion 121 (cid:2) We also wanted to investigate the presence of the putative nuclear variants in a homologous system using endogenous extracted protein . Since BeWo cell line was described to express ENTs transporters at the nuclear membrane ( Mani et al . 1998 ) , we analyzed the expression of endogenous hENT2 isoforms in both BeWo and HeLa cells . We compared the protein pattern of BeWo with HeLa cells transfected with the wt - HA and two tagged variants and conﬁrmed that BeWo cells have high expression levels of both splice variants which are presumed to be located at the nuclear membrane . (cid:2) The putative ER variants , 22C and 17G , could not be detected by immunoblotting ( data not shown ) . Similarly , the 4D truncated proteins of 143 aa and 120 aa , and the 178 aa protein derived from a 16D ORF , could not be detected even when using special nitrocellulose membranes for small molecular weight peptides . Before concluding that these proteins are not synthesized by transient overexpression , we decided to continue with immunocytochemistry ( ICC ) assays to conﬁrm immunoblotting results and also determine the cellular localization of proteins we have conﬁrmed are synthesized . (cid:2) For ICC assays , both HeLa and HEK - 293 cells were seeded on glass coverslips ( 12 mm diameter ) in a 24 - well plate . We transfected the cells with constructs and ﬁxed the cells after 36 hours according to the protocol described in materials and methods section . Initially , we used the anti - HA antibody to conﬁrm expression of the proteins . As previously noted with immunoblotting , we did not detect the putative ER variants 22C and 17G , neither for the proteins of 143 aa and 120 aa . In contrast , we conﬁrmed protein synthesis in the cases of the wild type isoform ( F10C - HA ) which is apparently localized at the plasma membrane , and also for the potential nuclear variants : F4A - HA , F16D - HA and F45F - HA ( ﬁgure 28 ) , which seemed to be located at the nuclear periphery according to the nucleoplasma staining with DAPI . The I16D - HA and 4D - HA constructs appeared to be present in some kind of intracellular vesicles that do not reach neither the cytoplasmic nor the nuclear membrane . These vesicles did not co - localize with mitochondria , as detected by Mitotracker® , so we presume they may be lysosomal - like structures that degrade mis - folded proteins . Novel approaches to understanding hENT2 and hENT2 - related proteins 122 F i gu r e 28 . D i s t r i bu t i on o f h E N T 2 - HA a nd i t s s p li ce d va r i a n t s i n hu m a n ce ll s . I mm u no cy t o c he m i s t r y o f H eLa c e ll s t r an s f e c t ed w i t h h E N T 2 - H A and i t s s p li c ed v a r i an t s . F 10 C - H A s a m p l e s be l ong t o t he w il d t y pe i s o f o r m o f t he gene , w h i c h appea r s t o be l o c a t ed t o t he p l a s m a m e m b r ane . F 4 A - H A , F 1 6 D - H A and F 45 F - H A a r e t ho s e v a r i an t s p r ed i c t ed t o be l o c a t ed a t t he nu c l ea r m e m b r ane w h i c h i s c on ﬁ r m ed w i t h D AP I s t a i n i ng . 4 D - H A i s o f o r m w a s f ound i n s o m e i n t r a c e ll u l a r v e s i c l e s , w h i c h m a y be l ys o s o m e s a s f o r I 16 D - H A , s i n c e v e s i c l e s d i d no t c o - l o c a li z e w i t h m i t o c hond r i a de t e c t ed b y M i t o T r a ck e r ® p r obe . F 10 C - H A F 4 A - H A F 4 A - H A + D AP I F 16 D - H A F 45 F - H A F 45 F - H A + D AP I I 16 D - H A I 16 D - H A I 16 D - H A + M i t o t r ac k e r 4 D - H A 4 D - H A F 10 C - H A Results and Discussion 123 Figure 29 . Co - localization of hENT2 - HA nuclear variants with the nuclear membrane in human cells . We transfected HEK - 293 with the wild type isoform F10C - HA , together with the nuclear variants F4A - HA , F16D - HA and F45F - HA . As shown , the wild type isoform is not present at the nuclear membrane , unlike the nuclear variants which clearly co - localize with the NPC . Anti - HA Anti - NPC Merge F 4 A - H A F 16 D - H A F 45 F - H A F 10 C - H A Novel approaches to understanding hENT2 and hENT2 - related proteins 124 (cid:2) To conﬁrm that our novel nuclear variants are located at the nuclear membrane , we repeated the ICC transfecting only the wild type isoform and the three nuclear variants with the HA tag . We immunodetected the HA tag and the Nuclear Pore Complex ( NPC ) , a nuclear membrane marker ( ﬁgure 29 ) , at the same time . Results conﬁrmed the co - localization between the hENT2 variants 4A , 16D and 45F and the NPC proteins located at the nuclear membrane but not for the wild type isoform , 10C . 15 . 3 NUCLEAR SPLICED VARIANTS mRNA SURVEILLANCE (cid:2) Our results thus far were obtained in a heterologous system where we over - expressed the various constructs . Unfortunately , we have not been able to detect them in a homologous system . Therefore , we must conﬁrm that our observations to date are not an artefact due to over - expression and that maybe these proteins would never be synthesized at all because the mRNAs decay before being translated . (cid:2) It is well known that all eukaryotic cells conserve the nonsense mediated decay ( NMD ) pathway , which detects and degrade mRNA transcripts that contain premature termination codons ( PTC ) . These PTCs may be generated either by mutations , transcriptional mistakes or errors during mRNA processing , like the alternative splicing phenomenon . Failure to recognize and degrade these mRNA transcripts can result in the production of truncated proteins , which may be harmful to the organism since they might turn out to be some sort of deleterious dominant - negative or gain of function effects . (cid:2) The NMD pathway is linked to the synthesis of proteins as it detects the PTC once the ribosome binds to the mRNA and the translation starts . One way to ﬁnd out whether our novel spliced variants are degraded or not by that system , is to block the NMD pathway and determine if there is an accumulation of the mRNA afterwards . That would mean that the transcript is indeed degraded by that pathway and results obtained so far are a consequence of the over - expression protocol . Results and Discussion 125 Figure 30 . NMD pathway analysis . ( a ) Example of a realtime PCR proﬁle for mRNA degraded by the NMD pathway where its expression increases after the treatment with CHX . ( b ) Example of a realtime PCR proﬁle for a mRNA not degraded by the NMD pathway where the expression level is the same before and after the treatment with CHX . ( c ) PCR ampliﬁcation of the nPTB gene was used as a positive control . ( d ) Results of realtime analysis of the hENT2 spliced variants . The four isoforms , wild type plus three nuclear variants , have the same expression before and after the treatment with CHX , what means they are usually translated into proteins since they are not degraded by the NMD pathway . Last bar represents the expression of our control gene , nPTB , which increases its expression 12 - fold after the treatment indicating this mRNA is regularly degraded by the NMD pathway . Control CHX mRNA degraded by NMD = Variant NO VALID mRNA not degraded by NMD = Variant VALID 0 4 8 12 16 WT 4A 16D 45F nPTB 12 , 04 1 , 28 0 , 98 0 , 97 1 , 07 mRNA expression after CHX Treatment (cid:21) (cid:19) (cid:4) (cid:19) (cid:2)(cid:3) (cid:4)(cid:3) nPTB mRNA 200 bp 300 bp ● CHX ● Control ● CHX ● Control Cycle Cycle Δ Rn Δ Rn Novel approaches to understanding hENT2 and hENT2 - related proteins 126 (cid:2) To block the NMD pathway , we treated HEK - 293 cells with cycloheximide ( CHX ) ( 20 μg / mL for 6 hours ) to inhibit protein synthesis and the NMD machinery . We then extracted the RNA from control ( DMSO ) and treated samples ( CHX ) and generated cDNA to analyze the expression of the transcripts and determine if there is any increase in the mRNA levels before and after treatment ( ﬁgure 30a and 30b ) . As a positive control we used the nPTB gene , which has been previously described to have an alternative splicing variant where exon 10 is skipped leading to degradation of the variant mRNA by the NMD pathway ( Boutz et al . 2007 ) . As shown ( ﬁgure 30c ) , we observed an increase of the smallest transcript of nPTB gene ( corresponding to the exon 10 - skipped variant ) after treatment with CHX , conﬁrming the involvement of the NMD pathway . (cid:2) Once we had validated this technique , we analyzed the expression of our variants before and after the treatment . For this , we designed a set of primers such that each couple would amplify only one isoform speciﬁcally . We used these primers to detect the levels of these transcripts by real time PCR with SYBR Green® . Results ( ﬁgure 30d ) show that neither the wild type isoform nor the three nuclear variants experience any change in their expression levels after treatment with CHX , which means these mRNAs are not degraded by NMD pathway , so they appear to be translated into proteins in a homologous system . On the contrary , our positive control , nPTB exon 10 skipped variant , showed elevated mRNA expression levels by about 12 - fold when we blocked the NMD pathway , which conﬁrms its degradation by this system . 15 . 4 FUNCTIONAL CHARACTERIZATION OF hENT2 NUCLEAR VARIANTS (cid:2) After conﬁrming the expression and localization of our novel spliced variants , we continued with their functional characterization . The ﬁrst assay we performed was a transport assay using transiently transfected HeLa cells and constructs of the wild type isoform and the three variants ( ﬁgure 31a ) . As expected , we only observed a signiﬁcant increase in uptake in HeLa cells transfected with the wild type isoform . Interestingly , we observed an increase of ENT2 activity while ENT1 - dependent uptake decreased . However , we did not see any change in uptake with the nuclear variants which is consistent with their presence at the nuclear membrane instead of the cytoplasmic membrane . Results and Discussion 127 0 500 1000 1500 2000 Control Wt 4A 16D 45F Hypoxanthine Uptake in Oocytes C p m / O o c y t e 0 750 1500 2250 3000 Control Wt 4A 16D 45F Cl - Adenosine Uptake in Oocytes C p m / O o c y t e 0 13 25 38 50 Control hENT2 wt 4A - Nuclei 45F - Nuclei 16D - Nuclei Uridine Uptake in HeLa cells p m o l / u g p r o t e i n · m i n Total ENT ENT1 ENT2 (cid:5) (cid:23) * * * * (cid:6) (cid:23) (cid:2) (cid:23) Figure 31 . Transport assays of hENT2 and its nuclear variants . ( a ) Uridine transport assays performed in HeLa cells transfected with four isoforms together with the empty vector as a control ( pCDNA3 ) . Transfection of the wild type isoform led to ENT2 - dependent uptake while ENT1 - dependent uptake decreases . Presence of nuclear variants leads to no increase in ENT2 - dependent uptake and there is no change in ENT1 - dependent uptake . ( b ) Hypoxanthine transport assays in oocytes injected with hENT2 wild - type ( wt ) or the splice variants ( 4A , 16D , 45F ) and water as a control . ( c ) Chloro - adenosine uptake in oocytes injected with hENT2 wt , three nuclear variants and water as a control . Novel approaches to understanding hENT2 and hENT2 - related proteins 128 (cid:2) To determine if the nuclear variants were functional or not , we attempted to purify nuclei from BeWo cells to conduct transport assays since this cell line appears to express nuclear variants ( ﬁgure 27 ) . Unfortunately , despite trying different protocols , we were unable to obtain a pure fraction of functional nuclei . Nuclei preparations were either contaminated with mitochondria or the nuclear membranes were damaged affecting the functionality of proteins present within them . We therefore decided to purify nuclei from Xenopus laevis oocytes injected with our variants . Surprisingly , we observed a signiﬁcant uptake of hypoxanthine in the oocytes injected with hENT2 wild type as well as the putative nuclear isoforms ( ﬁgure 31b ) . We hypothesize that the sorting signal that usually sends the spliced variants to the nuclear membrane in human cells , is not recognized in oocytes and they therefore reach the plasma membrane resulting in measurable uptake . (cid:2) Transport results with injected oocytes are still preliminary and need to be repeated to conﬁrm the results . However , a priori , the nuclear variants appear to be functional for hypoxanthine uptake although they would have less capacity to translocate the substrate , either because there is less protein reaching the membrane or the transporter variant has less afﬁnity for the substrate than the wild type isoform . We repeated the assay with the same samples but using chloro - adenosine as a substrate . We observed that the nuclear variants do not transport the nucleoside compared to the nucleobase hypoxanthine . This difference could be explained by the lack of the ﬁrst transmembrane domains in these variants which would be determinant for interaction and recognition of the substrate ( Yao et al . 2001 ; Yao et al . 2002 ) . Transport assays with the ENT1 / 2 inhibitor dipyridamole were also performed but data were equivocal so we could not determine whether nuclear variants are sensitive to this inhibitor . Results and Discussion 129 (cid:2) (cid:3) (cid:4) (cid:2) (cid:5) (cid:4) (cid:6) M ) D N A l a dd e r 100 bp 1 ) M C F 7 2 ) M D A - M B 231 3 ) H e L a 4 ) F i b r o b l a s t s 5 ) H e p G 2 h i g h G l c c o nﬂu e n t 6 ) H e p G 2 h i g h G l c n o c o nﬂu e n t 7 ) H e p G 2 l o w G l c c o nﬂu e n t 8 ) H e p G 2 l o w G l c n o c o nﬂu e n t 9 ) H K 2 n o c o nﬂu e n t 10 ) H K 2 c o nﬂu e n t (cid:5) (cid:22) (cid:6) (cid:22) 300 bp M 400 bp 500 bp F i gu r e 32 . h E N T 2 m RNA ex p r ess i on i n d i ff e r e n t ce ll li n es a nd c ond i t i on s . ( a ) S t r a t eg y u s ed t o de t e c t f ou r i s o f o r m s o f h E N T 2 . ( b ) E x p r e ss i on o f t ho s e i s o f o r m s i n d i ff e r en t c e ll li ne s and d i ff e r en t c ond i t i on s . P r o ﬁ l e c hange s be t w een s a m p l e s ( i . e . l ane 3 and 6 ) and a l s o depend i ng on t he g r o w t h c ond i t i on s li k e l ane 9 and 10 , w he r e H K 2 non - c on ﬂ uen t c e ll s do no t e x p r e s s 16 D and 45 F i s o f o r m s ( e4 and e2 + e4 ) , w h il e t he s a m e c e ll li ne w hen h i gh l y c on ﬂ uen t e x p r e ss e s a ll f ou r . Novel approaches to understanding hENT2 and hENT2 - related proteins 130 15 . 5 EXPRESSION ANALYSIS OF hENT2 NUCLEAR VARIANTS (cid:2) After conﬁrming that the nuclear variants were functional , we asked the question as to whether they are constitutively expressed in a range of tissues and cell lines , and if there is any regulation of their expression depending on the growth conditions . To answer this question , we selected two primers ( FL4F and E4R ) that amplify the region between exon1 and exon 5 in such a way that each variant produces a product of a unique molecular weight making presence of each variant easy to distinguish ( ﬁgure 32a ) . We conducted PCR analyses with these conditions using a battery of different cDNAs as templates . This set of cDNA samples was derived from cell lines of different origin ( mammary , uterus , ﬁbroblasts , liver and kidney ) and some cell lines had been exposed to different growth conditions ( e . g . high / low glucose and conﬂuent or not ) . (cid:2) Our results ( ﬁgure 32b ) suggest that the four isoforms are extensively expressed . However , some of them show a different pattern of expression : HeLa cells seem to express more 45F than the other three variants unlike MCF7 cells , where this variant is less expressed . We also note a different expression pattern depending the condition used to grow the cells : the clearest case is the HK2 cells which only seem to express the wt and 4A isoforms when cells are not conﬂuent , but express all four variants when the cells reach conﬂuence . These results provide some evidences of a possible regulation of these variants depending on the needs of the cell . (cid:2) After this qualitative analysis , we performed relative screening in three different cell lines using real - time PCR analysis to better understand the relevance of the presence of each isoform within a single cell type and between cell types . We used three cell lines with different origins : HEK - 293 from kidney , NP31 from pancreas and TFK - 1 from gallbladder . We analyzed the results using as a reference the wild type isoform of each sample ( ﬁgure 33a ) to compare the relative expression of each isoform within the same sample , and used HEK - 293 values as a control ( ﬁgure 33b ) to analyze the expression of the same transcript among samples . Our data suggest that HEK - 293 and NP31 have a similar pattern of expression where the wild type isoform is the prevalent form present . The only difference between the cell types is the overall expression levels , where NP31 have greater expression for all the transcripts compared to HEK - 293 . TFK - 1 has highly expressed nuclear variants , about 3 to 10 - fold greater than the wild type . Results and Discussion 131 Figure 33 . hENT2 mRNA expression detected by relative real - time PCR in three different cell lines . ( a ) Expression levels of hENT2 isoforms using the wt as a reference within each sample . ( b ) Expression levels of hENT2 isoforms using HEK - 293 values as a reference for each transcript . 10 16 hENT2 Splice Variants Expression relativized to Wt isoform 0 1 2 3 HEK293 NP31 TFK1 A r b i t r a r y U n i t s Wt 4A 16D 45F (cid:5) (cid:22) (cid:6) (cid:22) 0 1 , 5 3 , 0 4 , 5 6 , 0 HEK293 NP31 TFK1 hENT2 Splice Variants Expression relativized to HEK293 A r b i t r a r y U n i t s Wt 4A 16D 45F Novel approaches to understanding hENT2 and hENT2 - related proteins 132 20 25 hENT2 Splice Variants Expression in human tissues relativized to Wt isoform 0 0 , 5 1 , 0 1 , 5 2 , 0 H e k 2 9 3 H e a r t B r a i n P l a c e n t a L u n g L i v e r S . M . K i d n e y P a n c r e a s T e s t i s O v a r y P r o s t a t e S p l e e n S . I . C o l o n T h y m u s L e u k o c y t e A r b i t r a r y U n i t s Wt 4A 16D 45F 4 10 15 hENT2 Splice Variants Expression in human tissues relativized to HEK293 0 1 2 3 4 H e k 2 9 3 H e a r t B r a i n P l a c e n t a L u n g L i v e r S . M . K i d n e y P a n c r e a s T e s t i s O v a r y P r o s t a t e S p l e e n S . I . C o l o n T h y m u s L e u k o c y t e A r b i t r a r y U n i t s Wt 4A 16D 45F (cid:5) (cid:22) (cid:6) (cid:22) Figure 34 . hENT2 mRNA expression in different human tissues ( a ) Expression levels of hENT2 isoforms using the wt as a reference within each sample . ( b ) Expression levels of hENT2 isoforms using HEK - 293 values as a reference for each transcript . Samples : S . M = Skeletal Muscle ; S . I = Small Intestine . Results and Discussion 133 (cid:2) A second relative screening was performed using a commercial multiple tissue cDNA panel as a template . Samples are from human tissues free of genomic DNA , ensuring that all signals generated are from actual mRNA transcripts . In most of these samples , the wild type isoform is the predominant form except in kidney , where the three nuclear variants are more highly expressed than the wild type , and in testis in where the 16D nuclear variant has a similar expression to that of the wt isoform ( ﬁgure 34a ) . When comparing samples to HEK - 293 values ( ﬁgure 34b ) , we noticed an interesting variability among samples . However , what stood out is the low expression levels in kidney compared to the cancer cell line HEK - 293 , whose origin is also human kidney . The different expression pattern of these two samples is very different , being the 16D variant the most present in the healthy kidney tissue while HEK - 293 mainly expresses the wt isoform . These results suggest a different expression pattern depending on the cell growing conditions instead of being tissue - speciﬁc , coinciding with the results shown in ﬁgure 32 . 15 . 6 DISCUSSION (cid:2) For the last few years , alternative splicing has been proved to be one of the most important mechanisms in generating a large number of mRNA and protein isoforms from a low number of genes ( Bracco & Kearsey 2003 ) . In addition , it has been demonstrated that alternative splicing is also a mechanism of regulation changing the structure of transcripts and their encoded proteins . These changes determine the binding properties , intracellular localization , enzymatic activity , protein stability and post - translational modiﬁcations of a large number of proteins . Consequences of alternative splicing might range from a complete loss of function or acquisition of a new one to very subtle modulations ( Stamm et al . 2005 ) . (cid:2) Alternative splicing occurs in a high percentage of transcripts derived from the whole genome and in most cases results in either proteins with a new function , localization or regulatory activity such as producing dominant negatives which block the activity of the wild type protein . New proteins generated by alternative splicing may Novel approaches to understanding hENT2 and hENT2 - related proteins 134 have lost a speciﬁc domain or residues that determine localization or are responsible for activity ( Jang 2002 ; Vallejo - Illarramendi et al . 2005 ) . Dominant negative variants are generated , in most cases , when the proteins affected interact with themselves as monomers . As a consequence , a truncated or non - functional protein might block or inhibit the functionality of the complex ( J . - Y . Wu et al . 2003 ; Kitayama et al . 1999 ; Sairam et al . 1996 ; Y . Wang & Miksicek 1991 ; Watanabe et al . 1995 ) . In both cases , there is a high risk of causing disease or dysfunction in the organism . (cid:2) For nucleoside transporters , very few spliced variants have been described and their roles as novel functional transporters remains unclear . For the SLC28 family , the Concentrative Nucleoside Transporters , one spliced variant has been described for the CNT3 family member ( Errasti - Murugarren et al . 2009 ) . In this case , the novel protein does not reach the cytoplasmic membrane but it is retained at the endoplasmic reticulum , except when in a polarized system . This variant seems to be functional although its role inside the cell remains unclear . (cid:2) In the case of ENTs more variants have been previously described . For mENT1 , the ﬁrst variant was described in 2000 , and is a protein which is identical to the wild type isoform but with 2 extra amino - acids in the internal loop . This addition results in the protein acquiring a new putative CK2 phosphorylation site that makes the protein functional but less active than the wild type ( Kiss et al . 2000 ) . In 2008 , a novel variant was found in which exon 11 had been skipped resulting in the protein missing the last three transmembrane domains . This protein reaches the plasma membrane and is active like the wild type but is less sensitive to the inhibitor NBMPR ( Robillard et al . 2008 ) . Intriguingly , no spliced variants have been described for hENT1 to date . In contrast , many polymorphic variants have been analyzed and it has been determined that there are cases where regulation by CK2 might be altered ( Handa et al . 2001 ; Bone et al . 2007 ) , or where the functionality as a nucleoside transporter is altered ( Osato et al . 2003 ; Fukuchi et al . 2010 ; Kim et al . 2011 ) . Results and Discussion 135 (cid:2) ENT2 is the nucleoside transporter with the most spliced variants described so far . In 2005 , a rbENT2 protein isoform was described which was missing 41 residues but which was still functional ( S . K . Wu et al . 2005 ) . Previously , in 2003 , a hENT2 spliced variant was found , which possessed a 40 base pair deletion in exon 9 resulting in a 301 amino acid protein named hENT2A ( Mangravite et al . 2003 ) . This protein never reached the plasma membrane but stayed in an intracellular location within vesicular structures and consequently no transport activity was determined . The most interesting , due to its novel location , ENT2 spliced variant found to date is the HNP36 protein , which is a 36 KDa hydrophobic nucleolar protein described as a mitogenic delayed - early response gene ( Williams & Lanahan 1995 ; Crawford et al . 1998 ) . (cid:2) Among all the spliced variants we cloned for the hENT2 gene we found the one previously deﬁned as hENT2A , which is equivalent to our identiﬁed variant 22C , together with another similar isoform which we named as 17G . In both cases , the potential proteins would lack the last 5 transmembrane domains . Unlike the report from 2003 ( Mangravite et al . 2003 ) , we could not demonstrate protein synthesis of these variants either by immunoblotting or immunocytochemistry . We had the same results with variants P143 and P120 , which would have produced proteins of 143 and 120 amino acids respectively . The results of Mangravite et al . ( 2003 ) are more similar to our results for the constructs 4D - HA and I16D - HA , where the protein is synthesized but retained intracellularly in a vesicular structure . Our interpretation of these results is that these proteins are artefacts which are a consequence of the overexpression of the constructs , resulting in the synthesis of misfolded or nonsense proteins which are retained in vesicles to be degraded instead of being expressed with a functional purpose . Considering that , we decided to continue further studies with the proteins located at the nuclear membrane since they seemed to be potentially more physiologically relevant . (cid:2) When we compare our results relating to the nuclear variants with what has been published in the literature , the main discrepancy we found is the amino - acidic sequence of the HNP36 protein ( Williams & Lanahan 1995 ; Crawford et al . 1998 ) . This protein was predicted from the cDNA sequence X86681 which would result in a Novel approaches to understanding hENT2 and hENT2 - related proteins 136 product of 326 amino acids . However , current bioinformatic analysis programs designed to ﬁnd Open Reading Frames ( ORF ) in a DNA sequence predict a protein of 336 amino acids for this sequence . Therefore , we predicted that HNP36 is a 336 amino acid protein , although this remains to be conﬁrmed . (cid:2) Interestingly , we not only cloned the X86681 isoform but another cDNA variant in which exon 4 had been skipped resulting in the same 336 amino acid protein . In addition , three other spliced variants were found , whose predicted ORFs gave an identical 302 amino acid protein , similar to our predicted HNP36 but which lacked the fourth transmembrane domain . The fact that several spliced variants would produce the same or similar proteins suggests a signiﬁcant role of those proteins . (cid:2) Immunocytochemical assays conﬁrmed our hypothesis about the localization of these proteins since we observed that they co - localized with the NPC at the nuclear membrane . Our results also show a concentration of protein around the nuclear membrane , probably within the ER , indicating that even though the proteins are being over - expressed in an heterologous system , trafﬁcking to nuclear membrane is ﬁnely regulated such that not all the protein is sent to the ﬁnal location but some is retained in the ER . These data suggest that these proteins might have a speciﬁc role inside the cell and that the presence at the membrane is highly regulated . (cid:2) Furthermore , immunoblotting conﬁrmed the expression of the nuclear variants but not the other variants . The molecular weight , 36 KDa , of the 4A - HA protein coincides with that described for HNP36 . Our novel hENT2 isoform of 302 amino acids has a predicted molecular weight of 32 KDa , and was therefore named as HNP32 . In addition , we determined that the antibody against the ENT2 intracellular loop also recognizes those variants whether expressed heterologously or endogenously . BeWo cells were previously described to have ENT type proteins at nuclear membranes ( Mani et al . 1998 ) and we demonstrated that they express both nuclear hENT2 isoforms HNP36 and HNP32 at readily detected levels . We conﬁrmed that our results obtained by transient expression after transfection are reliable since NMD pathway assays determined those variants are not degraded by the machinery in that pathway but rather , they are translated into proteins . Results and Discussion 137 (cid:2) Functional assays in which we transfected nuclear variants into HeLa cells did provide evidence of functional transporters which supported the proposal that these proteins are sorted to the nuclear membrane . When wild type isoform was transfected , we observed an increase of hENT2 activity at the same time that hENT1 decreased , both of them signiﬁcantly . That suggests hENT activity is also highly regulated at the plasma membrane so when hENT2 increases , hENT1 decreases to compensate and produce minimal changes in the total hENT activity . Similar results had been previously reported in HUVEC cells , where it appeared that ENT1 and ENT2 , despite being co - expressed , had an opposite regulation ( Aguayo et al . 2005 ) . However , we can not conﬁrm that these variants do play a dominant negative role since HeLa cells do not show hENT2 endogenous activity to be blocked . Although the location of variants was conﬁrmed to be at the nuclear membrane , they could also act as dominant negative proteins . Assuming the wild type protein interacts with any nuclear variant forming a kind of heteromer ( ﬁgure 61 - appendix I ) , then the wild type ENT2 might be retained at the nuclear membrane instead of trafﬁcking to the plasma membrane . As a consequence , nuclear variants would act as dominant - negative for the wild type hENT2 . One example of this kind of regulation is the ghrelin receptor ( GRLN - R ) , which is located at the plasma membrane as homodimer . This protein has a spliced variant isoform , GHS - R1b , that acts as a dominant - negative in such a way that it changes the localization of the wild type receptor by forming heterodimers GRLN - R / GHS - R1b and retaining the functional receptor at the nuclear membrane ( P . - K . Leung et al . 2007 ) . Further studies are needed to either conﬁrm or discard this possibility regarding the hENT2 protein . (cid:2) Interestingly , nuclear variants injected into oocytes seem to be sorted to the cytoplasmic membrane , what facilitated the transport assays . Preliminary results show hypoxanthine uptake when injected hENT2 wild type and also with the three nuclear variants , however nuclear variants rate is minor than the wild type apparently , either because they have less afﬁnity to the substrate or are less expressed than the full - length protein . Interestingly , hENT2 wild type transports chloro - adenosine inside the cell but not the nuclear variants . Based on the structural determinants of ENTs described to date , transmembrane domains ( TMD ) 5 - 6 of hENT2 would be responsible Novel approaches to understanding hENT2 and hENT2 - related proteins 138 for nucleobase transport ( Yao et al . 2002 ) and these are totally or partially conserved in HNP36 and HNP32 . In contrast , the ﬁrst TMD seem to be determinants for the 3ʻ - deoxy - nucleotides transport ( Yao et al . 2001 ) , which are not conserved in HNP36 or HNP32 but are present in the wild type isoform . As expected , we saw a chloro - adenosine uptake through hENT2 wt but not by the nuclear variants . According to previous work , the ﬁrst TMD are the ones responsible for the interaction of the transporter with its inhibitors like NMBPR or dilazep and dipyridamole ( Visser , Baldwin , et al . 2005 ; Visser , Zhang , et al . 2005 ) , however , we could not determine if this was the case for our variants . (cid:2) Glycosylation of hENT1 affects its activity and binding to the inhibitor NMBPPR . Glycosylation of hENT2 inﬂuences its trafﬁcking to the plasma membrane ( Vickers et al . 1999 ) and hENT2 is heterogenously glycosylated on the residues Asn48 and Asn57 in the extracellular loop between TM1 and TM2 . Loss of both glycosylation sites has been demonstrated to considerably decrease hENT2 sorting to the plasma membrane , although it does not affect its activity ( Ward et al . 2003 ) . These data support our observations that the nuclear variants lack the ﬁrst transmembrane domains , including glycosylation sites and might explain , in part why these variants are trafﬁcked to the nuclear membrane instead of the plasma membrane . (cid:2) The presence of a functional nucleoside transporter at the nuclear membrane may be correlated with the presence of nucleoside metabolism enzymes which are translocated into the nucleus to convert nucleosides into nucleotides required for RNA / DNA synthesis . There is some evidence for the presence of CAD , aspartate carbamoyltransferase , inside the nucleus , where it is translocated to after being phosphorylated . CAD is a multifunctional protein that performs the three ﬁrst reactions of de novo nucleotide synthesis which migrates into the nucleus in a cell cycle - dependent manner ( Sigoillot et al . 2005 ) . However there are no evidences of enzymes of the salvage pathway inside the nucleus . Results and Discussion 139 (cid:2) hENT2 nuclear variants might be able to transport more than nucleosides into the cell nucleus . It has been demonstrated that hENT2 was responsible for the internalization of an intranuclear delivery vehicle for the transport of therapeutic macromolecules across the plasma and nuclear membrane , the anti - DNA antibody fragment 3E10 Fv ( Hansen et al . 2007 ) . Although they showed the presence of this peptide inside the nucleus , the only transport across the plasma membrane was proved to be carried out by hENT2 , assuming it was also responsible for its nuclear translocation . This way , further studies need to be performed in order to understand the relevance of hENT2 at the nuclear membrane as an active transporter . (cid:2) Since the role of alternative splicing in cell physiology involves multiple transcript expression and protein modulation at different levels , the regulation of splicing itself is ﬁnely controlled by many other factors and pathways . Changing alternative splicing patterns in response to an external stimulus is likely to be a physiological process performed by many cells . This regulation mainly controls the concentration and activity of splicing regulatory factors , either by de novo synthesis of those proteins , regulating their intracellular localization or phosphorylation . Hence , external stimuli like growth factors , cytokines , hormones or depolarization result in a change of splice site selection regulating the alternative splicing pattern as a part of the physiological adaptation of the cell ( Stamm 2002 ) . (cid:2) In the case of hENT2 , the role of growth factors in stimulating the expression of the nuclear protein HNP36 has already been described and , based upon our results , we suggest that induction might be conditioned to the regulation of alternative splicing phenomenon triggered by the same factors . We also show here that the splicing proﬁle for hENT2 changes according to the growth conditions of the cells and the nature of either cell line or tissue . The fact that so many different mRNA isoforms produce the same functional protein at the nuclear membrane suggests that the alternative splicing process for hENT2 is highly regulated . (cid:2) We could not demonstrate the translation or functionality of all hENT2 spliced variants and while they seemed to be widely expressed in different tissues , they do not Novel approaches to understanding hENT2 and hENT2 - related proteins 140 have a clear role in the cell ( Mangravite et al . 2003 ) . To understand the reasons underlying the existence of these non - functional isoforms , we propose that the cell uses the alternative splicing as a mechanism to regulate the expression of wild type hENT2 and its nuclear isoforms . The promoter region of a gene is in charge of the transcript generation , the same pre - mRNA for all the spliced variants . A second level of post - transcriptional regulation might be the checkpoint where the cell can decide to produce more transporter at the plasma or nuclear membrane according to the needs of the situation . Additionally , the situation might require less transporter so the cell might prefer to increase the production of non - translated or non - functional variants just to reduce the rate of wild type or nuclear isoform expressed . (cid:2) Many recent studies describe a large number of molecules that modify the alternative splicing pattern in different models ( Hagiwara 2005 ; Sumanasekera et al . 2008 ) . In many cases , hENT2 plays a crucial role as a nucleoside derived anticancer drugs transporter . Often , the bottle - neck in these treatments is the internalization of the drug into the cell , specially in the case of CLL where hENT2 plays a crucial role for drug uptake ( Molina - Arcas et al . 2003 ; Pastor - Anglada et al . 2004 ) . Therefore , an understanding of the pharmacological modulation of hENT2 splicing proﬁle in cancer cells , with the aim of optimizing the expression of the transporter at the cytoplasmic membrane , is an important goal . A deeper understanding of this form of regulation of ENT2 may allow us to increase the drug uptake rate and improve the therapy . This is particularly relevant because it has been frequently described that in cancer cells the pattern of alternative splicing undergoes considerable change promoting cell proliferation ( Tazi et al . 2009 ; Venables et al . 2009 ; Al - Ayoubi et al . 2012 ; Das et al . 2012 ) . Since HNP36 was detected as a mitogenic response gene it seems it might be involved in the cell proliferation process . So , we raise the possibility the hENT2 expression proﬁle varies considerably in cancer cells . Results and Discussion 141 16 STUDY OF PHOSPHORYLATION STATUS OF HENT2 AND THE ROLE OF PHOSPHORYLATION IN TRAFFICKING 16 . 1 PREVIOUS FINDINGS (cid:2) (cid:2) Previous experiments of immunocytochemistry performed with the hENT2 wt HA - tagged construct during the study of its splice variants , gave us some evidence that the full - length protein was located just under the plasma membrane rather than being inserted in it . As shown in ﬁgure 35 , hENT2 wt ( green ) does not co - localize with the plasma membrane ( red ) but seems to be present just below it . Interestingly , it does not seem that hENT2 wt is clustered in vesicles or in speciﬁc sub - membrane regions but rather , is widely extended close yo the plasma membrane . (cid:2) To conﬁrm whether hENT2 wt is located at the sub - membrane region we performed biotinylation assays treating intact HeLa cells with biotin , a molecule that attaches covalently to lysine residues on proteins at the plasma membrane . Once we lysed the cells , we separated the intracellular fraction from the membrane fraction using streptavidin beads . Streptavidin recognizes and binds biotin , together with the proteins present at the plasma membrane attached to biotin . Fractions obtained were separated by SDS - PAGE and the presence of hENT2 was determined by immunoblotting using a commercial hENT2 antibody . (cid:2) In this experiment we used two different batches of HeLa cells , one without endogenous hENT2 activity ( lane 1 ) and another with endogenous hENT2 activity ( lane 2 ) , to detect differences in the protein patterns . As shown in ﬁgure 36 , what a priori we thought was a single band at 54 KDa is in fact a doublet where the smallest band ( ‡ ) is present at the plasma membrane while the largest ( # ) remains in the intracellular fraction . Coinciding with hENT2 activity of the samples , those cells with active hENT2 ( 2 ) show higher levels of the protein of 54 KDa present at the membrane ( ‡ ) while the levels of protein for the sample with no hENT2 activity ( 1 ) are lower . The band at 45 KDa ( (cid:3) ) is present at similar levels in both preparations suggesting it is not correlated with functional hENT2 . Results and Discussion 143 F i gu r e 35 . I mm uno cy t o c h e m i s t r y o f H e L a ce ll s t r a n s i e n t l y t r a n s f ec t e d w i t h h E N T 2 w t HA - t a gg e d c on s t r u c t . H eLa c e ll s e x p r e ss i ng t r an s f e c t ed F 10 C - H A c on s t r u c t , w h i c h gene r a t e s h E N T 2 f u ll - l eng t h p r o t e i n , i s s een i n g r een l o c a t ed be l o w t he p l a s m a m e m b r ane P l a s m a m e m b r ane i s l abe ll ed w i t h W G A ( r ed ) w h il e t he nu c l eop l a s m a i s s t a i ned w i t h D AP I ( b l ue ) . Novel approaches to understanding hENT2 and hENT2 - related proteins 144 50 K D a H o m o g e n a t e I n t r a c e ll u l a r M e m b r a n e 1 2 1 2 1 2 (cid:2) (cid:3) (cid:2) (cid:3)(cid:4) F i gu r e 36 . I mm unob l o tt i ng o f d i f f e r e n t p r o t e i n f r ac t i on s ob t a i n e d f r o m H e L a ce ll s a ft e r B i o t i n y l a t i on . P r o t e i n f r a c t i on s ob t a i ned a ft e r B i o t i n - S t r ep t a v i d i n e x t r a c t i on f r o m H eLa c e ll s w e r e ana y l z ed u s i n g an an t i - h E N T 2 an t i bod y ( Lane 1 = H eLa c e ll s w i t h no endogenou s h E N T 2 a c t i v i t y , l ane 2 = H eLa c e ll s w i t h endogenou s h E N T 2 a c t i v i t y ) . Results and Discussion 145 (cid:2) To date we cannot explain the differences of weight between bands at 54 and 45 KDa . However , since the difference between the doublet at 54 KDa is small , we propose that the doublet may represent hENT2 variants with different phosphorylation proﬁles with the non - phosphorylated ( lower molecular weight - ‡ ) isoform being present at the plasma membrane . (cid:2) Based on these antecedents , we decided to study the phosphorylation status of hENT2 in more depth and determine the effects of this kind of regulation on hENT2 localization and / or function . 16 . 2 BIOINFORMATIC ANALYSIS OF hENT2 PUTATIVE PHOSPHORYLATION SITES (cid:2) (cid:2) The ENTs intracellular loop between TMD 6 and 7 is the best candidate for a region of regulation and protein - protein interactions since is the largest part of the protein that is accessible to cytoplasmic factors . Therefore , we designed two different constructs containing the mouse and human ENT2 - loop sequence preceded by 6 histidines ( His ) and a ubiquitin ( Ubq ) sequence ( ﬁgure 37a ) . These constructs were over - expressed in bacteria and ENT2 - loop peptides produced . The His tag is needed for the peptide puriﬁcation using nickel - column afﬁnity , and the advantage of fusing our peptide to Ubq is the dramatic increase in yield of protein production . Complete sequences are included in the appendix I - table 22 and table 23 . Constructs were ordered generated in pJExpress401 - T5 - kan expression vector by DNA 2 . 0 G . (cid:2) Analysis of mouse and human ENT2 by NetPhosK H identiﬁed putative phosphosites and directed which kinases we would test in further experiments . Results are shown in ﬁgure 37b . Similar constructs were generated for ENT1 ( Coe et al . unpublished ) . We compared these sequences with ENT2 since protein similarity between ENT1 and ENT2 is around 50 % . For the four peptides , three kinases stood out as potential candidates to phosphorylate ENT1 and ENT2 : PKA , PKC and CKII . Novel approaches to understanding hENT2 and hENT2 - related proteins 146 F i gu r e 37 . E N T - l oop p e p t i d e d es i gn a nd N e t P ho s K 1 . 0 a n a l ys i s . ( a ) S t r u c t u r e o f t he H i s / U b i qu i t i n t agged E N T - l oop c on s t r u c t s de s i gned . S i x h i s t i d i ne ( H i s ) r e s i due s f o ll o w ed b y ub i qu i t i n ( U bq ) and t he E N T - l oop s equen c e . ( b ) C o m pu t a t i ona l ana l ys i s o f E N T - l oop w i t h t he p r ed i c t ed c on s en s u s t a r ge t s s i t e s w i t h PKA , P K C and C K II . T ho s e r e s i due s c on s e r v ed a m ong s pe c i e s a r e h i gh li gh t ed i n b l ue . Results and Discussion 147 Figure 38 . mENT1 and hENT1 phosphosites . Proposed 2D topologies of mENT1 and hENT1 with the conﬁrmed phosphosites shown in red . ( a ) mENT1 : Ser264 was the only serine in the large intracellular loop that was shown to be phosphorylated by PKA in vitro . ( b ) hENT1 : Ser266 , Ser269 , Ser271 , Ser273 and Ser279 / 281 were conﬁrmed as being phosphorylated by PKA in vitro . Ser279 and Ser281 are highlighted in blue , since both have been implicated , but not yet conﬁrmed , as being phosphorylated . Taken from MSc thesis , Pedram Mehrabi 2010 , with permission . Novel approaches to understanding hENT2 and hENT2 - related proteins 148 (cid:2) Previous research in Dr . Coeʼs lab analyzed the phosphorylation status of ENT1 and described the phosphorylation by PKA and PKC ( Reyes et al . 2011 ) although speciﬁc target residues were not deﬁned . Following studies by mass spectrometry , speciﬁc target residues have now been identiﬁed as being phosphorylated by PKA in vitro and conﬁrmed them in an ex vivo model ( data not published ) . Those residues are serine 264 for mENT1 , and serines 266 , 269 , 271 , 273 and 279 / 281 ( only one of them is phosphorylated but it remains unclear which one ) for the case of hENT1 ( ﬁgure 38 ) . 16 . 3 IN VITRO PHOSPHORYLATION ASSAYS OF ENT2 - LOOPS WITH RADIO - LABELED ATP (cid:2) We performed in vitro phosphorylation assays with radio - labeled ATP to determine which kinases phosphorylate the h / mENT2 - loop . The kinases selected for testing were the main three kinases obtained by the computational analysis : PKA , PKC and CKII . We also included Ca 2 + / Calmodulin - Kinase II ( CamKII ) in our study since recent work from Dr . Coeʼs lab has found a clear link between ENT1 - loop and calmodulin ( data not published ) . In these experiments we used Histone H1 ( H1 ) of 30 KDa as a positive control for PKA , PKC and CKII . Following the in vitro reactions , we separated the samples by SDS - PAGE and detected the signal by auto - radiography . Assays were performed according to the protocol previously described in the materials and methods section . (cid:2) The in vitro phosphorylation assay ( ﬁgure 39 ) showed positive results for CKII in both mouse and human ENT2 . Negative controls ( i . e . those lacking enzyme - lanes 1 , 3 and 5 ) did not show any signal . The positive control with H1 showed a pattern of three bands , of which we could only identify the band around 30 KDa ( ‡ ) as corresponding to the H1 protein , together with CKII which auto - phosphorylates . This pattern was repeated at lower intensity in lanes 4 and 6 , conﬁrming it was the auto - phosphorylated CKII kinase . Both human and mouse ENT2 - loops showed a radio - labeled signal at approximately 17 KDa ( (cid:3) ) which corresponds to the size of the loop . Results and Discussion 149 Figure 39 . In vitro phosphorylation of h / mENT2 - loop using radio - labeled ATP . Samples used in these assays : H1 without ( 1 ) and with ( 2 ) enzyme ; hENT2 - loop without ( 3 ) and with ( 4 ) enzyme ; mENT2 - loop without ( 5 ) and with ( 6 ) enzyme . Kinases tested : PKA ( a ) , PKC ( b ) , CKII ( c ) and CamKII ( d ) . Positive results were obtained for CKII were the band shown at 30 KDa corresponds to H1 and CKII auto - phosphorylated ( ‡ ) . The band around 17 KDa corresponds to the ENT2 - loop ( (cid:3) ) . PKA results were positive for H1 and mENT2 - loop but the negative control of hENT2 shown an intense band , like the case of PKC , invalidating the positive results . Negative results were obtained for CamKII . Novel approaches to understanding hENT2 and hENT2 - related proteins 150 (cid:2) Therefore , we concluded CKII does phosphorylate both the hENT2 and the mENT2 loop in vitro . PKA also appeared to phosphorylate H1 ( 30kDa signal - ‡ ) and mENT2 ( 17 KDa - (cid:3) ) corresponding to the mENT2 . There is band in the negative control of mENT2 . Negative controls for H1 and the mENT2 - loop showed no labelling . However , there was a signiﬁcant signal for the hENT2 - loop negative control . We could not explain the appearance of that band which was repeated in the case of PKC but not for CKII or CamKII . Unfortunately , we cannot rely on the positive bands found for hENT2 with both PKA and PKC since the negative control showed speciﬁc labelling . PKC results did not show any other signal even though H1 is a known target for that kinase and we detected PKC - phosphorylated H1 by MS in later analysis . CamKII did not show any positive results , neither for H1 , which actually is not a positive control for CamKII . 16 . 4 MASS SPECTROMETRIC ANALYSIS OF ENT2 - LOOP PHOSPHOSITES AFTER IN VITRO PHOSPHORYLATION ASSAYS (cid:2) To determine which phospho - amino sites are present in the ENT2 - loop , we performed the same reactions as before using unlabeled ATP and analyzed the samples by MRM / MS . The mass spectrometry analysis has not , to date , been successful in identifying phosphosites in the hENT2 - loop . Despite ubiquitin is always detected indicating that the hENT2 peptide is deﬁnitively present , it has not been possible to obtain sufﬁcient coverage of the hENT2 - loop sequence to identify speciﬁc phospho - amino sites . However , the sensitivity of the analysis was sufﬁcient for the mENT2 - loop and speciﬁc residues targeted by PKA and CKII were identiﬁed . No phosphosites were found in mENT2 - loop following incubation with PKC and CamK while the H1 protein was clearly phosphorylated suggesting that the enzymes were functional and that the ENT2 loop is not a target of either kinase . (cid:2) Phospho - amino sites for the mENT2 - loop are shown in ﬁgure 40 together with the residues previously identiﬁed for mENT1 and hENT1 loops . MRM / MS results shown a phosphosite in Thre223 after CKII in vitro phosphorylation and also Ser227 phosphorylated by PKA . Thre223 is not conserved in the human peptide so we do not know where CKII would phosphorylate hENT2 - loop if it does . However , Ser227 is conserved among species , therefore we propose that hENT2 could also be phosphorylated by PKA at the conserved residue , which would be Ser228 . Results and Discussion 151 F i gu r e 40 . E N T - l oop s pho s pho s i t es c on ﬁ r m e d b y m ass s p ec t r o m e t r y . S equen c e s o f t he f ou r E N T - l oop s ana l yz ed b y M a ss S pe c t r o m e t r y a ft e r i n v i t r o pho s pho r y l a t i on w i t h d i ff e r en t k i na s e s . C on ﬁ r m ed s e r i ne s pho s pho r y l a t ed b y PKA i n v i t r o a r e h i gh l i gh t ed i n r ed . T h r eon i ne c on ﬁ r m ed t o be pho s pho r y l a t ed i n v i t r o b y C K II i s h i gh li gh t ed i n g r een . Novel approaches to understanding hENT2 and hENT2 - related proteins 152 (cid:2) Since the data obtained by the mass spectrometry analysis are still preliminary , further experiments need to be done in order to improve the detection of speciﬁc phosphosites ( such as those suspected to be targeted by CKII ) in the hENT2 - loop . 16 . 5 EFFECT OF PKC ACTIVATION BY PDD TREATMENT ON hENT2 (cid:2) As previously explained , there is a lot of evidence for regulation of ENTs by kinase - dependent pathways . After we conﬁrmed ENT2 was phosphorylated in vitro by CKII , we studied the role of phosphorylation in ENT2 physiology inside the cell . Despite ENT2 phosphorylation by PKC has not been conﬁrmed yet , we cannot discard the possibility of ENT2 being regulated by PKC based on previous work . (cid:2) PDD ( Phorbol 12 , 13 - didecanoate ) strongly stimulates the action of PKC and has been previously described to increase transport activity presumably by activating hENT2 in a neuronal model ( G . Lu et al . 2010 ) . To determine if activation of PKC affects ENT2 - dependent uptake in other cell types , we treated HEK - 293 cells with PDD ( 500nM , 10 min ) and measured chloro - adenosine uptake via hENT1 and hENT2 . Chloro - adenosine uptake via hENT1 was signiﬁcantly decreased after PKC activation , whereas hENT2 - dependent uptake did not seem to be affected by the treatment ( ﬁgure 41 ) . (cid:2) To determine if a PKC - dependent pathway regulates hENT2 trafﬁcking to the plasma membrane , we also performed immunocytochemistry ( ICC ) assays using the hENT2 HA - tagged construct . As a membrane marker we used hENT1 - FLAG , since both tags are different we could use different non cross - reactive antibodies to detect them separately . HEK - 293 cells were co - transfected with both constructs according to the protocol previously described . After 48 hours of expression , we treated the cells with PDD ( 500 nM , 10 min ) and ﬁxed them with paraformaldehyde followed by the ICC protocol described in the materials and methods section ( ﬁgure 42 ) . Results and Discussion 153 F i gu r e 41 . E ff ec t o f P KC ac t i va t i on on h E N T 2 ac t i v i t y . H EK - 293 c e ll s t r ea t ed w i t h P DD ( 500 n M , 10 m i n . ) t o a c t i v a t e PK C and m ea s u r ed c h l o r o - adeno s i ne up t a k e v i a h E N T 1 and h E N T 2 . h E N T 1 - dependen t c h l o r o - adeno s i ne up t a k e i s s i gn i ﬁc an t l y de c r ea s ed b y PK C a c t i v a t i on w h il e up t a k e v i a h E N T 2 s ee m s no t t o be a ff e c t ed b y t he t r ea t m en t . R e s u l t s s ho w t he m ean o f t h r ee i ndependen t e x pe r i m en t s ( n = 3 ) w i t h s t anda r d de v i a t i on r ep r e s en t ed b y ba r s . S t a t i s t i cs : * = p < 0 . 05 0 25 50 75 C O N T R O L P DD pmol chloro - adenosine uptake / ug prot h E N T 1 h E N T 2 * Novel approaches to understanding hENT2 and hENT2 - related proteins 154 F i gu r e 42 . E ff ec t o f P KC ac t i v a t i on on h E N T 2 t r a f ﬁ ck i ng . H EK - 293 c e ll s t r an s f e c t e d w i t h h E N T 2 - H A and h E N T 1 - F L A G c on s t r u c t s w e r e t r ea t ed w i t h P DD t o a c t i v a t e PK C . I n un s t i m u l a t ed c ond i t i on s , h E N T 2 i s p r edo m i nan t l y p r e s en t unde r t he m e m b r ane ( g r een ) w h il e h E N T 1 i s l o c a li z ed a t t he p l a s m a m e m b r ane ( r ed ) . F o ll o w i ng PK C s t i m u l a t i on , h E N T 2 c o - l o c a li z e s w i t h h E N T 1 a t t he m e m b r ane ( y e ll o w ) . Results and Discussion 155 (cid:2) Control cells treated with DMSO express hENT1 ( red ) at the plasma membrane while hENT2 ( green ) is present just below the plasma membrane , in a sub - membrane region . After PDD treatment and presumably consequent PKC activation , hENT2 is trafﬁcked to the membrane and co - localizes with hENT1 ( yellow ) . (cid:2) To conﬁrm the results obtained by ICC , we conducted and analyzed if there was any signiﬁcant change in the hENT2 protein pattern after PDD treatment . As shown in ﬁgure 43b , ENT2 ( (cid:3) ) at 46 KDa increases signiﬁcantly in intensity after PKC activation . The smallest band of the doublet at 54 KDa ( ‡ ) also seems to increase after the treatment but not as dramatically as the band at 46 KDa . These bands correlate with those identiﬁed to be at the plasma membrane by biotinylation assays ( ﬁgure 43a ) conﬁrming that PDD appears to trigger hENT2 translocation to the plasma membrane . 16 . 6 DISCUSSION (cid:2) Phosphorylation is the main mechanism whereby a cell can have rapid and reversible regulation . Many enzymes , receptors and transporters switch their status from active to inactive due to the conformational change in their structure caused by de / phosphorylation . Previous work has studied the involvement of phosphorylation in the regulation of ENTs , however the presence and physiological relevance of this phenomenon still remains unclear . PKA , PKC and CKII are likely candidates in the regulation of ENTs although it has not been determined yet if there is direct phosphorylation of ENTs . Recently , it has been proved that direct phosphorylation of ENT1 by PKA and PKC occurs in vitro ( Reyes et al . 2011 ) and also ex vivo ( data not published ) . However , further studies are needed to fully understand the role of phosphorylation on ENTs . (cid:2) In this chapter we demonstrated the existence of in vitro phosphorylation of both human and mouse ENT2 by CKII , and also by PKA for mouse ENT2 using an in vitro kinase assay . These results were later conﬁrmed by MRM / MS analysis for the mouse sample , revealing the speciﬁc residues phosphorylated in each case : Thre223 by CKII and Ser227 by PKA . However , more assays need to be performed to have a better coverage of the hENT2 - loop and deﬁne the speciﬁc phospho - sites of the human protein . Novel approaches to understanding hENT2 and hENT2 - related proteins 156 F i gu r e 43 . C o m p a r i s on o f H e L a p r o t e i n f r ac t i on s ob t a i n e d a ft e r b i o t i n y l a t i on ve r s u s t o t a l p r o t e i n ex t r ac t e d f r o m H E K - 293 ce ll s t r ea t e d w i t h P DD . ( a ) I n t r a c e ll u l a r and p l a s m a t i c m e m b r ane f r a c t i on s f r o m endogenou s H eLa c e ll s p r o t e i n a ft e r b i o t i n - s t r ep t a v i d i n e x t r a c t i on i n c uba t ed w i t h an t i bod y an t i - h E N T 2 ( Lane 1 = H eLa c e ll s w i t h no endog e nou s h E N T 2 a c t i v i t y , l ane 2 = H eLa c e ll s w i t h endo g enou s h E N T 2 a c t i v i t y ) . T h e s m a ll e r band o f t he doub l e t abo v e 50 K D a ( ‡ ) appea r s t o be p r e s en t a t t he m e m b r ane f r a c t i on w h il e t he l a r ge s t band r e m a i n s i n t r a c e ll u l a r . T he band a r ound 46 K D a ( (cid:3) ) i s a l s o l o c a t ed m o s t l y a t t he m e m b r ane . ( b ) T o t a l p r o t e i n e x t r a c t i on o f H EK - 293 c e ll s t r ea t ed w i t h P D D ( 500 n M , 10 m i n . ) t o a c t i v a t e PK C . T he t w o ba n d s p r e v i ou s l y de t e r m i ned t o be l o c a t ed a t t he p l a s m a m e m b r ane s ee m t o be i n c r ea s ed a ft e r t r ea t m en t , de s p i t e t he m o s t s i gn i ﬁc an t i n c r ea s e i s i n t he 46 K D a band . Results and Discussion 157 (cid:2) CKII is ubiquitously expressed and regulates many substrates involved in all kinds of dynamic cellular functions . Paradoxically , despite the central role of CKII in a large number of cellular signalling pathways , its own activity appears to be unregulated since it is constitutively active . Therefore , it has been suggested that changes in the phosphorylation status of CKII substrates would depend on regulated dephosphorylation ( Pinna 1990 ) . In contrast , PKA is a highly regulated kinase which is activated by cAMP and down - regulated via a feedback mechanism through phosphodiesterases . (cid:2) Although we could not deﬁnitively demonstrate direct phosphorylation of ENT2 by PKC , we analyzed the effects of PKC activation on both hENT1 and hENT2 activity and localization . Treatment with PDD , a PKC activator , showed a change in the location of hENT2 from a sub - membrane region to the plasma membrane . Contrary to our expectations , this translocation to the membrane did not lead to any increase in hENT2 - dependent uptake but it did lead to a signiﬁcant decrease in hENT1 - dependent uptake . When we analyzed the protein pattern of hENT2 by SDS - PAGE following PDD treatment , we observed higher intensity of banding of those bands supposed to be at the membrane , according to biotinylation assays . Our results differ from previous studies where PKC activation by PMA led to an increased hENT1 activity in a cellular model without hENT2 activity ( Coe et al . 2002 ) . Another study described how PDD treatment increased hENT2 activity in a neuronal model without hENT1 activity ( G . Lu et al . 2010 ) demonstrating how ﬂexible and variable regulation of ENTs can be . (cid:2) The observed effects of PKC activation does not necessarily mean that hENT2 is a direct substrate of the kinase . In fact , direct phosphorylation of hENT2 by PKC has not yet been proved . However we have obtained evidence that phosphorylation of ENT2 by CKII might exist in vivo . The protein pattern obtained after biotinylation suggests that the smaller band of the 54 KDa doublet may be the form of the protein present at the plasma membrane while the largest band would be the form which is retained intracellularly . If the difference in the weight of these two bands is due to phosphorylation , then the non - phosphorylated isoform would be the active form and is located at the plasma membrane . As we previously explained , CKII is constitutively Novel approaches to understanding hENT2 and hENT2 - related proteins 158 active so if hENT2 were a CKII substrate , the transporter could probably be constitutively phosphorylated . As a consequence , regulation of hENT2 activity would be particularly sensitive to phosphatases instead of kinases , promoting the active isoform at the membrane depending on the cell necessities . The trafﬁcking and “activation” might be a phosphatase dependent event . (cid:2) Based on our results , we propose the existence of two different populations of hENT2 , one located at the sub - membrane region and the other one at the plasma membrane . Translocation to the plasma membrane is regulated by the PKC signalling pathway . However , translocation to the membrane would not have any speciﬁc effect on hENT2 activity since there are two different isoforms at the membrane , one apparently related with active hENT2 ( 54 KDa ) , and another one non - correlated with the transport activity ( 45 KDa ) . Although we hypothesised the difference between the bands in the doublet might be due to their phosphorylation status , we currently cannot explain the difference between the bands at 54 KDa and 45 KDa . There may be some differences in glycosylation although we think that is quite unlikely since it has been previously described the involvement of glycosylation in the ENTs trafﬁcking to the plasma membrane ( Vickers et al . 1999 ; Ward et al . 2003 ) . Therefore , ENT2 non - glycosylated ( 45 KDa ) would be less present at the plasma membrane that the protein glycosylated ( 54 KDa ) unlike our results show . Another possibility is that hENT2 activity is regulated by cleavage , as it happens for the case of the GABA transporter ( Gomes et al . 2011 ) , the ENaC channel ( Hamm et al . 2010 ) or the glycine transporter GlyT2 , whose cleavage is regulated by phosphatases ( Baliova et al . 2004 ) . We propose that the isoform which is capable of functioning as a nucleoside transporter is the full - length un - phosphorylated protein of 54 KDa approximately , whereas the band shown at 45 KDa could be an hENT2 isoform inactivated by cleavage . Further experiments need to be done to understand the origin of this 9 KDa weight difference . (cid:2) A recent study described a disrupted localization of hENT2 at the plasma membrane while protein expression and mRNA levels were not altered , supporting the idea that hENT2 is localised intracellularly . The concept of a hENT2 sub - membrane population is novel for nucleoside transporters although it has been previously Results and Discussion 159 described for other membrane proteins such as ABC transporters in hepatocytes and other transporters or potassium channels in myocytes ( Kipp & Arias 2002 ; Roma 2008 ; Sathe et al . 2011 ; Balse et al . 2009 ) . In all these examples , the researchers describe the presence of a population of vesicles in the sub - membrane space that undergo rapid recycling which is ﬁnely regulated . Taken together , our hypothesis is that hENT2 is localised at the plasma membrane or in vesicles below the membrane generating a rapid system to send or remove hENT2 proteins from the membrane according to the cell needs . Novel approaches to understanding hENT2 and hENT2 - related proteins 160 17 LARGE - SCALE SCREENING FOR hENT2 INTERACTIONS USING MEMBRANE YEAST TWO - HYBRID TECHNIQUE ( MYTH ) 17 . 1 BAIT GENERATION AND VALIDATION BY N UB G / I CONTROL TEST (cid:2) The Two - Hybrid technique is commonly used to identify putative partners for proteins providing information about their biological function . Membrane proteins are of particular interest because of their role in disease and as pharmaceutical targets . However , due to their hydrophobic nature the classic Two - Hybrid technique could not be applied to full - length membrane proteins ( Huber - Ruano et al . 2010 ; Carneiro et al . 2002 ) . Recently , a new version of the Two - Hybrid technique has been developed by Dr . Staglar which allows this principle to be applied to membrane proteins . This technique is known as the Membrane Yeast Two - Hybrid ( MYTH ) . A large - scale screen for hENT2 interactions using the MYTH technique identiﬁed novel putative partners of hENT2 . These candidates will provide us with relevant information about the biology of hENT2 . (cid:2) The ﬁrst step of the MYTH screening is to clone the gene that encodes our protein of interest , hENT2 , into an appropriate vector to generate the bait plasmid . The bait must have its intracellular terminus attached to the ubiquitin C - terminal ( C ub ) moiety together with the transcription factors for the reporter genes and all the component must be in frame . hENT2 is a transmembrane protein with a cytosolic N - terminus and an extracellular C - terminus . Therefore , we cloned hENT2 full - length cDNA sequence into the pTLB - 1 vector so the C ub fraction would be in frame just before the intracellular hENT2 N - terminal ( ﬁgure 44 ) . (cid:2) To clone hENT2 into the pTLB - 1 vector ﬁrst we inserted PstI and StuI restriction enzyme sites at both ends of hENT2 open reading frame ( ORF ) , using a PCR technique according to the protocol described in the materials and methods section . We digested both hENT2 and the vector with these enzymes and ligated them in order to incorporate our gene into the vector . The product generated by this cloning process was validated by sequencing to ensure there were no mutations in the hENT2 cDNA . The next step was to validate our generated hENT2 - bait plasmid as an appropriate bait for the large - scale screening using the N ub I / N ub G test . Results and Discussion 161 (cid:2) b L R G G M H R S A L S T V S I S L I S N ctaagaggtggtatgcacagatcagctttgtcgacggtatcgataagcttgatatcgaat MCS Cub domain tcctgcagatatacccatggaggccttccgcggagcgctgacgtcagatcttaataggtc S C R Y T H G G L P R S A D V R S - - Bgl II Sal I Linker CEN / ARS LexA VP16 CYCt LEU2 KanR Cub TEF1 pTLB - 1 7821bp Figure 44 . pTLB - 1 vector . pTLB - 1 vector contains the sequences for LexA and VP16 transcription factors followed by the C ub domain and a multi - cloning site ( MCS ) . We cloned hENT2 into pTBL - 1 vector using the PstI and StuI restriction enzymes to ensure that hENT2 would be in frame with the other genes upstream . Novel approaches to understanding hENT2 and hENT2 - related proteins 162 F i gu r e 45 . B a i t va li d a t i on u s i n g N ub I / N ub G c on t r o l t es t . N M Y 51 y ea s t c e ll s e x p r e ss i ng h E N T 2 - ba i t c on s t r u c t p l u s one p r e y : O s tI - N ub I ( A ) , O s tI - N ub G ( B ) , F u r 4 - N u b I ( C ) and F u r 4 - N ub G ( D ) . C o l on i e s w e r e s po tt ed a ft e r be i ng d il u t ed s e v e r a l t i m e s : 1 / 1 ( 1 ) , 1 / 10 ( 2 ) , 1 / 100 ( 3 ) and 1 / 1000 ( 4 ) . E a c h s a m p l e w a s g r o w n i n d i ff e r en t s e l e c t i on m ed i a : S D - W L ( i ) , S D - W L A H ( ii ) , S D - W L A H + 10 mM 3 ʼ A T ( iii ) , S D - W L A H + 25 mM 3 ʼ A T ( i v ) , S D - W L A H + 50 mM 3 ʼ A T ( v ) , S D - W L A H + 100 mM 3 ʼ A T ( v i ) . C e ll s c on t a i n i ng t he f ou r p r e ys g r e w on t he non - i n t e r a c t i on s e l e c t i v e m ed i u m S D - W L bu t on l y t he N ub I p r e ys g r e w on t he i n t e r a c t i on s e l e c t i v e m ed i a S D - W L A H + / - 3 ʼ A T . R e s u l t s c on ﬁ r m ed h E N T 2 - ba i t c o n s t r u c t a s a v a li d p l a s m i d f o r t he M Y T H sc r een i ng . Results and Discussion 163 (cid:2) The prey proteins of the library are fused to the N - terminal moiety of ubiquitin ( N ub ) . Wild type N ub has an isoleucine at position 13 ( N ub I ) which is responsible of the high afﬁnity between N ub I and C ub . Consequently , the pseudo - ubiquitin protein is spontaneously reassembled and activates the reporter genes . By replacing Ile - 13 with a glycine ( N ub G ) , the afﬁnity between N ub G and C ub is decreased in a way that the pseudo - ubiquitin protein is reconstituted only when bait and prey proteins interact with each other . To validate our hENT2 - bait construct , we transformed the plasmid in the yeast strain NMY51 together with the N ub I or N ub G version of two different control preys . In our case , the controls used were Ost1 , a component of the oligosaccharyltransferase complex localized to the endoplasmic reticulum membrane , and Fur4 , an uracil permease localized to the plasma membrane . (cid:2) Yeast cells containing hENT2 - bait and the four preys were spotted on different selection media . Cells containing both bait and prey plasmids will grow on SD - WL plates but only the cells with a bait - prey interaction will grow on SD - WLAH with or without 3ʼAT medium . Results ( ﬁgure 45 ) conﬁrmed our hENT2 - bait construct as a valid plasmid for the MYTH screening . Positive colonies were obtained for the four preys ( A - D ) when grown on SD - WL plate ( i ) . However , on SD - WLAH ( ii ) medium N ub G preys did not grow unlike the N ub I ( positive control ) . When increasing the 3ʼAT concentration ( iii - vi ) we observed a decrease of the N ub I colonies growth according to the selectivity of the media . 17 . 2 LIBRARY SCREENING AND BAIT DEPENDENCY TEST (cid:2) The large - scale screening for hENT2 interactors was performed following the protocol described in the materials and methods section . The library used was a cDNA library from a mouse embryo on day 11 ( Dual - systems P02234 ) . Preys were inserted into the pPR3 - N vector with the N ub G domain fused to the N - terminal and a total of 1 . 5x106 independent clones were screened . Library transformation into yeast cells containing hENT2 - bait had a coverage of 950 , 000 total transformants , which is within the optimal range for a full coverage of the library . Novel approaches to understanding hENT2 and hENT2 - related proteins 164 Figure 46 . Bait dependency test . Each prey was transformed in different yeast cells containing either hENT2 - bait or CD4 - artiﬁcial bait ( negative control ) . All the samples were grown on a non - interaction medium SD - WL as a control of bait and prey expression but not interacting necessarily . Samples were also plated on SD - WLAH + 10 mM 3ʼAT + XGal to identify those who were unspeciﬁc positives ( positives for both hENT2 and CD4 baits ) from those interactors speciﬁc for hENT2 ( negatives for CD4 bait ) . Each spot of ﬁgures a - c represent one single prey grown in different media and baits . Figure d explains the distribution of baits and media of the plates in ﬁgures a - c . Results and Discussion 165 (cid:2) We obtained around 400 positive colonies during the screening but after the prey plasmid recovery and propagation in E . coli , the number of positives was reduced to approximately 220 colonies . These 220 preys were revalidated by the bait dependency test by transforming them into yeast cells containing either hENT2 - bait or CD4 - bait , an artiﬁcial bait used as a negative control . Those which were positive for the CD4 - artiﬁcial bait were discarded as a false positive interactors of hENT2 and only those clones which were positive for hENT2 but not CD4 were considered for the bioinformatic analysis ( ﬁgure 46 ) . 17 . 3 BIOINFORMATIC ANALYSIS (cid:2) After we discarded false - positives from the preliminary screen , we sequenced a total of 198 samples using the N ub G forward internal sequencing primer , which gave us 171 good quality sequences . We identiﬁed those sequences using BLASTF analysis , being certain to verify that detected sequences are appropriately in frame with the N ub G tag to ensure proper identiﬁcation of preys and discard potentially spurious interactions with short peptide sequences . (cid:2) We obtained a ﬁnal number of 110 genes that are putative hENT2 interacting partners . In order to facilitate the discussion and understanding of all the putative interactors , we sub - classiﬁed them into different sets according to their known function , localization or activity . Results are shown in the next 8 tables and discussed below . Novel approaches to understanding hENT2 and hENT2 - related proteins 166 Table 12 . Nuuclear - related hENT2 MYTH partners Gene Protein Function known Snrpb Small nuclear ribonucleoprotein B Spliceosome member ; determines site cleavage in pre - mRNA processing promoting exon skipping ( Yang et al . 2009 ; Cheng et al . 2007 ) Snapc2 Small nuclear RNA activating complex Small nuclear RNA genes transcription activator Factor required for mitotic progression : localizes to centrosomes during mitosis ( Shanmugam et al . 2008 ) SERTAD2 TRIP - Br2 Proto - oncogene exported out of the nucleus through CRM1 ( Exportin 1 ) to the cytosol where it is ubiquitinated and degraded ( Cheong et al . 2008 ) SAP18 Sin3A - associated protein 18 KDa Component of the Histone Deacetylase Complex ( HDAC ) together with RbAp46 Nuclear protein involved in RNA splicing mediating assembly of splicing regulatory multiprotein complex ( Singh et al . 2010 ) Rbbp7 / RbAp46 Retinoblastoma binding protein 7 Component of the Histone Deacetylase Complex ( HDAC ) together with SAP18 Ptma Prothymosin alpha Mediates nuclear import of Keap1 / Cul3 Rbx1 complex to degrade nuclear Nrf2 ( Niture & Jaiswal 2009 ) Phax Phosphorylated adaptor for RNA export Additional factor required for U snRNA export but not for CRM1 - mediated export . PHAX is phosphorylated in the nucleus and then exported with RNA to the cytoplasm ( Ohno et al . 2000 ; Boulon et al . 2004 ) Med30 Mediator complex subunit 30 Mediator of RNA polymerase II transcription Habp4 / Ki - 1 / 57 Hyaluronic acid binding protein 4 Nuclear unstructured protein with capacity to interact with many different proteins , most of them involved in pre - mRNA splicing control ( Bressan et al . 2009 ; Bressan & Kobarg 2010 ) . H2afz H2A histone family member Z Nuclear protein responsible for the nucleosome structure of the chromosomal ﬁbre in eukaryotes FOXK1 Forkhead box K1 Nuclear protein . Eif6 Eukaryotic translation initiation factor Insoluble protein found both in the nucleus and cytoplasm . It functions as a translation initiation factor and catalyzes the association of the 40S and 60S ribosomal subunits . Calcineurin phosphatase regulates its nuclear localization by phosphorylation ( Biswas et al . 2011 ) Pdcd5 Programmed cell death Protein up - regulated during apoptosis where it translocates rapidly from the cytoplasm to the nucleus Cd2bp2 CD2 Antigen ( cytoplasmic tail ) binding protein Bi - functional protein . In cytoplasm , it binds the cytoplasmic tail of human surface antigen CD2 . In the nucleus , itʼs a component of the U5 small nuclear ribonucleoprotein complex and is involved in RNA splicing Irf3 Interferon regulatory factor 3 Inactive in the cytoplasm , once phosphorylated forms a complex with CREBBP and translocates into the nucleus as a TF Hmgb1 High Mobility Group - 1 Intracellular protein that can translocate to the nucleus where it binds DNS and regulates gene expression Results and Discussion 167 Table 13 . Mitocchondria - related hENT2 MYTH partners Gene Protein Function known Sucla2 Succinate - CoA ligase Mitochondrial matrix enzyme that catalyzes the reversible synthesis of succinyl - CoA from succinate and CoA . The reverse reaction occurs in the Krebs cycle , while the forward reaction may produce succinyl - CoA for activation of ketone bodies and heme synthesis Slc25a3 Mitochondrial phosphate carrier Catalyzes the transport of phosphate into the mitochondrial matrix , either by proton co - transport or in exchange for hydroxyl ions Ndufa5 NADH dehydrogenase ( ubiquinone ) 1 alpha subcomplex , 5 The multisubunit NADH : ubiquinone oxidoreductase ( complex I ) is the ﬁrst enzyme complex in the electron transport chain of mitochondria . Ndufs3 NADH dehydrogenase ( ubiquinone ) Fe - S protein 3 The multisubunit NADH : ubiquinone oxidoreductase ( complex I ) is the ﬁrst enzyme complex in the electron transport chain of mitochondria . Ndufb9 NADH dehydrogenase ( ubiquinone ) 1 beta subcomplex , 9 The multisubunit NADH : ubiquinone oxidoreductase ( complex I ) is the ﬁrst enzyme complex in the electron transport chain of mitochondria . Ndufa7 NADH dehydrogenase ( ubiquinone ) 1 alpha subcomplex , 7 The multisubunit NADH : ubiquinone oxidoreductase ( complex I ) is the ﬁrst enzyme complex in the electron transport chain of mitochondria . Ndufa10 NADH dehydrogenase ( ubiquinone ) 1 alpha subcomplex 10 The multisubunit NADH : ubiquinone oxidoreductase ( complex I ) is the ﬁrst enzyme complex in the electron transport chain of mitochondria . Cox5a Cytochrome c oxidase , subunit Va The terminal component of the mitochondrial respiratory chain , catalyzes the electron transfer from reduced cytochrome c to oxygen Coq4 Coenzyme Q4 homolog ( yeast ) Coenzyme Q ( CoQ ) is a small lipophilic molecule that transports electrons between mitochondrial respiratory chain complexes and functions as a cofactor for mitochondrial enzymes Atp5g1 ATP synthase , H + transporting , mitochondrial F0 complex , subunit c1 Subunit of mitochondrial ATP synthase . Mitochondrial ATP synthase catalyzes ATP synthesis , using an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation . LOC10004668 4 ES1 protein homolog , mitochondrial - like ES1 is serving a basic function in mitochondria , however , no function of the human ES1 protein is known yet . ( Shanmugam & Hernandez 2008 ) Novel approaches to understanding hENT2 and hENT2 - related proteins 168 Table 14 . ER - Golgi - Vessicle - Trafﬁcking related hENT2 MYTH partners Gene Protein Function known Tusc3 Tumor suppressor candidate 3 Subunit of the oligosaccharyltransferase ( OST ) complex that glycosylates Asn residues in the acceptor proteins in the ER lumen Krtcap2 Keratinocyte associated protein 2 Subunit of the oligosaccharyltransferase ( OST ) complex that glycosylates Asn residues in the acceptor proteins in the ER lumen Tmem59 Transmembrane protein 59 Membrane bound protein that is localized to the Golgi apparatus . Its functions is not know but related to amyloid peptide formation in Alzheimer disease Tmem111 Transmembrane protein 111 Part of the endoplasmic reticulum - associated secretory pathway Pdia6 Protein disulﬁde isomerase 6 Enzyme in the ER in eukaryotes that catalyzes the formation and breakage of disulﬁde bonds between cysteine residues within proteins as they fold Arf1 ADP - ribosylation factor 1 Protein localized to the Golgi apparatus with a central role in intra - Golgi transport Sec 13 SEC13 homolog ( S . cerevisiae ) Member of the family of WD - repeat proteins . It has similarity to the yeast SEC13 protein , which is required for vesicle biogenesis from ER during the transport of proteins Scamp3 Secretory carrier membrane protein 3 Function as carrier to the cell surface in post - Golgi recycling pathways RAB14 Member Ras oncogene family 14 Protein involved in membrane trafﬁcking between the Golgi complex and endosomes SGMS1 Sphingomyelin Synthetase 1 Five - pass transmembrane protein that regulates protein trafﬁcking and secretion Becn1 Beclin 1 Also known as autophagy related gene 6 , that protein is requires for the initiation of the formation of the autophagosome in autophagy Hspe1 Heat shock protein 1 This gene encodes a major heat shock protein which functions as a chaperonin Results and Discussion 169 Table 15 . Cytooskeletal - related hENT2 MYTH partners Gene Protein Function known Tubg1 Tubulin gamma 1 Tubulin , cytoskeleton Tubb2a Tubulin beta 2A Tubulin , cytoskeleton Tsg101 Tumor susceptibility gene 101 This gene belongs to a group of apparently inactive homologs of ubiquitin - conjugating enzymes . Tsg101 Interacts with Stathmin , a cytosolic phosphoprotein implicated in tumorigenesis . STMN1 Stathmin 1 Cytosolic phosphoprotein that functions as an important regulatory protein of microtubule ( tubulin ) dynamics Tpm3 Tropomyosin 3 Cytoskeleton - Actin related Tpm1 Tropomyosin 1 Cytoskeleton - Actin related Table 16 . Ribbosome related hENT2 MYTH partners Gene Protein Function known Mrpl53 mitochondrial ribosomal protein L53 Encoded by nuclear genes to help in protein synthesis within the mitochondrion RPS8 Ribosomal protein S8 40S Ribosomal Protein RPS25 Ribosomal protein S25 40S Ribosomal Protein RPS16 Ribosomal protein S16 40S Ribosomal Protein RPLP0 Ribosomal protein large P0 60S acidic ribosomal protein P0 RPL8 Ribosomal protein L8 60S Ribosomal protein RPL3 Ribosomal protein L3 60S Ribosomal protein RPL27 Ribosomal protein L27 60S Ribosomal protein RPL18 Ribosomal protein L18 60S Ribosomal protein RPL15 Ribosomal protein L15 60S Ribosomal protein Novel approaches to understanding hENT2 and hENT2 - related proteins 170 Table 17 . Ennzyme - related hENT2 MYTH partners Gene Protein Function known Ruvbl2 RuvB - like protein Protein belonging to the AAA + family , ATPases Associated with diverse cellular Activities Rnaseh2c Ribonuclease H2 RNAse H2 complex Ppp1r7 Protein Phosphatase 1 Ser / Thre Phosphatase . Pp1 has been found to be important in the control of glycogen metabolism , neuronal activities , RNA splicing and regulation of membrane receptors and channels . Ppp3cc Calcineurin Calmodulin - dependent protein phosphatase , calcineurin , is involved in a wide range of biological activities acting as a Ca 2 + - dependent modiﬁer of phosphorylation status . NME / NM23 Nucleoside diphosphate Kinase 2 Involved in diverse physiological and pathological processes including proliferation , differentiation and ciliary functions . Htra1 Htra serine peptidase 1 Member of the trypsin family of Ser proteases . This protein is a secreted enzyme that is proposed to regulate the availability of insulin - like growth factors by cleaving their binding proteins Hint1 His triad nucleotide binding protein 1 Adenosine 5ʼ - monophosphoramidase or protein Kinase C - interacting protein 1 . It exerts its major cellular function as gene transcription regulator . DDT DE - Dopachrome tautomerase Protein belonging to the family of carboxy - lyases that cleave carbon - carbon bonds Ctsz Cathepsin Z Lysosomal cysteine proteinase and member of the peptidase C1 family BCR Breakpoint Cluster Region The BCR gene is one of the two genes in the bcr - abl complex with Tyr kinase activity Dok2 Docking Protein 2 Protein constitutively Tyr phosphorylated and possibly a critical substrate of the bcr - abl complex Aarsd1 Alanyl - tRNA synthetase Enzyme that interprets the RNA code and attaches speciﬁc aminoacids ( alanine ) to the tRNAs Results and Discussion 171 TTable 18 . hENT2 MYTH parrtners with unknown or miscellaneous functions Gene Protein Function known Tmem150a Transmembrane protein 150A Function unknown Tmem 119 Transmembrane protein 119 Induced by parathyroid hormone . Promotes osteoblast differentiation and interacts with the bone morphogenetic protein - Runx2 pathway TCTE1 T - complex - Associated - Testis - Expressed 1 Function unknown Sssca1 Sjogrenʼs Syndrome / scleroderma autoantigen 1 Function unknown Selh Selenoproetin H Protein that includes a Selenocystein aminoacid residue NTN4 Netrin 4 Class of proteins involved in axon guidance NEFL Nasal Embryonic LHRH factor Protein involved in guidance of olfactory axon projections and migration of luteinizing hormone - releasing hormone neurons MTRNR2L2 16S RNA / humanin Mitochondrial 16S ribosomal RNA and also the humanin polypeptide Morf4l2 Mortality Factor 4 like 2 Transcriptional regulator Mlf1ip Myeloid leukemia factor 1 interacting protein Function unknown Mettl9 Methyltransferase like 9 Function unknown Mettl3 Methyltransferase like 3 Function unknown Lrrc58 Leucine Rich repeat containing 58 Function unknown Lgals1 Galectin - 1 Family of beta - galactoside - binding proteins implicated in modulating cell - cell and cell - matrix interactions . Galectin - 1 modulates CaV1 . 2 calcium channel activity binding to the transporterʼs loop ( Wang et al . 2011 ) . Iﬁtm2 Interferon induced transmembrane protein Activated in response to bacterial and viral infections Id3 Inhibitor of DNA binding 3 Helix - loop - helix ( HLH ) protein that inhibits DNA binding of any HLH protein that interacts with . GNAS Gs alpha subunit G protein subunit that activates the cAMP - dependent pathway by activating adenylate cyclase . Itʼs coupled to many different receptors , adenosine A 2a and A 2b receptors among them Ctla2a Cytotoxic T lymphocyte - associated protein 2 A Function unknown . Cathepsin L inhibitor Cthrc1 Collagen Triple Helix repeat containing 1 Protein that may play a role in the cellular response to arterial injury through involvement in vascular remodelling Creg1 CREG Protein may contribute to the transcriptional control of cell growth and differentiation CLU Clusterin Protein able to bind and form complexes with numerous partners Atxn10 Ataxin 10 Protein may function in neuronal survival and differentiation Novel approaches to understanding hENT2 and hENT2 - related proteins 172 Table 19 . hENT2 MYTH partners described as common false positives * Gene Protein Function known USP11 Ubiquitin speciﬁc peptidase Ubiquitin related enzyme Ufc1 Ub - fold modiﬁer conjugating enzyme Ubiquitin related enzyme Ubl3 Ubiquitin - like 3 Ubiquitin related Ube2n Ub - conjugating enzyme E2 Ubiquitin related enzyme Ube2j1 Ub - conjugating enzyme E2J 1 Ubiquitin related enzyme Ubb Ubiquitin B Ubiquitin CYC1 Cytochrome C 1 Heme protein component of the electron transport chain in mitochondria Cyb5b Cytochrome B 5b Component of the respiratory chain complex III Rabac1 Rab acceptor 1 ( prenylated ) Protein involved in vesicles trafﬁcking RNF41 Ringer ﬁnger protein 41 E3 Ubiquitin - protein ligase NRDP1 . Function not yet determined Hbb - y Hemoglobin gamma Iron - containing oxygen - transport protein in the red blood cells Hba - a1 / a2 Hemoglobin alpha Iron - containing oxygen - transport protein in the red blood cells Gpx1 gluthatione peroxidase1 Detoxiﬁcation of hydrogen peroxide Gpx3 gluthatione peroxidase3 Detoxiﬁcation of hydrogen peroxide Prdx6 Peroxiredoxin 6 Member of the thiol - speciﬁc antioxidant protein family FTL1 Ferritin light chain Ubiquitous intracellular protein that stores iron Ttr * Transthyretin Thyroxine and retinol carrier in ﬂuids . Pre - Albumin family member SCMH1 * Sex comb on midleg homolog 1 Acts as a E3 Ub - ligase for Geminin , a DNA replication inhibitor LEPREL2 * Leprecan - like 2 Family of collagen prolyl hydroxylases required for proper collagen biosynthesis , folding and assembly Cd63 * Cd63 antigen Cell surface glycoprotein that is known to complex with integrins AldoA * Aldolase A , fructose bisphosphate Enzyme that catalyzes a reversible reaction of the glycolysis * Proteins in technique b positive for M described as fa ENT1 and C those nucleos n this table have been prev based on data - bases comp MYTH technique found by D alse - positives for MYTH bu NT2 , we decided to discar ide transporters ( Huber - Ru Deane et a viously described as common false - positives for the Two - Hybrid piling thousands of results obtained during years . Speciﬁc false - Dr . Staglar are also included . The last ﬁve proteins have not been ut based on results obtained in two other two - hybrid screenings for rd them as such since they also appeared as putative partners of uano et al . 2010 ; Ratushny & Golemis 2008 ; Berggård et al . 2007 ; al . 2002 ; Serebriiskii & Golemis 2001 ) . ( Huber - Ruano et al . 2010 ) Results and Discussion 173 17 . 4 DISCUSSION OF PUTATIVE hENT2 PARTNERS IDENTIFIED BY MYTH (cid:2) The two - hybrid system if one of the most widely used methods to screen or conﬁrm protein - protein interactions ( PPI ) . However , there are several disadvantages to using this system for screening of PPIs . First , only binary interactions can be identiﬁed with this technique , limiting the detection of proteins involved as complexes . Another inconvenience is the large number of false positive identiﬁed with this system . However , the Membrane Yeast Two Hybrid ( MYTH ) provides us with the capacity to detect potential partners for full - length membrane proteins , which has been impossible to do to date . (cid:2) A major limitation of MYTH is the potential isolation of false positives . It is important to discard those predicted to be false positives . Over the years , several studies have analyzed and described what we call “common false - positives” based on the results of thousands of large - scale two - hybrid screenings . The exact rate of identiﬁcation of false - positive results is not known , but it has been estimated to be as high as 50 % of the identiﬁed interactions ( Deane et al . 2002 ; Berggård et al . 2007 ) . (cid:2) False positives can be divided into two categories : technical and biological . Technical false - positives are due to the reporter system , wherein reporter activity is induced in the absence of any PPI . In this category are proteins that interact directly with the promoter , or in general with DNA upstream of the reporter genes like transcription factors or histone - related proteins . This class of false - positives was much reduced with widespread adaptation of dual reporter system with minimal sequence overlap in their promoter regions , in our case LexA and VP16 . Nevertheless , proteins that appear to be operating at the level of chromatin and transcription still are occasionally isolated with apparently biologically irrelevant baits . (cid:2) Biological false - positive are genuine interactions that occur in the context of the two - hybrid system but are not representative PPI in a cellular model based on the known physiology of bait and prey . There are some common false - positives obtained with many diverse baits : ribosomal subunits , heat - shock proteins , proteasome subunits and cytoskeletal components . It has been hypothesized that their false positive character is because these proteins are intrinsically “sticky” and their natural biological Novel approaches to understanding hENT2 and hENT2 - related proteins 174 function involves binding a large number of different proteins . In addition , many eukaryotic protein interactions depend on post - translational modiﬁcations and the yeast model is quite limited in this respect compared with mammalian cells . Of course , even if an interaction does not make immediate sense to the investigator , it may still occur inside living cells and contribute to regulatory pathways yet to be discovered ( Ratushny & Golemis 2008 ; Serebriiskii & Golemis 2001 ) . (cid:2) Following we discuss about the most relevant PPI found for hENT2 and their possible meaning in cell physiology . We discarded those partners found belonging to ER - Golgi and vesicular trafﬁcking system , as well as cytoskeletal and ribosomal proteins as common false - positives proteins . (cid:3) 17 . 4 . 1 Nuclear - related hENT2 MYTH putative partners : (cid:2) (cid:2) Within the group of potential nuclear partners for hENT2 , we found two different kinds of proteins : those connected with alternative splicing regulation , and some other proteins related with the transport across the nuclear membrane , either as a substrates or cofactors . (cid:2) As outlined in the introduction , the pre - mRNA splicing process is carried out within the nuclei by a complex machinery called the spliceosome . Each spliceosome is composed of ﬁve small nuclear RNA ( snRNA ) and a range of associated protein factors comprising a dynamic PPI network ( Hegele et al . 2012 ) . Combined , they make an RNA - protein complex called snRNP , which catalyzes the removal of introns and the ligation of the ﬂanking exons ( Ritchie et al . 2009 ) . Alternative splicing is a process by which the exons of a molecule of RNA are reconnected in multiple ways during the pre - mRNA splicing . The production of alternatively spliced mRNAs is regulated by a variety of proteins acting either as activators promoting the usage of a particular splice site , or repressors reducing the usage of it . Mechanisms of alternative splicing are highly variable but mainly they are regulated by changing the concentration and activity of these splicing regulatory factors . This is achieved by de novo protein synthesis , regulation of the intracellular localization and phosphorylation . Results and Discussion 175 (cid:2) In our MYTH screening for hENT2 , we found putative interactions with 5 different proteins involved in alternative splicing regulation : • Snrpb : Spliceosome member that determines site cleavage promoting exon skipping ( Yang et al . 2009 ; Cheng et al . 2007 ) . • SAP18 and RbAp46 : two members of the Histone Deacetylase complex ( HDAC ) . Nuclear proteins involved in RNA splicing mediating assembly of splicing regulatory multiprotein complex ( Singh et al . 2010 ) and chromatin modiﬁcations ( Hnilicová et al . 2011 ) . • Habp4 : Nuclear unstructured protein with capacity to interact with many different proteins , most of them involved in pre - mRNA splicing control ( Bressan et al . 2009 ; Bressan & Kobarg 2010 ) . • Cd2bp2 : Component of the U5 small nuclear ribonucleoprotein complex involved in RNA splicing ( Koﬂer 2004 ; Laggerbauer 2005 ) . (cid:2) Considering the hENT2 wild type isoform as a possible partner of interaction of these proteins , our results might not have any sense as that isoform is mainly located at the plasma membrane and is thus inaccessible to the splicing regulation factors . However , in this thesis we describe two novel hENT2 functional variants located at the nuclear membrane , which share around 70 % of their structure with the wild type and , most importantly , the internal loop between transmembrane domains 6 and 7 . Based on hENT2 2D structure , we consider this loop as the principal region of regulation and interaction with other proteins , since it has 76 amino acids which are accessible for interaction while the rest of the protein is inserted into the membrane . MYTH screening was carried out using the full - length isoform , therefore partners of the nuclear variants might also be isolated if interaction takes place at the conserved intracellular loop . Thus , nuclear proteins found to be possible hENT2 partners make sense in terms of plausible cell physiology but also help us to ﬁgure out new roles of the nuclear variants of this transporter . Novel approaches to understanding hENT2 and hENT2 - related proteins 176 (cid:2) Our interpretation of these data suggest that nuclear variants of hENT2 might be linked to the regulation process of pre - mRNA splicing . This hypothesis is strengthened by the fact that the isoforms are generated by an alternative splicing phenomenon . There are some examples of self - regulation of alternative splicing by speciﬁc proteins . For instance , SF2 / ASF is a serine / arginine - rich ( SR ) protein involved in regulating and selecting splice sites and therefore crucial for the alternative splicing . It has been found that SF2 / ASF negatively autoregulates its expression to maintain homeostatic levels . This autoregulation involves a post - transcriptional control that generates alternative spliced RNA isoforms that would either be retained in the nucleus or degraded by NMD ( Sun et al . 2010 ) . Another similar case is the one of SC35 , another SR protein that regulates alternative splicing in a concentration - dependent manner . This protein also regulates its own wild type expression levels by promoting alternative splicing non - functional isoforms to keep homeostatic expression levels ( Sureau et al . 2001 ) . A more interesting example of self - regulation is the case of AHNAK , a 700 KDa protein involved in cytoarchitecture and calcium signalling . A common AHNAK transcript encodes two different proteins , a large one of 700 KDa and a smaller one of 17 KDa . During muscle differentiation the small 17 KDa isoform shows strongly increased trafﬁcking into the nucleus where it establishes a positive feedback loop to regulate mRNA splicing of its own locus ( de Morree et al . 2012 ) . Considering these examples , we propose the hypothesis that nuclear isoforms of hENT2 play a role in the regulation of the alternative splicing process thereby modulating their own expression and the expression of the wild type isoform . That way , hENT2 could adapt the levels of expression of itʼs own isoforms levels or even generate nonsense spliced variants , as a response and adaptation to cell growth conditions and demands . (cid:2) Another interesting set of proteins found in our MYTH results are nucleus - related proteins involved in cytoplasm - nuclear transport : • SERTAD2 : Proto - oncogene exported out of the nucleus through Exportin 1 to the cytosol where is ubiquitinated and degraded ( Cheong et al . 2008 ) . Results and Discussion 177 • Ptma : Mediates nuclear import of Keap1 / Cul3 Rbx1 complex to degrade nuclear Nrf2 ( Niture & Jaiswal 2009 ) . • Phax : Aditional factor required for U snRNA export but not for CRM1 - mediated export . PHAX is phosphorylated in the nucleus and then exported together with RNA to the cytoplasm . The transporter that mediates the exportation is still undetermined ( Ohno et al . 2000 ; Boulon et al . 2004 ) . • Eif6 : Insoluble protein found both in the nucleus and cytoplasm where it functions as a translation initiation factor . Calcineurin phosphatase regulates its nuclear localization by phosphorylation ( Biswas et al . 2011 ) • Pdcd5 : Protein upregulated during apoptosis where it translocates rapidly from the cytoplasm to the nucleus . • Irf3 : Inactive in the cytoplasm , once phosphorylated forms a complex with CREBBP and translocates into the nucleus as a transcription factor . • HMG - 1 : Intracellular protein that can translocate to the nucleus where it regulates gene expression interacting with DNA / Chromatin ( Stros 2010 ) (cid:2) The underlying commonality for all these proteins is the fact that all are translocated through the nuclear membrane at some speciﬁc moment and all of them need a transporter to mediate their translocation . All of them could be potential substrates for the novel hENT2 nuclear variants except that hENT2 has been characterized as a nucleoside / nucleobase transporter and is highly unlikely to translocate small proteins . However , a previous study demonstrated for the ﬁrst time a protein transport through ENT2 . In that study , the substrate was an intranuclear delivery vehicle and pathway for the transport of therapeutic macromolecules across plasma and nuclear membranes , the anti - DNA antibody fragment 3E10 Fv . These researchers showed that 3E10 Fv is unable to penetrate into cells deﬁcient in ENT2 and reconstitution of the transporter restores its transport into cell nuclei ( Hansen et al . Novel approaches to understanding hENT2 and hENT2 - related proteins 178 2007 ) . 3E10 Fv is a 30 KDa protein with the property of binding nucleic acids , similar to Phax , one of the proteins found to interact with hENT2 . Phax is a 394 amino acid protein , similar in size to 3E10 Fv , with the similar capability to bind nucleic acids , speciﬁcally RNA . Therefore , we should consider the possibility that hENT2 plays a major role in the nuclear membrane in addition to being a nucleoside transporter but also as a transporter involved in translocating bigger molecules with a protein nature such as transcriptional factors or speciﬁc carriers like Phax . (cid:2) Furthermore , this is not the ﬁrst time that a nuclear isoform of hENT2 has been associated with HMG - 1 , one of the proteins found with the MYTH screening . In 1995 , when HNP36 was cloned for the ﬁrst time , HMG - 1 was identiﬁed as a delayed - early response gene ( Williams & Lanahan 1995 ) . These researchers could not relate ENT2 and HMG - 1 in a functional way but our results suggest there may be a role for these proteins in a mitogenic response . (cid:2) Four more nuclear proteins were identiﬁed in the MYTH screening ( Snapc2 , Med30 , H2afz and Foxk1 ) . These proteins could be considered as false - positives since are proteins that either bind a large number of different proteins , as they are considered “sticky” proteins , or they are involved in gene transcription and activation of the promoter which could activate the reporter genes without physiologically relevant real PPI . (cid:2) As a summary , from the ﬁrst set of results obtained by the MYTH technique , we pose the hypothesis that nuclear hENT2 variants might play a dual role at the nuclear membrane as alternative splicing regulators binding to splicing factors and interfering with their availability to promote / inhibit some alternative sites , and as a nuclear translocator of small proteins or carriers . In addition , it is described how mRNA export is coupled to pre - mRNA splicing in an even more complex multiprotein machinery ( Reed & Hurt 2002 ) , where hENT2 might have its own role . Results and Discussion 179 (cid:3) 17 . 4 . 2 Mitochondria - related hENT2 MYTH partners : (cid:2) We found a total of 11 different proteins in the mitochondria that could be interacting with hENT2 at some speciﬁc point . Curiously , 8 over 11 are elements of the respiratory chain found in the mitochondrial membrane . We have to consider these results cautiously although there are a number of studies that conﬁrm the presence of ENTs at the mitochondrial membrane . ENT1 was shown to be present at the mitochondrial membrane ( Lai et al . 2004 ) and the use of autoﬂuorescent nucleosides conﬁrmed functionality of the protein at the mitochondria ( Zhang , Sun , et al . 2006a ) . More recently , hENT3 was also described to be located at the mitochondrial membrane ( Govindarajan et al . 2009 ) . Despite lack of evidence , the presence of ENT2 in the mitochondria can be indirectly inferred from experimental data since ENT1 and ENT3 cannot be responsible for the internalization of all the drugs tested in the previous studies ( Leung & Tse 2007 ) . (cid:2) Furthermore , recent work describes a link between mitochondrial DNA ( mtDNA ) depletion and molecular mechanisms involving ENTs to compensate the mitochondrial respiratory chain and ensure respiratory activity despite profound depletion in mtDNA levels ( Villarroya et al . 2011 ) . In this case , a decrease in thymidine kinase 2 ( TK2 ) levels with consequent severe mtDNA depletion , showed increased cytochrome c oxidase activity together with higher transcript and protein levels . No alterations of the deoxynucleotide pools were found , whereas a reduction in the expression of genes involved in the nucleoside / nucleotide homeostasis ( hENT1 among others ) was observed , indicating a connection between the respiratory chain activity and the role of ENTs at the mitochondrial membrane . In addition , it has been published recently that Fun26 , a yeast ENT homolog , is responsible of the intracellular pool of NmR , one of the substrates for NAD + synthesis , though the salvage pathway ( S . P . Lu & Lin 2011 ) , since NAD + / NADH is a crucial element of the respiratory chain . (cid:2) Mitochondrial proteins are also common false - positives of MYTH , especially cytochrome C oxidase and NADH dehydrogenase , which means we must be cautious about our results . Therefore , the possible connection between hENT2 , NAD + Novel approaches to understanding hENT2 and hENT2 - related proteins 180 metabolism and respiratory chain remains to be conﬁrmed by other techniques . However , the presence of functional ENTs at the mitochondria seems to be certain and their role in mitochondrial physiology remains to be clariﬁed . Two other protein interactors have been found : Slc25a3 , a phosphate carrier and the enzyme Sucla2 , what supports a presence of hENT2 at the mitochondrial membrane but does not give us any information about the role of ENTs at the mitochondria . (cid:3) 17 . 4 . 3 hENT2 MYTH partners with enzymatic activity and other proteins : (cid:2) A total of 12 potential protein interactors with an enzymatic activity have been identiﬁed . Among them , some are particularly noted : (cid:2) (cid:2) PHOSPHATASES : • Ppp1r7 : Ser / Thre phosphatase . Interesting for its important role in RNA splicing and regulation of membrane receptors and channels . • Calcineurin : Calmodulin - dependent protein phosphatase . Involved in a wide range of biological activities acting as a Ca 2 + - dependent modiﬁer of phosphorylation status . (cid:2) (cid:2) KINASES : • NME / NM23 : Nucleoside Kinase . Involved in diverse physiological roles like proliferation , differentiation and ciliary functions . • BCR : Element of the bcr - abl complex with Tyr kinase activity . • Dok2 : Constitutively Tyr phosphorylated , it may be a critical substrate of the bcr - abl complex . (cid:2) (cid:2) LYASES : • Ruvbl2 : ATPase associated with diverse cellular activities . • Htra1 : Member of the trypsin family of Ser proteases . Results and Discussion 181 • Hint1 : Adenosine 5ʼ - monophosphoramidase or protein Kinase C - interacting protein 1 . It exerts its major cellular function as gene transcription regulator . • DDT : A member of the family of carboxy - lyases that cleave carbon - carbon bonds . • Cathepsin Z : Lysosomal cysteine proteinase and member of the peptidase C1 family . (cid:2) Phosphatases and kinases are especially interesting given our interest in phosphorylation - dependent regulation of hENT2 . Protein phosphatase 1 has been described to play a very important role in alternative splicing regulation . PP1 binds directly to some speciﬁc splicing factors via a phylogenetically conserved RVDF sequence and dephosphorylates them , promoting recognition of alternative RNA splice sites ( Novoyatleva et al . 2008 ; Stamm 2008 ) . We have previously discussed the possible role of hENT2 in its own splicing regulation since we found that it might interact with some splicing factors . If those PPI were conﬁrmed , we could propose a plausible scenario where , through PP1 - dependent pathway , which is regulated upstream by second messengers like cAMP and ceramide , the phosphorylation status of hENT2 would be altered to affect or regulate its own splicing pattern to adapt it to the cell conditions and needs . (cid:2) Another interesting ﬁnding in our screen is calcineurin , a Ca 2 + / calmodulin dependent phosphatase . A previous MYTH study performed with mENT1 as a bait found calmodulin as an interacting protein of ENT1 , and this interaction has been conﬁrmed in further studies ( data not published ) . ENT1 and ENT2 seem to have a ﬁne cross - regulated activity where overexpression of one transporter seems to be compensated by a decrease of the other ( Aguayo et al . 2005 ) . Therefore , the possibility of a dual regulation of ENT1 and ENT2 via Ca 2 + / Calmodulin opens a new and important line of research . (cid:2) The other enzymes found in the screen do not seem to have a clear connection with hENT2ʼs role as a transporter at the plasma membrane or at the nuclear membrane . DDT is the only gene with a previous connection to ENT2 , since it is described as a DER gene together with HNP36 , although any functional link with ENT2 was not established ( Lanahan et al . 1992 ; Williams & Lanahan 1995 ) . Novel approaches to understanding hENT2 and hENT2 - related proteins 182 C a v 1 . 2 hE N T 2 - l oo p m E N T 2 - l oo p F i gu r e 47 . A li gn m e n t o f G a l - 1 b i nd i ng do m a i n i n C av1 . 2 a nd m / h E N T 2 - l oop se qu e n ces . T he r eg i on de t e r m i ned t o b i nd G a l - 1 i n C a v 1 . 2 c hanne l s ho w s a h i gh ho m o l og y w i t h bo t h hu m an and m ou s e E N T 2 - l oop s equen c e s . T he a m i no a c i d s equen c e D X D PEXEXEXXXXXKP a t t he C - t e r m o f E N T 2 - l oop s c ou l d be r e s pon s i b l e o f t he i n t e r a c t i on be t w een t he nu c l e o s i de t r an s po r t e r and G a l - 1 , i n c a s e t ha t i n t e r a c t i on w e r e f u r t he r c on ﬁ r m ed . Results and Discussion 183 (cid:2) Among the other putative hENT2 PPI partners , we want to highlight the identiﬁcation of Galectin - 1 and the Gs α subunit . Galectin - 1 is a family member of beta - galactoside - binding proteins implicated in modulating cell - cell and cell - matrix interactions . It is interesting to note that there is a demonstrated interaction between Gal - 1 and the Cav1 . 2 calcium channel . Gal - 1 binds to the internal loop of Cav1 . 2 for a speciﬁc splice variant of the channel decreasing its functional surface expression ( J . Wang et al . 2011 ) . Since hENT2 coincides having a large intracellular loop , we pose the possibility that Gal - 1 binds hENT2 intracellular loop regulating its activity or localisation . When comparing the amino acid sequence of the calcium channel determined to bind Gal - 1 and the sequences of the mouse and human ENT2 - loop , we notice a highly coincident region critical for Gal - 1 recognition and binding ( ﬁgure 47 ) . The amino acid sequence DXDPEXEXEXXXXXKP might be responsible for the interaction between Gal - 1 and Cav1 . 2 , and also between Gal - 1 and ENT2 in case that interaction were conﬁrmed by other techniques . In addition , recent work from our laboratory ( Fernández - Calotti and Pastor - Anglada - data not published ) demonstrated the interaction between CNT3 and Gal - 4 , which has been previously described to be involved in trafﬁcking of glycosylated proteins to the apical membrane . (cid:2) Gs α subunit triggers the cAMP - dependent pathway by activating adenylate cyclase . Gs α it is coupled to many receptors , including adenosine A 2a and A 2b receptors among them . Previous work has described the regulation by P 1 adenosine receptors on nucleoside transporters at the plasma membrane . In the case of CNT2 , ATP - sensitive potassium channels have been shown to regulate CNT2 through A 1 adenosine receptors ( Duﬂot et al . 2004 ) . For ENT2 , there is some evidence that shows a regulation of ENT2 at the plasma membrane via activation of A 1 adenosine receptors ( G . Lu et al . 2010 ; Knight et al . 2010 ) . A 1 receptors are not typically linked to Gs α speciﬁcally but those studies show an existing linkage between the pathways triggered by adenosine receptors and nucleoside transporters . In addition , during this chapter we have been developing a hypothesis where PP1 is activated via cAMP , triggered by Gs α leading to the dephosphorylation of a hENT2 variant at the nuclear membrane thereby altering its splicing pattern in response to the physiological needs of the cell . This novel hypothesis is shown in ﬁgure 48 . Novel approaches to understanding hENT2 and hENT2 - related proteins 184 Figure 48 . Cartoon showing possible regulation of hENT2 splicing pattern by phosphorylation . ENT2 transports adenosine ( Ado ) into the cell thereby modulating its extracellular levels . Extracellular adenosine binds to adenosine receptors ( AR ) , activating Gs protein which may also interact with ENT2 directly according to our MYTH results . Gs also activates adenylate cyclase which synthesizes cAMP from ATP . cAMP activates PKA which phosphorylates the PP1 inhibitor proteins ( DARP - 32 and I - 1 ) . These inhibitors interact allosterically with PP1 , inhibiting phosphatase activity ( Aggen et al . 2000 ) . PP1 may interact directly with hENT2 and also HNP32 and HNP36 regulating their phosphorylation status . PP1 is also involved in alternative splicing regulation since it dephosphorylates splicing factors ( SF ) . Phosphorylation status of the SF would determine its afﬁnity to some speciﬁc splice sites but also could be involved in the interaction between SF and HNP32 / 36 . If HNP32 / 36 binds to SF , this would compromise their availability to determine the sites recognised by the spliceosome during the pre - mRNA processing . Therefore , depending on the phosphorylation status of HNP32 / 36 and SF , the cell would produce a different pattern of alternative splicing , thereby modulating the expression of the hENT2 isoforms . In our example , phosphorylated SF ( red ) would determine some speciﬁc splice sites producing a mRNA variant “A” that codiﬁes for HNP36 protein . Non - phosphoryated SF ( blue ) would be interacting with HNP32 / 36 proteins and would be retained at the nuclear membrane and thus would not be available for the splicing process . As a consequence , less mRNA “B” product would be generated and so hENT2 protein expression would be decreased . Results and Discussion 185 18 PHARMACOGENOMIC ANALYSIS OF THE RESPONSIVENESS OF SOLID TUMORS TO DRUG THERAPY : A TRANSPORTOME APPROACH 18 . 1 THE TRANSPORTOME PROJECT (cid:2) Drug transport across the plasma membrane is mediated by a wide range of membrane proteins , which are crucial for their cytotoxic action . To establish the role these proteins might play in anticancer therapy we performed a “transportome” transcriptomic approach on cell lines derived from gastrointestinal tumors . The aim of this study was to identify a discrete set of genes whose expression levels in tumor cells may allow prediction of sensitivity / resistance to chemotherapy , and also to identify putative novel networks of biological relevance . (cid:2) We selected a total of 15 cell lines from three different kind of tumors representative of three gastro - hepatic cancers : pancreas , stomach and biliary tract ( ﬁgure 49a ) . Those samples were treated with 6 drugs commonly administrated as a treatment for these kinds of tumors . Three of these drugs are nucleoside - derived : 5 - Fluorouracil , its pro - drug 5ʼ - DFUR and gemcitabine . The other three treatments have a different chemical nature : cisplatin , doxorubicin and paclitaxel ( ﬁgure 49b ) . (cid:2) For the transcriptomic study we chose , based upon existing knowledge , a total of 96 genes to be analyzed by real - time PCR . These genes encompass the main membrane proteins involved in anticancer drugs import and export , like OATP , OCT , OAT , NT , AQPs and ABC families . We also included enzymes related to drug metabolism and detoxiﬁcation , and genes with a highlighted role in apoptosis / survival balance and DNA repairing ( ﬁgure 49c ) . Results and Discussion 187 U P T AK E CAARR I E R S E FFL U X P U M PS M E T AB O L I S M A P O P T O S I S - S UR V I V A L - P R O L I F E RA T I O N - I N V A S I O N N O R M A L I Z E R S O A T P 1 B 1 E N T 1 AB C A 2 D i h y d r op y r i m i d i ne deh y d r ogena s e - D PY D E RCC 1 B a x 18 S O A T P 1 B 3 E N T 2 AB C A 3 T h y m i d i ne pho s pho r y l a s e - T Y M P XPA p21 G AP DH O A T P 2 B 1 E N T 3 AB C B 1 U r i d i ne pho s pho r y l a s e 1 - U PP 1 XP C F a s G U SB O A T P 4 A 1 E N T 4 AB C B 4 U r i d i ne pho s pho r y l a s e 2 - U PP 2 U r a c il - DN A g l yc o sy l a s e - UD G B c l - 2 O C T 1 CN T 1 AB C B 11 E po x i de h y d r o l a s e 1 - EP H X 1 h M L H 1 S m a c / D I AB L O O C T 2 CN T 2 AB CC 1 D eo xycy t i d i ne k i na s e - DC K h P M S 2 c - I AP - 1 - B I RC 2 O C T 3 CN T 3 AB CC 11 R i bonu c l eo s i de - d i pho s pha t e r edu c t a s e - RR M 1 h M S H 2 X I AP O C T N 1 AB CC 2 T h y m i d il a t e sy n t he t a s e - T Y M S G T BP / h M S H 6 s u r v i v i n - B I RC 5 O C T N 2 A Q P 1 AB CC 3 T h y m i d i ne k i na s e 1 - T K 1 G A DD 45 L i v i n - B I RC 7 O A T 1 A Q P 3 AB CC 4 5 ' - N u c l eo t i da s e , cy t o s o li c I A - N T 5 C 1 A T opo i s o m e r a s e I - T O P 1 c - F L I P - C F L A R O A T 2 A Q P 4 AB CC 5 5 ' - N u c l eo t i da s e , cy t o s o li c I B - N T 5 C 1 B T opo i s o m e r a s e II - a l pha - T O P 2 A E G F R O A T 3 A Q P 5 AB C G 2 O r o t a t e pho s pho r i bo sy l t r an s f e r a s e o U M PS K I T P I 3 K O A T 4 A Q P 7 U r i d i ne - cy t i d i ne k i na s e 2 - UC K 2 P D G F R A c - m yc C T R 1 A Q P 8 L R P o M VP F o l y l po l y g l u t a m a t e sy n t ha s e - F P G S M a t r i x M e t a ll op r o t e i na s e 1 - MM P 1 t i ga r / C 12o r f 5 A Q P 9 A T P 7 A γ - G l u t a m y l c i s t e i n sy n t he t a s e - G C L C M a t r i x M e t a ll op r o t e i na s e 2 - MM P 2 NR F 2 A T P 7 B M e t a ll o t h i one i n 4 - M T 4 M a t r i x M e t a ll op r o t e i na s e 3 - MM P 3 KEAP 1 U G T 1 A 1 / U G T 1 A 8 / U G T 1 A 10 - U G T X α - F e t op r o t e i n - A F P P A NC R E A S S T O M ACH B I L I AR Y T RAC T P an C - 1 A G S M z - C h A - 1 B x P C 3 S NU - 1 M z - C h A - 2 N P 9 S NU - 5 SK - C h A - 1 N P 29 M K N - 45 TF K - 1 N P 31 KA T O III E G I - 1 D R U G T R EE A T M E N T S 5 ’ - D F UR C i s p l a t i n 5 - F U D o x o r ub i c i n G e m c i t ab i ne P a c li t a x e l (cid:5) (cid:5) (cid:6) (cid:5) (cid:2) (cid:5) F i gu r e 49 . T r a n s po r t o m e d es i gn . ( a ) C e ll li ne s s e l e c t ed f o r t h i s s t ud y , 15 i n t o t a l . T he s e s a m p l e s c o m e f r o m t h r ee d i ff e r en t k i nd s o f t u m o r : pan c r ea s , s t o m a c h and b ili a r y t r a c t . ( b ) T r ea t m en t s c ho s en f o r t he cy t o t o x i c i t y a ss a ys . T h r ee o f t he m a r e nu c l eo s i de de r i v ed d r ug s ( 5 ʻ - D F UR , 5 - F U and ge m c i t ab i ne ) w h il e t he r e s t ha s a d i ff e r en t c he m i c a l na t u r e ( c i s p l a t i n , do x o rr ub i c i n and pa c li t a x e l ) . ( c ) G ene s s e l e c t ed f o r t he t r an sc r i p t o m i c s t ud y . T he s e gene s en c o m pa ss up t a k e c a rr i e r s and e f ﬂ u x pu m p s , m e t abo li s m en zy m e s , and gene s r e l a t ed t o apop t o s i s / s u r v i v a l . W e a l s o i n c l uded t h r ee hou s e k eep i ng gene s a s no r m a li z e r s . Novel approaches to understanding hENT2 and hENT2 - related proteins 188 18 . 2 CYTOTOXICITY ASSAYS (cid:2) In the cytotoxic assays , we treated the 15 cell lines with each drug at 5 different doses inside the normal range of usage . Determining IC 50 for 6 drugs and 15 cell lines turned out to be very complex and laborious , so we deﬁned the proﬁle of each cell lines for each drug inside the dose framework of the treatments . After 48 hours of treatments we analyzed cell survival using the MTT technique . Assays were performed as described in the materials and methods section . (cid:2) Results obtained ( ﬁgure 50 ) show the differences in the responsiveness proﬁles to a speciﬁc treatment inside a same kind of tumor and among the three different types . When we compared results obtained with the three nucleoside - derived drugs ( ﬁgure 50a ) , we observed cases where the response inside the same kind of tumor is quite similar for the 5 cell lines , like 5 - FU in stomach samples , where the proﬁles are almost identical . On the contrary , we also found proﬁles completely different among samples with the same origin , like the case of gemcitabine in pancreas cell lines , where we have cells 100 % resistant to the treatment ( PanC - 1 ) or cell that almost reach 25 % survival with the lowest dose ( NP31 ) . (cid:2) When comparing results obtained for the three non nucleoside - derived drugs , we also found different varieties of patterns inside the same kind of samples . For instance , in pancreas cell lines , the responsiveness proﬁle in doxorubicin treatment is quite similar for the 5 cell lines . On the contrary , cisplatin and paclitaxel show proﬁles completely different inside the same kind of tumor . Considering this variety of response we assume that in these cases we cannot consider responsiveness to a treatment dependent to the kind of tumor of the sample but to a speciﬁc cell line . Therefore , in further analyzes , we do not consider samples divided in three different groups ( pancreas , stomach and biliary tract ) but as a pool of 15 different cell lines , since responsiveness is not tumor - dependent . Results and Discussion 189 Figure 50 . Responsiveness to cytotoxicity assays . Each graph represents the results obtained of cytotoxicity assays for one drug and ﬁve cell lines from the same kind of tumor . Y axis represents the percentage of survival compared to control cells no treated . X axis represents the 5 concrete doses applied for each treatment . 0 25 50 75 100 0 , 1 m M 0 , 5 m M 1 m M 2 . 5 m M 5 m M 5 D F U R % Survival P a n C - 1 B x P C 3 N P 9 N P 29 N P 31 0 25 50 75 100 0 , 1 m M 0 , 25 m M 0 , 5 m M 1 m M 2 . 5 m M 5 F U % Survival 0 25 50 75 100 0 , 1u M 0 , 5u M 1u M 5u M 10u M G e m c i t a b i n e % Survival Pancreas 0 25 50 75 100 0 , 1 m M 0 , 5 m M 1 m M 2 . 5 m M 5 m M 5 D F U R % Survival A G S S NU - 1 S NU - 5 M K N - 45 K A T O III 0 25 50 75 100 0 , 1 m M 0 , 25 m M 0 , 5 m M 1 m M 2 . 5 m M 5 F U % Survival 0 25 50 75 100 0 , 1u M 0 , 5u M 1u M 5u M 10u M G e m c i t a b i n e % Survival Stomach 0 25 50 75 100 0 , 1 m M 0 , 5 m M 1 m M 2 . 5 m M 5 m M 5 D F U R % Survival M z - C h A - 1 M z - C h A - 2 S K - C h A - 1 TF K - 1 E G I - 1 0 25 50 75 100 0 , 1 m M 0 , 25 m M 0 , 5 m M 1 m M 2 . 5 m M 5 F U % Survival 0 25 50 75 100 0 , 1u M 0 , 5u M 1u M 5u M 10u M G e m c i t a b i n e % Survival Biliary Tract (cid:5) (cid:2) Novel approaches to understanding hENT2 and hENT2 - related proteins 190 ( a ) Results obtained after treatment with three nucleoside - derived drugs : 5 - FU , 5ʼ - DFUR and gemcitabine . ( b ) Results obtained after treatment with three non nucleoside - derived drugs : cisplatine ( CPt ) , doxorubicin and paclitaxel . Pancreas Stomach Biliary Tract 0 25 50 75 100 10u M 50u M 75u M 100u M 250u M C P t % Survival 0 25 50 75 100 0 , 05 u M 0 , 1u M 0 , 5u M 1u M 5u M D o x o r u b i c i n % Survival 0 25 50 75 100 10u M 50u M 75u M 100u M 250u M C P t % Survival A G S S NU - 1 S NU - 5 M K N - 45 K A T O III 0 25 50 75 100 0 , 05 u M 0 , 1u M 0 , 5u M 1u M 5u M D o x o r u b i c i n % Survival 0 25 50 75 100 0 , 1u M 0 , 5u M 1u M 5u M 10u M P ac li t a x e l % Survival 0 25 50 75 100 0 , 1u M 0 , 5u M 1u M 5u M 10u M P ac li t a x e l % Survival P a n C - 1 B x P C 3 N P 9 N P 29 N P 31 0 25 50 75 100 10u M 50u M 75u M 100u M 250u M C P t % Survival M z - C h A - 1 M z - C A - 2 S K - C h A - 1 TF K - 1 E G I - 1 0 25 50 75 100 0 , 05 u M 0 , 1u M 0 , 5u M 1u M 5u M D o x o r u b i c i n % Survival 0 25 50 75 100 0 , 1u M 0 , 5u M 1u M 5u M 10u M P ac li t a x e l % Survival (cid:3) (cid:2) Results and Discussion 191 18 . 3 GENE EXPRESSION ANALYSIS (cid:2) To perform the transcriptomic analysis we used microﬂuidic cards , also know as TaqMan® Low Density Arrays ( TLDA ) . This tool allows us to run 384 real - time PCR at once with predetermined TaqMan® probes already tested and validated . We analyzed as explained in materials and methods section , a total of 96 genes in 30 different cDNA samples , obtained from two independent RNA extractions of the 15 different cells lines . Each sample was analyzed twice to discard errors due to the technique . (cid:2) Nineteen of these genes ( highlighted in grey in ﬁgure 51 ) could not be used in later studies as their expression levels were too low to be detected by the TLDA system , like CNT1 and CNT2 for instance , or because the number of samples that expressed them did not reach the minimum to be analyzed statistically ( supplementary data in appendix I - tables 24 - 26 ) . As our group experience focuses mostly on nucleoside transporters , we decided to determine CNT1 and CNT2 expression levels by using individual TaqMan® probes in a relative real time PCR . We re - analyzed ENT1 , ENT2 , CNT1 , CNT2 and CNT3 expression levels and compared them with previous values obtained by TLDA . As results obtained for ENT1 , ENT2 and CNT3 were the same in both techniques , we decided to include the new values for CNT1 and CNT2 to the global correlation analysis in order to keep them in the study . (cid:2) Once we got gene expression levels , we studied correlations among cell lines based on their expression values to determine whether data should be treated separately depending upon the origin of the samples or as a global set ( ﬁgure 52 ) . As the heatmap did not deﬁne any cluster grouping samples , we considered them disparate enough to be analyzed as a whole instead of 3 different kinds of tumors separately . All computation were done by CIBERehd bioinformatics platform J using R v2 . 12 . o software I . Novel approaches to understanding hENT2 and hENT2 - related proteins 192 U P T A K E CAARR I E R S E FFL U X P U M PS M E T AB O L I S M A P O P T O S I S - S U R V I V A L - P R O L I F E RA T I O N - I N V A S I O N N O R M A L I Z E R S O A T P 1 B 1 E N T 1 AB C A 2 D i h y d r op y r i m i d i ne deh y d r ogena s e - D PY D E RC C 1 B a x 18 S O A T P 1 B 3 E N T 2 AB C A 3 T h y m i d i ne pho s pho r y l a s e - T Y M P XPA p21 G AP DH O A T P 2 B 1 E N T 3 AB C B 1 U r i d i ne pho s pho r y l a s e 1 - U PP 1 XP C F a s G U SB O A T P 4 A 1 E N T 4 AB C B 4 U r i d i ne pho s pho r y l a s e 2 - U PP 2 U r a c il - DN A g l yc o sy l a s e - UD G B c l - 2 O C T 1 CN T 1 AB C B 11 E po x i de h y d r o l a s e 1 - EP H X 1 h M L H 1 S m a c / D I AB L O O C T 2 CN T 2 AB CC 1 D eo xycy t i d i ne k i na s e - DC K h P M S 2 c - I AP - 1 - B I RC 2 O C T 3 CN T 3 AB CC 11 R i bonu c l eo s i de - d i pho s pha t e r edu c t a s e - RR M 1 h M S H 2 X I AP O C T N 1 AB CC 2 T h y m i d il a t e sy n t he t a s e - T Y M S G T BP / h M S H 6 s u r v i v i n - B I RC 5 O C T N 2 A Q P 1 AB CC 3 T h y m i d i ne k i na s e 1 - T K 1 G A DD 45 L i v i n - B I RC 7 O A T 1 A Q P 3 AB CC 4 5 ' - N u c l eo t i da s e , cy t o s o li c I A - N T 5 C 1 A T opo i s o m e r a s e I - T O P 1 c - F L I P - C F L A R O A T 2 A Q P 4 AB CC 5 5 ' - N u c l eo t i da s e , cy t o s o li c I B - N T 5 C 1 B T opo i s o m e r a s e II - a l pha - T O P 2 A E G F R O A T 3 A Q P 5 AB C G 2 O r o t a t e pho s pho r i bo sy l t r an s f e r a s e o U M PS K I T P I 3 K O A T 4 A Q P 7 U r i d i ne - cy t i d i ne k i na s e 2 - UC K 2 P D G F R A c - m yc C T R 1 A Q P 8 L R P o M VP F o l y l po l y g l u t a m a t e sy n t ha s e - F P G S M a t r i x M e t a ll op r o t e i na s e 1 - MM P 1 t i ga r / C 12o r f 5 A Q P 9 A T P 7 A γ - G l u t a m y l c i s t e i n sy n t he t a s e - G C L C M a t r i x M e t a ll op r o t e i na s e 2 - MM P 2 NR F 2 A T P 7 B M e t a ll o t h i one i n 4 - M T 4 M a t r i x M e t a ll op r o t e i na s e 3 - MM P 3 KEAP 1 U G T 1 A 1 / U G T 1 A 8 / U G T 1 A 10 - U G T X α - F e t op r o t e i n - A F P F i gu r e 51 . G e n es a n a l y z e d b y TL DA . A t o t a l o f 93 gene s , be s i de s 3 no r m a li z e r s ( 1 8 S , G AP DH and G U SB ) , w e r e ana l yz ed b y T L D A sys t e m and c l a ss i ﬁ ed a cc o r d i ng t o t he i r m a i n ph ys i o l og i c a l r o l e . N i ne t een o f t he s e gene s ( h i gh li gh t ed i n g r e y ) w e r e no t i n c l u d ed i n l a t e r s t ud i e s a s t he y w e r e no t de t e c t ed i n m o s t o f t he 15 c e ll li ne s , t he r e f o r e a t o t a l o f 74 gene s w ou l d be c on s i de r ed i n f u r t h e r ana l ys i s . Results and Discussion 193 E G I − 1 M z − C h A − 1 M z − C h A − 2 S k − C h A − 1 TF K − 1 A G S KA T O III M K N − 45 S NU − 1 S NU − 5 B x P C 3 N P 29 N P 31 N P 9 P an C 1 PanC1 NP9 NP31 NP29 BxPC3 SNU−5 SNU−1 MKN−45 KATOIII AGS TFK−1 Sk−ChA−1 Mz−ChA−2 Mz−ChA−1 EGI−1 0 . 6 0 . 9 BILIARY TRACT STOMACH PANCREAS B I L I A RY TR A C T S T O M A C H P A N C R E A S Figure 52 . Correlations between samples based on genes expression proﬁles . Heatmap depicting Pearson correlations among samples based on their genes expression proﬁles . Data do not generate any speciﬁc cluster matching with the different tissues origin . Red pixels correspond to positive correlations , whereas green pixels indicate negative correlations . Novel approaches to understanding hENT2 and hENT2 - related proteins 194 (cid:2) Next step was to evaluate correlations among genes to determine possible clusters or linking networks ( ﬁgure 53 ) . In this case , we could clearly notice two clusters well - deﬁned with forceful statistics , and how they might be related by some other genes in common . When we extracted correlation values from these clusters ( ﬁgure 54a ) we appreciated how consistent these clusters are with all genes strongly connected among themselves supported by statistics values most of them with a p value under 0 , 01 ( ﬁgure 54b ) . When we analyzed these genes in detail focusing in their physiological role , we classiﬁed them in 4 main groups : membrane proteins ( including NT transporters , OATPs and OCTs transporters , and Growth Factor Receptors ) , enzymes of nucleotide metabolism and genes belonging to IAP family and the DNA mismatch repair system ( ﬁgure 55 ) . (cid:2) Regarding membrane proteins , we exclusively found hENT1 and hCNT3 as nucleoside transporters , both of them showing broad substrate selectivity and being major players in providing nucleosides for growth purposes ( promoting salvage pathways ) . Several works describe ENT1 as an essential gene involved in proliferation . When proliferation of murine bone marrow - derived macrophages is induced by M - CSF , mENT1 is up - regulated becoming indispensable , whereas its expression level decreases when proliferation is blocked by macrophage activation through IFN - y . Also in rat intestinal epithelia cells , rENT1 is up - regulated when cell proliferation is induced by EGF , as well as in rat liver ( del Santo et al . 1998 ) or human proximal tubular cells ( Guillén - Gómez et al . 2011 ) . In all those cases , CNT1 and CNT2 have been negatively associated with proliferation , acquiring a key role , especially CNT2 , in differentiation , modulation of purinergic signaling and energy metabolism in both intestinal and liver parenchymal cells ( Duﬂot et al . 2004 ; Aymerich et al . 2006 ; Huber - Ruano et al . 2010 ) . Interestingly , those more specialized transporters , hCNT1 and hCNT2 , do not deﬁne any particular cluster in our study , like hENT3 , which has been described as an intracellular transporter protein ( Baldwin et al . 2005 ) . Results and Discussion 195 Figure 53 . Correlations between genes . Pearson correlation coefﬁcient - based heatmap between genes . ENTs and CNTs expression data obtained by individual Taqman® probes are included and indicated as ENTXn or CNTXn . Associated P - values were also calculated for each gene ( * : p < 0 , 01 ; · : p < 0 , 05 ) . Red pixels correspond to positive correlations , whereas green pixels indicate negative correlations . All computation were done using R v2 . 12 . o software I . O A T P 1 B 1 P D G F R A AB CC 2 E N T 4 AB C G 2 A Q P 5 O A T P 2 B 1 A Q P 1 CN T 2n NR F 2 XP C BAX A T P 7 B T I G A R AB CC 4 AB CC 5 A Q P 3 B C L2 MM P 1 E N T 3 AB C A 3 U G T X O C T 2 D PY D AB C A 2 AB C B 11 P 21 E N T 2 E N T 2n AB CC 1 G C L C O C T N 1 AB CC 3 O C T N 2 M VP O A T P 1 B 3 T Y M P AB CC 11 K I T T O P 2 A O C T 3 EP H X 1 E G F R O A T P 4 A 1 RR M 1 CN T 3 F P G S CN T 3n T K 1 M Y C T O P 1 XPA KEAP 1 DC K X I AP M S H 2 M S H 6 M L H 1 UD G B I RC 5 U M PS UC K 2 C F L A R C T R 1 F AS MM P 2 U PP 1 B I RC 2 E N T 1 E N T 1n G A DD 45 A T P 7 A E RCC 1 O C T 1 P M S 2 D I AB L O CN T 1n T Y M S B I RC 7 BIRC7TYMSCNT1nDIABLOPMS2OCT1ERCC1ATP7AGADD45ENT1nENT1BIRC2UPP1MMP2FASCTR1CFLARUCK2UMPSBIRC5UDGMLH1MSH6MSH2XIAPDCKKEAP1XPATOP1MYCTK1CNT3nFPGSCNT3RRM1OATP4A1EGFREPHX1OCT3TOP2AKIT ABCC11 TYMPOATP1B3MVPOCTN2ABCC3OCTN1GCLCABCC1ENT2nENT2P21ABCB11ABCA2DPYDOCT2UGTXABCA3ENT3MMP1BCL2AQP3ABCC5ABCC4TIGARATP7BBAXXPCNRF2CNT2nAQP1OATP2B1AQP5ABCG2ENT4ABCC2PDGFRAOATP1B1 . * . . . . * * . * . * . . * . . . . . . * . . * . * * . . . . . . * * . . * * * . . . . . . * * . . . * . * * . * . . * . . . . . * . * . * * . . * * . . . . . . * * . * . . . . * . . * . . . * . . * * * * * . * . . . * * * . . . * * * * * . * * * * . * . . . . . . . * . . * * . . . . * * * * . . . . . . . . * . . . * . * * . . . * * . . * * * * * * . . . . . * . . . * * . * . * . . . . . . . * . . . * . * . . * * . . . . . . . . * . * . . . . . * . * * . . . . . . . . . . . . . * * . . * * * * * . . . . * . * . . . . . . * . * . * . . * . . . * * * * . . * * * * . . * . . . * * . . . . * * * * * * . * * * . . . * . . . * * . . . * * . . . * * * . . . . . . * . * * * * . * * * . . . . . . * . . . * . . * * * . * . . . * * * * * * . * * * * * * . . . . . . * . . * . . * . . * * * . . . . * * * * * * . . . . . . . . . * * . . . * . * * * . . * * * * * . * * . . . . . . * * . * . . * . * * * * . * * . . * . . . . * * * * * * . * * * . . . . . * * . . . . * * * . * * * * * . * * . * * . . . . * * * * * * * . . . . * * . * * . * . * . * . . . * . * * * * * * * . * . * . * . . . . . . . . . * . * . . . . * . * * * * * * . * * * . * . * * . * . . * . . . . * * * * * * . * . * * * * * * * * . * . * . . * . . . . * . . * . . . . . * * * * * * * . * . * * * * * * . . . . . . . . . * * * * . . * . * * * * . . . . * * * * . . . . . * . . . . * * * . . . * . . * . * . . * . . . . . . . * . * . * . . . . * . . . * . . * * . . . . * . * . * . . . . . . . . . * * * * * . . * . . . . . . . * * * * * * . * . * . . . . . * . . * * * * * . . . * . . * . . . . . . . * * * * * * * . . * * * * * . . . * * * * * . . . . . . * . * . . . . . . . . . . . . * * . . . * . . . . * * . . * . . * . * . . . . * * . * . * * * . * * * . * * * . . . * * * * . . . * * * . . * . . * * * * * . . . * . . . * . . * . . . . * * . . . . . . * * . . . . . . * * * * . . . . . . * * * . * . * . . * * . . . . * * . * * * . * . . * . . . * . . . . . . * * . . . . * . * . . . . . . * . . * . . . . * . * . * . . . . . * : p < 0 . 05 · : p < 0 . 1 −0 . 5 0 . 5 Novel approaches to understanding hENT2 and hENT2 - related proteins 196 F i gu r e 54 . E x p r ess i on v a l u es o f t h e c l u s t e r s ob t a i n e d f r o m h ea t m a p o f g e n e c o rr e l a t i on s . ( a ) C o rr e l a t i on v a l ue s a m ong 35 gene s de ﬁ n i ng a po ss i b l e ne t w o r k . P o s i t i v e c o rr e l a t i on s ( > 0 , 45 ) a r e h i gh li gh t ed i n r ed and nega t i v e c o rr e l a t i on s ( < - 0 , 45 ) i n g r een . ( b ) P v a l ue s o f c o r r e l a t i on s de sc r i be abo v e . R ed : p < 0 , 01 ; P i n k : p < 0 , 05 and L i gh t P i n k : p < 0 , 1 . T w o po ss i b l e ne t w o r ks a r e f r a m ed i n b l a ck a cc o r d i ng t o f o r c e f u l c o r r e l a t i on s o f t ho s e gene s . A B CC 3 O C T N 2 M V P G C L C O A T P 1 B 3 E N T 2 A B CC 1 M L H 1 O C T N 1 T Y M P CN T 3 U PP 1 F P G S O A T P 1 B 1 P D G F R A O A T P 4 A 1 E N T 1 RR M 1 T K 1 U M P S UC K 2 B I R C 2 X I A P B I R C 5 K E A P 1 DC K T O P 1 M S H 2 UD G O C T 1 M Y C M S H 6 E G F R E N T 4 O A T P 2 B 1 A B CC 3 O C T N 2 M V P G C L C O A T P 1 B 3 E N T 2 A B CC 1 M L H 1 O C T N 1 T Y M P CN T 3 U PP 1 F P G S O A T P 1 B 1 P D G F R A O A T P 4 A 1 E N T 1 RR M 1 T K 1 U M P S UC K 2 B I R C 2 X I A P B I R C 5 K E A P 1 DC K T O P 1 M S H 2 UD G O C T 1 M Y C M S H 6 E G F R E N T 4 O A T P 2 B 1 0 , 000 0 , 000 0 , 000 0 , 001 0 , 018 0 , 00 3 0 , 028 0 , 000 0 , 000 0 , 020 0 , 006 0 , 027 0 , 011 0 , 025 0 , 034 0 , 179 0 , 328 0 , 203 0 , 148 0 , 173 0 , 472 0 , 135 0 , 163 0 , 045 0 , 209 0 , 976 0 , 250 0 , 386 0 , 372 0 , 471 0 , 510 0 , 331 0 , 599 0 , 431 0 , 359 0 , 000 0 , 000 0 , 000 0 , 007 0 , 003 0 , 02 8 0 , 048 0 , 012 0 , 001 0 , 019 0 , 010 0 , 228 0 , 010 0 , 032 0 , 092 0 , 198 0 , 962 0 , 186 0 , 093 0 , 274 0 , 361 0 , 532 0 , 255 0 , 207 0 , 157 0 , 738 0 , 200 0 , 458 0 , 619 0 , 872 0 , 216 0 , 431 0 , 631 0 , 281 0 , 981 0 , 000 0 , 000 0 , 000 0 , 002 0 , 016 0 , 01 5 0 , 065 0 , 030 0 , 000 0 , 085 0 , 008 0 , 105 0 , 033 0 , 128 0 , 048 0 , 073 0 , 492 0 , 199 0 , 350 0 , 461 0 , 798 0 , 257 0 , 279 0 , 145 0 , 123 0 , 716 0 , 440 0 , 847 0 , 702 0 , 811 0 , 474 0 , 878 0 , 733 0 , 482 0 , 852 0 , 001 0 , 007 0 , 002 0 , 000 0 , 125 0 , 02 2 0 , 013 0 , 021 0 , 001 0 , 027 0 , 064 0 , 028 0 , 037 0 , 346 0 , 177 0 , 318 0 , 290 0 , 699 0 , 474 0 , 239 0 , 704 0 , 106 0 , 456 0 , 185 0 , 472 0 , 935 0 , 801 0 , 627 0 , 773 0 , 293 0 , 768 0 , 633 0 , 698 0 , 497 0 , 606 0 , 018 0 , 003 0 , 016 0 , 125 0 , 000 0 , 20 7 0 , 514 0 , 112 0 , 003 0 , 022 0 , 016 0 , 407 0 , 013 0 , 091 0 , 442 0 , 063 0 , 958 0 , 043 0 , 141 0 , 250 0 , 376 0 , 716 0 , 333 0 , 425 0 , 050 0 , 154 0 , 089 0 , 257 0 , 341 0 , 420 0 , 012 0 , 288 0 , 561 0 , 063 0 , 678 0 , 003 0 , 028 0 , 015 0 , 022 0 , 207 0 , 00 0 0 , 373 0 , 002 0 , 028 0 , 200 0 , 004 0 , 038 0 , 065 0 , 637 0 , 230 0 , 057 0 , 144 0 , 124 0 , 049 0 , 018 0 , 103 0 , 036 0 , 154 0 , 025 0 , 192 0 , 578 0 , 186 0 , 292 0 , 131 0 , 307 0 , 273 0 , 319 0 , 951 0 , 376 0 , 445 0 , 028 0 , 048 0 , 065 0 , 013 0 , 514 0 , 373 0 , 000 0 , 021 0 , 023 0 , 042 0 , 061 0 , 014 0 , 056 0 , 038 0 , 006 0 , 298 0 , 087 0 , 468 0 , 249 0 , 070 0 , 072 0 , 058 0 , 208 0 , 036 0 , 183 0 , 336 0 , 339 0 , 516 0 , 192 0 , 087 0 , 776 0 , 299 0 , 060 0 , 860 0 , 557 0 , 000 0 , 012 0 , 030 0 , 021 0 , 112 0 , 00 2 0 , 021 0 , 000 0 , 008 0 , 029 0 , 004 0 , 010 0 , 007 0 , 033 0 , 158 0 , 172 0 , 130 0 , 093 0 , 019 0 , 004 0 , 028 0 , 030 0 , 095 0 , 006 0 , 133 0 , 503 0 , 037 0 , 127 0 , 069 0 , 128 0 , 218 0 , 085 0 , 618 0 , 323 0 , 859 0 , 000 0 , 001 0 , 000 0 , 001 0 , 003 0 , 02 8 0 , 023 0 , 008 0 , 000 0 , 004 0 , 001 0 , 005 0 , 001 0 , 021 0 , 017 0 , 025 0 , 219 0 , 027 0 , 099 0 , 104 0 , 317 0 , 168 0 , 052 0 , 053 0 , 066 0 , 344 0 , 150 0 , 153 0 , 143 0 , 117 0 , 082 0 , 070 0 , 195 0 , 134 0 , 538 0 , 020 0 , 019 0 , 085 0 , 027 0 , 022 0 , 20 0 0 , 042 0 , 029 0 , 004 0 , 000 0 , 008 0 , 011 0 , 009 0 , 066 0 , 389 0 , 015 0 , 168 0 , 027 0 , 074 0 , 166 0 , 052 0 , 106 0 , 071 0 , 152 0 , 232 0 , 048 0 , 318 0 , 130 0 , 119 0 , 125 0 , 051 0 , 128 0 , 080 0 , 169 0 , 754 0 , 006 0 , 010 0 , 008 0 , 064 0 , 016 0 , 00 4 0 , 061 0 , 004 0 , 001 0 , 008 0 , 000 0 , 003 0 , 000 0 , 159 0 , 044 0 , 000 0 , 062 0 , 001 0 , 006 0 , 013 0 , 018 0 , 021 0 , 003 0 , 016 0 , 008 0 , 028 0 , 006 0 , 030 0 , 029 0 , 022 0 , 005 0 , 038 0 , 047 0 , 046 0 , 536 0 , 027 0 , 228 0 , 105 0 , 028 0 , 407 0 , 038 0 , 014 0 , 010 0 , 005 0 , 011 0 , 003 0 , 000 0 , 008 0 , 220 0 , 017 0 , 002 0 , 001 0 , 014 0 , 066 0 , 017 0 , 048 0 , 001 0 , 015 0 , 002 0 , 096 0 , 070 0 , 213 0 , 051 0 , 009 0 , 002 0 , 144 0 , 052 0 , 024 0 , 231 0 , 026 0 , 011 0 , 010 0 , 033 0 , 037 0 , 013 0 , 06 5 0 , 056 0 , 007 0 , 001 0 , 009 0 , 000 0 , 008 0 , 000 0 , 222 0 , 045 0 , 006 0 , 118 0 , 002 0 , 001 0 , 015 0 , 078 0 , 024 0 , 003 0 , 006 0 , 001 0 , 024 0 , 002 0 , 026 0 , 042 0 , 015 0 , 014 0 , 007 0 , 035 0 , 004 0 , 284 0 , 025 0 , 032 0 , 128 0 , 346 0 , 091 0 , 63 7 0 , 038 0 , 033 0 , 021 0 , 066 0 , 159 0 , 220 0 , 222 0 , 000 1 , 000 0 , 280 0 , 677 0 , 297 0 , 498 0 , 259 0 , 263 0 , 556 0 , 241 0 , 231 0 , 189 0 , 227 0 , 343 0 , 758 0 , 221 0 , 539 0 , 087 0 , 933 0 , 200 0 , 654 1 , 000 0 , 034 0 , 092 0 , 048 0 , 177 0 , 442 0 , 23 0 0 , 006 0 , 158 0 , 017 0 , 389 0 , 044 0 , 017 0 , 045 1 , 000 0 , 000 0 , 045 0 , 009 0 , 007 0 , 074 0 , 285 0 , 398 0 , 075 0 , 023 0 , 008 0 , 030 0 , 170 0 , 171 0 , 303 0 , 015 0 , 225 0 , 079 0 , 091 0 , 023 0 , 249 1 , 000 0 , 179 0 , 198 0 , 073 0 , 318 0 , 063 0 , 057 0 , 298 0 , 172 0 , 025 0 , 015 0 , 000 0 , 002 0 , 006 0 , 280 0 , 045 0 , 000 0 , 005 0 , 000 0 , 021 0 , 060 0 , 054 0 , 008 0 , 001 0 , 012 0 , 004 0 , 001 0 , 041 0 , 078 0 , 010 0 , 021 0 , 002 0 , 078 0 , 019 0 , 061 0 , 213 0 , 328 0 , 962 0 , 492 0 , 290 0 , 958 0 , 14 4 0 , 087 0 , 130 0 , 219 0 , 168 0 , 062 0 , 001 0 , 118 0 , 677 0 , 009 0 , 005 0 , 000 0 , 044 0 , 174 0 , 020 0 , 038 0 , 000 0 , 008 0 , 002 0 , 047 0 , 010 0 , 169 0 , 064 0 , 005 0 , 006 0 , 248 0 , 169 0 , 072 0 , 825 0 , 021 0 , 203 0 , 186 0 , 199 0 , 699 0 , 043 0 , 124 0 , 468 0 , 093 0 , 027 0 , 027 0 , 001 0 , 014 0 , 002 0 , 297 0 , 007 0 , 000 0 , 044 0 , 000 0 , 001 0 , 094 0 , 039 0 , 015 0 , 004 0 , 007 0 , 011 0 , 005 0 , 011 0 , 006 0 , 001 0 , 076 0 , 000 0 , 002 0 , 032 0 , 038 0 , 135 0 , 148 0 , 093 0 , 350 0 , 474 0 , 141 0 , 049 0 , 249 0 , 019 0 , 099 0 , 074 0 , 006 0 , 066 0 , 001 0 , 498 0 , 074 0 , 021 0 , 174 0 , 001 0 , 000 0 , 011 0 , 006 0 , 012 0 , 022 0 , 002 0 , 013 0 , 037 0 , 003 0 , 004 0 , 002 0 , 126 0 , 004 0 , 000 0 , 072 0 , 083 0 , 315 0 , 173 0 , 274 0 , 461 0 , 239 0 , 250 0 , 01 8 0 , 070 0 , 004 0 , 104 0 , 166 0 , 013 0 , 017 0 , 015 0 , 259 0 , 285 0 , 060 0 , 020 0 , 094 0 , 011 0 , 000 0 , 000 0 , 019 0 , 016 0 , 002 0 , 007 0 , 023 0 , 003 0 , 151 0 , 007 0 , 005 0 , 058 0 , 062 0 , 250 0 , 355 0 , 583 0 , 472 0 , 361 0 , 798 0 , 704 0 , 376 0 , 10 3 0 , 072 0 , 028 0 , 317 0 , 052 0 , 018 0 , 048 0 , 078 0 , 263 0 , 398 0 , 054 0 , 038 0 , 039 0 , 006 0 , 000 0 , 000 0 , 036 0 , 013 0 , 024 0 , 074 0 , 012 0 , 005 0 , 031 0 , 002 0 , 016 0 , 011 0 , 023 0 , 085 0 , 505 0 , 847 0 , 135 0 , 532 0 , 257 0 , 106 0 , 716 0 , 03 6 0 , 058 0 , 030 0 , 168 0 , 106 0 , 021 0 , 001 0 , 024 0 , 556 0 , 075 0 , 008 0 , 000 0 , 015 0 , 012 0 , 019 0 , 036 0 , 000 0 , 051 0 , 000 0 , 049 0 , 049 0 , 117 0 , 008 0 , 002 0 , 020 0 , 273 0 , 024 0 , 114 0 , 545 0 , 130 0 , 163 0 , 255 0 , 279 0 , 456 0 , 333 0 , 15 4 0 , 208 0 , 095 0 , 052 0 , 071 0 , 003 0 , 015 0 , 003 0 , 241 0 , 023 0 , 001 0 , 008 0 , 004 0 , 022 0 , 016 0 , 013 0 , 051 0 , 000 0 , 027 0 , 002 0 , 000 0 , 001 0 , 088 0 , 029 0 , 005 0 , 003 0 , 059 0 , 007 0 , 053 0 , 215 0 , 045 0 , 207 0 , 145 0 , 185 0 , 425 0 , 02 5 0 , 036 0 , 006 0 , 053 0 , 152 0 , 016 0 , 002 0 , 006 0 , 231 0 , 008 0 , 012 0 , 002 0 , 007 0 , 002 0 , 002 0 , 024 0 , 000 0 , 027 0 , 000 0 , 003 0 , 045 0 , 042 0 , 123 0 , 000 0 , 064 0 , 097 0 , 021 0 , 121 0 , 680 0 , 035 0 , 209 0 , 157 0 , 123 0 , 472 0 , 050 0 , 192 0 , 183 0 , 133 0 , 066 0 , 232 0 , 008 0 , 096 0 , 001 0 , 189 0 , 030 0 , 004 0 , 047 0 , 011 0 , 013 0 , 007 0 , 074 0 , 049 0 , 002 0 , 003 0 , 000 0 , 000 0 , 001 0 , 397 0 , 036 0 , 023 0 , 014 0 , 147 0 , 076 0 , 114 0 , 477 0 , 976 0 , 738 0 , 716 0 , 935 0 , 154 0 , 57 8 0 , 336 0 , 503 0 , 344 0 , 048 0 , 028 0 , 070 0 , 024 0 , 227 0 , 170 0 , 001 0 , 010 0 , 005 0 , 037 0 , 023 0 , 012 0 , 049 0 , 000 0 , 045 0 , 000 0 , 000 0 , 004 0 , 199 0 , 026 0 , 006 0 , 003 0 , 125 0 , 009 0 , 107 0 , 401 0 , 250 0 , 200 0 , 440 0 , 801 0 , 089 0 , 186 0 , 339 0 , 037 0 , 150 0 , 318 0 , 006 0 , 213 0 , 002 0 , 343 0 , 171 0 , 041 0 , 169 0 , 011 0 , 003 0 , 003 0 , 005 0 , 117 0 , 001 0 , 042 0 , 001 0 , 004 0 , 000 0 , 026 0 , 030 0 , 014 0 , 001 0 , 014 0 , 102 0 , 035 0 , 921 0 , 386 0 , 458 0 , 847 0 , 627 0 , 257 0 , 29 2 0 , 516 0 , 127 0 , 153 0 , 130 0 , 030 0 , 051 0 , 026 0 , 758 0 , 303 0 , 078 0 , 064 0 , 006 0 , 004 0 , 151 0 , 031 0 , 008 0 , 088 0 , 123 0 , 397 0 , 199 0 , 026 0 , 000 0 , 004 0 , 028 0 , 017 0 , 000 0 , 063 0 , 032 0 , 628 0 , 372 0 , 619 0 , 702 0 , 773 0 , 341 0 , 13 1 0 , 192 0 , 069 0 , 143 0 , 119 0 , 029 0 , 009 0 , 042 0 , 221 0 , 015 0 , 010 0 , 005 0 , 001 0 , 002 0 , 007 0 , 002 0 , 002 0 , 029 0 , 000 0 , 036 0 , 026 0 , 030 0 , 004 0 , 000 0 , 036 0 , 006 0 , 000 0 , 059 0 , 648 0 , 210 0 , 471 0 , 872 0 , 811 0 , 293 0 , 420 0 , 30 7 0 , 087 0 , 128 0 , 117 0 , 125 0 , 022 0 , 002 0 , 015 0 , 539 0 , 225 0 , 021 0 , 006 0 , 076 0 , 126 0 , 005 0 , 016 0 , 020 0 , 005 0 , 064 0 , 023 0 , 006 0 , 014 0 , 028 0 , 036 0 , 000 0 , 091 0 , 043 0 , 010 0 , 072 0 , 807 0 , 510 0 , 216 0 , 474 0 , 768 0 , 012 0 , 273 0 , 776 0 , 218 0 , 082 0 , 051 0 , 005 0 , 144 0 , 014 0 , 087 0 , 079 0 , 002 0 , 248 0 , 000 0 , 004 0 , 058 0 , 011 0 , 273 0 , 003 0 , 097 0 , 014 0 , 003 0 , 001 0 , 017 0 , 006 0 , 091 0 , 000 0 , 010 0 , 061 0 , 034 0 , 473 0 , 331 0 , 431 0 , 878 0 , 633 0 , 288 0 , 31 9 0 , 299 0 , 085 0 , 070 0 , 128 0 , 038 0 , 052 0 , 007 0 , 933 0 , 091 0 , 078 0 , 169 0 , 002 0 , 000 0 , 062 0 , 023 0 , 024 0 , 059 0 , 021 0 , 147 0 , 125 0 , 014 0 , 000 0 , 000 0 , 043 0 , 010 0 , 000 0 , 026 0 , 112 0 , 312 0 , 599 0 , 631 0 , 733 0 , 698 0 , 561 0 , 95 1 0 , 060 0 , 618 0 , 195 0 , 080 0 , 047 0 , 024 0 , 035 0 , 200 0 , 023 0 , 019 0 , 072 0 , 032 0 , 072 0 , 250 0 , 085 0 , 114 0 , 007 0 , 121 0 , 076 0 , 009 0 , 102 0 , 063 0 , 059 0 , 010 0 , 061 0 , 026 0 , 000 0 , 180 0 , 011 0 , 431 0 , 281 0 , 482 0 , 497 0 , 063 0 , 376 0 , 860 0 , 323 0 , 134 0 , 169 0 , 046 0 , 231 0 , 004 0 , 654 0 , 249 0 , 061 0 , 825 0 , 038 0 , 083 0 , 355 0 , 505 0 , 545 0 , 053 0 , 680 0 , 114 0 , 107 0 , 035 0 , 032 0 , 648 0 , 072 0 , 034 0 , 112 0 , 180 0 , 000 0 , 644 0 , 359 0 , 981 0 , 852 0 , 606 0 , 678 0 , 44 5 0 , 557 0 , 859 0 , 538 0 , 754 0 , 536 0 , 026 0 , 284 1 , 000 1 , 000 0 , 213 0 , 021 0 , 135 0 , 315 0 , 583 0 , 847 0 , 130 0 , 215 0 , 035 0 , 477 0 , 401 0 , 921 0 , 628 0 , 210 0 , 807 0 , 473 0 , 312 0 , 011 0 , 644 0 , 000 A B CC 3 O C T N 2 M V P G C L C O A T P 1 B 3 E N T 2 A B CC 1 M L H 1 O C T N 1 T Y M P CN T 3 U PP 1 F P G S O A T P 1 B 1 P D G F R A O A T P 4 A 1 E N T 1 RR M 1 T K 1 U M P S UC K 2 B I R C 2 X I A P B I R C 5 K E A P 1 DC K T O P 1 M S H 2 UD G O C T 1 M Y C M S H 6 E G F R E N T 4 O A T P 2 B 1 A B CC 3 O C T N 2 M V P G C L C O A T P 1 B 3 E N T 2 A B CC 1 M L H 1 O C T N 1 T Y M P CN T 3 U PP 1 F P G S O A T P 1 B 1 P D G F R A O A T P 4 A 1 E N T 1 RR M 1 T K 1 U M P S UC K 2 B I R C 2 X I A P B I R C 5 K E A P 1 DC K T O P 1 M S H 2 UD G O C T 1 M Y C M S H 6 E G F R E N T 4 O A T P 2 B 1 1 , 000 0 , 829 0 , 867 0 , 806 0 , 668 0 , 733 0 , 584 0 , 816 0 , 875 0 , 635 0 , 714 0 , 587 0 , 653 - 0 , 867 - 0 , 792 0 , 381 0 , 282 0 , 362 0 , 408 0 , 386 0 , 210 0 , 420 0 , 3 94 0 , 543 0 , 358 0 , 009 0 , 329 0 , 263 0 , 259 0 , 220 0 , 193 0 , 281 0 , 154 - 0 , 239 - 0 , 376 0 , 829 1 , 000 0 , 874 0 , 688 0 , 775 0 , 586 0 , 536 0 , 652 0 , 812 0 , 637 0 , 687 0 , 344 0 , 660 - 0 , 850 - 0 , 681 0 , 366 - 0 , 014 0 , 376 0 , 465 0 , 314 0 , 265 0 , 183 0 , 326 0 , 359 0 , 400 0 , 099 0 , 365 0 , 226 0 , 146 0 , 050 0 , 353 0 , 229 0 , 141 - 0 , 324 - 0 , 010 0 , 867 0 , 874 1 , 000 0 , 749 0 , 676 0 , 633 0 , 506 0 , 578 0 , 856 0 , 496 0 , 694 0 , 451 0 , 570 - 0 , 692 - 0 , 758 0 , 493 0 , 200 0 , 365 0 , 270 0 , 215 0 , 075 0 , 325 0 , 3 11 0 , 410 0 , 432 0 , 107 0 , 225 0 , 060 0 , 112 0 , 074 0 , 209 0 , 045 0 , 100 - 0 , 214 - 0 , 079 0 , 806 0 , 688 0 , 749 1 , 000 0 , 468 0 , 60 4 0 , 643 0 , 608 0 , 788 0 , 611 0 , 527 0 , 586 0 , 562 - 0 , 470 - 0 , 575 0 , 288 0 , 305 0 , 113 0 , 209 0 , 337 0 , 112 0 , 450 0 , 2 17 0 , 376 0 , 210 - 0 , 024 0 , 074 0 , 149 0 , 085 0 , 316 - 0 , 087 0 , 140 0 , 114 - 0 , 207 0 , 217 0 , 668 0 , 775 0 , 676 0 , 468 1 , 000 0 , 39 3 0 , 209 0 , 483 0 , 802 0 , 649 0 , 700 0 , 264 0 , 691 - 0 , 742 - 0 , 392 0 , 552 - 0 , 017 0 , 590 0 , 451 0 , 361 0 , 281 0 , 118 0 , 3 06 0 , 255 0 , 575 0 , 438 0 , 512 0 , 374 0 , 301 0 , 271 0 , 693 0 , 334 0 , 187 - 0 , 577 0 , 175 0 , 733 0 , 586 0 , 633 0 , 604 0 , 393 1 , 000 0 , 258 0 , 752 0 , 608 0 , 380 0 , 732 0 , 558 0 , 506 - 0 , 247 - 0 , 522 0 , 520 0 , 411 0 , 431 0 , 534 0 , 620 0 , 454 0 , 562 0 , 4 02 0 , 594 0 , 371 0 , 163 0 , 375 0 , 317 0 , 423 0 , 308 0 , 315 0 , 288 - 0 , 018 - 0 , 268 0 , 317 0 , 584 0 , 536 0 , 506 0 , 643 0 , 209 0 , 258 1 , 000 0 , 607 0 , 621 0 , 570 0 , 532 0 , 640 0 , 521 - 0 , 837 - 0 , 896 0 , 300 0 , 474 0 , 212 0 , 330 0 , 498 0 , 494 0 , 518 0 , 359 0 , 564 0 , 378 0 , 278 0 , 276 0 , 198 0 , 371 0 , 493 0 , 084 0 , 299 0 , 514 0 , 054 - 0 , 246 0 , 816 0 , 652 0 , 578 0 , 608 0 , 483 0 , 752 0 , 607 1 , 000 0 , 702 0 , 605 0 , 734 0 , 661 0 , 682 - 0 , 848 - 0 , 596 0 , 387 0 , 424 0 , 466 0 , 617 0 , 714 0 , 585 0 , 580 0 , 463 0 , 693 0 , 422 0 , 195 0 , 562 0 , 445 0 , 500 0 , 444 0 , 352 0 , 477 0 , 146 - 0 , 298 - 0 , 076 0 , 875 0 , 812 0 , 856 0 , 788 0 , 802 0 , 608 0 , 621 0 , 702 1 , 000 0 , 766 0 , 823 0 , 729 0 , 820 - 0 , 880 - 0 , 843 0 , 615 0 , 366 0 , 609 0 , 477 0 , 471 0 , 301 0 , 406 0 , 5 49 0 , 548 0 , 525 0 , 285 0 , 423 0 , 439 0 , 429 0 , 476 0 , 500 0 , 517 0 , 384 - 0 , 458 - 0 , 283 0 , 635 0 , 637 0 , 496 0 , 611 0 , 649 0 , 380 0 , 570 0 , 605 0 , 766 1 , 000 0 , 725 0 , 679 0 , 688 - 0 , 781 - 0 , 434 0 , 654 0 , 406 0 , 609 0 , 512 0 , 408 0 , 550 0 , 469 0 , 515 0 , 421 0 , 356 0 , 556 0 , 301 0 , 462 0 , 454 0 , 468 0 , 551 0 , 445 0 , 503 - 0 , 425 - 0 , 133 0 , 714 0 , 687 0 , 694 0 , 527 0 , 700 0 , 732 0 , 532 0 , 734 0 , 823 0 , 725 1 , 000 0 , 758 0 , 844 - 0 , 654 - 0 , 768 0 , 847 0 , 531 0 , 814 0 , 712 0 , 665 0 , 641 0 , 631 0 , 7 59 0 , 653 0 , 700 0 , 607 0 , 711 0 , 625 0 , 604 0 , 651 0 , 730 0 , 579 0 , 560 - 0 , 585 - 0 , 285 0 , 587 0 , 344 0 , 451 0 , 586 0 , 264 0 , 55 8 0 , 640 0 , 661 0 , 729 0 , 679 0 , 758 1 , 000 0 , 672 - 0 , 588 - 0 , 842 0 , 748 0 , 800 0 , 636 0 , 504 0 , 623 0 , 537 0 , 774 0 , 634 0 , 744 0 , 463 0 , 498 0 , 355 0 , 551 0 , 670 0 , 762 0 , 411 0 , 529 0 , 598 - 0 , 357 - 0 , 769 0 , 653 0 , 660 0 , 570 0 , 562 0 , 691 0 , 506 0 , 521 0 , 682 0 , 820 0 , 688 0 , 844 0 , 672 1 , 000 - 0 , 586 - 0 , 764 0 , 695 0 , 438 0 , 742 0 , 793 0 , 633 0 , 486 0 , 598 0 , 730 0 , 691 0 , 768 0 , 597 0 , 742 0 , 612 0 , 549 0 , 655 0 , 636 0 , 685 0 , 566 - 0 , 736 - 0 , 433 - 0 , 867 - 0 , 850 - 0 , 692 - 0 , 470 - 0 , 742 - 0 , 24 7 - 0 , 837 - 0 , 848 - 0 , 880 - 0 , 781 - 0 , 654 - 0 , 588 - 0 , 586 1 , 000 0 , 000 - 0 , 529 - 0 , 219 - 0 , 514 - 0 , 349 - 0 , 549 - 0 , 545 0 , 306 - 0 , 567 - 0 , 577 - 0 , 620 - 0 , 580 - 0 , 474 0 , 163 - 0 , 586 - 0 , 371 - 0 , 749 0 , 045 - 0 , 608 0 , 275 0 , 000 - 0 , 792 - 0 , 681 - 0 , 758 - 0 , 575 - 0 , 392 - 0 , 522 - 0 , 896 - 0 , 596 - 0 , 843 - 0 , 434 - 0 , 768 - 0 , 842 - 0 , 764 0 , 000 1 , 000 - 0 , 764 - 0 , 882 - 0 , 892 - 0 , 710 - 0 , 472 - 0 , 382 - 0 , 708 - 0 , 822 - 0 , 886 - 0 , 802 - 0 , 582 - 0 , 581 - 0 , 456 - 0 , 852 - 0 , 583 - 0 , 701 - 0 , 683 - 0 , 823 0 , 558 0 , 000 0 , 381 0 , 366 0 , 493 0 , 288 0 , 552 0 , 52 0 0 , 300 0 , 387 0 , 615 0 , 654 0 , 847 0 , 748 0 , 695 - 0 , 529 - 0 , 764 1 , 000 0 , 701 0 , 875 0 , 608 0 , 514 0 , 525 0 , 676 0 , 7 84 0 , 650 0 , 715 0 , 800 0 , 551 0 , 505 0 , 658 0 , 629 0 , 744 0 , 487 0 , 615 - 0 , 532 - 0 , 495 0 , 282 - 0 , 014 0 , 200 0 , 305 - 0 , 017 0 , 41 1 0 , 474 0 , 424 0 , 366 0 , 406 0 , 531 0 , 800 0 , 438 - 0 , 219 - 0 , 882 0 , 701 1 , 000 0 , 545 0 , 385 0 , 611 0 , 559 0 , 858 0 , 6 73 0 , 752 0 , 539 0 , 660 0 , 389 0 , 528 0 , 707 0 , 714 0 , 331 0 , 389 0 , 494 - 0 , 068 - 0 , 786 0 , 362 0 , 376 0 , 365 0 , 113 0 , 590 0 , 43 1 0 , 212 0 , 466 0 , 609 0 , 609 0 , 814 0 , 636 0 , 742 - 0 , 514 - 0 , 892 0 , 875 0 , 545 1 , 000 0 , 802 0 , 465 0 , 556 0 , 633 0 , 720 0 , 685 0 , 653 0 , 699 0 , 658 0 , 713 0 , 786 0 , 508 0 , 875 0 , 747 0 , 572 - 0 , 579 - 0 , 576 0 , 408 0 , 465 0 , 270 0 , 209 0 , 451 0 , 53 4 0 , 330 0 , 617 0 , 477 0 , 512 0 , 712 0 , 504 0 , 793 - 0 , 349 - 0 , 710 0 , 608 0 , 385 0 , 802 1 , 000 0 , 657 0 , 689 0 , 647 0 , 606 0 , 759 0 , 641 0 , 560 0 , 732 0 , 734 0 , 755 0 , 447 0 , 709 0 , 841 0 , 496 - 0 , 499 - 0 , 409 0 , 386 0 , 314 0 , 215 0 , 337 0 , 361 0 , 62 0 0 , 498 0 , 714 0 , 471 0 , 408 0 , 665 0 , 623 0 , 633 - 0 , 549 - 0 , 472 0 , 514 0 , 611 0 , 465 0 , 657 1 , 000 0 , 834 0 , 617 0 , 630 0 , 743 0 , 683 0 , 603 0 , 726 0 , 422 0 , 687 0 , 729 0 , 517 0 , 511 0 , 330 - 0 , 280 0 , 231 0 , 210 0 , 265 0 , 075 0 , 112 0 , 281 0 , 45 4 0 , 494 0 , 585 0 , 301 0 , 550 0 , 641 0 , 537 0 , 486 - 0 , 545 - 0 , 382 0 , 525 0 , 559 0 , 556 0 , 689 0 , 834 1 , 000 0 , 562 0 , 646 0 , 599 0 , 492 0 , 651 0 , 701 0 , 597 0 , 741 0 , 649 0 , 652 0 , 602 0 , 477 - 0 , 203 0 , 082 0 , 420 0 , 183 0 , 325 0 , 450 0 , 118 0 , 56 2 0 , 518 0 , 580 0 , 406 0 , 469 0 , 631 0 , 774 0 , 598 0 , 306 - 0 , 708 0 , 676 0 , 858 0 , 633 0 , 647 0 , 617 0 , 562 1 , 000 0 , 530 0 , 846 0 , 534 0 , 535 0 , 438 0 , 701 0 , 744 0 , 633 0 , 315 0 , 598 0 , 442 - 0 , 185 - 0 , 582 0 , 394 0 , 326 0 , 311 0 , 217 0 , 306 0 , 40 2 0 , 359 0 , 463 0 , 549 0 , 515 0 , 759 0 , 634 0 , 730 - 0 , 567 - 0 , 822 0 , 784 0 , 673 0 , 720 0 , 606 0 , 630 0 , 646 0 , 530 1 , 000 0 , 587 0 , 745 0 , 839 0 , 784 0 , 491 0 , 583 0 , 723 0 , 735 0 , 516 0 , 688 - 0 , 547 - 0 , 493 0 , 543 0 , 359 0 , 410 0 , 376 0 , 255 0 , 59 4 0 , 564 0 , 693 0 , 548 0 , 421 0 , 653 0 , 744 0 , 691 - 0 , 577 - 0 , 886 0 , 650 0 , 752 0 , 685 0 , 759 0 , 743 0 , 599 0 , 846 0 , 587 1 , 000 0 , 727 0 , 542 0 , 549 0 , 450 0 , 836 0 , 527 0 , 461 0 , 610 0 , 434 - 0 , 127 - 0 , 743 0 , 358 0 , 400 0 , 432 0 , 210 0 , 575 0 , 37 1 0 , 378 0 , 422 0 , 525 0 , 356 0 , 700 0 , 463 0 , 768 - 0 , 620 - 0 , 802 0 , 715 0 , 539 0 , 653 0 , 641 0 , 683 0 , 492 0 , 534 0 , 745 0 , 727 1 , 000 0 , 813 0 , 784 0 , 257 0 , 562 0 , 621 0 , 637 0 , 408 0 , 489 - 0 , 460 - 0 , 296 0 , 009 0 , 099 0 , 107 - 0 , 024 0 , 438 0 , 16 3 0 , 278 0 , 195 0 , 285 0 , 556 0 , 607 0 , 498 0 , 597 - 0 , 580 - 0 , 582 0 , 800 0 , 660 0 , 699 0 , 560 0 , 603 0 , 651 0 , 535 0 , 839 0 , 542 0 , 813 1 , 000 0 , 714 0 , 381 0 , 591 0 , 713 0 , 727 0 , 430 0 , 671 - 0 , 468 - 0 , 346 0 , 329 0 , 365 0 , 225 0 , 074 0 , 512 0 , 37 5 0 , 276 0 , 562 0 , 423 0 , 301 0 , 711 0 , 355 0 , 742 - 0 , 474 - 0 , 581 0 , 551 0 , 389 0 , 658 0 , 732 0 , 726 0 , 701 0 , 438 0 , 7 84 0 , 549 0 , 784 0 , 714 1 , 000 0 , 611 0 , 580 0 , 658 0 , 771 0 , 636 0 , 455 - 0 , 586 - 0 , 042 0 , 263 0 , 226 0 , 060 0 , 149 0 , 374 0 , 31 7 0 , 198 0 , 445 0 , 439 0 , 462 0 , 625 0 , 551 0 , 612 0 , 163 - 0 , 456 0 , 505 0 , 528 0 , 713 0 , 734 0 , 422 0 , 597 0 , 701 0 , 4 91 0 , 450 0 , 257 0 , 381 0 , 611 1 , 000 0 , 743 0 , 630 0 , 647 0 , 936 0 , 529 - 0 , 618 - 0 , 204 0 , 259 0 , 146 0 , 112 0 , 085 0 , 301 0 , 42 3 0 , 371 0 , 500 0 , 429 0 , 454 0 , 604 0 , 670 0 , 549 - 0 , 586 - 0 , 852 0 , 658 0 , 707 0 , 786 0 , 755 0 , 687 0 , 741 0 , 744 0 , 583 0 , 836 0 , 562 0 , 591 0 , 580 0 , 743 1 , 000 0 , 583 0 , 692 0 , 808 0 , 516 - 0 , 140 - 0 , 497 0 , 220 0 , 050 0 , 074 0 , 316 0 , 271 0 , 30 8 0 , 493 0 , 444 0 , 476 0 , 468 0 , 651 0 , 762 0 , 655 - 0 , 371 - 0 , 583 0 , 629 0 , 714 0 , 508 0 , 447 0 , 729 0 , 649 0 , 633 0 , 723 0 , 527 0 , 621 0 , 713 0 , 658 0 , 630 0 , 583 1 , 000 0 , 488 0 , 568 0 , 684 - 0 , 514 - 0 , 114 0 , 193 0 , 353 0 , 209 - 0 , 087 0 , 693 0 , 31 5 0 , 084 0 , 352 0 , 500 0 , 551 0 , 730 0 , 411 0 , 636 - 0 , 749 - 0 , 701 0 , 744 0 , 331 0 , 875 0 , 709 0 , 517 0 , 652 0 , 315 0 , 735 0 , 461 0 , 637 0 , 727 0 , 771 0 , 647 0 , 692 0 , 488 1 , 000 0 , 665 0 , 512 - 0 , 591 - 0 , 298 0 , 281 0 , 229 0 , 045 0 , 140 0 , 334 0 , 28 8 0 , 299 0 , 477 0 , 517 0 , 445 0 , 579 0 , 529 0 , 685 0 , 045 - 0 , 683 0 , 487 0 , 389 0 , 747 0 , 841 0 , 511 0 , 602 0 , 598 0 , 516 0 , 610 0 , 408 0 , 430 0 , 636 0 , 936 0 , 808 0 , 568 0 , 665 1 , 000 0 , 592 - 0 , 462 - 0 , 411 0 , 154 0 , 141 0 , 100 0 , 114 0 , 187 - 0 , 018 0 , 514 0 , 146 0 , 384 0 , 503 0 , 560 0 , 598 0 , 566 - 0 , 608 - 0 , 823 0 , 615 0 , 494 0 , 572 0 , 496 0 , 330 0 , 477 0 , 442 0 , 6 88 0 , 434 0 , 489 0 , 671 0 , 455 0 , 529 0 , 516 0 , 684 0 , 512 0 , 592 1 , 000 - 0 , 396 - 0 , 828 - 0 , 239 - 0 , 324 - 0 , 214 - 0 , 207 - 0 , 577 - 0 , 26 8 0 , 054 - 0 , 298 - 0 , 458 - 0 , 425 - 0 , 585 - 0 , 357 - 0 , 736 0 , 275 0 , 558 - 0 , 532 - 0 , 068 - 0 , 579 - 0 , 499 - 0 , 280 - 0 , 203 - 0 , 185 - 0 , 547 - 0 , 127 - 0 , 460 - 0 , 468 - 0 , 586 - 0 , 618 - 0 , 140 - 0 , 514 - 0 , 591 - 0 , 462 - 0 , 396 1 , 000 0 , 215 - 0 , 376 - 0 , 010 - 0 , 079 0 , 217 0 , 175 0 , 31 7 - 0 , 246 - 0 , 076 - 0 , 283 - 0 , 133 - 0 , 285 - 0 , 769 - 0 , 433 0 , 000 0 , 000 - 0 , 495 - 0 , 786 - 0 , 576 - 0 , 409 0 , 231 0 , 082 - 0 , 582 - 0 , 493 - 0 , 743 - 0 , 296 - 0 , 346 - 0 , 042 - 0 , 204 - 0 , 497 - 0 , 114 - 0 , 298 - 0 , 411 - 0 , 828 0 , 215 1 , 000 (cid:5) (cid:4) (cid:6) (cid:4) Results and Discussion 197 F i gu r e 55 . C a r t oon r e p r ese n t i ng g e n es o f a pu t a t i ve no ve l g e n e n e t w o r k . D i ag r a m dep i c t i ng ph ys i o l og i c a l r o l e s o f gene s s e l e c t ed f o r t h i s s t ud y and r e l a t i on s a m ong t he m s t ab li s hed f r o m T L D A ana l ys i s . I n r ed , gene s w i t h a h i gh l y po s i t i v e c o rr e l a t i on ; i n li gh t p i n k , gene s w ho s e po s i t i v e c o rr e l a t i on i s no t s o f o r c e f u l i n t he c on t e x t o f t he g l oba l s e t o f gene s ; i n g r een , gene s c o rr e l a t i ng nega t i v e l y . G S H S y n t h e s i s G C L C F o l a t e C y c l e F P G S M V P ? ? N P C N r f 2 K E A P 1 T O P 1 N T G S H G C L C O C T 1 O A T P 4 A 1 E N T 1 C N T 3 A Q P ’ s A B C C 1 O A T P 1 B 1 O A T P 2 B 1 M M P ’ s G F E G F R K I T S C F P D G F R A G F F A S T N F N T M e t a b o li s m T Y M P U PP 1 T K 1 RR M 1 U M P S U C K 2 D C K T Y M S D P Y D C F L A R I A P F a m il y B I R C 2 B I R C 5 X I A P B I R C 7 T O P 2 A P 21 U D G M L H 1 P M S 2 M S H 2 M S H 6 E R CC 1 X P A X P C D I A B L O G A D D 45 B A X B C L - 2 N r f 2 M Y C ⊕ C y t o p r o t e c t i v e R e s p o n s e ( G C L C ) ⊕ G r o w t h A rr e s t U p r e g u l a t e d b y D N A - D a m ag e D N A M i s m a t c h R e p a i r N E R T I G A R ⊗ G l yc o li s i s ⊗ R O S a n d A p o p t o s i s E P H X 1 U G T x D e t o x i ﬁ c a t i o n ⊕ B r e a k d o w n o f e x t r a c e ll u l a r m a t r i x ⊗ A p o p t o s i s ⊗ C a s p a s e s A c t i v a t i o n S u r v i v i n ⊗ F a s a n d B a x L i v i n ⊕ S y n t h e s i s / R e p a i r D N A ⊕ C e ll D i v i s i o n & P r o li f e r a t i o n ⊗ ⊗ A p o p t o s i s ⊕ A p o p t o s i s ⊕ C e ll P r o li f e r a t i o n & S u r v i v a l ⊕ D N A S y n t h e s i s ⊕ A p o p t o s i s B A , T 3 , P r o s t , E s t r o g e n - S E N T 4 O C T ’ s S u b s t r a t e s B ili r u b i n , E s t r a d i o l , C 4 S t e r o i d s - S E N T 2 O C T N 1 Novel approaches to understanding hENT2 and hENT2 - related proteins 198 (cid:2) Gene clusters deﬁned by broad selectivity transporter proteins also incorporate almost all genes ( 7 out of 9 ) included in the card and related to nucleotide metabolism , highlighting the probable link between membrane processes implicated in nucleoside salvage and nucleos ( t ) ide metabolism . Furthermore , some of these enzymes have been demonstrated to be important for cell proliferation and crucial for dTTP supply in DNA repairing , in the case of TK1 ( Y . L . Chen et al . 2010 ) , and also to induce metastasis , angiogenesis and to protect cancer cells against apoptosis , in the case of TYMP ( Bronckaers et al . 2009 ) . (cid:2) hENT2 also shows some positive correlation with different genes of interest , being relevant as it is the main known transporter protein so far implicated in nucleobase salvage . hENT2 has been described as a putative cancer gene in human hepatocellular carcinoma , where its aberrant up - regulation was signiﬁcantly associated with advanced stages , vascular invasion and poor patient survival . At the same time , when hENT2 was down - regulated , cell proliferation and tumor formation decreased considerably ( C . - F . Chen et al . 2010 ) . Curiously , hENT1 and hENT2 are both involved in cellular proliferation but not at the same time , as theyʼre differently regulated in a cell cycle - dependent way ( del Santo et al . 1998 ) . On the other hand , hCNT3 is the only member of the SLC28 family with a broad selectivity , highly conserved in species including procaryotes , in contrast with equilibrative transporters . In addition , hCNT3 appears to be highly expressed in human endothelial stem cells , together with hENT1 ( Guzmán - Gutiérrez et al . 2010 ) . (cid:2) Surprisingly , hENT4 shows a strong negative correlation with genes deﬁning hENT1 and hCNT3 related clusters . Despite it was assigned to the equilibrative nucleoside transporter family , hENT4 ( also known as PMAT ) mainly functions as a polyspeciﬁc organic cations transporter ( M . Zhou et al . 2007 ) . It has been demonstrated that PMAT - mediated adenosine transport is saturable , pH - dependent , and membrane - potential sensitive ( M . Zhou et al . 2010 ) . These functional differences between hENT1 - 2 and hENT4 coincide with their no - correlated expression . Besides the possibility of being an adenosine transporter , hENT4 might be contributing to translocate substrates also recognized by SLC22 members , such as selected hOCTs . A previous study about non - neuronal monoamine transporters reported a negative correlation between hENT4 and OCT1 expression , coinciding with our results ( Bottalico et al . 2007 ) . Results and Discussion 199 (cid:2) Interestingly , hOATP1B1 and hOAT2B1 show signiﬁcant negative correlations with these gene clusters and also their transport activity is pH gradient inﬂuenced , as it happens with hENT4 ( Svoboda et al . 2011 ) . Some studies reported that tissue - speciﬁc distribution of OATPs is not maintained in cancer cells and , according with our results , hOATP4A1 shows increased mRNA levels in tumors , while hOATP1B1 / 2B1 are downregulated comparing cancerous versus non - cancerous samples ( Wlcek et al . 2011 ) . Genes in the deﬁned clusters also showing positive correlations include those of the IAP family implicated in cell survival blocking caspase activity and also regulating canonical NF - kB activation ( Plati et al . 2011 ) . Therefore , an enhanced expression of IAPs has been seen to contribute to colon carcinogenesis and its poor prognosis , acquiring a potential role as prognostic markers ( Miura et al . 2011 ) . (cid:2) Growth factor receptors , EGFR and PDGFRA , also show signiﬁcant correlations with those clusters although they maintain an inverse relationship , being EGFR positively and PDGFRA negatively correlated with this novel gene network . Despite these two receptors trigger similar pathways involved in proliferation , it has been reported in different cases that their gene ampliﬁcation are mutually exclusive ( Fleming et al . 1992 ; Perrone et al . 2010 ) . However , it still remains unclear the reason of their mutual exclusion although probably it would be related to the distinct signalling cascades triggered by their different ligands ( Besson & Yong 2001 ) . Anyway , this discrimination between genes apparently contributing to similar cellular events also occurs with genes encoding some of the proteins implicated in DNA repair . Genes of the DNA mismatch repair ( MMR ) system positively correlate whereas the NER system is not included in the cluster . Once again , there is no evidence to explain this phenomenon , beyond the reported connection between mRNA expression among members of MMR ( D . Chang et al . 2000 ) and also the fact proliferating cells have higher expression levels of MMR genes than resting cells ( Jascur & Boland 2006 ) . 18 . 4 CORRELATION BETWEEN GENE EXPRESSION AND TREATMENT RESPONSE (cid:2) To determine if there is any set of genes whose expression would predict responsiveness to those speciﬁc treatments , we analyzed correlations between the percentage of survival for each sample and treatment condition , and the basal expression of each gene , based on the Pearson coefﬁcient . Results are shown in ﬁgure 56 . Novel approaches to understanding hENT2 and hENT2 - related proteins 200 X 5d F UR _ 0 . 1 mM X 5d F UR _ 0 . 5 mM X 5d F UR _ 1 mM X 5d F UR _ 2 . 5 mM X 5d F UR _ 5 mM X 5 F U _ 0 . 1 mM X 5 F U _ 0 . 25 mM X 5 F U _ 0 . 5 mM X 5 F U _ 1 mM X 5 F U _ 2 . 5 mM C P t _ 10u M C P t _ 50u M C P t _ 75u M C P t _ 100u M C P t _ 250u M D o x _ 0 . 05 . u M D o x _ 0 . 1u M D o x _ 0 . 5u M D o x _ 1u M D o x _ 5u M G e m _ 0 . 1u M G e m _ 0 . 5u M G e m _ 1u M G e m _ 5u M G e m _ 10u M T a x _ 0 . 1u M T a x _ 0 . 5u M T a x _ 1u M T a x _ 5u M T a x _ 10u M ABCC2ENT4ABCG2DPYDEPHX1ABCA3UGTXABCA2BCL2AQP3TOP2AATP7AERCC1GADD45ABCC5PMS2DIABLOXPCBAXABCC4ATP7BTIGARTYMSNRF2ENT3EGFROCT1 UPP1 ENT1BIRC2DCKXIAPTOP1KEAP1OATP4A1CNT3FPGSRRM1MYCTK1MSH2MSH6UMPSUCK2UDGBIRC5MMP1CFLARFASCTR1XPAP21ENT2MLH1OCTN1OCTN2GCLCABCC3MVPABCC1TYMP * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * −0 . 6 0 0 . 6 Figure 56 . Heatmap representing correlations between genes expression and responsiveness to treatments . Pearson correlation coefﬁcient - based heatmap between genes and percentage of survival in each treatment condition . Positive values are highlighted in red while negative correlations in green . Statistics : * = p < 0 , 05 Results and Discussion 201 (cid:2) As results show , for each treatment there is a discrete set of genes that signiﬁcantly correlates with the responsiveness to the drug . Since we represent percentage of survival versus gene expression , a positive value means that the expression of the gene is correlated with resistance to the treatment . On the contrary , a negative value means the expression of the gene is correlated with sensitivity to the treatment . (cid:2) In the case of paclitaxel , there are 11 genes ( OCT1 , ENT2 , CNT3 , TKI , RRMI , UMPS , UCK2 , XIAP , AQP3 , ENT3 and MYC ) whose expression would be associated to sensitivity of the cell to the treatment . Interestingly , 9 of these genes ( all except AQP3 and ENT3 ) belong to the previous network described in ﬁgure 55 . There are also 4 genes ( ABCG2 , ENT4 , EPHX1 and ATP7B ) that correlate with resistance to the treatment . There is no apparent reason to justify why these genes would determine the cell response to this drug since most of they are nucleoside - related genes , like enzymes from the nucleot ( s ) ide metabolism and also some transporters , and paclitaxel is not a nucleoside - derived drug . However , based on our previous speculations about the existence of a putative global network , these genes would be linked to the expression of other genes , not identiﬁed in this study , which might be directly responsible of the cell response to that speciﬁc treatment . Therefore , if these correlations were conﬁrmed in further studies , we could deﬁne a set of genes as markers / predictors for treatment responsiveness . (cid:2) Another example illustrated here is the case of cisplatin , where 4 genes are correlated with sensitivity to the treatment ( AQPs , ABCG2 , ENT4 and CNT1 ) and 9 other genes correlate with resistance to that drug ( MVP . GCLC , OCTN2 , ABCC1 , EPHX1 , UGTx , TYMP , KEAP1 and MLH1 ) . Also in that case we cannot ﬁnd a plausible reason to justify the correlation between the expression of these genes and the cell response to cisplatin . Interestingly , the genes found for cisplatin are totally different than the ones obtained for the response to paclitaxel treatment . Novel approaches to understanding hENT2 and hENT2 - related proteins 202 F i gu r e 57 . C a r t oo n r e p r ese n t i ng g e n es w i t h a s i gn i ﬁ ca n t c o rr e l a t i o n t o ce ll r es pon s i ve n ess t o p ac li t axe l t r ea t m e n t . G ene s h i gh li gh t ed i n pu r p l e po s i t i v e l y c o rr e l a t e w i t h c e ll s en s i t i v i t y t o t he t r ea t m en t . G ene s h i gh li gh t ed i n y e ll o w po s i t i v e l y c o r r e l a t e w i t h c e ll r e s i s t an c e t o t he t r ea t m en t . G S H S y n t h e s i s G C L C F o l a t e C y c l e F P G S M V P ? ? N P C N r f 2 K E A P 1 T O P 1 N T C u + + G S H G C L C C u + + O C T 1 O A T P ’ s E N T 2 C N T 3 A Q P 3 A B C G 2 C T R 1 A T P 7 B M M P ’ s G F E G F R K I T S C F P D G F R A G F F A S T N F ? ? ? ? N T M e t a b o li s m T Y M P U PP 1 T K 1 RR M 1 U M P S U C K 2 D C K T Y M S D P Y D C F L A R I A P F a m il y B I R C 2 B I R C 5 X I A P B I R C 7 T O P 2 A P 21 U D G M L H 1 P M S 2 M S H 2 M S H 6 E R CC 1 X P A X P C D I A B L O G A DD 45 B A X B C L - 2 N r f 2 M Y C ⊕ C y t o p r o t e c t i v e R e s p o n s e ( G C L C ) ⊕ G r o w t h A rr e s t - U p r e g u l a t e d b y D N A - D a m ag e D N A M i s m a t c h R e p a i r N E R T I G A R ⊗ G l yc o li s i s ⊗ R O S a n d A p o p t o s i s E P H X 1 U G T x D e t o x i ﬁ c a t i o n ⊕ B r e a k d o w n o f e x t r a c e ll u l a r m a t r i x ⊗ A p o p t o s i s - ⊗ C a s p a s e s A c t i v a t i o n - S u r v i v i n - ⊗ F a s a n d B a x - L i v i n - ⊕ S y n t h e s i s / R e p a i r D N A - ⊕ C e ll D i v i s i o n & P r o li f e r a t i o n ⊗ ⊗ A p o p t o s i s ⊕ A p o p t o s i s - ⊕ C e ll P r o li f e r a t i o n & S u r v i v a l - ⊕ D N A S y n t h e s i s ⊕ A p o p t o s i s E N T 3 P a c li t a x e l D E A T H S U RV I V A L E N T 4 Results and Discussion 203 G S H S y n t h e s i s G C L C F o l a t e C y c l e F P G S M V P ? ? N P C N r f 2 K E A P 1 T O P 1 N T C u + + G S H G C L C C u + + O C T N 2 O A T P ’ s E N T ’ s C N T 1 A B C G 2 C T R 1 A T P 7 ’ s M M P ’ s G F E G F R K I T S C F P D G F R A G F F A S T N F ? ? ? ? N T M e t a b o li s m T Y M P U PP 1 T K 1 RR M 1 U M P S U C K 2 D C K T Y M S D P Y D C F L A R I A P F a m il y B I R C 2 B I R C 5 X I A P B I R C 7 T O P 2 A P 21 U D G M L H 1 P M S 2 M S H 2 M S H 6 E R CC 1 X P A X P C D I A B L O G A D D 45 B A X B C L - 2 N r f 2 M Y C ⊕ C y t o p r o t e c t i v e R e s p o n s e ( G C L C ) ⊕ G r o w t h A rr e s t - U p r e g u l a t e d b y D N A - D a m ag e D N A M i s m a t c h R e p a i r N E R T I G A R ⊗ G l yc o li s i s ⊗ R O S a n d A p o p t o s i s E P H X 1 U G T x D e t o x i ﬁ c a t i o n ⊕ B r e a k d o w n o f e x t r a c e ll u l a r m a t r i x ⊗ A p o p t o s i s - ⊗ C a s p a s e s A c t i v a t i o n - S u r v i v i n - ⊗ F a s a n d B a x - L i v i n - ⊕ S y n t h e s i s / R e p a i r D N A - ⊕ C e ll D i v i s i o n & P r o li f e r a t i o n ⊗ ⊗ A p o p t o s i s ⊕ A p o p t o s i s - ⊕ C e ll P r o li f e r a t i o n & S u r v i v a l - ⊕ D N A S y n t h e s i s ⊕ A p o p t o s i s C P t D E A T H A B C C 1 E N T 4 S U RV I V A L A Q P 3 / 5 F i gu r e 58 . C a r t oon r e p r ese n t i ng g e n es w i t h a s i gn i ﬁ ca n t c o rr e l a t i on t o ce ll r es pon s i ve n ess t o c i s p l a t i n t r ea t m e n t . G ene s h i gh li gh t ed i n pu r p l e po s i t i v e l y c o rr e l a t e w i t h c e ll s en s i t i v i t y t o t he t r ea t m en t . G ene s h i gh li gh t ed i n y e ll o w po s i t i v e l y c o rr e l a t e w i t h c e ll r e s i s t an c e t o t he t r ea t m en t . Novel approaches to understanding hENT2 and hENT2 - related proteins 204 18 . 5 DISCUSSION (cid:2) There is wide variability in the response of individuals to standard doses of drug therapy . This is an important problem in clinical practice , where it can lead to therapeutic failures or adverse drug events . Polymorphisms and different expression levels in genes coding for metabolising enzymes and drug transporters can affect drug efﬁcacy and toxicity . Pharmacogenetics aims to identify individuals predisposed to high risk of toxicity and low response from standard doses of anticancer drugs . Therefore , measurement of transporter and drug metabolising enzyme genes may prove useful in predicting anticancer drug response ( Y . Huang et al . 2004 ; Bosch 2008 ) (cid:2) Drug metabolising enzymes are proteins that catalyse the biochemical modiﬁcations of xenobiotics ( e . g . drugs ) and endogenous chemicals ( e . g . hormones , neurotransmitters ) . Broadly , drug metabolising enzymes are divided into two categories : Phase I ( functionalising ) enzymes that introduce or remove functional groups in a substrate through oxidation , reduction , or hydrolysis ; and Phase II ( conjugating ) enzymes that transfer moieties from a cofactor to a substrate . Essentially all of the major human metabolising enzymes exhibit genetic polymorphisms at the genomic level or variable expression levels , and many of these enzymes have clinically relevant genetic polymorphisms . A gene is considered to be polymorphic when the frequency of a variant allele in a speciﬁc population is at least 1 % . ( Evans & Relling 1999 ; Bluth & J . Li 2011 ) . (cid:2) Membrane transporters play a critical role in drug response as they provide the targets for many commonly used drugs and are major determinants of drug absorption , distribution , and elimination . Most of them belong to one of the two major super - families of membrane transport proteins , the ATP - binding cassette ( ABC ) transporters , and the solute carrier ( SLC ) transporters . They are subject to both genotypic and phenotypic polymorphisms , and variation in drug transporters may be the reason for inter - individual variability in pharmacokinetic disposition , efﬁcacy , and toxicity of drug transporter substrates ( Benjeddou 2010 ; Y . Huang et al . 2004 ; V . H . Lee et al . 2001 ) . Results and Discussion 205 (cid:2) The solute carrier ( SLC ) superfamily of transporters consists of more than 300 members subdivided into 47 families . They are expressed in most tissues , but primarily in the liver , lung , kidney , and intestine . Most solute carrier transporters are localised at either the basolateral or apical plasma membrane of polarised cells , but some are expressed in mitochondria and other organelles ( Wojtal et al . 2009 ) . Typical SLC transporters consist of several trans - membranes α - helices connected by intra - and extracellular loops and function as either monomers or hetero - or homodimers ( Wojtal et al . 2009 ) . SLC transporters are membrane - associated transporters that facilitate the passage of solutes , including peptides , bile acids , amino acids , ions , xenobiotics , drugs , and other biologically active compounds , across cell membranes in epithelial tissues , such as intestine and liver ( Hediger et al . 2004 ; Koepsell et al . 2007 ) . In the intestine , SLCs are critically involved in drug absorption , thus determining distribution and pharmacokinetic characteristics of many drugs ( Meier et al . 2007 ) . (cid:2) The new era of personalised medicine , which integrates the uniqueness of an individual with respect to the pharmacokinetics and pharmacodynamics of a drug , holds promise as a means to provide greater safety and efﬁcacy in drug design and development . Personalised medicine is particularly important in oncology , whereby most clinically used anticancer drugs have a narrow therapeutic window and exhibit a large interindividual pharmacokinetic and pharmacodynamic variability . This variability can be explained , at least in part , by genetic variations in the genes encoding drug metabolising enzymes , transporters , or drug targets . Understanding of how genetic variations inﬂuence drug disposition and action could help in tailoring cancer therapy based on individualʼs genetic makeup . The growing number of publications reporting genetic population data for the solute carrier transporters in particular shows their importance , as well as the increased interest in investigating them in most recent pharmacogenetics / genomics research projects ( Bluth & J . Li 2011 ; Benjeddou 2010 ) . (cid:2) An overview picture of the gene clusters here identiﬁed would suggest that genes encoding broad selectivity NT transporters positively correlate with nucleos ( t ) ide metabolism related genes , selected growth factor receptors , DNA MMR system and IAP family members , together with some other genes ( FPGS , KEAP1 , MYC and Novel approaches to understanding hENT2 and hENT2 - related proteins 206 TOP1 ) , they all providing a general framework for cell survival and proliferation . Some other transporter proteins belonging to the SLC22 and SLCO families show very consistent correlations , either positive or negative thus suggesting they might play roles in these events , however the rationale for that will require further analysis . Correlations within clusters are statistically very consistent and it is highly likely that they deﬁne particular cell phenotypes , probably implicated in cell survival and proliferation , as discussed above . (cid:2) In fact , the concept of a global network connecting different pathways has been previously developed , specially in yeast , where a global network governing DNA integrity was identiﬁed including 16 functional modules like DNA replication , oxidative stress response or DNA repair , all of them being essential for efﬁcient repair of the endogenous DNA damage and cell survival ( Pan et al . 2006 ) . Subsequent studies compiled extensive experimental data in yeast and human models and performed an even wider gene association , where genes involved in regulation of nucleotide metabolism and DNA repair stood out as the most solid related pathways by both natural and synthetic connections ( Hannum et al . 2009 ; Conde - Pueyo et al . 2009 ) . (cid:2) Going one step further , we analyzed possible master genes that could regulate or connect somehow all these different modules or mini - pathways among them , closing this global network as a whole . One potential candidate was Protein Kinase C ( PKC ) , at least as a meeting point for most of them . (cid:2) PKC is a family of phospholipid - dependent serine / threonine kinases that regulate a wide variety of cellular functions . The PKC family consists of at least eleven members that have been categorised into three groups based on their structure and biochemical properties . Conventional or cPKCs ( α , βI , βII and γ ) require Ca 2 + and diacylglycerol ( DAG ) for their activation . Novel or nPKCs ( δ , ε , η and θ ) are dependent on DAG but not Ca 2 + whereas atypical or aPKCs ( ζ and λ / ι ) are independent of both Ca 2 + and DAG ( Basu & Sivaprasad 2007 ) . Various PKC isozymes are present in the same cell and mediate speciﬁc functions , some of them being capable to phosphorylate the same protein substrate ( Totoń et al . 2011 ) . However , PKCε is the Results and Discussion 207 only PKC isozyme that has been associated with oncogenesis , behaving as an oncoprotein and is believed to function as an antiapoptotic protein . Such a way that PKCε contribution to oncogenesis is not only by inducing disordered cell growth but also by inhibiting cell death ( Basu & Sivaprasad 2007 ) . (cid:2) Numerous cellular activities are modulated by PKCε interaction with cytoskeletal structures , including migration and adhesion , proliferation and differentiation . Gene expression , transport mechanisms , inﬂammation and immunity and secretory functions are also affected by PKCε - mediated mechanisms ( Figure 59 ) ( Totoń et al . 2011 ) . One of those mechanisms to regulate cell proliferation is via activation of Ras / Raf - 1 pathway acting downstream of Ras but upstream of Raf - 1 , remaining unclear if it exists a direct phosphorylation , and also at some other points of this cascade . On the other hand , PKCε involvement in NF - kB activation develops a key role in differentiation and regulation of apoptosis , together with the ERKs / MAPKs cascade activation . (cid:2) Growth factor tyrosine kinase receptors , including EGFR and PDGFR , once bounded to their ligands , trigger a signalling cascade that leads to activation of transcription and translation of genes involved in proliferation , increasing growth activity . Precisely , signalling pathways activated by RTK stimulation include the Ras / Raf / MAPK pathway , the PLCγ / PKC pathway , PI3K / Akt , and Src family tyrosine kinases ( Besson & Yong 2001 ) . In fact , it has been reported that PKCε could activate both indirectly and directly phosphorylating Akt , promoting cell survival . Even more , the PKCε - Akt complex could crosstalk with a third pathway to mediate antiapoptotic effects ( Basu & Sivaprasad 2007 ) . (cid:2) Novel approaches to understanding hENT2 and hENT2 - related proteins 208 N T O C T 1 E N T 1 O A T P 1 B 1 O A T P 2 B 1 G F E G F R P D G F R A G F N r f 2 K E A P 1 U D G M L H 1 P M S 2 M S H 2 M S H 6 N r f 2 M Y C ⊕ C h e m o r e s i s t a n c e D N A M i s m a t c h R e p a i r I A P F a m il y B I R C 2 B I R C 5 X I A P B I R C 7 B A , T 3 , P r o s t , E s t r o g e n - S B ili r u b i n , E s t r a d i o l , C 4 S t e r o i d s - S P K C P L C γ D A G / C a 2 + ⊕ ⊕ P S r c ⊕ S t r e ss Exp o s u r e P I 3 K P D K 1 A k t A d h e s i o n / m o t ili t y R A C K 1 E R K s / M A P K s R a s / R a f - 1 P r o li f e r a t i o n C h e m o / U V R e s i s t a n c e ⊕ ⊕ R e g u l a t i o n o f A p o p t o s i s E G F R P ⊕ C e ll S u r v i v a l N F - κ B D i ff e r e n t i a t i o n ⊕ ⊕ ⊕ ⊕ ⊕ P P ⊕ ⊗ M S H 2 M S H 6 P P P P ⊕ P ⊕ P M Y C ⊕ P P ⊕ P r o li f e r a t i o n P E 2 P E 2 ⊕ F i gu r e 59 . C a r t oon r e p r ese n t i n g a no ve l n e t w o r k c onn ec t e d t o P KC . R ep r e s en t a t i on o f t he g l oba l ne t w o r k i n v o l v ed i n c e ll s u r v i v a l and p r o li f e r a t i on and t he r o l e o f PK C r egu l a t i ng and c onne c t i ng t he d i ff e r en t m i n i - pa t h w a ys t ha t c o m po s e i t . C o l o r ed gene s w e r e f ound t o be c o rr e l a t ed i n ou r t r an sc r i p t o m i c s t ud y . G ene s i n r ed ha v e a po s i t i v e c o rr e l a t i on a m on g t he m . G ene s i n g r een ha v e nega t i v e c o rr e l a t i on s r e s pe c t t o t he gene s c o l o r ed i n r e d . PK C s ee m s t o be a c o mm on e l e m en t t ha t m i gh t e s t a b li s h a g l oba l c onne c t i on i n s i de t he ne t w o r k . Results and Discussion 209 (cid:2) Being EGFR and PDGFRA members of the same family and activating , in principle , the same kind of pathways , might not be easy to understand the rationale for the inverse correlation of those RTK with PKC shown in our results . A possible explanation could be , on one hand , EGFR PKC - mediated phosphorylation stabilises ligand - receptor interactions and results in intensiﬁcation of EGFR signalling ( Gulliford et al . 1999 ) . Furthermore , it has been recently described that this phosphorylation is also a key step in Src - mediated translocation of EGFR to the nucleus , where it induces the transcription of genes essential for cell survival after stress exposure ( Dittmann et al . 2009 ) . On the other hand , different biochemical events are initiated by PDGF depending on the cell stage ( Jones & Kazlauskas 2001 ) . PDGF activates PKC at two different times and these two intervals of PKC activity make unequal contributions to the mitogenic response ( Balciunaite et al . 2000 ) in a way that progression into phase S can be promoted or inhibited depending on the time when PKC is activated ( W . Zhou et al . 1993 ) . Ambiguous role of PDGF - mediated PKC activation and the multiple implications of EGFR in survival and cell proliferation might explain why the ﬁrst one is negatively correlated with those gene clusters , whereas the second one is positively correlated with the global network apparently focused on proliferation and cell survival . (cid:2) Inhibitors of apoptosis protein ( IAP ) family members can bind and potently inhibit the proteolytic activities of some caspases and block their activation , and thus prevent apoptosis induced by TNF . In addition , IAPs have diverse functions in signal transduction , independently of caspase inhibition , like playing a complex role in modulating the signalling pathways that activate NF - kB transcription factors promoting cell survival ( Plati et al . 2011 ; Altieri 2010 ) . In turn , it has been shown that c - IAP2 expression is upregulated by PKC in PMA - mediated induction ( Q . Wang et al . 2003 ) and also by activating Akt via PI3K - dependent signalling ( Sade & Sarin 2003 ) , thus completing a complex system of reciprocal regulation . (cid:2) Members of the DNA MMR system are also closely regulated by PKC . It has been reported a correlation between PKC activity and MMR protein expression and activity ( Humbert et al . 2002 ) , consistent with our results of mRNA expression levels . Furthermore , it has been demonstrated a direct interaction between PKC and hMSH2 Novel approaches to understanding hENT2 and hENT2 - related proteins 210 and hMSH6 and their consequent phosphorylation ( Hernandez - Pigeon et al . 2005 ) , in such a manner that hMutSα , a protein complex formed by hMSH2 and hMSH6 , increases its stability and is translocated into the nucleus ( Christmann et al . 2002 ) (cid:2) Genes like KEAP1 or c - Myc , that appeared to be positively correlated with gene clusters of our study , have their own connection with PKC . In the case of KEAP1 , PKC directly phosphorylates the transcription factor Nrf2 while bound to KEAP1 , promoting their dissociation and Nrf2 translocation into the nucleus in response to oxidative stress ( H . C . Huang 2002 ; Niture et al . 2010 ) . Regarding c - Myc , an oncogenic transcription factor , a recent study demonstrated how Prostaglandin E2 ( an OCT1 substrate ) , increased the mRNA and protein expression of c - Myc and its nuclear accumulation via phosphorylation in a ERK - dependent manner , post PKC activation ( L . Yu et al . 2009 ) . (cid:2) Concerning transporter membrane proteins , several studies described how they are generally regulated by different kinases , including PKC , but probably never being linked to a global network of proliferation and cell survival . In the particular case of ENT1 , it was proved that an acute stimulation of PKC causes a rapid increase in hENT1 nucleoside uptake in a manner which is PKC δ or ε - dependent ( Coe et al . 2002 ) . Most recently , this group also demonstrated , for the same time , a directly phosphorylation of ENT1 by PKC ( Reyes et al . 2011 ) . Similarly , OCT1 is stimulated by PKC - dependent phosphorylation ( Ciarimboli 2005 ; Mehrens et al . 2000 ) , despite a direct interaction between the transporter and the kinase has not been proved yet . In contrast , OATP1B1 / 2B1 transporter activity is downregulated by PKC but not by direct phosphorylation , but in a PKC - mediated clathrin - dependent internalization and followed by lysosomal degradation ( Köck et al . 2010 ; Guo & Klaassen 2001 ) . (cid:2) In conclusion , in this study we present a potential global network , which encompasses genes from several modules some of them have not been related before , with the general purpose of promoting cell survival and proliferation . This network would probably be connected / modulated through PKC and its different mechanisms of regulation ( ﬁgure 59 ) . In addition , this is the ﬁrst time such idea is Results and Discussion 211 raised in a human model with the particularity to include key membrane transporters , considering their role far beyond than mere substrate transporters . Finally , further analysis should be performed in order to understand more in depth how this system is regulated and , over all , how it could be applied in future strategies against cancer . (cid:2) Regarding the correlation between gene expression and cell response to a speciﬁc treatment , results obtained to date anticipate the existence of sets of genes whose expression correlate with chemosensitivity , in a manner which appears to be independent of the origin of the cell line , thus proving to be probable common predictors of digestive cancer chemotherapy . However , further studies need to be done to validate these results and deﬁne a reliable set of chemotherapy responsiveness predictors . Novel approaches to understanding hENT2 and hENT2 - related proteins 212 (cid:2) As previously explained , hENT2 is the human nucleoside transporter for which most splice variants have been described to date , in contrast to hENT1 for which no variants have been reported yet . In this dissertation , we have identiﬁed 3 novel splice variants of hENT2 which encode 2 novel nuclear isoforms of this transporter protein . As we demonstrated , these variants appear to be functional and ubiquitously expressed among cell lines and tissues , although the pattern of expression levels may vary depending on the growth conditions and the cellular needs . (cid:2) The physiological role of these novel nuclear variants of hENT2 still remains unclear , since there is no evidence of the presence of the nucleoside salvage pathway inside the nucleus . If that would be eventually the case , the presence of nucleoside transporters at the nuclear membrane might not have any relevant meaning . Nonetheless , based on the protein - protein interactions obtained from the screening with MYTH technique , other functional implications might be coming up . (cid:2) On one hand , nuclear variants of hENT2 could be involved in alternative splicing regulation , since they appeared to interact with several splicing factors . As we proved , hENT2 splicing patterns vary depending upon growth conditions , suggesting the existence of a regulation ( or even a self - regulation ) mechanism of the splicing phenomenon . Several proteins have been previously described as self - regulators of alternative splicing ( Sureau et al . 2001 ; Sun et al . 2010 ; de Morree et al . 2012 ) . In this dissertation we propose the hypothesis of HNP32 and HNP36 proteins , localised at the nuclear membrane , interacting with splice regulation factors and modulating their availability to bind pre - mRNA , thus determining the splice sites recognised by the spliceosome . In such a way , hENT2 itself would regulate the ratio between the wt isoform and the nuclear variants to adapt itself to the cellular situation . (cid:2) On the other hand , there is the possibility that HNP32 and HNP36 would function as nuclear translocators of small peptides or carriers . In fact , the nuclear internalization of a drug vehicle used in therapy via hENT2 has been reported ( Hansen et al . 2007 ) . In our results , we found several putative interactions between hENT2 and proteins involved in mRNA export to the cytosol . Although this hypothesis comes from General Discussion 215 our speculations of the results obtained by MYTH , we consider the necessity of a deeper study on the transport capacity of the hENT2 nuclear variants and their potential role in alternative splicing regulation . (cid:2) Among the PPI obtained from the MYTH screening , several proteins were kinases and phosphatases , outstanding the case of protein phosphatase 1 ( PP1 ) . This protein is well known to regulate alternative splicing phenomena by phosphorylation ( Novoyatleva et al . 2008 ; Stamm 2008 ) , coinciding with our proposal of HNP32 and HNP36 as alternative splicing self - regulators . In addition , PP1 could also participate in the hENT2 wt regulation by phosphorylation . (cid:2) According to our in vitro phosphorylation assays , hENT2 could be phosphorylated by CKII inside the cell . CKII is a kinase that appears to be unregulated because it is constitutively active . Therefore , it has been suggested that changes in the phosphorylation status of CKII substrates would depend on regulated dephosphorylation ( Pinna 1990 ) . Considering the putative interaction between hENT2 and PP1 , we propose a possible regulation of hENT2 by phosphorylation , where the transporter would be phosphorylated by default and regulation would come by dephosphorylation via PP1 . Actually , considering our biotinylation results where we found a double band at 54 KDa , the supposed phosphorylated protein would remain intracellular while the supposed non - phosphorylated protein would be active at the plasma membrane . (cid:2) Although we could not demonstrate a direct in vitro phosphorylation of hENT2 by PKC , this kinase appears to be involved in hENT2 trafﬁcking regulation . Activation of PKC promotes hENT2 trafﬁcking to the plasma membrane although it does not necessarily entails an increase of hENT2 - related transport activity . Actually , the clear consequence of the hENT2 translocation to the plasma membrane is a signiﬁcant decrease on hENT1 activity . These observations coincide with the fact that hENT1 and hENT2 appear to have a ﬁne opposite regulated transport activity ( Aguayo et al . 2005 ) . As a consequence , an increase of hENT2 presence at the plasma membrane supposes a downregulation on hENT1 activity . Novel approaches to understanding hENT2 and hENT2 - related proteins 216 (cid:2) GLUT - 4 has been described to have a dual population at the plasma membrane , where some of the proteins are active while the others are not functional ( Funaki et al . 2004 ) . Considering all the results obtained from the phosphorylation and biotinylation assays we performed , we propose the theory of a dual population of hENT2 proteins at the plasma membrane . One non - phosphorylated hENT2 isoform of 54 KDa could be related with transport activity , while another isoform of 45 KDa would not be active as a transporter , despite being present at the plasma membrane . Similarly , two different kinds of regulation by phosphorylation would affect hENT2 function , either regulating its trafﬁcking to the plasma membrane via PKC , or activating its function as a nucleoside transporter via PP1 . These two putative pathways of regulation would not necessarily be independent of each other . (cid:2) (cid:2) Finally , our transcriptomic analysis of gastro - hepatic cell lines allowed us to place hENT2 within a global gene network involved in cell proliferation and survival . PKC appeared to be a possible central point of regulation of that network , coordinating a global response of the cell to the growth and environmental conditions . In addition , part of that novel network , including hENT2 , could be involved in response to paclitaxel treatment . As we understand , a positive response to the therapy would not be determined by the hENT2 role as a transporter , but by the context of this network connecting several genes involved in proliferation and cell survival . Further studies need to be developed in order to validate those genes as potential response predictors . General Discussion 217 1 . We have identiﬁed 3 novel splice variants of hENT2 which encode 2 novel nuclear isoforms of the transporter . These variants appear to be functional and ubiquitously expressed among cell lines and tissues . 2 . hENT2 is in vitro phosphorylated by CKII . Since CKII is constitutively active , hENT2 could be regulated by dephosphorylation via PP1 . 3 . Activation of PKC by PDD treatment promotes hENT2 trafﬁcking to the plasma membrane in HEK - 293 cells , at the same time that it decreases hENT1 transport activity . 4 . hENT2 could have a dual population at the plasma membrane . One non - phosphorylated hENT2 isoform of 54 KDa could be related with transport activity , while another isoform of 45 KDa would not be active as a transporter , despite being present at the plasma membrane . 5 . We deﬁned a novel global gene network apparently involved in cell proliferation and survival . ENT1 , ENT2 and CNT3 are part of this network , where PKC could play a central role as a regulator . 6 . ENT2 , together with some other genes involved in cell proliferation and survival , negatively correlate to cell survival as a response to paclitaxel treatment in gastro - hepatic cell lines . Conclusions 221 A Abdulla , P . & Coe , I . R . , 2007 . Characterization and functional analysis of the promoter for the human equilibrative nucleoside transporter gene , hENT1 . Nucleosides , Nucleotides and Nucleic Acids , 26 ( 1 ) , pp . 99 – 110 . Acimovic , Y . & Coe , I . R . , 2002 . Molecular evolution of the equilibrative nucleoside transporter family : identiﬁcation of novel family members in prokaryotes and eukaryotes . Molecular biology and evolution , 19 ( 12 ) , pp . 2199 – 2210 . Aggen , J . B . , Nairn , A . C . & Chamberlin , R . , 2000 . Regulation of protein phosphatase - 1 . Chemistry & biology , 7 ( 1 ) , pp . R13 – 23 . Aguayo , C . et al . , 2005 . Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium , but is not involved in the inhibition of adenosine transport induced by hyperglycaemia . Placenta , 26 ( 8 - 9 ) , pp . 641 – 653 . Al - Ayoubi , A . M . et al . , 2012 . Mitogen - Activated Protein Kinase Phosphorylation of Splicing Factor 45 ( SPF45 ) Regulates SPF45 Alternative Splicing Site Utilization , Proliferation , and Cell Adhesion . Molecular and cellular biology , 32 ( 14 ) , pp . 2880 – 2893 . Altieri , D . C . , 2010 . Survivin and IAP proteins in cell - death mechanisms . The Biochemical journal , 430 ( 2 ) , pp . 199 – 205 . Aly , A . S . I . et al . , 2010 . Subpatent infection with nucleoside transporter 1 - deﬁcient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice . Cellular microbiology , 12 ( 7 ) , pp . 930 – 938 . Amanchy , R . et al . , 2007 . A curated compendium of phosphorylation motifs . Nature biotechnology , 25 ( 3 ) , pp . 285 – 286 . Angelakos , E . T . & Glassman , P . M . , 1961 . Cardiovascular action of adenosine and other nucleosides . Proceedings of the Society for Experimental Biology and Medicine . Society for Experimental Biology and Medicine ( New York , N . Y . ) , 106 , pp . 762 – 763 . Arastu - Kapur , S . et al . , 2005 . Second - site suppression of a nonfunctional mutation within the Leishmania donovani inosine - guanosine transporter . The Journal of biological chemistry , 280 ( 3 ) , pp . 2213 – 2219 . Bibliography 225 Aridor , M . & Traub , L . M . , 2002 . Cargo selection in vesicular transport : the making and breaking of a coat . Trafﬁc ( Copenhagen , Denmark ) , 3 ( 8 ) , pp . 537 – 546 . Aymerich , I . et al . , 2006 . Extracellular adenosine activates AMP - dependent protein kinase ( AMPK ) . Journal of cell science , 119 ( Pt 8 ) , pp . 1612 – 1621 . Aymerich , I . et al . , 2005 . The concentrative nucleoside transporter family ( SLC28 ) : new roles beyond salvage ? Biochemical Society transactions , 33 ( Pt 1 ) , pp . 216 – 219 . B Balciunaite , E . et al . , 2000 . PDGF initiates two distinct phases of protein kinase C activity that make unequal contributions to the G0 to S transition . Current biology : CB , 10 ( 5 ) , pp . 261 – 267 . Baldwin , S . A . et al . , 2005 . Functional characterization of novel human and mouse equilibrative nucleoside transporters ( hENT3 and mENT3 ) located in intracellular membranes . The Journal of biological chemistry , 280 ( 16 ) , pp . 15880 – 15887 . Baldwin , S . A . et al . , 1999 . Nucleoside transporters : molecular biology and implications for therapeutic development . Molecular medicine today , 5 ( 5 ) , pp . 216 – 224 . Baliova , M . , Betz , H . & Jursky , F . , 2004 . Calpain - mediated proteolytic cleavage of the neuronal glycine transporter , GlyT2 . Journal of neurochemistry , 88 ( 1 ) , pp . 227 – 232 . Balnave , K . et al . , 1981 . Observation on the efﬁcacy and pharmacokinetics of betaxolol ( SL 75212 ) , a cardioselective beta - adrenoceptor blocking drug . British journal of clinical pharmacology , 11 ( 2 ) , pp . 171 – 180 . Balse , E . et al . , 2009 . Cholesterol modulates the recruitment of Kv1 . 5 channels from Rab11 - associated recycling endosome in native atrial myocytes . Proceedings of the National Academy of Sciences of the United States of America , 106 ( 34 ) , pp . 14681 – 14686 . Bardenheuer , W . et al . , 2005 . Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells . Leukemia : ofﬁcial journal of the Leukemia Society of America , Leukemia Research Fund , UK , 19 ( 12 ) , pp . 2281 – 2288 . Novel approaches to understanding hENT2 and hENT2 - related proteins 226 Barlowe , C . , 1998 . COPII and selective export from the endoplasmic reticulum . Biochimica et biophysica acta , 1404 ( 1 - 2 ) , pp . 67 – 76 . Barnes , K . et al . , 2006 . Distribution and functional characterization of equilibrative nucleoside transporter - 4 , a novel cardiac adenosine transporter activated at acidic pH . Circulation Research , 99 ( 5 ) , pp . 510 – 519 . Basu , A . & Sivaprasad , U . , 2007 . Protein kinase Cepsilon makes the life and death decision . Cellular signalling , 19 ( 8 ) , pp . 1633 – 1642 . Bauer , P . M . et al . , 2003 . Compensatory phosphorylation and protein - protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric - oxide synthase . The Journal of biological chemistry , 278 ( 17 ) , pp . 14841 – 14849 . Beal , P . R . et al . , 2004 . The equilibrative nucleoside transporter family , SLC29 . Pﬂ gers Archiv European Journal of Physiology , 447 ( 5 ) , pp . 735 – 743 . Benjeddou , M . , 2010 . Solute carrier transporters : Pharmacogenomics research opportunities in Africa . African Journal of Biotechnology , 9 ( 54 ) , pp . 9191 – 9195 . Bennett , E . R . & Kanner , B . I . , 1997 . The membrane topology of GAT - 1 , a ( Na + + Cl - ) - coupled gamma - aminobutyric acid transporter from rat brain . The Journal of biological chemistry , 272 ( 2 ) , pp . 1203 – 1210 . Berggård , T . , Linse , S . & James , P . , 2007 . Methods for the detection and analysis of protein - protein interactions . Proteomics , 7 ( 16 ) , pp . 2833 – 2842 . Besson , A . & Yong , V . W . , 2001 . Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas . Journal of neuro - oncology , 51 ( 3 ) , pp . 245 – 264 . Bi , X . , Corpina , R . A . & Goldberg , J . , 2002 . Structure of the Sec23 / 24 - Sar1 pre - budding complex of the COPII vesicle coat . Nature , 419 ( 6904 ) , pp . 271 – 277 . Bielli , A . et al . , 2005 . Regulation of Sar1 NH2 terminus by GTP binding and hydrolysis promotes membrane deformation to control COPII vesicle ﬁssion . The Journal of cell biology , 171 ( 6 ) , pp . 919 – 924 . Biswas , A . et al . , 2011 . Opposing Action of Casein Kinase 1 and Calcineurin in Nucleo - cytoplasmic Shuttling of Mammalian Translation Initiation Factor eIF6 . Journal of Biological Chemistry , 286 ( 4 ) , pp . 3129 – 3138 . Bibliography 227 Black , D . L . , 2003 . Mechanisms of alternative pre - messenger RNA splicing . Annual review of biochemistry , 72 , pp . 291 – 336 . Bluth , M . & Li , J . , 2011 . Pharmacogenomics of drug metabolizing enzymes and transporters : implications for cancer therapy . Pharmacogenomics and Personalized Medicine , p . 11 . Boleti , H . et al . , 1997 . Molecular identiﬁcation of the equilibrative NBMPR - sensitive ( es ) nucleoside transporter and demonstration of an equilibrative NBMPR - insensitive ( ei ) transport activity in human erythroleukemia ( K562 ) cells . Neuropharmacology , 36 ( 9 ) , pp . 1167 – 1179 . Bone , D . B . J . et al . , 2007 . Differential regulation of mouse equilibrative nucleoside transporter 1 ( mENT1 ) splice variants by protein kinase CK2 . Molecular Membrane Biology , 24 ( 4 ) , pp . 294 – 303 . Bonifacino , J . S . & Glick , B . S . , 2004 . The mechanisms of vesicle budding and fusion . Cell , 116 ( 2 ) , pp . 153 – 166 . Bosch , T . M . , 2008 . Methods in Molecular Biology™ J . M . Walker & Q . Yan , eds . , Totowa , NJ : Humana Press . Bottalico , B . et al . , 2007 . The organic cation transporters ( OCT1 , OCT2 , EMT ) and the plasma membrane monoamine transporter ( PMAT ) show differential distribution and cyclic expression pattern in human endometrium and early pregnancy decidua . Molecular Reproduction and Development , 74 ( 10 ) , pp . 1303 – 1311 . Boulon , S . et al . , 2004 . PHAX and CRM1 Are Required Sequentially to Transport U3 snoRNA to Nucleoli . Molecular Cell , 16 ( 5 ) , pp . 777 – 787 . Boutz , P . L . et al . , 2007 . A post - transcriptional regulatory switch in polypyrimidine tract - binding proteins reprograms alternative splicing in developing neurons . Genes & development , 21 ( 13 ) , pp . 1636 – 1652 . Bracco , L . & Kearsey , J . , 2003 . The relevance of alternative RNA splicing to pharmacogenomics . Trends in biotechnology , 21 ( 8 ) , pp . 346 – 353 . Bressan , G . C . & Kobarg , J . , 2010 . From protein interaction proﬁle to functional assignment : the human protein Ki - 1 / 57 is associated with pre - mRNA splicing events . RNA biology , 7 ( 3 ) , pp . 268 – 271 . Novel approaches to understanding hENT2 and hENT2 - related proteins 228 Bressan , G . C . et al . , 2009 . Functional association of human Ki - 1 / 57 with pre - mRNA splicing events . FEBS Journal , 276 ( 14 ) , pp . 3770 – 3783 . Bronckaers , A . et al . , 2009 . The dual role of thymidine phosphorylase in cancer development and chemotherapy . Medicinal research reviews , 29 ( 6 ) , pp . 903 – 953 . Buck , T . M . , Eledge , J . & Skach , W . R . , 2004 . Evidence for stabilization of aquaporin - 2 folding mutants by N - linked glycosylation in endoplasmic reticulum . American journal of physiology . Cell physiology , 287 ( 5 ) , pp . C1292 – 9 . Butt , S . J . B . & Pitman , R . M . , 2005 . Indirect phosphorylation - dependent modulation of postsynaptic nicotinic acetylcholine responses by 5 - hydroxytryptamine . The European journal of neuroscience , 21 ( 5 ) , pp . 1181 – 1188 . C Cabrita , M . A . et al . , 2002 . Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes . Biochemistry and cell biology = Biochimie et biologie cellulaire , 80 ( 5 ) , pp . 623 – 638 . Cai , G . et al . , 2005 . The role of N - glycosylation in the stability , trafﬁcking and GABA - uptake of GABA - transporter 1 . Terminal N - glycans facilitate efﬁcient GABA - uptake activity of the GABA transporter . The FEBS journal , 272 ( 7 ) , pp . 1625 – 1638 . Cao , W . , Jamison , S . F . & Garcia - Blanco , M . A . , 1997 . Both phosphorylation and dephosphorylation of ASF / SF2 are required for pre - mRNA splicing in vitro . RNA ( New York , NY ) , 3 ( 12 ) , pp . 1456 – 1467 . Carneiro , A . M . et al . , 2002 . The multiple LIM domain - containing adaptor protein Hic - 5 synaptically colocalizes and interacts with the dopamine transporter . Journal of Neuroscience , 22 ( 16 ) , pp . 7045 – 7054 . Castro - Fernández , C . , Maya - Núñez , G . & Conn , P . M . , 2005 . Beyond the signal sequence : protein routing in health and disease . Endocrine reviews , 26 ( 4 ) , pp . 479 – 503 . Cerecedo , L . R . , 1927 . Studies on the Physiology of Pyrimidines . The Journal of biological chemistry , 75 , pp . 661 – 670 . Bibliography 229 Chakrabarti , S . & Freedman , J . E . , 2008 . Dipyridamole , cerebrovascular disease , and the vasculature . Vascular pharmacology , 48 ( 4 - 6 ) , pp . 143 – 149 . Chang , C . et al . , 2004 . Molecular requirements of the human nucleoside transporters hCNT1 , hCNT2 , and hENT1 . Molecular pharmacology , 65 ( 3 ) , pp . 558 – 570 . Chang , D . et al . , 2000 . Steady - state regulation of the human DNA mismatch repair system . Journal of Biological Chemistry , 275 ( 37 ) , p . 29178 . Chanrion , B . et al . , 2007 . Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity . Proceedings of the National Academy of Sciences of the United States of America , 104 ( 19 ) , pp . 8119 – 8124 . Chaudary , N . et al . , 2004 . The adenosine transporter , mENT1 , is a target for adenosine receptor signaling and protein kinase Cepsilon in hypoxic and pharmacological preconditioning in the mouse cardiomyocyte cell line , HL - 1 . The Journal of pharmacology and experimental therapeutics , 310 ( 3 ) , pp . 1190 – 1198 . Che , M . , Ortiz , D . F . & Arias , I . M . , 1995 . Primary structure and functional expression of a cDNA encoding the bile canalicular , purine - speciﬁc Na ( + ) - nucleoside cotransporter . The Journal of biological chemistry , 270 ( 23 ) , pp . 13596 – 13599 . Chen , C . - F . et al . , 2010a . Overlapping high - resolution copy number alterations in cancer genomes identiﬁed putative cancer genes in hepatocellular carcinoma . Hepatology ( Baltimore , Md ) , 52 ( 5 ) , pp . 1690 – 1701 . Chen , G . et al . , 2006 . Loss of N - linked glycosylation reduces urea transporter UT - A1 response to vasopressin . The Journal of biological chemistry , 281 ( 37 ) , pp . 27436 – 27442 . Chen , Y . L . , Eriksson , S . & Chang , Z . F . , 2010b . Regulation and Functional Contribution of Thymidine Kinase 1 in Repair of DNA Damage . Journal of Biological Chemistry , 285 ( 35 ) , pp . 27327 – 27335 . Cheng , D . et al . , 2007 . The Arginine Methyltransferase CARM1 Regulates the Coupling of Transcription and mRNA Processing . Molecular Cell , 25 ( 1 ) , pp . 71 – 83 . Cheong , J . K . , Gunaratnam , L . & Hsu , S . I . - H . , 2008 . CRM1 - mediated nuclear export is required for 26 S proteasome - dependent degradation of the TRIP - Br2 proto - oncoprotein . The Journal of biological chemistry , 283 ( 17 ) , pp . 11661 – 11676 . Novel approaches to understanding hENT2 and hENT2 - related proteins 230 Cherry , C . L . & Wesselingh , S . L . , 2003 . Nucleoside analogues and HIV : the combined cost to mitochondria . The Journal of antimicrobial chemotherapy , 51 ( 5 ) , pp . 1091 – 1093 . Cheung , J . C . & Reithmeier , R . A . F . , 2007 . Scanning N - glycosylation mutagenesis of membrane proteins . Methods ( San Diego , Calif . ) , 41 ( 4 ) , pp . 451 – 459 . Choi , D . - S . S . et al . , 2004 . The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference . Nature neuroscience , 7 ( 8 ) , pp . 855 – 861 . Chow , L . et al . , 2005 . Analysis of human equilibrative nucleoside transporter 1 ( hENT1 ) protein in non - Hodgkin ' s lymphoma by immunohistochemistry . Modern pathology : an ofﬁcial journal of the United States and Canadian Academy of Pathology , Inc , 18 ( 4 ) , pp . 558 – 564 . Christmann , M . , Tomicic , M . T . & Kaina , B . , 2002 . Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSalpha mismatch - binding activity . Nucleic acids research , 30 ( 9 ) , pp . 1959 – 1966 . Chu , S . et al . , 2012 . Regulation of adenosine levels during cerebral ischemia . Nature Publishing Group , pp . 1 – 7 . Ciarimboli , G . , 2005 . Individual PKC - Phosphorylation Sites in Organic Cation Transporter 1 Determine Substrate Selectivity and Transport Regulation . Journal of the American Society of Nephrology , 16 ( 6 ) , pp . 1562 – 1570 . Clarke , M . L . et al . , 2002 . The role of membrane transporters in cellular resistance to anticancer nucleoside drugs . Cancer treatment and research , 112 , pp . 27 – 47 . Coe , I . R . et al . , 2002 . PKC regulation of the human equilibrative nucleoside transporter , hENT1 . FEBS letters , 517 ( 1 - 3 ) , pp . 201 – 205 . Conde - Pueyo , N . et al . , 2009 . Human synthetic lethal inference as potential anti - cancer target gene detection . BMC Systems Biology , 3 ( 1 ) , p . 116 . C r a w f o r d , C . R . e t a l . , 1 9 9 8 . C l o n i n g o f t h e h u m a n e q u i l i b r a t i v e , nitrobenzylmercaptopurine riboside ( NBMPR ) - insensitive nucleoside transporter ei by functional expression in a transport - deﬁcient cell line . The Journal of biological chemistry , 273 ( 9 ) , pp . 5288 – 5293 . Bibliography 231 Cui , L . , Rajasekariah , G . R . & Martin , S . K . , 2001 . A nonspeciﬁc nucleoside hydrolase from Leishmania donovani : implications for purine salvage by the parasite . Gene , 280 ( 1 - 2 ) , pp . 153 – 162 . D Damaraju , V . L . et al . , 2003 . Nucleoside anticancer drugs : the role of nucleoside transporters in resistance to cancer chemotherapy . Oncogene , 22 ( 47 ) , pp . 7524 – 7536 . Das , S . et al . , 2012 . ONCOGENIC SPLICING FACTOR SRSF1 IS A CRITICAL TRANSCRIPTIONAL TARGET OF MYC . Cell reports , 1 ( 2 ) , pp . 110 – 117 . de Morree , A . et al . , 2012 . Self - regulated alternative splicing at the AHNAK locus . The FASEB journal : ofﬁcial publication of the Federation of American Societies for Experimental Biology , 26 ( 1 ) , pp . 93 – 103 . De Koning , H . P . et al . , 2003 . Identiﬁcation and characterisation of high afﬁnity nucleoside and nucleobase transporters in Toxoplasma gondii . International Journal for Parasitology , 33 ( 8 ) , pp . 821 – 831 . Deane , C . M . et al . , 2002 . Protein interactions : two methods for assessment of the reliability of high throughput observations . Molecular & cellular proteomics : MCP , 1 ( 5 ) , pp . 349 – 356 . del Santo , B . et al . , 1998 . Differential expression and regulation of nucleoside transport systems in rat liver parenchymal and hepatoma cells . Hepatology ( Baltimore , Md ) , 28 ( 6 ) , pp . 1504 – 1511 . Diaz - Font , A . & Beales , P . L . , 2008 . How to shape cells and inﬂuence polarized protein trafﬁcking . Developmental cell , 15 ( 6 ) , pp . 799 – 800 . Dittmann , K . , Mayer , C . & Rodemann , H . P . , 2009 . Nuclear EGFR as Novel Therapeutic Target . Strahlentherapie und Onkologie , 186 ( 1 ) , pp . 1 – 6 . Doyle , T . H . , Mornex , F . & McKenna , W . G . , 2001 . The clinical implications of gemcitabine radiosensitization . Clinical cancer research : an ofﬁcial journal of the American Association for Cancer Research , 7 ( 2 ) , pp . 226 – 228 . Draheim , V . et al . , 2010 . N - glycosylation of ABC transporters is associated with functional activity in sandwich - cultured rat hepatocytes . European journal of Novel approaches to understanding hENT2 and hENT2 - related proteins 232 pharmaceutical sciences : ofﬁcial journal of the European Federation for Pharmaceutical Sciences , 41 ( 2 ) , pp . 201 – 209 . Duﬂot , S . et al . , 2004 . ATP - sensitive K ( + ) channels regulate the concentrative adenosine transporter CNT2 following activation by A ( 1 ) adenosine receptors . Molecular and cellular biology , 24 ( 7 ) , pp . 2710 – 2719 . Dunwiddie , T . V . & Diao , L . , 2000 . Regulation of extracellular adenosine in rat hippocampal slices is temperature dependent : role of adenosine transporters . Neuroscience , 95 ( 1 ) , pp . 81 – 88 . E Eckford , P . D . W . & Sharom , F . J . , 2009 . ABC efﬂux pump - based resistance to chemotherapy drugs . Chemical reviews , 109 ( 7 ) , pp . 2989 – 3011 . Edwards , A . S . et al . , 1999 . Carboxyl - terminal phosphorylation regulates the function and subcellular localization of protein kinase C betaII . The Journal of biological chemistry , 274 ( 10 ) , pp . 6461 – 6468 . Eltzschig , H . K . et al . , 2005 . HIF - 1 - dependent repression of equilibrative nucleoside transporter ( ENT ) in hypoxia . The Journal of experimental medicine , 202 ( 11 ) , pp . 1493 – 1505 . Elwi , A . N . et al . , 2006 . Renal nucleoside transporters : physiological and clinical implications . Biochemistry and cell biology = Biochimie et biologie cellulaire , 84 ( 6 ) , pp . 844 – 858 . Endres , C . J . & Unadkat , J . D . , 2005 . Residues Met89 and Ser160 in the human equilibrative nucleoside transporter 1 affect its afﬁnity for adenosine , guanosine , S6 - ( 4 - nitrobenzyl ) - mercaptopurine riboside , and dipyridamole . Molecular pharmacology , 67 ( 3 ) , pp . 837 – 844 . Endres , C . J . et al . , 2009 . The role of the equilibrative nucleoside transporter 1 ( ENT1 ) in transport and metabolism of ribavirin by human and wild - type or Ent1 - / - mouse erythrocytes . Journal of Pharmacology and Experimental Therapeutics , 329 ( 1 ) , pp . 387 – 398 . Endres , C . J . , Sengupta , D . J . & Unadkat , J . D . , 2004 . Mutation of leucine - 92 selectively reduces the apparent afﬁnity of inosine , guanosine , NBMPR [ S6 - ( 4 - nitrobenzyl ) - mercaptopurine riboside ] and dilazep for the human equilibrative nucleoside transporter , hENT1 . The Biochemical journal , 380 ( Pt 1 ) , pp . 131 – 137 . Bibliography 233 Engel , A . & Gaub , H . E . , 2008 . Structure and Mechanics of Membrane Proteins . Annual review of biochemistry , 77 ( 1 ) , pp . 127 – 148 . Engel , K . , Zhou , M . & Wang , J . , 2004 . Identiﬁcation and characterization of a novel monoamine transporter in the human brain . The Journal of biological chemistry , 279 ( 48 ) , pp . 50042 – 50049 . Errasti - Murugarren , E . et al . , 2012 . Role of the Transporter Regulator Protein ( RS1 ) in the Modulation of Concentrative Nucleoside Transporters ( CNTs ) in Epithelia . Molecular pharmacology , 82 ( 1 ) , pp . 59 – 67 . Errasti - Murugarren , E . et al . , 2009 . A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter - 3 ( hCNT3 ) protein localized in the endoplasmic reticulum . The FASEB journal : ofﬁcial publication of the Federation of American Societies for Experimental Biology , 23 ( 1 ) , pp . 172 – 182 . Errasti - Murugarren , E . et al . , 2008 . Functional characterization of a nucleoside - derived drug transporter variant ( hCNT3C602R ) showing altered sodium - binding capacity . Molecular pharmacology , 73 ( 2 ) , pp . 379 – 386 . Evans , W . E . & Relling , M . V . , 1999 . Pharmacogenomics : translating functional genomics into rational therapeutics . Science , 286 ( 5439 ) , pp . 487 – 491 . F Farhan , H . et al . , 2007 . Concentrative export from the endoplasmic reticulum of the gamma - aminobutyric acid transporter 1 requires binding to SEC24D . The Journal of biological chemistry , 282 ( 10 ) , pp . 7679 – 7689 . Farias , M . et al . , 2010 . Nitric oxide reduces SLC29A1 promoter activity and adenosine transport involving transcription factor complex hCHOP - C / EBP(cid:5) in human umbilical vein endothelial cells from gestational diabetes . Cardiovascular research , 86 ( 1 ) , pp . 45 – 54 . Farrell , J . J . et al . , 2009 . Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer . Gastroenterology , 136 ( 1 ) , pp . 187 – 195 . Fleming , T . P . et al . , 1992 . Ampliﬁcation and / or overexpression of platelet - derived growth factor receptors and epidermal growth factor receptor in human glial tumors . Cancer Research , 52 ( 16 ) , pp . 4550 – 4553 . Novel approaches to understanding hENT2 and hENT2 - related proteins 234 Fletcher , L . M . et al . , 2000 . Role for the microtubule cytoskeleton in GLUT4 vesicle trafﬁcking and in the regulation of insulin - stimulated glucose uptake . The Biochemical journal , 352 Pt 2 , pp . 267 – 276 . Fowler , J . D . et al . , 2008 . Kinetic investigation of the inhibitory effect of gemcitabine on DNA polymerization catalyzed by human mitochondrial DNA polymerase . The Journal of biological chemistry , 283 ( 22 ) , pp . 15339 – 15348 . Freeze , H . H . & Aebi , M . , 2005 . Altered glycan structures : the molecular basis of congenital disorders of glycosylation . Current opinion in structural biology , 15 ( 5 ) , pp . 490 – 498 . Fukuchi , Y . et al . , 2010 . Characterization of ribavirin uptake systems in human hepatocytes . Journal of Hepatology , 52 ( 4 ) , pp . 486 – 492 . Funaki , M . , Randhawa , P . & Janmey , P . A . , 2004 . Separation of insulin signaling into distinct GLUT4 translocation and activation steps . Molecular and cellular biology , 24 ( 17 ) , pp . 7567 – 7577 . Futai , E . et al . , 2004 . GTP / GDP exchange by Sec12p enables COPII vesicle bud formation on synthetic liposomes . The EMBO journal , 23 ( 21 ) , pp . 4146 – 4155 . G Galmarini , C . M . et al . , 2002 . Expression of a non - functional p53 affects the sensitivity of cancer cells to gemcitabine . International journal of cancer Journal international du cancer , 97 ( 4 ) , pp . 439 – 445 . Galmarini , C . M . et al . , 2003 . Inﬂuence of p53 and p21 ( WAF1 ) expression on sensitivity of cancer cells to cladribine . Biochemical pharmacology , 65 ( 1 ) , pp . 121 – 129 . Garcia - Blanco , M . A . , Baraniak , A . P . & Lasda , E . L . , 2004 . Alternative splicing in disease and therapy . Nature biotechnology , 22 ( 5 ) , pp . 535 – 546 . Geiger , J . D . , LaBella , F . S . & Nagy , J . I . , 1985 . Characterization of nitrobenzylthioinosine binding to nucleoside transport sites selective for adenosine in rat brain . The Journal of neuroscience : the ofﬁcial journal of the Society for Neuroscience , 5 ( 3 ) , pp . 735 – 740 . Gerstin , K . M . , Dresser , M . J . & Giacomini , K . M . , 2002 . Speciﬁcity of human and rat orthologs of the concentrative nucleoside transporter , SPNT . American journal of physiology Renal physiology , 283 ( 2 ) , pp . F344 – 9 . Bibliography 235 Gilbert , J . A . et al . , 2006 . Gemcitabine pharmacogenomics : cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics . Clinical cancer research : an ofﬁcial journal of the American Association for Cancer Research , 12 ( 6 ) , pp . 1794 – 1803 . Gill , R . K . et al . , 2008 . Function , expression , and characterization of the serotonin transporter in the native human intestine . American journal of physiology . Gastrointestinal and liver physiology , 294 ( 1 ) , pp . G254 – 62 . Giovannetti , E . et al . , 2008 . Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples . Nucleosides , Nucleotides and Nucleic Acids , 27 ( 6 ) , pp . 720 – 725 . Gomes , J . R . et al . , 2011 . Cleavage of the Vesicular GABA Transporter under Excitotoxic Conditions Is Followed by Accumulation of the Truncated Transporter in Nonsynaptic Sites . Journal of Neuroscience , 31 ( 12 ) , pp . 4622 – 4635 . Govindarajan , R . et al . , 2009 . Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter - 3 . AJP : Gastrointestinal and Liver Physiology , 296 ( 4 ) , pp . G910 – G922 . Gray , J . H . , Owen , R . P . & Giacomini , K . M . , 2004 . The concentrative nucleoside transporter family , SLC28 . Pﬂ gers Archiv European Journal of Physiology , 447 ( 5 ) , pp . 728 – 734 . Grden , M . et al . , 2008 . High glucose suppresses expression of equilibrative nucleoside transporter 1 ( ENT1 ) in rat cardiac ﬁbroblasts through a mechanism dependent on PKC - zeta and MAP kinases . Journal of Cellular Physiology , 215 ( 1 ) , pp . 151 – 160 . Grifﬁth , D . A . & Jarvis , S . M . , 1996 . Nucleoside and nucleobase transport systems of mammalian cells . Biochimica et biophysica acta , 1286 ( 3 ) , pp . 153 – 181 . Grifﬁths , M . , Beaumont , N . , et al . , 1997a . Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs . Nature medicine , 3 ( 1 ) , pp . 89 – 93 . Grifﬁths , M . , Yao , S . Y . M . , et al . , 1997b . Molecular cloning and characterization of a nitrobenzylthioinosine - insensitive ( ei ) equilibrative nucleoside transporter from human placenta . The Biochemical journal , 328 ( Pt 3 ) , pp . 739 – 743 . Novel approaches to understanding hENT2 and hENT2 - related proteins 236 Guillén - Gómez , E . et al . , 2011 . New role of the human equilibrative nucleoside transporter 1 ( hENT1 ) in epithelial - to - mesenchymal transition in renal tubular cells . Journal of Cellular Physiology , pp . n / a – n / a . Gulliford , T . , Ouyang , X . & Epstein , R . J . , 1999 . Intensiﬁcation of growth factor receptor signalling by phorbol treatment of ligand - primed cells implies a dimer - stabilizing effect of protein kinase C - dependent juxtamembrane domain phosphorylation . Cellular signalling , 11 ( 4 ) , pp . 245 – 252 . Guo , G . L . & Klaassen , C . D . , 2001 . Protein kinase C suppresses rat organic anion transporting polypeptide 1 - and 2 - mediated uptake . The Journal of pharmacology and experimental therapeutics , 299 ( 2 ) , pp . 551 – 557 . Guzmán - Gutiérrez , E . et al . , 2010 . Differential expression of functional nucleoside transporters in non - differentiated and differentiated human endothelial progenitor cells . Placenta , 31 ( 10 ) , pp . 928 – 936 . H Hagiwara , M . , 2005 . Alternative splicing : a new drug target of the post - genome era . Biochimica et biophysica acta , 1754 ( 1 - 2 ) , pp . 324 – 331 . Hamilton , S . R . et al . , 2001 . Subcellular distribution and membrane topology of the mammalian concentrative Na + - nucleoside cotransporter rCNT1 . The Journal of biological chemistry , 276 ( 30 ) , pp . 27981 – 27988 . Hamm , L . L . , Feng , Z . & Hering - Smith , K . S . , 2010 . Regulation of sodium transport by ENaC in the kidney . Current opinion in nephrology and hypertension , 19 ( 1 ) , pp . 98 – 105 . Hammond , J . R . , 2000 . Interaction of a series of draﬂazine analogues with equilibrative nucleoside transporters : species differences and transporter subtype selectivity . Naunyn - Schmiedeberg ' s archives of pharmacology , 361 ( 4 ) , pp . 373 – 382 . Handa , M . et al . , 2001 . Cloning of a novel isoform of the mouse NBMPR - sensitive equilibrative nucleoside transporter ( ENT1 ) lacking a putative phosphorylation site . Gene , 262 ( 1 - 2 ) , pp . 301 – 307 . Hannum , G . et al . , 2009 . Genome - Wide Association Data Reveal a Global Map of Genetic Interactions among Protein Complexes . PLoS Genetics , 5 ( 12 ) , p . e1000782 . Bibliography 237 Hansen , J . E . et al . , 2007 . Intranuclear protein transduction through a nucleoside salvage pathway . The Journal of biological chemistry , 282 ( 29 ) , pp . 20790 – 20793 . Hanton , S . L . et al . , 2005 . Diacidic motifs inﬂuence the export of transmembrane proteins from the endoplasmic reticulum in plant cells . The Plant cell , 17 ( 11 ) , pp . 3081 – 3093 . Hartmann , E . et al . , 2008 . Five - gene model to predict survival in mantle - cell lymphoma using frozen or formalin - ﬁxed , parafﬁn - embedded tissue . Journal of Clinical Oncology , 26 ( 30 ) , pp . 4966 – 4972 . Hediger , M . A . et al . , 2004 . The ABCs of solute carriers : physiological , pathological and therapeutic implications of human membrane transport proteins . Pﬂ gers Archiv European Journal of Physiology , 447 ( 5 ) , pp . 465 – 468 . Hegele , A . et al . , 2012 . Dynamic Protein - Protein Interaction Wiring of the Human Spliceosome . Molecular Cell , 45 ( 4 ) , pp . 567 – 580 . Helenius , A . & Aebi , M . , 2001 . Intracellular functions of N - linked glycans . Science , 291 ( 5512 ) , pp . 2364 – 2369 . Hendriks , G . et al . , 2004 . Glycosylation is important for cell surface expression of the water channel aquaporin - 2 but is not essential for tetramerization in the endoplasmic reticulum . The Journal of biological chemistry , 279 ( 4 ) , pp . 2975 – 2983 . Hernandez - Pigeon , H . et al . , 2005 . hMutS alpha is protected from ubiquitin - proteasome - dependent degradation by atypical protein kinase C zeta phosphorylation . Journal of molecular biology , 348 ( 1 ) , pp . 63 – 74 . Hnilicová , J . et al . , 2011 . Histone Deacetylase Activity Modulates Alternative Splicing J . Valcarcel , ed . PLoS ONE , 6 ( 2 ) , p . e16727 . Hu , H . et al . , 2006 . Electrophysiological characterization and modeling of the structure activity relationship of the human concentrative nucleoside transporter 3 ( hCNT3 ) . Molecular pharmacology , 69 ( 5 ) , pp . 1542 – 1553 . Huang , H . C . , 2002 . Phosphorylation of Nrf2 at Ser - 40 by Protein Kinase C Regulates Antioxidant Response Element - mediated Transcription . Journal of Biological Chemistry , 277 ( 45 ) , pp . 42769 – 42774 . Novel approaches to understanding hENT2 and hENT2 - related proteins 238 Huang , Q . Q . et al . , 1994 . Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein . The Journal of biological chemistry , 269 ( 27 ) , pp . 17757 – 17760 . Huang , Y . et al . , 2004 . Membrane transporters and channels : role of the transportome in cancer chemosensitivity and chemoresistance . Cancer Research , 64 ( 12 ) , pp . 4294 – 4301 . Hubeek , I . et al . , 2005 . The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia . British journal of cancer , 93 ( 12 ) , pp . 1388 – 1394 . Huber - Ruano , I . et al . , 2010 . Link between high - afﬁnity adenosine concentrative nucleoside transporter - 2 ( CNT2 ) and energy metabolism in intestinal and liver parenchymal cells . Journal of Cellular Physiology , 225 ( 2 ) , pp . 620 – 630 . Huber - Ruano , I . et al . , 2012 . Functional outcome of a novel SLC29A3 mutation identiﬁed in a patient with H syndrome . Biochemical and biophysical research communications , pp . 1 – 6 . Humbert , O . et al . , 2002 . Implication of protein kinase C in the regulation of DNA mismatch repair protein expression and function . The Journal of biological chemistry , 277 ( 20 ) , pp . 18061 – 18068 . Hyde , R . J . et al . , 2001 . The ENT family of eukaryote nucleoside and nucleobase transporters : recent advances in the investigation of structure / function relationships and the identiﬁcation of novel isoforms . Molecular Membrane Biology , 18 ( 1 ) , pp . 53 – 63 . I Iyer , K . et al . , 2005 . Utilizing the split - ubiquitin membrane yeast two - hybrid system to identify protein - protein interactions of integral membrane proteins . Science ' s STKE : signal transduction knowledge environment , 2005 ( 275 ) , p . pl3 . J Jang , J . - H . , 2002 . Identiﬁcation and characterization of soluble isoform of ﬁbroblast growth factor receptor 3 in human SaOS - 2 osteosarcoma cells . Biochemical and biophysical research communications , 292 ( 2 ) , pp . 378 – 382 . Bibliography 239 Jascur , T . & Boland , C . R . , 2006 . Structure and function of the components of the human DNA mismatch repair system . International journal of cancer Journal international du cancer , 119 ( 9 ) , pp . 2030 – 2035 . Jayanthi , L . D . et al . , 2005 . Evidence for biphasic effects of protein kinase C on serotonin transporter function , endocytosis , and phosphorylation . Molecular pharmacology , 67 ( 6 ) , pp . 2077 – 2087 . Jennings , L . L . et al . , 2001 . Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 ( hENT1 and hENT2 ) in the central nervous system . Neuropharmacology , 40 ( 5 ) , pp . 722 – 731 . Johnson , Z . L . , Cheong , C . - G . & Lee , S . - Y . , 2012 . Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2 . 4 Å . Nature , pp . 1 – 6 . Johnsson , N . & Varshavsky , A . , 1994 . Split ubiquitin as a sensor of protein interactions in vivo . Proceedings of the National Academy of Sciences of the United States of America , 91 ( 22 ) , pp . 10340 – 10344 . Jones , S . M . & Kazlauskas , A . , 2001 . Growth - factor - dependent mitogenesis requires two distinct phases of signalling . Nature cell biology , 3 ( 2 ) , pp . 165 – 172 . K Kaji , H . et al . , 2007 . Proteomics reveals N - linked glycoprotein diversity in Caenorhabditis elegans and suggests an atypical translocation mechanism for integral membrane proteins . Molecular & cellular proteomics : MCP , 6 ( 12 ) , pp . 2100 – 2109 . Kalckar , H . M . , 1950 . The biological incorporation of purines and pyrimidines into nucleosides and nucleic acid . Biochimica et biophysica acta , 4 ( 1 - 3 ) , pp . 232 – 237 . Kang , N . et al . , 2010 . Human equilibrative nucleoside transporter - 3 ( hENT3 ) spectrum disorder mutations impair nucleoside transport , protein localization , and stability . Journal of Biological Chemistry , 285 ( 36 ) , pp . 28343 – 28352 . Keller , P . & Simons , K . , 1997 . Post - Golgi biosynthetic trafﬁcking . Journal of cell science , 110 ( Pt 24 ) , pp . 3001 – 3009 . Novel approaches to understanding hENT2 and hENT2 - related proteins 240 Keskanokwong , T . et al . , 2007 . Interaction of integrin - linked kinase with the kidney chloride / bicarbonate exchanger , kAE1 . The Journal of biological chemistry , 282 ( 32 ) , pp . 23205 – 23218 . Kim , J . - H . et al . , 2011 . Functional role of the polymorphic 647 T / C variant of ENT1 ( SLC29A1 ) and its association with alcohol withdrawal seizures . PLoS ONE , 6 ( 1 ) , p . e16331 . King , A . E . et al . , 2006 . Nucleoside transporters : from scavengers to novel therapeutic targets . Trends in pharmacological sciences , 27 ( 8 ) , pp . 416 – 425 . Kipp , H . & Arias , I . M . , 2002 . Trafﬁcking of Canalicular ABC Transporters in Hepatocytes . Annual Review of Physiology , 64 ( 1 ) , pp . 595 – 608 . Kiss , A . et al . , 2000 . Molecular cloning and functional characterization of inhibitor - sensitive ( mENT1 ) and inhibitor - resistant ( mENT2 ) equilibrative nucleoside transporters from mouse brain . The Biochemical journal , 352 Pt 2 , pp . 363 – 372 . Kitayama , S . et al . , 1999 . Dominant negative isoform of rat norepinephrine transporter produced by alternative RNA splicing . The Journal of biological chemistry , 274 ( 16 ) , pp . 10731 – 10736 . Kittanakom , S . et al . , 2009 . Analysis of membrane protein complexes using the split - ubiquitin membrane yeast two - hybrid ( MYTH ) system . Methods in molecular biology ( Clifton , N . J . ) , 548 , pp . 247 – 271 . Klein , K . et al . , 2009 . Hepatocyte nuclear factor - 4(cid:5) and bile acids regulate human concentrative nucleoside transporter - 1 gene expression . AJP : Gastrointestinal and Liver Physiology , 296 ( 4 ) , pp . G936 – G947 . Knight , D . et al . , 2010 . Equilibrative nucleoside transporter 2 regulates associative learning and synaptic function in Drosophila . Journal of Neuroscience , 30 ( 14 ) , pp . 5047 – 5057 . Koepsell , H . , Lips , K . & Volk , C . , 2007 . Polyspeciﬁc organic cation transporters : structure , function , physiological roles , and biopharmaceutical implications . Pharmaceutical research , 24 ( 7 ) , pp . 1227 – 1251 . Koﬂer , M . , 2004 . Recognition Sequences for the GYF Domain Reveal a Possible Spliceosomal Function of CD2BP2 . Journal of Biological Chemistry , 279 ( 27 ) , pp . 28292 – 28297 . Bibliography 241 Kong , W . , Engel , K . & Wang , J . , 2004 . Mammalian nucleoside transporters . Current drug metabolism , 5 ( 1 ) , pp . 63 – 84 . Korn , T . , 2001 . The Plasma Membrane - associated Protein RS1 Decreases Transcription of the Transporter SGLT1 in Conﬂuent LLC - PK1 Cells . Journal of Biological Chemistry , 276 ( 48 ) , pp . 45330 – 45340 . Köck , K . et al . , 2010 . Rapid modulation of the organic anion transporting polypeptide 2B1 ( OATP2B1 , SLCO2B1 ) function by protein kinase C - mediated internalization . Journal of Biological Chemistry , 285 ( 15 ) , pp . 11336 – 11347 . Kroep , J . R . et al . , 2002 . Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity . Molecular cancer therapeutics , 1 ( 6 ) , pp . 371 – 376 . L Laggerbauer , B . , 2005 . The human U5 snRNP 52K protein ( CD2BP2 ) interacts with U5 - 102K ( hPrp6 ) , a U4 / U6 . U5 tri - snRNP bridging protein , but dissociates upon tri - snRNP formation . RNA ( New York , NY ) , 11 ( 5 ) , pp . 598 – 608 . Lai , Y . , Bakken , A . H . & Unadkat , J . D . , 2002 . Simultaneous expression of hCNT1 - CFP and hENT1 - YFP in Madin - Darby canine kidney cells . Localization and vectorial transport studies . The Journal of biological chemistry , 277 ( 40 ) , pp . 37711 – 37717 . Lai , Y . , Tse , C . - M . & Unadkat , J . D . , 2004 . Mitochondrial expression of the human equilibrative nucleoside transporter 1 ( hENT1 ) results in enhanced mitochondrial toxicity of antiviral drugs . The Journal of biological chemistry , 279 ( 6 ) , pp . 4490 – 4497 . Lamba , J . K . , 2009 . Genetic factors inﬂuencing cytarabine therapy . Pharmacogenomics , 10 ( 10 ) , pp . 1657 – 1674 . Lanahan , A . et al . , 1992 . Growth factor - induced delayed early response genes . Molecular and cellular biology , 12 ( 9 ) , pp . 3919 – 3929 . Landfear , S . M . , 2010 . Transporters for drug delivery and as drug targets in parasitic protozoa . Clinical pharmacology and therapeutics , 87 ( 1 ) , pp . 122 – 125 . Larráyoz , I . M . et al . , 2004 . Electrophysiological characterization of the human Na ( + ) / nucleoside cotransporter 1 ( hCNT1 ) and role of adenosine on hCNT1 function . The Journal of biological chemistry , 279 ( 10 ) , pp . 8999 – 9007 . Novel approaches to understanding hENT2 and hENT2 - related proteins 242 Law , R . M . , Stafford , A . & Quick , M . W . , 2000 . Functional regulation of gamma - aminobutyric acid transporters by direct tyrosine phosphorylation . The Journal of biological chemistry , 275 ( 31 ) , pp . 23986 – 23991 . Leabu , M . , 2006 . Membrane fusion in cells : molecular machinery and mechanisms . Journal of cellular and molecular medicine , 10 ( 2 ) , pp . 423 – 427 . Lee , E . - W . et al . , 2006 . Identiﬁcation of the mitochondrial targeting signal of the human equilibrative nucleoside transporter 1 ( hENT1 ) : implications for interspecies differences in mitochondrial toxicity of ﬁaluridine . The Journal of biological chemistry , 281 ( 24 ) , pp . 16700 – 16706 . Lee , M . C . S . & Miller , E . A . , 2007 . Molecular mechanisms of COPII vesicle formation . Seminars in cell & developmental biology , 18 ( 4 ) , pp . 424 – 434 . Lee , V . H . , Sporty , J . L . & Fandy , T . E . , 2001 . Pharmacogenomics of drug transporters : the next drug delivery challenge . Advanced drug delivery reviews , 50 Suppl 1 , pp . S33 – 40 . Leisewitz , A . V . et al . , 2011 . Regulation of ENT1 expression and ENT1 - dependent nucleoside transport by c - Jun N - terminal kinase . Biochemical and biophysical research communications , 404 ( 1 ) , pp . 370 – 375 . Leung , G . P . et al . , 2001 . Characterization of nucleoside transport systems in cultured rat epididymal epithelium . American journal of physiology . Cell physiology , 280 ( 5 ) , pp . C1076 – 82 . Leung , G . P . H . & Tse , C . - M . , 2007 . The role of mitochondrial and plasma membrane nucleoside transporters in drug toxicity . Expert Opinion on Drug Metabolism & Toxicology , 3 ( 5 ) , pp . 705 – 718 . Leung , P . - K . et al . , 2007 . The truncated ghrelin receptor polypeptide ( GHS - R1b ) acts as a dominant - negative mutant of the ghrelin receptor . Cellular signalling , 19 ( 5 ) , pp . 1011 – 1022 . Levy , E . D . , Landry , C . R . & Michnick , S . W . , 2010 . Cell signaling . Signaling through cooperation . Science , 328 ( 5981 ) , pp . 983 – 984 . Li , H . et al . , 2008 . Adenosine Transporter ENT4 Is a Direct Target of EWS / WT1 Translocation Product and Is Highly Expressed in Desmoplastic Small Round Cell Tumor . PLoS ONE , 3 ( 6 ) , p . e2353 . Bibliography 243 Lodish , H . et al . , 2007 . Molecular Cell Biology , W . H . Freeman . Lotﬁ , K . et al . , 2001 . Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide . British journal of haematology , 113 ( 2 ) , pp . 339 – 346 . Löfﬂer , M . et al . , 2007 . Physiological roles of vascular nucleoside transporters . Arteriosclerosis , thrombosis , and vascular biology , 27 ( 5 ) , pp . 1004 – 1013 . Lu , G . et al . , 2010 . Chronic morphine treatment impaired hippocampal long - term potentiation and spatial memory via accumulation of extracellular adenosine acting on adenosine A1 receptors . Journal of Neuroscience , 30 ( 14 ) , pp . 5058 – 5070 . Lu , S . P . & Lin , S . J . , 2011 . Phosphate - responsive Signaling Pathway Is a Novel Component of NAD + Metabolism in Saccharomyces cerevisiae . Journal of Biological Chemistry , 286 ( 16 ) , pp . 14271 – 14281 . M Maase , von der , H . , 2001 . Gemcitabine - containing regimens in bladder cancer : A new standard of care . Seminars in oncology , 28 ( 3 Suppl 10 ) , pp . 1 – 3 . Mackey , J . R . et al . , 2005 . Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia ( CLL ) : identiﬁcation of ﬂudarabine - sensitive and - insensitive populations . Blood , 105 ( 2 ) , pp . 767 – 774 . Malakooti , J . et al . , 2006 . Transcriptional stimulation of the human NHE3 promoter activity by PMA : PKC independence and involvement of the transcription factor EGR - 1 . The Biochemical journal , 396 ( 2 ) , pp . 327 – 336 . Mangravite , L . M . , Xiao , G . & Giacomini , K . M . , 2003 . Localization of human equilibrative nucleoside transporters , hENT1 and hENT2 , in renal epithelial cells . American journal of physiology Renal physiology , 284 ( 5 ) , pp . F902 – 10 . Mani , R . S . et al . , 1998 . Demonstration of equilibrative nucleoside transporters ( hENT1 and hENT2 ) in nuclear envelopes of cultured human choriocarcinoma ( BeWo ) cells by functional reconstitution in proteoliposomes . The Journal of biological chemistry , 273 ( 46 ) , pp . 30818 – 30825 . Novel approaches to understanding hENT2 and hENT2 - related proteins 244 Maniatis , T . & Tasic , B . , 2002 . Alternative pre - mRNA splicing and proteome expansion in metazoans . Nature , 418 ( 6894 ) , pp . 236 – 243 . Martínez - Maza , R . et al . , 2001 . The role of N - glycosylation in transport to the plasma membrane and sorting of the neuronal glycine transporter GLYT2 . The Journal of biological chemistry , 276 ( 3 ) , pp . 2168 – 2173 . Matlin , A . J . , Clark , F . & Smith , C . W . J . , 2005 . Understanding alternative splicing : towards a cellular code . Nature reviews . Molecular cell biology , 6 ( 5 ) , pp . 386 – 398 . Matsumoto , H . et al . , 2005 . Congenital muscular dystrophy with glycosylation defects of alpha - dystroglycan in Japan . Neuromuscular disorders : NMD , 15 ( 5 ) , pp . 342 – 348 . McGee , S . L . et al . , 2008 . AMP - activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5 . Diabetes , 57 ( 4 ) , pp . 860 – 867 . Mehrens , T . et al . , 2000 . The afﬁnity of the organic cation transporter rOCT1 is increased by protein kinase C - dependent phosphorylation . Journal of the American Society of Nephrology : JASN , 11 ( 7 ) , pp . 1216 – 1224 . Meier , Y . et al . , 2007 . Regional distribution of solute carrier mRNA expression along the human intestinal tract . Drug Metabolism and Disposition , 35 ( 4 ) , pp . 590 – 594 . Menéndez - Arias , L . , 2008 . Mechanisms of resistance to nucleoside analogue inhibitors of HIV - 1 reverse transcriptase . Virus research , 134 ( 1 - 2 ) , pp . 124 – 146 . Mikosch , M . et al . , 2006 . Diacidic motif is required for efﬁcient transport of the K + channel KAT1 to the plasma membrane . Plant physiology , 142 ( 3 ) , pp . 923 – 930 . Miura , K . et al . , 2011 . Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer . Surgery Today , 41 ( 2 ) , pp . 175 – 182 . Molina - Arcas , M . et al . , 2005 . Equilibrative nucleoside transporter - 2 ( hENT2 ) protein expression correlates with ex vivo sensitivity to ﬂudarabine in chronic lymphocytic leukemia ( CLL ) cells . Leukemia : ofﬁcial journal of the Leukemia Society of America , Leukemia Research Fund , UK , 19 ( 1 ) , pp . 64 – 68 . Molina - Arcas , M . et al . , 2003 . Fludarabine uptake mechanisms in B - cell chronic lymphocytic leukemia . Blood , 101 ( 6 ) , pp . 2328 – 2334 . Bibliography 245 Molina - Arcas , M . , Casado , F . J . & Pastor - Anglada , M . , 2009 . Nucleoside transporter proteins . Current vascular pharmacology , 7 ( 4 ) , pp . 426 – 434 . Molinari , M . , 2007 . N - glycan structure dictates extension of protein folding or onset of disposal . Nature chemical biology , 3 ( 6 ) , pp . 313 – 320 . Montero , T . D . et al . , 2012 . PPARa and PPARg regulate the nucleoside transporter hENT1 . Biochemical and biophysical research communications , 419 ( 2 ) , pp . 405 – 411 . Mornex , F . & Girard , N . , 2006 . Gemcitabine and radiation therapy in non - small cell lung cancer : state of the art . Annals of oncology : ofﬁcial journal of the European Society for Medical Oncology / ESMO , 17 ( 12 ) , pp . 1743 – 1747 . Murray , A . W . , 1971 . The biological signiﬁcance of purine salvage . Annual review of biochemistry , 40 , pp . 811 – 826 . Musa , H . et al . , 2002 . Immunocytochemical demonstration of the equilibrative nucleoside transporter rENT1 in rat sinoatrial node . The journal of histochemistry and cytochemistry : ofﬁcial journal of the Histochemistry Society , 50 ( 3 ) , pp . 305 – 309 . N Naydenova , Z . , Rose , J . B . & Coe , I . R . , 2008 . Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL - 1 cell line . American journal of physiology Heart and circulatory physiology , 294 ( 6 ) , pp . H2687 – 92 . Nelson , R . D . et al . , 1998 . Expression of an AQP2 Cre recombinase transgene in kidney and male reproductive system of transgenic mice . The American journal of physiology , 275 ( 1 Pt 1 ) , pp . C216 – 26 . Newton , A . C . , 2003 . Regulation of the ABC kinases by phosphorylation : protein kinase C as a paradigm . The Biochemical journal , 370 ( Pt 2 ) , pp . 361 – 371 . Nguyen , T . T . & Amara , S . G . , 1996 . N - linked oligosaccharides are required for cell surface expression of the norepinephrine transporter but do not inﬂuence substrate or inhibitor recognition . Journal of neurochemistry , 67 ( 2 ) , pp . 645 – 655 . Novel approaches to understanding hENT2 and hENT2 - related proteins 246 Niture , S . K . & Jaiswal , A . K . , 2009 . Prothymosin - (cid:5) Mediates Nuclear Import of the INrf2 / Cul3 { middle dot } Rbx1 Complex to Degrade Nuclear Nrf2 . Journal of Biological Chemistry , 284 ( 20 ) , pp . 13856 – 13868 . Niture , S . K . , Jain , A . K . & Jaiswal , A . K . , 2010 . Antioxidant - induced modiﬁcation of INrf2 cysteine 151 and PKC - (cid:5) - mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance . Journal of cell science , 123 ( 11 ) , pp . 1969 – 1969 . Nivillac , N . M . I . , Bacani , J . & Coe , I . R . , 2011 . The life cycle of human equilibrative nucleoside transporter 1 : From ER export to degradation . Experimental cell research , 317 ( 11 ) , pp . 1567 – 1579 . Noji , T . , Karasawa , A . & Kusaka , H . , 2004 . Adenosine uptake inhibitors . European journal of pharmacology , 495 ( 1 ) , pp . 1 – 16 . Novoyatleva , T . et al . , 2008 . Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre - mRNA processing . Human molecular genetics , 17 ( 1 ) , pp . 52 – 70 . O O ' Reilly , E . M . , 2009 . Pancreatic adenocarcinoma : new strategies for success . Gastrointestinal cancer research : GCR , 3 ( 2 Suppl ) , pp . S11 – 5 . Oguri , T . et al . , 2007 . The absence of human equilibrative nucleoside transporter 1 expression predicts nonresponse to gemcitabine - containing chemotherapy in non - small cell lung cancer . Cancer letters , 256 ( 1 ) , pp . 112 – 119 . Ohno , M . et al . , 2000 . PHAX , a Mediator of U snRNA Nuclear Export Whose Activity Is Regulated by Phosphorylation . Cell , 101 ( 2 ) , pp . 187 – 198 . Okazaki , T . et al . , 2010 . Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity . Clinical cancer research : an ofﬁcial journal of the American Association for Cancer Research , 16 ( 1 ) , pp . 320 – 329 . Olsen , J . V . et al . , 2006 . Global , in vivo , and site - speciﬁc phosphorylation dynamics in signaling networks . Cell , 127 ( 3 ) , pp . 635 – 648 . Bibliography 247 Osato , D . H . et al . , 2003 . Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter , ENT1 . Pharmacogenetics , 13 ( 5 ) , pp . 297 – 301 . Otterbein , L . R . et al . , 2002 . Crystal structures of the vitamin D - binding protein and its complex with actin : structural basis of the actin - scavenger system . Proceedings of the National Academy of Sciences of the United States of America , 99 ( 12 ) , pp . 8003 – 8008 . P Pan , X . et al . , 2006 . A DNA integrity network in the yeast Saccharomyces cerevisiae . Cell , 124 ( 5 ) , pp . 1069 – 1081 . Paproski , R . J . et al . , 2008 . Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters afﬁnity for coronary vasodilator drugs and nucleoside selectivity . The Biochemical journal , 414 ( 2 ) , pp . 291 – 300 . Pastor - Anglada , M . et al . , 2005 . Cell entry and export of nucleoside analogues . Virus research , 107 ( 2 ) , pp . 151 – 164 . Pastor - Anglada , M . et al . , 2004 . Nucleoside transporters in chronic lymphocytic leukaemia . Leukemia : ofﬁcial journal of the Leukemia Society of America , Leukemia Research Fund , UK , 18 ( 3 ) , pp . 385 – 393 . Pastor - Anglada , M . et al . , 2008 . SLC28 genes and concentrative nucleoside transporter ( CNT ) proteins . Xenobiotica ; the fate of foreign compounds in biological systems , 38 ( 7 - 8 ) , pp . 972 – 994 . Pastor - Anglada , M . , Felipe , A . & Casado , F . J . , 1998 . Transport and mode of action of nucleoside derivatives used in chemical and antiviral therapies . Trends in pharmacological sciences , 19 ( 10 ) , pp . 424 – 430 . Pennycooke , M . et al . , 2001 . Differential expression of human nucleoside transporters in normal and tumor tissue . Biochemical and biophysical research communications , 280 ( 3 ) , pp . 951 – 959 . Perez - Bercoff , D . et al . , 2007 . Human immunodeﬁciency virus type 1 : resistance to nucleoside analogues and replicative capacity in primary human macrophages . Journal of virology , 81 ( 9 ) , pp . 4540 – 4550 . Novel approaches to understanding hENT2 and hENT2 - related proteins 248 Perrone , F . et al . , 2010 . Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma . European Journal of Cancer , 46 ( 15 ) , pp . 2837 – 2848 . Pérez - Torras , S . et al . , 2008 . Adenoviral - mediated overexpression of human equilibrative nucleoside transporter 1 ( hENT1 ) enhances gemcitabine response in human pancreatic cancer . Biochemical pharmacology , 76 ( 3 ) , pp . 322 – 329 . Pinilla - Macua , I . , Casado , F . J . & Pastor - Anglada , M . , 2012 . Structural determinants for rCNT2 sorting to the plasma membrane of polarized and non - polarized cells . The Biochemical journal , 442 ( 3 ) , pp . 517 – 525 . Pinna , L . A . , 1990 . Casein kinase 2 : an “eminence grise” in cellular regulation ? Biochimica et biophysica acta , 1054 ( 3 ) , pp . 267 – 284 . Plati , J . , Bucur , O . & Khosravi - Far , R . , 2011 . Apoptotic cell signaling in cancer progression and therapy . Integrative Biology , 3 ( 4 ) , pp . 279 – 296 . Pocard , T . et al . , 2007 . Distinct v - SNAREs regulate direct and indirect apical delivery in polarized epithelial cells . Journal of cell science , 120 ( Pt 18 ) , pp . 3309 – 3320 . Prakasha Gowda , A . S . et al . , 2010 . Incorporation of Gemcitabine and Cytarabine into DNA by DNA Polymerase β and Ligase III / XRCC1 . Biochemistry , 49 ( 23 ) , pp . 4833 – 4840 . Procino , G . et al . , 2003 . Ser - 256 phosphorylation dynamics of Aquaporin 2 during maturation from the ER to the vesicular compartment in renal cells . The FASEB journal : ofﬁcial publication of the Federation of American Societies for Experimental Biology , 17 ( 13 ) , pp . 1886 – 1888 . Puebla , C . et al . , 2008 . High D - glucose reduces SLC29A1 promoter activity and adenosine transport involving speciﬁc protein 1 in human umbilical vein endothelium . Journal of Cellular Physiology , 215 ( 3 ) , pp . 645 – 656 . Q Quashie , N . B . et al . , 2008 . A comprehensive model of purine uptake by the malaria parasite Plasmodium falciparum : identiﬁcation of four purine transport activities in intraerythrocytic parasites . The Biochemical journal , 411 ( 2 ) , p . 287 . Bibliography 249 R Racine , V . et al . , 2007 . Visualization and quantiﬁcation of vesicle trafﬁcking on a three - dimensional cytoskeleton network in living cells . Journal of microscopy , 225 ( Pt 3 ) , pp . 214 – 228 . Ratushny , V . & Golemis , E . A . , 2008 . Resolving the network of cell signaling pathways using the evolving yeast two - hybrid system . BioTechniques , 44 Supplement ( 4 ) , pp . 655 – 662 . Reed , R . & Hurt , E . , 2002 . A conserved mRNA export machinery coupled to pre - mRNA splicing . Cell , 108 ( 4 ) , pp . 523 – 531 . Reid , G . et al . , 2003 . Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5 . Molecular pharmacology , 63 ( 5 ) , pp . 1094 – 1103 . Reyes , G . & Coe , I . R . , 2005 . Genomics and proteomics of nucleoside transporters . Current Pharmacogenomics . Reyes , G . et al . , 2011 . The Equilibrative Nucleoside Transporter ( ENT1 ) can be phosphorylated at multiple sites by PKC and PKA . Molecular Membrane Biology , 28 ( 6 ) , pp . 412 – 426 . Riegelhaupt , P . M . , Frame , I . J . & Akabas , M . H . , 2010 . Transmembrane segment 11 appears to line the purine permeation pathway of the Plasmodium falciparum equilibrative nucleoside transporter 1 ( PfENT1 ) . Journal of Biological Chemistry , 285 ( 22 ) , pp . 17001 – 17010 . Ritchie , D . B . , Schellenberg , M . J . & MacMillan , A . M . , 2009 . Spliceosome structure : Piece by piece . BBA - Gene Regulatory Mechanisms , 1789 ( 9 - 10 ) , pp . 624 – 633 . Ritzel , M . W . et al . , 1997 . Molecular cloning and functional expression of cDNAs encoding a human Na + - nucleoside cotransporter ( hCNT1 ) . The American journal of physiology , 272 ( 2 Pt 1 ) , pp . C707 – 14 . Ritzel , M . W . et al . , 2001 . Molecular identiﬁcation and characterization of novel human and mouse concentrative Na + - nucleoside cotransporter proteins ( hCNT3 and mCNT3 ) broadly selective for purine and pyrimidine nucleosides ( system cib ) . The Journal of biological chemistry , 276 ( 4 ) , pp . 2914 – 2927 . Novel approaches to understanding hENT2 and hENT2 - related proteins 250 Rius , M . et al . , 2010 . Vectorial transport of nucleoside analogs from the apical to the basolateral membrane in double - transfected cells expressing the human concentrative nucleoside transporter hCNT3 and the export pump ABCC4 . Drug metabolism and disposition : the biological fate of chemicals , 38 ( 7 ) , pp . 1054 – 1063 . Robak , T . , Korycka , A . & Robak , E . , 2006 . Older and new formulations of cladribine . Pharmacology and clinical efﬁcacy in hematological malignancies . Recent patents on anti - cancer drug discovery , 1 ( 1 ) , pp . 23 – 38 . Robertson , A . S . , Smythe , E . & Ayscough , K . R . , 2009 . Functions of actin in endocytosis . Cellular and molecular life sciences : CMLS , 66 ( 13 ) , pp . 2049 – 2065 . Robillard , K . R . et al . , 2008 . Characterization of mENT1(cid:5)11 , a Novel Alternative Splice Variant of the Mouse Equilibrative Nucleoside Transporter 1 . Molecular pharmacology , 74 ( 1 ) , pp . 264 – 273 . Rodriguez , O . C . et al . , 2003 . Conserved microtubule - actin interactions in cell movement and morphogenesis . Nature cell biology , 5 ( 7 ) , pp . 599 – 609 . Roffers - Agarwal , J . , Xanthos , J . B . & Miller , J . R . , 2005 . Regulation of actin cytoskeleton architecture by Eps8 and Abi1 . BMC cell biology , 6 , p . 36 . Roma , M . - G . , 2008 . Dynamic localization of hepatocellular transporters in health and disease . World journal of gastroenterology : WJG , 14 ( 44 ) , p . 6786 . Rose , J . B . et al . , 2010 . Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection . American journal of physiology Heart and circulatory physiology , 298 ( 3 ) , pp . H771 – 7 . Ross , S . R . , McTavish , D . & Faulds , D . , 1993 . Fludarabine . A review of its pharmacological properties and therapeutic potential in malignancy . Drugs , 45 ( 5 ) , pp . 737 – 759 . S Saarikangas , J . , Zhao , H . & Lappalainen , P . , 2010 . Regulation of the actin cytoskeleton - plasma membrane interplay by phosphoinositides . Physiological reviews , 90 ( 1 ) , pp . 259 – 289 . Bibliography 251 Sabolić , I . et al . , 2002 . NHE3 and NHERF are targeted to the basolateral membrane in proximal tubules of colchicine - treated rats . Kidney international , 61 ( 4 ) , pp . 1351 – 1364 . Sade , H . & Sarin , A . , 2003 . IL - 7 inhibits dexamethasone - induced apoptosis via Akt / PKB in mature , peripheral T cells . European journal of immunology , 33 ( 4 ) , pp . 913 – 919 . Safarjalani , Al , O . N . , Naguib , F . N . M . & Kouni , El , M . H . , 2003 . Uptake of nitrobenzylthioinosine and purine beta - L - nucleosides by intracellular Toxoplasma gondii . Antimicrobial agents and chemotherapy , 47 ( 10 ) , pp . 3247 – 3251 . Sairam , M . R . et al . , 1996 . Follitropin signal transduction : alternative splicing of the FSH receptor gene produces a dominant negative form of receptor which inhibits hormone action . Biochemical and biophysical research communications , 226 ( 3 ) , pp . 717 – 722 . Salazar , C . & Höfer , T . , 2009 . Multisite protein phosphorylation - - from molecular mechanisms to kinetic models . The FEBS journal , 276 ( 12 ) , pp . 3177 – 3198 . Salmon , W . C . , Adams , M . C . & Waterman - Storer , C . M . , 2002 . Dual - wavelength ﬂuorescent speckle microscopy reveals coupling of microtubule and actin movements in migrating cells . The Journal of cell biology , 158 ( 1 ) , pp . 31 – 37 . Santini , D . et al . , 2011 . Human equilibrative nucleoside transporter 1 ( hENT1 ) levels predict response to gemcitabine in patients with biliary tract cancer ( BTC ) . Current cancer drug targets , 11 ( 1 ) , pp . 123 – 129 . Sathe , M . N . et al . , 2011 . Regulation of Purinergic Signaling in Biliary Epithelial Cells by Exocytosis of SLC17A9 - dependent ATP - enriched Vesicles . Journal of Biological Chemistry , 286 ( 28 ) , pp . 25363 – 25376 . Sechi , A . S . & Wehland , J . , 2000 . The actin cytoskeleton and plasma membrane connection : PtdIns ( 4 , 5 ) P ( 2 ) inﬂuences cytoskeletal protein activity at the plasma membrane . Journal of cell science , 113 Pt 21 , pp . 3685 – 3695 . Sengupta , D . J . & Unadkat , J . D . , 2004 . Glycine 154 of the equilibrative nucleoside transporter , hENT1 , is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine , dipyridamole , and dilazep . Biochemical pharmacology , 67 ( 3 ) , pp . 453 – 458 . Novel approaches to understanding hENT2 and hENT2 - related proteins 252 Sengupta , D . J . et al . , 2002 . A single glycine mutation in the equilibrative nucleoside transporter gene , hENT1 , alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine . Biochemistry , 41 ( 5 ) , pp . 1512 – 1519 . Serebriiskii , I . G . & Golemis , E . A . , 2001 . Two - hybrid system and false positives . Approaches to detection and elimination . Methods in molecular biology ( Clifton , N . J . ) , 177 , pp . 123 – 134 . Sevier , C . S . et al . , 2000 . Efﬁcient export of the vesicular stomatitis virus G protein from the endoplasmic reticulum requires a signal in the cytoplasmic tail that includes both tyrosine - based and di - acidic motifs . Molecular biology of the cell , 11 ( 1 ) , pp . 13 – 22 . Shanmugam , M . & Hernandez , N . , 2008 . Mitotic Functions for SNAP45 , a Subunit of the Small Nuclear RNA - activating Protein Complex SNAPc . Journal of Biological Chemistry , 283 ( 21 ) , pp . 14845 – 14856 . Sigoillot , F . D . et al . , 2005 . Nuclear localization and mitogen - activated protein kinase phosphorylation of the multifunctional protein CAD . The Journal of biological chemistry , 280 ( 27 ) , pp . 25611 – 25620 . Singh , K . K . et al . , 2010 . Human SAP18 mediates assembly of a splicing regulatory multiprotein complex via its ubiquitin - like fold . RNA ( New York , NY ) , 16 ( 12 ) , pp . 2442 – 2454 . Smith , C . W . & Valcárcel , J . , 2000 . Alternative pre - mRNA splicing : the logic of combinatorial control . Trends in biochemical sciences , 25 ( 8 ) , pp . 381 – 388 . Snider , J . et al . , 2010 . Detecting interactions with membrane proteins using a membrane two - hybrid assay in yeast . Nature Protocols , 5 ( 7 ) , pp . 1281 – 1293 . Stamm , S . , 2008 . Regulation of alternative splicing by reversible protein phosphorylation . The Journal of biological chemistry , 283 ( 3 ) , pp . 1223 – 1227 . Stamm , S . , 2002 . Signals and their transduction pathways regulating alternative splicing : a new dimension of the human genome . Human molecular genetics , 11 ( 20 ) , pp . 2409 – 2416 . Stamm , S . et al . , 2005 . Function of alternative splicing . Gene , 344 , pp . 1 – 20 . Stamnes , M . , 2002 . Regulating the actin cytoskeleton during vesicular transport . Current Opinion in Cell Biology , 14 ( 4 ) , pp . 428 – 433 . Bibliography 253 Stewart , M . , 2007 . Molecular mechanism of the nuclear protein import cycle . Nature reviews . Molecular cell biology , 8 ( 3 ) , pp . 195 – 208 . Stolk , M . et al . , 2005 . Subtype - speciﬁc regulation of equilibrative nucleoside transporters by protein kinase CK2 . The Biochemical journal , 386 ( Pt 2 ) , pp . 281 – 289 . Stros , M . , 2010 . HMGB proteins : interactions with DNA and chromatin . Biochimica et biophysica acta , 1799 ( 1 - 2 ) , pp . 101 – 113 . Sturiale , L . et al . , 2005 . Hypoglycosylation with increased fucosylation and branching of serum transferrin N - glycans in untreated galactosemia . Glycobiology , 15 ( 12 ) , pp . 1268 – 1276 . Sumanasekera , C . , Watt , D . S . & Stamm , S . , 2008 . Substances that can change alternative splice - site selection . Biochemical Society transactions , 36 ( Pt 3 ) , pp . 483 – 490 . Sun , S . et al . , 2010 . SF2 / ASF autoregulation involves multiple layers of post - transcriptional and translational control . Nature structural & molecular biology , 17 ( 3 ) , pp . 306 – 312 . Sundaram , M . et al . , 1998 . Chimeric constructs between human and rat equilibrative nucleoside transporters ( hENT1 and rENT1 ) reveal hENT1 structural domains interacting with coronary vasoactive drugs . The Journal of biological chemistry , 273 ( 34 ) , pp . 21519 – 21525 . Sundaram , M . et al . , 2001 . Topology of a human equilibrative , nitrobenzylthioinosine ( NBMPR ) - sensitive nucleoside transporter ( hENT1 ) implicated in the cellular uptake of adenosine and anti - cancer drugs . The Journal of biological chemistry , 276 ( 48 ) , pp . 45270 – 45275 . Sureau , A . et al . , 2001 . SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs . The EMBO journal , 20 ( 7 ) , pp . 1785 – 1796 . Suzuki , T . & Lennarz , W . J . , 2002 . Glycopeptide export from the endoplasmic reticulum into cytosol is mediated by a mechanism distinct from that for export of misfolded glycoprotein . Glycobiology , 12 ( 12 ) , pp . 803 – 811 . Svoboda , M . et al . , 2011 . Organic anion transporting polypeptides ( OATPs ) : regulation of expression and function . Current drug metabolism , 12 ( 2 ) , pp . 139 – 153 . Novel approaches to understanding hENT2 and hENT2 - related proteins 254 T Takahashi , T . et al . , 2010 . Adenosine and inosine release during hypoxia in the isolated spinal cord of neonatal rats . British Journal of Pharmacology , 161 ( 8 ) , pp . 1806 – 1816 . Tazi , J . , Bakkour , N . & Stamm , S . , 2009 . Alternative splicing and disease . Biochimica et biophysica acta , 1792 ( 1 ) , pp . 14 – 26 . Tietz , P . S . et al . , 2006 . Cytoskeletal and motor proteins facilitate trafﬁcking of AQP1 - containing vesicles in cholangiocytes . Biology of the cell / under the auspices of the European Cell Biology Organization , 98 ( 1 ) , pp . 43 – 52 . Tilgner , H . et al . , 2012 . Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co - transcriptional in the human genome but inefﬁcient for lncRNAs . Genome research , 22 ( 9 ) , pp . 1616 – 1625 . Tortorella , L . L . & Pilch , P . F . , 2002 . C2C12 myocytes lack an insulin - responsive vesicular compartment despite dexamethasone - induced GLUT4 expression . American journal of physiology Endocrinology and metabolism , 283 ( 3 ) , pp . E514 – 24 . Totoń , E . et al . , 2011 . Protein kinase Cε as a cancer marker and target for anticancer therapy . Pharmacological reports : PR , 63 ( 1 ) , pp . 19 – 29 . Tsang , R . Y . et al . , 2008 . Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts ﬂudarabine sensitivity in chronic lymphocytic leukemia . Modern pathology : an ofﬁcial journal of the United States and Canadian Academy of Pathology , Inc , 21 ( 11 ) , pp . 1387 – 1393 . Tseng , Y . et al . , 2005 . How actin crosslinking and bundling proteins cooperate to generate an enhanced cell mechanical response . Biochemical and biophysical research communications , 334 ( 1 ) , pp . 183 – 192 . U Ukairo , O . T . et al . , 2005 . Recognition of benztropine by the dopamine transporter ( DAT ) differs from that of the classical dopamine uptake inhibitors cocaine , methylphenidate , and mazindol as a function of a DAT transmembrane 1 aspartic acid residue . The Journal of pharmacology and experimental therapeutics , 314 ( 2 ) , pp . 575 – 583 . Bibliography 255 V Valdés , R . et al . , 2006 . TGF - β transcriptionally activates the gene encoding the high - afﬁnity adenosine transporter CNT2 in rat liver parenchymal cells . Cellular and molecular life sciences : CMLS , 63 ( 21 ) , pp . 2527 – 2537 . Valdés , R . et al . , 2009 . An ab Initio structural model of a nucleoside permease predicts functionally important residues . The Journal of biological chemistry , 284 ( 28 ) , pp . 19067 – 19076 . Valdés , R . , Shinde , U . & Landfear , S . M . , 2012 . Cysteine Crosslinking Deﬁnes the Extracellular Gate for the Leishmania donovani Nucleoside Transporter 1 . 1 . ( LdNT1 . 1 ) . Journal of Biological Chemistry . Vallejo - Illarramendi , A . , Domercq , M . & Matute , C . , 2005 . A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptake . Journal of neurochemistry , 95 ( 2 ) , pp . 341 – 348 . van Balkom , B . W . M . et al . , 2002 . The role of putative phosphorylation sites in the targeting and shuttling of the aquaporin - 2 water channel . The Journal of biological chemistry , 277 ( 44 ) , pp . 41473 – 41479 . Van Belle , H . , 1993 . Nucleoside transport inhibition : a therapeutic approach to cardioprotection via adenosine ? Cardiovascular research , 27 ( 1 ) , pp . 68 – 76 . van den Ent , F . , Amos , L . A . & Löwe , J . , 2001 . Prokaryotic origin of the actin cytoskeleton . Nature , 413 ( 6851 ) , pp . 39 – 44 . Venables , J . P . , 2006 . Unbalanced alternative splicing and its signiﬁcance in cancer . BioEssays : news and reviews in molecular , cellular and developmental biology , 28 ( 4 ) , pp . 378 – 386 . Venables , J . P . et al . , 2009 . Cancer - associated regulation of alternative splicing . Nature structural & molecular biology , 16 ( 6 ) , pp . 670 – 676 . Vickers , M . F . et al . , 1999 . Functional production and reconstitution of the human equilibrative nucleoside transporter ( hENT1 ) in Saccharomyces cerevisiae . Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation - defective derivative ( hENT1 / N48Q ) . The Biochemical journal , 339 ( Pt 1 ) , pp . 21 – 32 . Novel approaches to understanding hENT2 and hENT2 - related proteins 256 Villarroya , J . et al . , 2011 . Targeted impairment of thymidine kinase 2 expression in cells induces mitochondrial DNA depletion and reveals molecular mechanisms of compensation of mitochondrial respiratory activity . Biochemical and biophysical research communications , 407 ( 2 ) , pp . 333 – 338 . Visser , F . et al . , 2002 . Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole . The Journal of biological chemistry , 277 ( 1 ) , pp . 395 – 401 . Visser , F . , Baldwin , S . A . , et al . , 2005a . Identiﬁcation and mutational analysis of amino acid residues involved in dipyridamole interactions with human and Caenorhabditis elegans equilibrative nucleoside transporters . The Journal of biological chemistry , 280 ( 12 ) , pp . 11025 – 11034 . Visser , F . , Zhang , J . , et al . , 2005b . Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites . Molecular pharmacology , 67 ( 4 ) , pp . 1291 – 1298 . Vivet - Boudou , V . et al . , 2006 . Nucleoside and nucleotide inhibitors of HIV - 1 replication . Cellular and molecular life sciences : CMLS , 63 ( 2 ) , pp . 163 – 186 . W Wang , J . et al . , 1997 . Functional and molecular characteristics of Na ( + ) - dependent nucleoside transporters . Pharmaceutical research , 14 ( 11 ) , pp . 1524 – 1532 . Wang , J . et al . , 2011 . Splice Variant Speciﬁc Modulation of CaV1 . 2 Calcium Channel by Galectin - 1 Regulates Arterial Constriction . Circulation Research , 109 ( 11 ) , pp . 1250 – 1258 . Wang , Q . , Wang , X . & Evers , B . M . , 2003 . Induction of cIAP - 2 in human colon cancer cells through PKC delta / NF - kappa B . The Journal of biological chemistry , 278 ( 51 ) , pp . 51091 – 51099 . Wang , X . et al . , 2004 . COPII - dependent export of cystic ﬁbrosis transmembrane conductance regulator from the ER uses a di - acidic exit code . The Journal of cell biology , 167 ( 1 ) , pp . 65 – 74 . Wang , Y . & Miksicek , R . J . , 1991 . Identiﬁcation of a dominant negative form of the human estrogen receptor . Molecular endocrinology ( Baltimore , Md . ) , 5 ( 11 ) , pp . 1707 – 1715 . Bibliography 257 Wang , Y . - N . et al . , 2010 . Nuclear trafﬁcking of the epidermal growth factor receptor family membrane proteins . Oncogene , 29 ( 28 ) , pp . 3997 – 4006 . Ward , J . L . et al . , 2003 . Functional analysis of site - directed glycosylation mutants of the human equilibrative nucleoside transporter - 2 . Archives of Biochemistry and Biophysics , 411 ( 1 ) , pp . 19 – 26 . Ward , J . L . et al . , 2000 . Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters , ENT1 and ENT2 , stably expressed in nucleoside transporter - deﬁcient PK15 cells . Ent2 exhibits a low afﬁnity for guanosine and cytidine but a high afﬁnity for inosine . The Journal of biological chemistry , 275 ( 12 ) , pp . 8375 – 8381 . Watanabe , K . et al . , 1995 . Splicing isoforms of rat Ash / Grb2 . Isolation and characterization of the cDNA and genomic DNA clones and implications for the physiological roles of the isoforms . The Journal of biological chemistry , 270 ( 23 ) , pp . 13733 – 13739 . Watson , P . & Stephens , D . J . , 2005 . ER - to - Golgi transport : form and formation of vesicular and tubular carriers . Biochimica et biophysica acta , 1744 ( 3 ) , pp . 304 – 315 . Wendeler , M . W . , Paccaud , J . - P . & Hauri , H . - P . , 2007 . Role of Sec24 isoforms in selective export of membrane proteins from the endoplasmic reticulum . EMBO reports , 8 ( 3 ) , pp . 258 – 264 . Wiley , J . S . et al . , 1982 . Cytosine arabinoside inﬂux and nucleoside transport sites in acute leukemia . The Journal of clinical investigation , 69 ( 2 ) , pp . 479 – 489 . Williams , J . B . & Lanahan , A . A . , 1995 . A mammalian delayed - early response gene encodes HNP36 , a novel , conserved nucleolar protein . Biochemical and biophysical research communications , 213 ( 1 ) , pp . 325 – 333 . Wlcek , K . et al . , 2011 . The analysis of organic anion transporting polypeptide ( OATP ) mRNA and protein patterns in primary and metastatic liver cancer . Cancer biology & therapy , 11 ( 9 ) , pp . 801 – 811 . Wojtal , K . A . et al . , 2009 . Changes in mRNA Expression Levels of Solute Carrier Transporters in Inﬂammatory Bowel Disease Patients . Drug Metabolism and Disposition , 37 ( 9 ) , pp . 1871 – 1877 . Novel approaches to understanding hENT2 and hENT2 - related proteins 258 Wu , J . - C . , Liang , Z . - Q . & Qin , Z . - H . , 2006 . Quality control system of the endoplasmic reticulum and related diseases . Acta biochimica et biophysica Sinica , 38 ( 4 ) , pp . 219 – 226 . Wu , J . - Y . , Tang , H . & Havlioglu , N . , 2003 . Alternative pre - mRNA splicing and regulation of programmed cell death . Progress in molecular and subcellular biology , 31 , pp . 153 – 185 . Wu , S . K . et al . , 2005 . Fine tuning of rabbit equilibrative nucleoside transporter activity by an alternatively spliced variant . Journal of drug targeting , 13 ( 8 - 9 ) , pp . 521 – 533 . X Xia , L . , Zhou , M . & Wang , J . , 2007 . Drug Transporters G . You & M . E . Morris , eds . , Hoboken , NJ , USA : John Wiley & Sons , Inc . Y Yang , X . C . et al . , 2009 . Three Proteins of the U7 - Speciﬁc Sm Ring Function as the Molecular Ruler To Determine the Site of 3 ' - End Processing in Mammalian Histone Pre - mRNA . Molecular and cellular biology , 29 ( 15 ) , pp . 4045 – 4056 . Yao , S . Y . M . et al . , 2002 . Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2 . Chimeric constructs reveal a role for the ENT2 helix 5 - 6 region in nucleobase translocation . The Journal of biological chemistry , 277 ( 28 ) , pp . 24938 – 24948 . Yao , S . Y . M . et al . , 2011 . Nucleobase Transport by Human Equilibrative Nucleoside Transporter 1 ( hENT1 ) . Journal of Biological Chemistry , 286 ( 37 ) , pp . 32552 – 32562 . Yao , S . Y . M . et al . , 2001 . Transport of antiviral 3 ' - deoxy - nucleoside drugs by recombinant human and rat equilibrative , nitrobenzylthioinosine ( NBMPR ) - insensitive ( ENT2 ) nucleoside transporter proteins produced in Xenopus oocytes . Molecular Membrane Biology , 18 ( 2 ) , pp . 161 – 167 . Yegutkin , G . G . , 2008 . Nucleotide - and nucleoside - converting ectoenzymes : Important modulators of purinergic signalling cascade . Biochimica et biophysica acta , 1783 ( 5 ) , pp . 673 – 694 . Bibliography 259 Young , J . D . et al . , 2008 . Human equilibrative nucleoside transporter ( ENT ) family of nucleoside and nucleobase transporter proteins . Xenobiotica ; the fate of foreign compounds in biological systems , 38 ( 7 - 8 ) , pp . 995 – 1021 . Yu , L . et al . , 2009a . Prostaglandin E 2promotes cell proliferation viaprotein kinase C / extracellular signal regulated kinase pathway - dependent induction of c - Myc expression in human esophageal squamous cell carcinoma cells . International journal of cancer Journal international du cancer , 125 ( 11 ) , pp . 2540 – 2546 . Yu , M . - J . et al . , 2009b . Systems - level analysis of cell - speciﬁc AQP2 gene expression in renal collecting duct . Proceedings of the National Academy of Sciences of the United States of America , 106 ( 7 ) , pp . 2441 – 2446 . Z Zhang , J . et al . , 2007 . The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs . Cancer and Metastasis Reviews , 26 ( 1 ) , pp . 85 – 110 . Zhang , J . , Sun , X . , et al . , 2006a . Studies of nucleoside transporters using novel autoﬂuorescent nucleoside probes . Biochemistry , 45 ( 4 ) , pp . 1087 – 1098 . Zhang , J . , Tackaberry , T . , et al . , 2006b . Cysteine - accessibility analysis of transmembrane domains 11 - 13 of human concentrative nucleoside transporter 3 . The Biochemical journal , 394 ( Pt 2 ) , pp . 389 – 398 . Zhou , F . et al . , 2005 . The role of N - linked glycosylation in protein folding , membrane targeting , and substrate binding of human organic anion transporter hOAT4 . Molecular pharmacology , 67 ( 3 ) , pp . 868 – 876 . Zhou , M . et al . , 2010 . Adenosine Transport by Plasma Membrane Monoamine Transporter : Reinvestigation and Comparison with Organic Cations . Drug metabolism and disposition : the biological fate of chemicals , 38 ( 10 ) , pp . 1798 – 1805 . Zhou , M . et al . , 2007 . Molecular determinants of substrate selectivity of a novel organic cation transporter ( PMAT ) in the SLC29 family . The Journal of biological chemistry , 282 ( 5 ) , pp . 3188 – 3195 . Zhou , W . et al . , 1993 . Protein kinase C - mediated bidirectional regulation of DNA synthesis , RB protein phosphorylation , and cyclin - dependent kinases in human vascular endothelial cells . The Journal of biological chemistry , 268 ( 31 ) , pp . 23041 – 23048 . Novel approaches to understanding hENT2 and hENT2 - related proteins 260 Zoulim , F . , 2005 . Combination of nucleoside analogues in the treatment of chronic hepatitis B virus infection : lesson from experimental models . The Journal of antimicrobial chemotherapy , 55 ( 5 ) , pp . 608 – 611 . Zuleger , N . , Korfali , N . & Schirmer , E . C . , 2008 . Inner nuclear membrane protein transport is mediated by multiple mechanisms . Biochemical Society transactions , 36 ( Pt 6 ) , pp . 1373 – 1377 . Zuzarte , M . et al . , 2007 . A di - acidic sequence motif enhances the surface expression of the potassium channel TASK - 3 . Trafﬁc ( Copenhagen , Denmark ) , 8 ( 8 ) , pp . 1093 – 1100 . Bibliography 261 19 ANTECEDENTES (cid:2) La bioasequibilidad y la acción de los fármacos derivados de nucleósidos utilizados en la terapia antitumoral dependen en gran medida de la capacidad de las células diana para internalizarlos y activarlos metabólicamente . Estos fármacos interﬁeren en los procesos de captación y metabolización de los nucleósidos naturales , incidiendo así en una de las rutas metabólicas probablemente mejor conservadas evolutivamente , la vía de recuperación , ﬁnamente regulada y de notable eﬁcacia energética si se tiene en cuenta el coste asociado a la síntesis de novo de nucleósidos ( Molina - Arcas et al . 2006 ) . (cid:2) Dado su carácter hidrofílico , tanto los nucleósidos como sus derivados requieren de transportadores de membrana para poder ser internalizados . Existen dos grupos de transportadores de nucleósidos ( NTs ) según su dependencia energética : los transportadores de tipo equilibrativo ( ENTs ) independientes de sodio , los cuales transportan sustratos por difusión facilitada a favor de gradiente , y los transportadores de tipo concentrativo ( CNTs ) , que transportan en contra de gradiente con un gasto energético asociado ( Molina - Arcas et al . 2006 ; Pastor - Anglada et al . 2004 ) . De todos ellos , sólo uno , hENT2 ( human Equilibrative Nucleoside Transporter 2 ) tiene además la capacidad de poder transportar nucleobases , lo cual le conﬁere un papel crucial en la captación de estas unidades elementales susceptibles también de ser incorporadas a ácidos nucleicos mediante las vías de recuperación de las nucleobases . (cid:2) Por otro lado , el fenómeno de splicing alternativo es una de las mayores fuentes de diversidad proteómica en humanos , destacando su efecto tanto en enfermedades como en terapéutica ( Garcia - Blanco et al . 2004 ) . La actividad ﬁsiológica de los distintos productos obtenidos mediante este proceso , en comparación con la proteína original , pueden ser totalmente distintos . Por ejemplo , se han descrito variantes que actúan como dominantes negativos , bloqueando la actividad de la proteína original ( Wu et al . 2003 ) , mientras que otros pueden alterar su localización subcelular , transformando así proteínas integrales de membrana en proteínas solubles Resumen en Castellano 265 ( Jang 2002 ) o asociadas a otros orgánulos como el retículo endoplasmático o el núcleo ( Vallejo - Illarramendi et al . 2005 ; Errasti - Murugarren et al . 2009 ) . (cid:2) Tal y como se ha comentado , los transportadores de nucleósidos , además de transportar sus sustratos naturales , los nucleósidos , tienen también la capacidad de transportar fármacos antivirales y antitumorales derivados de nucleósidos . En estas terapias se suelen dar casos de resistencia a dichos tratamientos , lo cual podría ser debido , entre otros factores , a deﬁciencias en el transporte y entrada de los fármacos al interior celular . En el caso concreto de hENT2 , éste juega un importante papel en el tratamiento de leucemia linfática crónica ( LLC ) ( Pastor - Anglada et al . 2004 ) , dado que es el mediador de la respuesta transcriptómica derivada del tratamiento con ﬂudarabina , el fármaco más utilizado en el tratamiento de LLC , por lo que hENT2 se erige claramente como diana farmacológica en ésta y quizá otras enfermedades linfoproliferativas . Por otro lado , hENT2 también fue identiﬁcado , independientemente , como uno de los cinco genes que permiten anticipar progresión y / o mejoría de la enfermedad en pacientes diagnosticados de linfoma de células de manto ( LCM ) ( Hartmann et al . 2008 ) . De esta manera , la existencia de formas de splicing alternativo de hENT2 las cuales no fuesen funcionales o , incluso , actuasen como dominantes negativos de la proteína natural , podrían estar relacionados con mecanismos de resistencia a tratamientos con fármacos derivados de nucleósidos . (cid:2) El gen SLC29A2 codiﬁca para una proteína de 456 aminoácidos , hENT2 , de amplia expresión tisular y poco caracterizada hasta la fecha en cuanto a su regulación y a su papel biológico . No obstante , existen evidencias descritas sobre dos posibles variantes fruto del splicing alternativo de este transportador . Una de ellas es una variante con una deleción de 40 pares de bases en el exón 9 del ARNm . Dicha alteración produce un codón de parada prematuro , el cual se traduce en una proteína de tan solo 6 dominios transmembrana , mientras que la proteína original tiene 11 . Se apunta que esta proteína no sería funcional en cuanto a transporte de nucleósidos y derivados , y que probablemente vaya dirigida al retículo endoplasmático en lugar de la membrana plasmática ( Mangravite et al . 2003 ) . La otra variante descrita fue identiﬁcada antes de la clonación de hENT2 . Se identiﬁcó como un gen de respuesta Novel approaches to understanding hENT2 and hENT2 - related proteins 266 tardía a estímulos mitogénicos ( HNP36 ) , a pesar de que su papel funcional no se determinó entonces . Esta variante es fruto de una deleción de 65 pares de bases en el exón 4 , hecho que genera una proteína que contiene los últimos 8 dominios transmembrana de la proteína natural . A pesar de no saber su funcionalidad sí que se observó su localización en la periferia del núcleo celular ( Williams & Lanahan 1995 ) . (cid:2) En nuestro laboratorio se generaron evidencias de la posible existencia de una nueva variante de splicing del transportador de hENT2 , a pesar de que en su momento no se profundizó ni en su caracterización ni en su papel funcional . Aún así , nos sirvió como punto de partida para iniciar una nueva vía de investigación sobre las variantes de splicing alternativo del transportador de nucleósidos y fármacos antitumorales hENT2 . (cid:2) Recientemente , se ha sugerido que el análisis transcriptómico de genes que codiﬁquen para proteínas transportadoras de membrana , determinantes para la internalización de fármacos y su acción citotóxica , en tumores podría suponer una herramienta de predicción de respuesta terapéutica , introduciendo así el concepto de Transportoma ( Huang et al . 2004 ) . En base a esto , surge la idea de poder desarrollar un test reproducible que , mediante la caracterización de la expresión de una batería de genes , incluyendo transportadores de nucleósidos y sus correspondientes variantes de splicing , permita predecir la sensibilidad / resistencia a la quimioterapia en tumores digestivos . 20 OBJETIVOS GENERALES • Identiﬁcación y clonación de posibles nuevas variantes de splicing del transportador hENT2 . • Caracterización y análisis de la localización y función de dichas variantes en su posible papel como transportadores de nucleósidos y fármacos derivados de éstos . Resumen en Castellano 267 • Análisis de la presencia de estas variantes de splicing en distintas líneas y tejidos , tanto tumorales como muestras sanas . • Identiﬁcación de los aminoácidos fosforilados por determinadas kinasas en el loop intracelular de h / mENT2 . • Efecto de la regulación de hENT2 por fosforilación . • Identiﬁcación de posibles proteínas de interacción del transportador de nucleósidos hENT2 mediante la técnica del doble - híbrido en membrana de levaduras ( MYTH ) . • Identiﬁcación de genes relacionados con transportadores de membrana cuya expresión basal permita predecir la respuesta a distintos tratamientos antineoplásicos . 21 RESUMEN DE LOS RESULTADOS OBTENIDOS EN EL PROYECTO DE TESIS 21 . 1 IDENTIFICACIÓN Y CARACTERIZACIÓN DE 3 NUEVAS VARIANTES NUCLEARES DE SPLICING ALTERNATIVO DEL TRANSPORTADOR DE NUCLEÓSIDOS EQUILIBRATIVO HUMANO 2 ( hENT2 ) (cid:2) El principal objetivo en la fase inicial de este proyecto ha sido la identiﬁcación y clonación de nuevas variantes de splicing del gen SLC29A2 , el cual codiﬁca para la proteína hENT2 , a partir del ADNc de la línea celular de cáncer de mama MCF7 . De todas las posibles variantes de este gen generadas por el proceso de splicing alternativo , decidimos seguir con el estudio de 6 de ellas : 3 con deleciones al inicio del tránscrito ( exones 2 y 4 ) , 2 con deleciones al ﬁnal del tránscrito ( exón 8 y 40 pbs del exón 9 ) y otra variante con deleciones tanto al inicio como al ﬁnal de la secuencia ( exón 2 y 40 pbs del exón 9 ) . Novel approaches to understanding hENT2 and hENT2 - related proteins 268 (cid:2) Para analizar la expresión proteica de dichas variantes y su localización subcelular , se le añadió un epítopo “HA” de nueve aminoácidos a cada una de las isoformas de hENT2 . De esta manera , con un anticuerpo especíﬁco contra el epítopo distinguimos la banda proteica que se corresponde a cada una de las variantes mediante la técnica de Western - Blott ( WB ) y así determinamos su peso molecular alrededor de 32 - 36KDa . Estas mismas bandas fueron identiﬁcadas en el extracto de proteína total de células pertenecientes a la línea celular de placenta BeWo , de la cual ya se había descrito previamente la presencia de transportadores ENTs en la membrana nuclear ( Mani et al . 1998 ) . Dado que dichas variantes conservan el loop intracelular entre los dominios transmembrana 6 y 7 , el uso de un anticuerpo comercial diseñado para reconocer esta región como epítopo nos permitió detectar las nuevas variantes nucleares de hENT2 endógenamente . (cid:2) Una vez conﬁrmada la síntesis proteica de estas variantes de splicing , realizamos experimentos de inmunocitoquímica ( ICQ ) en células HeLa y también HEK - 293 , transfectadas con los distintos constructos con el epítopo HA para poder determinar la localización subcelular de las distintas variantes . Los resultados obtenidos a partir de estos experimentos nos muestran claramente como las tres variantes con deleciones en los exones 2 y / o 4 sintetizan proteínas localizadas en la membrana nuclear en lugar de la membrana plasmática . En cuanto a las otras tres posibles variantes que probamos , no las llegamos a identiﬁcar ni por WB ni por ICQ . (cid:2) A pesar de tener evidencias de la síntesis proteica de las isoformas nucleares de hENT2 tanto por WB como por ICQ , queríamos descartar la posibilidad de que fuese un hecho artefactual debido a la sobreexpresión de estas variantes . Realizamos experimentos de bloqueo de la vía de NMD para ver si realmente el ARNm de estas variantes de splicing es estable y no se degrada , permitiendo sintetizar las proteínas resultantes de manera endógena , sin que sea por efecto de la sobreexpresión ( Boutz et al . 2007 ) . Resumen en Castellano 269 (cid:2) La vía de NMD ( Non - sense Mediated Decay ) es un mecanismo celular que permite degradar todos aquellos ARNm generados durante su proceso de maduración y cuyos productos no tengan ninguna viabilidad , de manera que no se llegue a sintetizar tal proteína aberrante . Al bloquear esta vía tratando las muestras con cicloheximida ( CHX ) , impedimos que este mecanismo tenga lugar . De esta manera , si los niveles de expresión de un determinado transcrito aumentan después del tratamiento con CHX signiﬁca que éste es degradado por dicha vía y por tanto no expresado endógenamente . Por lo contrario , si los niveles no se ven alterados tras el tratamiento signiﬁca que ese mensajero se traduce a proteína regularmente . (cid:2) En nuestro caso hicimos estos ensayos con células HEK - 293 . Para analizar los niveles de expresión de las distintas variantes usamos la técnica de PCR a tiempo real utilizando el reactivo SYBRGreen® y un conjunto de oligos diseñados especíﬁcamente para reconocer cada una de las isoformas individualmente . Los resultados muestran que , coincidiendo con los resultados observados por WB e ICQ , las variantes nucleares de hENT2 se llegan a sintetizar de manera natural al no degradar su ARNm , mientras que las demás variantes serían degradadas a través de la vía de NMD . (cid:2) Seguidamente , determinamos la capacidad transportadora de dichas isoformas transfectadas en células HeLa . En aquellas muestras que sobreexpresaban hENT2 wt sí que se observó un aumento de la capacidad de transportar el sustrato uridina marcado radioactivamente . En cambio , no se apreciaron cambios en el transporte basal cuando se transfectaron las variantes de splicing de hENT2 , coincidiendo así con su localización celular alrededor del núcleo en vez de la membrana plasmática . Con tal de determinar si dichas variantes de hENT2 son funcionales en la membrana nuclear , inyectamos oocitos de Xenopus laevis con las distintas isoformas de hENT2 para poder sustraer los núcleos y determinar su capacidad transportadora . Sorprendentemente , las variantes nucleares de hENT2 parecen ir dirigidas a la membrana plasmática en lugar de la nuclear tal y como sucedió con células humanas . Así pues , pudimos realizar ensayos de transporte con oocitos para determinar que las variantes nucleares de hENT2 son ciertamente Novel approaches to understanding hENT2 and hENT2 - related proteins 270 funcionales , capaces de internalizar la nucleobase hipoxantina pero no el nucleósido cloro - adenosina . (cid:2) Finalmente , analizamos la expresión de las variantes de hENT2 por PCR cualitativa en una batería de líneas tumorales con distintas condiciones de crecimiento . Los resultados observados mostraban cambios en los perﬁles de expresión según las condiciones de crecimiento y entre las líneas de distintos orígenes tumorales . De esta manera se abre una posible vía de estudio sobre las distintas condiciones y mecanismos de regulación del fenómeno de splicing alternativo que afecta al gen de hENT2 . 21 . 2 ESTUDIO DE LA REGULACIÓN DE hENT2 POR FOSFORILACIÓN Y SU EFECTO EN EL TRÁFICO A MEMBRANA PLASMÁTICA (cid:2) Cuando realizamos los experimentos de inmunocitoquímica en células HeLa transfectadas con las distintas isoformas de hENT2 - HA , observamos que la proteína wt no solamente se encontraba en la membrana plasmática sino que además podía hallarse justo por debajo de ésta . Con tal de veriﬁcar la presencia de esta proteína tanto en membrana plasmática como en el interior celular , hicimos ensayos de biotinilización en células HeLa , esta vez sin transfectar . (cid:2) En el proceso de biotinilización lo que se hace es incubar células intactas con una solución rica en biotina , una molécula capaz de unirse a residuos NHS de otras proteínas , de manera que se formen enlaces entre las proteínas presentes en la membrana plasmática y la biotina . A continuación , se obtiene un homogenado proteico total de estas células , el cual se incubará con Streptavidina unida a unas bolitas de resina . La Streptavidina tiene la capacidad de unirse a la biotina , y al estar unida a una resina nos permite separar la biotina unida a las proteínas de membrana del extracto proteico total . De esta manera , mediante la técnica de WB aplicada a las proteínas de membrana obtenidas por biotinilización , observamos que la banda perteneciente a hENT2 wt realmente era un doblete , cuya banda de menor peso molecular se encuentra en la membrana plasmática , mientras que la otra es intracelular , Resumen en Castellano 271 probablemente justo por debajo de la membrana según mostraba la ICQ . Nuestra hipótesis , basada en parte en trabajos previos sobre hENT1 ( Stolk et al . 2005 ; Bone et al . 2007 ) , fue que la pequeña diferencia de peso entre las dos bandas podría deberse a la presencia de residuos fosforilados . De modo que según el estado de fosforilación de hENT2 , éste podría estar localizado en la membrana plasmática o bien en vesículas cercanas a esta región , listas para ser enviadas a la membrana en caso de ser necesario . (cid:2) Basados en estas suposiciones , decidimos estudiar en detalle el estado de fosforilación de la proteína hENT2 y los efectos de este tipo de regulación en el transportador . Para ello , decidimos centrarnos en la región del loop intracelular entre los dominios transmembrana 6 y 7 dado que es la región con más probabilidades de interaccionar con otras proteínas tales como kinasas . Así pues , analizamos bioinformáticamente los posibles residuos susceptibles de ser fosforilados por determinadas kinasas en tal secuencia de aminoácidos , tanto para la proteína humana hENT2 como su ortólogo en ratón , mENT2 . Tales resultados apuntan como los principales candidatos para fosforilar ENT2 las kinasas PKA , PKC y CKII . (cid:2) Con tal de llevar a cabo estudios de fosforilación in vitro y análisis por espectrometria de masas ( MS ) , obtuvimos grandes cantidades de péptido artiﬁcial con la secuencia del loop de ENT2 incorporada , sobreexpresándolo y puriﬁcándolo a partir de cultivo bacteriano . Ambos péptidos , hENT2 - loop y mENT2 - loop , fueron tratados in vitro con las distintas kinasas predichas , utilizando ATP marcado radioactivamente para detectar los casos en los que se añadieron grupos fosfatos en el péptido . Los resultados mostraron claramente como tanto hENT2 y mENT2 son fosforilados por CKII . La misma reacción fue repetida con ATP frío solamente y se procesaron las muestras por MS / MRM con tal de hallar aquellos residuos los cuales son fosforilados por CKII . Desafortunadamente , hasta la fecha solo hemos identiﬁcado un residuo fosforilado por CKII en el caso de mENT2 , Thre223 , mientras que los protocolos seguidos hasta la fecha no han conseguido una buena cobertura de la secuencia total de la muestra humana . Novel approaches to understanding hENT2 and hENT2 - related proteins 272 A pesar de que nuestros resultados de fosforilación in vitro con PKC no fueron concluyentes , se publicó anteriormente cómo la activación de PKC a través del tratamiento con PDD ( 10 minutos , 500 nM ) incrementa la actividad del transportador ( Lu et al . 2010 ) . Decidimos analizar el efecto de la activación de PKC en la actividad y localización subcelular de hENT2 . Cuando realizamos ensayos de transporte en células HEK - 293 tratadas con PDD , no observamos ningún cambio aparente en la actividad del transportador . Sin embargo , hubo una signiﬁcativa disminución de la actividad de hENT1 debido a la activación de PKC . Por otro lado , realizamos ensayos de ICQ con células HEK - 293 transfectadas con los constructos hENT2 - HA y hENT1 - FLAG , con tal de detectar selectivamente cada uno de los transportadores según su epítopo especíﬁco . Después de tratar las células con PDD lo que observamos fue como en células no estimuladas , hENT2 se encuentra mayoritariamente por debajo de la membrana , dónde se encuentra hENT1 . Sin embargo , después de la activación de PKC hENT2 es translocado a la membrana plasmática donde colocaliza con hENT1 ( ﬁgura 1 - ﬁgure 42 ) . Figura 1 ( ﬁgure 42 ) . Efecto de la activación de PKC por PDD en el tráﬁco de hENT2 a la membrana plasmática . Células HEK - 293 transfectadas con los constructos de hENT2 - HA y hENT1 - FLAG y tratadas con PDD para activar PKC . En condiciones control , hENT2 es predominantemente presente por debajo de la membrana plasmática ( verde ) mientras que hENT1 está localizado en la membrana plasmática ( rojo ) . Después del tratamiento con PDD , hENT2 colocaliza con hENT1 en la membrana plasmática ( amarillo ) . Resumen en Castellano 273 (cid:2) Estos resultados nos muestran claramente como existe una cierta regulación de hENT2 por fosforilación , a pesar de que aún no se haya resuelto qué kinasa es responsable de ello en un sistema ex vivo . No obstante , la activación de PKC , ya sea por fosforilación directa o indirecta , promueve la translocación de hENT2 a la membrana plasmática , inhibiendo aparentemente la actividad del transportador de la misma familia , hENT1 . 21 . 3 DETECCIÓN A GRAN ESCALA DE PROTEÍNAS DE INTERACCIÓN DE hENT2 MEDIANTE LA TÉCNICA DE DOBLE - HÍBRIDO EN MEMBRANA DE LEVADURAS ( MYTH ) (cid:2) La técnica del doble - híbrido es comúnmente utilizada para identiﬁcar posibles proteínas de interacción aportando información sobre la función biológica de tales proteínas . Debido a su carácter hidrófobo , la clásica técnica del doble - híbrido difícilmente proporciona resultados positivos ﬁables en el caso de las proteínas de membrana tales como nuestro transportador hENT2 . Recientemente , una nueva versión del doble - híbrido desarrollada por el laboratorio del Dr . Staglar nos permite aplicar el principio de esta técnica a proteínas de membrana , el MYTH ( Snider et al . 2010 ) . (cid:2) Esta técnica se basa en los estudios previos de 1994 ( Johnsson & Varshavsky 1994 ) en los que se describía como la ubiquitina , dividida en dos mitades podía re - asociarse debido a la alta aﬁnidad de dichas mitades entre sí . Estás dos fracciones fueron nombradas Nub para el N - terminal de la proteína , y Cub para el C - terminal de la ubiquitina . De esta manera , al fusionar Cub con nuestra proteína de interés , llamada cebo , y analizarla frente a una librería de cDNAs con el Nub fusionado en cada tránscrito , llamado presas , podemos detectar aquellas proteínas que interactuen con nuestro cebo re - estableciendo la molécula de ubiquitina . Una vez se completa la unión de Nub y Cub completando la ubiquitina , ésta es reconocida por proteasas especíﬁcas que cortarán la proteína Cub , liberando los genes reporteros unidos a ella . Dado que esta técnica tiene lugar en el citosol en lugar del interior nuclear , se puede aplicar a Novel approaches to understanding hENT2 and hENT2 - related proteins 274 proteínas de membrana las cuales tienen un lado intracellular con el que interactuar con otras proteínas y restaurar la molécula de ubiquitina . (cid:2) Los resultados obtenidos para hENT2 mediante esta técnica han dado un número muy elevado de posibles proteínas de interacción , faltando ser validadas mediante otras técnicas . Un total de 110 proteínas fueron identiﬁcadas , buena parte de ellas pudiendo ser consideradas como falsos positivos de la técnica en sí . Sorprendentemente , los resultados mostraron un buen número de proteínas localizadas en el interior nuclear , la mayoría relacionadas con el proceso de splicing o bien con el transporte de moléculas a través de la membrana nuclear . A priori , estos resultados no tendrían sentido de solo considerar ENT2 como proteína cebo . No obstante , en apartados anteriores hemos descrito 3 nuevas variantes de splicing de hENT2 que codiﬁcan dos nuevas isoformas nucleares del transportador . Estas variantes conservan el gran loop intracelular de hENT2 , la única región a través de la cual esta proteína podría interactuar con otras . De manera que los resultados obtenidos referentes a proteínas nucleares reﬂejen posibles interacciones con las variantes nucleares del transportador . (cid:2) Otras proteínas interesantes halladas a partir del MYTH son ciertas kinasas y fosfatasas , junto la proteína Gs vinculada a la activación de PKA por AMP cíclico ( cAMP ) . A pesar de que tales interacciones aún no has sido validadas , proponemos un plausible escenario en el que ENT2 regularía su propia expresión modulando su propio patrón de splicing a través de su estado de fosforilación ( ﬁgura 2 - ﬁgure 48 ) . Resumen en Castellano 275 Figura 2 ( ﬁgure 48 ) . Especulación de una plausible regulación del patrón de splicing de hENT2 mediante fosforilación . ENT2 internaliza adenosina ( Ado ) modulando sus niveles extracelulares . La adenosina extracelular se une a los receptores de adenosina ( AR ) dependiendo de su concentración , activando así la proteína Gs , la cual a su vez podría estar interactuando con ENT2 según nuestros resultados obtenidos con la técnica del MYTH . Gs activa la adenilato ciclasa la cual sintetiza cAMP a partir de ATP . cAMP activa PKA quien fosforila los inhibidores de la proteína fosfatasa 1 ( PP1 ) ( DARP - 32 i I - 1 ) . Estos inhibidores una vez fosforilados interactúan alostéricamente con PP1 inhibiendo su actividad fosfatasa . Tal y como muestran nuestros resultados , PP1 podría interactuar con hENT2 al igual que HNP32 y HNP36 , sus variantes nucleares de 32 y 36 KDa respectivamente , regulando su estado de fosforilación . Se ha descrito que PP1 está también involucrada en en la regulación del splicing alternativo dado que desfosforila un buen número de factores de splicing ( SF ) . El estado de fosforilación de dichos factores puede condicionar su aﬁnidad por determinados sitios de corte en el pre - mRNA , aunque a su vez también podría determinar la interacción entre SF y HNP32 / 36 . Si HNP32 / 36 se unieses a determinados SF , esto comprometería la disponibilidad de éstos para deﬁnir los sitios de corte del pre - mRNA por el spliceosoma . De esta manera , dependiendo del estado de fosforilación de tanto HNP32 / 36 como de los SF , la célula produciría un patrón distinto de splicing alternativo modulando la expresión de las isoformas de HENT2 . En nuestro ejemplo , el SF fosforilado ( rojo ) determinaría unos sitios concretos de corte del pre - mRNA que producirían la variante de splicing “A” , la cual codiﬁca la proteína HNP36 . En cambio , los SF no fosforilados ( azul ) , permanecerían unidos a HNP32 / 36 siendo retenidos en la membrana nuclear y no estando disponibles durante el proceso de splicing . Como consecuencia , se producirían menores cantidades del producto “b” y por lo tanto la expresión de ENT2 disminuiría . Novel approaches to understanding hENT2 and hENT2 - related proteins 276 21 . 4 ANÁLISIS FARMACOGENÓMICO DE LA RESPUESTA A TRATAMIENTOS DE TUMORES SÓLIDOS : PROYECTO TRANSPORTOMA (cid:2) Paralelamente , se empezó otro proyecto basado en el concepto de “Transportoma” . Durante el primer período de la tesis se llevó a cabo toda la parte experimental , que incluía los tratamientos de las 15 lineas tumorales con los 6 fármacos antineoplásicos , además del análisis de expresión de 96 genes . (cid:2) (cid:2) El objetivo inicial de este proyecto , tal y como se ha explicado anteriormente , era el de poder correlacionar niveles expresión basal de genes que codiﬁcan para distintas proteínas transportadoras con respuesta a tratamientos antitumorales . Una vez realizada toda la parte experimental , tanto los tratamientos con fármacos como el análisis de los niveles de ARNm de los 96 genes , restaba procesar todos los datos obtenidos para ver si existía tales correlaciones que nos permitiesen obtener una herramienta de carácter predictivo . (cid:2) Una vez realizado el análisis bioinformático , obtuvimos correlaciones entre niveles de expresión entre determinados genes y respuesta a los tratamientos con cisplatino y paclitaxel , principalmente . No obstante , resta por hacer algunos experimentos adicionales que nos permitan acabar de conﬁrmar estas correlaciones ampliando el número de muestras . (cid:2) Por otro lado , solamente el análisis de expresión de todos estos genes en 15 muestras distintas nos ha permitido deﬁnir redes de genes correlacionados entre sí , independientemente de las respuestas a los tratamientos . Este análisis nos ha reportado resultados inesperados en los que se vincula , a nivel de expresión de ARNm , transportadores de membrana ( entre ellos hENT2 ) con genes clave para el metabolismo de nucleótidos , reparación del ADN , proliferación y supervivencia celular ( ﬁgura 3 - ﬁgure 55 ) . Dichas correlaciones no han sido descritas en humanos hasta la fecha . No obstante , en el campo de las levaduras sí que existen trabajos de análisis masivo del genoma en que se establecen vínculos entre genes del metabolismo de nucleótidos con sistemas de reparación del ADN , proliferación y supervivencia , donde Resumen en Castellano 277 describen la vital importancia de estas redes génicas a nivel celular ( Hannum et al . 2009 ; Pan et al . 2006 ; Conde - Pueyo et al . 2009 ) . Después de un intensivo trabajo bibliográﬁca , encontramos evidencias de la regulación y / o interacción de muchos de los genes encontrados en nuestra red génica con la kinasa PKC , ya sea directa o indirectamente ( ﬁgura 4 - ﬁgure 59 ) . Estas interacciones se corresponden además con el tipo de correlaciones halladas en las expresiones génicas , de manera que PKC regularía de manera similar a genes con una correlación positiva entre sí . Estos hallazgos nos indican que dicha red de genes correlacionados entre sí no sería algo azaroso sino ﬁnamente regulado por otros elementos no identiﬁcados en nuestro análisis inicial . Figura 3 ( ﬁgure 55 ) . Esquema de los genes correlacionados entre sí , todos ellos involucrados en vías de metabolismo de nuceótidos , reparación del ADN , supervivencia y proliferación . En rojo están representados genes que correlacionan signiﬁcativamente entre ellos y en verde aquellos con correlaciones negativas . Novel approaches to understanding hENT2 and hENT2 - related proteins 278 Figura 4 ( ﬁgure 59 ) . Representación de aquellos genes presentes en nuestra red génica , de los cuales hay evidencias de su relación / interacción con PKC , directa o indirectamente . 22 CONCLUSIONES 1 . Hemos identiﬁcado 3 nuevas variantes de splicing del transportador de nucleósidos equilibrativo 2 ( hENT2 ) , las cuales codiﬁcan dos nuevas isoformas nucleares de la proteína . Dichas variantes parecen ser funcionales i estar ubicuamente expresadas en líneas celulares y tejidos sanos . 2 . hENT2 es fosforilado in vitro por la kinasa CKII . Dado que CKII se encuentra constitutivamente activa , hENT2 podría estar regulado por desfosforilación a través de PP1 . Resumen en Castellano 279 3 . La activación de PKC mediante el tratamiento con PDD promueve la translocación de de hENT2 hacia la membrana plasmática en células HEK - 293 , a la vez que disminuye la actividad transportadora de hENT1 . 4 . hENT2 podría tener una población dual en la membrana plasmática . De manera que una isoforma no fosforilada de hENT2 , de unos 54 KDa , podría estar relacionada con la actividad transportadora , mientras que otra isoforma de 45 KDa no sería activa como transportador , a pesar de estar situada en la membrana plasmática . 5 . Hemos deﬁnido una red global de genes aparentemente invueltos en proliferación celular y proliferación . ENT1 , ENT2 y CNT3 forman parte de esta red génica , en la cual PKC podría tener un papel central regulador . 6 . ENT2 , junto con otros genes implicados en la proliferación celular y supervivencia , correlacionan negativamente con la supervivencia celular en respuesta al tratamiento con paclitaxel en lineas celulares gastro - hepáticas . Novel approaches to understanding hENT2 and hENT2 - related proteins 280 Figure 60 . Predicted ORF for the transcript X86681 . Unlike it has been described in 1995 , results obtained from ORF Finder software and “Clone Manager” program we used , the main ORF predicted for the transcript X86681 is a 336 aa protein , instead of 326 aa they assumed for the HNP36 protein , which would start at the second methionine highlighted . Appendix I 283 F i gu r e 61 . I mm uno cy t o c h e m i s t r y o f h E N T 2 - HA w t c on s t r u c t s i n H e L a ce ll s . U n li k e ou r da t a f r o m H EK - 293 c e ll s , t he w t h E N T 2 - H A c on s t r u c t w a s s o r t ed t o t he nu c l ea r m e m b r ane ( o r r e l a t ed s t r u c t u r e s ) . H o w e v e r , t he s e r e s u l t s a r e p r e li m i na r y and h E N T 2 - H A w t i s u s ua ll y l o c a t ed t o t he p l a s m a m e m b r ane . W e p r opo s e t ha t t he w t m a y f o r m he t e r o m e r s w i t h t he nu c l ea r v a r i an t s , and t hu s a c t a s a do m i nan t nega t i v e . H eLa s p li c i ng pa tt e r n s s ugge s t t ha t t he s e c e ll s e x p r e ss m o r e nu c l ea r v a r i an t 45 F t han w t a s s ho w n i n ﬁ gu r e 32 . F u r t he r a ss a ys need t o be pe r f o r m ed t o c on ﬁ r m o r d i sc a r d t ha t h y po t he s i s . Novel approaches to understanding hENT2 and hENT2 - related proteins 284 Table 20 . Primers used for this dissertation hENT2 CLONING : FL4F : 5ʼ - CCTGTAGGACTGCACTGAAG - 3ʼ FL5R : 5ʼ - GGATCTCAGCTCCGGAAGG - 3ʼ E4R : 5ʼ - CCTGTAGGACTGCACTGAAC - 3ʼ SYBR GREEN REAL - RIME PCR : F1 : 5ʼ - CGCGGGACAGTACTTCCAGG - 3ʼ F2 : 5ʼ - CCGCCATCCCGTACTTCCAGG - 3ʼ R1 : 5ʼ - CCGGGACGCACTGGTACAGG - 3ʼ R2 : 5ʼ - GCACTGAAGGCACTGGTACAGG - 3ʼ nPTB exon 8 Fwd : 5ʼ - GCATTTGCCAAGGAGACATCC - 3ʼ nPTB exon 9 - 11 Rv : 5ʼ - CCATAAACACCTCTTCATTT - 3ʼ GAPDH Fwd : 5ʼ - GACCTTGGCCAGGGGTGCTAA - 3ʼ GAPDH Rv : 5ʼ - GGAGAAGGCTGGGGCTCATTTG - 3ʼ Combination : Wt = F2 + R1 ; 4A = F1 + R1 ; 16D = F2 + R2 ; 45F = F1 + R2 CLONING INTO pBSxG VECTOR : SmaI - FL4F : 5ʼ - TCCCCCGGGGGACCCCAGGCGCATCCG - 3ʼ FL5R - SmaI : 5ʼ - TCCCCCGGGGGATGGATCTCAGCTCCG - 3ʼ CLONING INTO pTLB1 VECTOR : PstI - FL4F : 5ʼ - AACTGCAGTTTCACCCCAGGCGCATCCG - 3ʼ FL5R - StuI : 5ʼ - AAGGCCTGGATCTCAGCTCCGGAAGG - 3ʼ Appendix I 285 Table 21 . Primers used for the HA - hENT2 constructs cloning Initial HA - Samples : 22C , 17G and 16D Initial F1 : 5ʼ - CCAGGCGCATCCGCCGCGGCGGCCGACTACGCGATGGCGCGAGGAGACGCCCGC - 3ʼ Initial F2 : 5ʼ - CCAGGCGCATCCGCCGCGGCGGCCGACGTCCCAGACTACGCGATGGCGCGAGGAGACG - 3ʻ Initial F3 : 5ʼ - CCAGGCGCATCCGCCGCGGCGGCCCCGTATGACGTCCCAGACTACGCGATGGCGCGAGG - 3ʼ Initial F4 : 5ʼ - CCAGGCGCATCCGCCGCGGCGGCCATGTACCCGTATGACGTCCCAGACTACGCGATGG - 3ʼ Initial R1 : 5ʼ - GCGGGCGTCTCCTCGCGCCATCGCGTAGTCGGCCGCCGCGGCGGATGCGCCTGG - 3ʼ Initial R2 : 5ʼ - CGTCTCCTCGCGCCATCGCGTAGTCTGGGACGTCGGCCGCCGCGGCGGATGCGCCTGG - 3ʼ Initial R3 : 5ʼ - CCTCGCGCCATCGCGTAGTCTGGGACGTCATACGGGGCCGCCGCGGCGGATGCGCCTGG - 3ʼ Initial R4 : 5ʼ - CCATCGCGTAGTCTGGGACGTCATACGGGTACATGGCCGCCGCGGCGGATGCGCCTGG - 3ʼ Final HA - Samples : 10C , 22C , 17G , 4A , 16D , 45F and 4D Final F1 : 5ʼ - CTTCCTCTTCAAGGCGCTGCTCGACTACGCGTGAAGTGGCCCCTCCAGGCTC - 3ʼ Final F2 : 5ʼ - CCTTCCTCTTCAAGGCGCTGCTCGACGTCCCAGACTACGCGTGAAGTGGCCCCTCC - 3ʼ Final F3 : 5ʼ - CCTTCCTCTTCAAGGCGCTGCTCTACCCGTATGACGTCCCAGACTACGCGTGAAGTG - 3ʼ Final R1 : 5ʼ - GAGCCTGGAGGGGCCACTTCACGCGTAGTCGAGCAGCGCCTTGAAGAGGAAG - 3ʼ Final R2 : 5ʼ - GGAGGGGCCACTTCACGCGTAGTCTGGGACGTCGAGCAGCGCCTTGAAGAGGAAG - 3ʼ Final R3 : 5ʼ - CACTTCACGCGTAGTCTGGGACGTCATACGGGTAGAGCAGCGCCTTGAAGAGGAAG - 3ʼ 4D HA - Samples : 4D 4D F1 : 5ʼ - CTTCCCCGCCATCACAGCCATGGTACCCGTATTGACCAGCTCCACCAGTCCTGGG - 3ʼ 4D F2 : 5ʼ - GCCATCACAGCCATGGTACCCGTATGACGTCCCATGACCAGCTCCACCAGTCCTGGG - 3ʼ 4D F3 : 5ʼ - GCCATGGTACCCGTATGACGTCCCAGACTACGCGTGACCAGCTCCACCAGTCCTGGG - 3ʼ 4D R1 : 5ʼ - CCCAGGACTGGTGGAGCTGGTCAATACGGGTACCATGGCTGTGATGGCGGGGAAG - 3ʼ 4D R2 : 5ʼ - CCCAGGACTGGTGGAGCTGGTCATGGGACGTCATACGGGTACCATGGCTGTGATGGC - 3ʼ 4D R3 : 5ʼ - CCCAGGACTGGTGGAGCTGGTCACGCGTAGTCTGGGACGTCATACGGGTACCATGGC - 3ʼ P120 HA - 22C and 4D P120 F1 : 5ʼ - CCTTCATGCTGCTCTTTGCCGTTTCGACTACGCGTAATGGCTACCTGGTGTCCCTCACC - 3ʼ P120 F2 : 5ʼ - CCTTCATGCTGCTCTTTGCCGTTTCGACGTCCCAGACTACGCGTAATGGCTACCTGG - 3ʼ P120 F3 : 5ʼ - CCTTCATGCTGCTCTTTGCCGTTTCTACCCGTATGACGTCCCAGACTACGCGTAATGG - 3ʼ P120 R1 : 5ʼ - GGTGAGGGACACCAGGTAGCCATTACGCGTAGTCGAAACGGCAAAGAGCAGCATGAAGG - 3ʼ P120 R2 : 5ʼ - CCAGGTAGCCATTACGCGTAGTCTGGGACGTCGAAACGGCAAAGAGCAGCATGAAGG - 3ʼ P120 R3 : 5ʼ - CCATTACGCGTAGTCTGGGACGTCATACGGGTAGAAACGGCAAAGAGCAGCATGAAGG - 3ʼ Novel approaches to understanding hENT2 and hENT2 - related proteins 286 Table 22 . Ubq - hENT2 - loop construct sequences 518 pb : AGGAGGTAAAACATATGCACCACCACCATCATCACATGCAAATCTTCGTGAAAACGTTGACCGGCAAG ACCATTACCCTGGAGGTCGAGCCAAGCGACACGATCGAGAATGTTAAAGCAAAGATCCAGGATAAAGA AGGCATTCCGCCGGATCAGCAGCGTCTGATTTTTGCGGGTAAGCAACTGGAAGATGGCCGCACCCTG AGCGACTACAACATTCAGAAAGAGTCCACCCTGCATCTGGTTCTGCGTTTGCGCGGTGGTCTGGTGC CGCGTGGATCCCACCTGAAGTTTGCCCGCTACTACCTGGCCAATAAATCATCCCAGGCCCAAGCTCAG GAGCTGGAGACCAAAGCTGAGCTCCTCCAGTCTGATGAGAACGGGATTCCCAGTAGTCCCCAGAAAG TAGCTCTGACCCTGGATCTTGACCTGGAGAAGGAGCCGGAATCAGAGCCAGATGAGCCCCAGAAGCC AGGAAAACCTTCAGTCTTCACTGTCTTCCAGAAGATCTAACTCGAG Protein - 165 aa : MHHHHHHMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKEST LHLVLRLRGGLVPRGSHLKFARYYLANKSSQAQAQELETKAELLQSDENGIPSSPQKVALTLDLDLEKEPES EPDEPQKPGKPSVFTVFQKI Table 23 . Ubq - mENT2 - loop construct sequences 518 pb : AGGAGGTAAAACATATGCACCACCACCATCATCACATGCAAATCTTCGTGAAAACGTTGACCGGCAAG ACCATTACCCTGGAGGTCGAGCCAAGCGACACGATCGAGAATGTTAAAGCAAAGATCCAGGATAAAGA AGGCATTCCGCCGGATCAGCAGCGTCTGATTTTTGCGGGTAAGCAACTGGAAGATGGCCGCACCCTG AGCGACTACAACATTCAGAAAGAGTCCACCCTGCATCTGGTTCTGCGTTTGCGCGGTGGTCTGGTGC CGCGTGGATCCCATCTGAAGTTTGCCCGTTACTACCTGACCGAGAAGCTGTCTCAGGCTCCAACTCAG GAGCTGGAGACTAAAGCTGAGCTCCTCCAAGCTGATGAGAAGAATGGGGTTCCCATCAGCCCCCAAC AGGCCAGCCCAACTCTGGATCTTGACCCTGAGAAGGAGCCAGAGCCGGAGGAGCCACAGAAGCCAG GAAAACCTTCAGTCTTTGTTGTCTTCCGGAAGTAACTCGAG Protein - 163 aa : MHHHHHHMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKEST LHLVLRLRGGLVPRGSHLKFARYYLTEKLSQAPTQELETKAELLQADEKNGVPISPQQASPTLDLDPEKEPE PEEPQKPGKPSVFVVFRK Appendix I 287 Cell / Gen OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 OAT1 OAT2 OAT3 OAT4 CTR1 AGS BxPC3 EGI - 1 MKN - 45 Mz - ChA - 1 Mz - ChA - 2 NP29 NP31 NP9 PanC1 Sk - ChA - 1 SNU - 1 SNU - 5 TFK - 1 NA - 4 , 20971 - 5 , 435465 - 3 , 665235 - 11 , 76831 NA NA - 11 , 18556 - 5 , 034325 NA NA NA NA - 4 , 429015 - 10 , 69173 - 4 , 956665 NA - 2 , 994855 - 9 , 23744 NA - 7 , 13413 - 8 , 595715 - 6 , 61803 NA NA NA NA - 3 , 462865 - 10 , 05249 - 3 , 556385 NA - 2 , 60149 - 11 , 42369 NA - 9 , 728725 - 10 , 01162 - 6 , 00497 NA NA NA NA - 4 , 36339 NA - 11 , 52148 - 7 , 797 - 5 , 1114 - 12 , 05624 NA - 9 , 94456 NA - 6 , 752815 NA NA NA - 12 , 3437 - 4 , 79635 NA NA NA - 4 , 92122 - 11 , 42547 - 10 , 17476 - 6 , 24082 - 8 , 692235 - 5 , 46582 NA NA NA NA - 4 , 71838 - 9 , 6066 - 15 , 72675 - 8 , 36523 - 7 , 16294 - 11 , 76959 - 15 , 44028 - 8 , 3963 - 15 , 15602 - 8 , 9475 NA NA - 13 , 68473 - 9 , 23388 - 4 , 443935 - 11 , 09852 - 3 , 81181 NA - 0 , 941765 - 9 , 278685 NA - 7 , 247705 - 8 , 004215 - 5 , 61443 NA NA NA NA - 4 , 818325 NA - 10 , 80012 - 13 , 39471 - 2 , 29445 - 11 , 79997 - 10 , 75569 - 5 , 4065 - 10 , 36194 - 5 , 74578 NA NA NA NA - 3 , 633275 - 11 , 17343 - 3 , 31581 - 10 , 7776 - 3 , 286005 NA NA - 7 , 98885 - 7 , 961525 - 5 , 246475 NA NA NA NA - 3 , 971235 NA - 9 , 16901 NA - 1 , 682615 - 9 , 62681 NA NA - 9 , 57969 - 7 , 194345 NA NA NA NA - 4 , 430015 NA - 7 , 711915 - 7 , 512015 - 4 , 444155 - 12 , 95942 - 12 , 65529 - 6 , 603785 - 11 , 07523 - 6 , 35938 NA NA NA - 11 , 02004 - 4 , 750225 NA NA NA - 4 , 8176 - 12 , 17037 NA NA - 15 , 67475 - 9 , 32421 NA NA NA NA - 4 , 788885 NA - 7 , 65809 - 9 , 12831 - 3 , 933715 - 12 , 86918 - 12 , 07471 - 7 , 621695 - 10 , 55413 - 6 , 777625 NA NA NA NA - 4 , 30338 - 11 , 12423 - 4 , 87962 - 7 , 93727 - 5 , 139255 - 12 , 2882 - 13 , 96125 - 6 , 711245 - 9 , 08694 - 4 , 36496 NA NA NA NA - 5 , 371035 Cell / Gen ENT1 ENT2 ENT3 ENT4 CNT1 CNT2 CNT3 AQP1 AQP3 AQP4 AQP5 AQP7 AQP8 AQP9 AGS BxPC3 EGI - 1 MKN - 45 Mz - ChA - 1 Mz - ChA - 2 NP29 NP31 NP9 PanC1 Sk - ChA - 1 SNU - 1 SNU - 5 TFK - 1 - 4 , 48816 - 5 , 108655 - 6 , 040615 - 10 , 3049 NA NA - 8 , 621785 - 9 , 74808 - 3 , 3001 NA - 8 , 815705 NA NA NA - 3 , 55663 - 5 , 66195 - 6 , 83732 - 13 , 29748 NA NA - 8 , 855135 - 13 , 68616 - 1 , 75554 NA - 11 , 16697 NA NA NA - 4 , 11311 - 4 , 856205 - 7 , 358815 - 10 , 41705 NA NA - 8 , 522945 NA - 3 , 558975 NA - 11 , 23419 NA - 14 , 70913 NA - 4 , 477365 - 5 , 755195 - 7 , 417955 - 6 , 713935 NA - 10 , 88145 - 11 , 11477 - 7 , 709175 - 8 , 0008 NA - 11 , 38667 NA NA NA - 4 , 828465 - 8 , 21024 - 5 , 51053 - 9 , 28921 NA NA - 10 , 05569 - 14 , 936 - 9 , 18969 NA - 9 , 50263 NA NA NA - 4 , 51722 - 8 , 28933 - 5 , 609685 - 5 , 6049 - 12 , 63622 - 15 , 20588 - 12 , 7799 - 13 , 03119 - 7 , 02197 - 14 , 94784 NA - 14 , 48962 NA NA - 3 , 32804 - 4 , 16842 - 5 , 790305 - 11 , 14844 NA NA - 5 , 531055 - 9 , 19134 - 6 , 130935 NA - 5 , 60757 NA NA NA - 3 , 61151 - 5 , 758665 - 4 , 788785 - 9 , 689315 NA NA - 8 , 662195 - 13 , 70469 - 4 , 382915 NA - 12 , 68652 NA NA NA - 3 , 912125 - 8 , 428165 - 9 , 151665 NA NA NA - 8 , 9394 NA - 9 , 831825 NA - 11 , 59395 NA NA NA - 1 , 12045 - 5 , 23147 - 7 , 26113 - 5 , 52936 NA NA - 8 , 536215 NA - 9 , 22808 NA NA - 12 , 06724 - 13 , 1866 NA - 4 , 598565 - 5 , 58829 - 7 , 100105 - 5 , 64634 NA NA - 11 , 14247 - 6 , 78028 - 0 , 748245 NA - 7 , 765215 NA NA NA - 5 , 110555 - 12 , 08074 - 8 , 540745 - 7 , 36897 NA NA - 13 , 41086 - 12 , 03358 NA NA NA NA NA NA - 4 , 458995 - 5 , 963585 - 7 , 863375 - 8 , 37507 - 14 , 23356 NA NA NA - 6 , 72121 NA - 10 , 72669 - 14 , 92393 NA NA - 5 , 06459 - 5 , 582785 - 6 , 37544 - 5 , 81507 NA NA - 9 , 595065 - 10 , 3983 - 6 , 68229 NA - 11 , 49227 NA NA - 11 , 062 Cell / Gen ABCA2 ABCA3 ABCB1 ABCB4 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A AGS BxPC3 EGI - 1 MKN - 45 Mz - ChA - 1 Mz - ChA - 2 NP29 NP31 NP9 PanC1 Sk - ChA - 1 SNU - 1 SNU - 5 TFK - 1 - 5 , 41722 - 7 , 085075 NA NA NA - 3 , 98453 - 11 , 48586 - 4 , 385635 - 3 , 52155 - 6 , 188875 NA - 13 , 55328 - 3 , 040235 - 4 , 75924 - 3 , 89874 - 13 , 65283 NA NA - 8 , 7893 - 3 , 818015 - 10 , 5806 - 4 , 492505 - 5 , 212655 - 5 , 75565 NA - 10 , 40449 - 4 , 80388 - 5 , 17156 - 5 , 697745 - 14 , 46329 NA NA - 12 , 26137 - 3 , 948185 - 9 , 49191 - 3 , 4013 - 5 , 90329 - 8 , 199575 NA - 7 , 87334 - 2 , 54769 - 6 , 87543 - 4 , 64829 - 9 , 264445 NA NA NA - 3 , 754625 - 12 , 19454 - 3 , 643625 - 5 , 616965 - 6 , 257425 - 12 , 23887 NA - 2 , 929135 - 5 , 508155 - 4 , 93282 - 6 , 126265 NA NA - 9 , 86442 - 2 , 67724 - 10 , 66025 - 1 , 87665 - 5 , 22998 - 7 , 244495 NA - 5 , 24591 - 2 , 76473 - 4 , 51397 - 6 , 902985 - 12 , 97593 NA - 11 , 24568 - 12 , 65375 - 4 , 290905 - 6 , 95164 - 8 , 108415 - 4 , 071185 - 5 , 710435 - 13 , 2543 - 6 , 889 - 6 , 93537 - 6 , 27479 - 4 , 807005 - 5 , 20956 NA NA - 10 , 62884 - 3 , 240725 - 10 , 26468 - 2 , 27473 - 4 , 75562 - 6 , 24291 - 12 , 66776 - 9 , 610475 - 2 , 894275 - 5 , 324655 - 4 , 90704 - 5 , 735895 - 9 , 296155 NA - 10 , 65084 - 3 , 353325 - 10 , 70574 - 2 , 757485 - 5 , 65783 - 7 , 260135 - 11 , 82627 - 8 , 274495 - 3 , 383585 - 5 , 04453 - 3 , 402425 - 5 , 71973 NA NA NA - 2 , 56444 - 10 , 63572 - 1 , 76093 - 3 , 500135 - 6 , 145955 NA - 11 , 4493 - 2 , 24129 - 4 , 36951 - 5 , 89955 - 3 , 693405 NA NA NA - 1 , 825585 - 8 , 23494 - 3 , 891615 - 3 , 875345 - 5 , 406305 NA - 5 , 377025 - 3 , 44152 - 4 , 479565 - 4 , 616145 - 7 , 74906 - 6 , 95206 NA - 10 , 19418 - 5 , 00557 - 6 , 014445 - 4 , 854745 - 4 , 81766 - 7 , 748145 - 11 , 27209 - 8 , 65869 - 3 , 48108 - 7 , 022115 - 4 , 07565 - 4 , 69544 NA NA NA - 5 , 231355 - 11 , 28198 - 16 , 26229 - 5 , 26948 - 7 , 47478 - 12 , 61088 NA - 7 , 070585 - 5 , 908625 - 4 , 348695 - 7 , 673805 - 9 , 67136 NA NA - 5 , 40117 - 5 , 89557 - 4 , 068065 - 6 , 87289 - 6 , 869305 NA - 5 , 988395 - 3 , 734565 - 6 , 33067 - 5 , 595585 NA NA NA - 12 , 95264 - 1 , 987495 - 2 , 14282 - 2 , 27818 - 5 , 07186 - 6 , 322225 - 12 , 2226 - 6 , 54682 - 3 , 025015 - 6 , 492285 Cell / Gen ATP7B DPYD TYMP UPP1 UPP2 EPHX1 DCK RRM1 TYMS TK1 NT5C1A NT5C1B UMPS UCK2 AGS BxPC3 EGI - 1 MKN - 45 Mz - ChA - 1 Mz - ChA - 2 NP29 NP31 NP9 PanC1 Sk - ChA - 1 SNU - 1 SNU - 5 TFK - 1 - 5 , 2312 - 9 , 55241 - 5 , 03248 - 4 , 81043 NA - 3 , 312615 - 3 , 94119 - 2 , 20443 - 1 , 967005 - 1 , 01614 NA NA - 3 , 782425 - 2 , 740605 - 7 , 655925 - 6 , 64923 - 4 , 79445 - 1 , 69193 NA - 4 , 28779 - 3 , 81116 - 1 , 86295 - 2 , 268095 - 0 , 751955 NA NA - 2 , 90513 - 2 , 948895 - 8 , 76941 - 6 , 546565 - 6 , 34925 - 2 , 777885 NA - 2 , 470405 - 4 , 618635 - 1 , 535325 - 1 , 84546 - 0 , 65284 NA NA - 4 , 23781 - 3 , 77673 - 6 , 315025 - 6 , 48279 - 9 , 385135 - 3 , 84305 NA - 5 , 43189 - 5 , 132985 - 3 , 93188 - 3 , 70968 - 3 , 26001 NA NA - 4 , 370795 - 4 , 194575 - 6 , 429625 - 4 , 174035 - 5 , 122935 - 3 , 21162 NA - 0 , 299175 - 5 , 288545 - 3 , 067245 - 2 , 373485 - 2 , 475675 NA NA - 5 , 29534 - 4 , 19783 - 4 , 50392 - 10 , 93061 - 10 , 97152 - 5 , 02388 NA - 3 , 8264 - 5 , 34487 - 3 , 347995 - 2 , 14418 - 1 , 763025 NA NA - 4 , 27379 - 3 , 37312 - 7 , 55245 - 5 , 028225 - 5 , 425465 - 1 , 62119 NA - 2 , 43024 - 3 , 505315 - 1 , 063265 - 2 , 54269 - 0 , 65654 NA NA - 3 , 1979 - 2 , 20119 - 7 , 975065 - 5 , 22744 - 5 , 48285 - 2 , 40618 NA - 1 , 95234 - 3 , 91126 - 1 , 3618 - 2 , 710565 - 0 , 206065 NA NA - 4 , 25396 - 3 , 169075 - 5 , 356765 - 3 , 229125 - 6 , 5662 - 3 , 274425 NA - 0 , 8261 - 3 , 89873 - 1 , 67711 - 2 , 506805 - 1 , 375045 NA NA - 4 , 0643 - 3 , 566115 - 5 , 139875 - 7 , 363455 - 3 , 869365 - 0 , 482755 NA - 3 , 48613 - 3 , 531935 - 1 , 77187 - 1 , 6029 - 1 , 414395 NA NA - 3 , 216435 - 2 , 446915 - 8 , 66074 - 9 , 320865 - 8 , 471835 - 5 , 091665 NA - 3 , 0345 - 4 , 89407 - 2 , 78724 - 3 , 26232 - 1 , 84193 - 12 , 77128 NA - 4 , 403795 - 3 , 96438 - 4 , 74977 - 6 , 472475 NA - 5 , 713025 NA - 2 , 89532 - 4 , 165195 - 2 , 94331 - 2 , 36634 - 2 , 7432 NA NA - 5 , 27619 - 3 , 838375 - 7 , 56741 - 5 , 611825 - 6 , 65077 - 3 , 417005 NA - 3 , 444625 - 5 , 289615 - 1 , 92674 - 2 , 499755 - 2 , 24703 - 12 , 00014 NA - 5 , 07836 - 3 , 935285 - 9 , 39455 - 8 , 229725 - 4 , 402055 - 3 , 224915 NA - 0 , 02381 - 5 , 153975 - 2 , 667355 - 3 , 318605 - 1 , 073245 NA NA - 3 , 60683 - 2 , 668715 Novel approaches to understanding hENT2 and hENT2 - related proteins 288 Cell / Gen FPGS GCLC MT4 UGTX TOP1 TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 AGS BxPC3 EGI - 1 MKN - 45 Mz - ChA - 1 Mz - ChA - 2 NP29 NP31 NP9 PanC1 Sk - ChA - 1 SNU - 1 SNU - 5 TFK - 1 - 2 , 83425 - 3 , 09693 NA - 3 , 744045 - 1 , 93892 - 0 , 80761 NA - 4 , 54685 - 2 , 95385 - 4 , 518545 - 3 , 809865 - 4 , 488545 - 4 , 329915 - 4 , 100245 - 1 , 94934 - 2 , 684275 NA - 1 , 233145 - 2 , 165455 - 0 , 750075 - 12 , 19914 - 9 , 22018 - 3 , 176485 - 4 , 03085 - 6 , 438705 - 3 , 670535 - 4 , 10751 - 4 , 059545 - 2 , 56791 - 2 , 682565 NA - 9 , 74681 - 2 , 957845 - 0 , 92547 NA NA - 3 , 71978 - 4 , 045945 - 5 , 793415 - 3 , 786175 - 4 , 57863 - 5 , 10102 - 4 , 1679 - 2 , 8151 NA - 3 , 01843 - 3 , 78872 - 2 , 76173 NA NA - 4 , 237545 - 5 , 395835 - 5 , 015945 - 5 , 35719 - 5 , 121545 - 3 , 84644 - 3 , 08278 - 1 , 71934 NA - 1 , 798195 - 3 , 664065 - 0 , 94129 NA NA - 4 , 00461 - 5 , 544315 - 6 , 047305 - 4 , 94315 - 5 , 489885 - 4 , 301985 - 4 , 23683 - 4 , 505625 NA - 12 , 18246 - 2 , 869695 - 1 , 121205 - 13 , 7148 - 4 , 40695 - 3 , 711855 - 5 , 400275 - 5 , 7583 - 4 , 09597 - 5 , 07167 - 4 , 59143 - 2 , 483215 - 3 , 41416 NA - 10 , 15364 - 1 , 62344 - 0 , 92748 NA - 14 , 29259 - 3 , 410115 - 4 , 11076 - 4 , 998695 - 3 , 210885 - 4 , 17463 - 3 , 231165 - 2 , 525425 - 3 , 40312 NA - 2 , 029025 - 2 , 78366 - 0 , 116265 - 9 , 76655 - 13 , 76424 - 4 , 19674 - 3 , 935955 - 5 , 48546 - 3 , 75522 - 4 , 731805 - 4 , 03652 - 2 , 28207 - 3 , 4213 NA - 3 , 001175 - 1 , 974945 - 0 , 11038 NA - 14 , 04978 - 2 , 28218 - 3 , 989205 - 4 , 606745 - 3 , 834125 - 4 , 37435 - 4 , 552975 - 3 , 05818 - 2 , 385335 NA NA - 2 , 902915 - 1 , 1054 - 11 , 74103 NA - 1 , 82376 - 4 , 755265 - 5 , 209425 - 2 , 987445 - 4 , 268455 - 2 , 79553 - 3 , 680795 - 3 , 27236 NA - 4 , 4128 - 3 , 228395 0 , 702535 - 9 , 71743 NA - 4 , 96376 - 4 , 585485 - 5 , 589145 - 4 , 08331 - 6 , 203325 - 5 , 611255 - 4 , 669465 - 5 , 506225 NA NA - 3 , 72961 - 1 , 971265 NA - 2 , 68858 - 3 , 666895 - 5 , 072695 - 4 , 652205 - 4 , 64091 - 8 , 15654 - 4 , 44663 - 3 , 98417 - 3 , 8363 NA - 10 , 82671 - 3 , 633195 - 1 , 59533 NA NA - 3 , 883085 - 4 , 832885 - 5 , 14812 - 4 , 152435 - 4 , 86563 - 4 , 176445 - 3 , 26699 - 2 , 65895 NA - 0 , 862465 - 3 , 243055 - 0 , 81168 - 8 , 83685 NA - 5 , 47927 - 6 , 02476 - 5 , 73341 - 3 , 804205 - 3 , 768235 - 4 , 737925 Cell / Gen MSH2 MSH6 GADD45 BAX P21 FAS BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR AGS BxPC3 EGI - 1 MKN - 45 Mz - ChA - 1 Mz - ChA - 2 NP29 NP31 NP9 PanC1 Sk - ChA - 1 SNU - 1 SNU - 5 TFK - 1 - 3 , 459645 - 4 , 247045 - 3 , 84307 0 , 488515 - 1 , 24083 - 4 , 762275 NA - 2 , 236875 - 4 , 441605 - 4 , 282845 - 3 , 255655 - 8 , 380915 - 5 , 30825 - 3 , 450015 - 3 , 167525 - 3 , 31743 - 4 , 507185 - 1 , 455085 - 4 , 69617 - 3 , 541885 - 6 , 6567 - 2 , 70301 - 4 , 062575 - 3 , 967425 - 2 , 60949 NA - 5 , 4731 - 1 , 762135 - 3 , 10419 - 3 , 48713 - 3 , 51895 - 1 , 675695 - 2 , 16363 - 3 , 935825 - 9 , 35913 - 3 , 41603 - 2 , 873845 - 5 , 537715 - 2 , 48763 NA - 4 , 70796 - 2 , 706125 - 4 , 698175 - 5 , 81438 - 3 , 133125 - 1 , 211575 - 2 , 37337 - 4 , 28363 - 10 , 81212 - 2 , 8193 - 5 , 43695 - 5 , 45988 - 3 , 43222 - 13 , 80426 - 5 , 57455 - 3 , 751195 - 3 , 371035 - 4 , 086815 - 4 , 41253 - 2 , 323115 - 3 , 8269 - 5 , 86882 - 9 , 66895 - 4 , 15395 - 5 , 026565 - 5 , 14086 - 3 , 76406 - 12 , 96066 - 6 , 5353 - 1 , 48603 - 3 , 33151 - 3 , 7091 - 3 , 028615 - 2 , 511515 - 8 , 08444 NA NA - 3 , 487355 - 4 , 60777 - 5 , 54674 - 3 , 172805 - 10 , 38 - 6 , 699595 - 3 , 040785 - 2 , 747765 - 3 , 176625 - 3 , 20866 - 0 , 80986 - 4 , 546285 - 4 , 15081 - 8 , 14708 - 2 , 88111 - 3 , 850535 - 3 , 456385 - 2 , 669715 - 11 , 61153 - 5 , 858845 - 0 , 140285 - 3 , 44189 - 3 , 59144 - 4 , 56694 - 2 , 0975 - 4 , 29661 - 3 , 328465 - 8 , 072075 - 3 , 50348 - 3 , 64403 - 3 , 866945 - 2 , 324725 NA - 5 , 20667 - 0 , 435 - 3 , 69125 - 3 , 90251 - 2 , 80108 - 1 , 05884 - 5 , 49351 - 5 , 01614 - 7 , 005225 - 3 , 074095 - 4 , 567035 - 4 , 18329 - 2 , 46183 NA - 5 , 792455 - 1 , 61083 NA - 3 , 79927 - 2 , 75506 - 1 , 716555 - 2 , 160485 - 4 , 464 - 13 , 27072 - 1 , 894005 - 1 , 753005 - 4 , 028315 - 1 , 963575 - 9 , 188175 - 4 , 68466 - 1 , 368455 - 3 , 90591 - 4 , 32886 - 4 , 429765 - 3 , 03571 - 3 , 78881 - 6 , 126575 - 9 , 156065 - 4 , 691465 - 5 , 12595 - 5 , 12644 - 3 , 02137 - 11 , 9623 - 5 , 19976 - 3 , 53287 - 3 , 983925 - 4 , 69763 - 5 , 522745 - 1 , 502165 - 4 , 521185 - 4 , 773355 - 6 , 00932 - 4 , 191125 - 6 , 156315 - 5 , 619 - 4 , 032565 NA - 6 , 368255 - 2 , 05668 - 3 , 54879 - 4 , 29558 - 4 , 807325 - 2 , 569065 - 4 , 867085 - 5 , 200455 - 9 , 973355 - 3 , 2266 - 5 , 229685 - 5 , 22723 - 3 , 37898 - 7 , 613685 - 5 , 23483 - 4 , 06814 - 3 , 626835 - 3 , 88848 - 5 , 90541 - 2 , 74736 - 4 , 11514 - 5 , 883515 - 10 , 09025 - 3 , 60978 - 4 , 94117 - 5 , 64547 - 2 , 74347 - 11 , 22107 - 7 , 56556 - 2 , 81749 Cell / Gen PI3K MYC MMP1 MMP2 MMP3 AFP TIGAR NRF2 KEAP1 ENT1n ENT2n CNT1n CNT2n CNT3n AGS BxPC3 EGI - 1 MKN - 45 Mz - ChA - 1 Mz - ChA - 2 NP29 NP31 NP9 PanC1 Sk - ChA - 1 SNU - 1 SNU - 5 TFK - 1 NA - 1 , 743085 - 2 , 22808 - 11 , 91178 NA NA - 3 , 271425 - 3 , 312215 - 3 , 61227 - 3 , 700049 - 8 , 668126 - 16 , 54985 - 18 , 2536 - 9 , 609247 - 7 , 199105 - 1 , 41507 - 0 , 668855 NA NA NA - 4 , 80616 - 3 , 51612 - 3 , 310605 - 2 , 071276 - 8 , 768869 - 16 , 71301 - 16 , 0193 - 9 , 62803 - 7 , 862385 - 2 , 67423 - 8 , 232075 - 10 , 57992 NA NA - 5 , 20692 - 4 , 14742 - 3 , 66429 - 2 , 457211 - 7 , 360897 - 16 , 12107 - 16 , 82166 - 9 , 977932 NA - 5 , 216055 - 6 , 07865 NA NA NA - 3 , 83117 - 4 , 57965 - 4 , 350795 - 3 , 066386 - 7 , 971486 - 18 , 06109 - 12 , 39992 - 13 , 14338 NA - 4 , 1619 - 5 , 793285 NA NA - 15 , 11438 - 5 , 448265 - 4 , 681545 - 5 , 06276 - 3 , 873138 - 12 , 01284 - 18 , 19187 - 16 , 98654 - 9 , 917473 NA - 4 , 17769 NA NA NA - 0 , 580935 - 3 , 560275 - 4 , 366645 - 4 , 96801 - 3 , 299921 - 11 , 26149 - 12 , 3137 - 14 , 21486 - 11 , 65455 - 11 , 57008 0 , 271045 - 8 , 63939 NA NA NA - 5 , 385585 - 3 , 821965 - 3 , 23286 - 2 , 861931 - 5 , 600281 - 13 , 77298 - 16 , 13238 - 6 , 368245 NA - 1 , 879395 - 2 , 60261 - 10 , 50093 NA NA - 4 , 92335 - 3 , 71385 - 3 , 518305 - 2 , 025837 - 8 , 521285 - 14 , 00645 - 15 , 80163 - 8 , 148745 - 13 , 01374 - 1 , 45755 - 8 , 29967 - 10 , 91249 NA NA - 4 , 67876 - 4 , 2399 - 2 , 62472 - 2 , 970685 - 11 , 16807 - 15 , 60731 - 14 , 13019 - 8 , 033955 NA - 2 , 637895 - 6 , 76227 - 5 , 55476 NA NA - 3 , 911425 - 3 , 22109 - 3 , 48964 0 , 0084813 - 8 , 161475 - 16 , 80808 - 15 , 48811 - 10 , 062 NA - 2 , 877845 - 5 , 659205 - 14 , 91166 NA - 11 , 40031 - 6 , 55251 - 3 , 953105 - 3 , 831825 - 2 , 806299 - 8 , 133876 - 16 , 88235 - 14 , 28706 - 11 , 61002 NA - 2 , 799495 NA NA NA NA - 4 , 662585 - 3 , 078135 - 4 , 65431 - 3 , 231682 - 13 , 48696 - 15 , 89879 - 17 , 02107 - 13 , 67259 NA - 2 , 131115 - 11 , 83926 NA NA NA - 6 , 43421 - 4 , 711915 - 5 , 195785 - 2 , 834947 - 8 , 504425 - 13 , 97103 - 18 , 9253 - 13 , 39149 NA - 2 , 6331 - 11 , 1846 NA NA NA - 5 , 93218 - 3 , 74637 - 4 , 435795 - 3 , 576006 - 8 , 991659 - 14 , 70727 - 16 , 30568 - 10 , 12759 Table 24 . Values of normalized expression of the Transportome genes in the 15 cell lines . Appendix I 289 Correlat . OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 CTR1 ENT1 ENT2 ENT3 ENT4 CNT3 OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 CTR1 ENT1 ENT2 ENT3 ENT4 CNT3 AQP1 AQP3 AQP5 ABCA2 ABCA3 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A ATP7B DPYD TYMP UPP1 EPHX1 DCK RRM1 TYMS TK1 UMPS UCK2 FPGS GCLC UGTX TOP1 TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 MSH2 MSH6 GADD45 BAX P21 FAS BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR MYC MMP1 MMP2 TIGAR NRF2 KEAP1 ENT1n ENT2n CNT1n CNT2n CNT3n 1 , 000 - 0 , 742 0 , 000 - 0 , 529 - 0 , 371 0 , 000 - 0 , 684 - 0 , 880 - 0 , 850 0 , 167 - 0 , 219 - 0 , 247 0 , 351 0 , 275 - 0 , 654 - 0 , 742 1 , 000 0 , 175 0 , 552 0 , 271 0 , 342 0 , 065 0 , 802 0 , 775 - 0 , 015 - 0 , 017 0 , 393 - 0 , 355 - 0 , 577 0 , 700 0 , 000 0 , 175 1 , 000 - 0 , 495 - 0 , 114 - 0 , 702 - 0 , 520 - 0 , 283 - 0 , 010 - 0 , 697 - 0 , 786 0 , 317 - 0 , 078 0 , 215 - 0 , 285 - 0 , 529 0 , 552 - 0 , 495 1 , 000 0 , 629 0 , 754 0 , 184 0 , 615 0 , 366 0 , 360 0 , 701 0 , 520 0 , 001 - 0 , 532 0 , 847 - 0 , 371 0 , 271 - 0 , 114 0 , 629 1 , 000 0 , 193 0 , 030 0 , 476 0 , 050 0 , 341 0 , 714 0 , 308 0 , 195 - 0 , 514 0 , 651 0 , 000 0 , 342 - 0 , 702 0 , 754 0 , 193 1 , 000 0 , 764 0 , 708 0 , 503 0 , 394 0 , 347 0 , 102 0 , 181 - 0 , 877 0 , 704 - 0 , 684 0 , 065 - 0 , 520 0 , 184 0 , 030 0 , 764 1 , 000 0 , 227 0 , 376 0 , 134 0 , 064 - 0 , 050 0 , 523 - 0 , 113 0 , 199 - 0 , 880 0 , 802 - 0 , 283 0 , 615 0 , 476 0 , 708 0 , 227 1 , 000 0 , 812 0 , 161 0 , 366 0 , 608 0 , 058 - 0 , 458 0 , 823 - 0 , 850 0 , 775 - 0 , 010 0 , 366 0 , 050 0 , 503 0 , 376 0 , 812 1 , 000 - 0 , 051 - 0 , 014 0 , 586 0 , 239 - 0 , 324 0 , 687 0 , 167 - 0 , 015 - 0 , 697 0 , 360 0 , 341 0 , 394 0 , 134 0 , 161 - 0 , 051 1 , 000 0 , 369 0 , 065 0 , 009 - 0 , 587 0 , 219 - 0 , 219 - 0 , 017 - 0 , 786 0 , 701 0 , 714 0 , 347 0 , 064 0 , 366 - 0 , 014 0 , 369 1 , 000 0 , 411 0 , 020 - 0 , 068 0 , 531 - 0 , 247 0 , 393 0 , 317 0 , 520 0 , 308 0 , 102 - 0 , 050 0 , 608 0 , 586 0 , 065 0 , 411 1 , 000 0 , 372 - 0 , 268 0 , 732 0 , 351 - 0 , 355 - 0 , 078 0 , 001 0 , 195 0 , 181 0 , 523 0 , 058 0 , 239 0 , 009 0 , 020 0 , 372 1 , 000 - 0 , 224 0 , 253 0 , 275 - 0 , 577 0 , 215 - 0 , 532 - 0 , 514 - 0 , 877 - 0 , 113 - 0 , 458 - 0 , 324 - 0 , 587 - 0 , 068 - 0 , 268 - 0 , 224 1 , 000 - 0 , 585 - 0 , 654 0 , 700 - 0 , 285 0 , 847 0 , 651 0 , 704 0 , 199 0 , 823 0 , 687 0 , 219 0 , 531 0 , 732 0 , 253 - 0 , 585 1 , 000 0 , 000 0 , 230 0 , 631 0 , 072 - 0 , 294 - 0 , 345 - 0 , 422 0 , 044 0 , 167 - 0 , 500 - 0 , 085 0 , 427 - 0 , 396 0 , 373 0 , 075 0 , 278 0 , 206 0 , 274 0 , 121 - 0 , 085 - 0 , 060 0 , 184 - 0 , 186 0 , 047 0 , 243 - 0 , 191 0 , 507 0 , 215 - 0 , 401 0 , 042 - 0 , 268 0 , 320 0 , 735 0 , 285 0 , 291 - 0 , 066 0 , 131 0 , 043 0 , 042 - 0 , 413 0 , 104 0 , 355 0 , 217 - 0 , 073 0 , 393 - 0 , 733 0 , 484 - 0 , 331 0 , 257 0 , 003 0 , 766 0 , 168 0 , 319 0 , 140 0 , 308 - 0 , 134 - 0 , 243 - 0 , 549 - 0 , 429 0 , 088 - 0 , 791 0 , 096 - 0 , 392 0 , 314 - 0 , 009 0 , 970 0 , 553 0 , 116 0 , 140 - 0 , 283 0 , 249 - 0 , 197 - 0 , 080 0 , 266 0 , 149 - 0 , 323 0 , 229 0 , 000 0 , 404 0 , 471 0 , 850 0 , 473 0 , 472 0 , 064 0 , 531 0 , 452 0 , 056 0 , 013 - 0 , 611 0 , 256 - 0 , 837 0 , 209 - 0 , 246 0 , 300 0 , 493 0 , 128 0 , 220 0 , 621 0 , 536 - 0 , 085 0 , 474 0 , 258 0 , 212 0 , 054 0 , 532 - 0 , 002 - 0 , 073 0 , 154 - 0 , 292 - 0 , 346 - 0 , 683 0 , 217 - 0 , 017 0 , 118 - 0 , 419 - 0 , 136 0 , 189 0 , 048 0 , 533 - 0 , 119 - 0 , 867 0 , 668 - 0 , 376 0 , 381 0 , 220 0 , 737 0 , 263 0 , 875 0 , 829 0 , 128 0 , 282 0 , 733 0 , 304 - 0 , 239 0 , 714 - 0 , 164 0 , 065 0 , 286 0 , 012 0 , 336 - 0 , 557 0 , 042 - 0 , 000 0 , 074 - 0 , 006 0 , 297 - 0 , 082 0 , 006 0 , 192 0 , 094 - 0 , 207 - 0 , 201 0 , 275 0 , 010 0 , 527 - 0 , 775 - 0 , 080 0 , 154 - 0 , 042 0 , 124 0 , 467 0 , 147 0 , 064 0 , 073 0 , 174 0 , 000 0 , 339 - 0 , 139 0 , 300 - 0 , 469 0 , 000 0 , 472 0 , 422 0 , 513 0 , 110 0 , 020 0 , 394 - 0 , 068 0 , 065 0 , 146 0 , 505 - 0 , 514 - 0 , 261 - 0 , 242 - 0 , 164 0 , 120 0 , 115 - 0 , 129 - 0 , 341 - 0 , 343 0 , 098 - 0 , 167 0 , 139 0 , 558 - 0 , 319 - 0 , 692 0 , 676 - 0 , 079 0 , 493 0 , 074 0 , 741 0 , 011 0 , 856 0 , 874 - 0 , 040 0 , 200 0 , 633 0 , 033 - 0 , 214 0 , 694 - 0 , 580 0 , 117 - 0 , 299 0 , 362 0 , 562 0 , 707 0 , 265 0 , 389 0 , 222 0 , 372 0 , 465 - 0 , 075 0 , 085 - 0 , 327 0 , 368 0 , 340 - 0 , 383 0 , 165 - 0 , 248 0 , 119 - 0 , 245 - 0 , 283 - 0 , 477 - 0 , 547 0 , 089 0 , 151 - 0 , 575 - 0 , 206 0 , 216 - 0 , 379 - 0 , 710 0 , 419 - 0 , 684 0 , 473 0 , 261 0 , 918 0 , 137 0 , 564 0 , 300 0 , 266 0 , 135 - 0 , 124 - 0 , 257 - 0 , 472 0 , 404 - 0 , 781 0 , 649 - 0 , 133 0 , 654 0 , 468 0 , 628 0 , 527 0 , 766 0 , 637 0 , 106 0 , 406 0 , 380 0 , 093 - 0 , 425 0 , 725 - 0 , 588 0 , 264 - 0 , 769 0 , 748 0 , 762 0 , 647 0 , 201 0 , 729 0 , 344 0 , 328 0 , 800 0 , 558 0 , 164 - 0 , 357 0 , 758 - 0 , 628 0 , 481 - 0 , 355 0 , 053 - 0 , 128 0 , 378 0 , 519 0 , 423 0 , 559 - 0 , 230 - 0 , 212 - 0 , 158 0 , 124 0 , 009 0 , 222 - 0 , 580 0 , 438 - 0 , 346 0 , 800 0 , 713 0 , 431 0 , 221 0 , 285 0 , 099 0 , 438 0 , 660 0 , 163 - 0 , 064 - 0 , 468 0 , 607 - 0 , 514 0 , 590 - 0 , 576 0 , 875 0 , 508 0 , 503 0 , 282 0 , 609 0 , 376 0 , 482 0 , 545 0 , 431 0 , 041 - 0 , 579 0 , 814 0 , 703 0 , 146 0 , 004 0 , 336 0 , 468 0 , 038 - 0 , 055 - 0 , 125 - 0 , 225 0 , 386 0 , 477 - 0 , 065 0 , 015 - 0 , 311 0 , 216 - 0 , 349 0 , 451 - 0 , 409 0 , 608 0 , 447 - 0 , 016 0 , 360 0 , 477 0 , 465 0 , 431 0 , 385 0 , 534 0 , 401 - 0 , 499 0 , 712 - 0 , 549 0 , 361 0 , 231 0 , 514 0 , 729 - 0 , 603 0 , 015 0 , 471 0 , 314 0 , 215 0 , 611 0 , 620 0 , 181 - 0 , 280 0 , 665 - 0 , 545 0 , 281 0 , 082 0 , 525 0 , 649 - 0 , 479 0 , 318 0 , 301 0 , 265 0 , 039 0 , 559 0 , 454 0 , 343 - 0 , 203 0 , 641 - 0 , 586 0 , 691 - 0 , 433 0 , 695 0 , 655 0 , 697 0 , 291 0 , 820 0 , 660 0 , 537 0 , 438 0 , 506 0 , 208 - 0 , 736 0 , 844 - 0 , 470 0 , 468 0 , 217 0 , 288 0 , 316 0 , 619 0 , 121 0 , 788 0 , 688 0 , 009 0 , 305 0 , 604 0 , 290 - 0 , 207 0 , 527 - 0 , 666 0 , 231 - 0 , 119 0 , 012 0 , 005 0 , 517 0 , 422 0 , 491 0 , 583 0 , 092 - 0 , 130 - 0 , 082 0 , 038 - 0 , 091 - 0 , 012 - 0 , 474 0 , 512 - 0 , 042 0 , 551 0 , 658 - 0 , 397 0 , 121 0 , 423 0 , 365 0 , 404 0 , 389 0 , 375 0 , 162 - 0 , 586 0 , 711 - 0 , 625 0 , 296 - 0 , 252 0 , 251 0 , 006 0 , 157 0 , 621 0 , 391 0 , 428 0 , 281 0 , 112 0 , 230 0 , 214 - 0 , 103 0 , 299 0 , 000 0 , 578 0 , 000 0 , 250 - 0 , 526 0 , 000 0 , 792 0 , 551 0 , 921 - 0 , 393 - 0 , 294 0 , 667 0 , 018 0 , 123 0 , 391 0 , 000 - 0 , 392 0 , 000 - 0 , 764 - 0 , 583 0 , 000 - 0 , 515 - 0 , 843 - 0 , 681 - 0 , 398 - 0 , 882 - 0 , 522 - 0 , 105 0 , 558 - 0 , 768 - 0 , 025 0 , 157 - 0 , 096 0 , 470 0 , 667 0 , 166 - 0 , 260 0 , 138 - 0 , 163 0 , 478 0 , 686 - 0 , 059 - 0 , 305 - 0 , 273 0 , 309 - 0 , 135 0 , 429 - 0 , 511 0 , 747 0 , 433 0 , 441 0 , 049 0 , 329 0 , 153 0 , 730 0 , 438 0 , 299 - 0 , 100 - 0 , 674 0 , 562 - 0 , 459 0 , 210 0 , 338 0 , 133 - 0 , 200 0 , 003 - 0 , 260 - 0 , 189 0 , 037 - 0 , 153 - 0 , 019 - 0 , 122 - 0 , 312 0 , 100 0 , 058 - 0 , 586 0 , 301 - 0 , 497 0 , 658 0 , 583 - 0 , 435 0 , 303 0 , 429 0 , 146 0 , 265 0 , 707 0 , 423 0 , 078 - 0 , 140 0 , 604 - 0 , 848 0 , 483 - 0 , 076 0 , 387 0 , 444 - 0 , 252 - 0 , 042 0 , 702 0 , 652 0 , 226 0 , 424 0 , 752 0 , 304 - 0 , 298 0 , 734 - 0 , 429 - 0 , 087 - 0 , 193 0 , 513 0 , 678 0 , 390 0 , 043 0 , 263 - 0 , 044 0 , 132 0 , 706 0 , 229 0 , 162 - 0 , 174 0 , 461 0 , 163 0 , 374 - 0 , 204 0 , 505 0 , 630 0 , 063 0 , 301 0 , 439 0 , 226 0 , 273 0 , 528 0 , 317 0 , 438 - 0 , 618 0 , 625 0 , 045 0 , 334 - 0 , 411 0 , 487 0 , 568 - 0 , 193 0 , 402 0 , 517 0 , 229 0 , 377 0 , 389 0 , 288 0 , 363 - 0 , 462 0 , 579 0 , 315 - 0 , 185 0 , 007 0 , 253 0 , 452 - 0 , 256 - 0 , 607 0 , 186 - 0 , 062 0 , 227 0 , 558 0 , 251 - 0 , 060 0 , 006 0 , 292 - 0 , 424 0 , 415 0 , 290 0 , 392 0 , 408 0 , 485 - 0 , 399 0 , 134 0 , 179 0 , 183 0 , 184 0 , 118 - 0 , 089 - 0 , 509 0 , 410 - 0 , 303 0 , 390 0 , 406 0 , 418 0 , 061 0 , 717 - 0 , 202 0 , 320 0 , 402 - 0 , 155 0 , 221 0 , 449 - 0 , 049 - 0 , 144 0 , 339 0 , 595 - 0 , 143 - 0 , 561 0 , 635 0 , 551 0 , 446 - 0 , 206 0 , 063 - 0 , 190 0 , 648 0 , 465 0 , 243 0 , 170 - 0 , 596 0 , 388 - 0 , 198 0 , 497 - 0 , 710 - 0 , 028 0 , 020 0 , 482 0 , 309 - 0 , 258 - 0 , 155 0 , 357 - 0 , 431 - 0 , 499 - 0 , 155 - 0 , 580 - 0 , 138 - 0 , 390 0 , 129 0 , 201 0 , 470 0 , 597 - 0 , 210 - 0 , 433 0 , 328 0 , 145 0 , 300 0 , 671 0 , 463 - 0 , 014 - 0 , 254 0 , 526 0 , 306 0 , 118 - 0 , 582 0 , 676 0 , 633 0 , 173 - 0 , 051 0 , 406 0 , 183 0 , 350 0 , 858 0 , 562 0 , 215 - 0 , 185 0 , 631 - 0 , 567 0 , 306 - 0 , 493 0 , 784 0 , 723 0 , 655 0 , 435 0 , 549 0 , 326 0 , 539 0 , 673 0 , 402 0 , 233 - 0 , 547 0 , 759 - 0 , 577 0 , 255 - 0 , 743 0 , 650 0 , 527 - 0 , 127 0 , 116 0 , 548 0 , 359 0 , 405 0 , 752 0 , 594 0 , 093 - 0 , 127 0 , 653 0 , 000 0 , 187 0 , 057 0 , 232 - 0 , 017 - 0 , 258 0 , 139 - 0 , 289 - 0 , 122 0 , 598 0 , 278 0 , 193 - 0 , 233 - 0 , 108 0 , 234 0 , 182 0 , 111 - 0 , 151 0 , 621 0 , 202 0 , 472 - 0 , 232 0 , 189 - 0 , 007 0 , 526 0 , 572 0 , 448 - 0 , 179 - 0 , 278 0 , 365 - 0 , 608 0 , 187 - 0 , 828 0 , 615 0 , 684 0 , 562 0 , 497 0 , 384 0 , 141 0 , 291 0 , 494 - 0 , 018 0 , 301 - 0 , 396 0 , 560 - 0 , 749 0 , 693 - 0 , 298 0 , 744 0 , 488 0 , 260 0 , 363 0 , 500 0 , 353 0 , 316 0 , 331 0 , 315 - 0 , 000 - 0 , 591 0 , 730 0 , 271 - 0 , 170 - 0 , 015 0 , 126 0 , 307 0 , 649 0 , 268 - 0 , 176 - 0 , 129 0 , 579 0 , 152 0 , 036 0 , 408 - 0 , 464 - 0 , 106 0 , 000 - 0 , 260 0 , 000 0 , 920 0 , 986 0 , 000 0 , 000 0 , 425 - 0 , 496 0 , 241 0 , 926 0 , 094 - 0 , 055 0 , 147 0 , 712 0 , 685 - 0 , 332 0 , 197 - 0 , 100 0 , 294 - 0 , 379 - 0 , 475 - 0 , 326 - 0 , 294 0 , 197 0 , 268 - 0 , 136 0 , 086 0 , 009 - 0 , 141 - 0 , 530 0 , 306 0 , 156 0 , 374 0 , 363 - 0 , 157 0 , 414 - 0 , 194 - 0 , 123 0 , 075 0 , 345 - 0 , 047 - 0 , 016 - 0 , 100 0 , 112 - 0 , 620 0 , 575 - 0 , 296 0 , 715 0 , 621 0 , 187 0 , 031 0 , 525 0 , 400 0 , 449 0 , 539 0 , 371 - 0 , 142 - 0 , 460 0 , 700 0 , 083 - 0 , 124 - 0 , 842 0 , 603 0 , 519 0 , 220 0 , 035 0 , 196 - 0 , 180 0 , 410 0 , 915 0 , 321 - 0 , 106 0 , 044 0 , 302 - 0 , 252 0 , 335 0 , 192 0 , 609 0 , 332 0 , 031 - 0 , 159 0 , 524 0 , 437 0 , 019 0 , 425 0 , 943 0 , 247 - 0 , 267 0 , 724 0 , 340 - 0 , 271 - 0 , 414 - 0 , 048 - 0 , 055 - 0 , 627 0 , 143 - 0 , 304 - 0 , 183 0 , 081 - 0 , 030 - 0 , 005 0 , 249 0 , 067 0 , 063 0 , 144 - 0 , 454 - 0 , 132 - 0 , 223 0 , 039 - 0 , 473 - 0 , 343 0 , 001 - 0 , 153 - 0 , 027 0 , 125 - 0 , 023 - 0 , 098 0 , 429 - 0 , 278 - 0 , 735 0 , 507 - 0 , 460 0 , 651 0 , 639 0 , 405 0 , 395 0 , 705 0 , 620 0 , 281 0 , 417 0 , 426 0 , 395 - 0 , 533 0 , 892 Novel approaches to understanding hENT2 and hENT2 - related proteins 290 P Values OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 CTR1 ENT1 ENT2 ENT3 ENT4 CNT3 OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 CTR1 ENT1 ENT2 ENT3 ENT4 CNT3 AQP1 AQP3 AQP5 ABCA2 ABCA3 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A ATP7B DPYD TYMP UPP1 EPHX1 DCK RRM1 TYMS TK1 UMPS UCK2 FPGS GCLC UGTX TOP1 TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 MSH2 MSH6 GADD45 BAX P21 FAS BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR MYC MMP1 MMP2 TIGAR NRF2 KEAP1 ENT1n ENT2n CNT1n CNT2n CNT3n 0 , 000 0 , 091 1 , 000 0 , 280 0 , 539 1 , 000 0 , 134 0 , 021 0 , 032 0 , 752 0 , 677 0 , 637 0 , 495 0 , 654 0 , 159 0 , 091 0 , 000 0 , 678 0 , 063 0 , 420 0 , 573 0 , 858 0 , 003 0 , 003 0 , 964 0 , 958 0 , 207 0 , 258 0 , 063 0 , 016 1 , 000 0 , 678 0 , 000 0 , 213 0 , 807 0 , 186 0 , 232 0 , 538 0 , 981 0 , 055 0 , 021 0 , 445 0 , 854 0 , 644 0 , 536 0 , 280 0 , 063 0 , 213 0 , 000 0 , 021 0 , 084 0 , 589 0 , 025 0 , 198 0 , 206 0 , 005 0 , 057 0 , 996 0 , 061 0 , 000 0 , 539 0 , 420 0 , 807 0 , 021 0 , 000 0 , 714 0 , 933 0 , 117 0 , 872 0 , 254 0 , 006 0 , 307 0 , 523 0 , 072 0 , 022 1 , 000 0 , 573 0 , 186 0 , 084 0 , 714 0 , 000 0 , 077 0 , 116 0 , 310 0 , 440 0 , 501 0 , 848 0 , 732 0 , 022 0 , 185 0 , 134 0 , 858 0 , 232 0 , 589 0 , 933 0 , 077 0 , 000 0 , 528 0 , 255 0 , 694 0 , 851 0 , 883 0 , 099 0 , 756 0 , 581 0 , 021 0 , 003 0 , 538 0 , 025 0 , 117 0 , 116 0 , 528 0 , 000 0 , 001 0 , 599 0 , 219 0 , 028 0 , 850 0 , 134 0 , 001 0 , 032 0 , 003 0 , 981 0 , 198 0 , 872 0 , 310 0 , 255 0 , 001 0 , 000 0 , 862 0 , 962 0 , 028 0 , 411 0 , 281 0 , 010 0 , 752 0 , 964 0 , 055 0 , 206 0 , 254 0 , 440 0 , 694 0 , 599 0 , 862 0 , 000 0 , 194 0 , 824 0 , 975 0 , 035 0 , 473 0 , 677 0 , 958 0 , 021 0 , 005 0 , 006 0 , 501 0 , 851 0 , 219 0 , 962 0 , 194 0 , 000 0 , 144 0 , 946 0 , 825 0 , 062 0 , 637 0 , 207 0 , 445 0 , 057 0 , 307 0 , 848 0 , 883 0 , 028 0 , 028 0 , 824 0 , 144 0 , 000 0 , 190 0 , 376 0 , 004 0 , 495 0 , 258 0 , 854 0 , 996 0 , 523 0 , 732 0 , 099 0 , 850 0 , 411 0 , 975 0 , 946 0 , 190 0 , 000 0 , 462 0 , 404 0 , 654 0 , 063 0 , 644 0 , 061 0 , 072 0 , 022 0 , 756 0 , 134 0 , 281 0 , 035 0 , 825 0 , 376 0 , 462 0 , 000 0 , 046 0 , 159 0 , 016 0 , 536 0 , 000 0 , 022 0 , 185 0 , 581 0 , 001 0 , 010 0 , 473 0 , 062 0 , 004 0 , 404 0 , 046 0 , 000 1 , 000 0 , 584 0 , 179 0 , 843 0 , 409 0 , 570 0 , 298 0 , 911 0 , 644 0 , 141 0 , 815 0 , 219 0 , 257 0 , 289 0 , 836 0 , 593 0 , 520 0 , 512 0 , 695 0 , 792 0 , 911 0 , 589 0 , 563 0 , 879 0 , 423 0 , 533 0 , 077 0 , 481 0 , 197 0 , 896 0 , 663 0 , 367 0 , 060 0 , 396 0 , 415 0 , 916 0 , 718 0 , 907 0 , 902 0 , 207 0 , 761 0 , 284 0 , 522 0 , 842 0 , 261 0 , 098 0 , 111 0 , 423 0 , 375 0 , 993 0 , 075 0 , 622 0 , 288 0 , 633 0 , 283 0 , 649 0 , 403 0 , 042 0 , 143 0 , 776 0 , 111 0 , 778 0 , 384 0 , 296 0 , 978 0 , 006 0 , 098 0 , 720 0 , 649 0 , 350 0 , 412 0 , 519 0 , 794 0 , 404 0 , 643 0 , 596 0 , 621 1 , 000 0 , 321 0 , 239 0 , 068 0 , 237 0 , 237 0 , 881 0 , 176 0 , 261 0 , 894 0 , 975 0 , 108 0 , 540 0 , 038 0 , 514 0 , 557 0 , 298 0 , 087 0 , 809 0 , 516 0 , 023 0 , 048 0 , 773 0 , 087 0 , 373 0 , 466 0 , 860 0 , 061 0 , 997 0 , 822 0 , 716 0 , 311 0 , 247 0 , 135 0 , 522 0 , 955 0 , 687 0 , 136 0 , 644 0 , 517 0 , 870 0 , 061 0 , 700 0 , 025 0 , 018 0 , 359 0 , 179 0 , 471 0 , 094 0 , 435 0 , 000 0 , 000 0 , 663 0 , 328 0 , 003 0 , 291 0 , 431 0 , 006 0 , 756 0 , 841 0 , 492 0 , 968 0 , 262 0 , 251 0 , 903 1 , 000 0 , 801 0 , 985 0 , 303 0 , 780 0 , 982 0 , 529 0 , 760 0 , 694 0 , 531 0 , 511 0 , 972 0 , 064 0 , 070 0 , 815 0 , 616 0 , 887 0 , 673 0 , 092 0 , 615 0 , 827 0 , 814 0 , 570 1 , 000 0 , 511 0 , 823 0 , 514 0 , 288 1 , 000 0 , 344 0 , 405 0 , 239 0 , 814 0 , 966 0 , 382 0 , 885 0 , 891 0 , 755 0 , 306 0 , 106 0 , 572 0 , 448 0 , 629 0 , 821 0 , 751 0 , 690 0 , 278 0 , 274 0 , 762 0 , 604 0 , 668 0 , 075 0 , 340 0 , 128 0 , 016 0 , 852 0 , 073 0 , 811 0 , 092 0 , 975 0 , 000 0 , 000 0 , 891 0 , 492 0 , 015 0 , 912 0 , 482 0 , 008 0 , 227 0 , 718 0 , 472 0 , 203 0 , 046 0 , 116 0 , 431 0 , 189 0 , 446 0 , 190 0 , 094 0 , 800 0 , 773 0 , 275 0 , 217 0 , 509 0 , 220 0 , 695 0 , 393 0 , 698 0 , 639 0 , 399 0 , 099 0 , 043 0 , 762 0 , 607 0 , 031 0 , 480 0 , 478 0 , 201 0 , 114 0 , 175 0 , 061 0 , 087 0 , 390 0 , 010 0 , 687 0 , 045 0 , 298 0 , 358 0 , 645 0 , 672 0 , 376 0 , 103 0 , 171 0 , 066 0 , 022 0 , 754 0 , 015 0 , 125 0 , 182 0 , 096 0 , 004 0 , 019 0 , 729 0 , 168 0 , 200 0 , 763 0 , 169 0 , 008 0 , 220 0 , 407 0 , 026 0 , 002 0 , 002 0 , 165 0 , 554 0 , 005 0 , 228 0 , 252 0 , 001 0 , 038 0 , 575 0 , 231 0 , 003 0 , 182 0 , 113 0 , 388 0 , 857 0 , 678 0 , 460 0 , 102 0 , 150 0 , 038 0 , 430 0 , 468 0 , 589 0 , 672 0 , 977 0 , 465 0 , 227 0 , 154 0 , 401 0 , 001 0 , 006 0 , 394 0 , 513 0 , 344 0 , 738 0 , 117 0 , 010 0 , 578 0 , 827 0 , 107 0 , 028 0 , 297 0 , 043 0 , 135 0 , 000 0 , 076 0 , 309 0 , 401 0 , 027 0 , 186 0 , 081 0 , 044 0 , 124 0 , 890 0 , 038 0 , 001 0 , 119 0 , 652 0 , 992 0 , 240 0 , 107 0 , 942 0 , 871 0 , 684 0 , 439 0 , 173 0 , 084 0 , 825 0 , 958 0 , 301 0 , 478 0 , 498 0 , 141 0 , 315 0 , 021 0 , 126 0 , 976 0 , 277 0 , 099 0 , 093 0 , 124 0 , 174 0 , 049 0 , 155 0 , 083 0 , 006 0 , 259 0 , 250 0 , 583 0 , 060 0 , 005 0 , 205 0 , 964 0 , 104 0 , 274 0 , 460 0 , 020 0 , 018 0 , 535 0 , 355 0 , 013 0 , 263 0 , 376 0 , 847 0 , 054 0 , 016 0 , 336 0 , 341 0 , 317 0 , 361 0 , 896 0 , 038 0 , 103 0 , 231 0 , 505 0 , 018 0 , 222 0 , 013 0 , 284 0 , 006 0 , 015 0 , 124 0 , 386 0 , 001 0 , 010 0 , 048 0 , 118 0 , 065 0 , 475 0 , 004 0 , 000 0 , 346 0 , 125 0 , 606 0 , 318 0 , 293 0 , 190 0 , 724 0 , 001 0 , 007 0 , 976 0 , 290 0 , 022 0 , 314 0 , 497 0 , 064 0 , 149 0 , 495 0 , 780 0 , 971 0 , 989 0 , 294 0 , 196 0 , 125 0 , 047 0 , 777 0 , 687 0 , 800 0 , 907 0 , 790 0 , 972 0 , 343 0 , 089 0 , 921 0 , 041 0 , 014 0 , 436 0 , 723 0 , 150 0 , 200 0 , 152 0 , 169 0 , 186 0 , 581 0 , 035 0 , 006 0 , 185 0 , 351 0 , 547 0 , 386 0 , 984 0 , 767 0 , 042 0 , 186 0 , 127 0 , 331 0 , 704 0 , 429 0 , 463 0 , 737 0 , 320 1 , 000 0 , 230 1 , 000 0 , 632 0 , 284 1 , 000 0 , 110 0 , 257 0 , 009 0 , 441 0 , 572 0 , 148 0 , 973 0 , 817 0 , 444 1 , 000 0 , 442 1 , 000 0 , 045 0 , 225 1 , 000 0 , 375 0 , 017 0 , 092 0 , 377 0 , 009 0 , 230 0 , 823 0 , 249 0 , 044 0 , 963 0 , 625 0 , 821 0 , 090 0 , 013 0 , 753 0 , 439 0 , 653 0 , 579 0 , 084 0 , 007 0 , 841 0 , 289 0 , 367 0 , 305 0 , 799 0 , 164 0 , 195 0 , 002 0 , 139 0 , 381 0 , 887 0 , 273 0 , 601 0 , 003 0 , 117 0 , 299 0 , 733 0 , 012 0 , 046 0 , 360 0 , 512 0 , 414 0 , 649 0 , 512 0 , 996 0 , 441 0 , 537 0 , 900 0 , 601 0 , 950 0 , 678 0 , 277 0 , 746 0 , 851 0 , 221 0 , 341 0 , 210 0 , 010 0 , 036 0 , 389 0 , 365 0 , 143 0 , 619 0 , 360 0 , 005 0 , 131 0 , 790 0 , 648 0 , 029 0 , 033 0 , 112 0 , 859 0 , 172 0 , 128 0 , 630 0 , 902 0 , 008 0 , 012 0 , 438 0 , 130 0 , 002 0 , 291 0 , 323 0 , 004 0 , 396 0 , 787 0 , 647 0 , 061 0 , 011 0 , 445 0 , 900 0 , 385 0 , 882 0 , 653 0 , 005 0 , 431 0 , 581 0 , 569 0 , 113 0 , 758 0 , 257 0 , 628 0 , 078 0 , 028 0 , 906 0 , 368 0 , 153 0 , 458 0 , 367 0 , 064 0 , 292 0 , 135 0 , 032 0 , 030 0 , 933 0 , 288 0 , 312 0 , 078 0 , 043 0 , 714 0 , 221 0 , 070 0 , 431 0 , 184 0 , 169 0 , 319 0 , 202 0 , 112 0 , 038 0 , 543 0 , 565 0 , 987 0 , 383 0 , 121 0 , 624 0 , 048 0 , 543 0 , 832 0 , 435 0 , 038 0 , 386 0 , 838 0 , 983 0 , 333 0 , 402 0 , 180 0 , 486 0 , 165 0 , 166 0 , 330 0 , 224 0 , 661 0 , 540 0 , 531 0 , 528 0 , 688 0 , 763 0 , 076 0 , 164 0 , 559 0 , 210 0 , 319 0 , 136 0 , 843 0 , 109 0 , 551 0 , 287 0 , 155 0 , 596 0 , 448 0 , 108 0 , 869 0 , 638 0 , 257 0 , 290 0 , 674 0 , 190 0 , 020 0 , 063 0 , 451 0 , 568 0 , 847 0 , 533 0 , 017 0 , 110 0 , 424 0 , 579 0 , 041 0 , 213 0 , 749 0 , 144 0 , 114 0 , 931 0 , 954 0 , 411 0 , 386 0 , 443 0 , 630 0 , 255 0 , 162 0 , 099 0 , 631 0 , 061 0 , 687 0 , 444 0 , 689 0 , 633 0 , 090 0 , 031 0 , 690 0 , 183 0 , 273 0 , 620 0 , 298 0 , 009 0 , 095 0 , 963 0 , 402 0 , 065 0 , 556 0 , 716 0 , 130 0 , 008 0 , 020 0 , 743 0 , 882 0 , 168 0 , 532 0 , 221 0 , 000 0 , 036 0 , 460 0 , 545 0 , 021 0 , 241 0 , 333 0 , 215 0 , 001 0 , 005 0 , 158 0 , 181 0 , 052 0 , 255 0 , 046 0 , 008 0 , 154 0 , 423 0 , 053 0 , 003 0 , 231 0 , 425 0 , 035 0 , 012 0 , 064 0 , 810 0 , 735 0 , 053 0 , 207 0 , 150 0 , 002 0 , 025 0 , 752 0 , 680 0 , 016 1 , 000 0 , 658 0 , 914 0 , 547 0 , 966 0 , 675 0 , 767 0 , 488 0 , 754 0 , 089 0 , 469 0 , 618 0 , 546 0 , 782 0 , 577 0 , 730 0 , 732 0 , 721 0 , 018 0 , 507 0 , 344 0 , 492 0 , 536 0 , 980 0 , 053 0 , 033 0 , 108 0 , 541 0 , 357 0 , 220 0 , 200 0 , 561 0 , 011 0 , 019 0 , 010 0 , 246 0 , 120 0 , 195 0 , 631 0 , 312 0 , 072 0 , 951 0 , 296 0 , 180 0 , 047 0 , 087 0 , 012 0 , 473 0 , 002 0 , 091 0 , 619 0 , 272 0 , 082 0 , 216 0 , 270 0 , 248 0 , 273 1 , 000 0 , 034 0 , 005 0 , 659 0 , 616 0 , 974 0 , 696 0 , 359 0 , 236 0 , 453 0 , 604 0 , 689 0 , 048 0 , 637 0 , 910 0 , 188 0 , 151 0 , 757 1 , 000 0 , 619 1 , 000 0 , 009 0 , 002 1 , 000 1 , 000 0 , 401 0 , 317 0 , 645 0 , 008 0 , 859 0 , 917 0 , 814 0 , 113 0 , 133 0 , 292 0 , 639 0 , 733 0 , 329 0 , 459 0 , 140 0 , 277 0 , 308 0 , 499 0 , 355 0 , 643 0 , 770 0 , 977 0 , 645 0 , 280 0 , 333 0 , 713 0 , 188 0 , 223 0 , 767 0 , 206 0 , 525 0 , 675 0 , 800 0 , 227 0 , 874 0 , 958 0 , 744 0 , 715 0 , 189 0 , 050 0 , 477 0 , 004 0 , 023 0 , 723 0 , 928 0 , 066 0 , 157 0 , 108 0 , 047 0 , 192 0 , 628 0 , 114 0 , 008 0 , 876 0 , 702 0 , 009 0 , 023 0 , 069 0 , 675 0 , 920 0 , 522 0 , 539 0 , 146 0 , 000 0 , 263 0 , 718 0 , 887 0 , 316 0 , 630 0 , 288 0 , 648 0 , 021 0 , 268 0 , 953 0 , 642 0 , 066 0 , 118 0 , 948 0 , 129 0 , 000 0 , 395 0 , 378 0 , 005 0 , 510 0 , 394 0 , 307 0 , 869 0 , 859 0 , 182 0 , 676 0 , 313 0 , 531 0 , 783 0 , 919 0 , 985 0 , 390 0 , 828 0 , 837 0 , 786 0 , 139 0 , 755 0 , 444 0 , 900 0 , 344 0 , 302 0 , 997 0 , 601 0 , 926 0 , 670 0 , 939 0 , 740 0 , 144 0 , 357 0 , 096 0 , 093 0 , 251 0 , 012 0 , 019 0 , 425 0 , 230 0 , 007 0 , 018 0 , 331 0 , 138 0 , 129 0 , 163 0 , 061 0 , 000 Appendix I 291 Correlat . AQP1 AQP3 AQP5 ABCA2 ABCA3 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 CTR1 ENT1 ENT2 ENT3 ENT4 CNT3 AQP1 AQP3 AQP5 ABCA2 ABCA3 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A ATP7B DPYD TYMP UPP1 EPHX1 DCK RRM1 TYMS TK1 UMPS UCK2 FPGS GCLC UGTX TOP1 TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 MSH2 MSH6 GADD45 BAX P21 FAS BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR MYC MMP1 MMP2 TIGAR NRF2 KEAP1 ENT1n ENT2n CNT1n CNT2n CNT3n 0 , 000 0 , 278 - 0 , 268 - 0 , 733 - 0 , 791 - 0 , 323 - 0 , 837 - 0 , 002 - 0 , 867 - 0 , 164 - 0 , 207 0 , 000 0 , 505 - 0 , 692 - 0 , 580 0 , 230 0 , 206 0 , 320 0 , 484 0 , 096 0 , 229 0 , 209 - 0 , 073 0 , 668 0 , 065 - 0 , 201 0 , 339 - 0 , 514 0 , 676 0 , 117 0 , 631 0 , 274 0 , 735 - 0 , 331 - 0 , 392 0 , 000 - 0 , 246 0 , 154 - 0 , 376 0 , 286 0 , 275 - 0 , 139 - 0 , 261 - 0 , 079 - 0 , 299 0 , 072 0 , 121 0 , 285 0 , 257 0 , 314 0 , 404 0 , 300 - 0 , 292 0 , 381 0 , 012 0 , 010 0 , 300 - 0 , 242 0 , 493 0 , 362 - 0 , 294 - 0 , 085 0 , 291 0 , 003 - 0 , 009 0 , 471 0 , 493 - 0 , 346 0 , 220 0 , 336 0 , 527 - 0 , 469 - 0 , 164 0 , 074 0 , 562 - 0 , 345 - 0 , 060 - 0 , 066 0 , 766 0 , 970 0 , 850 0 , 128 - 0 , 683 0 , 737 - 0 , 557 - 0 , 775 0 , 000 0 , 120 0 , 741 0 , 707 - 0 , 422 0 , 184 0 , 131 0 , 168 0 , 553 0 , 473 0 , 220 0 , 217 0 , 263 0 , 042 - 0 , 080 0 , 472 0 , 115 0 , 011 0 , 265 0 , 044 - 0 , 186 0 , 043 0 , 319 0 , 116 0 , 472 0 , 621 - 0 , 017 0 , 875 - 0 , 000 0 , 154 0 , 422 - 0 , 129 0 , 856 0 , 389 0 , 167 0 , 047 0 , 042 0 , 140 0 , 140 0 , 064 0 , 536 0 , 118 0 , 829 0 , 074 - 0 , 042 0 , 513 - 0 , 341 0 , 874 0 , 222 - 0 , 500 0 , 243 - 0 , 413 0 , 308 - 0 , 283 0 , 531 - 0 , 085 - 0 , 419 0 , 128 - 0 , 006 0 , 124 0 , 110 - 0 , 343 - 0 , 040 0 , 372 - 0 , 085 - 0 , 191 0 , 104 - 0 , 134 0 , 249 0 , 452 0 , 474 - 0 , 136 0 , 282 0 , 297 0 , 467 0 , 020 0 , 098 0 , 200 0 , 465 0 , 427 0 , 507 0 , 355 - 0 , 243 - 0 , 197 0 , 056 0 , 258 0 , 189 0 , 733 - 0 , 082 0 , 147 0 , 394 - 0 , 167 0 , 633 - 0 , 075 - 0 , 396 0 , 215 0 , 217 - 0 , 549 - 0 , 080 0 , 013 0 , 212 0 , 048 0 , 304 0 , 006 0 , 064 - 0 , 068 0 , 139 0 , 033 0 , 085 0 , 373 - 0 , 401 - 0 , 073 - 0 , 429 0 , 266 - 0 , 611 0 , 054 0 , 533 - 0 , 239 0 , 192 0 , 073 0 , 065 0 , 558 - 0 , 214 - 0 , 327 0 , 075 0 , 042 0 , 393 0 , 088 0 , 149 0 , 256 0 , 532 - 0 , 119 0 , 714 0 , 094 0 , 174 0 , 146 - 0 , 319 0 , 694 0 , 368 1 , 000 0 , 258 0 , 435 0 , 080 0 , 148 - 0 , 160 - 0 , 247 0 , 178 0 , 098 0 , 163 - 0 , 069 0 , 482 - 0 , 388 0 , 342 - 0 , 495 0 , 258 1 , 000 0 , 193 0 , 054 - 0 , 446 0 , 355 - 0 , 567 0 , 047 - 0 , 307 - 0 , 181 - 0 , 393 0 , 769 - 0 , 417 - 0 , 163 - 0 , 480 0 , 435 0 , 193 1 , 000 - 0 , 108 0 , 334 0 , 228 - 0 , 195 - 0 , 020 - 0 , 101 0 , 294 0 , 014 - 0 , 170 - 0 , 180 0 , 068 - 0 , 053 0 , 080 0 , 054 - 0 , 108 1 , 000 0 , 276 0 , 876 - 0 , 188 - 0 , 363 - 0 , 023 - 0 , 198 - 0 , 166 0 , 531 - 0 , 394 0 , 171 0 , 248 0 , 148 - 0 , 446 0 , 334 0 , 276 1 , 000 0 , 327 0 , 302 - 0 , 145 - 0 , 031 0 , 238 0 , 061 0 , 363 0 , 052 0 , 189 0 , 514 - 0 , 160 0 , 355 0 , 228 0 , 876 0 , 327 1 , 000 - 0 , 196 - 0 , 634 0 , 206 - 0 , 168 0 , 012 0 , 612 - 0 , 475 0 , 118 0 , 597 - 0 , 247 - 0 , 567 - 0 , 195 - 0 , 188 0 , 302 - 0 , 196 1 , 000 0 , 067 0 , 584 0 , 426 0 , 443 - 0 , 041 0 , 153 0 , 506 0 , 553 0 , 178 0 , 047 - 0 , 020 - 0 , 363 - 0 , 145 - 0 , 634 0 , 067 1 , 000 0 , 125 - 0 , 129 0 , 022 0 , 131 0 , 520 - 0 , 036 - 0 , 596 0 , 098 - 0 , 307 - 0 , 101 - 0 , 023 - 0 , 031 0 , 206 0 , 584 0 , 125 1 , 000 0 , 023 0 , 159 0 , 360 - 0 , 034 0 , 867 0 , 262 0 , 163 - 0 , 181 0 , 294 - 0 , 198 0 , 238 - 0 , 168 0 , 426 - 0 , 129 0 , 023 1 , 000 0 , 545 - 0 , 501 - 0 , 467 - 0 , 004 0 , 478 - 0 , 069 - 0 , 393 0 , 014 - 0 , 166 0 , 061 0 , 012 0 , 443 0 , 022 0 , 159 0 , 545 1 , 000 - 0 , 736 - 0 , 142 - 0 , 109 0 , 500 0 , 482 0 , 769 - 0 , 170 0 , 531 0 , 363 0 , 612 - 0 , 041 0 , 131 0 , 360 - 0 , 501 - 0 , 736 1 , 000 - 0 , 301 0 , 596 - 0 , 232 - 0 , 388 - 0 , 417 - 0 , 180 - 0 , 394 0 , 052 - 0 , 475 0 , 153 0 , 520 - 0 , 034 - 0 , 467 - 0 , 142 - 0 , 301 1 , 000 - 0 , 174 - 0 , 259 0 , 342 - 0 , 163 0 , 068 0 , 171 0 , 189 0 , 118 0 , 506 - 0 , 036 0 , 867 - 0 , 004 - 0 , 109 0 , 596 - 0 , 174 1 , 000 0 , 253 - 0 , 495 - 0 , 480 - 0 , 053 0 , 248 0 , 514 0 , 597 0 , 553 - 0 , 596 0 , 262 0 , 478 0 , 500 - 0 , 232 - 0 , 259 0 , 253 1 , 000 - 0 , 241 - 0 , 516 0 , 054 - 0 , 083 0 , 301 0 , 006 - 0 , 030 - 0 , 459 - 0 , 471 0 , 561 0 , 450 - 0 , 718 - 0 , 160 - 0 , 453 0 , 521 - 0 , 329 - 0 , 428 - 0 , 204 0 , 664 0 , 374 0 , 492 0 , 268 - 0 , 415 0 , 311 - 0 , 281 - 0 , 179 0 , 150 0 , 037 0 , 442 0 , 475 - 0 , 295 - 0 , 015 - 0 , 012 0 , 196 0 , 426 0 , 329 0 , 570 - 0 , 026 0 , 635 0 , 043 0 , 076 0 , 289 - 0 , 048 0 , 496 0 , 453 - 0 , 265 - 0 , 227 - 0 , 107 0 , 002 0 , 091 0 , 377 0 , 640 - 0 , 040 0 , 587 - 0 , 040 0 , 350 0 , 058 0 , 228 0 , 451 0 , 421 - 0 , 332 - 0 , 278 - 0 , 052 0 , 062 0 , 391 - 0 , 277 0 , 502 0 , 295 0 , 309 0 , 106 - 0 , 267 0 , 171 0 , 177 0 , 361 0 , 124 - 0 , 035 0 , 121 0 , 211 0 , 273 0 , 376 0 , 494 0 , 278 - 0 , 468 0 , 009 0 , 428 0 , 278 0 , 044 - 0 , 541 0 , 107 0 , 552 - 0 , 155 0 , 180 0 , 106 0 , 182 0 , 153 0 , 222 0 , 212 - 0 , 068 0 , 362 0 , 018 - 0 , 017 0 , 143 - 0 , 322 0 , 365 0 , 220 - 0 , 608 - 0 , 044 0 , 078 - 0 , 293 - 0 , 065 0 , 026 0 , 072 - 0 , 218 - 0 , 150 0 , 302 0 , 141 - 0 , 631 - 0 , 039 - 0 , 188 0 , 308 - 0 , 192 0 , 433 - 0 , 003 - 0 , 164 - 0 , 154 - 0 , 055 0 , 330 0 , 088 0 , 408 0 , 193 0 , 067 0 , 123 - 0 , 468 0 , 270 0 , 080 0 , 183 0 , 221 0 , 170 - 0 , 140 - 0 , 148 0 , 104 0 , 498 0 , 062 0 , 386 0 , 435 0 , 625 - 0 , 065 - 0 , 395 0 , 215 0 , 228 0 , 013 0 , 062 0 , 308 - 0 , 280 0 , 201 - 0 , 119 0 , 494 0 , 144 0 , 210 0 , 460 0 , 584 - 0 , 287 - 0 , 268 0 , 075 0 , 286 - 0 , 256 0 , 207 - 0 , 034 0 , 199 - 0 , 087 0 , 530 0 , 521 - 0 , 224 0 , 653 0 , 228 0 , 143 0 , 290 - 0 , 533 0 , 570 0 , 449 - 0 , 028 - 0 , 122 - 0 , 090 - 0 , 101 - 0 , 080 0 , 365 0 , 643 0 , 019 0 , 806 0 , 020 0 , 098 0 , 503 0 , 203 0 , 749 0 , 312 - 0 , 131 0 , 033 - 0 , 409 0 , 432 0 , 280 0 , 446 0 , 550 - 0 , 164 0 , 481 0 , 158 0 , 067 0 , 719 - 0 , 223 0 , 383 0 , 457 0 , 026 0 , 208 0 , 342 0 , 069 - 0 , 016 0 , 254 0 , 276 - 0 , 240 0 , 329 0 , 583 0 , 421 - 0 , 216 - 0 , 820 0 , 225 0 , 395 - 0 , 005 0 , 444 0 , 173 0 , 059 0 , 055 0 , 328 0 , 151 0 , 261 0 , 354 0 , 329 - 0 , 190 0 , 567 - 0 , 369 0 , 272 - 0 , 023 0 , 517 0 , 240 0 , 000 0 , 391 0 , 619 - 0 , 062 0 , 239 0 , 413 0 , 825 - 0 , 602 - 0 , 687 0 , 000 - 0 , 007 0 , 877 - 0 , 281 - 0 , 036 0 , 332 0 , 071 - 0 , 408 - 0 , 290 0 , 000 - 0 , 896 0 , 158 - 0 , 792 0 , 128 - 0 , 039 0 , 000 - 0 , 083 - 0 , 758 - 0 , 586 - 0 , 304 - 0 , 327 0 , 049 0 , 102 0 , 245 0 , 402 0 , 242 - 0 , 496 - 0 , 006 0 , 525 0 , 487 - 0 , 632 - 0 , 292 0 , 015 0 , 678 - 0 , 013 0 , 407 0 , 068 0 , 379 - 0 , 062 0 , 471 - 0 , 107 - 0 , 450 0 , 193 0 , 076 - 0 , 123 0 , 313 - 0 , 585 0 , 240 0 , 217 0 , 454 - 0 , 180 0 , 231 0 , 164 0 , 542 - 0 , 307 - 0 , 127 - 0 , 331 - 0 , 200 0 , 395 0 , 117 - 0 , 168 - 0 , 571 0 , 101 0 , 293 - 0 , 069 0 , 105 0 , 170 - 0 , 159 0 , 072 - 0 , 102 0 , 371 0 , 316 0 , 259 0 , 234 0 , 276 - 0 , 014 0 , 028 0 , 112 0 , 045 - 0 , 010 - 0 , 157 - 0 , 206 - 0 , 232 - 0 , 227 - 0 , 238 0 , 607 0 , 201 0 , 816 0 , 185 0 , 517 - 0 , 049 - 0 , 250 0 , 578 0 , 253 - 0 , 175 - 0 , 442 0 , 170 - 0 , 049 0 , 441 0 , 307 0 , 417 - 0 , 343 0 , 144 0 , 158 0 , 628 - 0 , 451 0 , 070 0 , 081 0 , 663 - 0 , 441 0 , 202 0 , 349 - 0 , 250 - 0 , 188 0 , 090 0 , 198 0 , 072 0 , 263 0 , 091 0 , 057 - 0 , 326 - 0 , 046 0 , 060 0 , 085 - 0 , 455 0 , 215 0 , 162 - 0 , 195 - 0 , 166 0 , 061 0 , 299 0 , 184 0 , 281 0 , 172 0 , 102 - 0 , 182 - 0 , 082 0 , 045 0 , 074 0 , 219 - 0 , 365 0 , 221 - 0 , 217 - 0 , 084 - 0 , 035 0 , 254 - 0 , 388 0 , 307 0 , 491 0 , 409 - 0 , 344 - 0 , 211 0 , 236 0 , 374 0 , 152 0 , 002 0 , 212 0 , 177 0 , 146 0 , 304 0 , 094 - 0 , 699 0 , 010 0 , 442 0 , 302 - 0 , 384 - 0 , 777 0 , 192 0 , 552 0 , 439 0 , 169 0 , 080 0 , 005 0 , 178 0 , 185 0 , 182 - 0 , 272 0 , 237 - 0 , 026 - 0 , 196 0 , 668 - 0 , 179 0 , 562 0 , 163 - 0 , 279 0 , 188 - 0 , 270 0 , 021 - 0 , 330 0 , 202 0 , 009 - 0 , 571 - 0 , 010 - 0 , 119 0 , 174 - 0 , 358 - 0 , 281 - 0 , 115 0 , 255 - 0 , 421 0 , 402 0 , 011 0 , 738 - 0 , 137 0 , 703 - 0 , 390 - 0 , 366 - 0 , 409 - 0 , 004 - 0 , 247 - 0 , 321 - 0 , 843 - 0 , 455 - 0 , 001 0 , 055 - 0 , 229 - 0 , 074 - 0 , 136 0 , 032 0 , 057 0 , 393 - 0 , 267 0 , 304 0 , 346 0 , 723 - 0 , 476 - 0 , 313 0 , 237 0 , 539 - 0 , 235 - 0 , 012 - 0 , 055 - 0 , 396 - 0 , 053 - 0 , 074 0 , 518 - 0 , 034 0 , 420 0 , 241 0 , 237 0 , 015 0 , 102 0 , 325 0 , 265 - 0 , 099 0 , 068 0 , 293 0 , 255 0 , 367 0 , 643 0 , 359 - 0 , 383 0 , 394 0 , 367 0 , 406 0 , 136 - 0 , 485 0 , 311 0 , 660 0 , 026 0 , 063 - 0 , 244 - 0 , 151 - 0 , 045 - 0 , 111 0 , 564 0 , 153 0 , 543 0 , 261 0 , 293 0 , 306 - 0 , 090 0 , 410 0 , 176 - 0 , 076 0 , 127 - 0 , 020 - 0 , 203 0 , 116 - 0 , 847 - 0 , 238 0 , 253 - 0 , 303 0 , 105 0 , 304 - 0 , 453 - 0 , 208 - 0 , 231 0 , 027 0 , 272 0 , 322 0 , 007 0 , 130 - 0 , 043 0 , 417 - 0 , 198 - 0 , 365 0 , 183 - 0 , 097 - 0 , 158 0 , 553 - 0 , 205 0 , 308 0 , 106 - 0 , 506 - 0 , 190 0 , 127 0 , 143 0 , 394 0 , 414 0 , 514 - 0 , 346 0 , 154 0 , 197 0 , 108 - 0 , 122 - 0 , 016 0 , 100 0 , 551 0 , 021 0 , 274 0 , 365 0 , 337 0 , 236 0 , 312 0 , 084 - 0 , 042 0 , 193 0 , 151 0 , 106 0 , 061 - 0 , 590 0 , 209 0 , 194 - 0 , 375 0 , 477 - 0 , 054 0 , 106 - 0 , 195 0 , 830 - 0 , 072 - 0 , 619 - 0 , 372 0 , 280 0 , 122 0 , 527 - 0 , 487 - 0 , 425 0 , 416 0 , 000 - 0 , 744 - 0 , 886 - 0 , 444 0 , 342 0 , 000 0 , 897 - 0 , 188 0 , 267 0 , 169 0 , 614 0 , 000 0 , 539 - 0 , 049 0 , 574 - 0 , 147 - 0 , 231 - 0 , 168 - 0 , 333 - 0 , 066 - 0 , 193 0 , 181 - 0 , 535 - 0 , 214 0 , 576 0 , 548 - 0 , 703 - 0 , 359 - 0 , 252 0 , 495 0 , 013 0 , 380 0 , 148 - 0 , 004 0 , 288 0 , 201 0 , 105 - 0 , 115 - 0 , 414 0 , 390 0 , 164 0 , 089 - 0 , 411 - 0 , 276 0 , 177 0 , 278 0 , 202 0 , 073 0 , 311 0 , 105 0 , 391 0 , 378 - 0 , 335 0 , 358 0 , 478 0 , 196 0 , 495 - 0 , 667 0 , 432 0 , 392 - 0 , 082 - 0 , 022 - 0 , 291 - 0 , 087 0 , 131 0 , 364 0 , 280 - 0 , 021 0 , 103 0 , 062 0 , 263 0 , 484 0 , 232 0 , 054 0 , 215 0 , 569 0 , 422 0 , 406 - 0 , 139 - 0 , 136 0 , 041 0 , 117 0 , 111 0 , 581 - 0 , 167 0 , 072 0 , 359 - 0 , 163 0 , 547 - 0 , 165 - 0 , 175 - 0 , 014 0 , 024 - 0 , 312 - 0 , 088 - 0 , 580 - 0 , 153 0 , 399 - 0 , 106 - 0 , 033 0 , 155 - 0 , 578 0 , 079 - 0 , 357 - 0 , 290 0 , 404 - 0 , 184 - 0 , 124 - 0 , 013 - 0 , 120 - 0 , 100 0 , 212 - 0 , 105 0 , 094 0 , 293 0 , 252 0 , 116 - 0 , 026 0 , 007 0 , 020 - 0 , 178 - 0 , 002 0 , 258 0 , 021 0 , 162 0 , 254 0 , 610 - 0 , 180 0 , 598 0 , 403 0 , 194 0 , 040 - 0 , 451 0 , 504 0 , 472 Novel approaches to understanding hENT2 and hENT2 - related proteins 292 P Values AQP1 AQP3 AQP5 ABCA2 ABCA3 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 CTR1 ENT1 ENT2 ENT3 ENT4 CNT3 AQP1 AQP3 AQP5 ABCA2 ABCA3 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A ATP7B DPYD TYMP UPP1 EPHX1 DCK RRM1 TYMS TK1 UMPS UCK2 FPGS GCLC UGTX TOP1 TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 MSH2 MSH6 GADD45 BAX P21 FAS BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR MYC MMP1 MMP2 TIGAR NRF2 KEAP1 ENT1n ENT2n CNT1n CNT2n CNT3n 1 , 000 0 , 593 0 , 663 0 , 098 0 , 111 0 , 596 0 , 038 0 , 997 0 , 025 0 , 756 0 , 694 1 , 000 0 , 306 0 , 128 0 , 227 0 , 584 0 , 520 0 , 367 0 , 111 0 , 778 0 , 621 0 , 514 0 , 822 0 , 018 0 , 841 0 , 531 0 , 511 0 , 106 0 , 016 0 , 718 0 , 179 0 , 512 0 , 060 0 , 423 0 , 384 1 , 000 0 , 557 0 , 716 0 , 359 0 , 492 0 , 511 0 , 823 0 , 572 0 , 852 0 , 472 0 , 843 0 , 695 0 , 396 0 , 375 0 , 296 0 , 321 0 , 298 0 , 311 0 , 179 0 , 968 0 , 972 0 , 514 0 , 448 0 , 073 0 , 203 0 , 409 0 , 792 0 , 415 0 , 993 0 , 978 0 , 239 0 , 087 0 , 247 0 , 471 0 , 262 0 , 064 0 , 288 0 , 629 0 , 811 0 , 046 0 , 570 0 , 911 0 , 916 0 , 075 0 , 006 0 , 068 0 , 809 0 , 135 0 , 094 0 , 251 0 , 070 1 , 000 0 , 821 0 , 092 0 , 116 0 , 298 0 , 589 0 , 718 0 , 622 0 , 098 0 , 237 0 , 516 0 , 522 0 , 435 0 , 903 0 , 815 0 , 344 0 , 751 0 , 975 0 , 431 0 , 911 0 , 563 0 , 907 0 , 288 0 , 720 0 , 237 0 , 023 0 , 955 0 , 000 1 , 000 0 , 616 0 , 405 0 , 690 0 , 000 0 , 189 0 , 644 0 , 879 0 , 902 0 , 633 0 , 649 0 , 881 0 , 048 0 , 687 0 , 000 0 , 801 0 , 887 0 , 239 0 , 278 0 , 000 0 , 446 0 , 141 0 , 423 0 , 207 0 , 283 0 , 350 0 , 176 0 , 773 0 , 136 0 , 663 0 , 985 0 , 673 0 , 814 0 , 274 0 , 891 0 , 190 0 , 815 0 , 533 0 , 761 0 , 649 0 , 412 0 , 261 0 , 087 0 , 644 0 , 328 0 , 303 0 , 092 0 , 966 0 , 762 0 , 492 0 , 094 0 , 219 0 , 077 0 , 284 0 , 403 0 , 519 0 , 894 0 , 373 0 , 517 0 , 003 0 , 780 0 , 615 0 , 382 0 , 604 0 , 015 0 , 800 0 , 257 0 , 481 0 , 522 0 , 042 0 , 794 0 , 975 0 , 466 0 , 870 0 , 291 0 , 982 0 , 827 0 , 885 0 , 668 0 , 912 0 , 773 0 , 289 0 , 197 0 , 842 0 , 143 0 , 404 0 , 108 0 , 860 0 , 061 0 , 431 0 , 529 0 , 814 0 , 891 0 , 075 0 , 482 0 , 275 0 , 836 0 , 896 0 , 261 0 , 776 0 , 643 0 , 540 0 , 061 0 , 700 0 , 006 0 , 760 0 , 570 0 , 755 0 , 340 0 , 008 0 , 217 0 , 000 0 , 502 0 , 281 0 , 825 0 , 704 0 , 732 0 , 491 0 , 622 0 , 788 0 , 653 0 , 851 0 , 273 0 , 342 0 , 333 0 , 146 0 , 502 0 , 000 0 , 569 0 , 860 0 , 146 0 , 388 0 , 043 0 , 879 0 , 307 0 , 554 0 , 185 0 , 074 0 , 177 0 , 596 0 , 097 0 , 281 0 , 569 0 , 000 0 , 752 0 , 346 0 , 622 0 , 565 0 , 954 0 , 767 0 , 381 0 , 968 0 , 785 0 , 618 0 , 842 0 , 876 0 , 825 0 , 860 0 , 752 0 , 000 0 , 361 0 , 004 0 , 520 0 , 202 0 , 937 0 , 497 0 , 571 0 , 220 0 , 205 0 , 560 0 , 393 0 , 704 0 , 146 0 , 346 0 , 361 0 , 000 0 , 475 0 , 316 0 , 637 0 , 920 0 , 434 0 , 842 0 , 479 0 , 879 0 , 537 0 , 072 0 , 732 0 , 388 0 , 622 0 , 004 0 , 475 0 , 000 0 , 641 0 , 092 0 , 624 0 , 692 0 , 977 0 , 273 0 , 234 0 , 781 0 , 118 0 , 491 0 , 043 0 , 565 0 , 520 0 , 316 0 , 641 0 , 000 0 , 821 0 , 028 0 , 129 0 , 112 0 , 930 0 , 635 0 , 065 0 , 040 0 , 622 0 , 879 0 , 954 0 , 202 0 , 637 0 , 092 0 , 821 0 , 000 0 , 671 0 , 661 0 , 939 0 , 779 0 , 083 0 , 903 0 , 025 0 , 788 0 , 307 0 , 767 0 , 937 0 , 920 0 , 624 0 , 028 0 , 671 0 , 000 0 , 938 0 , 588 0 , 428 0 , 916 0 , 000 0 , 366 0 , 653 0 , 554 0 , 381 0 , 497 0 , 434 0 , 692 0 , 129 0 , 661 0 , 938 0 , 000 0 , 044 0 , 252 0 , 126 0 , 990 0 , 084 0 , 851 0 , 185 0 , 968 0 , 571 0 , 842 0 , 977 0 , 112 0 , 939 0 , 588 0 , 044 0 , 000 0 , 060 0 , 660 0 , 712 0 , 069 0 , 273 0 , 074 0 , 785 0 , 220 0 , 479 0 , 273 0 , 930 0 , 779 0 , 428 0 , 252 0 , 060 0 , 000 0 , 623 0 , 158 0 , 617 0 , 342 0 , 177 0 , 618 0 , 205 0 , 879 0 , 234 0 , 635 0 , 083 0 , 916 0 , 126 0 , 660 0 , 623 0 , 000 0 , 588 0 , 416 0 , 333 0 , 596 0 , 842 0 , 560 0 , 537 0 , 781 0 , 065 0 , 903 0 , 000 0 , 990 0 , 712 0 , 158 0 , 588 0 , 000 0 , 382 0 , 146 0 , 097 0 , 876 0 , 393 0 , 072 0 , 118 0 , 040 0 , 025 0 , 366 0 , 084 0 , 069 0 , 617 0 , 416 0 , 382 0 , 000 0 , 502 0 , 071 0 , 876 0 , 777 0 , 317 0 , 989 0 , 920 0 , 099 0 , 089 0 , 037 0 , 106 0 , 069 0 , 620 0 , 104 0 , 056 0 , 353 0 , 145 0 , 548 0 , 010 0 , 208 0 , 215 0 , 354 0 , 141 0 , 278 0 , 331 0 , 539 0 , 749 0 , 910 0 , 113 0 , 086 0 , 441 0 , 961 0 , 971 0 , 520 0 , 167 0 , 427 0 , 042 0 , 934 0 , 020 0 , 889 0 , 806 0 , 578 0 , 881 0 , 085 0 , 120 0 , 460 0 , 457 0 , 755 0 , 995 0 , 768 0 , 357 0 , 014 0 , 891 0 , 027 0 , 891 0 , 219 0 , 902 0 , 477 0 , 105 0 , 134 0 , 349 0 , 358 0 , 879 0 , 832 0 , 186 0 , 507 0 , 067 0 , 305 0 , 283 0 , 719 0 , 357 0 , 714 0 , 582 0 , 204 0 , 672 0 , 923 0 , 693 0 , 534 0 , 345 0 , 206 0 , 214 0 , 336 0 , 091 0 , 976 0 , 127 0 , 336 0 , 925 0 , 069 0 , 716 0 , 041 0 , 669 0 , 556 0 , 756 0 , 535 0 , 618 0 , 597 0 , 468 0 , 819 0 , 203 0 , 951 0 , 954 0 , 760 0 , 307 0 , 199 0 , 450 0 , 062 0 , 886 0 , 820 0 , 309 0 , 834 0 , 952 0 , 807 0 , 455 0 , 610 0 , 294 0 , 630 0 , 128 0 , 905 0 , 520 0 , 284 0 , 596 0 , 140 0 , 994 0 , 575 0 , 616 0 , 898 0 , 249 0 , 766 0 , 148 0 , 508 0 , 819 0 , 793 0 , 125 0 , 350 0 , 785 0 , 614 0 , 468 0 , 618 0 , 633 0 , 630 0 , 806 0 , 070 0 , 833 0 , 173 0 , 120 0 , 017 0 , 890 0 , 204 0 , 461 0 , 433 0 , 972 0 , 841 0 , 357 0 , 332 0 , 510 0 , 779 0 , 072 0 , 624 0 , 472 0 , 098 0 , 028 0 , 533 0 , 400 0 , 798 0 , 322 0 , 475 0 , 497 0 , 921 0 , 496 0 , 777 0 , 176 0 , 056 0 , 442 0 , 011 0 , 433 0 , 627 0 , 529 0 , 075 0 , 033 0 , 108 0 , 939 0 , 692 0 , 792 0 , 730 0 , 794 0 , 374 0 , 013 0 , 947 0 , 001 0 , 945 0 , 739 0 , 250 0 , 526 0 , 002 0 , 278 0 , 738 0 , 918 0 , 212 0 , 160 0 , 404 0 , 268 0 , 064 0 , 612 0 , 113 0 , 625 0 , 835 0 , 107 0 , 510 0 , 220 0 , 135 0 , 943 0 , 495 0 , 304 0 , 814 0 , 960 0 , 544 0 , 339 0 , 409 0 , 250 0 , 029 0 , 134 0 , 643 0 , 001 0 , 440 0 , 162 0 , 990 0 , 128 0 , 611 0 , 841 0 , 859 0 , 428 0 , 607 0 , 368 0 , 214 0 , 250 0 , 515 0 , 185 0 , 238 0 , 346 0 , 938 0 , 373 0 , 647 1 , 000 0 , 443 0 , 265 0 , 921 0 , 648 0 , 416 0 , 043 0 , 206 0 , 131 1 , 000 0 , 989 0 , 022 0 , 590 0 , 946 0 , 521 0 , 910 0 , 364 0 , 529 1 , 000 0 , 006 0 , 735 0 , 034 0 , 784 0 , 934 1 , 000 0 , 876 0 , 048 0 , 167 0 , 393 0 , 276 0 , 886 0 , 730 0 , 419 0 , 324 0 , 404 0 , 071 0 , 983 0 , 054 0 , 077 0 , 128 0 , 357 0 , 959 0 , 008 0 , 971 0 , 167 0 , 842 0 , 181 0 , 841 0 , 239 0 , 715 0 , 107 0 , 509 0 , 797 0 , 674 0 , 495 0 , 046 0 , 409 0 , 456 0 , 187 0 , 556 0 , 495 0 , 576 0 , 056 0 , 460 0 , 666 0 , 248 0 , 493 0 , 163 0 , 690 0 , 718 0 , 053 0 , 730 0 , 309 0 , 851 0 , 732 0 , 618 0 , 587 0 , 815 0 , 809 0 , 192 0 , 272 0 , 372 0 , 420 0 , 340 0 , 977 0 , 932 0 , 702 0 , 880 0 , 977 0 , 608 0 , 543 0 , 424 0 , 456 0 , 570 0 , 021 0 , 490 0 , 000 0 , 526 0 , 059 0 , 918 0 , 434 0 , 030 0 , 382 0 , 630 0 , 131 0 , 618 0 , 869 0 , 132 0 , 459 0 , 138 0 , 230 0 , 622 0 , 589 0 , 016 0 , 310 0 , 830 0 , 783 0 , 010 0 , 202 0 , 530 0 , 292 0 , 409 0 , 559 0 , 833 0 , 516 0 , 816 0 , 386 0 , 768 0 , 854 0 , 476 0 , 893 0 , 847 0 , 783 0 , 187 0 , 481 0 , 635 0 , 503 0 , 589 0 , 885 0 , 299 0 , 528 0 , 331 0 , 556 0 , 728 0 , 697 0 , 799 0 , 878 0 , 802 0 , 543 0 , 220 0 , 514 0 , 457 0 , 784 0 , 935 0 , 380 0 , 170 0 , 285 0 , 075 0 , 147 0 , 450 0 , 510 0 , 417 0 , 188 0 , 676 0 , 994 0 , 532 0 , 545 0 , 633 0 , 463 0 , 750 0 , 005 0 , 974 0 , 114 0 , 294 0 , 395 0 , 003 0 , 511 0 , 041 0 , 204 0 , 581 0 , 815 0 , 987 0 , 560 0 , 661 0 , 534 0 , 347 0 , 415 0 , 929 0 , 503 0 , 101 0 , 577 0 , 037 0 , 579 0 , 467 0 , 559 0 , 422 0 , 946 0 , 294 0 , 664 0 , 978 0 , 042 0 , 973 0 , 700 0 , 570 0 , 486 0 , 403 0 , 708 0 , 400 0 , 299 0 , 220 0 , 976 0 , 006 0 , 688 0 , 078 0 , 210 0 , 243 0 , 187 0 , 990 0 , 439 0 , 534 0 , 002 0 , 137 0 , 997 0 , 879 0 , 451 0 , 828 0 , 644 0 , 917 0 , 894 0 , 165 0 , 356 0 , 291 0 , 226 0 , 004 0 , 280 0 , 322 0 , 415 0 , 046 0 , 512 0 , 968 0 , 872 0 , 161 0 , 863 0 , 862 0 , 058 0 , 909 0 , 135 0 , 406 0 , 415 0 , 974 0 , 752 0 , 257 0 , 360 0 , 786 0 , 826 0 , 382 0 , 379 0 , 217 0 , 086 0 , 208 0 , 177 0 , 163 0 , 197 0 , 150 0 , 771 0 , 110 0 , 279 0 , 010 0 , 944 0 , 839 0 , 470 0 , 606 0 , 883 0 , 794 0 , 036 0 , 601 0 , 045 0 , 368 0 , 310 0 , 505 0 , 781 0 , 145 0 , 548 0 , 871 0 , 745 0 , 966 0 , 600 0 , 785 0 , 070 0 , 538 0 , 511 0 , 428 0 , 788 0 , 426 0 , 443 0 , 621 0 , 550 0 , 946 0 , 448 0 , 284 0 , 983 0 , 657 0 , 890 0 , 304 0 , 499 0 , 199 0 , 530 0 , 740 0 , 590 0 , 198 0 , 523 0 , 283 0 , 717 0 , 136 0 , 535 0 , 711 0 , 626 0 , 183 0 , 308 0 , 060 0 , 226 0 , 599 0 , 499 0 , 713 0 , 795 0 , 960 0 , 733 0 , 041 0 , 955 0 , 366 0 , 269 0 , 239 0 , 439 0 , 452 0 , 776 0 , 887 0 , 510 0 , 605 0 , 718 0 , 896 0 , 043 0 , 474 0 , 507 0 , 360 0 , 117 0 , 875 0 , 742 0 , 566 0 , 021 0 , 824 0 , 032 0 , 233 0 , 377 0 , 705 0 , 362 0 , 129 0 , 168 0 , 179 1 , 000 0 , 090 0 , 045 0 , 378 0 , 507 1 , 000 0 , 015 0 , 721 0 , 609 0 , 748 0 , 194 1 , 000 0 , 270 0 , 927 0 , 233 0 , 686 0 , 448 0 , 622 0 , 245 0 , 829 0 , 647 0 , 536 0 , 049 0 , 462 0 , 031 0 , 043 0 , 078 0 , 251 0 , 385 0 , 072 0 , 971 0 , 200 0 , 663 0 , 989 0 , 339 0 , 634 0 , 722 0 , 695 0 , 141 0 , 168 0 , 576 0 , 850 0 , 184 0 , 340 0 , 544 0 , 437 0 , 509 0 , 832 0 , 280 0 , 733 0 , 338 0 , 183 0 , 242 0 , 209 0 , 084 0 , 501 0 , 259 0 , 018 0 , 123 0 , 166 0 , 823 0 , 944 0 , 386 0 , 766 0 , 669 0 , 376 0 , 332 0 , 944 0 , 725 0 , 834 0 , 364 0 , 271 0 , 468 0 , 855 0 , 460 0 , 086 0 , 151 0 , 216 0 , 634 0 , 659 0 , 923 0 , 691 0 , 706 0 , 029 0 , 568 0 , 807 0 , 429 0 , 613 0 , 043 0 , 573 0 , 628 0 , 964 0 , 945 0 , 277 0 , 776 0 , 131 0 , 601 0 , 157 0 , 720 0 , 910 0 , 596 0 , 175 0 , 808 0 , 210 0 , 315 0 , 247 0 , 548 0 , 715 0 , 965 0 , 696 0 , 813 0 , 467 0 , 722 0 , 749 0 , 310 0 , 385 0 , 805 0 , 935 0 , 981 0 , 946 0 , 623 0 , 995 0 , 444 0 , 943 0 , 597 0 , 544 0 , 020 0 , 539 0 , 024 0 , 153 0 , 507 0 , 931 0 , 141 0 , 066 0 , 088 Appendix I 293 Correlat . ATP7B DPYD TYMP UPP1 EPHX1 DCK RRM1 TYMS TK1 UMPS UCK2 FPGS GCLC UGTX TOP1 OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 CTR1 ENT1 ENT2 ENT3 ENT4 CNT3 AQP1 AQP3 AQP5 ABCA2 ABCA3 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A ATP7B DPYD TYMP UPP1 EPHX1 DCK RRM1 TYMS TK1 UMPS UCK2 FPGS GCLC UGTX TOP1 TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 MSH2 MSH6 GADD45 BAX P21 FAS BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR MYC MMP1 MMP2 TIGAR NRF2 KEAP1 ENT1n ENT2n CNT1n CNT2n CNT3n 0 , 340 - 0 , 710 - 0 , 781 - 0 , 588 - 0 , 628 - 0 , 580 - 0 , 514 0 , 703 - 0 , 349 - 0 , 549 - 0 , 545 - 0 , 586 - 0 , 470 - 0 , 666 - 0 , 474 - 0 , 383 0 , 419 0 , 649 0 , 264 0 , 481 0 , 438 0 , 590 0 , 146 0 , 451 0 , 361 0 , 281 0 , 691 0 , 468 0 , 231 0 , 512 0 , 165 - 0 , 684 - 0 , 133 - 0 , 769 - 0 , 355 - 0 , 346 - 0 , 576 0 , 004 - 0 , 409 0 , 231 0 , 082 - 0 , 433 0 , 217 - 0 , 119 - 0 , 042 - 0 , 248 0 , 473 0 , 654 0 , 748 0 , 053 0 , 800 0 , 875 0 , 336 0 , 608 0 , 514 0 , 525 0 , 695 0 , 288 0 , 012 0 , 551 0 , 119 0 , 261 0 , 468 0 , 762 - 0 , 128 0 , 713 0 , 508 0 , 468 0 , 447 0 , 729 0 , 649 0 , 655 0 , 316 0 , 005 0 , 658 - 0 , 245 0 , 918 0 , 628 0 , 647 0 , 378 0 , 431 0 , 503 0 , 038 - 0 , 016 - 0 , 603 - 0 , 479 0 , 697 0 , 619 0 , 517 - 0 , 397 - 0 , 283 0 , 137 0 , 527 0 , 201 0 , 519 0 , 221 0 , 282 - 0 , 055 0 , 360 0 , 015 0 , 318 0 , 291 0 , 121 0 , 422 0 , 121 - 0 , 477 0 , 564 0 , 766 0 , 729 0 , 423 0 , 285 0 , 609 - 0 , 125 0 , 477 0 , 471 0 , 301 0 , 820 0 , 788 0 , 491 0 , 423 - 0 , 547 0 , 300 0 , 637 0 , 344 0 , 559 0 , 099 0 , 376 - 0 , 225 0 , 465 0 , 314 0 , 265 0 , 660 0 , 688 0 , 583 0 , 365 0 , 089 0 , 266 0 , 106 0 , 328 - 0 , 230 0 , 438 0 , 482 0 , 386 0 , 431 0 , 215 0 , 039 0 , 537 0 , 009 0 , 092 0 , 404 0 , 151 0 , 135 0 , 406 0 , 800 - 0 , 212 0 , 660 0 , 545 0 , 477 0 , 385 0 , 611 0 , 559 0 , 438 0 , 305 - 0 , 130 0 , 389 - 0 , 575 - 0 , 124 0 , 380 0 , 558 - 0 , 158 0 , 163 0 , 431 - 0 , 065 0 , 534 0 , 620 0 , 454 0 , 506 0 , 604 - 0 , 082 0 , 375 - 0 , 206 - 0 , 257 0 , 093 0 , 164 0 , 124 - 0 , 064 0 , 041 0 , 015 0 , 401 0 , 181 0 , 343 0 , 208 0 , 290 0 , 038 0 , 162 0 , 216 - 0 , 472 - 0 , 425 - 0 , 357 0 , 009 - 0 , 468 - 0 , 579 - 0 , 311 - 0 , 499 - 0 , 280 - 0 , 203 - 0 , 736 - 0 , 207 - 0 , 091 - 0 , 586 - 0 , 379 0 , 404 0 , 725 0 , 758 0 , 222 0 , 607 0 , 814 0 , 216 0 , 712 0 , 665 0 , 641 0 , 844 0 , 527 - 0 , 012 0 , 711 - 0 , 241 - 0 , 329 - 0 , 295 - 0 , 265 - 0 , 332 - 0 , 035 - 0 , 155 - 0 , 608 - 0 , 192 0 , 183 0 , 013 - 0 , 256 - 0 , 028 - 0 , 131 0 , 026 - 0 , 516 - 0 , 428 - 0 , 015 - 0 , 227 - 0 , 278 0 , 121 0 , 180 - 0 , 044 0 , 433 0 , 221 0 , 062 0 , 207 - 0 , 122 0 , 033 0 , 208 0 , 054 - 0 , 204 - 0 , 012 - 0 , 107 - 0 , 052 0 , 211 0 , 106 0 , 078 - 0 , 003 0 , 170 0 , 308 - 0 , 034 - 0 , 090 - 0 , 409 0 , 342 - 0 , 083 0 , 664 0 , 196 0 , 002 0 , 062 0 , 273 0 , 182 - 0 , 293 - 0 , 164 - 0 , 140 - 0 , 280 0 , 199 - 0 , 101 0 , 432 0 , 069 0 , 301 0 , 374 0 , 426 0 , 091 0 , 391 0 , 376 0 , 153 - 0 , 065 - 0 , 154 - 0 , 148 0 , 201 - 0 , 087 - 0 , 080 0 , 280 - 0 , 016 0 , 006 0 , 492 0 , 329 0 , 377 - 0 , 277 0 , 494 0 , 222 0 , 026 - 0 , 055 0 , 104 - 0 , 119 0 , 530 0 , 365 0 , 446 0 , 254 - 0 , 030 0 , 268 0 , 570 0 , 640 0 , 502 0 , 278 0 , 212 0 , 072 0 , 330 0 , 498 0 , 494 0 , 521 0 , 643 0 , 550 0 , 276 - 0 , 459 - 0 , 415 - 0 , 026 - 0 , 040 0 , 295 - 0 , 468 - 0 , 068 - 0 , 218 0 , 088 0 , 062 0 , 144 - 0 , 224 0 , 019 - 0 , 164 - 0 , 240 - 0 , 471 0 , 311 0 , 635 0 , 587 0 , 309 0 , 009 0 , 362 - 0 , 150 0 , 408 0 , 386 0 , 210 0 , 653 0 , 806 0 , 481 0 , 329 0 , 561 - 0 , 281 0 , 043 - 0 , 040 0 , 106 0 , 428 0 , 018 0 , 302 0 , 193 0 , 435 0 , 460 0 , 228 0 , 020 0 , 158 0 , 583 0 , 450 - 0 , 179 0 , 076 0 , 350 - 0 , 267 0 , 278 - 0 , 017 0 , 141 0 , 067 0 , 625 0 , 584 0 , 143 0 , 098 0 , 067 0 , 421 - 0 , 718 0 , 150 0 , 289 0 , 058 0 , 171 0 , 044 0 , 143 - 0 , 631 0 , 123 - 0 , 065 - 0 , 287 0 , 290 0 , 503 0 , 719 - 0 , 216 - 0 , 160 0 , 037 - 0 , 048 0 , 228 0 , 177 - 0 , 541 - 0 , 322 - 0 , 039 - 0 , 468 - 0 , 395 - 0 , 268 - 0 , 533 0 , 203 - 0 , 223 - 0 , 820 - 0 , 453 0 , 442 0 , 496 0 , 451 0 , 361 0 , 107 0 , 365 - 0 , 188 0 , 270 0 , 215 0 , 075 0 , 570 0 , 749 0 , 383 0 , 225 0 , 521 0 , 475 0 , 453 0 , 421 0 , 124 0 , 552 0 , 220 0 , 308 0 , 080 0 , 228 0 , 286 0 , 449 0 , 312 0 , 457 0 , 395 1 , 000 - 0 , 090 - 0 , 244 - 0 , 262 - 0 , 277 0 , 184 - 0 , 294 0 , 418 - 0 , 404 - 0 , 162 - 0 , 028 - 0 , 322 - 0 , 386 - 0 , 158 0 , 062 - 0 , 090 1 , 000 0 , 374 0 , 432 0 , 386 0 , 260 0 , 399 - 0 , 036 - 0 , 006 - 0 , 177 - 0 , 180 0 , 389 0 , 202 0 , 215 0 , 047 - 0 , 244 0 , 374 1 , 000 0 , 679 0 , 450 0 , 556 0 , 609 0 , 345 0 , 512 0 , 408 0 , 550 0 , 688 0 , 611 0 , 466 0 , 301 - 0 , 262 0 , 432 0 , 679 1 , 000 0 , 083 0 , 498 0 , 636 0 , 281 0 , 504 0 , 623 0 , 537 0 , 672 0 , 586 0 , 130 0 , 355 - 0 , 277 0 , 386 0 , 450 0 , 083 1 , 000 - 0 , 050 0 , 243 - 0 , 016 0 , 276 - 0 , 146 0 , 082 0 , 316 0 , 235 0 , 299 0 , 060 0 , 184 0 , 260 0 , 556 0 , 498 - 0 , 050 1 , 000 0 , 699 0 , 432 0 , 560 0 , 603 0 , 651 0 , 597 - 0 , 024 0 , 168 0 , 714 - 0 , 294 0 , 399 0 , 609 0 , 636 0 , 243 0 , 699 1 , 000 0 , 463 0 , 802 0 , 465 0 , 556 0 , 742 0 , 113 - 0 , 156 0 , 658 0 , 418 - 0 , 036 0 , 345 0 , 281 - 0 , 016 0 , 432 0 , 463 1 , 000 0 , 352 0 , 161 0 , 317 0 , 298 - 0 , 021 - 0 , 405 0 , 356 - 0 , 404 - 0 , 006 0 , 512 0 , 504 0 , 276 0 , 560 0 , 802 0 , 352 1 , 000 0 , 657 0 , 689 0 , 793 0 , 209 0 , 012 0 , 732 - 0 , 162 - 0 , 177 0 , 408 0 , 623 - 0 , 146 0 , 603 0 , 465 0 , 161 0 , 657 1 , 000 0 , 834 0 , 633 0 , 337 0 , 154 0 , 726 - 0 , 028 - 0 , 180 0 , 550 0 , 537 0 , 082 0 , 651 0 , 556 0 , 317 0 , 689 0 , 834 1 , 000 0 , 486 0 , 112 - 0 , 000 0 , 701 - 0 , 322 0 , 389 0 , 688 0 , 672 0 , 316 0 , 597 0 , 742 0 , 298 0 , 793 0 , 633 0 , 486 1 , 000 0 , 562 0 , 350 0 , 742 - 0 , 386 0 , 202 0 , 611 0 , 586 0 , 235 - 0 , 024 0 , 113 - 0 , 021 0 , 209 0 , 337 0 , 112 0 , 562 1 , 000 0 , 641 0 , 074 - 0 , 158 0 , 215 0 , 466 0 , 130 0 , 299 0 , 168 - 0 , 156 - 0 , 405 0 , 012 0 , 154 - 0 , 000 0 , 350 0 , 641 1 , 000 - 0 , 049 0 , 062 0 , 047 0 , 301 0 , 355 0 , 060 0 , 714 0 , 658 0 , 356 0 , 732 0 , 726 0 , 701 0 , 742 0 , 074 - 0 , 049 1 , 000 - 0 , 360 - 0 , 053 0 , 193 0 , 084 0 , 461 0 , 235 0 , 448 0 , 069 0 , 609 0 , 243 0 , 207 0 , 532 0 , 188 0 , 209 0 , 449 - 0 , 872 0 , 380 0 , 440 - 0 , 022 0 , 816 - 0 , 062 0 , 239 - 0 , 788 0 , 313 - 0 , 195 - 0 , 037 0 , 169 0 , 441 0 , 724 - 0 , 544 0 , 710 - 0 , 779 - 0 , 434 - 0 , 842 - 0 , 644 - 0 , 582 - 0 , 892 0 , 777 - 0 , 710 - 0 , 472 - 0 , 382 - 0 , 764 - 0 , 575 - 0 , 256 - 0 , 581 0 , 646 0 , 237 0 , 263 0 , 401 - 0 , 205 0 , 667 0 , 418 0 , 727 0 , 153 0 , 330 0 , 323 0 , 356 0 , 011 - 0 , 164 0 , 508 - 0 , 118 0 , 337 0 , 213 0 , 364 - 0 , 124 0 , 711 0 , 788 0 , 362 0 , 621 0 , 354 0 , 224 0 , 669 - 0 , 023 - 0 , 101 0 , 660 0 , 497 0 , 002 0 , 026 - 0 , 324 - 0 , 105 0 , 338 0 , 065 0 , 072 - 0 , 140 - 0 , 084 0 , 134 - 0 , 170 - 0 , 365 - 0 , 073 0 , 241 - 0 , 238 0 , 017 0 , 454 0 , 670 0 , 165 0 , 591 0 , 786 0 , 426 0 , 755 0 , 687 0 , 741 0 , 549 0 , 085 - 0 , 260 0 , 580 - 0 , 308 0 , 046 0 , 605 0 , 661 0 , 124 0 , 195 0 , 466 0 , 112 0 , 617 0 , 714 0 , 585 0 , 682 0 , 608 0 , 100 0 , 562 0 , 364 0 , 263 0 , 408 0 , 645 - 0 , 256 0 , 538 0 , 289 0 , 292 0 , 072 0 , 419 0 , 553 0 , 188 0 , 166 - 0 , 027 0 , 266 - 0 , 216 0 , 084 0 , 462 0 , 551 0 , 310 0 , 381 0 , 713 0 , 681 0 , 734 0 , 422 0 , 597 0 , 612 0 , 149 - 0 , 376 0 , 611 - 0 , 265 0 , 072 0 , 445 0 , 529 0 , 374 0 , 430 0 , 747 0 , 545 0 , 841 0 , 511 0 , 602 0 , 685 0 , 140 - 0 , 218 0 , 636 0 , 439 0 , 044 - 0 , 325 0 , 296 - 0 , 334 0 , 280 0 , 136 0 , 313 0 , 063 0 , 323 0 , 130 0 , 231 0 , 177 - 0 , 411 0 , 427 0 , 422 0 , 118 0 , 254 0 , 068 - 0 , 231 0 , 619 0 , 255 0 , 312 0 , 180 0 , 342 0 , 357 0 , 348 0 , 003 0 , 079 0 , 604 - 0 , 168 0 , 026 0 , 460 0 , 204 - 0 , 114 0 , 243 0 , 102 0 , 055 0 , 036 0 , 138 0 , 071 0 , 197 0 , 518 0 , 351 - 0 , 047 0 , 061 0 , 212 0 , 138 0 , 482 - 0 , 452 0 , 609 0 , 484 0 , 315 0 , 459 0 , 413 0 , 310 0 , 432 - 0 , 079 - 0 , 118 0 , 391 0 , 046 0 , 332 - 0 , 052 - 0 , 377 0 , 138 0 , 281 0 , 178 - 0 , 020 0 , 174 - 0 , 112 - 0 , 097 0 , 182 - 0 , 571 0 , 162 0 , 347 0 , 308 - 0 , 000 0 , 356 0 , 566 - 0 , 381 0 , 532 0 , 354 0 , 404 0 , 287 0 , 658 0 , 599 0 , 389 0 , 272 - 0 , 039 0 , 509 - 0 , 081 0 , 018 0 , 469 0 , 774 - 0 , 023 0 , 535 0 , 633 0 , 594 0 , 647 0 , 617 0 , 562 0 , 598 0 , 450 - 0 , 218 0 , 438 0 , 055 0 , 336 0 , 515 0 , 634 - 0 , 003 0 , 839 0 , 720 0 , 292 0 , 606 0 , 630 0 , 646 0 , 730 0 , 217 0 , 171 0 , 784 - 0 , 293 0 , 081 0 , 421 0 , 744 0 , 100 0 , 542 0 , 685 0 , 246 0 , 759 0 , 743 0 , 599 0 , 691 0 , 376 0 , 069 0 , 549 0 , 238 - 0 , 264 0 , 284 0 , 074 - 0 , 124 0 , 275 0 , 554 0 , 651 0 , 423 0 , 145 0 , 370 0 , 083 - 0 , 393 - 0 , 466 0 , 301 - 0 , 047 0 , 111 0 , 100 0 , 343 - 0 , 474 0 , 428 0 , 471 0 , 349 0 , 226 0 , 165 - 0 , 022 0 , 302 0 , 177 - 0 , 184 0 , 189 0 , 025 0 , 536 0 , 503 0 , 598 0 , 385 0 , 671 0 , 572 0 , 276 0 , 496 0 , 330 0 , 477 0 , 566 0 , 114 0 , 175 0 , 455 - 0 , 227 0 , 286 0 , 551 0 , 411 0 , 219 0 , 727 0 , 875 0 , 287 0 , 709 0 , 517 0 , 652 0 , 636 - 0 , 087 - 0 , 089 0 , 771 0 , 259 - 0 , 204 0 , 099 - 0 , 006 - 0 , 351 0 , 429 - 0 , 017 0 , 182 0 , 244 0 , 268 0 , 095 0 , 420 0 , 203 0 , 514 0 , 317 0 , 506 0 , 289 0 , 860 0 , 942 - 0 , 137 0 , 773 0 , 615 0 , 770 0 , 191 0 , 820 0 , 722 0 , 318 0 , 700 - 0 , 099 0 , 008 0 , 754 - 0 , 279 - 0 , 148 - 0 , 049 - 0 , 427 0 , 305 - 0 , 205 0 , 367 - 0 , 038 0 , 248 0 , 234 - 0 , 025 - 0 , 100 0 , 018 0 , 268 0 , 153 - 0 , 257 0 , 579 0 , 106 - 0 , 061 0 , 717 0 , 304 0 , 335 0 , 384 0 , 455 0 , 614 0 , 171 - 0 , 215 0 , 335 0 , 341 - 0 , 081 0 , 252 0 , 356 0 , 463 0 , 050 0 , 813 0 , 653 0 , 165 0 , 641 0 , 683 0 , 492 0 , 768 0 , 210 0 , 263 0 , 784 0 , 016 0 , 062 0 , 314 0 , 697 - 0 , 300 0 , 538 0 , 459 0 , 387 0 , 307 0 , 470 0 , 368 0 , 276 0 , 188 - 0 , 059 0 , 130 - 0 , 565 - 0 , 054 0 , 197 0 , 531 - 0 , 265 0 , 253 0 , 477 - 0 , 120 0 , 479 0 , 590 0 , 439 0 , 407 0 , 400 - 0 , 245 0 , 369 - 0 , 033 - 0 , 179 - 0 , 219 - 0 , 037 0 , 098 - 0 , 016 0 , 310 0 , 108 0 , 385 0 , 090 0 , 354 - 0 , 079 - 0 , 552 - 0 , 601 0 , 264 0 , 129 - 0 , 084 - 0 , 579 - 0 , 029 - 0 , 256 - 0 , 071 - 0 , 399 - 0 , 479 - 0 , 220 0 , 181 - 0 , 158 - 0 , 107 0 , 042 0 , 168 - 0 , 025 - 0 , 196 0 , 345 0 , 541 0 , 585 0 , 461 0 , 613 0 , 706 0 , 228 0 , 786 0 , 598 0 , 632 0 , 865 0 , 391 0 , 170 0 , 807 Novel approaches to understanding hENT2 and hENT2 - related proteins 294 P Values ATP7B DPYD TYMP UPP1 EPHX1 DCK RRM1 TYMS TK1 UMPS UCK2 FPGS GCLC UGTX TOP1 OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 CTR1 ENT1 ENT2 ENT3 ENT4 CNT3 AQP1 AQP3 AQP5 ABCA2 ABCA3 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A ATP7B DPYD TYMP UPP1 EPHX1 DCK RRM1 TYMS TK1 UMPS UCK2 FPGS GCLC UGTX TOP1 TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 MSH2 MSH6 GADD45 BAX P21 FAS BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR MYC MMP1 MMP2 TIGAR NRF2 KEAP1 ENT1n ENT2n CNT1n CNT2n CNT3n 0 , 509 0 , 114 0 , 066 0 , 220 0 , 182 0 , 227 0 , 297 0 , 119 0 , 498 0 , 259 0 , 263 0 , 222 0 , 346 0 , 149 0 , 343 0 , 220 0 , 175 0 , 022 0 , 407 0 , 113 0 , 154 0 , 043 0 , 652 0 , 141 0 , 250 0 , 376 0 , 013 0 , 125 0 , 495 0 , 089 0 , 695 0 , 061 0 , 754 0 , 026 0 , 388 0 , 401 0 , 135 0 , 992 0 , 315 0 , 583 0 , 847 0 , 284 0 , 606 0 , 780 0 , 921 0 , 393 0 , 087 0 , 015 0 , 002 0 , 857 0 , 001 0 , 000 0 , 240 0 , 021 0 , 060 0 , 054 0 , 006 0 , 318 0 , 971 0 , 041 0 , 698 0 , 390 0 , 125 0 , 002 0 , 678 0 , 006 0 , 076 0 , 107 0 , 126 0 , 005 0 , 016 0 , 015 0 , 293 0 , 989 0 , 014 0 , 639 0 , 010 0 , 182 0 , 165 0 , 460 0 , 394 0 , 309 0 , 942 0 , 976 0 , 205 0 , 336 0 , 124 0 , 190 0 , 294 0 , 436 0 , 399 0 , 687 0 , 096 0 , 554 0 , 102 0 , 513 0 , 401 0 , 871 0 , 277 0 , 964 0 , 341 0 , 386 0 , 724 0 , 196 0 , 723 0 , 099 0 , 045 0 , 004 0 , 005 0 , 150 0 , 344 0 , 027 0 , 684 0 , 099 0 , 104 0 , 317 0 , 001 0 , 001 0 , 125 0 , 150 0 , 043 0 , 298 0 , 019 0 , 228 0 , 038 0 , 738 0 , 186 0 , 439 0 , 093 0 , 274 0 , 361 0 , 010 0 , 007 0 , 047 0 , 200 0 , 762 0 , 358 0 , 729 0 , 252 0 , 430 0 , 117 0 , 081 0 , 173 0 , 124 0 , 460 0 , 896 0 , 048 0 , 976 0 , 777 0 , 152 0 , 607 0 , 645 0 , 168 0 , 001 0 , 468 0 , 010 0 , 044 0 , 084 0 , 174 0 , 020 0 , 038 0 , 118 0 , 290 0 , 687 0 , 169 0 , 031 0 , 672 0 , 200 0 , 038 0 , 589 0 , 578 0 , 124 0 , 825 0 , 049 0 , 018 0 , 103 0 , 065 0 , 022 0 , 800 0 , 186 0 , 480 0 , 376 0 , 763 0 , 575 0 , 672 0 , 827 0 , 890 0 , 958 0 , 155 0 , 535 0 , 231 0 , 475 0 , 314 0 , 907 0 , 581 0 , 478 0 , 103 0 , 169 0 , 231 0 , 977 0 , 107 0 , 038 0 , 301 0 , 083 0 , 355 0 , 505 0 , 004 0 , 497 0 , 790 0 , 035 0 , 201 0 , 171 0 , 008 0 , 003 0 , 465 0 , 028 0 , 001 0 , 478 0 , 006 0 , 013 0 , 018 0 , 000 0 , 064 0 , 972 0 , 006 0 , 502 0 , 353 0 , 441 0 , 460 0 , 349 0 , 923 0 , 669 0 , 062 0 , 596 0 , 614 0 , 972 0 , 475 0 , 939 0 , 738 0 , 943 0 , 071 0 , 145 0 , 961 0 , 457 0 , 358 0 , 693 0 , 556 0 , 886 0 , 140 0 , 468 0 , 841 0 , 497 0 , 692 0 , 918 0 , 495 0 , 876 0 , 548 0 , 971 0 , 755 0 , 879 0 , 534 0 , 756 0 , 820 0 , 994 0 , 618 0 , 357 0 , 921 0 , 792 0 , 212 0 , 304 0 , 777 0 , 010 0 , 520 0 , 995 0 , 832 0 , 345 0 , 535 0 , 309 0 , 575 0 , 633 0 , 332 0 , 496 0 , 730 0 , 160 0 , 814 0 , 317 0 , 208 0 , 167 0 , 768 0 , 186 0 , 206 0 , 618 0 , 834 0 , 616 0 , 630 0 , 510 0 , 777 0 , 794 0 , 404 0 , 960 0 , 989 0 , 215 0 , 427 0 , 357 0 , 507 0 , 214 0 , 597 0 , 952 0 , 898 0 , 806 0 , 779 0 , 176 0 , 374 0 , 268 0 , 544 0 , 920 0 , 354 0 , 042 0 , 014 0 , 067 0 , 336 0 , 468 0 , 807 0 , 249 0 , 070 0 , 072 0 , 056 0 , 013 0 , 064 0 , 339 0 , 099 0 , 141 0 , 934 0 , 891 0 , 305 0 , 091 0 , 819 0 , 455 0 , 766 0 , 833 0 , 624 0 , 442 0 , 947 0 , 612 0 , 409 0 , 089 0 , 278 0 , 020 0 , 027 0 , 283 0 , 976 0 , 203 0 , 610 0 , 148 0 , 173 0 , 472 0 , 011 0 , 001 0 , 113 0 , 250 0 , 037 0 , 331 0 , 889 0 , 891 0 , 719 0 , 127 0 , 951 0 , 294 0 , 508 0 , 120 0 , 098 0 , 433 0 , 945 0 , 625 0 , 029 0 , 106 0 , 539 0 , 806 0 , 219 0 , 357 0 , 336 0 , 954 0 , 630 0 , 819 0 , 017 0 , 028 0 , 627 0 , 739 0 , 835 0 , 134 0 , 069 0 , 749 0 , 578 0 , 902 0 , 714 0 , 925 0 , 760 0 , 128 0 , 793 0 , 890 0 , 533 0 , 529 0 , 250 0 , 107 0 , 643 0 , 620 0 , 910 0 , 881 0 , 477 0 , 582 0 , 069 0 , 307 0 , 905 0 , 125 0 , 204 0 , 400 0 , 075 0 , 526 0 , 510 0 , 001 0 , 104 0 , 113 0 , 085 0 , 105 0 , 204 0 , 716 0 , 199 0 , 520 0 , 350 0 , 461 0 , 798 0 , 033 0 , 002 0 , 220 0 , 440 0 , 056 0 , 086 0 , 120 0 , 134 0 , 672 0 , 041 0 , 450 0 , 284 0 , 785 0 , 433 0 , 322 0 , 108 0 , 278 0 , 135 0 , 162 0 , 000 0 , 760 0 , 421 0 , 366 0 , 338 0 , 530 0 , 308 0 , 137 0 , 153 0 , 579 0 , 925 0 , 262 0 , 173 0 , 624 0 , 834 0 , 760 0 , 000 0 , 208 0 , 123 0 , 173 0 , 370 0 , 157 0 , 904 0 , 985 0 , 546 0 , 538 0 , 169 0 , 489 0 , 503 0 , 872 0 , 421 0 , 208 0 , 000 0 , 011 0 , 123 0 , 048 0 , 027 0 , 249 0 , 074 0 , 166 0 , 052 0 , 009 0 , 027 0 , 127 0 , 318 0 , 366 0 , 123 0 , 011 0 , 000 0 , 778 0 , 070 0 , 014 0 , 330 0 , 066 0 , 017 0 , 048 0 , 008 0 , 028 0 , 687 0 , 213 0 , 338 0 , 173 0 , 123 0 , 778 0 , 000 0 , 865 0 , 402 0 , 957 0 , 339 0 , 618 0 , 781 0 , 271 0 , 419 0 , 345 0 , 839 0 , 530 0 , 370 0 , 048 0 , 070 0 , 865 0 , 000 0 , 005 0 , 123 0 , 037 0 , 023 0 , 012 0 , 024 0 , 935 0 , 601 0 , 004 0 , 308 0 , 157 0 , 027 0 , 014 0 , 402 0 , 005 0 , 000 0 , 096 0 , 001 0 , 094 0 , 039 0 , 002 0 , 699 0 , 629 0 , 011 0 , 137 0 , 904 0 , 249 0 , 330 0 , 957 0 , 123 0 , 096 0 , 000 0 , 218 0 , 583 0 , 270 0 , 301 0 , 945 0 , 191 0 , 211 0 , 153 0 , 985 0 , 074 0 , 066 0 , 339 0 , 037 0 , 001 0 , 218 0 , 000 0 , 011 0 , 006 0 , 001 0 , 474 0 , 969 0 , 003 0 , 579 0 , 546 0 , 166 0 , 017 0 , 618 0 , 023 0 , 094 0 , 583 0 , 011 0 , 000 0 , 000 0 , 015 0 , 239 0 , 633 0 , 003 0 , 925 0 , 538 0 , 052 0 , 048 0 , 781 0 , 012 0 , 039 0 , 270 0 , 006 0 , 000 0 , 000 0 , 078 0 , 704 1 , 000 0 , 005 0 , 262 0 , 169 0 , 009 0 , 008 0 , 271 0 , 024 0 , 002 0 , 301 0 , 001 0 , 015 0 , 078 0 , 000 0 , 037 0 , 265 0 , 002 0 , 173 0 , 489 0 , 027 0 , 028 0 , 419 0 , 935 0 , 699 0 , 945 0 , 474 0 , 239 0 , 704 0 , 037 0 , 000 0 , 025 0 , 801 0 , 624 0 , 503 0 , 127 0 , 687 0 , 345 0 , 601 0 , 629 0 , 191 0 , 969 0 , 633 1 , 000 0 , 265 0 , 025 0 , 000 0 , 880 0 , 834 0 , 872 0 , 318 0 , 213 0 , 839 0 , 004 0 , 011 0 , 211 0 , 003 0 , 003 0 , 005 0 , 002 0 , 801 0 , 880 0 , 000 0 , 207 0 , 858 0 , 527 0 , 775 0 , 097 0 , 420 0 , 109 0 , 815 0 , 021 0 , 403 0 , 478 0 , 050 0 , 519 0 , 515 0 , 107 0 , 024 0 , 458 0 , 382 0 , 967 0 , 048 0 , 908 0 , 648 0 , 063 0 , 545 0 , 711 0 , 945 0 , 748 0 , 381 0 , 166 0 , 265 0 , 074 0 , 039 0 , 389 0 , 017 0 , 119 0 , 170 0 , 007 0 , 040 0 , 074 0 , 285 0 , 398 0 , 045 0 , 177 0 , 625 0 , 171 0 , 013 0 , 414 0 , 385 0 , 156 0 , 483 0 , 009 0 , 137 0 , 003 0 , 602 0 , 249 0 , 260 0 , 211 0 , 970 0 , 610 0 , 064 0 , 689 0 , 239 0 , 484 0 , 200 0 , 672 0 , 004 0 , 001 0 , 204 0 , 018 0 , 215 0 , 441 0 , 009 0 , 939 0 , 755 0 , 010 0 , 071 0 , 995 0 , 932 0 , 258 0 , 721 0 , 237 0 , 826 0 , 808 0 , 634 0 , 774 0 , 647 0 , 561 0 , 199 0 , 821 0 , 407 0 , 413 0 , 954 0 , 119 0 , 009 0 , 573 0 , 026 0 , 001 0 , 129 0 , 002 0 , 007 0 , 002 0 , 042 0 , 773 0 , 414 0 , 030 0 , 284 0 , 875 0 , 029 0 , 010 0 , 673 0 , 503 0 , 093 0 , 704 0 , 019 0 , 004 0 , 028 0 , 007 0 , 021 0 , 757 0 , 037 0 , 201 0 , 364 0 , 167 0 , 013 0 , 377 0 , 047 0 , 317 0 , 310 0 , 807 0 , 136 0 , 040 0 , 520 0 , 571 0 , 933 0 , 357 0 , 479 0 , 786 0 , 130 0 , 051 0 , 303 0 , 199 0 , 006 0 , 010 0 , 004 0 , 151 0 , 031 0 , 026 0 , 627 0 , 229 0 , 026 0 , 360 0 , 806 0 , 128 0 , 052 0 , 187 0 , 125 0 , 002 0 , 044 0 , 000 0 , 062 0 , 023 0 , 007 0 , 633 0 , 497 0 , 014 0 , 116 0 , 880 0 , 278 0 , 305 0 , 243 0 , 332 0 , 643 0 , 276 0 , 832 0 , 261 0 , 657 0 , 427 0 , 545 0 , 184 0 , 128 0 , 132 0 , 689 0 , 403 0 , 819 0 , 427 0 , 018 0 , 380 0 , 278 0 , 539 0 , 231 0 , 210 0 , 223 0 , 992 0 , 807 0 , 022 0 , 567 0 , 930 0 , 114 0 , 484 0 , 699 0 , 403 0 , 729 0 , 851 0 , 904 0 , 637 0 , 810 0 , 500 0 , 058 0 , 264 0 , 874 0 , 844 0 , 486 0 , 668 0 , 095 0 , 121 0 , 027 0 , 094 0 , 295 0 , 115 0 , 161 0 , 303 0 , 141 0 , 798 0 , 729 0 , 186 0 , 886 0 , 292 0 , 878 0 , 226 0 , 669 0 , 376 0 , 580 0 , 950 0 , 589 0 , 728 0 , 764 0 , 570 0 , 053 0 , 655 0 , 269 0 , 285 0 , 999 0 , 232 0 , 035 0 , 179 0 , 050 0 , 214 0 , 152 0 , 321 0 , 011 0 , 024 0 , 169 0 , 347 0 , 904 0 , 063 0 , 783 0 , 952 0 , 106 0 , 001 0 , 937 0 , 049 0 , 015 0 , 025 0 , 012 0 , 019 0 , 036 0 , 024 0 , 106 0 , 497 0 , 117 0 , 853 0 , 239 0 , 071 0 , 015 0 , 991 0 , 000 0 , 004 0 , 312 0 , 022 0 , 016 0 , 013 0 , 003 0 , 456 0 , 594 0 , 001 0 , 310 0 , 783 0 , 152 0 , 002 0 , 734 0 , 045 0 , 007 0 , 397 0 , 002 0 , 002 0 , 024 0 , 006 0 , 185 0 , 831 0 , 042 0 , 538 0 , 493 0 , 459 0 , 849 0 , 751 0 , 474 0 , 122 0 , 058 0 , 257 0 , 709 0 , 328 0 , 833 0 , 295 0 , 244 0 , 431 0 , 874 0 , 706 0 , 745 0 , 230 0 , 087 0 , 127 0 , 089 0 , 222 0 , 437 0 , 572 0 , 942 0 , 294 0 , 545 0 , 566 0 , 519 0 , 932 0 , 048 0 , 080 0 , 024 0 , 174 0 , 009 0 , 032 0 , 340 0 , 072 0 , 250 0 , 085 0 , 035 0 , 698 0 , 587 0 , 102 0 , 435 0 , 322 0 , 051 0 , 144 0 , 451 0 , 003 0 , 000 0 , 321 0 , 004 0 , 058 0 , 011 0 , 014 0 , 768 0 , 784 0 , 001 0 , 416 0 , 524 0 , 759 0 , 986 0 , 264 0 , 164 0 , 958 0 , 571 0 , 445 0 , 400 0 , 770 0 , 174 0 , 527 0 , 106 0 , 316 0 , 306 0 , 578 0 , 028 0 , 005 0 , 795 0 , 071 0 , 193 0 , 074 0 , 717 0 , 046 0 , 106 0 , 540 0 , 122 0 , 875 0 , 987 0 , 002 0 , 334 0 , 629 0 , 869 0 , 128 0 , 289 0 , 483 0 , 197 0 , 897 0 , 393 0 , 420 0 , 933 0 , 734 0 , 957 0 , 354 0 , 601 0 , 375 0 , 038 0 , 719 0 , 835 0 , 004 0 , 291 0 , 241 0 , 175 0 , 102 0 , 019 0 , 559 0 , 459 0 , 287 0 , 232 0 , 783 0 , 385 0 , 232 0 , 096 0 , 864 0 , 000 0 , 011 0 , 573 0 , 013 0 , 007 0 , 074 0 , 001 0 , 472 0 , 409 0 , 001 0 , 956 0 , 833 0 , 296 0 , 006 0 , 298 0 , 047 0 , 099 0 , 172 0 , 286 0 , 090 0 , 195 0 , 340 0 , 519 0 , 856 0 , 657 0 , 035 0 , 854 0 , 519 0 , 051 0 , 359 0 , 383 0 , 084 0 , 684 0 , 083 0 , 026 0 , 116 0 , 148 0 , 157 0 , 442 0 , 194 0 , 912 0 , 540 0 , 472 0 , 900 0 , 740 0 , 957 0 , 281 0 , 714 0 , 175 0 , 760 0 , 215 0 , 787 0 , 041 0 , 039 0 , 362 0 , 659 0 , 775 0 , 038 0 , 921 0 , 377 0 , 809 0 , 158 0 , 083 0 , 450 0 , 535 0 , 591 0 , 717 0 , 885 0 , 602 0 , 931 0 , 501 0 , 226 0 , 056 0 , 028 0 , 098 0 , 020 0 , 005 0 , 433 0 , 001 0 , 024 0 , 015 0 , 000 0 , 167 0 , 597 0 , 000 Appendix I 295 Correlat . TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 MSH2 MSH6 GADD45 BAX P21 FAS OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 CTR1 ENT1 ENT2 ENT3 ENT4 CNT3 AQP1 AQP3 AQP5 ABCA2 ABCA3 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A ATP7B DPYD TYMP UPP1 EPHX1 DCK RRM1 TYMS TK1 UMPS UCK2 FPGS GCLC UGTX TOP1 TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 MSH2 MSH6 GADD45 BAX P21 FAS BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR MYC MMP1 MMP2 TIGAR NRF2 KEAP1 ENT1n ENT2n CNT1n CNT2n CNT3n - 0 , 625 0 , 000 0 , 000 - 0 , 025 - 0 , 135 - 0 , 459 - 0 , 586 - 0 , 848 - 0 , 429 0 , 163 0 , 045 0 , 315 - 0 , 424 - 0 , 303 0 , 595 0 , 296 0 , 578 - 0 , 392 0 , 157 0 , 429 0 , 210 0 , 301 0 , 483 - 0 , 087 0 , 374 0 , 334 - 0 , 185 0 , 415 0 , 390 - 0 , 143 - 0 , 252 0 , 000 0 , 000 - 0 , 096 - 0 , 511 0 , 338 - 0 , 497 - 0 , 076 - 0 , 193 - 0 , 204 - 0 , 411 0 , 007 0 , 290 0 , 406 - 0 , 561 0 , 251 0 , 250 - 0 , 764 0 , 470 0 , 747 0 , 133 0 , 658 0 , 387 0 , 513 0 , 505 0 , 487 0 , 253 0 , 392 0 , 418 0 , 635 0 , 006 - 0 , 526 - 0 , 583 0 , 667 0 , 433 - 0 , 200 0 , 583 0 , 444 0 , 678 0 , 630 0 , 568 0 , 452 0 , 408 0 , 061 0 , 551 0 , 157 0 , 000 0 , 000 0 , 166 0 , 441 0 , 003 - 0 , 435 - 0 , 252 0 , 390 0 , 063 - 0 , 193 - 0 , 256 0 , 485 0 , 717 0 , 446 0 , 621 0 , 792 - 0 , 515 - 0 , 260 0 , 049 - 0 , 260 0 , 303 - 0 , 042 0 , 043 0 , 301 0 , 402 - 0 , 607 - 0 , 399 - 0 , 202 - 0 , 206 0 , 391 0 , 551 - 0 , 843 0 , 138 0 , 329 - 0 , 189 0 , 429 0 , 702 0 , 263 0 , 439 0 , 517 0 , 186 0 , 134 0 , 320 0 , 063 0 , 428 0 , 921 - 0 , 681 - 0 , 163 0 , 153 0 , 037 0 , 146 0 , 652 - 0 , 044 0 , 226 0 , 229 - 0 , 062 0 , 179 0 , 402 - 0 , 190 0 , 281 - 0 , 393 - 0 , 398 0 , 478 0 , 730 - 0 , 153 0 , 265 0 , 226 0 , 132 0 , 273 0 , 377 0 , 227 0 , 183 - 0 , 155 0 , 648 0 , 112 - 0 , 294 - 0 , 882 0 , 686 0 , 438 - 0 , 019 0 , 707 0 , 424 0 , 706 0 , 528 0 , 389 0 , 558 0 , 184 0 , 221 0 , 465 0 , 230 0 , 667 - 0 , 522 - 0 , 059 0 , 299 - 0 , 122 0 , 423 0 , 752 0 , 229 0 , 317 0 , 288 0 , 251 0 , 118 0 , 449 0 , 243 0 , 214 0 , 018 - 0 , 105 - 0 , 305 - 0 , 100 - 0 , 312 0 , 078 0 , 304 0 , 162 0 , 438 0 , 363 - 0 , 060 - 0 , 089 - 0 , 049 0 , 170 - 0 , 103 0 , 123 0 , 558 - 0 , 273 - 0 , 674 0 , 100 - 0 , 140 - 0 , 298 - 0 , 174 - 0 , 618 - 0 , 462 0 , 006 - 0 , 509 - 0 , 144 - 0 , 596 0 , 299 0 , 391 - 0 , 768 0 , 309 0 , 562 0 , 058 0 , 604 0 , 734 0 , 461 0 , 625 0 , 579 0 , 292 0 , 410 0 , 339 0 , 388 - 0 , 005 0 , 517 - 0 , 036 - 0 , 304 - 0 , 013 0 , 454 - 0 , 069 - 0 , 010 - 0 , 175 - 0 , 441 - 0 , 455 0 , 219 0 , 152 0 , 439 - 0 , 279 0 , 444 0 , 240 0 , 332 - 0 , 327 0 , 407 - 0 , 180 0 , 105 - 0 , 157 - 0 , 442 0 , 202 0 , 215 - 0 , 365 0 , 002 0 , 169 0 , 188 0 , 173 0 , 000 0 , 071 0 , 049 0 , 068 0 , 231 0 , 170 - 0 , 206 0 , 170 0 , 349 0 , 162 0 , 221 0 , 212 0 , 080 - 0 , 270 0 , 059 0 , 391 - 0 , 408 0 , 102 0 , 379 0 , 164 - 0 , 159 - 0 , 232 - 0 , 049 - 0 , 250 - 0 , 195 - 0 , 217 0 , 177 0 , 005 0 , 021 0 , 055 0 , 619 - 0 , 290 0 , 245 - 0 , 062 0 , 542 0 , 072 - 0 , 227 0 , 441 - 0 , 188 - 0 , 166 - 0 , 084 0 , 146 0 , 178 - 0 , 330 0 , 328 - 0 , 062 0 , 000 0 , 402 0 , 471 - 0 , 307 - 0 , 102 - 0 , 238 0 , 307 0 , 090 0 , 061 - 0 , 035 0 , 304 0 , 185 0 , 202 0 , 151 0 , 239 - 0 , 896 0 , 242 - 0 , 107 - 0 , 127 0 , 371 0 , 607 0 , 417 0 , 198 0 , 299 0 , 254 0 , 094 0 , 182 0 , 009 0 , 261 0 , 413 0 , 158 - 0 , 496 - 0 , 450 - 0 , 331 0 , 316 0 , 201 - 0 , 343 0 , 072 0 , 184 - 0 , 388 - 0 , 699 - 0 , 272 - 0 , 571 0 , 354 0 , 825 - 0 , 792 - 0 , 006 0 , 193 - 0 , 200 0 , 259 0 , 816 0 , 144 0 , 263 0 , 281 0 , 307 0 , 010 0 , 237 - 0 , 010 0 , 329 - 0 , 602 0 , 128 0 , 525 0 , 076 0 , 395 0 , 234 0 , 185 0 , 158 0 , 091 0 , 172 0 , 491 0 , 442 - 0 , 026 - 0 , 119 - 0 , 190 - 0 , 687 - 0 , 039 0 , 487 - 0 , 123 0 , 117 0 , 276 0 , 517 0 , 628 0 , 057 0 , 102 0 , 409 0 , 302 - 0 , 196 0 , 174 0 , 567 0 , 000 0 , 000 - 0 , 632 0 , 313 - 0 , 168 - 0 , 014 - 0 , 049 - 0 , 451 - 0 , 326 - 0 , 182 - 0 , 344 - 0 , 384 0 , 668 - 0 , 358 - 0 , 369 - 0 , 007 - 0 , 083 - 0 , 292 - 0 , 585 - 0 , 571 0 , 028 - 0 , 250 0 , 070 - 0 , 046 - 0 , 082 - 0 , 211 - 0 , 777 - 0 , 179 - 0 , 281 0 , 272 0 , 877 - 0 , 758 0 , 015 0 , 240 0 , 101 0 , 112 0 , 578 0 , 081 0 , 060 0 , 045 0 , 236 0 , 192 0 , 562 - 0 , 115 - 0 , 023 - 0 , 281 - 0 , 586 0 , 678 0 , 217 0 , 293 0 , 045 0 , 253 0 , 663 0 , 085 0 , 074 0 , 374 0 , 552 0 , 163 0 , 255 - 0 , 360 - 0 , 872 0 , 710 0 , 646 - 0 , 118 0 , 497 - 0 , 238 - 0 , 308 0 , 364 - 0 , 216 - 0 , 265 0 , 439 0 , 422 - 0 , 168 0 , 061 - 0 , 053 0 , 380 - 0 , 779 0 , 237 0 , 337 0 , 002 0 , 017 0 , 046 0 , 263 0 , 084 0 , 072 0 , 044 0 , 118 0 , 026 0 , 212 0 , 193 0 , 440 - 0 , 434 0 , 263 0 , 213 0 , 026 0 , 454 0 , 605 0 , 408 0 , 462 0 , 445 - 0 , 325 0 , 254 0 , 460 0 , 138 0 , 084 - 0 , 022 - 0 , 842 0 , 401 0 , 364 - 0 , 324 0 , 670 0 , 661 0 , 645 0 , 551 0 , 529 0 , 296 0 , 068 0 , 204 0 , 482 0 , 461 0 , 816 - 0 , 644 - 0 , 205 - 0 , 124 - 0 , 105 0 , 165 0 , 124 - 0 , 256 0 , 310 0 , 374 - 0 , 334 - 0 , 231 - 0 , 114 - 0 , 452 0 , 235 - 0 , 062 - 0 , 582 0 , 667 0 , 711 0 , 338 0 , 591 0 , 195 0 , 538 0 , 381 0 , 430 0 , 280 0 , 619 0 , 243 0 , 609 0 , 448 0 , 239 - 0 , 892 0 , 418 0 , 788 0 , 065 0 , 786 0 , 466 0 , 289 0 , 713 0 , 747 0 , 136 0 , 255 0 , 102 0 , 484 0 , 069 - 0 , 788 0 , 777 0 , 727 0 , 362 0 , 072 0 , 426 0 , 112 0 , 292 0 , 681 0 , 545 0 , 313 0 , 312 0 , 055 0 , 315 0 , 609 0 , 313 - 0 , 710 0 , 153 0 , 621 - 0 , 140 0 , 755 0 , 617 0 , 072 0 , 734 0 , 841 0 , 063 0 , 180 0 , 036 0 , 459 0 , 243 - 0 , 195 - 0 , 472 0 , 330 0 , 354 - 0 , 084 0 , 687 0 , 714 0 , 419 0 , 422 0 , 511 0 , 323 0 , 342 0 , 138 0 , 413 0 , 207 - 0 , 037 - 0 , 382 0 , 323 0 , 224 0 , 134 0 , 741 0 , 585 0 , 553 0 , 597 0 , 602 0 , 130 0 , 357 0 , 071 0 , 310 0 , 532 0 , 169 - 0 , 764 0 , 356 0 , 669 - 0 , 170 0 , 549 0 , 682 0 , 188 0 , 612 0 , 685 0 , 231 0 , 348 0 , 197 0 , 432 0 , 188 0 , 441 - 0 , 575 0 , 011 - 0 , 023 - 0 , 365 0 , 085 0 , 608 0 , 166 0 , 149 0 , 140 0 , 177 0 , 003 0 , 518 - 0 , 079 0 , 209 0 , 724 - 0 , 256 - 0 , 164 - 0 , 101 - 0 , 073 - 0 , 260 0 , 100 - 0 , 027 - 0 , 376 - 0 , 218 - 0 , 411 0 , 079 0 , 351 - 0 , 118 0 , 449 - 0 , 544 - 0 , 581 0 , 508 0 , 660 0 , 241 0 , 580 0 , 562 0 , 266 0 , 611 0 , 636 0 , 427 0 , 604 - 0 , 047 0 , 391 1 , 000 0 , 576 - 0 , 767 - 0 , 056 0 , 448 - 0 , 184 0 , 480 0 , 205 - 0 , 402 0 , 398 0 , 575 - 0 , 032 - 0 , 215 - 0 , 126 - 0 , 194 0 , 576 1 , 000 0 , 000 - 0 , 664 - 0 , 085 0 , 266 - 0 , 073 0 , 003 - 0 , 336 - 0 , 685 - 0 , 461 - 0 , 778 - 0 , 446 0 , 565 - 0 , 581 - 0 , 767 0 , 000 1 , 000 - 0 , 157 - 0 , 848 0 , 175 - 0 , 852 - 0 , 596 - 0 , 492 - 0 , 456 - 0 , 683 - 0 , 391 0 , 038 0 , 037 - 0 , 377 - 0 , 056 - 0 , 664 - 0 , 157 1 , 000 0 , 481 0 , 366 0 , 359 0 , 196 0 , 580 0 , 291 0 , 238 0 , 648 0 , 587 0 , 103 0 , 391 0 , 448 - 0 , 085 - 0 , 848 0 , 481 1 , 000 0 , 125 0 , 491 0 , 209 0 , 100 0 , 430 0 , 485 0 , 342 0 , 402 0 , 106 0 , 638 - 0 , 184 0 , 266 0 , 175 0 , 366 0 , 125 1 , 000 - 0 , 169 - 0 , 139 0 , 228 - 0 , 273 - 0 , 372 0 , 205 0 , 684 0 , 316 - 0 , 037 0 , 480 - 0 , 073 - 0 , 852 0 , 359 0 , 491 - 0 , 169 1 , 000 0 , 500 0 , 298 0 , 743 0 , 808 0 , 199 - 0 , 052 - 0 , 115 0 , 291 0 , 205 0 , 003 - 0 , 596 0 , 196 0 , 209 - 0 , 139 0 , 500 1 , 000 0 , 327 0 , 445 0 , 477 0 , 338 0 , 194 0 , 122 0 , 247 - 0 , 402 - 0 , 336 - 0 , 492 0 , 580 0 , 100 0 , 228 0 , 298 0 , 327 1 , 000 0 , 194 0 , 086 0 , 373 0 , 433 0 , 196 0 , 461 0 , 398 - 0 , 685 - 0 , 456 0 , 291 0 , 430 - 0 , 273 0 , 743 0 , 445 0 , 194 1 , 000 0 , 936 0 , 099 0 , 091 - 0 , 208 0 , 267 0 , 575 - 0 , 461 - 0 , 683 0 , 238 0 , 485 - 0 , 372 0 , 808 0 , 477 0 , 086 0 , 936 1 , 000 0 , 071 - 0 , 046 - 0 , 283 0 , 286 - 0 , 032 - 0 , 778 - 0 , 391 0 , 648 0 , 342 0 , 205 0 , 199 0 , 338 0 , 373 0 , 099 0 , 071 1 , 000 0 , 394 0 , 040 0 , 332 - 0 , 215 - 0 , 446 0 , 038 0 , 587 0 , 402 0 , 684 - 0 , 052 0 , 194 0 , 433 0 , 091 - 0 , 046 0 , 394 1 , 000 0 , 440 0 , 441 - 0 , 126 0 , 565 0 , 037 0 , 103 0 , 106 0 , 316 - 0 , 115 0 , 122 0 , 196 - 0 , 208 - 0 , 283 0 , 040 0 , 440 1 , 000 0 , 107 - 0 , 194 - 0 , 581 - 0 , 377 0 , 391 0 , 638 - 0 , 037 0 , 291 0 , 247 0 , 461 0 , 267 0 , 286 0 , 332 0 , 441 0 , 107 1 , 000 0 , 203 0 , 012 0 , 856 - 0 , 026 0 , 417 0 , 070 - 0 , 085 - 0 , 346 - 0 , 334 0 , 262 0 , 210 - 0 , 308 0 , 296 - 0 , 717 0 , 212 - 0 , 272 - 0 , 452 - 0 , 219 0 , 692 0 , 267 0 , 335 0 , 347 0 , 643 0 , 751 0 , 185 0 , 126 0 , 539 0 , 644 0 , 350 0 , 513 0 , 259 - 0 , 259 - 0 , 708 0 , 526 0 , 469 - 0 , 162 0 , 744 0 , 580 0 , 445 0 , 701 0 , 598 0 , 511 0 , 149 0 , 306 0 , 489 0 , 379 - 0 , 083 - 0 , 822 0 , 568 0 , 697 0 , 174 0 , 583 0 , 463 0 , 608 0 , 491 0 , 516 0 , 366 0 , 484 0 , 099 0 , 510 0 , 477 0 , 141 - 0 , 886 0 , 348 0 , 538 - 0 , 182 0 , 836 0 , 693 0 , 267 0 , 450 0 , 610 0 , 395 0 , 030 0 , 108 0 , 427 0 , 094 0 , 000 0 , 000 0 , 477 0 , 348 0 , 464 0 , 432 0 , 382 0 , 192 0 , 375 0 , 351 - 0 , 049 0 , 175 0 , 004 0 , 121 0 , 135 - 0 , 108 - 0 , 480 0 , 462 0 , 707 0 , 160 0 , 258 0 , 112 0 , 205 0 , 057 0 , 047 0 , 436 0 , 271 0 , 504 0 , 496 0 , 265 0 , 025 - 0 , 823 0 , 342 0 , 422 - 0 , 136 0 , 516 0 , 146 0 , 479 0 , 529 0 , 592 0 , 141 0 , 160 - 0 , 122 0 , 434 0 , 434 0 , 381 - 0 , 701 0 , 323 0 , 687 0 , 223 0 , 692 0 , 352 0 , 250 0 , 647 0 , 665 - 0 , 019 0 , 372 - 0 , 019 0 , 313 0 , 216 - 0 , 604 0 , 657 0 , 216 0 , 385 - 0 , 057 - 0 , 128 - 0 , 102 0 , 102 0 , 027 0 , 061 0 , 096 0 , 388 0 , 258 0 , 461 - 0 , 761 0 , 000 0 , 000 0 , 763 - 0 , 156 - 0 , 029 0 , 834 0 , 724 0 , 881 0 , 744 0 , 555 0 , 661 0 , 152 0 , 242 0 , 533 - 0 , 368 - 0 , 834 0 , 701 0 , 562 0 , 003 0 , 393 - 0 , 145 0 , 088 0 , 427 - 0 , 144 - 0 , 167 0 , 542 0 , 630 0 , 123 0 , 481 0 , 144 0 , 220 0 , 416 0 , 291 0 , 241 0 , 281 0 , 408 - 0 , 114 0 , 258 0 , 139 0 , 232 - 0 , 202 0 , 374 0 , 288 0 , 283 0 , 489 0 , 215 - 0 , 802 0 , 495 0 , 776 0 , 210 0 , 562 0 , 422 0 , 192 0 , 257 0 , 408 0 , 431 0 , 510 0 , 241 0 , 472 0 , 095 - 0 , 196 - 0 , 606 0 , 513 0 , 408 - 0 , 159 0 , 657 0 , 232 0 , 510 0 , 206 0 , 283 0 , 345 - 0 , 049 0 , 215 0 , 474 0 , 128 0 , 641 - 0 , 595 - 0 , 051 0 , 389 - 0 , 032 0 , 453 0 , 602 0 , 273 0 , 275 0 , 236 0 , 277 0 , 156 0 , 412 0 , 348 0 , 125 - 0 , 255 - 0 , 159 - 0 , 094 0 , 081 0 , 001 0 , 436 0 , 176 0 , 002 0 , 446 0 , 470 - 0 , 032 - 0 , 210 - 0 , 682 0 , 202 0 , 010 - 0 , 414 - 0 , 400 - 0 , 046 - 0 , 072 - 0 , 143 - 0 , 102 - 0 , 006 - 0 , 053 - 0 , 483 - 0 , 302 0 , 485 - 0 , 126 - 0 , 199 0 , 071 0 , 550 0 , 331 - 0 , 895 0 , 297 0 , 545 - 0 , 019 0 , 596 0 , 612 0 , 281 0 , 668 0 , 720 0 , 314 0 , 343 0 , 030 0 , 312 Novel approaches to understanding hENT2 and hENT2 - related proteins 296 P Values TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 MSH2 MSH6 GADD45 BAX P21 FAS OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 CTR1 ENT1 ENT2 ENT3 ENT4 CNT3 AQP1 AQP3 AQP5 ABCA2 ABCA3 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A ATP7B DPYD TYMP UPP1 EPHX1 DCK RRM1 TYMS TK1 UMPS UCK2 FPGS GCLC UGTX TOP1 TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 MSH2 MSH6 GADD45 BAX P21 FAS BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR MYC MMP1 MMP2 TIGAR NRF2 KEAP1 ENT1n ENT2n CNT1n CNT2n CNT3n 0 , 185 1 , 000 1 , 000 0 , 963 0 , 799 0 , 360 0 , 221 0 , 033 0 , 396 0 , 758 0 , 933 0 , 543 0 , 402 0 , 559 0 , 290 0 , 351 0 , 230 0 , 442 0 , 625 0 , 164 0 , 512 0 , 341 0 , 112 0 , 787 0 , 257 0 , 288 0 , 565 0 , 180 0 , 210 0 , 674 0 , 547 1 , 000 1 , 000 0 , 821 0 , 195 0 , 414 0 , 210 0 , 859 0 , 647 0 , 628 0 , 312 0 , 987 0 , 486 0 , 319 0 , 190 0 , 386 0 , 632 0 , 045 0 , 090 0 , 002 0 , 649 0 , 010 0 , 172 0 , 061 0 , 078 0 , 078 0 , 383 0 , 165 0 , 136 0 , 020 0 , 984 0 , 284 0 , 225 0 , 013 0 , 139 0 , 512 0 , 036 0 , 128 0 , 011 0 , 028 0 , 043 0 , 121 0 , 166 0 , 843 0 , 063 0 , 767 1 , 000 1 , 000 0 , 753 0 , 381 0 , 996 0 , 389 0 , 630 0 , 445 0 , 906 0 , 714 0 , 624 0 , 330 0 , 109 0 , 451 0 , 042 0 , 110 0 , 375 0 , 439 0 , 887 0 , 441 0 , 365 0 , 902 0 , 900 0 , 368 0 , 221 0 , 048 0 , 224 0 , 551 0 , 568 0 , 186 0 , 257 0 , 017 0 , 653 0 , 273 0 , 537 0 , 143 0 , 008 0 , 385 0 , 153 0 , 070 0 , 543 0 , 661 0 , 287 0 , 847 0 , 127 0 , 009 0 , 092 0 , 579 0 , 601 0 , 900 0 , 619 0 , 012 0 , 882 0 , 458 0 , 431 0 , 832 0 , 540 0 , 155 0 , 533 0 , 331 0 , 441 0 , 377 0 , 084 0 , 003 0 , 601 0 , 360 0 , 438 0 , 653 0 , 367 0 , 184 0 , 435 0 , 531 0 , 596 0 , 017 0 , 704 0 , 572 0 , 009 0 , 007 0 , 117 0 , 950 0 , 005 0 , 130 0 , 005 0 , 064 0 , 169 0 , 038 0 , 528 0 , 448 0 , 110 0 , 429 0 , 148 0 , 230 0 , 841 0 , 299 0 , 678 0 , 131 0 , 002 0 , 431 0 , 292 0 , 319 0 , 386 0 , 688 0 , 108 0 , 424 0 , 463 0 , 973 0 , 823 0 , 289 0 , 733 0 , 277 0 , 790 0 , 291 0 , 581 0 , 135 0 , 202 0 , 838 0 , 763 0 , 869 0 , 579 0 , 737 0 , 817 0 , 249 0 , 367 0 , 012 0 , 746 0 , 648 0 , 323 0 , 569 0 , 032 0 , 112 0 , 983 0 , 076 0 , 638 0 , 041 0 , 320 0 , 444 0 , 044 0 , 305 0 , 046 0 , 851 0 , 029 0 , 004 0 , 113 0 , 030 0 , 038 0 , 333 0 , 164 0 , 257 0 , 213 0 , 990 0 , 373 0 , 946 0 , 393 0 , 971 0 , 187 0 , 851 0 , 977 0 , 630 0 , 202 0 , 187 0 , 543 0 , 676 0 , 204 0 , 467 0 , 128 0 , 647 0 , 521 0 , 276 0 , 167 0 , 556 0 , 732 0 , 608 0 , 131 0 , 530 0 , 481 0 , 220 0 , 994 0 , 581 0 , 559 0 , 611 1 , 000 0 , 910 0 , 886 0 , 842 0 , 495 0 , 618 0 , 543 0 , 618 0 , 292 0 , 635 0 , 514 0 , 532 0 , 815 0 , 422 0 , 841 0 , 443 0 , 364 0 , 730 0 , 181 0 , 576 0 , 587 0 , 424 0 , 869 0 , 409 0 , 503 0 , 457 0 , 545 0 , 987 0 , 946 0 , 859 0 , 265 0 , 529 0 , 419 0 , 841 0 , 056 0 , 815 0 , 456 0 , 132 0 , 559 0 , 589 0 , 784 0 , 633 0 , 560 0 , 294 0 , 428 0 , 921 1 , 000 0 , 324 0 , 239 0 , 460 0 , 809 0 , 570 0 , 459 0 , 833 0 , 885 0 , 935 0 , 463 0 , 661 0 , 664 0 , 607 0 , 648 0 , 006 0 , 404 0 , 715 0 , 666 0 , 192 0 , 021 0 , 138 0 , 516 0 , 299 0 , 380 0 , 750 0 , 534 0 , 978 0 , 368 0 , 416 0 , 735 0 , 071 0 , 107 0 , 248 0 , 272 0 , 490 0 , 230 0 , 816 0 , 528 0 , 170 0 , 005 0 , 347 0 , 042 0 , 214 0 , 043 0 , 034 0 , 983 0 , 509 0 , 493 0 , 372 0 , 000 0 , 622 0 , 386 0 , 331 0 , 285 0 , 974 0 , 415 0 , 973 0 , 250 0 , 206 0 , 784 0 , 054 0 , 797 0 , 163 0 , 420 0 , 526 0 , 589 0 , 768 0 , 556 0 , 075 0 , 114 0 , 929 0 , 700 0 , 515 0 , 131 0 , 934 0 , 077 0 , 674 0 , 690 0 , 340 0 , 059 0 , 016 0 , 854 0 , 728 0 , 147 0 , 294 0 , 503 0 , 570 0 , 185 1 , 000 1 , 000 0 , 128 0 , 495 0 , 718 0 , 977 0 , 918 0 , 310 0 , 476 0 , 697 0 , 450 0 , 395 0 , 101 0 , 486 0 , 238 0 , 989 0 , 876 0 , 357 0 , 046 0 , 053 0 , 932 0 , 434 0 , 830 0 , 893 0 , 799 0 , 510 0 , 003 0 , 577 0 , 403 0 , 346 0 , 022 0 , 048 0 , 959 0 , 409 0 , 730 0 , 702 0 , 030 0 , 783 0 , 847 0 , 878 0 , 417 0 , 511 0 , 037 0 , 708 0 , 938 0 , 590 0 , 167 0 , 008 0 , 456 0 , 309 0 , 880 0 , 382 0 , 010 0 , 783 0 , 802 0 , 188 0 , 041 0 , 579 0 , 400 0 , 207 0 , 024 0 , 074 0 , 013 0 , 689 0 , 071 0 , 413 0 , 284 0 , 201 0 , 479 0 , 360 0 , 116 0 , 132 0 , 567 0 , 844 0 , 858 0 , 458 0 , 039 0 , 414 0 , 239 0 , 995 0 , 954 0 , 875 0 , 364 0 , 786 0 , 806 0 , 880 0 , 689 0 , 930 0 , 486 0 , 527 0 , 382 0 , 389 0 , 385 0 , 484 0 , 932 0 , 119 0 , 029 0 , 167 0 , 130 0 , 128 0 , 278 0 , 403 0 , 114 0 , 668 0 , 775 0 , 967 0 , 017 0 , 156 0 , 200 0 , 258 0 , 009 0 , 010 0 , 013 0 , 051 0 , 052 0 , 305 0 , 819 0 , 484 0 , 095 0 , 097 0 , 048 0 , 119 0 , 483 0 , 672 0 , 721 0 , 573 0 , 673 0 , 377 0 , 303 0 , 187 0 , 243 0 , 427 0 , 699 0 , 121 0 , 420 0 , 908 0 , 170 0 , 009 0 , 004 0 , 237 0 , 026 0 , 503 0 , 047 0 , 199 0 , 125 0 , 332 0 , 018 0 , 403 0 , 027 0 , 109 0 , 648 0 , 007 0 , 137 0 , 001 0 , 826 0 , 001 0 , 093 0 , 317 0 , 006 0 , 002 0 , 643 0 , 380 0 , 729 0 , 094 0 , 815 0 , 063 0 , 040 0 , 003 0 , 204 0 , 808 0 , 129 0 , 704 0 , 310 0 , 010 0 , 044 0 , 276 0 , 278 0 , 851 0 , 295 0 , 021 0 , 545 0 , 074 0 , 602 0 , 018 0 , 634 0 , 002 0 , 019 0 , 807 0 , 004 0 , 000 0 , 832 0 , 539 0 , 904 0 , 115 0 , 403 0 , 711 0 , 285 0 , 249 0 , 215 0 , 774 0 , 007 0 , 004 0 , 136 0 , 151 0 , 062 0 , 261 0 , 231 0 , 637 0 , 161 0 , 478 0 , 945 0 , 398 0 , 260 0 , 441 0 , 647 0 , 002 0 , 028 0 , 040 0 , 031 0 , 023 0 , 657 0 , 210 0 , 810 0 , 303 0 , 050 0 , 748 0 , 045 0 , 211 0 , 009 0 , 561 0 , 042 0 , 007 0 , 520 0 , 026 0 , 007 0 , 427 0 , 223 0 , 500 0 , 141 0 , 519 0 , 381 0 , 177 0 , 970 0 , 939 0 , 199 0 , 773 0 , 021 0 , 571 0 , 627 0 , 633 0 , 545 0 , 992 0 , 058 0 , 798 0 , 515 0 , 166 0 , 625 0 , 610 0 , 755 0 , 821 0 , 414 0 , 757 0 , 933 0 , 229 0 , 497 0 , 184 0 , 807 0 , 264 0 , 729 0 , 107 0 , 265 0 , 171 0 , 064 0 , 010 0 , 407 0 , 030 0 , 037 0 , 357 0 , 026 0 , 014 0 , 128 0 , 022 0 , 874 0 , 186 0 , 000 0 , 231 0 , 044 0 , 850 0 , 108 0 , 528 0 , 082 0 , 482 0 , 154 0 , 178 0 , 032 0 , 914 0 , 461 0 , 669 0 , 526 0 , 231 0 , 000 1 , 000 0 , 151 0 , 873 0 , 611 0 , 891 0 , 995 0 , 515 0 , 202 0 , 358 0 , 069 0 , 375 0 , 243 0 , 304 0 , 044 1 , 000 0 , 000 0 , 736 0 , 016 0 , 707 0 , 015 0 , 158 0 , 262 0 , 303 0 , 091 0 , 386 0 , 935 0 , 938 0 , 461 0 , 850 0 , 151 0 , 736 0 , 000 0 , 082 0 , 198 0 , 208 0 , 502 0 , 030 0 , 335 0 , 413 0 , 012 0 , 027 0 , 726 0 , 186 0 , 108 0 , 873 0 , 016 0 , 082 0 , 000 0 , 671 0 , 074 0 , 474 0 , 735 0 , 142 0 , 079 0 , 231 0 , 155 0 , 719 0 , 019 0 , 528 0 , 611 0 , 707 0 , 198 0 , 671 0 , 000 0 , 563 0 , 635 0 , 434 0 , 367 0 , 190 0 , 481 0 , 007 0 , 271 0 , 904 0 , 082 0 , 891 0 , 015 0 , 208 0 , 074 0 , 563 0 , 000 0 , 069 0 , 301 0 , 004 0 , 000 0 , 495 0 , 860 0 , 694 0 , 334 0 , 482 0 , 995 0 , 158 0 , 502 0 , 474 0 , 635 0 , 069 0 , 000 0 , 254 0 , 127 0 , 085 0 , 237 0 , 506 0 , 677 0 , 416 0 , 154 0 , 515 0 , 262 0 , 030 0 , 735 0 , 434 0 , 301 0 , 254 0 , 000 0 , 525 0 , 770 0 , 188 0 , 122 0 , 502 0 , 113 0 , 178 0 , 202 0 , 303 0 , 335 0 , 142 0 , 367 0 , 004 0 , 127 0 , 525 0 , 000 0 , 000 0 , 748 0 , 767 0 , 495 0 , 401 0 , 032 0 , 358 0 , 091 0 , 413 0 , 079 0 , 190 0 , 000 0 , 085 0 , 770 0 , 000 0 , 000 0 , 810 0 , 876 0 , 326 0 , 343 0 , 914 0 , 069 0 , 386 0 , 012 0 , 231 0 , 481 0 , 495 0 , 237 0 , 188 0 , 748 0 , 810 0 , 000 0 , 164 0 , 892 0 , 268 0 , 461 0 , 375 0 , 935 0 , 027 0 , 155 0 , 007 0 , 860 0 , 506 0 , 122 0 , 767 0 , 876 0 , 164 0 , 000 0 , 116 0 , 131 0 , 669 0 , 243 0 , 938 0 , 726 0 , 719 0 , 271 0 , 694 0 , 677 0 , 502 0 , 495 0 , 326 0 , 892 0 , 116 0 , 000 0 , 728 0 , 526 0 , 304 0 , 461 0 , 186 0 , 019 0 , 904 0 , 334 0 , 416 0 , 113 0 , 401 0 , 343 0 , 268 0 , 131 0 , 728 0 , 000 0 , 528 0 , 985 0 , 064 0 , 936 0 , 178 0 , 828 0 , 792 0 , 271 0 , 288 0 , 436 0 , 513 0 , 329 0 , 351 0 , 009 0 , 508 0 , 346 0 , 368 0 , 638 0 , 006 0 , 356 0 , 242 0 , 224 0 , 013 0 , 002 0 , 544 0 , 668 0 , 047 0 , 013 0 , 220 0 , 073 0 , 371 0 , 620 0 , 075 0 , 053 0 , 090 0 , 580 0 , 002 0 , 030 0 , 111 0 , 008 0 , 024 0 , 062 0 , 610 0 , 287 0 , 090 0 , 182 0 , 876 0 , 023 0 , 034 0 , 006 0 , 553 0 , 029 0 , 095 0 , 021 0 , 088 0 , 059 0 , 198 0 , 079 0 , 735 0 , 075 0 , 085 0 , 790 0 , 008 0 , 223 0 , 047 0 , 533 0 , 000 0 , 006 0 , 357 0 , 123 0 , 021 0 , 162 0 , 918 0 , 714 0 , 145 0 , 811 1 , 000 1 , 000 0 , 194 0 , 358 0 , 208 0 , 246 0 , 310 0 , 620 0 , 360 0 , 354 0 , 901 0 , 652 0 , 991 0 , 775 0 , 646 0 , 839 0 , 275 0 , 097 0 , 005 0 , 585 0 , 372 0 , 702 0 , 481 0 , 854 0 , 872 0 , 119 0 , 349 0 , 066 0 , 085 0 , 360 0 , 962 0 , 023 0 , 231 0 , 133 0 , 642 0 , 059 0 , 618 0 , 083 0 , 063 0 , 026 0 , 632 0 , 584 0 , 677 0 , 138 0 , 121 0 , 456 0 , 079 0 , 260 0 , 007 0 , 444 0 , 006 0 , 218 0 , 389 0 , 017 0 , 010 0 , 949 0 , 190 0 , 948 0 , 298 0 , 500 0 , 280 0 , 229 0 , 500 0 , 216 0 , 861 0 , 691 0 , 753 0 , 753 0 , 936 0 , 850 0 , 766 0 , 213 0 , 419 0 , 131 0 , 079 1 , 000 1 , 000 0 , 078 0 , 768 0 , 956 0 , 039 0 , 104 0 , 020 0 , 150 0 , 253 0 , 153 0 , 774 0 , 645 0 , 276 0 , 196 0 , 039 0 , 079 0 , 037 0 , 991 0 , 164 0 , 620 0 , 764 0 , 128 0 , 638 0 , 568 0 , 045 0 , 016 0 , 676 0 , 096 0 , 623 0 , 675 0 , 353 0 , 313 0 , 406 0 , 331 0 , 148 0 , 699 0 , 374 0 , 651 0 , 424 0 , 488 0 , 188 0 , 317 0 , 349 0 , 076 0 , 683 0 , 030 0 , 072 0 , 001 0 , 472 0 , 036 0 , 133 0 , 510 0 , 397 0 , 147 0 , 124 0 , 063 0 , 406 0 , 104 0 , 748 0 , 710 0 , 149 0 , 061 0 , 148 0 , 587 0 , 011 0 , 424 0 , 063 0 , 500 0 , 326 0 , 227 0 , 867 0 , 460 0 , 102 0 , 664 0 , 170 0 , 159 0 , 862 0 , 169 0 , 912 0 , 104 0 , 023 0 , 345 0 , 363 0 , 416 0 , 338 0 , 593 0 , 143 0 , 244 0 , 671 0 , 626 0 , 734 0 , 750 0 , 783 0 , 998 0 , 119 0 , 547 0 , 994 0 , 127 0 , 090 0 , 913 0 , 472 0 , 007 0 , 508 0 , 973 0 , 414 0 , 374 0 , 875 0 , 807 0 , 625 0 , 729 0 , 985 0 , 856 0 , 095 0 , 294 0 , 079 0 , 669 0 , 495 0 , 817 0 , 042 0 , 522 0 , 006 0 , 303 0 , 044 0 , 950 0 , 025 0 , 020 0 , 330 0 , 013 0 , 004 0 , 274 0 , 230 0 , 920 0 , 300 Appendix I 297 Correlat . BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR MYC MMP1 MMP2 TIGAR NRF2 KEAP1 ENT1n OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 CTR1 ENT1 ENT2 ENT3 ENT4 CNT3 AQP1 AQP3 AQP5 ABCA2 ABCA3 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A ATP7B DPYD TYMP UPP1 EPHX1 DCK RRM1 TYMS TK1 UMPS UCK2 FPGS GCLC UGTX TOP1 TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 MSH2 MSH6 GADD45 BAX P21 FAS BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR MYC MMP1 MMP2 TIGAR NRF2 KEAP1 ENT1n ENT2n CNT1n CNT2n CNT3n - 0 , 198 - 0 , 390 0 , 306 - 0 , 567 - 0 , 577 0 , 000 0 , 182 - 0 , 608 - 0 , 749 0 , 271 0 , 000 0 , 685 - 0 , 530 - 0 , 620 0 , 083 0 , 497 0 , 129 0 , 118 0 , 306 0 , 255 0 , 187 0 , 111 0 , 187 0 , 693 - 0 , 170 - 0 , 260 - 0 , 332 0 , 306 0 , 575 - 0 , 124 - 0 , 710 0 , 201 - 0 , 582 - 0 , 493 - 0 , 743 0 , 057 - 0 , 151 - 0 , 828 - 0 , 298 - 0 , 015 0 , 000 0 , 197 0 , 156 - 0 , 296 - 0 , 842 - 0 , 028 0 , 470 0 , 676 0 , 784 0 , 650 0 , 232 0 , 621 0 , 615 0 , 744 0 , 126 0 , 920 - 0 , 100 0 , 374 0 , 715 0 , 603 0 , 020 0 , 597 0 , 633 0 , 723 0 , 527 - 0 , 017 0 , 202 0 , 684 0 , 488 0 , 307 0 , 986 0 , 294 0 , 363 0 , 621 0 , 519 0 , 482 - 0 , 210 0 , 173 0 , 655 - 0 , 127 - 0 , 258 0 , 472 0 , 562 0 , 260 0 , 649 0 , 000 - 0 , 379 - 0 , 157 0 , 187 0 , 220 0 , 309 - 0 , 433 - 0 , 051 0 , 435 0 , 116 0 , 139 - 0 , 232 0 , 497 0 , 363 0 , 268 0 , 000 - 0 , 475 0 , 414 0 , 031 0 , 035 - 0 , 258 0 , 328 0 , 406 0 , 549 0 , 548 - 0 , 289 0 , 189 0 , 384 0 , 500 - 0 , 176 0 , 425 - 0 , 326 - 0 , 194 0 , 525 0 , 196 - 0 , 155 0 , 145 0 , 183 0 , 326 0 , 359 - 0 , 122 - 0 , 007 0 , 141 0 , 353 - 0 , 129 - 0 , 496 - 0 , 294 - 0 , 123 0 , 400 - 0 , 180 0 , 357 0 , 300 0 , 350 0 , 539 0 , 405 0 , 598 0 , 526 0 , 291 0 , 316 0 , 579 0 , 241 0 , 197 0 , 075 0 , 449 0 , 410 - 0 , 431 0 , 671 0 , 858 0 , 673 0 , 752 0 , 278 0 , 572 0 , 494 0 , 331 0 , 152 0 , 926 0 , 268 0 , 345 0 , 539 0 , 915 - 0 , 499 0 , 463 0 , 562 0 , 402 0 , 594 0 , 193 0 , 448 - 0 , 018 0 , 315 0 , 036 0 , 094 - 0 , 136 - 0 , 047 0 , 371 0 , 321 - 0 , 155 - 0 , 014 0 , 215 0 , 233 0 , 093 - 0 , 233 - 0 , 179 0 , 301 - 0 , 000 0 , 408 - 0 , 055 0 , 086 - 0 , 016 - 0 , 142 - 0 , 106 - 0 , 580 - 0 , 254 - 0 , 185 - 0 , 547 - 0 , 127 - 0 , 108 - 0 , 278 - 0 , 396 - 0 , 591 - 0 , 464 0 , 147 0 , 009 - 0 , 100 - 0 , 460 0 , 044 - 0 , 138 0 , 526 0 , 631 0 , 759 0 , 653 0 , 234 0 , 365 0 , 560 0 , 730 - 0 , 106 0 , 712 - 0 , 141 0 , 112 0 , 700 0 , 302 - 0 , 421 0 , 055 - 0 , 235 - 0 , 099 0 , 026 - 0 , 076 0 , 272 - 0 , 506 0 , 021 - 0 , 375 0 , 000 - 0 , 147 0 , 013 0 , 278 - 0 , 082 0 , 402 - 0 , 229 - 0 , 012 0 , 068 0 , 063 0 , 127 0 , 322 - 0 , 190 0 , 274 0 , 477 - 0 , 744 - 0 , 231 0 , 380 0 , 202 - 0 , 022 0 , 011 - 0 , 074 - 0 , 055 0 , 293 - 0 , 244 - 0 , 020 0 , 007 0 , 127 0 , 365 - 0 , 054 - 0 , 886 - 0 , 168 0 , 148 0 , 073 - 0 , 291 0 , 738 - 0 , 136 - 0 , 396 0 , 255 - 0 , 151 - 0 , 203 0 , 130 0 , 143 0 , 337 0 , 106 - 0 , 444 - 0 , 333 - 0 , 004 0 , 311 - 0 , 087 - 0 , 137 0 , 032 - 0 , 053 0 , 367 - 0 , 045 0 , 116 - 0 , 043 0 , 394 0 , 236 - 0 , 195 0 , 342 - 0 , 066 0 , 288 0 , 105 0 , 131 0 , 703 0 , 057 - 0 , 074 0 , 643 - 0 , 111 - 0 , 847 0 , 417 0 , 414 0 , 312 0 , 830 0 , 000 - 0 , 193 0 , 201 0 , 391 0 , 364 - 0 , 390 0 , 393 0 , 518 0 , 359 0 , 564 - 0 , 238 - 0 , 198 0 , 514 0 , 084 - 0 , 072 0 , 897 0 , 181 0 , 105 0 , 378 0 , 280 - 0 , 366 - 0 , 267 - 0 , 034 - 0 , 383 0 , 153 0 , 253 - 0 , 365 - 0 , 346 - 0 , 042 - 0 , 619 - 0 , 188 - 0 , 535 - 0 , 115 - 0 , 335 - 0 , 021 - 0 , 409 0 , 304 0 , 420 0 , 394 0 , 543 - 0 , 303 0 , 183 0 , 154 0 , 193 - 0 , 372 0 , 267 - 0 , 214 - 0 , 414 0 , 358 0 , 103 - 0 , 004 0 , 346 0 , 241 0 , 367 0 , 261 0 , 105 - 0 , 097 0 , 197 0 , 151 0 , 280 0 , 169 0 , 576 0 , 390 0 , 478 0 , 062 - 0 , 247 0 , 723 0 , 237 0 , 406 0 , 293 0 , 304 - 0 , 158 0 , 108 0 , 106 0 , 122 0 , 614 0 , 548 0 , 164 0 , 196 0 , 263 - 0 , 321 - 0 , 476 0 , 015 0 , 136 0 , 306 - 0 , 453 0 , 553 - 0 , 122 0 , 061 0 , 527 0 , 000 - 0 , 703 0 , 089 0 , 495 0 , 484 - 0 , 843 - 0 , 313 0 , 102 - 0 , 485 - 0 , 090 - 0 , 208 - 0 , 205 - 0 , 016 - 0 , 590 - 0 , 487 0 , 539 - 0 , 359 - 0 , 411 - 0 , 667 0 , 232 - 0 , 455 0 , 237 0 , 325 0 , 311 0 , 410 - 0 , 231 0 , 308 0 , 100 0 , 209 - 0 , 425 - 0 , 049 - 0 , 252 - 0 , 276 0 , 432 0 , 054 - 0 , 001 0 , 539 0 , 265 0 , 660 0 , 176 0 , 027 0 , 106 0 , 551 0 , 194 0 , 416 0 , 574 0 , 495 0 , 177 0 , 392 0 , 215 0 , 046 0 , 308 - 0 , 081 0 , 055 - 0 , 293 0 , 238 - 0 , 047 0 , 025 - 0 , 227 0 , 259 0 , 506 0 , 754 0 , 153 - 0 , 081 0 , 016 0 , 332 - 0 , 000 0 , 018 0 , 336 0 , 081 - 0 , 264 0 , 111 0 , 536 0 , 286 - 0 , 204 0 , 289 - 0 , 279 - 0 , 257 0 , 252 0 , 062 - 0 , 052 0 , 356 0 , 469 0 , 515 0 , 421 0 , 284 0 , 100 0 , 503 0 , 551 0 , 099 0 , 860 - 0 , 148 0 , 579 0 , 356 0 , 314 - 0 , 377 0 , 566 0 , 774 0 , 634 0 , 744 0 , 074 0 , 343 0 , 598 0 , 411 - 0 , 006 0 , 942 - 0 , 049 0 , 106 0 , 463 0 , 697 0 , 138 - 0 , 381 - 0 , 023 - 0 , 003 0 , 100 - 0 , 124 - 0 , 474 0 , 385 0 , 219 - 0 , 351 - 0 , 137 - 0 , 427 - 0 , 061 0 , 050 - 0 , 300 0 , 281 0 , 532 0 , 535 0 , 839 0 , 542 0 , 275 0 , 428 0 , 671 0 , 727 0 , 429 0 , 773 0 , 305 0 , 717 0 , 813 0 , 538 0 , 178 0 , 354 0 , 633 0 , 720 0 , 685 0 , 554 0 , 471 0 , 572 0 , 875 - 0 , 017 0 , 615 - 0 , 205 0 , 304 0 , 653 0 , 459 - 0 , 020 0 , 404 0 , 594 0 , 292 0 , 246 0 , 651 0 , 349 0 , 276 0 , 287 0 , 182 0 , 770 0 , 367 0 , 335 0 , 165 0 , 387 0 , 174 0 , 287 0 , 647 0 , 606 0 , 759 0 , 423 0 , 226 0 , 496 0 , 709 0 , 244 0 , 191 - 0 , 038 0 , 384 0 , 641 0 , 307 - 0 , 112 0 , 658 0 , 617 0 , 630 0 , 743 0 , 145 0 , 165 0 , 330 0 , 517 0 , 268 0 , 820 0 , 248 0 , 455 0 , 683 0 , 470 - 0 , 097 0 , 599 0 , 562 0 , 646 0 , 599 0 , 370 - 0 , 022 0 , 477 0 , 652 0 , 095 0 , 722 0 , 234 0 , 614 0 , 492 0 , 368 0 , 182 0 , 389 0 , 598 0 , 730 0 , 691 0 , 083 0 , 302 0 , 566 0 , 636 0 , 420 0 , 318 - 0 , 025 0 , 171 0 , 768 0 , 276 - 0 , 571 0 , 272 0 , 450 0 , 217 0 , 376 - 0 , 393 0 , 177 0 , 114 - 0 , 087 0 , 203 0 , 700 - 0 , 100 - 0 , 215 0 , 210 0 , 188 0 , 162 - 0 , 039 - 0 , 218 0 , 171 0 , 069 - 0 , 466 - 0 , 184 0 , 175 - 0 , 089 0 , 514 - 0 , 099 0 , 018 0 , 335 0 , 263 - 0 , 059 0 , 347 0 , 509 0 , 438 0 , 784 0 , 549 0 , 301 0 , 189 0 , 455 0 , 771 0 , 317 0 , 008 0 , 268 0 , 341 0 , 784 0 , 130 0 , 203 - 0 , 272 0 , 259 0 , 379 0 , 477 0 , 094 0 , 135 0 , 265 0 , 434 0 , 216 - 0 , 761 - 0 , 368 0 , 144 0 , 489 0 , 095 0 , 012 - 0 , 452 - 0 , 259 - 0 , 083 0 , 141 0 , 000 - 0 , 108 0 , 025 0 , 381 - 0 , 604 0 , 000 - 0 , 834 0 , 220 0 , 215 - 0 , 196 0 , 856 - 0 , 219 - 0 , 708 - 0 , 822 - 0 , 886 0 , 000 - 0 , 480 - 0 , 823 - 0 , 701 0 , 657 0 , 000 0 , 701 0 , 416 - 0 , 802 - 0 , 606 - 0 , 026 0 , 692 0 , 526 0 , 568 0 , 348 0 , 477 0 , 462 0 , 342 0 , 323 0 , 216 0 , 763 0 , 562 0 , 291 0 , 495 0 , 513 0 , 417 0 , 267 0 , 469 0 , 697 0 , 538 0 , 348 0 , 707 0 , 422 0 , 687 0 , 385 - 0 , 156 0 , 003 0 , 241 0 , 776 0 , 408 0 , 070 0 , 335 - 0 , 162 0 , 174 - 0 , 182 0 , 464 0 , 160 - 0 , 136 0 , 223 - 0 , 057 - 0 , 029 0 , 393 0 , 281 0 , 210 - 0 , 159 - 0 , 085 0 , 347 0 , 744 0 , 583 0 , 836 0 , 432 0 , 258 0 , 516 0 , 692 - 0 , 128 0 , 834 - 0 , 145 0 , 408 0 , 562 0 , 657 - 0 , 346 0 , 643 0 , 580 0 , 463 0 , 693 0 , 382 0 , 112 0 , 146 0 , 352 - 0 , 102 0 , 724 0 , 088 - 0 , 114 0 , 422 0 , 232 - 0 , 334 0 , 751 0 , 445 0 , 608 0 , 267 0 , 192 0 , 205 0 , 479 0 , 250 0 , 102 0 , 881 0 , 427 0 , 258 0 , 192 0 , 510 0 , 262 0 , 185 0 , 701 0 , 491 0 , 450 0 , 375 0 , 057 0 , 529 0 , 647 0 , 027 0 , 744 - 0 , 144 0 , 139 0 , 257 0 , 206 0 , 210 0 , 126 0 , 598 0 , 516 0 , 610 0 , 351 0 , 047 0 , 592 0 , 665 0 , 061 0 , 555 - 0 , 167 0 , 232 0 , 408 0 , 283 - 0 , 308 0 , 539 0 , 511 0 , 366 0 , 395 - 0 , 049 0 , 436 0 , 141 - 0 , 019 0 , 096 0 , 661 0 , 542 - 0 , 202 0 , 431 0 , 345 0 , 296 0 , 644 0 , 149 0 , 484 0 , 030 0 , 175 0 , 271 0 , 160 0 , 372 0 , 388 0 , 152 0 , 630 0 , 374 0 , 510 - 0 , 049 - 0 , 717 0 , 350 0 , 306 0 , 099 0 , 108 0 , 004 0 , 504 - 0 , 122 - 0 , 019 0 , 258 0 , 242 0 , 123 0 , 288 0 , 241 0 , 215 0 , 212 0 , 513 0 , 489 0 , 510 0 , 427 0 , 121 0 , 496 0 , 434 0 , 313 0 , 461 0 , 533 0 , 481 0 , 283 0 , 472 0 , 474 1 , 000 - 0 , 383 - 0 , 433 0 , 143 - 0 , 246 - 0 , 308 - 0 , 230 0 , 278 0 , 434 0 , 346 - 0 , 673 - 0 , 101 0 , 208 0 , 240 - 0 , 422 - 0 , 383 1 , 000 0 , 583 0 , 549 0 , 480 0 , 461 0 , 392 0 , 116 0 , 284 0 , 179 0 , 776 0 , 604 0 , 266 0 , 432 0 , 485 - 0 , 433 0 , 583 1 , 000 0 , 530 0 , 846 0 , 347 0 , 555 0 , 442 0 , 315 0 , 146 0 , 911 0 , 226 0 , 283 0 , 534 0 , 782 0 , 143 0 , 549 0 , 530 1 , 000 0 , 587 0 , 249 0 , 405 0 , 688 0 , 735 0 , 456 0 , 468 0 , 167 0 , 369 0 , 745 0 , 460 - 0 , 246 0 , 480 0 , 846 0 , 587 1 , 000 0 , 269 0 , 417 0 , 434 0 , 461 0 , 053 0 , 822 0 , 034 0 , 253 0 , 727 0 , 714 - 0 , 308 0 , 461 0 , 347 0 , 249 0 , 269 1 , 000 0 , 357 - 0 , 213 0 , 452 - 0 , 151 0 , 000 0 , 090 0 , 359 0 , 023 0 , 288 - 0 , 230 0 , 392 0 , 555 0 , 405 0 , 417 0 , 357 1 , 000 - 0 , 002 0 , 217 0 , 317 0 , 475 0 , 082 0 , 114 0 , 452 0 , 635 0 , 278 0 , 116 0 , 442 0 , 688 0 , 434 - 0 , 213 - 0 , 002 1 , 000 0 , 512 0 , 219 0 , 615 0 , 039 0 , 332 0 , 489 0 , 346 0 , 434 0 , 284 0 , 315 0 , 735 0 , 461 0 , 452 0 , 217 0 , 512 1 , 000 0 , 010 - 0 , 012 - 0 , 221 0 , 432 0 , 637 0 , 196 0 , 346 0 , 179 0 , 146 0 , 456 0 , 053 - 0 , 151 0 , 317 0 , 219 0 , 010 1 , 000 - 0 , 221 0 , 520 0 , 461 0 , 361 0 , 141 - 0 , 673 0 , 776 0 , 911 0 , 468 0 , 822 0 , 000 0 , 475 0 , 615 - 0 , 012 - 0 , 221 1 , 000 0 , 586 0 , 481 0 , 215 0 , 825 - 0 , 101 0 , 604 0 , 226 0 , 167 0 , 034 0 , 090 0 , 082 0 , 039 - 0 , 221 0 , 520 0 , 586 1 , 000 0 , 289 0 , 172 0 , 128 0 , 208 0 , 266 0 , 283 0 , 369 0 , 253 0 , 359 0 , 114 0 , 332 0 , 432 0 , 461 0 , 481 0 , 289 1 , 000 0 , 421 0 , 380 0 , 240 0 , 432 0 , 534 0 , 745 0 , 727 0 , 023 0 , 452 0 , 489 0 , 637 0 , 361 0 , 215 0 , 172 0 , 421 1 , 000 0 , 422 - 0 , 422 0 , 485 0 , 782 0 , 460 0 , 714 0 , 288 0 , 635 0 , 346 0 , 196 0 , 141 0 , 825 0 , 128 0 , 380 0 , 422 1 , 000 - 0 , 389 0 , 423 0 , 510 0 , 413 0 , 558 0 , 077 0 , 503 0 , 039 0 , 398 - 0 , 088 0 , 054 - 0 , 175 0 , 002 0 , 409 0 , 359 0 , 256 - 0 , 032 0 , 039 0 , 071 0 , 187 0 , 434 - 0 , 258 0 , 134 0 , 356 - 0 , 409 0 , 032 - 0 , 079 - 0 , 039 - 0 , 096 - 0 , 055 - 0 , 111 - 0 , 038 - 0 , 015 - 0 , 035 0 , 201 - 0 , 689 - 0 , 052 0 , 014 - 0 , 402 0 , 127 - 0 , 096 0 , 264 - 0 , 201 0 , 243 0 , 135 0 , 162 0 , 298 0 , 548 0 , 771 0 , 643 - 0 , 067 0 , 075 0 , 746 0 , 672 0 , 207 0 , 297 0 , 026 0 , 183 0 , 721 0 , 156 Novel approaches to understanding hENT2 and hENT2 - related proteins 298 P Values BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR MYC MMP1 MMP2 TIGAR NRF2 KEAP1 ENT1n OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 CTR1 ENT1 ENT2 ENT3 ENT4 CNT3 AQP1 AQP3 AQP5 ABCA2 ABCA3 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A ATP7B DPYD TYMP UPP1 EPHX1 DCK RRM1 TYMS TK1 UMPS UCK2 FPGS GCLC UGTX TOP1 TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 MSH2 MSH6 GADD45 BAX P21 FAS BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR MYC MMP1 MMP2 TIGAR NRF2 KEAP1 ENT1n ENT2n CNT1n CNT2n CNT3n 0 , 749 0 , 444 0 , 556 0 , 241 0 , 231 1 , 000 0 , 730 0 , 200 0 , 087 0 , 659 1 , 000 0 , 133 0 , 280 0 , 189 0 , 876 0 , 144 0 , 689 0 , 716 0 , 333 0 , 425 0 , 658 0 , 732 0 , 561 0 , 012 0 , 616 0 , 619 0 , 292 0 , 333 0 , 050 0 , 702 0 , 114 0 , 633 0 , 130 0 , 215 0 , 035 0 , 914 0 , 721 0 , 011 0 , 473 0 , 974 1 , 000 0 , 639 0 , 713 0 , 477 0 , 009 0 , 931 0 , 090 0 , 008 0 , 001 0 , 012 0 , 547 0 , 018 0 , 019 0 , 002 0 , 696 0 , 009 0 , 733 0 , 188 0 , 004 0 , 023 0 , 954 0 , 031 0 , 020 0 , 005 0 , 064 0 , 966 0 , 507 0 , 010 0 , 091 0 , 359 0 , 002 0 , 329 0 , 223 0 , 023 0 , 069 0 , 411 0 , 690 0 , 743 0 , 158 0 , 810 0 , 675 0 , 344 0 , 246 0 , 619 0 , 236 1 , 000 0 , 459 0 , 767 0 , 723 0 , 675 0 , 386 0 , 183 0 , 882 0 , 181 0 , 735 0 , 767 0 , 492 0 , 120 0 , 272 0 , 453 1 , 000 0 , 140 0 , 206 0 , 928 0 , 920 0 , 443 0 , 273 0 , 168 0 , 052 0 , 053 0 , 488 0 , 536 0 , 195 0 , 082 0 , 604 0 , 401 0 , 277 0 , 525 0 , 066 0 , 522 0 , 630 0 , 620 0 , 532 0 , 255 0 , 207 0 , 754 0 , 980 0 , 631 0 , 216 0 , 689 0 , 317 0 , 308 0 , 675 0 , 157 0 , 539 0 , 255 0 , 298 0 , 221 0 , 046 0 , 150 0 , 089 0 , 053 0 , 312 0 , 270 0 , 048 0 , 645 0 , 499 0 , 800 0 , 108 0 , 146 0 , 162 0 , 009 0 , 000 0 , 008 0 , 002 0 , 469 0 , 033 0 , 072 0 , 248 0 , 637 0 , 008 0 , 355 0 , 227 0 , 047 0 , 000 0 , 099 0 , 095 0 , 036 0 , 154 0 , 025 0 , 618 0 , 108 0 , 951 0 , 273 0 , 910 0 , 859 0 , 643 0 , 874 0 , 192 0 , 263 0 , 631 0 , 963 0 , 460 0 , 423 0 , 752 0 , 546 0 , 541 0 , 296 1 , 000 0 , 188 0 , 917 0 , 770 0 , 958 0 , 628 0 , 718 0 , 061 0 , 402 0 , 545 0 , 053 0 , 680 0 , 782 0 , 357 0 , 180 0 , 034 0 , 151 0 , 814 0 , 977 0 , 744 0 , 114 0 , 887 0 , 687 0 , 065 0 , 021 0 , 003 0 , 016 0 , 577 0 , 220 0 , 047 0 , 005 0 , 757 0 , 113 0 , 645 0 , 715 0 , 008 0 , 316 0 , 299 0 , 879 0 , 512 0 , 786 0 , 944 0 , 871 0 , 448 0 , 136 0 , 955 0 , 360 1 , 000 0 , 686 0 , 971 0 , 437 0 , 823 0 , 220 0 , 451 0 , 968 0 , 826 0 , 839 0 , 745 0 , 284 0 , 535 0 , 366 0 , 117 0 , 090 0 , 448 0 , 200 0 , 509 0 , 944 0 , 976 0 , 828 0 , 872 0 , 382 0 , 470 0 , 966 0 , 983 0 , 711 0 , 269 0 , 875 0 , 045 0 , 622 0 , 663 0 , 832 0 , 386 0 , 006 0 , 644 0 , 161 0 , 379 0 , 606 0 , 600 0 , 657 0 , 626 0 , 239 0 , 742 0 , 378 0 , 245 0 , 989 0 , 280 0 , 766 0 , 688 0 , 917 0 , 863 0 , 217 0 , 883 0 , 785 0 , 890 0 , 183 0 , 439 0 , 566 0 , 507 0 , 829 0 , 339 0 , 733 0 , 669 0 , 078 0 , 894 0 , 862 0 , 086 0 , 794 0 , 070 0 , 304 0 , 308 0 , 452 0 , 021 1 , 000 0 , 647 0 , 634 0 , 338 0 , 376 0 , 210 0 , 165 0 , 058 0 , 208 0 , 036 0 , 538 0 , 499 0 , 060 0 , 776 0 , 824 0 , 015 0 , 536 0 , 722 0 , 183 0 , 332 0 , 243 0 , 356 0 , 909 0 , 177 0 , 601 0 , 511 0 , 199 0 , 226 0 , 887 0 , 032 0 , 721 0 , 049 0 , 695 0 , 242 0 , 944 0 , 187 0 , 291 0 , 135 0 , 163 0 , 045 0 , 428 0 , 530 0 , 599 0 , 510 0 , 233 0 , 609 0 , 462 0 , 141 0 , 209 0 , 725 0 , 990 0 , 226 0 , 406 0 , 197 0 , 368 0 , 788 0 , 740 0 , 499 0 , 605 0 , 377 0 , 748 0 , 031 0 , 168 0 , 084 0 , 834 0 , 439 0 , 004 0 , 415 0 , 150 0 , 310 0 , 426 0 , 590 0 , 713 0 , 718 0 , 705 0 , 194 0 , 043 0 , 576 0 , 501 0 , 364 0 , 534 0 , 280 0 , 974 0 , 771 0 , 505 0 , 443 0 , 198 0 , 795 0 , 896 0 , 362 1 , 000 0 , 078 0 , 850 0 , 259 0 , 271 0 , 002 0 , 322 0 , 752 0 , 110 0 , 781 0 , 621 0 , 523 0 , 960 0 , 043 0 , 129 0 , 270 0 , 251 0 , 184 0 , 018 0 , 468 0 , 137 0 , 415 0 , 257 0 , 279 0 , 145 0 , 550 0 , 283 0 , 733 0 , 474 0 , 168 0 , 927 0 , 385 0 , 340 0 , 123 0 , 855 0 , 997 0 , 046 0 , 360 0 , 010 0 , 548 0 , 946 0 , 717 0 , 041 0 , 507 0 , 179 0 , 233 0 , 072 0 , 544 0 , 166 0 , 460 0 , 886 0 , 285 0 , 783 0 , 853 0 , 310 0 , 538 0 , 874 0 , 932 0 , 435 0 , 416 0 , 306 0 , 002 0 , 601 0 , 783 0 , 956 0 , 292 0 , 999 0 , 952 0 , 239 0 , 783 0 , 493 0 , 706 0 , 048 0 , 322 0 , 524 0 , 578 0 , 334 0 , 375 0 , 385 0 , 833 0 , 878 0 , 232 0 , 106 0 , 071 0 , 152 0 , 459 0 , 745 0 , 080 0 , 051 0 , 759 0 , 028 0 , 629 0 , 038 0 , 232 0 , 296 0 , 226 0 , 035 0 , 001 0 , 015 0 , 002 0 , 849 0 , 230 0 , 024 0 , 144 0 , 986 0 , 005 0 , 869 0 , 719 0 , 096 0 , 006 0 , 669 0 , 179 0 , 937 0 , 991 0 , 734 0 , 751 0 , 087 0 , 174 0 , 451 0 , 264 0 , 795 0 , 128 0 , 835 0 , 864 0 , 298 0 , 376 0 , 050 0 , 049 0 , 000 0 , 045 0 , 474 0 , 127 0 , 009 0 , 003 0 , 164 0 , 071 0 , 289 0 , 004 0 , 000 0 , 047 0 , 580 0 , 214 0 , 015 0 , 004 0 , 007 0 , 122 0 , 089 0 , 032 0 , 000 0 , 958 0 , 193 0 , 483 0 , 291 0 , 011 0 , 099 0 , 950 0 , 152 0 , 025 0 , 312 0 , 397 0 , 058 0 , 222 0 , 340 0 , 321 0 , 571 0 , 074 0 , 197 0 , 241 0 , 573 0 , 172 0 , 589 0 , 321 0 , 012 0 , 022 0 , 002 0 , 257 0 , 437 0 , 072 0 , 004 0 , 445 0 , 717 0 , 897 0 , 175 0 , 013 0 , 286 0 , 728 0 , 011 0 , 019 0 , 016 0 , 002 0 , 709 0 , 572 0 , 250 0 , 058 0 , 400 0 , 046 0 , 393 0 , 102 0 , 007 0 , 090 0 , 764 0 , 024 0 , 036 0 , 013 0 , 024 0 , 328 0 , 942 0 , 085 0 , 011 0 , 770 0 , 106 0 , 420 0 , 019 0 , 074 0 , 195 0 , 570 0 , 169 0 , 024 0 , 003 0 , 006 0 , 833 0 , 294 0 , 035 0 , 014 0 , 174 0 , 540 0 , 933 0 , 559 0 , 001 0 , 340 0 , 053 0 , 347 0 , 106 0 , 456 0 , 185 0 , 295 0 , 545 0 , 698 0 , 768 0 , 527 0 , 122 0 , 734 0 , 459 0 , 472 0 , 519 0 , 655 0 , 904 0 , 497 0 , 594 0 , 831 0 , 244 0 , 566 0 , 587 0 , 784 0 , 106 0 , 875 0 , 957 0 , 287 0 , 409 0 , 856 0 , 269 0 , 063 0 , 117 0 , 001 0 , 042 0 , 431 0 , 519 0 , 102 0 , 001 0 , 316 0 , 987 0 , 354 0 , 232 0 , 001 0 , 657 0 , 528 0 , 346 0 , 371 0 , 182 0 , 085 0 , 811 0 , 646 0 , 360 0 , 121 0 , 500 0 , 079 0 , 196 0 , 623 0 , 076 0 , 748 0 , 985 0 , 368 0 , 620 0 , 876 0 , 790 1 , 000 0 , 839 0 , 962 0 , 456 0 , 280 1 , 000 0 , 039 0 , 675 0 , 683 0 , 710 0 , 064 0 , 638 0 , 075 0 , 023 0 , 008 1 , 000 0 , 275 0 , 023 0 , 079 0 , 229 1 , 000 0 , 079 0 , 353 0 , 030 0 , 149 0 , 936 0 , 006 0 , 053 0 , 034 0 , 223 0 , 194 0 , 097 0 , 231 0 , 260 0 , 500 0 , 078 0 , 037 0 , 313 0 , 072 0 , 061 0 , 178 0 , 356 0 , 090 0 , 006 0 , 047 0 , 358 0 , 005 0 , 133 0 , 007 0 , 216 0 , 768 0 , 991 0 , 406 0 , 001 0 , 148 0 , 828 0 , 242 0 , 580 0 , 553 0 , 533 0 , 208 0 , 585 0 , 642 0 , 444 0 , 861 0 , 956 0 , 164 0 , 331 0 , 472 0 , 587 0 , 792 0 , 224 0 , 002 0 , 029 0 , 000 0 , 246 0 , 372 0 , 059 0 , 006 0 , 691 0 , 039 0 , 620 0 , 148 0 , 036 0 , 011 0 , 271 0 , 013 0 , 030 0 , 095 0 , 006 0 , 310 0 , 702 0 , 618 0 , 218 0 , 753 0 , 104 0 , 764 0 , 699 0 , 133 0 , 424 0 , 288 0 , 002 0 , 111 0 , 021 0 , 357 0 , 620 0 , 481 0 , 083 0 , 389 0 , 753 0 , 020 0 , 128 0 , 374 0 , 510 0 , 063 0 , 436 0 , 544 0 , 008 0 , 088 0 , 123 0 , 360 0 , 854 0 , 063 0 , 017 0 , 936 0 , 150 0 , 638 0 , 651 0 , 397 0 , 500 0 , 513 0 , 668 0 , 024 0 , 059 0 , 021 0 , 354 0 , 872 0 , 026 0 , 010 0 , 850 0 , 253 0 , 568 0 , 424 0 , 147 0 , 326 0 , 329 0 , 047 0 , 062 0 , 198 0 , 162 0 , 901 0 , 119 0 , 632 0 , 949 0 , 766 0 , 153 0 , 045 0 , 488 0 , 124 0 , 227 0 , 351 0 , 013 0 , 610 0 , 079 0 , 918 0 , 652 0 , 349 0 , 584 0 , 190 0 , 213 0 , 774 0 , 016 0 , 188 0 , 063 0 , 867 0 , 009 0 , 220 0 , 287 0 , 735 0 , 714 0 , 991 0 , 066 0 , 677 0 , 948 0 , 419 0 , 645 0 , 676 0 , 317 0 , 406 0 , 460 0 , 508 0 , 073 0 , 090 0 , 075 0 , 145 0 , 775 0 , 085 0 , 138 0 , 298 0 , 131 0 , 276 0 , 096 0 , 349 0 , 104 0 , 102 0 , 000 0 , 219 0 , 160 0 , 658 0 , 440 0 , 502 0 , 471 0 , 382 0 , 158 0 , 297 0 , 213 0 , 756 0 , 517 0 , 453 0 , 172 0 , 219 0 , 000 0 , 029 0 , 042 0 , 082 0 , 211 0 , 166 0 , 693 0 , 325 0 , 577 0 , 069 0 , 022 0 , 357 0 , 123 0 , 078 0 , 160 0 , 029 0 , 000 0 , 051 0 , 000 0 , 361 0 , 040 0 , 114 0 , 273 0 , 652 0 , 012 0 , 437 0 , 327 0 , 049 0 , 001 0 , 658 0 , 042 0 , 051 0 , 000 0 , 027 0 , 518 0 , 151 0 , 007 0 , 003 0 , 136 0 , 350 0 , 568 0 , 194 0 , 002 0 , 098 0 , 440 0 , 082 0 , 000 0 , 027 0 , 000 0 , 483 0 , 138 0 , 121 0 , 097 0 , 870 0 , 045 0 , 908 0 , 383 0 , 003 0 , 004 0 , 502 0 , 211 0 , 361 0 , 518 0 , 483 0 , 000 0 , 346 0 , 583 0 , 221 0 , 721 1 , 000 0 , 818 0 , 343 0 , 954 0 , 453 0 , 471 0 , 166 0 , 040 0 , 151 0 , 138 0 , 346 0 , 000 0 , 994 0 , 455 0 , 316 0 , 341 0 , 780 0 , 698 0 , 105 0 , 015 0 , 382 0 , 693 0 , 114 0 , 007 0 , 121 0 , 583 0 , 994 0 , 000 0 , 061 0 , 494 0 , 194 0 , 894 0 , 247 0 , 076 0 , 226 0 , 158 0 , 325 0 , 273 0 , 003 0 , 097 0 , 221 0 , 455 0 , 061 0 , 000 0 , 975 0 , 982 0 , 448 0 , 123 0 , 014 0 , 502 0 , 297 0 , 577 0 , 652 0 , 136 0 , 870 0 , 721 0 , 316 0 , 494 0 , 975 0 , 000 0 , 674 0 , 083 0 , 132 0 , 250 0 , 663 0 , 213 0 , 069 0 , 012 0 , 350 0 , 045 1 , 000 0 , 341 0 , 194 0 , 982 0 , 674 0 , 000 0 , 222 0 , 334 0 , 682 0 , 043 0 , 756 0 , 022 0 , 437 0 , 568 0 , 908 0 , 818 0 , 780 0 , 894 0 , 448 0 , 083 0 , 222 0 , 000 0 , 316 0 , 557 0 , 662 0 , 517 0 , 357 0 , 327 0 , 194 0 , 383 0 , 343 0 , 698 0 , 247 0 , 123 0 , 132 0 , 334 0 , 316 0 , 000 0 , 134 0 , 180 0 , 453 0 , 123 0 , 049 0 , 002 0 , 003 0 , 954 0 , 105 0 , 076 0 , 014 0 , 250 0 , 682 0 , 557 0 , 134 0 , 000 0 , 133 0 , 172 0 , 078 0 , 001 0 , 098 0 , 004 0 , 453 0 , 015 0 , 226 0 , 502 0 , 663 0 , 043 0 , 662 0 , 180 0 , 133 0 , 000 0 , 211 0 , 132 0 , 062 0 , 142 0 , 038 0 , 843 0 , 067 0 , 895 0 , 159 0 , 786 0 , 919 0 , 550 0 , 996 0 , 146 0 , 207 0 , 422 0 , 915 0 , 894 0 , 808 0 , 522 0 , 243 0 , 373 0 , 647 0 , 212 0 , 187 0 , 952 0 , 789 0 , 894 0 , 743 0 , 852 0 , 731 0 , 898 0 , 959 0 , 906 0 , 491 0 , 040 0 , 859 0 , 962 0 , 154 0 , 695 0 , 856 0 , 361 0 , 490 0 , 402 0 , 646 0 , 614 0 , 301 0 , 043 0 , 001 0 , 013 0 , 865 0 , 798 0 , 002 0 , 009 0 , 518 0 , 567 0 , 930 0 , 531 0 , 004 0 , 595 Appendix I 299 Correlat . ENT2n CNT1n CNT2n CNT3n OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 CTR1 ENT1 ENT2 ENT3 ENT4 CNT3 AQP1 AQP3 AQP5 ABCA2 ABCA3 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A ATP7B DPYD TYMP UPP1 EPHX1 DCK RRM1 TYMS TK1 UMPS UCK2 FPGS GCLC UGTX TOP1 TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 MSH2 MSH6 GADD45 BAX P21 FAS BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR MYC MMP1 MMP2 TIGAR NRF2 KEAP1 ENT1n ENT2n CNT1n CNT2n CNT3n - 0 , 252 0 , 340 0 , 144 - 0 , 735 0 , 335 - 0 , 271 - 0 , 454 0 , 507 0 , 192 - 0 , 414 - 0 , 132 - 0 , 460 0 , 609 - 0 , 048 - 0 , 223 0 , 651 0 , 332 - 0 , 055 0 , 039 0 , 639 0 , 031 - 0 , 627 - 0 , 473 0 , 405 - 0 , 159 0 , 143 - 0 , 343 0 , 395 0 , 524 - 0 , 304 0 , 001 0 , 705 0 , 437 - 0 , 183 - 0 , 153 0 , 620 0 , 019 0 , 081 - 0 , 027 0 , 281 0 , 425 - 0 , 030 0 , 125 0 , 417 0 , 943 - 0 , 005 - 0 , 023 0 , 426 0 , 247 0 , 249 - 0 , 098 0 , 395 - 0 , 267 0 , 067 0 , 429 - 0 , 533 0 , 724 0 , 063 - 0 , 278 0 , 892 0 , 569 - 0 , 175 0 , 404 - 0 , 178 0 , 422 - 0 , 014 - 0 , 184 - 0 , 002 0 , 406 0 , 024 - 0 , 124 0 , 258 - 0 , 139 - 0 , 312 - 0 , 013 0 , 021 - 0 , 136 - 0 , 088 - 0 , 120 0 , 162 0 , 041 - 0 , 580 - 0 , 100 0 , 254 0 , 117 - 0 , 153 0 , 212 0 , 610 0 , 111 0 , 399 - 0 , 105 - 0 , 180 0 , 581 - 0 , 106 0 , 094 0 , 598 - 0 , 167 - 0 , 033 0 , 293 0 , 403 0 , 072 0 , 155 0 , 252 0 , 194 0 , 359 - 0 , 578 0 , 116 0 , 040 - 0 , 163 0 , 079 - 0 , 026 - 0 , 451 0 , 547 - 0 , 357 0 , 007 0 , 504 - 0 , 165 - 0 , 290 0 , 020 0 , 472 - 0 , 565 - 0 , 033 0 , 129 - 0 , 196 - 0 , 054 - 0 , 179 - 0 , 084 0 , 345 0 , 197 - 0 , 219 - 0 , 579 0 , 541 0 , 531 - 0 , 037 - 0 , 029 0 , 585 - 0 , 265 0 , 098 - 0 , 256 0 , 461 0 , 253 - 0 , 016 - 0 , 071 0 , 613 0 , 477 0 , 310 - 0 , 399 0 , 706 - 0 , 120 0 , 108 - 0 , 479 0 , 228 0 , 479 0 , 385 - 0 , 220 0 , 786 0 , 590 0 , 090 0 , 181 0 , 598 0 , 439 0 , 354 - 0 , 158 0 , 632 0 , 407 - 0 , 079 - 0 , 107 0 , 865 0 , 400 - 0 , 552 0 , 042 0 , 391 - 0 , 245 - 0 , 601 0 , 168 0 , 170 0 , 369 0 , 264 - 0 , 025 0 , 807 0 , 128 0 , 125 0 , 010 0 , 550 0 , 641 - 0 , 255 - 0 , 414 0 , 331 - 0 , 595 - 0 , 159 - 0 , 400 - 0 , 895 - 0 , 051 - 0 , 094 - 0 , 046 0 , 297 0 , 389 0 , 081 - 0 , 072 0 , 545 - 0 , 032 0 , 001 - 0 , 143 - 0 , 019 0 , 453 0 , 436 - 0 , 102 0 , 596 0 , 602 0 , 176 - 0 , 006 0 , 612 0 , 273 0 , 002 - 0 , 053 0 , 281 0 , 275 0 , 446 - 0 , 483 0 , 668 0 , 236 0 , 470 - 0 , 302 0 , 720 0 , 277 - 0 , 032 0 , 485 0 , 314 0 , 156 - 0 , 210 - 0 , 126 0 , 343 0 , 412 - 0 , 682 - 0 , 199 0 , 030 0 , 348 0 , 202 0 , 071 0 , 312 - 0 , 389 0 , 256 - 0 , 111 0 , 162 0 , 423 - 0 , 032 - 0 , 038 0 , 298 0 , 510 0 , 039 - 0 , 015 0 , 548 0 , 413 0 , 071 - 0 , 035 0 , 771 0 , 558 0 , 187 0 , 201 0 , 643 0 , 077 0 , 434 - 0 , 689 - 0 , 067 0 , 503 - 0 , 258 - 0 , 052 0 , 075 0 , 039 0 , 134 0 , 014 0 , 746 0 , 398 0 , 356 - 0 , 402 0 , 672 - 0 , 088 - 0 , 409 0 , 127 0 , 207 0 , 054 0 , 032 - 0 , 096 0 , 297 - 0 , 175 - 0 , 079 0 , 264 0 , 026 0 , 002 - 0 , 039 - 0 , 201 0 , 183 0 , 409 - 0 , 096 0 , 243 0 , 721 0 , 359 - 0 , 055 0 , 135 0 , 156 1 , 000 0 , 069 0 , 030 0 , 380 0 , 069 1 , 000 - 0 , 135 0 , 168 0 , 030 - 0 , 135 1 , 000 - 0 , 006 0 , 380 0 , 168 - 0 , 006 1 , 000 P Values ENT2n CNT1n CNT2n CNT3n OATP1B1 OATP1B3 OATP2B1 OATP4A1 OCT1 OCT2 OCT3 OCTN1 OCTN2 CTR1 ENT1 ENT2 ENT3 ENT4 CNT3 AQP1 AQP3 AQP5 ABCA2 ABCA3 ABCB11 ABCC1 ABCC2 ABCC3 ABCC4 ABCC5 ABCC11 ABCG2 MVP ATP7A ATP7B DPYD TYMP UPP1 EPHX1 DCK RRM1 TYMS TK1 UMPS UCK2 FPGS GCLC UGTX TOP1 TOP2A KIT PDGFRA ERCC1 XPA XPC UDG MLH1 PMS2 MSH2 MSH6 GADD45 BAX P21 FAS BCL2 DIABLO BIRC2 XIAP BIRC5 BIRC7 CFLAR EGFR MYC MMP1 MMP2 TIGAR NRF2 KEAP1 ENT1n ENT2n CNT1n CNT2n CNT3n 0 , 630 0 , 510 0 , 786 0 , 096 0 , 288 0 , 394 0 , 139 0 , 093 0 , 648 0 , 307 0 , 755 0 , 251 0 , 021 0 , 869 0 , 444 0 , 012 0 , 268 0 , 859 0 , 900 0 , 019 0 , 953 0 , 182 0 , 344 0 , 425 0 , 642 0 , 676 0 , 302 0 , 230 0 , 066 0 , 313 0 , 997 0 , 007 0 , 118 0 , 531 0 , 601 0 , 018 0 , 948 0 , 783 0 , 926 0 , 331 0 , 129 0 , 919 0 , 670 0 , 138 0 , 000 0 , 985 0 , 939 0 , 129 0 , 395 0 , 390 0 , 740 0 , 163 0 , 378 0 , 828 0 , 144 0 , 061 0 , 005 0 , 837 0 , 357 0 , 000 0 , 086 0 , 628 0 , 247 0 , 623 0 , 151 0 , 964 0 , 548 0 , 995 0 , 216 0 , 945 0 , 715 0 , 444 0 , 634 0 , 277 0 , 965 0 , 943 0 , 659 0 , 776 0 , 696 0 , 597 0 , 923 0 , 131 0 , 813 0 , 544 0 , 691 0 , 601 0 , 467 0 , 020 0 , 706 0 , 157 0 , 722 0 , 539 0 , 029 0 , 720 0 , 749 0 , 024 0 , 568 0 , 910 0 , 310 0 , 153 0 , 807 0 , 596 0 , 385 0 , 507 0 , 429 0 , 175 0 , 805 0 , 931 0 , 613 0 , 808 0 , 935 0 , 141 0 , 043 0 , 210 0 , 981 0 , 066 0 , 573 0 , 315 0 , 946 0 , 088 0 , 035 0 , 912 0 , 659 0 , 501 0 , 854 0 , 540 0 , 775 0 , 226 0 , 519 0 , 472 0 , 038 0 , 056 0 , 051 0 , 900 0 , 921 0 , 028 0 , 359 0 , 740 0 , 377 0 , 098 0 , 383 0 , 957 0 , 809 0 , 020 0 , 084 0 , 281 0 , 158 0 , 005 0 , 684 0 , 714 0 , 083 0 , 433 0 , 083 0 , 175 0 , 450 0 , 001 0 , 026 0 , 760 0 , 535 0 , 024 0 , 116 0 , 215 0 , 591 0 , 015 0 , 148 0 , 787 0 , 717 0 , 000 0 , 157 0 , 041 0 , 885 0 , 167 0 , 442 0 , 039 0 , 602 0 , 597 0 , 194 0 , 362 0 , 931 0 , 000 0 , 664 0 , 671 0 , 973 0 , 042 0 , 170 0 , 626 0 , 414 0 , 522 0 , 159 0 , 734 0 , 374 0 , 006 0 , 862 0 , 750 0 , 875 0 , 303 0 , 169 0 , 783 0 , 807 0 , 044 0 , 912 0 , 998 0 , 625 0 , 950 0 , 104 0 , 119 0 , 729 0 , 025 0 , 023 0 , 547 0 , 985 0 , 020 0 , 345 0 , 994 0 , 856 0 , 330 0 , 363 0 , 127 0 , 095 0 , 013 0 , 416 0 , 090 0 , 294 0 , 004 0 , 338 0 , 913 0 , 079 0 , 274 0 , 593 0 , 472 0 , 669 0 , 230 0 , 143 0 , 007 0 , 495 0 , 920 0 , 244 0 , 508 0 , 817 0 , 300 0 , 211 0 , 422 0 , 731 0 , 614 0 , 132 0 , 915 0 , 898 0 , 301 0 , 062 0 , 894 0 , 959 0 , 043 0 , 142 0 , 808 0 , 906 0 , 001 0 , 038 0 , 522 0 , 491 0 , 013 0 , 843 0 , 243 0 , 040 0 , 865 0 , 067 0 , 373 0 , 859 0 , 798 0 , 895 0 , 647 0 , 962 0 , 002 0 , 159 0 , 212 0 , 154 0 , 009 0 , 786 0 , 187 0 , 695 0 , 518 0 , 919 0 , 952 0 , 856 0 , 567 0 , 550 0 , 789 0 , 361 0 , 930 0 , 996 0 , 894 0 , 490 0 , 531 0 , 146 0 , 743 0 , 402 0 , 004 0 , 207 0 , 852 0 , 646 0 , 595 0 , 000 0 , 814 0 , 919 0 , 180 0 , 814 0 , 000 0 , 646 0 , 566 0 , 919 0 , 646 0 , 000 0 , 982 0 , 180 0 , 566 0 , 982 0 , 000 Table 25 . Values of Pearson coefﬁcient and statistic P - value in correlations between genes . Novel approaches to understanding hENT2 and hENT2 - related proteins 300 23 RECIPES FOR SOLUTIONS AND BUFFERS - Ampicillin 1000x : Ampicillin 100 mg / ml in ddH 2 0 and autoclaved by 0 . 22 μm ﬁltering . - Biotinylation washing buffer 2 : Tris - HCl 50 mM ( pH 7 . 5 ) , NaCl 500 mM and NP - 40 0 . 001 % buffer . - Biotinylation washing buffer 3 : Tris - HCl 10 mM ( pH 7 . 5 ) - Crude membranes lysis buffer : Tris - HCl 10mM ( pH 7 . 5 ) , EDTA 1 mM , NaCl 0 . 1 mM . - Crude membranes solubilizing buffer : Tris - HCl ( pH 7 . 5 ) 50 mM , EDTA 1 mM , Triton X - 100 1 % and SDS 0 . 5 % . - Dropout mix 10x : Dissolve 400 mg adenine , 200 mg arginine , 200 mg histidine , 300 mg isoleucine , 1 , 000 mg leucine , 300 mg lysine , 1 , 500 mg methionine , 500 mg phenylalanine , 2 , 000 mg threonine , 400 mg tryptophan , 300 mg tyrosine , 200 mg uracil and 1 , 500 mg valine in a total volume of 1 litre ddH 2 O and autoclave . Store at 4 °C for up to 6 months . Remove the components indicated for speciﬁc selection . - Electrophoresis Solution A : see Acrylamide solution in commercial references . - Electrophoresis Solution B : Tris - HCl 1 . 5 M ( pH 8 . 8 ) and SDS 0 . 4 % - Electrophoresis Solution C : Tris - HCl 0 . 5 M ( pH 6 . 8 ) and SDS 0 . 4 % - Kanamycin 1000x : Kanamycin 50 mg / ml in ddH 2 0 and autoclaved by 0 . 22 μm ﬁltering . - LB ( Luria - Broth ) liquid medium : Bacto - tryptone 1 % ( w / v ) , yeast extract 0 . 5 % ( w / v ) and NaCl 1 % ( w / v ) , pH 7 adjusted by adding NaOH . Autoclaving . - LB - agar medium : Bacto - tryptone 1 % ( w / v ) , yeast extract 0 . 5 % ( w / v ) and NaCl 1 % ( w / v ) , pH 7 adjusted by adding NaOH . Agar 1 . 5 % added before autoclaving . - M9 Minimal medium : D - glucose 0 . 5 M , Na 2 HPO 4 ·7H 2 O 0 . 02 M , KH 2 PO 4 0 . 02 M , NaCl 0 . 01 M , NH 4 Cl 0 . 02 M supplemented with CaCl 2 0 . 1 mM , MgSO 4 1 mM , 50 μg / ml kanamycin and 200 μl / l trace metals . - ND96 medium : NaCl 96 mM , KCl 2 mM and Hepes 5 mM supplemented with gentamicin sulphate ( 50 μg / ml ) , penicillin G ( 100 μg / ml ) , pyruvic acid 2mM , theophylline 90 mg , MgCl 2 1mM and CaCl 2 1 . 8 mM - NP - 40 buffer : Tris - HCl 50 mM pH = 8 , NaCl 150 mM , NP - 40 1 % ( v / v ) , Na 4 P 2 O 7 5 mM and NaF 50 mM . - PBS : NaCl 140 mM , KCl 2 . 7 mM , KH 2 PO 4 1 . 5 mM and Na 2 HPO 4 8 . 1 mM . - PBS - Ca / Mg : PBS supplemented with CaCl 2 1mM and MgCl 2 1mM . - Ponceau solution : Acetic acid 5 % ( v / v ) and Ponceau S 0 . 1 % ( w / v ) Appendix II 303 - Protein Loading Buffer 5x ( PLB 5x ) : Tris - HCl 60 mM ( pH 6 . 8 ) , glycerol 25 % , SDS 2 % , β - mercaptoethanol 0 . 05 % and BrPheOH Blue 0 . 1 % - Running buffer 10x : Tris - HCl 25 mM ( pH 8 . 3 ) , glycine 192 mM and SDS 0 . 1 % . - Synthetic Dropout media ( liquid and solid ) : Dissolve 6 . 7 g yeast nitrogen base , 20 g d - glucose and 20 g agar ( omit if preparing liquid medium ) in a total volume of 900 ml ddH 2 O . Add 100 ml of the appropriate 10× Dropout Mix ( if preparing SD - Trp medium , use 10× Dropout Mix prepared without tryptophan ) and autoclave . For solid medium , allow to cool to 55 °C and pour into sterile Petri dishes . Note that if you wish to include 3 - AT in the solid medium , reduce the initial volume of ddH 2 O by the volume of 1 M 3 - AT solution needed to obtain the desired concentration . Add 3 - AT solution after autoclaving , once the medium has cooled to 55 °C . - T300 : Tris - HCL 10 mM , NaCl 0 . 5 M ; pH8 - TBS 10x : Tris - HCl 2 M ( pH 7 . 5 ) NaCl 4 M - TBS - T : TBS 1x and Tween - 20 0 . 1 % - Transfection calcium buffer : 500 mM CaCl 2 and 100 mM BES , pH = 6 . 95 . Sterilized by 0 . 22 μm membrane - ﬁltering . pH is adjusted with NaOH . pH was optimized for HeLa cells transfection , other cell lines might need another pH . - Transfection phosphate buffer : 280 mM NaCl , 0 . 75 mM Na 2 HPO 4 , 0 . 75 mM NaH 2 PO 4 and 50 mM BES . Sterilized by 0 . 22 μm membrane - ﬁltering . - Transfer buffer 1x : Tris base 25 mM , Glycine 192 mM and Methanol 20 % . - Transport Choline buffer : Choline - chloride 137 mM , KCl 5 . 4 mM , CaCl 2 1 . 8 mM , MgSO 4 1 . 2 mM , and Hepes 10 mM . pH adjusted to 7 . 4 with Tris base 1M . - Transport Lysis buffer : Triton - X100 0 . 5 % , NaOH 100 mM . - Transport STOP buffer : NaCl 137 mM and Hepes 10 mM . pH adjusted to 7 . 4 with Tris base 1M . - Yeast transformation buffer : For 110 μl of reaction add 80 μl of PEG - 3350 50 % , 10 μl of LiOAc 1 M , 10 μl of DTT 0 . 1 M and 10 μl of commercial single - stranded DNA 2 mg / ml . - YPAD media ( liquid and solid ) : Dissolve 10 g yeast extract , 20 g peptone , 20 g d - glucose , 40 mg adenine sulphate and 20 g agar ( omit if preparing liquid medium ) in a total volume of 1 litre ddH 2 O and autoclave . For solid medium , allow to cool to 50 °C and pour into sterile Petri dishes . Novel approaches to understanding hENT2 and hENT2 - related proteins 304 24 COMMERCIAL REFERENCES - 3 - AT ( Bioshop - ATT124 ) : 3 - amino - 1 , 2 , 4 - triazole - [ γ - 32 P ] - ATP ( Perkin elmer - BLU002H250UC ) : ATP , [ γ - 32 P ] - 3000Ci / mmol 5mCi / ml - Acrylamide solution ( Bio - rad - 1610148 ) : 40 % Acrylamide / Bis Solution , 37 . 5 : 1 . - Antibiotic - antimycotic 100x ( GIBCO - 15240062 ) : contains penicillin G , streptomycin sulfate and amphotericin B in 0 . 85 % NaCl . - Antibodies : • Anti - ENT2 ( Abcam - ab48595 ) : Rabbit polyclonal . • Anti - FLAG ( Abcam - ab106218 ) : Mouse monoclonal , HRP conjugated . • Anti - HA ( Roche - 11867423001 ) : High afﬁnity , rat monoclonal , clone 3F10 . • Anti - NPC ( Abcam - ab50008 ) : Mouse monoclonal , clone 414 . • Donkey anti - mouse Alexa Fluor® 555 ( Invitrogen - A31570 ) : anti IgG ( H + L ) . • Donkey anti - rat Alexa Fluor® 488 ( Invitrogen - A21208 ) : anti IgG ( H + L ) . • Goat anti - mouse Alexa Fluor® 488 ( Invitrogen - A11001 ) : anti IgG ( H + L ) . • Goat anti - mouse Alexa Fluor @ 456 ( Invitrogen - A11003 ) : IgG ( H + L ) . • Goat anti - mouse HRP ( BioRad - 170 - 6516 ) : anti IgG ( H + L ) , HRP conjugated . • Goat anti - rabbit HRP ( BioRad - 170 - 6516 ) : anti IgG ( H + L ) , HRP conjugated . • Goat anti - rat HRP ( Abcam - ab7097 ) : anti IgG ( H + L ) , HRP conjugated . - BCA protein assay ( Thermo Scientiﬁc - 23227 ) : Pierce BCA protein assay kit . - BigDye® Terminator v3 . 1 Cycle Sequencing Kit ( Applied Biosystems - 4337455 ) - Bradford protein assay ( Bio - Rad - 500 - 0205 ) : Quick Start Bradford 1x dye reagent . - CamKII ( Calbiochem - 208707 ) : Ca 2 + / Calmodulin Kinase II , rat brain . - cDNA library for MYTH screening ( Dual - systems P02234 ) : mouse embryo on day 11 . - CKII ( Calbiochem - 218701 ) : Casein Kinase II , human . - Collagenase Type I ( Sigma - Aldrich - C1639 ) : form Clostridium histolyticum . - Competent cell ( Invitrogen - 18265 - 017 ) : Subcloning Efﬁciency TM DH5α TM . - Cycloheximide ( Sigma - Aldrich - C4859 ) : 100 mg / ml in DMSO , 0 . 2 μm ﬁltered . - DAPI ( Invitrogen - D1306 ) : Nucleic acid stain , excitation / emission : 358 / 461 nm . - DMEM ( GIBCO - 11965 - 118 ) : Dulbeccoʼs Modiﬁed Eagle Medium with high glucose . - DMEM - F12 ( GIBCO - 11320 - 033 ) : Dulbeccoʼs Modiﬁed Eagle Medium : Hamʼs F12 ( 1 : 1 ) . - DNA ladder 1 Kb ( New England Biolabs - N3231 ) Appendix II 305 - DNA ladder 100 bp ( New England Biolabs - N3232 ) - ECL Solution ( Thermo Scientiﬁc - 32106 ) : Pierce ECL Western - Blot substrate . - F12 - K ( GIBCO - 21127 - 022 ) : Kaighnʼs modiﬁcation of Hamʼs F - 12 Nutrient Mixture . - FBS ( GIBCO - 12483 - 020 ) : Fetal Bovine Serum , qualiﬁed . - Films for autoradiography ( Amersham - 28906835 ) : Amersham Hyperﬁlm ECL . - Gel extraction kit ( Qiagen - 28704 ) : DNA extraction from agarose gels . - Gel loading dye 6x ( New England Biolabs - B70216S ) - GlutaMAX TM - 1 100x ( GIBCO - 35050061 ) : 200 mM L - alanyl - L - glutamine dipeptide in 0 . 85 % NaCl . - Histone H1 ( Calbiochem - 382150 ) : Histone H1 from Calf Thymus . - IMDM ( GIBCO - 12440 - 053 ) : Iscoveʼs Modiﬁed Dulbeccoʼs Medium . - IPTG ( Calbiochem - 420322 ) : Isopropyl - β - D - thiogalactopyranoside , dioxane - free . - L - Glutamine 200 mM 100x ( GIBCO - 25030 - 081 ) : supplied at 29 . 2 mg / ml in 0 . 85 % NaCl . - Lipofectamine® 2000 ( Invitrogen - 11668 - 019 ) : solution in membrane - ﬁltered water . - Maxi - prep Kit ( Qiagen - 12163 ) : QIAGEN Plasmid Maxi Kit . - MEM non - essential aminoacids 100x ( GIBCO : 11140 - 050 ) : 10 mM in MEM - alpha medium . - Mini - prep kit ( Sigma - Aldrich - PLN70 ) : GenElute TM Plasmid Mini - prep kit . - Microcon YM - 3 columns ( Millipore - 42403 ) : Ultracel YM - 3 membrane . - MitoTracker® ( Invitrogen - M7510 ) : Orange CMTMRos in methanol . - mMessage mMachine® Kit ( Ambion - AM1344 ) - Mounting medium ( MP Biomedicals - ICN622701 ) : Immuno - ﬂuore 25 ml . - MTT ( Invitrogen : M - 6494 ) : 3 - ( 4 , 5 - Dimethylthiazol - 2 - yl ) - 2 , 5diphenyltetrazolium bromide . - Multiple tissue CDNA panel ( Clontech - 636742 / 636743 ) - Nitrocellulose membrane ( Bio - Rad - 1620090 ) : Supported Nitrocellulose Membrane 0 . 45 micron . - NP - 40 ( Bioshop - NON505 ) : Nonidet P40 - PageBlue TM Protein Staining solution ( Thermo Scientiﬁc - R0571 ) . - PDD ( Sigma - Aldrich - P9018 ) : Phorbol 12 , 13 - didecanoate . - Penicillin - Streptomycin 100x ( GIBCO - 15070 - 063 ) : contains 5000 units of penicillin and 5000 μg of streptomycin per ml . - PfuTurbo® DNA polymerase ( Roche - 600250 ) : High ﬁdelity polymerase . - pGemT® Easy vector ( Promega - A1360 ) Novel approaches to understanding hENT2 and hENT2 - related proteins 306 - PKA ( Calbiochem - 539481 ) : PKA , catalytic subunit from mouse . - PKC ( Calbiochem - 539513 ) : PKC , catalytic subunit from rat brain . - Protease inhibitors cocktail ( Roche - 11836153001 ) : Complete , Mini ; Tablets . - Protein marker ( New England Biolabs - P7709 ) : ColorPlus Prestained Protein Marker . - Reverse transcription kit ( Applied biosystems - 4374966 ) : High Capacity cDNA reverse transcription kit . - RPMI 1640 ( GIBCO - A10491 - 01 ) : Roswell Park Memorial Institute 1640 . - Single - stranded DNA ( Sigma - Aldrich - D7656 ) : ssDNA from salmon testes . - Sodium Pyruvate 100 mM ( GIBCO - 11360 - 070 ) : The ﬁnal concentration used in most cell culture medium is 1 mM . - Streptavidin - agarose beads ( Sigma - Aldrich - s1638 ) : from Streptomyces avidinii . - Sulfo - NHS - LC - Biotin ( Thermo scientiﬁc - 127062 - 22 - 0 ) : EZ - Link Sulfo - NHS - LC - Biotin . - SV Total RNA isolation System ( Promega - Z3100 ) - SYBR® Green PCR Master Mix ( Applied - Biosystems - 4309155 ) - SYBR® Safe ( Invitrogen - S33102 ) : DNA gel stain . - T4 DNA ligase ( New ENgland Biolabs - M0202 ) - Taq DNA polymerase ( New England Biolabs - M0273S ) - TaqMan @ Universal PCR master mix ( Applied - Biosystems - 4324018 ) - TEMED ( Sigma - Aldrich - T9281 ) : N , N , Nʼ , Nʼ - Tetramethylethylenediamine . - TO - PRO @ - 3 Iodide ( Invitrogen - T3605 ) : 1 mM in DMSO , excitation / emission : 642 / 661 nm . - TRITON® X - 100 ( Bioshop - TRX506 ) - Trypsin - EDTA ( GIBCO - 25200 - 072 ) : 0 , 25 % trypsin with EDTA 1mM and phenol red . - WGA ( Invitrogen - W11262 ) : Wheat germ agglutinin Alexa Fluor® 594 conjugated . Appendix II 307 25 EXTERNAL LINKS FROM INTERNET A . GenBank : http : / / www . ncbi . nlm . nih . gov / genbank B . Clone Manager : http : / / www . scied . com C . TMHMM 2 . 0 : http : / / www . cbs . dtu . dk / services / TMHMM D . ORF Finder - NCBI : http : / / www . ncbi . nlm . nih . gov / gorf . html E . NCBI : http : / / www . ncbi . nlm . nih . gov F . BLAST : http : / / blast . ncbi . nlm . nih . gov G . DNA 2 . 0 : http : / / www . dna20 . com H . NetPhosK : http : / / www . cbs . dtu . dk / services / NetPhosK I . R - Project : http : / / www . r - project . org J . CIBERehd Bioinformatics Platform : http : / / bioinfo . ciberehd . org K . ATCC : http : / / www . atcc . org L . DSMZ : http : / / www . dsmz . de M . CCiTUB : http : / / www . ccit . ub . edu Novel approaches to understanding hENT2 and hENT2 - related proteins 308